data_1gpx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gpx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.523 ' OG ' ' CG ' ' A' ' 90' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.332 0.587 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.06 117.21 28.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.655 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 3.5 t -120.69 144.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 7.9 t -128.53 130.22 68.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 121.803 0.811 . . . . 0.0 109.386 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 44.9 m-85 -106.48 137.61 44.16 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.479 0.657 . . . . 0.0 112.263 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.596 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 3.5 t -120.17 127.97 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.713 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 11' ' ' THR . 87.4 p -79.47 154.29 29.0 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.213 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.593 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -67.6 -5.28 14.8 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.262 0.553 . . . . 0.0 109.827 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -93.33 -13.2 28.43 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.146 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 28.19 4.19 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.167 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.527 ' CG2' ' OG ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -109.83 144.42 38.3 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.835 -1.391 . . . . 0.0 108.064 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.529 ' CG ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -123.71 147.65 47.27 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.856 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.594 ' CD ' ' CD1' ' A' ' 32' ' ' ILE . 2.6 ttm-85 -140.04 146.96 39.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.601 -0.687 . . . . 0.0 109.205 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 12.1 mp0 -130.51 117.26 19.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.633 -1.292 . . . . 0.0 110.965 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.689 ' CD2' ' ND2' ' A' ' 30' ' ' ASN . 1.3 mp -115.15 -172.64 2.17 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.215 1.007 . . . . 0.0 111.974 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -115.74 98.53 6.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 41.4 t -98.48 99.89 9.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.61 -165.75 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.734 0.778 . . . . 0.0 111.281 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -72.02 121.9 19.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.684 0.754 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.73 -8.17 29.87 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.399 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 22' ' ' SER . 58.2 t -103.77 166.78 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.461 . . . . 0.0 110.637 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.521 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.92 153.3 37.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' O ' ' CE1' ' A' ' 5' ' ' TYR . 6.5 mt -46.37 -31.39 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.303 . . . . 0.0 109.949 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 1.465 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 11.5 ttt -77.69 -57.89 3.57 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.861 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.517 ' CG ' HG11 ' A' ' 21' ' ' VAL . 6.3 tt0 -37.23 -68.8 0.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.99 -0.444 . . . . 0.0 111.203 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 15' ' ' LEU . . . -44.37 -68.69 0.18 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.65 -1.281 . . . . 0.0 108.429 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB3' HD13 ' A' ' 32' ' ' ILE . . . -47.33 -46.71 25.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.907 0.861 . . . . 0.0 109.638 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 24' ' ' MET . 1.2 t -46.56 -62.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.586 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -48.24 -46.86 35.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.206 1.003 . . . . 0.0 108.674 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.689 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 1.3 m-80 -66.02 -2.38 3.99 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.11 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 82.34 -8.82 60.14 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.602 HD13 ' HB3' ' A' ' 27' ' ' ALA . 1.4 mt -42.51 -33.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -1.021 . . . . 0.0 109.422 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.706 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 61.2 m-85 . . . . . 0 N--CA 1.496 1.843 0 C-N-CA 119.374 -0.93 . . . . 0.0 112.849 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 23.7 p . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.053 0.454 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.14 33.45 2.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.91 31.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' CYS . 43.7 t -140.09 7.98 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.375 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 65.67 56.75 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.316 1.055 . . . . 0.0 110.997 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.543 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -132.28 31.6 4.07 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -110.77 153.13 25.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -111.39 -4.44 14.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.543 -0.723 . . . . 0.0 109.101 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -110.34 -22.77 11.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.325 -0.859 . . . . 0.0 112.551 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.641 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 61.6 m -74.72 7.64 2.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.271 -1.518 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.605 ' CD2' HD22 ' A' ' 71' ' ' LEU . 2.2 t-160 -43.13 120.2 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.014 . . . . 0.0 108.339 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 14.9 m -142.96 164.71 16.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.011 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.728 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 12.5 m-30 -115.05 119.23 35.74 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.588 0.708 . . . . 0.0 110.293 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 97' ' ' ILE . 29.3 t -85.53 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -59.13 131.59 51.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.548 -1.97 . . . . 0.0 109.711 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CA ' HG22 ' A' ' 57' ' ' THR . 11.3 pt-20 -36.69 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.55 -42.39 67.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.454 -1.404 . . . . 0.0 112.172 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.652 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 49.6 m-85 -93.85 -4.56 49.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.748 -1.22 . . . . 0.0 109.956 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.533 HG22 ' CA ' ' A' ' 54' ' ' GLU . 4.5 p -81.06 -24.78 37.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -86.04 -30.24 22.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -0.803 . . . . 0.0 109.966 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . 7.6 mmtt -79.74 -50.04 11.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' A' ' 88' ' ' ILE . 4.5 m -39.73 162.92 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 110.975 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' HG21 ' A' ' 88' ' ' ILE . 38.8 Cg_endo -67.49 166.51 23.57 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.352 1.712 . . . . 0.0 110.957 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 115.18 20.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.822 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.53 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -69.44 146.63 51.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.484 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' O ' HD12 ' A' ' 68' ' ' ILE . 22.7 p30 -99.9 174.0 6.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.95 -1.094 . . . . 0.0 111.458 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 1.7 pp20? -43.31 -29.18 0.39 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.884 -0.51 . . . . 0.0 110.913 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.1 OUTLIER -64.69 -21.46 66.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.013 -1.054 . . . . 0.0 109.774 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' CG ' ' HG3' ' A' ' 83' ' ' ARG . 3.4 tm-20 -95.88 1.96 53.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.513 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -91.78 -61.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 111.297 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -73.24 -48.52 19.04 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.725 ' HE1' HD11 ' A' ' 84' ' ' LEU 0.308 3.3 ttp -48.63 -49.26 38.0 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 123.312 1.53 . . . . 0.0 108.496 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.605 HD22 ' CD2' ' A' ' 49' ' ' HIS 0.298 0.0 OUTLIER -72.35 -33.02 66.97 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.269 -179.547 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 3.2 tt0 -86.15 8.59 20.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.091 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' SG ' ' CB ' ' A' ' 46' ' ' ALA . 34.4 m -49.03 -49.44 41.13 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.66 -1.275 . . . . 0.0 108.216 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 76' ' ' ALA . 13.2 m -90.52 115.88 30.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.574 ' O ' ' CG2' ' A' ' 75' ' ' THR . 13.1 t -48.76 85.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 111.203 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 49' ' ' HIS . . . -117.17 36.38 4.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.931 -1.106 . . . . 0.0 109.977 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.23 52.55 2.15 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.526 0.679 . . . . 0.0 110.192 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -19.79 119.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.553 0.692 . . . . 0.0 112.13 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.588 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -83.46 -168.01 0.17 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.371 -0.831 . . . . 0.0 108.762 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 42.8 Cg_endo -81.07 -27.17 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.584 1.307 . . . . 0.0 109.395 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.512 ' HB2' HG23 ' A' ' 57' ' ' THR . 16.4 p30 -107.73 -5.55 17.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 111.319 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.6 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 21.5 m -48.97 153.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.617 -1.302 . . . . 0.0 110.409 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.665 ' HG2' ' OE1' ' A' ' 87' ' ' GLN . 4.9 mtp180 -175.03 153.28 1.61 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.484 -0.76 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.902 ' O ' ' NE2' ' A' ' 87' ' ' GLN . 11.0 mt -74.6 137.62 42.43 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.641 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 24.3 p -39.58 -22.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.137 -1.602 . . . . 0.0 113.257 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 1.465 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 11.5 m -110.82 43.43 1.43 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.6 -33.26 2.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.217 -1.552 . . . . 0.0 111.731 178.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.617 ' CG1' ' OE1' ' A' ' 87' ' ' GLN . 2.3 mt -85.73 148.37 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.007 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mm -111.43 156.04 12.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.616 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 20.6 tpp -108.37 128.59 54.9 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 120.668 -1.27 . . . . 0.0 111.525 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.491 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -97.13 167.78 11.38 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.56 -0.71 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.743 1.391 . . . . 0.0 111.261 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.6 pp20? -110.32 -40.75 4.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.636 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.616 ' O ' ' CE ' ' A' ' 90' ' ' MET . 1.5 mt -73.65 58.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.28 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.495 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.71 146.52 27.12 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.442 -1.411 . . . . 0.0 112.087 -178.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 105.46 20.14 9.86 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.652 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -73.04 136.56 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 122.365 1.079 . . . . 0.0 111.833 -177.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.514 ' N ' HD13 ' A' ' 97' ' ' ILE . 60.8 t -110.94 122.8 66.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.209 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.596 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 1.5 t -104.27 169.1 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.709 -1.244 . . . . 0.0 109.881 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.3 m-20 -162.06 138.84 8.13 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.73 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 8' ' ' HIS . 4.1 t -90.69 135.34 29.22 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.728 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 33.6 Cg_endo . . . . . 0 C--N 1.304 -1.792 0 O-C-N 123.757 1.398 . . . . 0.0 114.767 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 110.27 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -52.88 122.99 10.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 108.667 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.644 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 42.1 t -138.36 144.98 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 117.889 -1.524 . . . . 0.0 112.24 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 2.9 t -130.7 130.4 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.662 ' HE2' ' CG ' ' A' ' 15' ' ' LEU . 42.6 m-85 -103.33 141.46 35.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.82 0.819 . . . . 0.0 112.436 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 2.4 t -120.34 157.75 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.194 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.555 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.9 152.19 31.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.58 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.38 -13.41 5.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.945 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -96.84 -2.8 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 110.323 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.34 -36.45 4.26 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.154 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.511 HG23 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.5 133.18 20.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.768 -1.431 . . . . 0.0 109.229 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' CG ' HG12 ' A' ' 6' ' ' VAL . 37.4 mtm105 -124.38 162.24 24.26 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.669 0.747 . . . . 0.0 111.288 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' CD ' HG12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -140.17 156.7 46.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.649 -0.657 . . . . 0.0 109.266 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -130.69 127.19 38.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.787 -1.195 . . . . 0.0 110.471 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.662 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 12.6 mt -120.45 150.77 40.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 110.744 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -104.0 92.32 4.34 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.556 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 46.6 t -98.54 167.23 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 111.002 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -116.01 -133.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.449 -0.782 . . . . 0.0 110.738 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.525 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -110.24 123.01 49.0 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.279 -0.888 . . . . 0.0 110.671 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.29 -6.27 30.31 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.481 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 63.2 t -98.18 169.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.868 -1.372 . . . . 0.0 110.742 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.68 159.42 25.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HG ' ' HB ' ' A' ' 88' ' ' ILE . 10.9 mt -50.48 -35.8 30.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 109.616 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 1.187 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -73.33 -59.72 2.58 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.63 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.536 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.5 tt0 -37.85 -69.66 0.11 Allowed 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.763 -0.586 . . . . 0.0 111.691 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.503 ' CB ' HD11 ' A' ' 15' ' ' LEU . . . -47.27 -52.03 17.27 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.303 -1.498 . . . . 0.0 108.863 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.616 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -59.05 -59.51 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.766 0.793 . . . . 0.0 109.527 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.287 1.1 t -29.97 -60.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.584 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.53 -47.51 81.31 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.038 0.923 . . . . 0.0 108.872 179.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.578 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.4 m-80 -59.61 -10.67 3.76 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 81.71 -5.54 69.24 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 38.0 mt -42.92 -30.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.537 -0.978 . . . . 0.0 108.905 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.713 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 57.3 m-85 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.364 -0.835 . . . . 0.0 111.576 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.609 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 25.1 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 111.423 0.156 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.5 31.3 1.59 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.73 35.34 25.48 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.579 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 8.3 t -140.12 -0.8 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -1.128 . . . . 0.0 111.711 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 42' ' ' SER . . . 77.57 57.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.922 0.868 . . . . 0.0 113.336 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -133.55 27.39 4.04 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 5.9 p -111.04 142.28 43.4 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.562 ' CB ' ' HB3' ' A' ' 73' ' ' CYS . . . -110.61 8.97 22.99 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.4 p -111.01 -30.09 7.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.01 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 1.3 m -84.24 32.42 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.966 -1.084 . . . . 0.0 110.631 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.664 ' CE1' ' O ' ' A' ' 71' ' ' LEU . 6.0 t-160 -57.94 134.2 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.602 -1.311 . . . . 0.0 109.673 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 34.6 m -150.12 159.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.775 -1.203 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 30.2 m-85 -122.75 134.66 54.43 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.3 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 88' ' ' ILE . 15.1 t -91.57 156.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.824 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.586 ' O ' ' CG2' ' A' ' 57' ' ' THR . 4.4 p30 -59.23 -157.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.058 -1.651 . . . . 0.0 108.941 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.27 -7.25 23.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 110.309 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.72 -39.68 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 113.05 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.698 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 67.4 m-85 -84.7 1.94 44.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.739 -1.225 . . . . 0.0 111.772 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.586 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 8.3 p -80.56 -54.37 5.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.886 -1.134 . . . . 0.0 109.526 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 57' ' ' THR . 4.9 p-10 -62.29 -12.01 18.34 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.762 0.791 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.285 0.1 OUTLIER -79.67 -55.1 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 123.458 1.599 . . . . 0.0 109.553 180.0 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 61' ' ' PRO 0.321 0.4 OUTLIER -84.6 155.61 62.19 Favored Pre-proline 0 C--N 1.28 -2.43 0 CA-C-N 112.975 -1.92 . . . . 0.0 110.101 -177.552 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 60' ' ' VAL . 36.5 Cg_endo -62.65 159.13 38.3 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.919 1.484 . . . . 0.0 111.858 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.73 -169.99 2.43 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.547 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.582 ' CB ' ' NH2' ' A' ' 83' ' ' ARG . . . -110.11 162.73 14.28 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.763 -0.586 . . . . 0.0 110.918 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.531 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 54.8 p30 -100.33 -156.41 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 111.343 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 6.4 pt-20 -73.73 -28.71 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 110.286 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.6 ttm180 -64.57 -50.76 66.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.293 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 32.9 tt0 -72.53 14.55 0.24 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.856 -0.528 . . . . 0.0 111.903 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -91.65 -46.17 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.385 -1.447 . . . . 0.0 110.2 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -85.32 -60.27 1.84 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.717 ' HE1' HD11 ' A' ' 84' ' ' LEU . 2.8 ptm -48.13 -43.93 31.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.904 -1.351 . . . . 0.0 108.295 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.664 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -62.62 -38.56 90.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.597 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 2.8 tt0 -83.75 29.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.903 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -48.79 -81.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.418 -1.426 . . . . 0.0 107.931 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 76' ' ' ALA . 2.3 m -81.35 129.13 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.25 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.9 t -49.11 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.903 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -104.54 48.41 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 110.202 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.552 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 18.1 pt-20 39.3 60.73 1.47 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.507 -0.746 . . . . 0.0 110.786 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.1 tp -30.28 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.541 . . . . 0.0 111.466 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HD3' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -145.35 -166.56 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.314 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 46.1 Cg_endo -80.76 -32.59 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.334 1.176 . . . . 0.0 110.942 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.524 ' CB ' HG23 ' A' ' 57' ' ' THR . 39.7 p-10 -102.52 4.38 38.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 111.429 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -62.96 135.61 57.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.93 -1.106 . . . . 0.0 109.827 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.607 ' HG3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.07 169.28 23.9 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 118.455 -1.298 . . . . 0.0 110.759 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.717 HD11 ' HE1' ' A' ' 70' ' ' MET . 1.4 mt -90.81 148.35 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.9 m -46.8 -27.53 1.25 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.677 -1.265 . . . . 0.0 110.526 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 1.187 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 3.9 m -102.38 40.31 1.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.287 -0.883 . . . . 0.0 111.511 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.646 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.9 mm100 -126.25 -41.54 1.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 112.187 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.607 ' CD1' ' HG3' ' A' ' 83' ' ' ARG . 3.3 mm -79.39 147.71 6.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.2 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mm -112.31 151.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.535 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -110.46 111.72 23.16 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.482 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -100.65 170.86 6.08 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 42.3 Cg_endo -73.37 -5.21 16.75 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.824 1.434 . . . . 0.0 110.634 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.31 -29.54 8.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.117 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.512 ' O ' ' CE ' ' A' ' 90' ' ' MET . 7.3 mt -97.0 54.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 109.872 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.528 ' HB3' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.39 148.41 25.19 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.278 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.649 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.25 23.32 9.12 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.698 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.03 117.94 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.405 1.098 . . . . 0.0 113.324 -176.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 9.5 t -82.55 124.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.826 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.529 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 1.9 t -104.31 -179.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.673 -1.267 . . . . 0.0 109.547 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.542 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 9.5 m-20 -161.82 142.47 10.64 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.521 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.58 HG13 ' CE1' ' A' ' 8' ' ' HIS . 50.6 t -92.06 148.01 35.94 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.621 ' HG3' ' CG ' ' A' ' 49' ' ' HIS . 39.6 Cg_endo . . . . . 0 C--N 1.301 -1.938 0 O-C-N 123.521 1.274 . . . . 0.0 112.611 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.531 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.287 0.565 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -81.08 115.69 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.855 . . . . 0.0 109.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.614 HG13 ' CE2' ' A' ' 5' ' ' TYR . 3.8 t -109.85 137.37 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.913 -1.117 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 3.5 t -131.98 128.63 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.2 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 71.1 m-85 -104.75 146.98 28.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.571 0.7 . . . . 0.0 112.385 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 5.2 t -121.24 133.55 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.185 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 62.8 p -79.56 -152.56 0.07 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.49 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -110.06 -10.6 14.68 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.059 -1.025 . . . . 0.0 108.677 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.472 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 17.6 p-10 -100.55 3.66 42.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.357 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.57 -39.24 2.97 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.491 HG21 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.8 138.13 15.24 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.866 -1.373 . . . . 0.0 109.974 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 54.4 mtt180 -130.25 164.24 24.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.387 0.613 . . . . 0.0 111.215 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -128.2 161.04 30.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.316 -0.865 . . . . 0.0 109.09 179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 1.1 mp0 -131.11 139.64 49.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.7 -1.25 . . . . 0.0 110.856 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.577 ' CD2' ' ND2' ' A' ' 30' ' ' ASN . 10.8 mt -128.08 144.89 51.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.902 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.87 84.08 2.09 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 18.0 t -98.63 172.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.661 0.743 . . . . 0.0 111.526 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.541 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -123.43 -159.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.809 0.814 . . . . 0.0 111.537 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -87.26 125.56 34.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.312 -179.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.01 -5.13 30.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.831 HG11 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -102.3 172.1 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 122.442 1.115 . . . . 0.0 110.338 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.619 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -118.47 -169.72 1.76 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 18.0 mt -87.99 -14.07 40.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.832 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.65 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 2.3 ttp -90.9 -65.86 0.98 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.802 -1.186 . . . . 0.0 112.327 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.831 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.32 -26.42 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 111.44 -178.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -92.35 -34.83 14.03 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.642 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -77.28 -41.84 39.29 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.017 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.531 ' CG2' ' HE2' ' A' ' 24' ' ' MET . 62.8 t -55.17 -60.42 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.861 -1.15 . . . . 0.0 108.413 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -51.39 -38.31 52.76 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.577 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 2.8 m-80 -70.48 1.64 4.86 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 84.34 -15.63 38.93 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 1.2 mt -41.55 -42.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.323 -1.104 . . . . 0.0 108.122 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CE1' ' HA ' ' A' ' 24' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.549 -0.719 . . . . 0.0 109.778 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.66 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.9 p . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 120.853 0.359 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.53 36.64 4.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.16 28.44 49.29 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.9 m -124.71 -13.67 6.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -1.105 . . . . 0.0 110.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.614 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 75.51 55.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.797 0.808 . . . . 0.0 112.689 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.14 37.12 3.59 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 1.3 p -111.23 157.12 20.47 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -111.89 -10.24 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.016 . . . . 0.0 110.925 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.3 t -110.56 -19.01 13.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.857 -1.152 . . . . 0.0 113.257 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 1.8 m -80.36 20.31 0.7 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.316 -1.49 . . . . 0.0 110.994 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.611 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.7 t-160 -48.23 139.86 8.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.56 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 14.2 m -143.97 156.17 15.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.627 -1.296 . . . . 0.0 109.81 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.658 ' CD2' ' HB3' ' A' ' 102' ' ' PRO . 2.9 m-30 -119.8 119.02 32.36 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.998 0.904 . . . . 0.0 109.367 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 21.4 t -100.8 152.0 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 111.009 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' OD1' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -74.29 130.92 40.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.398 -1.439 . . . . 0.0 109.324 178.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.523 ' CA ' HG22 ' A' ' 57' ' ' THR . 0.5 OUTLIER -36.79 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.505 -0.747 . . . . 0.0 111.519 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.09 -19.82 63.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.03 -1.043 . . . . 0.0 111.273 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.687 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 43.7 m-85 -127.66 -11.36 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.881 -1.137 . . . . 0.0 110.572 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.53 ' CB ' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -81.14 -17.86 48.4 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.191 -0.943 . . . . 0.0 108.975 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.2 p-10 -89.68 -30.83 17.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 3.5 mmmm -82.81 12.01 5.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.833 . . . . 0.0 110.259 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -116.78 155.45 49.03 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.4 Cg_endo -62.94 156.76 52.36 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.084 1.57 . . . . 0.0 111.859 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.14 128.09 33.37 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.754 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.541 ' CB ' ' CD ' ' A' ' 67' ' ' GLU . . . -69.38 156.24 39.13 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.551 -0.718 . . . . 0.0 110.064 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.48 ' O ' HD11 ' A' ' 68' ' ' ILE . 27.5 p30 -100.57 -172.34 2.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 111.648 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.56 -21.49 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 110.711 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.3 ttm180 -64.12 -59.07 4.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.003 -1.061 . . . . 0.0 109.253 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.589 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 20.1 tt0 -65.55 10.71 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.656 . . . . 0.0 112.436 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.529 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -91.18 -40.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 119.453 -2.029 . . . . 0.0 110.952 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.18 -57.95 1.62 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.631 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 6.1 ptm -48.14 -43.05 30.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.222 -1.164 . . . . 0.0 109.173 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 67' ' ' GLU 0.281 0.0 OUTLIER -70.29 -33.2 71.27 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.935 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 4.4 tt0 -90.78 3.53 54.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.23 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 46' ' ' ALA . 1.6 m -49.11 -54.73 14.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.665 -1.272 . . . . 0.0 109.457 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 74' ' ' VAL . 34.8 m -90.04 105.72 16.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.9 t -48.53 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.384 -0.823 . . . . 0.0 110.888 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.2 50.9 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.67 60.45 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 110.309 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' A' ' 77' ' ' GLU . 2.3 tp -29.87 144.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 111.787 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 14.5 mtmt -120.6 170.76 6.65 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.747 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.6 Cg_endo -69.48 -30.7 23.16 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.649 1.341 . . . . 0.0 109.926 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.53 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 8.3 p-10 -97.35 -6.39 34.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.562 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 13.1 m -49.12 165.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.767 -1.208 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.531 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.27 167.45 3.39 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.638 -0.664 . . . . 0.0 109.48 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.631 ' CD1' ' CE ' ' A' ' 70' ' ' MET . 0.8 OUTLIER -95.7 141.4 29.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.589 ' CB ' ' HG3' ' A' ' 24' ' ' MET . 4.7 m -41.67 -27.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 110.462 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 84' ' ' LEU . 2.0 m -108.32 43.78 1.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.589 -0.694 . . . . 0.0 111.034 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.658 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 3.2 mm-40 -126.08 -33.83 2.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 111.845 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -92.03 149.97 3.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 110.267 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 5.2 mm -110.34 156.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 1.1 tpt -110.02 113.54 26.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 0.0 110.792 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.452 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -106.51 171.44 4.75 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -72.85 -1.62 10.71 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.908 1.478 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 4.7 pt-20 -110.19 -30.66 7.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 59' ' ' LYS . 7.3 mt -94.14 52.94 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.949 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 4.5 p-10 -100.48 145.66 28.0 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.017 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.32 22.0 10.22 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.687 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -70.9 130.05 34.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.994 0.902 . . . . 0.0 113.162 -176.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.536 ' CG2' ' OD1' ' A' ' 53' ' ' ASN . 11.0 t -103.75 122.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.655 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -103.98 -174.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 51' ' ' TYR . 7.2 m-20 -161.7 139.79 9.17 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.065 176.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 9.6 t -98.13 103.02 15.6 Favored Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.0 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.658 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 41.8 Cg_endo . . . . . 0 C--N 1.309 -1.53 0 C-N-CA 122.155 1.904 . . . . 0.0 112.772 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.542 ' HA ' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.317 0.58 . . . . 0.0 110.475 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -88.86 134.46 33.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.852 . . . . 0.0 109.928 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.607 HG13 ' CE2' ' A' ' 5' ' ' TYR . 14.0 t -122.61 147.43 26.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.883 -1.136 . . . . 0.0 111.155 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.585 ' CG2' ' CG ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -131.18 130.86 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.652 ' CE1' ' HB3' ' A' ' 23' ' ' LEU . 83.4 m-85 -111.46 123.73 50.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.462 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 99' ' ' VAL . 2.3 t -92.27 151.86 3.51 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.84 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.532 ' OG ' ' CB ' ' A' ' 11' ' ' THR . 17.1 p -113.53 141.36 47.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.981 -1.074 . . . . 0.0 109.403 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' SER . 1.0 OUTLIER -41.81 -23.88 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.607 -0.683 . . . . 0.0 110.723 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.2 p-10 -93.44 -1.22 55.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.878 -1.139 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.36 -32.05 6.93 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.949 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.532 ' CB ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.62 141.35 9.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.874 -1.368 . . . . 0.0 109.476 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.7 mtm180 -127.45 124.93 39.6 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.791 -0.568 . . . . 0.0 111.042 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -102.34 157.6 16.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' CG ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -130.58 135.31 47.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.989 -1.069 . . . . 0.0 110.804 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 7.3 mt -124.55 142.0 51.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 111.035 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -99.92 82.38 2.57 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.588 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 40.5 t -98.17 169.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.575 -0.703 . . . . 0.0 110.413 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.491 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -126.09 -149.95 0.43 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.521 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -90.85 122.65 33.74 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.617 0.722 . . . . 0.0 110.498 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -8.57 30.89 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 22' ' ' SER . 18.5 t -96.57 170.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.0 -1.294 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.572 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 166.51 13.91 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.652 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 4.8 mt -69.98 -5.34 25.69 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.083 -1.847 . . . . 0.0 108.332 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.587 ' HG3' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -84.22 -72.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.587 ' N ' ' HG3' ' A' ' 24' ' ' MET . 0.0 OUTLIER -42.87 -57.7 2.7 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 121.783 -0.573 . . . . 0.0 112.242 -176.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.588 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -57.95 -57.78 11.29 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.57 -1.956 . . . . 0.0 108.386 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.591 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -51.48 -57.96 7.6 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.516 0.674 . . . . 0.0 109.97 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 24' ' ' MET . 13.4 t -39.79 -71.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.302 0.572 . . . . 0.0 109.627 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -48.71 -46.41 40.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -0.835 . . . . 0.0 109.387 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.534 ' ND2' HD23 ' A' ' 15' ' ' LEU . 4.2 m-80 -59.67 -8.57 2.09 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.92 -5.96 76.86 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CG2' ' CE1' ' A' ' 33' ' ' TYR . 2.9 mt -44.68 -35.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.636 ' CE1' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.6 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 120.981 0.419 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.54 47.54 7.19 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.36 59.38 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 8.0 t -116.93 -36.74 3.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -1.078 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 72.04 60.68 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 111.331 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' C ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -131.3 14.01 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.237 -0.914 . . . . 0.0 110.438 178.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.621 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.94 124.28 52.26 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.586 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -79.14 4.55 14.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.689 -1.257 . . . . 0.0 109.885 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.6 p -91.38 -22.83 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.702 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.593 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -95.53 13.63 25.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.049 -1.032 . . . . 0.0 110.029 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.586 ' CE1' HD22 ' A' ' 71' ' ' LEU . 22.3 t-160 -50.51 137.33 19.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.505 -1.372 . . . . 0.0 108.733 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -142.67 158.93 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.635 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 3.5 m-30 -117.71 109.98 17.29 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.624 0.726 . . . . 0.0 109.694 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 99' ' ' VAL . 10.7 t -85.61 162.27 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' O ' ' CG2' ' A' ' 57' ' ' THR . 10.1 p30 -82.92 139.0 33.64 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 119.947 -1.72 . . . . 0.0 109.273 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 53' ' ' ASN . 5.1 pt-20 -41.68 -21.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.995 -1.065 . . . . 0.0 111.503 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.526 ' CB ' ' OD1' ' A' ' 53' ' ' ASN . . . -72.93 -53.02 12.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.756 -1.215 . . . . 0.0 111.637 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.656 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 48.3 m-85 -85.03 -4.75 59.27 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.841 -1.162 . . . . 0.0 111.072 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.56 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 10.2 p -80.28 -51.24 9.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.873 -1.142 . . . . 0.0 109.501 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD2' ' CE ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.05 -12.03 16.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' CB ' HD11 ' A' ' 94' ' ' LEU 0.284 8.8 mmpt? -79.29 -52.42 8.14 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.876 1.798 . . . . 0.0 108.208 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' CG1' ' CG2' ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -84.75 144.59 42.54 Favored Pre-proline 0 C--N 1.279 -2.458 0 CA-C-N 112.201 -2.272 . . . . 0.0 110.435 -177.494 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.7 Cg_endo -62.53 162.97 22.45 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.934 1.492 . . . . 0.0 112.145 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -168.64 1.84 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.352 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -110.9 171.52 7.42 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.379 0.609 . . . . 0.0 111.056 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.481 ' O ' HD11 ' A' ' 68' ' ' ILE . 48.1 p-10 -100.81 -153.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.605 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -71.67 -18.52 62.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 110.217 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -64.51 -52.16 59.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 109.241 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.631 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -63.55 0.09 0.82 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.865 -0.522 . . . . 0.0 111.33 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.552 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.1 mp -91.16 -18.78 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 119.79 -1.819 . . . . 0.0 111.359 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.52 -79.58 1.37 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 120.753 -1.217 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.668 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.58 -32.16 7.68 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.169 -1.195 . . . . 0.0 110.134 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.631 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -68.64 -30.63 69.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.251 -0.905 . . . . 0.0 108.783 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -85.07 -29.51 24.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 109.691 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.586 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -49.29 -44.26 43.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 109.491 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 13.4 m -90.17 70.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.531 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.2 t -48.92 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 0.0 111.11 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -118.12 66.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.02 -1.05 . . . . 0.0 109.529 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 1.7 pm0 39.88 49.08 2.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.814 0.816 . . . . 0.0 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.496 HD13 ' CD2' ' A' ' 71' ' ' LEU . 2.4 tp -23.46 142.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.363 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.03 170.48 5.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.755 . . . . 0.0 108.978 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.3 Cg_endo -69.2 -29.39 26.59 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.649 1.341 . . . . 0.0 109.481 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.521 ' HB2' HG23 ' A' ' 57' ' ' THR . 23.0 p-10 -99.58 -7.98 25.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.657 -0.652 . . . . 0.0 110.522 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.635 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 67.0 m -48.98 153.58 0.86 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.089 -1.007 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -175.45 161.67 2.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.898 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.668 ' CD1' ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -78.38 140.22 38.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 179.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.518 ' C ' ' HB2' ' A' ' 24' ' ' MET . 47.4 m -42.27 -28.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.542 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -92.53 35.6 1.02 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.636 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.9 tp-100 -126.49 -41.93 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.465 -1.397 . . . . 0.0 112.374 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 1.3 mt -94.65 154.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-O 122.099 0.952 . . . . 0.0 111.583 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 90' ' ' MET . 5.2 mm -110.88 160.85 9.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 21' ' ' VAL . 3.4 tpt -110.17 113.62 26.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 110.083 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.5 OUTLIER -92.92 166.12 17.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.5 Cg_endo -73.02 -25.46 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.502 . . . . 0.0 110.538 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.451 ' C ' HD21 ' A' ' 94' ' ' LEU . 1.4 pm0 -91.32 -26.76 18.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.813 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' A' ' 59' ' ' LYS . 7.3 mt -94.9 51.0 1.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.058 0.932 . . . . 0.0 109.417 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.542 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 4.6 p-10 -100.49 152.53 20.28 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.677 0.751 . . . . 0.0 112.203 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.64 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 97.06 28.1 8.93 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.656 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 9.8 tt -74.2 155.02 6.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 123.259 1.504 . . . . 0.0 113.533 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.524 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 6.4 t -120.79 91.55 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.362 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.603 HG12 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -104.66 171.35 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.644 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -145.69 172.79 12.76 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.32 1.057 . . . . 0.0 112.083 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 6' ' ' VAL . 13.1 t -105.69 111.94 64.62 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 42.8 Cg_endo . . . . . 0 C--N 1.303 -1.83 0 O-C-N 123.906 1.477 . . . . 0.0 111.754 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.544 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.502 0.667 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.494 ' CB ' ' HA2' ' A' ' 96' ' ' GLY . 0.8 OUTLIER -82.96 109.64 17.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.728 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 2.5 t -109.5 134.54 51.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.921 -1.112 . . . . 0.0 110.634 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.676 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 93.4 t -124.11 107.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.259 1.028 . . . . 0.0 111.807 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.728 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 22.6 m-30 -83.46 130.26 35.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.583 ' O ' ' N ' ' A' ' 101' ' ' VAL . 3.4 t -120.18 134.07 64.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.393 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.545 ' HB3' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -79.58 -167.28 1.17 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 108.51 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.508 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -97.94 -9.95 25.35 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.952 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.433 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.3 p30 -100.43 -6.68 25.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 19.48 8.07 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.541 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.545 ' CG2' ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -87.88 153.72 21.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.844 -1.386 . . . . 0.0 107.754 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 mtm180 -130.13 139.32 50.92 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.229 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.701 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.36 67.87 1.36 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.7 0.762 . . . . 0.0 108.991 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.676 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.6 mt-10 -67.96 140.21 56.41 Favored 'General case' 0 C--N 1.288 -2.065 0 O-C-N 120.767 -1.208 . . . . 0.0 110.896 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 8.0 mt -110.99 147.1 35.45 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.646 -0.659 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.59 86.43 3.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.578 HG13 HG13 ' A' ' 21' ' ' VAL . 25.3 t -98.88 172.32 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.697 0.761 . . . . 0.0 111.833 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.541 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -112.57 -144.78 0.39 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.603 0.716 . . . . 0.0 111.525 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -104.07 124.69 49.5 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.46 0.648 . . . . 0.0 110.346 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.3 3.19 38.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.825 HG11 ' NE2' ' A' ' 25' ' ' GLN . 2.5 t -107.65 172.36 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.613 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.65 179.85 4.21 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.876 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.48 ' CD2' ' SD ' ' A' ' 90' ' ' MET . 14.5 mt -79.06 -6.84 57.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.637 -1.289 . . . . 0.0 109.085 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.628 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.73 -76.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.904 0.859 . . . . 0.0 111.597 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.825 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.78 -24.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.075 -177.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -91.75 -33.18 15.12 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.631 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -77.48 -51.35 10.9 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.065 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.587 ' CG2' ' CE ' ' A' ' 24' ' ' MET . 96.5 t -45.04 -57.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -58.24 -37.72 75.47 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.026 0.917 . . . . 0.0 108.688 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 1.1 m-80 -68.92 1.81 3.12 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.279 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 85.78 -14.42 52.27 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 1.3 mt -44.76 -54.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -1.196 . . . . 0.0 107.826 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.607 ' CE1' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.504 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.257 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.6 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.8 p . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.21 32.61 3.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.769 -2.133 . . . . 0.0 107.769 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.53 35.15 26.64 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 48.2 m -137.98 0.63 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -1.153 . . . . 0.0 111.473 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 71.82 57.4 0.17 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 112.416 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.43 ' C ' ' HG2' ' A' ' 70' ' ' MET . 3.8 t -133.01 32.11 3.8 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.734 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.6 p -111.87 131.59 55.26 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -91.77 5.4 49.99 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.063 -1.648 . . . . 0.0 109.109 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 48' ' ' CYS . 5.9 t -110.55 -40.47 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.221 -0.924 . . . . 0.0 111.897 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.603 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.0 m -74.87 10.61 1.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.495 -1.378 . . . . 0.0 110.976 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.611 ' N ' HD22 ' A' ' 84' ' ' LEU . 18.1 t-160 -45.88 138.83 4.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.355 -1.466 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.532 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 17.7 m -140.94 160.38 23.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.037 -1.039 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.655 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 10.1 m-30 -119.28 122.19 41.34 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.545 0.688 . . . . 0.0 109.398 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 88' ' ' ILE . 41.2 t -96.31 169.66 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.339 -0.85 . . . . 0.0 110.079 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CG2' ' A' ' 57' ' ' THR . 11.9 p30 -86.45 137.41 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.648 -1.283 . . . . 0.0 108.854 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.0 pt-20 -40.3 -22.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.996 -1.065 . . . . 0.0 111.748 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.09 -53.87 11.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.81 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.733 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 55.5 m-85 -84.89 -4.78 59.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 0.0 111.286 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 6.5 p -80.35 -52.32 7.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 109.99 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -63.79 -9.32 13.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.412 -0.805 . . . . 0.0 110.178 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.566 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.299 1.9 mmtp -79.29 -53.23 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.796 1.76 . . . . 0.0 109.086 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.562 ' CG2' ' HD2' ' A' ' 61' ' ' PRO 0.336 0.3 OUTLIER -79.28 161.13 68.9 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 112.372 -2.195 . . . . 0.0 110.146 -177.56 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 36.1 Cg_endo -60.63 163.64 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.774 1.407 . . . . 0.0 112.638 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.51 -148.23 0.06 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.831 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.558 ' CB ' ' OE2' ' A' ' 67' ' ' GLU . . . -110.09 144.37 38.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.473 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 49.8 p30 -100.43 -153.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.535 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.433 ' OE2' ' HB2' ' A' ' 66' ' ' ARG . 1.2 pm0 -80.39 -27.37 38.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 110.065 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -75.21 -50.0 17.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.616 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 30.9 tt0 -63.84 -5.31 4.14 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.49 -0.756 . . . . 0.0 110.996 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.533 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -90.63 -13.47 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.28 -1.512 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -88.84 -80.32 1.3 Allowed Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.256 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.667 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.23 -34.77 10.74 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.977 -1.308 . . . . 0.0 109.528 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -70.29 -18.02 63.11 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.791 0.805 . . . . 0.0 109.269 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -90.95 -53.09 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.105 -0.997 . . . . 0.0 109.654 178.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.41 -24.08 1.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.807 . . . . 0.0 109.248 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 76' ' ' ALA . 34.5 m -79.74 57.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.299 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.517 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.0 t -48.97 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.0 112.534 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.52 63.37 1.57 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.798 -1.189 . . . . 0.0 108.938 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.55 58.17 2.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.732 0.777 . . . . 0.0 109.413 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.497 HD13 HD21 ' A' ' 71' ' ' LEU . 2.5 tp -30.64 138.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.523 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 51' ' ' TYR . 5.4 mmmt -93.03 168.69 11.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 109.067 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.57 -25.44 40.89 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.71 1.374 . . . . 0.0 109.155 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.531 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 3.3 p30 -113.06 5.46 17.16 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.67 -0.644 . . . . 0.0 111.652 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.595 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 72.7 m -48.52 144.32 4.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.546 -1.346 . . . . 0.0 111.292 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.586 ' CD ' ' OE2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -154.93 160.0 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -85.02 142.61 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 110.132 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.603 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 2.4 p -44.66 -25.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.3 m -108.65 40.71 1.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.444 0.64 . . . . 0.0 110.012 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.55 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 7.3 tp-100 -122.22 -48.47 2.09 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.491 -0.756 . . . . 0.0 111.965 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.535 ' CG2' HG23 ' A' ' 60' ' ' VAL . 1.2 mt -87.46 153.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 121.944 0.878 . . . . 0.0 111.104 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mm -111.26 156.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.544 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -110.5 92.49 4.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.099 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.473 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.72 171.73 11.69 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -78.86 -0.77 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.863 1.454 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.53 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 2.6 pt-20 -110.08 -31.22 7.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 109.403 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.53 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.3 mt -98.16 51.72 1.03 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.975 0.893 . . . . 0.0 108.791 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 8.0 p-10 -100.48 147.05 26.32 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 121.976 0.893 . . . . 0.0 113.189 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.647 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.57 28.1 7.69 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.733 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.9 125.52 38.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 8.6 t -82.49 120.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.754 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -104.55 -175.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.639 -1.288 . . . . 0.0 110.039 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 51' ' ' TYR . 13.9 m-20 -161.4 136.19 7.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.253 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 6' ' ' VAL . 2.6 t -95.71 115.7 65.7 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.626 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo . . . . . 0 C--N 1.304 -1.775 0 C-N-CA 121.894 1.729 . . . . 0.0 112.486 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.561 0.696 . . . . 0.0 110.494 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.472 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 5.9 ttmt -85.25 113.34 21.52 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.571 HG12 ' CZ ' ' A' ' 5' ' ' TYR . 5.0 t -109.16 137.05 43.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 2.2 t -131.21 125.38 57.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.992 0.901 . . . . 0.0 108.667 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.709 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.273 52.1 m-85 -105.08 140.21 38.6 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 -177.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 3.4 t -121.49 157.06 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.455 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.586 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 78.3 p -116.41 140.56 49.22 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.57 ' CE1' HG13 ' A' ' 101' ' ' VAL . 1.6 p-80 -48.0 -20.75 0.36 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.067 -1.02 . . . . 0.0 109.687 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.448 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 1.8 p30 -89.9 -3.89 57.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 -35.98 4.52 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.896 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.547 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.28 132.58 19.97 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.788 -1.419 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -130.32 153.05 49.06 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.709 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.83 163.45 27.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.916 . . . . 0.0 109.006 177.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 32.8 mt-10 -130.64 120.87 24.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.614 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 7.4 mt -109.72 145.45 36.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.872 -1.142 . . . . 0.0 112.123 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.7 92.09 5.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 HG11 ' CG1' ' A' ' 21' ' ' VAL . 96.2 t -98.77 170.75 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 112.029 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.456 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -119.67 -151.65 0.49 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.424 0.63 . . . . 0.0 110.623 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.19 121.2 42.18 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.381 -0.824 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 5.95 28.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.822 HG11 ' NE2' ' A' ' 25' ' ' GLN . 1.4 t -110.04 174.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.593 ' N ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.07 -177.25 3.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.19 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.506 HD11 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.84 -13.31 59.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 109.269 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.678 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -90.13 -73.58 0.52 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.822 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -36.75 -24.8 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 122.048 -0.408 . . . . 0.0 111.64 -177.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.623 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -91.11 -46.37 8.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.606 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -61.81 -54.27 44.48 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.283 0.8 OUTLIER -36.38 -60.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.66 177.607 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.583 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -65.14 -42.48 93.79 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.134 0.968 . . . . 0.0 109.148 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.558 ' ND2' HD23 ' A' ' 15' ' ' LEU . 4.8 m-80 -63.85 -3.27 2.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.97 -20.58 24.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.566 HD12 ' CD2' ' A' ' 5' ' ' TYR . 10.3 mt -42.06 -39.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.445 -1.033 . . . . 0.0 109.281 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.62 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 25.5 m-85 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.149 -0.969 . . . . 0.0 113.036 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.61 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.6 p . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 121.18 0.514 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.75 34.62 5.46 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.18 30.05 43.36 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 1.1 t -128.56 -6.79 5.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.137 . . . . 0.0 111.057 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.674 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 73.25 57.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.433 -0.792 . . . . 0.0 112.913 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -133.58 36.98 3.33 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.581 -1.636 . . . . 0.0 106.581 176.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.725 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -111.6 150.06 30.6 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -175.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.37 2.07 18.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.518 -1.364 . . . . 0.0 109.076 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -110.07 -34.52 6.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 111.3 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 1.8 m -77.92 8.06 5.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.544 -1.347 . . . . 0.0 110.203 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.642 ' CG ' ' CG ' ' A' ' 102' ' ' PRO . 21.5 t-160 -53.13 150.42 5.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.596 -1.315 . . . . 0.0 108.929 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 49' ' ' HIS . 12.5 m -160.39 164.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.852 0.834 . . . . 0.0 110.919 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 82' ' ' SER . 4.1 m-85 -118.68 122.87 43.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 15.8 t -92.75 151.61 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.241 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -75.18 130.62 39.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.137 -1.602 . . . . 0.0 109.664 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.549 ' CA ' HG22 ' A' ' 57' ' ' THR . 4.9 pt-20 -35.28 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.792 -0.568 . . . . 0.0 111.984 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -65.92 -18.1 65.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.891 -1.131 . . . . 0.0 111.558 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.709 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 46.9 m-85 -127.89 -11.62 5.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.845 -1.159 . . . . 0.0 110.444 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.585 HG23 ' CB ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -80.96 -50.91 9.13 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' HD2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.31 -20.98 64.88 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 0.0 109.224 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.578 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.279 20.5 mmmt -79.4 -56.22 4.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.602 1.668 . . . . 0.0 108.923 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG13 ' CG2' ' A' ' 88' ' ' ILE 0.314 0.3 OUTLIER -75.64 138.12 70.44 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 112.856 -1.974 . . . . 0.0 109.854 -178.263 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' HG21 ' A' ' 60' ' ' VAL . 36.8 Cg_endo -64.22 159.75 41.84 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 124.116 1.587 . . . . 0.0 111.982 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 -167.59 1.44 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.733 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.594 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.73 -169.13 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.377 0.608 . . . . 0.0 110.625 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 66' ' ' ARG . 53.4 p30 -100.27 -144.64 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -80.01 -23.81 41.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.768 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.9 ttm-85 -64.74 -50.98 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 11.4 tp10 -59.55 -11.48 4.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.3 mp -89.97 -16.59 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.658 -1.276 . . . . 0.0 109.813 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -90.6 -63.32 1.23 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.674 ' CE ' ' O ' ' A' ' 43' ' ' ALA 0.289 2.9 mpp? -48.6 -48.52 39.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.335 1.541 . . . . 0.0 108.149 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.624 ' CD2' ' NE2' ' A' ' 49' ' ' HIS 0.269 0.0 OUTLIER -66.01 -32.04 73.29 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.961 -178.323 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -70.0 -41.98 73.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 109.997 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -41.88 41.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 109.797 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.56 HG22 ' ND1' ' A' ' 49' ' ' HIS . 9.9 m -90.22 63.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 110.181 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.523 ' O ' ' CG2' ' A' ' 75' ' ' THR . 10.2 t -49.66 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.726 . . . . 0.0 111.113 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.27 74.93 1.62 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -0.999 . . . . 0.0 110.126 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.2 pt-20 39.17 60.46 1.49 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.495 1.141 . . . . 0.0 109.525 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.557 ' CD1' HD21 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -59.02 120.02 8.35 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.531 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -104.92 -167.01 0.11 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.604 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 41.7 Cg_endo -74.95 -28.27 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.041 1.021 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.585 ' CB ' HG23 ' A' ' 57' ' ' THR . 44.6 p-10 -87.16 -28.24 22.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.513 -0.742 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.684 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.9 m -49.9 106.37 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.834 -1.166 . . . . 0.0 108.796 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.509 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -145.68 171.91 14.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.796 -1.19 . . . . 0.0 111.48 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -84.32 136.52 33.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.467 0.651 . . . . 0.0 111.332 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.599 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 3.0 p -42.38 -29.93 0.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 110.832 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.678 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.9 m -98.78 35.24 1.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 111.304 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.665 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 5.0 mm-40 -126.75 -48.02 1.52 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 113.066 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.541 ' CG2' HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -79.86 151.36 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.643 -1.286 . . . . 0.0 110.534 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 90' ' ' MET . 3.9 mm -111.85 160.05 11.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 110.159 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.609 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.63 118.21 35.59 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 110.454 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -94.89 167.22 13.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.848 . . . . 0.0 109.713 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.8 Cg_endo -78.65 -2.07 12.15 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.868 1.457 . . . . 0.0 110.714 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.458 ' OE2' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.09 -29.94 7.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.1 -1.0 . . . . 0.0 109.765 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.609 ' O ' ' CE ' ' A' ' 90' ' ' MET . 4.6 mt -88.28 66.03 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 110.351 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.515 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 10.3 p30 -101.72 148.38 25.34 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.735 -1.228 . . . . 0.0 113.174 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.669 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.03 30.49 6.68 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.709 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -80.2 135.28 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.177 0.989 . . . . 0.0 112.779 -177.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.53 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 12.7 t -102.78 125.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.67 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -104.25 -179.69 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.996 -1.065 . . . . 0.0 108.971 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-20 -162.07 145.56 12.0 Favored 'General case' 0 C--N 1.276 -2.616 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.547 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 55.0 t -83.86 149.79 57.41 Favored Pre-proline 0 C--N 1.289 -2.033 0 C-N-CA 117.449 -1.7 . . . . 0.0 107.514 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.642 ' CG ' ' CG ' ' A' ' 49' ' ' HIS . 42.1 Cg_endo . . . . . 0 C--N 1.3 -2.01 0 C-N-CA 121.464 1.443 . . . . 0.0 111.956 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.528 ' CA ' ' O ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.518 0.675 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.32 127.86 33.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.72 . . . . 0.0 109.605 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.655 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 23.0 t -139.5 148.07 23.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.856 -1.152 . . . . 0.0 112.033 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 13.8 t -131.41 126.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 54.5 m-85 -100.16 140.36 34.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.636 0.731 . . . . 0.0 112.509 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 2.6 t -120.52 134.98 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.21 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.486 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 36.0 p -79.51 -152.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.579 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.36 -10.43 14.59 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.913 -1.117 . . . . 0.0 108.965 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 58.2 p30 -100.45 3.34 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.52 -0.737 . . . . 0.0 109.602 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.47 -29.6 8.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.466 ' HB ' ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -49.81 134.88 20.27 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.953 -1.322 . . . . 0.0 109.224 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HG2' ' CG1' ' A' ' 6' ' ' VAL . 12.8 mtm180 -130.11 161.72 30.42 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.612 0.72 . . . . 0.0 111.504 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 5' ' ' TYR . 2.8 ttp180 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 20.0 mt-10 -130.62 124.23 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.833 -1.167 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.643 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 12.3 mt -117.95 151.54 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.77 90.55 3.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.584 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 42.9 t -98.7 163.63 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.854 . . . . 0.0 110.557 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -112.97 -136.78 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.356 -0.84 . . . . 0.0 110.916 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -108.32 124.43 50.32 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.309 -0.869 . . . . 0.0 110.494 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -7.11 30.52 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 83.0 t -95.69 168.0 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.027 -1.278 . . . . 0.0 110.543 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.517 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.62 160.14 25.0 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 18.4 mt -57.77 -36.04 71.59 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.673 -1.267 . . . . 0.0 109.254 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 1.298 ' SD ' ' SG ' ' A' ' 39' ' ' CYS . 4.7 ttp -79.33 7.24 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.062 -1.024 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.535 ' CG ' HG11 ' A' ' 21' ' ' VAL . 4.9 tt0 -102.29 -71.13 0.73 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.54 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.584 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.48 -55.43 7.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.758 -1.214 . . . . 0.0 108.614 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -53.55 -53.05 57.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG2' ' O ' ' A' ' 24' ' ' MET 0.277 0.7 OUTLIER -37.8 -57.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.422 177.769 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.582 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.76 -47.14 85.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.075 0.941 . . . . 0.0 108.821 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.588 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 6.1 m-80 -64.42 -4.03 3.54 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.499 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.03 -14.94 51.37 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 10.2 mt -44.04 -37.9 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.505 -0.997 . . . . 0.0 108.542 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.661 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 72.0 m-85 . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.162 -0.961 . . . . 0.0 111.201 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 1.298 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 121.116 0.484 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.1 46.24 10.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 29.72 44.44 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 66.9 m -116.4 -39.42 3.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -1.129 . . . . 0.0 110.583 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.607 ' CB ' ' NE2' ' A' ' 87' ' ' GLN . . . 72.79 59.19 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 111.66 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.492 ' C ' ' HG2' ' A' ' 70' ' ' MET . 58.3 m -131.91 11.29 4.7 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 110.196 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.625 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -113.01 120.61 41.97 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -177.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.55 ' N ' ' HB3' ' A' ' 70' ' ' MET . . . -77.16 -0.87 26.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.434 -1.416 . . . . 0.0 109.564 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -83.65 -21.18 32.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 111.188 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.601 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -98.44 16.69 20.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.824 -1.172 . . . . 0.0 110.095 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.64 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 5.9 t-160 -46.16 134.32 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.604 -1.31 . . . . 0.0 108.054 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 18.1 m -138.27 156.24 30.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.766 -1.209 . . . . 0.0 110.037 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.669 ' CZ ' ' CG ' ' A' ' 79' ' ' LYS . 3.1 m-30 -118.29 116.67 27.23 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.597 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 88' ' ' ILE . 22.2 t -94.33 166.09 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 108.909 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.551 ' O ' ' CG2' ' A' ' 57' ' ' THR . 12.5 p30 -84.97 137.2 33.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.278 -1.514 . . . . 0.0 109.023 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 53' ' ' ASN . 6.7 pt-20 -41.05 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.169 -0.957 . . . . 0.0 112.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 59' ' ' LYS . . . -75.61 -51.03 13.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.639 -1.288 . . . . 0.0 111.762 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.769 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 64.4 m-85 -84.96 -5.06 59.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.079 -1.013 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 9.7 p -80.3 -55.04 5.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.884 -1.135 . . . . 0.0 109.815 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.452 ' N ' ' OG1' ' A' ' 57' ' ' THR . 1.6 p30 -60.89 -12.42 11.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.429 -0.794 . . . . 0.0 110.769 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 56' ' ' PHE 0.295 13.5 mtpt -79.4 -54.49 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.724 1.726 . . . . 0.0 109.336 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.545 HG12 ' CG2' ' A' ' 88' ' ' ILE 0.324 0.3 OUTLIER -76.51 155.06 83.8 Favored Pre-proline 0 C--N 1.278 -2.506 0 CA-C-N 112.546 -2.115 . . . . 0.0 110.593 -177.441 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 37.5 Cg_endo -63.58 168.09 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.024 1.539 . . . . 0.0 111.758 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.518 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -80.34 -170.22 2.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.543 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.567 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -110.74 157.85 19.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.555 -0.715 . . . . 0.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.537 ' ND2' ' HG3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -79.47 -161.84 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.496 -0.752 . . . . 0.0 110.884 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.11 -22.59 41.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 111.343 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.537 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -69.73 -42.44 73.95 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.612 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.616 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.31 -7.54 1.33 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.819 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.547 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -90.41 -15.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.608 -1.307 . . . . 0.0 109.642 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.84 -79.75 1.38 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.524 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.679 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.9 -35.17 14.22 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.881 -1.364 . . . . 0.0 109.778 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.64 ' CD2' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -65.35 -30.18 70.99 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 108.575 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.15 -29.08 18.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.474 -0.766 . . . . 0.0 109.561 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.545 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -49.02 -48.87 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.046 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 16.5 m -90.07 76.53 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.425 -0.797 . . . . 0.0 109.098 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.563 ' O ' ' CG2' ' A' ' 75' ' ' THR . 13.1 t -48.25 87.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.782 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.559 ' O ' ' HG2' ' A' ' 77' ' ' GLU . . . -105.5 41.04 1.43 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.745 -1.222 . . . . 0.0 109.748 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.596 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER 66.78 44.47 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.219 1.009 . . . . 0.0 109.207 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.509 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.5 tp -19.42 134.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.53 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.669 ' CG ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.42 172.48 3.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.1 Cg_endo -69.83 -26.69 26.97 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.585 1.308 . . . . 0.0 108.828 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.6 p-10 -104.67 -9.16 18.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.704 -0.622 . . . . 0.0 111.399 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.596 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 42.7 m -47.86 158.62 0.21 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.524 -1.36 . . . . 0.0 111.406 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.538 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 0.8 OUTLIER -175.6 161.87 2.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.683 -0.636 . . . . 0.0 109.822 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.679 ' CD1' ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -80.33 139.53 36.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.93 . . . . 0.0 109.625 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.596 ' C ' ' HB2' ' A' ' 24' ' ' MET . 20.0 m -38.54 -31.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.515 1.15 . . . . 0.0 108.496 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.53 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -91.44 37.11 0.94 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.184 -178.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.621 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.1 mm-40 -127.43 -40.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.409 -1.432 . . . . 0.0 113.444 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.545 ' CG2' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -92.61 150.9 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.551 -178.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.484 HG21 ' N ' ' A' ' 90' ' ' MET . 5.5 mm -111.35 163.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.547 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.5 tpt -110.28 108.74 18.94 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.905 -1.122 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -88.14 159.64 47.62 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.0 Cg_endo -72.16 -1.08 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.977 1.514 . . . . 0.0 110.82 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -110.1 -27.27 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.022 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.547 ' O ' ' CE ' ' A' ' 90' ' ' MET . 8.8 mt -98.38 60.5 1.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 109.931 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.517 ' HB3' ' CB ' ' A' ' 1' ' ' SER . 3.8 p-10 -100.54 145.02 28.83 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.443 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.81 23.68 8.57 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.769 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -76.19 115.07 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.357 1.075 . . . . 0.0 113.486 -176.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.461 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 10.5 t -77.25 123.32 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.273 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.571 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 1.7 t -104.29 -176.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.863 -1.148 . . . . 0.0 109.275 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.4 m-20 -162.1 141.58 9.7 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.907 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 8' ' ' HIS . 49.4 t -97.48 102.86 13.94 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.5 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.652 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 41.0 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 C-N-CA 122.306 2.004 . . . . 0.0 113.342 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.569 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.249 0.547 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.498 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.91 124.14 19.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.642 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 11.8 t -121.44 145.81 27.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 4.3 t -130.98 125.65 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.913 0.863 . . . . 0.0 109.158 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.696 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.265 43.3 m-85 -101.07 135.9 41.79 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 3.2 t -121.97 119.9 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.27 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.524 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 77.7 p -79.78 128.58 33.6 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 1.5 t60 -41.74 -24.31 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -79.45 -3.52 46.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.06 -1.025 . . . . 0.0 110.073 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' SER . . . 110.22 -36.48 4.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.493 ' CB ' ' OG ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.54 137.06 15.8 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.838 -1.39 . . . . 0.0 108.776 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 12.1 mtm180 -130.15 147.35 51.87 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.712 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.696 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -131.58 119.32 21.31 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 177.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.7 mt-10 -94.92 123.98 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.141 -0.974 . . . . 0.0 110.261 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 8.1 mt -109.78 146.81 34.34 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.071 -1.018 . . . . 0.0 110.741 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.63 88.17 3.76 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.574 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 42.8 t -98.96 165.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.769 . . . . 0.0 110.974 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -118.94 -141.44 0.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 110.547 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -101.14 126.46 47.85 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.508 -0.745 . . . . 0.0 110.49 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -9.74 30.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.547 HG11 ' CG ' ' A' ' 25' ' ' GLN . 55.4 t -99.67 170.73 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.843 -1.387 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.504 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.58 167.68 12.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 9.2 mt -59.29 -27.96 66.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.699 -1.25 . . . . 0.0 109.447 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 1.226 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -80.26 -58.22 3.24 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.547 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.2 tt0 -37.98 -68.97 0.13 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.402 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.574 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -47.8 -57.27 5.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.349 -1.469 . . . . 0.0 108.813 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.645 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -52.78 -56.92 12.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.936 0.874 . . . . 0.0 108.911 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.281 1.2 t -35.34 -63.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.219 178.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.584 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.34 -49.64 71.71 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.074 0.94 . . . . 0.0 109.034 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.587 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 m-80 -61.36 -6.94 2.52 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.379 0.609 . . . . 0.0 109.445 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.28 -7.3 64.57 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.54 ' HB ' ' CA ' ' A' ' 27' ' ' ALA . 3.9 mt -44.66 -31.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.305 -1.115 . . . . 0.0 109.323 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.706 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 47.4 m-85 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 113.204 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.578 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 19.5 p . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.87 31.82 4.26 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.36 37.27 21.47 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 20.2 t -138.84 5.67 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -1.122 . . . . 0.0 111.822 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 42' ' ' SER . . . 73.14 42.58 0.44 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.309 -0.87 . . . . 0.0 113.298 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.461 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.2 t -132.35 44.7 2.85 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.744 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.1 p -111.76 130.09 55.91 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -92.13 6.47 46.44 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.258 -1.526 . . . . 0.0 108.178 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 p -110.65 -40.06 4.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.374 -0.828 . . . . 0.0 111.714 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.6 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 1.9 m -79.26 24.04 0.36 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.662 -1.274 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.688 ' NE2' ' CD2' ' A' ' 71' ' ' LEU . 6.9 t-160 -46.32 137.01 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.737 -1.227 . . . . 0.0 108.214 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.525 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 19.3 m -145.86 152.82 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.027 -1.046 . . . . 0.0 110.873 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 102' ' ' PRO . 31.1 m-85 -122.87 128.66 50.64 Favored 'General case' 0 C--N 1.281 -2.413 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.895 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.564 ' CG1' HG21 ' A' ' 57' ' ' THR . 13.6 t -93.88 168.43 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.279 -0.888 . . . . 0.0 109.873 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.61 ' O ' ' CG2' ' A' ' 57' ' ' THR . 6.8 p30 -67.94 -147.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.609 -1.307 . . . . 0.0 109.518 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -103.34 -16.52 15.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.856 -1.152 . . . . 0.0 111.836 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.457 ' O ' ' OD2' ' A' ' 58' ' ' ASP . . . -100.52 -36.82 9.06 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.703 -1.248 . . . . 0.0 114.146 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.72 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.4 m-85 -84.11 -11.0 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.308 -1.495 . . . . 0.0 110.839 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.61 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -81.73 -29.25 33.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 2.1 p30 -79.84 -26.89 40.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.513 ' CB ' HD11 ' A' ' 94' ' ' LEU . 21.1 mmtm -79.65 -51.43 9.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.611 ' CG1' ' CG2' ' A' ' 88' ' ' ILE . 11.5 m -41.78 153.51 0.27 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.411 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -65.18 160.92 39.67 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.114 1.586 . . . . 0.0 112.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 118.01 22.19 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.885 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -69.82 163.89 24.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 109.821 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 24.5 p-10 -100.1 -167.61 1.48 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.19 -20.93 29.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.474 -0.766 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' SD ' ' A' ' 70' ' ' MET . 1.1 ttt-85 -64.53 -53.36 49.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.855 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 6.9 tp10 -59.14 -12.61 5.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 64' ' ' ASN . 1.8 mp -90.92 -9.83 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.826 -1.171 . . . . 0.0 111.244 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.05 -79.3 1.35 Allowed Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.224 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.649 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.09 -37.31 14.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.761 -1.435 . . . . 0.0 109.107 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.688 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -67.82 -23.54 65.19 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.09 -39.49 12.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.811 178.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.78 -43.53 38.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.024 . . . . 0.0 108.344 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 1.7 m -90.42 72.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' A' ' 75' ' ' THR . 10.5 t -48.18 104.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.763 0.792 . . . . 0.0 111.27 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -126.16 60.8 1.29 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.545 -0.722 . . . . 0.0 109.335 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.542 ' O ' ' CE ' ' A' ' 79' ' ' LYS . 11.3 pt-20 39.28 56.22 2.16 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.995 0.902 . . . . 0.0 109.784 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -33.99 143.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.661 0.743 . . . . 0.0 112.052 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.576 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -134.44 -176.44 0.58 Allowed Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.2 -25.56 43.03 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.146 1.077 . . . . 0.0 111.765 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' HG23 ' A' ' 57' ' ' THR . 24.6 p-10 -111.85 6.5 19.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.831 -1.168 . . . . 0.0 113.308 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.575 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -57.26 149.29 20.38 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.204 -1.56 . . . . 0.0 109.143 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.531 ' HG3' ' CD1' ' A' ' 88' ' ' ILE . 11.3 mmt-85 -154.15 179.7 8.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.737 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -114.94 134.93 54.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.6 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 9.1 m -40.31 -27.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.882 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 1.226 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.2 m -106.93 45.66 0.97 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.994 -1.067 . . . . 0.0 112.053 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.608 ' NE2' ' CE ' ' A' ' 70' ' ' MET . 90.3 mm-40 -125.34 -47.83 1.72 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.043 0.925 . . . . 0.0 111.394 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.611 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -84.35 149.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.932 0.872 . . . . 0.0 111.538 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 90' ' ' MET . 4.4 mm -110.9 160.96 9.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.569 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -110.1 104.21 13.05 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 110.224 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.454 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -91.1 164.24 26.03 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.86 . . . . 0.0 109.442 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 39.7 Cg_endo -71.88 -0.69 8.81 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.648 1.341 . . . . 0.0 110.503 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.1 pt-20 -110.06 -27.61 9.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.513 HD11 ' CB ' ' A' ' 59' ' ' LYS . 9.5 mt -100.25 54.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.363 -0.835 . . . . 0.0 109.824 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.62 143.96 30.16 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.623 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.23 23.33 8.56 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.72 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.79 118.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.339 1.066 . . . . 0.0 113.166 -176.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 21.1 t -82.03 127.08 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.7 t -104.21 -175.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.782 -1.199 . . . . 0.0 109.345 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.1 m-20 -161.34 136.66 7.64 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.527 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -90.84 137.95 26.56 Favored Pre-proline 0 C--N 1.289 -2.049 0 C-N-CA 118.896 -1.121 . . . . 0.0 108.987 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.632 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 56.3 Cg_endo . . . . . 0 C--N 1.301 -1.954 0 O-C-N 124.172 1.617 . . . . 0.0 111.892 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.521 ' HB2' ' CB ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.643 0.735 . . . . 0.0 110.482 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -90.29 101.11 13.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.657 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 48.6 t -109.64 145.52 16.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.677 -1.264 . . . . 0.0 111.118 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 6.0 t -130.95 127.81 61.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.45 0.643 . . . . 0.0 109.356 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 49.8 m-85 -102.51 136.53 42.17 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.778 0.799 . . . . 0.0 112.184 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.0 t -120.55 133.54 66.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.429 -0.909 . . . . 0.0 109.642 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.522 ' HB3' ' CG2' ' A' ' 11' ' ' THR . 24.0 p -79.73 -159.07 0.19 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.576 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.94 -6.72 21.0 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.894 -1.129 . . . . 0.0 108.916 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -100.44 1.61 41.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.45 -22.95 21.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.9 137.13 17.18 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.986 -1.302 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.503 ' CG ' HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -130.1 149.98 51.57 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.232 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' TYR . 2.6 tpp180 -140.15 155.93 46.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.796 . . . . 0.0 109.714 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 3.9 mt-10 -130.92 128.0 39.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.922 -1.112 . . . . 0.0 110.328 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.648 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 14.1 mt -120.43 -170.53 2.0 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.899 -1.126 . . . . 0.0 110.778 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -133.45 81.71 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 39.9 t -98.4 130.62 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.384 -0.823 . . . . 0.0 110.487 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 90' ' ' MET . . . -110.53 -160.29 0.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.799 0.809 . . . . 0.0 111.523 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.6 OUTLIER -70.53 124.13 23.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.642 0.734 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.71 -14.41 29.57 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 21.9 t -108.11 166.57 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.832 -1.393 . . . . 0.0 110.373 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -121.21 153.77 37.15 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 3' ' ' VAL . 16.8 mt -47.09 -27.37 1.35 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.686 -1.258 . . . . 0.0 107.919 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.684 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -72.42 -67.28 0.56 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.096 0.951 . . . . 0.0 110.609 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' CG ' HG11 ' A' ' 21' ' ' VAL 0.255 5.9 tt0 -37.75 -73.41 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.33 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -43.08 -56.21 3.48 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.558 -1.338 . . . . 0.0 109.264 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.616 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -56.88 -60.42 3.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.644 0.735 . . . . 0.0 109.08 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.586 ' CG2' ' HG3' ' A' ' 24' ' ' MET 0.288 0.9 OUTLIER -33.09 -66.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.658 0.742 . . . . 0.0 109.221 178.041 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.515 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -51.02 -51.87 48.69 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.924 0.869 . . . . 0.0 109.285 178.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.572 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.9 m-80 -60.43 -7.29 1.98 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.33 0.586 . . . . 0.0 109.77 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.93 63.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 27.5 mt -43.82 -36.45 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.417 -1.049 . . . . 0.0 108.687 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.684 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 44.5 m-85 . . . . . 0 N--CA 1.49 1.573 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.099 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.563 ' SG ' ' CE ' ' A' ' 24' ' ' MET . 1.7 p . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 120.706 0.289 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.28 40.43 10.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.49 40.42 12.98 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 39.3 t -131.22 -34.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 0.0 111.261 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.593 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 75.81 61.42 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.321 -0.862 . . . . 0.0 111.354 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.34 8.52 4.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.373 -0.829 . . . . 0.0 110.124 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.554 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.88 117.77 33.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.242 -0.911 . . . . 0.0 112.423 -178.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . . . -75.41 0.26 17.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.454 HG21 ' HB2' ' A' ' 45' ' ' CYS . 8.4 t -83.73 -32.41 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.575 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.606 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.3 11.68 16.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 179.277 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 18.0 t-160 -49.16 152.39 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.709 -1.244 . . . . 0.0 109.791 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 13.9 m -156.02 160.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.221 -0.924 . . . . 0.0 109.622 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.9 m-30 -119.97 118.06 29.71 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.555 HG12 ' CD1' ' A' ' 97' ' ' ILE . 29.1 t -98.53 155.02 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.365 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.534 ' OD1' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.22 131.69 40.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.325 -1.485 . . . . 0.0 109.364 178.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pt-20 -37.49 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.435 -0.791 . . . . 0.0 111.476 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.77 -24.9 67.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.018 . . . . 0.0 111.356 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.677 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 33.2 m-85 -123.02 -11.0 8.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.871 -1.143 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.549 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -80.57 -29.42 37.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 108.888 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.8 p-10 -76.41 -26.87 55.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 109.666 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.528 ' CB ' HD11 ' A' ' 94' ' ' LEU . 23.1 mmtm -80.85 -52.44 7.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.554 -0.716 . . . . 0.0 110.192 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 88' ' ' ILE . 6.0 m -40.91 153.75 0.22 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.535 -0.728 . . . . 0.0 110.48 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.3 Cg_endo -65.79 168.22 15.7 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.061 1.559 . . . . 0.0 111.352 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.66 125.88 30.58 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.392 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -69.35 170.93 9.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.455 ' O ' HD11 ' A' ' 68' ' ' ILE . 31.3 p30 -96.83 -161.72 0.9 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 111.131 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -73.37 -24.76 60.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.512 -0.742 . . . . 0.0 110.543 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.514 ' NE ' ' O ' ' A' ' 42' ' ' SER . 1.7 mtm-85 -64.71 -43.07 94.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.405 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 4.2 tp10 -66.64 -7.03 17.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.532 -0.73 . . . . 0.0 109.517 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.51 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -91.94 -30.16 4.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.579 -1.326 . . . . 0.0 111.006 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.03 -64.89 1.57 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.854 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.885 ' HG3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.77 -46.89 42.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.828 -1.395 . . . . 0.0 108.43 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.606 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -57.13 -25.2 58.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.483 -175.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -36.39 17.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.5 -0.75 . . . . 0.0 108.981 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.35 -32.01 10.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 108.809 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.585 ' CG1' ' CB ' ' A' ' 46' ' ' ALA . 14.7 m -90.12 65.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.8 t -48.87 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.445 0.64 . . . . 0.0 111.17 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.27 69.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -0.808 . . . . 0.0 109.109 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.62 46.27 1.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.695 0.76 . . . . 0.0 109.905 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.525 ' C ' ' O ' ' A' ' 77' ' ' GLU . 9.8 tp -23.93 134.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.601 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' HD2' ' CD2' ' A' ' 51' ' ' TYR . 5.5 mtpt -110.0 167.92 8.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.751 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.6 Cg_endo -68.19 -28.88 33.6 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.854 1.45 . . . . 0.0 109.379 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 11.8 p-10 -97.54 -11.93 23.14 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.643 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 50.4 m -48.99 153.74 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.831 -1.168 . . . . 0.0 110.665 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.537 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 3.8 ttp180 -175.5 158.48 2.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.416 -0.802 . . . . 0.0 110.086 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.885 HD13 ' HG3' ' A' ' 70' ' ' MET . 0.5 OUTLIER -76.38 142.38 41.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.933 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 17.3 p -44.88 -26.24 0.39 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.582 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -93.0 29.87 1.74 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.899 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.6 tp-100 -126.59 -38.32 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.394 -1.441 . . . . 0.0 112.687 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.584 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -92.6 142.79 12.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.001 -1.079 . . . . 0.0 110.85 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.516 HG21 ' N ' ' A' ' 90' ' ' MET . 7.2 mm -110.52 168.19 4.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.543 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 3.5 tpt -109.93 110.65 21.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.866 -1.147 . . . . 0.0 111.137 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.481 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -89.93 165.64 23.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.86 -6.36 18.87 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.864 1.455 . . . . 0.0 110.901 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.7 pt-20 -110.26 -28.48 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.007 . . . . 0.0 110.429 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.543 ' O ' ' CE ' ' A' ' 90' ' ' MET . 8.1 mt -93.78 55.92 2.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.521 ' CB ' ' HB2' ' A' ' 1' ' ' SER . 2.8 p30 -100.53 148.98 24.18 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.327 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.677 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.72 34.02 6.46 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.643 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 5.0 tt -83.96 157.41 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.214 1.007 . . . . 0.0 113.127 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.534 ' CG2' ' OD1' ' A' ' 53' ' ' ASN . 18.1 t -117.84 124.76 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.214 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -104.4 -177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.858 -1.151 . . . . 0.0 109.996 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 51' ' ' TYR . 16.5 m-20 -162.26 145.84 11.83 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.29 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.576 HG13 ' CE1' ' A' ' 8' ' ' HIS . 71.7 t -98.27 111.89 60.79 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 120.678 -1.264 . . . . 0.0 108.716 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.621 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.2 Cg_endo . . . . . 0 C--N 1.306 -1.707 0 O-C-N 124.057 1.556 . . . . 0.0 110.941 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.544 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.445 0.641 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.09 109.69 20.73 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.424 -0.797 . . . . 0.0 109.546 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.654 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 30.3 t -109.73 144.81 17.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.914 -1.116 . . . . 0.0 110.706 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 15.8 t -130.93 124.78 56.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.554 0.692 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 54.1 m-85 -100.38 138.6 37.22 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.702 0.763 . . . . 0.0 112.552 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.6 t -120.88 127.51 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.904 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.493 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 10.2 p -79.78 -159.25 0.2 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.979 -1.076 . . . . 0.0 108.315 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.44 -1.07 31.41 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.98 -1.075 . . . . 0.0 109.177 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -100.4 -4.63 28.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.483 -0.761 . . . . 0.0 109.389 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.27 -31.8 7.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.478 HG21 ' CB ' ' A' ' 7' ' ' SER . 1.1 t -49.94 130.58 22.01 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.899 -1.353 . . . . 0.0 109.802 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 16.2 mtm180 -120.04 134.29 55.29 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.484 0.659 . . . . 0.0 110.864 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -111.62 156.77 21.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 0.0 109.682 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 32.2 mt-10 -130.89 125.34 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.382 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 11.1 mt -118.72 149.36 41.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.056 . . . . 0.0 111.434 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.72 87.77 3.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.572 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 41.7 t -98.7 171.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.692 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -121.44 -139.52 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.925 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.7 OUTLIER -104.73 125.74 51.11 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.41 -0.806 . . . . 0.0 110.224 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -8.74 30.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 69.7 t -98.86 169.49 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.07 -1.253 . . . . 0.0 110.322 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.51 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 -175.1 2.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.508 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 19.9 mt -79.9 -36.87 35.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.749 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.7 ttp -79.64 9.02 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.536 ' CG ' HG11 ' A' ' 21' ' ' VAL . 4.7 tt0 -102.03 -70.94 0.73 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.348 -0.845 . . . . 0.0 109.362 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -49.39 -53.65 21.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.723 -1.236 . . . . 0.0 108.516 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.639 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -53.81 -51.77 62.42 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.604 ' CG2' ' O ' ' A' ' 24' ' ' MET 0.272 0.7 OUTLIER -38.91 -57.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 177.8 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.588 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.84 -50.34 74.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.056 0.931 . . . . 0.0 109.101 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.581 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.8 m-80 -60.04 -7.88 2.05 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.418 0.628 . . . . 0.0 109.642 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.47 -13.04 59.29 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 12.7 mt -41.76 -39.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.534 -0.98 . . . . 0.0 109.58 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.749 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 45.8 m-85 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.108 -0.995 . . . . 0.0 111.012 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HB2' ' CB ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.023 0.439 . . . . 0.0 110.481 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.29 52.63 8.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.33 34.8 28.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.7 t -125.73 -42.84 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -1.113 . . . . 0.0 110.281 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 72.15 57.22 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.369 -0.832 . . . . 0.0 111.342 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 p -132.65 8.24 4.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.884 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.661 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.29 151.55 29.54 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.74 -1.225 . . . . 0.0 113.647 -177.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.578 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -106.61 8.84 31.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.627 -1.296 . . . . 0.0 111.372 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.4 p -103.25 9.79 37.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -115.43 14.51 16.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.382 -0.824 . . . . 0.0 109.309 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.619 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 3.5 t-160 -41.83 141.17 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 16.1 m -147.04 155.81 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.9 -1.125 . . . . 0.0 109.326 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.638 ' CE2' ' HD2' ' A' ' 79' ' ' LYS . 7.9 m-30 -120.9 121.39 37.96 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.638 0.732 . . . . 0.0 110.67 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.551 ' CG1' HG21 ' A' ' 57' ' ' THR . 16.5 t -91.88 170.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.595 ' O ' ' CG2' ' A' ' 57' ' ' THR . 6.7 p30 -72.76 -148.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.526 -1.359 . . . . 0.0 109.222 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -102.85 -14.84 16.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.913 -1.117 . . . . 0.0 111.507 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.438 ' N ' ' OD1' ' A' ' 53' ' ' ASN . . . -100.56 -38.24 8.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.802 -1.186 . . . . 0.0 114.072 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.661 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 78.6 m-85 -84.24 -11.24 56.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.332 -1.48 . . . . 0.0 111.464 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.595 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -81.44 -49.16 10.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.934 -1.104 . . . . 0.0 109.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 3.7 p-10 -61.33 -13.53 20.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -93.46 -52.7 4.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.532 -0.73 . . . . 0.0 110.163 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.581 ' CG2' ' O ' ' A' ' 57' ' ' THR . 6.2 m -46.25 165.81 0.18 Allowed Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.7 Cg_endo -67.36 161.08 44.77 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.102 1.58 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.18 126.29 31.32 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.529 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -69.53 157.9 36.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 31.1 p-10 -100.24 -168.17 1.55 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.897 -1.127 . . . . 0.0 112.067 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -65.05 -19.68 66.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.818 -0.551 . . . . 0.0 110.493 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -64.14 -53.12 54.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.955 . . . . 0.0 108.809 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.1 tt0 -58.95 -47.37 85.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.535 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.4 mp -47.97 -26.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.016 -1.052 . . . . 0.0 111.281 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.67 -67.91 1.19 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.668 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.12 -44.05 31.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.35 -1.088 . . . . 0.0 109.279 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.619 ' CD2' ' CE1' ' A' ' 49' ' ' HIS 0.255 0.0 OUTLIER -68.63 -25.14 64.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.644 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -91.01 -25.89 19.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.499 -0.751 . . . . 0.0 110.769 178.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.578 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.09 -41.41 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.777 -1.202 . . . . 0.0 109.052 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 3.6 m -90.51 87.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.802 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.54 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.6 t -47.84 96.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.817 0.818 . . . . 0.0 111.475 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -125.17 47.38 2.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.222 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.563 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.3 pt-20 39.75 60.16 1.71 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.732 0.777 . . . . 0.0 109.384 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.8 tp -27.24 134.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.578 0.704 . . . . 0.0 112.089 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.638 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 5.1 mtpt -104.85 173.71 3.14 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.7 Cg_endo -69.32 -29.26 26.24 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.393 1.207 . . . . 0.0 110.054 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.8 p-10 -106.97 -2.32 21.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 111.061 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.568 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 69.6 m -49.21 161.83 0.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.813 -1.18 . . . . 0.0 111.069 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.516 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -175.32 166.39 3.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.668 ' CD1' ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -83.16 148.56 27.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.549 ' C ' ' HB2' ' A' ' 24' ' ' MET . 66.1 m -49.07 -27.36 3.28 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.576 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 4.7 p -106.95 43.65 1.14 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.878 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.57 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.4 tp-100 -125.57 -38.06 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.919 -1.113 . . . . 0.0 111.212 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -96.15 147.99 5.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.605 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 90' ' ' MET . 5.5 mm -110.61 161.67 8.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.576 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.29 124.31 51.41 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.789 -1.194 . . . . 0.0 110.792 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.499 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 3.9 p -110.02 168.07 8.18 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.63 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 43.9 Cg_endo -73.27 -1.75 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.823 1.433 . . . . 0.0 111.59 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -110.08 -24.13 10.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.812 -1.18 . . . . 0.0 110.233 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.576 ' O ' ' CE ' ' A' ' 90' ' ' MET . 4.8 mt -93.73 33.57 1.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 6.0 p-10 -80.65 144.39 32.34 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.822 0.82 . . . . 0.0 112.501 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.657 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.25 21.59 11.52 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 13.2 tt -74.17 157.49 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 123.131 1.443 . . . . 0.0 113.8 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 23.2 t -122.92 121.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.261 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -103.76 -176.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.0 109.531 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.8 m-20 -160.95 138.86 9.51 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.028 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 6' ' ' VAL . 12.7 t -102.05 116.68 62.84 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.984 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.637 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo . . . . . 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 109.953 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.523 ' HA ' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.341 0.591 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -80.73 137.56 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.812 . . . . 0.0 109.422 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.612 HG13 ' CZ ' ' A' ' 5' ' ' TYR . 2.5 t -125.74 135.94 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.823 -1.173 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 44.3 t -129.19 124.89 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.496 1.141 . . . . 0.0 110.324 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.669 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.29 30.1 m-85 -98.46 139.96 33.43 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.976 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 4.5 t -121.05 155.86 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.032 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.509 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 97.4 p -119.38 142.05 48.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.437 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -44.65 -23.72 0.15 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.421 -0.799 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.459 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.3 p30 -89.64 -4.07 57.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.067 -1.021 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.13 -32.22 7.23 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.459 ' HB ' ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -49.53 131.49 21.02 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.082 -1.246 . . . . 0.0 109.061 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -125.67 151.31 46.73 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.439 0.638 . . . . 0.0 111.122 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.669 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.41 118.41 17.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.325 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 6.9 mp0 -116.29 125.37 52.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 0.0 111.845 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.724 ' CD2' ' ND2' ' A' ' 30' ' ' ASN 0.25 6.7 mp -110.42 -175.23 2.67 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.225 1.012 . . . . 0.0 111.198 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -119.23 92.35 3.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.576 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 5.9 t -98.63 170.07 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.496 -0.752 . . . . 0.0 110.948 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.513 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -134.03 -143.64 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' MET . 1.3 p-10 -95.02 123.57 38.57 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.591 -0.693 . . . . 0.0 110.546 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.52 -7.67 30.21 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.579 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.576 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 46.0 t -98.4 167.91 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.776 -1.426 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.519 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.66 165.14 16.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.49 HD21 HG12 ' A' ' 3' ' ' VAL . 2.9 mt -59.69 -17.19 32.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.481 -1.387 . . . . 0.0 108.474 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.644 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -82.53 -66.5 0.88 Allowed 'General case' 0 C--O 1.204 -1.34 0 O-C-N 121.479 -0.763 . . . . 0.0 109.03 178.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' CG ' HG11 ' A' ' 21' ' ' VAL 0.27 6.4 tt0 -37.03 -71.15 0.08 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.366 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.532 ' C ' ' CD2' ' A' ' 15' ' ' LEU . . . -43.21 -66.3 0.39 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.683 -1.261 . . . . 0.0 108.518 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . . . -46.84 -49.9 19.34 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.065 0.936 . . . . 0.0 109.152 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.257 0.8 OUTLIER -43.68 -56.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.63 0.729 . . . . 0.0 109.137 179.033 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.28 -49.42 72.16 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.885 0.85 . . . . 0.0 108.879 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.724 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 1.5 m-80 -59.75 -10.65 3.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.62 -10.56 73.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CD1' ' CD2' ' A' ' 5' ' ' TYR . 4.1 mt -39.92 -41.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.694 -0.886 . . . . 0.0 110.038 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 25.6 m-85 . . . . . 0 C--N 1.3 -1.585 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.045 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 7.3 p . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.902 0.382 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.83 29.44 6.17 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.56 34.76 27.56 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 4.6 p -140.15 7.31 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -1.211 . . . . 0.0 111.752 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.608 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 71.21 58.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.12 -0.987 . . . . 0.0 112.514 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.404 ' H ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -133.61 30.78 3.76 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.685 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.5 p -111.25 150.41 29.63 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB2' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.11 16.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.086 -1.009 . . . . 0.0 108.672 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -110.35 -32.36 6.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 111.908 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.9 m -74.73 8.32 2.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.398 -1.439 . . . . 0.0 110.41 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.64 ' NE2' HD23 ' A' ' 71' ' ' LEU . 23.6 t-160 -46.03 140.53 3.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.65 -1.281 . . . . 0.0 109.292 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG11 ' O ' ' A' ' 49' ' ' HIS . 13.5 m -144.89 159.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.563 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.6 m-30 -118.4 120.76 38.54 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.56 ' CG1' HG21 ' A' ' 57' ' ' THR . 24.2 t -84.45 167.84 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' O ' ' CG2' ' A' ' 57' ' ' THR . 8.1 p-10 -80.27 -142.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.232 -1.543 . . . . 0.0 110.229 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -101.92 -28.02 12.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.253 -1.53 . . . . 0.0 113.384 -177.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -100.2 23.83 9.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.349 -1.469 . . . . 0.0 113.313 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.658 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 73.5 m-85 -140.58 -19.48 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.627 -1.296 . . . . 0.0 110.939 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.584 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -81.18 -50.67 9.3 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -64.92 -15.47 62.12 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.599 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.296 0.8 OUTLIER -79.28 -53.9 6.48 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.797 1.76 . . . . 0.0 108.942 179.154 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG13 ' CG2' ' A' ' 88' ' ' ILE 0.319 0.3 OUTLIER -77.42 139.44 63.84 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 112.519 -2.128 . . . . 0.0 110.22 -177.817 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -66.67 162.25 38.03 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.092 1.575 . . . . 0.0 112.011 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 -173.42 4.14 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.564 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.589 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -170.41 1.63 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.415 0.626 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.64 -164.4 1.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.0 110.671 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 1.1 pt-20 -61.37 -22.0 64.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 6.2 ttm180 -64.24 -57.93 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 0.0 109.164 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 15.6 tp10 -59.97 1.15 0.12 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.749 -0.594 . . . . 0.0 111.956 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 6.7 mm -90.9 -39.55 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 110.225 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -83.2 -60.5 2.02 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.647 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -47.65 -43.7 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.195 -1.179 . . . . 0.0 108.738 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.64 HD23 ' NE2' ' A' ' 49' ' ' HIS 0.257 0.0 OUTLIER -73.11 -34.31 66.09 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.819 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -70.29 -21.1 62.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 46' ' ' ALA . 74.4 m -48.99 -24.24 1.44 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.088 -1.008 . . . . 0.0 108.696 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' A' ' 76' ' ' ALA . 17.4 m -90.12 76.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.662 -0.649 . . . . 0.0 109.786 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 75' ' ' THR . 12.9 t -50.99 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.008 -0.432 . . . . 0.0 111.829 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -131.09 52.35 2.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.867 -1.146 . . . . 0.0 110.443 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 38.93 60.17 1.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.631 -0.668 . . . . 0.0 110.151 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.573 HD13 ' CE1' ' A' ' 49' ' ' HIS . 2.3 tp -22.91 141.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.44 0.638 . . . . 0.0 112.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -90.7 168.87 13.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.004 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.32 -26.37 41.58 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.653 1.344 . . . . 0.0 109.346 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.559 ' HB2' HG23 ' A' ' 57' ' ' THR . 14.2 p30 -105.38 -6.74 19.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.752 -0.593 . . . . 0.0 110.958 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.622 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.3 m -48.95 156.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 0.0 111.085 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.52 ' CD ' HG12 ' A' ' 88' ' ' ILE . 1.2 ttt180 -175.18 158.79 2.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.73 0.776 . . . . 0.0 110.8 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER -78.85 138.94 38.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.689 -0.632 . . . . 0.0 109.809 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 1.6 p -44.84 -31.85 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.886 -1.134 . . . . 0.0 110.005 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 3.7 m -101.08 39.58 1.38 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.433 -0.792 . . . . 0.0 111.17 -177.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.7 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 1.8 mm-40 -126.48 -43.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 112.608 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.544 ' CG2' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -83.75 149.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 118.634 -1.227 . . . . 0.0 110.656 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 22' ' ' SER . 4.9 mm -110.87 160.15 10.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.318 0.58 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 1.9 tpt -110.3 113.91 26.95 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.079 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -91.37 169.15 11.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 109.508 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 41.8 Cg_endo -72.73 -8.83 23.07 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.782 1.412 . . . . 0.0 111.291 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 1.9 pp20? -110.04 -41.58 4.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.863 -1.148 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.599 ' CD2' ' CB ' ' A' ' 59' ' ' LYS . 1.2 mt -72.56 54.28 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.541 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.523 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 50.0 p-10 -101.53 156.18 17.63 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.106 -0.997 . . . . 0.0 112.646 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.658 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.6 27.07 12.03 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.653 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 4.9 tt -79.99 157.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 122.219 1.009 . . . . 0.0 112.21 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.528 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 19.0 t -124.13 125.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.559 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.1 t -103.73 -176.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.0 m-20 -162.18 139.24 8.21 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.885 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 6' ' ' VAL . 16.4 t -90.67 117.18 67.77 Favored Pre-proline 0 C--N 1.285 -2.223 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.245 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.632 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.2 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 123.855 1.45 . . . . 0.0 110.312 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.343 0.592 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -80.02 138.6 37.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -0.793 . . . . 0.0 109.873 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.644 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 4.0 t -127.95 146.73 33.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.012 -1.055 . . . . 0.0 110.141 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 3.4 t -130.5 130.06 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.592 0.71 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.683 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.266 46.3 m-85 -106.09 138.83 41.6 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.523 ' HA ' ' CG ' ' A' ' 12' ' ' ARG . 11.3 t -121.71 152.17 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.738 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.525 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 80.5 p -114.97 138.0 51.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -46.59 -22.38 0.28 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.943 -1.098 . . . . 0.0 110.016 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 7' ' ' SER . 2.1 p30 -85.03 -6.22 59.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.049 . . . . 0.0 110.156 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.25 -36.1 4.46 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.73 133.28 21.66 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.817 -1.402 . . . . 0.0 109.226 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 16.9 mtm105 -129.04 154.9 46.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.283 0.563 . . . . 0.0 111.247 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.683 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -135.58 121.3 19.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 36.4 mt-10 -94.64 123.35 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.62 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 8.2 mt -109.79 147.23 33.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.979 . . . . 0.0 110.57 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -99.55 88.07 3.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.572 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 56.6 t -98.97 168.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.517 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -125.28 -133.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -108.1 123.98 49.53 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.248 -0.907 . . . . 0.0 110.382 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.32 -8.47 30.78 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 22' ' ' SER . 60.8 t -97.81 170.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.917 -1.343 . . . . 0.0 110.465 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.534 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.48 154.4 35.31 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 10.0 mt -48.78 -23.35 1.04 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.505 -1.372 . . . . 0.0 109.329 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.665 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.6 ttt -83.51 -62.73 1.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.621 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.6 tt0 -36.57 -54.22 0.87 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.257 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -61.39 -49.91 74.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.035 -1.665 . . . . 0.0 107.664 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.62 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -58.16 -61.2 2.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.308 1.051 . . . . 0.0 108.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.293 0.8 OUTLIER -29.63 -59.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.744 178.22 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.586 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -48.18 78.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.108 0.956 . . . . 0.0 108.871 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.589 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.3 m-80 -59.64 -11.42 4.89 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.07 -10.32 73.4 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 27' ' ' ALA . 4.8 mt -42.83 -30.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.395 -1.062 . . . . 0.0 108.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.665 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 26.4 m-85 . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 119.457 -0.897 . . . . 0.0 113.09 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.622 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.7 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.68 31.39 2.57 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.35 35.61 25.97 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 39' ' ' CYS . 0.4 OUTLIER -140.17 8.95 2.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -1.179 . . . . 0.0 111.024 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.58 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 68.49 54.28 0.53 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.283 1.039 . . . . 0.0 111.285 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.586 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -131.77 30.8 4.31 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -111.39 149.9 30.55 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB2' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.88 16.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.951 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 t -110.22 -25.13 10.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 112.152 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.599 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 19.0 m -76.71 15.16 0.68 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.509 -1.369 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.72 ' CD2' ' CD2' ' A' ' 71' ' ' LEU . 6.5 t-80 -49.97 136.32 18.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.833 -1.167 . . . . 0.0 108.036 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 9.9 m -160.27 170.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.668 -1.27 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CE2' ' HD2' ' A' ' 79' ' ' LYS . 11.4 m-30 -120.4 123.09 42.19 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.563 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' A' ' 97' ' ' ILE . 46.6 t -90.48 151.15 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.527 ' OD1' ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -73.25 133.77 44.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 119.835 -1.791 . . . . 0.0 109.863 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HA ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -40.95 -26.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.724 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.528 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -61.34 -17.23 52.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.875 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.699 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 50.1 m-85 -131.02 -9.19 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.011 -1.056 . . . . 0.0 110.835 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 81' ' ' ASN . 1.3 p -80.52 -39.44 27.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -12.11 60.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 109.57 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.281 22.0 mmmt -79.43 -54.64 5.73 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.669 1.7 . . . . 0.0 108.678 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' CG2' ' A' ' 88' ' ' ILE 0.326 0.3 OUTLIER -81.09 134.23 52.92 Favored Pre-proline 0 C--N 1.279 -2.47 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.943 -178.005 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.67 159.9 50.58 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.079 1.568 . . . . 0.0 112.212 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -81.07 177.44 9.04 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.614 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -152.41 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.403 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' O ' HD11 ' A' ' 68' ' ' ILE . 47.8 p-10 -100.04 -139.85 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.11 -18.05 50.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 110.109 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.7 OUTLIER -70.05 -52.55 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.614 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 1.7 tm-20 -58.35 -15.54 10.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.838 -1.164 . . . . 0.0 110.16 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.608 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.5 mp -91.31 -65.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.39 -48.01 26.14 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.271 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.664 ' CE ' HD11 ' A' ' 84' ' ' LEU 0.296 12.3 ttp -48.61 -52.34 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 123.207 1.479 . . . . 0.0 107.744 178.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.72 ' CD2' ' CD2' ' A' ' 49' ' ' HIS 0.284 0.0 OUTLIER -62.26 -52.56 63.24 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.379 179.609 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.621 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 7.4 tt0 -82.17 20.53 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.519 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' GLY . 1.3 m -49.18 -25.42 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.149 -1.594 . . . . 0.0 108.069 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.527 ' CG2' ' N ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -89.93 -148.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.527 ' N ' ' CG2' ' A' ' 74' ' ' VAL . 9.6 t -130.78 55.52 1.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.174 -1.579 . . . . 0.0 110.076 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -98.6 32.27 2.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 110.745 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.553 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.1 pt-20 39.19 60.48 1.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 77' ' ' GLU . 12.4 tp -19.77 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.579 0.704 . . . . 0.0 112.544 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.646 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 3.6 mtpt -97.53 -167.55 0.13 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 43.9 Cg_endo -82.58 -28.23 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.491 1.258 . . . . 0.0 109.777 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 9.8 p-10 -105.89 -7.21 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.52 -0.737 . . . . 0.0 111.508 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.568 ' CB ' HD12 ' A' ' 71' ' ' LEU . 1.5 m -49.56 143.68 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.59 -1.319 . . . . 0.0 110.326 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.594 ' CD ' ' CG ' ' A' ' 67' ' ' GLU . 1.5 mmt-85 -158.85 151.76 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 110.158 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.664 HD11 ' CE ' ' A' ' 70' ' ' MET . 12.2 mt -74.34 148.51 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.599 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 18.1 m -47.1 -25.38 0.85 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 2.8 m -110.08 48.18 0.91 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.837 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.528 ' NE2' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -125.24 -38.95 2.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 110.863 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.585 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -101.7 155.93 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.462 HG21 ' N ' ' A' ' 90' ' ' MET . 4.6 mm -110.3 163.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.513 -0.742 . . . . 0.0 109.369 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.7 tpt -110.07 106.73 16.32 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 110.438 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.1 p -89.4 163.79 32.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.7 Cg_endo -74.34 -6.88 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.956 1.503 . . . . 0.0 110.54 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.472 ' HG3' HD22 ' A' ' 94' ' ' LEU . 2.7 pt-20 -103.47 -27.76 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' A' ' 59' ' ' LYS . 9.9 mt -99.97 57.29 0.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 4.8 p-10 -100.43 149.89 23.19 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.662 0.744 . . . . 0.0 112.242 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.646 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.61 22.36 11.36 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.699 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 8.3 tt -72.84 154.49 7.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.747 1.261 . . . . 0.0 113.325 -177.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.527 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 5.8 t -122.57 127.76 75.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.334 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.65 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.8 t -103.81 -179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.015 -1.053 . . . . 0.0 108.578 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.519 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.6 m-20 -161.17 138.53 9.02 Favored 'General case' 0 C--N 1.274 -2.711 0 C-N-CA 118.408 -1.317 . . . . 0.0 110.726 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 15.2 t -97.38 117.75 65.18 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.644 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 37.2 Cg_endo . . . . . 0 C--N 1.302 -1.873 0 O-C-N 123.95 1.5 . . . . 0.0 110.613 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 95' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.563 0.697 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.524 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.4 OUTLIER -80.13 119.66 23.22 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.641 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 20.3 t -124.46 148.6 28.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.871 -1.143 . . . . 0.0 111.53 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 4.7 t -131.14 128.8 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.699 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.273 42.2 m-85 -107.68 140.99 39.89 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 3.2 t -122.16 129.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.05 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 77.6 p -79.36 -151.44 0.06 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.58 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.33 -10.51 14.6 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 120.874 -1.141 . . . . 0.0 108.915 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.443 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.7 p30 -100.41 1.99 41.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.34 -31.05 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.481 HG21 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.7 135.99 18.14 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.935 -1.332 . . . . 0.0 109.092 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.7 mtm180 -130.16 152.74 49.27 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.411 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.699 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -132.78 121.24 22.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 2.5 mm-40 -94.64 124.14 38.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.146 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 7.2 mt -109.67 147.98 32.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.009 -1.057 . . . . 0.0 111.851 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.02 84.89 2.31 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.548 HG11 ' CG1' ' A' ' 21' ' ' VAL . 16.6 t -98.89 172.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -177.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -120.3 -144.2 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.418 -0.801 . . . . 0.0 111.252 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -102.06 133.73 46.41 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.62 -0.675 . . . . 0.0 110.307 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.47 -3.09 57.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.831 HG11 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -100.43 172.48 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -1.105 . . . . 0.0 110.406 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.617 ' H ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.97 179.26 4.32 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.791 178.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 16.1 mt -76.63 -14.82 59.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.782 -1.199 . . . . 0.0 109.534 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.725 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.1 tmt? -90.6 -71.45 0.62 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.679 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.831 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -37.9 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.707 -0.621 . . . . 0.0 112.132 -176.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.607 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -88.37 -52.5 5.16 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -59.86 -45.43 92.47 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.624 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.262 0.8 OUTLIER -42.9 -61.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.72 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.613 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.55 -32.73 70.6 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.45 1.119 . . . . 0.0 108.163 178.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.583 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 3.7 m-80 -77.36 10.41 2.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.046 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 61.06 13.91 36.62 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.578 ' HB ' ' CB ' ' A' ' 27' ' ' ALA . 5.1 mt -72.1 -33.93 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.343 -1.092 . . . . 0.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.725 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.3 m-85 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.0 111.888 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.032 0.444 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 40.94 28.06 0.22 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . 80.09 30.54 41.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' CYS . 7.8 t -117.58 -36.13 3.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -1.14 . . . . 0.0 109.881 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 70' ' ' MET . . . 73.33 60.36 0.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.632 0.729 . . . . 0.0 111.762 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -131.95 22.02 4.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -112.56 161.15 17.11 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.495 0.664 . . . . 0.0 111.761 -177.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.531 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -110.95 -2.99 15.78 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.576 -1.328 . . . . 0.0 112.623 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -110.32 28.36 8.71 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.284 -1.51 . . . . 0.0 112.656 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -115.96 -3.4 12.14 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.616 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 2.7 t-160 -43.46 127.6 4.74 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 17.4 m -139.17 161.26 28.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.566 -1.334 . . . . 0.0 110.211 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.701 ' CE2' ' HD2' ' A' ' 79' ' ' LYS . 5.8 m-30 -116.9 121.8 42.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.69 0.757 . . . . 0.0 110.381 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.555 ' CG1' HG21 ' A' ' 57' ' ' THR . 14.6 t -91.41 172.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.598 ' O ' ' CG2' ' A' ' 57' ' ' THR . 6.6 p30 -75.84 -148.39 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.445 -1.41 . . . . 0.0 109.21 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 -16.02 16.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.878 -1.139 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.65 -36.12 9.25 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.853 -1.154 . . . . 0.0 113.832 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.676 ' CD2' ' HA ' ' A' ' 97' ' ' ILE . 70.0 m-85 -84.37 -13.21 52.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.338 -1.477 . . . . 0.0 111.608 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.598 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -80.79 -27.67 36.56 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.717 -1.239 . . . . 0.0 109.818 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -24.43 21.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . 15.3 mmtm -79.57 -52.12 8.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 56' ' ' PHE . 9.1 m -42.19 166.31 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.616 -0.678 . . . . 0.0 110.044 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 38.1 Cg_endo -66.34 165.29 25.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.027 1.541 . . . . 0.0 111.448 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 114.17 19.35 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.261 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.575 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -69.1 163.81 23.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.879 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.459 ' O ' HD12 ' A' ' 68' ' ' ILE . 44.3 p-10 -100.3 -146.45 0.34 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 0.0 111.335 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.523 ' HG3' ' CZ ' ' A' ' 66' ' ' ARG . 3.6 pt-20 -72.72 -27.76 62.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.55 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.616 ' O ' ' CB ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.37 -46.83 81.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 108.509 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.578 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 3.0 tm-20 -58.08 -16.05 11.64 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.43 -1.419 . . . . 0.0 109.298 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.518 HG21 ' N ' ' A' ' 69' ' ' GLY . 1.2 mp -92.14 -68.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 110.436 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.518 ' N ' HG21 ' A' ' 68' ' ' ILE . . . -77.38 -49.23 7.51 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.702 ' HE3' HD12 ' A' ' 84' ' ' LEU 0.253 0.0 OUTLIER -48.91 -41.4 33.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.029 1.395 . . . . 0.0 108.268 179.187 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.612 HD23 ' CD2' ' A' ' 49' ' ' HIS 0.323 0.0 OUTLIER -77.29 -30.34 54.17 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.737 -179.217 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 6.1 tt0 -86.33 10.24 15.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.868 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 46' ' ' ALA . 33.9 m -48.92 -52.88 22.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.648 -1.283 . . . . 0.0 108.039 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 18.3 m -90.48 116.45 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.565 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.8 OUTLIER -48.49 98.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.557 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -128.27 38.77 3.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.865 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.24 60.45 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.633 0.73 . . . . 0.0 110.038 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 72' ' ' GLU . 0.4 OUTLIER -27.98 119.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.494 0.664 . . . . 0.0 111.927 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.701 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 1.1 mttp -85.35 -167.68 0.15 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.568 ' CD ' ' HB3' ' A' ' 79' ' ' LYS . 43.1 Cg_endo -82.81 -29.02 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.305 1.161 . . . . 0.0 109.135 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.523 ' HB2' HG23 ' A' ' 57' ' ' THR . 42.0 p-10 -106.15 -7.3 18.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.597 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 13.9 m -48.08 128.7 14.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.555 -1.34 . . . . 0.0 110.072 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.572 ' CG ' ' HG3' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -142.29 164.17 30.86 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.82 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.702 HD12 ' HE3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -74.94 136.83 41.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.824 -0.548 . . . . 0.0 111.943 -178.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 1.9 p -55.99 -22.7 28.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.598 ' HB3' ' CB ' ' A' ' 39' ' ' CYS . 1.1 p -107.13 28.95 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.309 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.561 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 2.7 mm-40 -126.08 -41.28 1.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.175 . . . . 0.0 112.103 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -79.85 146.21 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.689 -178.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 5.9 mm -111.1 158.86 11.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 4.0 tpt -110.14 114.47 28.0 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.072 -1.017 . . . . 0.0 110.488 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.486 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -95.7 165.83 15.8 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.326 -0.858 . . . . 0.0 109.669 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.3 Cg_endo -70.51 -30.01 19.46 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.837 1.441 . . . . 0.0 110.965 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.5 pp20? -83.46 -41.39 18.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.982 -1.074 . . . . 0.0 109.911 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.531 ' O ' ' CE ' ' A' ' 90' ' ' MET . 1.6 mt -79.42 60.82 3.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.524 ' OD1' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -101.16 153.61 19.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.862 -1.149 . . . . 0.0 111.652 -178.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.48 19.52 12.2 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.676 ' HA ' ' CD2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -59.32 126.72 17.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.453 1.12 . . . . 0.0 112.537 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 2.8 t -105.73 116.63 49.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.637 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.5 t -104.11 -178.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 122.354 1.074 . . . . 0.0 110.542 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 51' ' ' TYR . 5.1 m-20 -162.05 140.24 8.98 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.035 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.58 HG13 ' CE1' ' A' ' 8' ' ' HIS . 52.5 t -96.59 112.08 59.07 Favored Pre-proline 0 N--CA 1.499 1.999 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.017 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.672 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 44.7 Cg_endo . . . . . 0 N--CA 1.496 1.636 0 C-N-CA 122.105 1.87 . . . . 0.0 113.928 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.41 0.624 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.484 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 6.2 tmtm? -79.98 109.32 14.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.669 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 4.9 t -111.37 143.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.997 -1.064 . . . . 0.0 110.75 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 3.1 t -130.89 125.09 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.232 1.015 . . . . 0.0 109.519 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.67 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.284 36.6 m-85 -101.02 138.32 38.22 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.585 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 3.5 t -121.79 158.02 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.454 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 60.7 p -120.03 137.86 53.85 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.578 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -43.84 -23.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.018 -1.051 . . . . 0.0 110.409 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD2' ' HB ' ' A' ' 11' ' ' THR . 6.6 p-10 -85.94 -3.5 58.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.086 -1.009 . . . . 0.0 110.577 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.22 -42.01 2.08 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.832 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.53 ' CG2' ' CZ ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -49.56 134.48 19.58 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 120.968 -1.313 . . . . 0.0 109.869 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.8 mtm180 -130.08 160.68 32.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.036 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.67 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -138.4 123.06 18.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 178.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 3.2 mp0 -95.36 128.27 42.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.644 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 9.0 mt -121.13 146.2 47.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.048 -1.032 . . . . 0.0 111.718 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 16.2 p30 -100.86 90.05 4.07 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.578 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 42.5 t -98.85 171.49 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 111.064 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -118.82 -134.16 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 0.0 110.546 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -110.13 124.36 51.39 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.276 -0.89 . . . . 0.0 110.527 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.39 -8.28 30.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.383 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 95.9 t -96.07 170.13 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.288 . . . . 0.0 110.651 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.526 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.98 171.72 8.44 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.88 -28.19 67.31 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.21 179.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.639 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -86.86 4.7 40.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.583 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.545 ' CG ' HG11 ' A' ' 21' ' ' VAL . 5.9 tt0 -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.15 -0.969 . . . . 0.0 109.372 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.578 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -51.24 -47.79 62.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 108.212 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.644 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -60.36 -53.28 59.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.279 0.8 OUTLIER -36.84 -58.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.65 0.738 . . . . 0.0 109.011 178.006 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.569 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.137 0.97 . . . . 0.0 108.459 178.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.587 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.1 m-80 -64.55 -5.0 4.62 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.506 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 74.29 2.06 61.98 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.577 ' HB ' ' CB ' ' A' ' 27' ' ' ALA . 3.0 mt -50.22 -30.1 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.329 -1.1 . . . . 0.0 109.393 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 54.0 m-85 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 112.064 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.2 p . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.852 0.358 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.13 41.96 11.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.32 37.03 22.32 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 10.2 t -126.96 -22.24 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 111.152 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.589 ' CB ' ' NE2' ' A' ' 87' ' ' GLN . . . 58.22 60.72 2.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.381 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.61 7.18 4.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.349 -0.845 . . . . 0.0 110.455 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.554 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.68 116.36 30.64 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.254 -0.904 . . . . 0.0 112.069 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.533 ' CB ' HG12 ' A' ' 74' ' ' VAL . . . -74.98 0.31 16.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 45' ' ' CYS . 9.4 t -85.42 -29.55 24.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.903 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.585 ' CB ' ' OG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -89.38 11.79 18.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.017 -1.052 . . . . 0.0 109.384 179.12 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.655 ' CG ' ' CG ' ' A' ' 102' ' ' PRO . 11.1 t-160 -42.5 139.83 1.41 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 83' ' ' ARG . 34.9 m -146.51 154.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 122.09 0.948 . . . . 0.0 109.929 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 11.9 m-85 -121.67 129.34 52.7 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.264 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 19.1 t -96.12 167.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.772 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.555 ' ND2' ' CG2' ' A' ' 98' ' ' VAL . 25.3 p-10 -91.97 136.1 33.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.722 -1.237 . . . . 0.0 109.337 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.8 pt-20 -37.1 -26.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.81 . . . . 0.0 111.989 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -69.81 -16.52 63.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.871 -1.143 . . . . 0.0 111.681 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.682 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 68.1 m-85 -131.11 -10.81 3.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.729 -1.232 . . . . 0.0 110.945 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.556 HG23 ' HB2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -80.57 -26.82 37.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 109.018 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.4 -31.59 63.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.983 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . 1.5 mmtt -79.92 -53.0 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' HB ' ' CG2' ' A' ' 88' ' ' ILE . 5.4 m -40.43 147.04 0.4 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.514 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 41.3 Cg_endo -68.52 170.7 14.43 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.397 1.735 . . . . 0.0 111.146 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 135.4 36.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.33 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -69.2 177.09 2.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 110.884 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -100.22 -156.13 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.338 -0.851 . . . . 0.0 111.015 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.7 pp20? -80.34 -30.79 38.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.514 ' NE ' ' O ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -65.0 -37.8 88.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.126 -0.984 . . . . 0.0 109.449 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.587 ' HG3' ' HG2' ' A' ' 87' ' ' GLN . 2.3 tm-20 -67.73 -6.89 23.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.684 -0.635 . . . . 0.0 109.478 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.573 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -91.47 -35.57 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 110.909 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -77.36 -65.31 1.95 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.174 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.864 ' HG3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.71 -48.55 40.27 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.017 1.389 . . . . 0.0 108.333 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.65 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -58.91 -30.47 67.84 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.184 -176.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -81.26 -39.58 25.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.6 -0.688 . . . . 0.0 109.476 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.32 -41.53 38.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.816 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG22 ' ND1' ' A' ' 49' ' ' HIS . 2.8 m -90.42 67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.464 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.0 t -48.79 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.685 -0.635 . . . . 0.0 111.349 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.16 64.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.49 60.16 1.64 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.241 1.02 . . . . 0.0 109.813 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' CD1' HD21 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -46.87 134.65 9.91 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.991 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -125.36 -176.86 0.5 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.0 Cg_endo -67.04 -25.53 44.04 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.173 1.091 . . . . 0.0 111.297 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB2' HG23 ' A' ' 57' ' ' THR . 26.0 p-10 -97.91 -13.13 21.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.813 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 1.4 m -54.44 151.34 7.83 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.596 -1.315 . . . . 0.0 109.761 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.562 ' CG ' ' HG2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -175.63 163.76 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.188 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.864 HD13 ' HG3' ' A' ' 70' ' ' MET . 0.4 OUTLIER -83.16 145.09 29.39 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.489 -0.757 . . . . 0.0 109.986 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 60.3 p -40.83 -32.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 123.116 1.436 . . . . 0.0 107.973 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.588 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -94.35 46.39 1.15 Allowed 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.589 ' NE2' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -127.43 -43.29 1.61 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.493 -1.379 . . . . 0.0 113.374 -178.44 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.28 152.88 5.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 122.044 0.926 . . . . 0.0 112.341 -176.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 90' ' ' MET . 6.9 mm -106.35 165.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.541 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tpt -110.17 117.7 34.39 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.385 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 10.4 p -95.41 165.67 16.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.648 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.9 Cg_endo -73.25 -1.38 10.52 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.929 1.489 . . . . 0.0 110.345 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -110.08 -51.79 2.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 109.097 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.541 ' O ' ' CE ' ' A' ' 90' ' ' MET . 1.3 mt -65.85 57.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.501 -0.749 . . . . 0.0 110.474 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.523 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 1.8 p30 -101.74 142.9 32.37 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.967 -1.083 . . . . 0.0 112.721 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.654 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.68 23.82 8.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.682 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.78 149.99 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.344 1.068 . . . . 0.0 112.904 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.555 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 22.1 t -115.09 123.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.788 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.59 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.1 t -103.94 176.7 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.828 -1.17 . . . . 0.0 109.423 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 51' ' ' TYR . 3.0 m-20 -162.53 143.85 10.31 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.349 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.578 HG13 ' CE1' ' A' ' 8' ' ' HIS . 53.2 t -94.26 132.98 28.0 Favored Pre-proline 0 C--N 1.287 -2.128 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.608 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.655 ' CG ' ' CG ' ' A' ' 49' ' ' HIS . 37.8 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 O-C-N 123.548 1.289 . . . . 0.0 112.852 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.313 0.578 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.34 123.07 21.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.666 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 35.1 t -124.3 144.15 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.515 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 14.8 t -131.9 124.54 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.486 0.66 . . . . 0.0 109.317 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.666 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 69.6 m-85 -102.73 141.6 35.28 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.652 -0.655 . . . . 0.0 111.434 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.7 t -120.84 148.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.901 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 2.2 p -110.15 139.33 45.41 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -45.36 -22.11 0.12 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.085 -1.009 . . . . 0.0 110.023 -179.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 9.9 p-10 -82.46 -7.66 59.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.987 -1.071 . . . . 0.0 110.374 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . 110.54 -36.87 4.02 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.173 -0.954 . . . . 0.0 111.673 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.493 HG23 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.64 145.33 5.16 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.586 -1.538 . . . . 0.0 109.499 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 9.8 mtt180 -130.05 158.03 40.75 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.573 -0.704 . . . . 0.0 111.187 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HG2' ' CD1' ' A' ' 32' ' ' ILE . 2.6 ttp180 -140.19 122.07 15.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 1.1 mp0 -98.86 123.19 42.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.725 -1.234 . . . . 0.0 110.79 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.631 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 9.4 mt -110.4 147.92 33.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -99.96 90.16 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.559 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 55.9 t -98.83 172.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 111.045 -177.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -124.64 -140.77 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.682 . . . . 0.0 110.324 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.91 123.42 47.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.63 -3.07 29.15 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.59 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 58.1 t -102.52 169.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.732 -1.451 . . . . 0.0 110.519 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.515 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.53 165.29 15.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.808 -0.557 . . . . 0.0 109.553 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -55.57 -33.94 64.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.637 -1.289 . . . . 0.0 107.602 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.738 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.5 ttt -68.43 -65.83 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.547 ' CG ' HG11 ' A' ' 21' ' ' VAL . 6.4 tt0 -38.05 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' CB ' HD11 ' A' ' 15' ' ' LEU . . . -43.8 -56.7 3.67 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.418 -1.426 . . . . 0.0 109.187 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -54.3 -58.71 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.929 0.871 . . . . 0.0 109.535 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.582 ' CG1' ' N ' ' A' ' 29' ' ' SER 0.277 1.2 t -31.37 -63.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.563 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.582 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.64 -47.04 87.15 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.119 0.961 . . . . 0.0 109.042 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.584 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 4.9 m-80 -59.67 -9.69 2.93 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.89 63.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 7.8 mt -41.99 -34.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.591 -0.947 . . . . 0.0 109.058 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.738 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.2 m-85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.858 . . . . 0.0 111.9 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 8.5 p . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.671 0.272 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.33 29.94 5.52 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.08 23.32 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.33 7.24 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.165 -1.197 . . . . 0.0 111.915 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' CB ' ' NE2' ' A' ' 87' ' ' GLN . . . 71.44 53.28 0.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 0.0 112.329 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.532 ' CA ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -132.57 34.35 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.762 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.2 p -111.39 122.26 47.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -85.82 7.85 22.29 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.127 -1.608 . . . . 0.0 107.887 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.2 p -110.84 -42.47 4.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.757 . . . . 0.0 112.121 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.595 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.6 m -75.34 19.16 0.18 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.54 -1.35 . . . . 0.0 111.791 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.616 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 5.0 t-160 -45.58 137.25 5.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.576 -1.327 . . . . 0.0 108.225 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 17.3 m -139.63 155.2 25.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.775 -1.203 . . . . 0.0 109.952 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.644 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.1 m-30 -119.02 122.18 41.57 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.153 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.562 ' CG1' HD12 ' A' ' 97' ' ' ILE . 5.2 t -100.55 174.66 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.325 -0.859 . . . . 0.0 109.859 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.563 ' O ' ' CG2' ' A' ' 57' ' ' THR . 10.2 p30 -94.68 137.36 33.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.768 -1.208 . . . . 0.0 109.075 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 53' ' ' ASN . 8.9 pm0 -37.98 -25.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.342 -0.849 . . . . 0.0 111.625 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.49 -44.74 64.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 111.875 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.645 ' CD2' ' HA ' ' A' ' 97' ' ' ILE . 53.4 m-85 -99.12 -9.45 23.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.658 -1.277 . . . . 0.0 111.831 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -80.29 -33.11 37.95 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.521 -1.362 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.91 -27.02 57.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -79.93 -53.72 6.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 57' ' ' THR . 11.9 m -41.17 163.49 0.1 Allowed Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 121.472 -0.767 . . . . 0.0 110.337 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -64.89 161.86 34.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.032 1.543 . . . . 0.0 111.915 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.63 26.27 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.815 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -69.59 152.72 44.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 27.6 p-10 -100.18 -173.04 2.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.102 -0.999 . . . . 0.0 111.187 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -54.43 -18.63 4.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.51 -55.77 18.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.1 tm-20 -59.55 -5.1 0.75 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.837 -0.539 . . . . 0.0 111.4 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -91.25 -16.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.344 -1.472 . . . . 0.0 111.488 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.29 -82.45 1.37 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.666 -1.271 . . . . 0.0 110.388 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.663 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -47.84 -33.74 7.81 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.005 -1.291 . . . . 0.0 109.755 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' CD2' ' CE1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -65.09 -29.32 70.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -90.32 -23.8 21.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.541 -0.724 . . . . 0.0 109.575 178.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.537 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 16.2 m -48.94 -44.72 40.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 108.779 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -90.53 80.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.042 178.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.8 t -47.9 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.423 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 77' ' ' GLU . . . -118.83 55.41 0.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.777 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 78' ' ' LEU . 1.6 pm0 39.54 48.64 1.84 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 109.457 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' CD1' HD21 ' A' ' 71' ' ' LEU . 1.7 tp -19.81 133.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.524 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -100.81 170.66 6.31 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -68.16 -27.77 34.98 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.559 1.294 . . . . 0.0 109.46 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.526 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 24.4 p-10 -105.77 -4.65 20.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.6 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.9 m -48.83 158.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 0.0 111.036 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.513 ' NH2' ' HB1' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -175.11 167.57 3.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.634 -0.666 . . . . 0.0 109.627 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -88.68 143.82 26.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.982 . . . . 0.0 110.368 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 6.4 p -46.57 -36.39 6.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 110.576 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.469 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 12.1 m -94.04 37.43 1.09 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 111.386 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.675 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 2.9 mm-40 -126.65 -43.27 1.74 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 112.259 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.481 HD13 HG23 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -84.18 148.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.549 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 90' ' ' MET . 5.8 mm -111.07 164.17 7.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.762 -0.586 . . . . 0.0 109.788 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.576 ' HE3' ' CG1' ' A' ' 97' ' ' ILE . 2.0 tpt -110.28 86.96 2.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.303 -0.873 . . . . 0.0 110.028 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.47 ' O ' ' OG ' ' A' ' 1' ' ' SER . 1.3 p -70.54 163.41 63.6 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.46 -0.775 . . . . 0.0 109.858 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -76.93 0.84 9.26 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.9 1.474 . . . . 0.0 110.144 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.528 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 22.8 pt-20 -110.03 -21.28 12.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 109.47 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.528 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 10.5 mt -103.98 63.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 109.826 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.55 147.45 25.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.476 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.12 24.36 9.05 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.645 ' HA ' ' CD2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -65.05 122.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 122.748 1.261 . . . . 0.0 113.045 -176.33 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.455 ' N ' HD11 ' A' ' 97' ' ' ILE . 3.8 t -98.75 116.03 40.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.486 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -104.34 -175.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.38 1.086 . . . . 0.0 110.381 -179.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 51' ' ' TYR . 11.5 m-20 -161.99 139.81 8.81 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.128 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 6' ' ' VAL . 5.3 t -96.06 108.04 38.57 Favored Pre-proline 0 C--N 1.289 -2.048 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.644 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.1 Cg_endo . . . . . 0 C--N 1.304 -1.768 0 O-C-N 124.175 1.619 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' CA ' ' O ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.513 0.673 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 105.91 4.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.65 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 4.8 t -109.94 145.92 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.051 -1.031 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 6.7 t -131.19 132.55 63.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.438 -0.789 . . . . 0.0 109.538 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.684 ' HE1' ' HB3' ' A' ' 23' ' ' LEU . 70.9 m-85 -110.21 129.04 55.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.011 0.91 . . . . 0.0 112.02 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 2.2 t -102.08 119.46 50.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.762 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.524 ' OG ' ' CB ' ' A' ' 11' ' ' THR . 91.5 p -79.62 130.29 35.23 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.56 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -38.18 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.749 -0.594 . . . . 0.0 111.049 -179.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.8 p30 -79.36 -3.07 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.989 -1.069 . . . . 0.0 110.672 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 7' ' ' SER . . . 109.99 -33.48 5.99 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.524 ' CB ' ' OG ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.71 142.06 9.06 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.946 -1.326 . . . . 0.0 109.29 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 27.8 mtt180 -126.98 120.84 30.04 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.345 0.593 . . . . 0.0 111.074 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 5' ' ' TYR . 3.0 ttp180 -99.94 153.04 19.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 5.3 mt-10 -130.51 134.09 46.77 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.852 -1.155 . . . . 0.0 110.238 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 7.4 mt -122.13 144.32 49.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -99.91 86.28 3.24 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.584 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 43.8 t -98.43 172.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.59 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' N ' HG13 ' A' ' 17' ' ' VAL . . . -125.78 -146.52 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 111.282 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -96.71 122.07 39.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.594 0.712 . . . . 0.0 110.354 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.23 -13.14 31.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' SER . 32.7 t -88.26 169.74 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.018 -1.284 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.49 152.24 39.37 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.684 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 5.4 mt -52.17 -23.29 5.28 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.336 -1.746 . . . . 0.0 107.788 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.721 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -73.17 -66.05 0.73 Allowed 'General case' 0 C--O 1.202 -1.421 0 CA-C-O 121.595 0.712 . . . . 0.0 109.887 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.536 ' NE2' ' HA ' ' A' ' 21' ' ' VAL 0.256 6.7 tt0 -37.13 -70.29 0.1 Allowed 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.735 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.584 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -49.66 -58.93 4.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.94 -1.725 . . . . 0.0 108.666 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.67 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -47.91 -58.74 4.0 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 108.888 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.284 1.0 OUTLIER -34.29 -64.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.715 178.176 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.577 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.03 -46.96 86.9 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.872 0.844 . . . . 0.0 109.6 179.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.542 ' ND2' HD21 ' A' ' 15' ' ' LEU . 2.8 m-80 -59.87 -7.01 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.419 0.628 . . . . 0.0 109.735 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.59 -18.82 44.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 59.5 mt -40.79 -38.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -1.028 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.721 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 23.4 m-85 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.96 . . . . 0.0 113.224 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 121.258 0.552 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.26 31.2 4.52 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.0 32.03 37.33 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 9.6 m -131.45 5.32 4.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 0.0 111.172 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.657 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 71.09 47.93 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.242 -0.911 . . . . 0.0 112.312 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 39' ' ' CYS . 3.2 m -133.16 44.53 2.82 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.709 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.96 153.5 25.43 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.497 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -111.55 -3.45 15.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.229 -0.92 . . . . 0.0 108.826 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 p -110.18 -30.49 7.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.272 -0.892 . . . . 0.0 112.039 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.567 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.1 m -80.32 34.0 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.545 -1.347 . . . . 0.0 110.964 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.576 ' NE2' HD22 ' A' ' 71' ' ' LEU . 8.0 t-160 -60.7 132.8 55.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.923 -1.111 . . . . 0.0 108.091 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.527 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 19.0 m -139.44 155.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.783 -1.198 . . . . 0.0 109.939 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.618 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.3 m-30 -116.21 106.34 13.58 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.928 0.871 . . . . 0.0 109.587 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 99' ' ' VAL . 15.8 t -88.09 148.47 4.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.547 ' OD1' ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -73.08 127.4 32.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 119.516 -1.99 . . . . 0.0 109.661 178.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' CA ' HG22 ' A' ' 57' ' ' THR . 16.8 pt-20 -34.38 -35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.698 -0.626 . . . . 0.0 111.621 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -55.26 -16.61 3.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.704 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 60.4 m-85 -128.66 -16.17 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.683 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.576 ' CG2' ' HB2' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -80.29 -32.01 38.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 108.984 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.1 p-10 -74.52 -27.28 60.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . 2.2 mmtt -79.88 -53.7 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.498 -0.752 . . . . 0.0 109.763 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 57' ' ' THR . 12.3 m -42.98 166.83 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 110.029 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.7 Cg_endo -62.26 162.16 24.4 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.966 1.508 . . . . 0.0 111.96 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.91 125.32 29.97 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.044 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HB1' ' NH1' ' A' ' 83' ' ' ARG . . . -69.78 146.28 51.56 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 109.768 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.547 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.65 -172.37 2.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.108 -0.995 . . . . 0.0 111.972 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -53.97 -20.81 6.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.59 . . . . 0.0 110.869 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.547 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 4.3 ttm180 -64.09 -55.59 20.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.47 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.3 tt0 -58.64 -49.97 75.55 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.716 -0.615 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.3 mp -48.01 -26.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 111.457 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.75 -68.7 1.19 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.657 ' CE ' ' O ' ' A' ' 43' ' ' ALA . 2.2 ptm -48.51 -41.47 30.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.83 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' CB ' ' O ' ' A' ' 67' ' ' GLU 0.25 0.0 OUTLIER -71.1 -24.19 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.925 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 2.5 tt0 -90.78 -13.41 33.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.731 -0.605 . . . . 0.0 109.87 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 46' ' ' ALA . 9.7 m -48.52 -49.68 35.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 108.861 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 4.3 m -90.32 92.9 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.1 t -48.29 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.369 -0.832 . . . . 0.0 110.757 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -124.49 50.59 1.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.1 pt-20 39.39 60.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.634 0.73 . . . . 0.0 109.609 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.8 OUTLIER -30.54 122.06 0.2 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.573 0.702 . . . . 0.0 111.806 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.606 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -86.05 171.21 10.87 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.8 Cg_endo -66.72 -25.91 46.05 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.46 1.242 . . . . 0.0 109.485 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.576 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 6.7 p-10 -109.87 -4.13 16.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.619 -0.676 . . . . 0.0 111.394 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.594 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.2 m -48.71 143.9 4.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.674 -1.266 . . . . 0.0 110.588 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.536 ' HD2' ' CG ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -154.86 165.53 36.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.0 110.046 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -88.4 143.08 27.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.362 -0.836 . . . . 0.0 109.369 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.567 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 5.7 p -46.64 -46.37 19.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.74 -1.225 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 2.8 m -91.91 38.82 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.598 -0.689 . . . . 0.0 109.893 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.538 ' NE2' ' HE3' ' A' ' 70' ' ' MET . 4.5 tp-100 -123.28 -40.99 2.33 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.41 -0.806 . . . . 0.0 111.318 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.531 ' CD1' ' CB ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -92.73 149.73 4.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.31 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.483 HG21 ' N ' ' A' ' 90' ' ' MET . 4.6 mm -110.7 164.28 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.533 ' HE1' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -110.4 126.37 54.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.96 -1.088 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.482 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.55 159.86 28.06 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.722 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -72.71 -1.61 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.915 1.481 . . . . 0.0 110.514 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -110.06 -28.59 8.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.588 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.53 ' O ' ' CE ' ' A' ' 90' ' ' MET . 7.5 mt -93.48 37.77 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.073 0.94 . . . . 0.0 109.286 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' CB ' ' OG ' ' A' ' 1' ' ' SER . 1.6 p-10 -82.06 142.83 31.98 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.707 0.765 . . . . 0.0 112.196 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.36 28.33 7.23 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.704 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.99 133.7 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 122.173 0.987 . . . . 0.0 112.483 -177.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.547 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 16.5 t -102.44 101.63 12.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.373 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -104.59 170.15 2.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.063 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -144.32 172.19 13.27 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.197 0.999 . . . . 0.0 111.57 -176.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.56 HG13 ' CE1' ' A' ' 8' ' ' HIS . 98.9 t -107.08 109.4 62.99 Favored Pre-proline 0 C--N 1.297 -1.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.264 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.618 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 47.0 Cg_endo . . . . . 0 C--N 1.305 -1.728 0 O-C-N 123.981 1.516 . . . . 0.0 111.585 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -70.18 125.28 26.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.698 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.663 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 3.2 t -121.76 136.88 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.975 -1.078 . . . . 0.0 110.231 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 95.1 t -121.14 110.75 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 112.197 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.663 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 19.6 m-30 -82.27 131.4 35.23 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.423 0.63 . . . . 0.0 111.708 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 4.4 t -120.49 128.78 76.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.064 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 26.8 p -79.33 -159.78 0.21 Allowed 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.95 -1.1 . . . . 0.0 108.5 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -11.33 19.39 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.895 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.55 -0.75 37.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 0.0 109.565 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 -19.9 26.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.464 ' CB ' ' OG ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.82 143.04 7.99 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.958 -1.319 . . . . 0.0 109.223 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 17.2 mtt180 -124.1 139.21 54.16 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.428 0.633 . . . . 0.0 111.329 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.655 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.25 67.82 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 4.0 mp0 -67.51 140.97 57.05 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.919 -1.113 . . . . 0.0 110.849 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 5' ' ' TYR . 8.8 mt -109.72 150.76 27.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.691 -0.631 . . . . 0.0 110.043 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.35 85.78 3.26 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.562 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 40.7 t -98.76 171.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.666 0.746 . . . . 0.0 111.337 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -118.57 -139.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.454 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -105.58 125.73 51.33 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.452 -0.78 . . . . 0.0 110.198 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.67 29.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 61.1 t -102.18 170.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.933 -1.333 . . . . 0.0 110.199 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.504 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.73 160.33 23.56 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' CD2' ' SD ' ' A' ' 90' ' ' MET . 16.8 mt -54.97 -18.4 4.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.694 -1.254 . . . . 0.0 109.448 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 1.225 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -90.23 -58.18 2.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.257 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.7 tt0 -38.63 -64.77 0.41 Allowed 'General case' 0 C--N 1.289 -2.062 0 O-C-N 122.127 -0.358 . . . . 0.0 110.762 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . . . -48.38 -55.97 9.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.437 -1.415 . . . . 0.0 108.283 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.583 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -52.72 -55.92 19.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' ' 33' ' ' TYR 0.264 0.7 OUTLIER -37.32 -47.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.472 177.592 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.519 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.8 -43.81 21.76 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.516 ' ND2' HD23 ' A' ' 15' ' ' LEU . 1.7 m-80 -59.86 -8.08 2.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 109.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.34 -18.4 18.53 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' A' ' 5' ' ' TYR . 58.2 mt -48.92 -29.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.851 -1.382 . . . . 0.0 107.643 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.677 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 3.1 m-85 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.1 p . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.106 0.479 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 48.26 25.48 4.22 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.03 28.81 61.71 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' CYS . 10.3 p -140.23 28.09 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.3 . . . . 0.0 111.998 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 66.56 45.29 2.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.547 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -130.6 46.79 2.61 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.078 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.664 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -111.72 157.06 20.95 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -177.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -112.0 -9.76 13.98 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.677 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.2 p -110.48 -30.11 7.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -0.78 . . . . 0.0 112.618 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 3.4 m -73.99 66.88 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.31 -1.494 . . . . 0.0 110.197 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.564 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 4.0 t-160 -87.85 132.74 34.08 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 17.1 m -142.29 155.24 18.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 109.277 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.679 ' CD1' ' HE2' ' A' ' 79' ' ' LYS . 5.1 m-30 -120.2 118.11 29.65 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 121.675 0.75 . . . . 0.0 111.015 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 42.2 t -97.96 165.71 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.346 -0.846 . . . . 0.0 109.643 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' ND2' ' CG2' ' A' ' 98' ' ' VAL . 21.1 p-10 -89.41 138.31 31.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.38 -1.45 . . . . 0.0 109.388 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -38.38 -26.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.382 -0.824 . . . . 0.0 111.441 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -68.31 -18.0 64.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.965 -1.084 . . . . 0.0 111.551 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.657 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 38.5 m-85 -129.62 -14.44 4.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.776 -1.203 . . . . 0.0 110.796 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -80.88 -22.69 39.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.906 -1.121 . . . . 0.0 108.746 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -85.96 -23.97 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.825 . . . . 0.0 110.028 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.468 ' HB3' HD23 ' A' ' 94' ' ' LEU . 9.2 mmtt -79.5 -47.66 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.452 -0.78 . . . . 0.0 109.111 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.598 ' CG1' ' CG2' ' A' ' 88' ' ' ILE . 6.3 m -45.3 161.39 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.786 -0.571 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.512 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -65.19 163.34 29.43 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 112.325 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.21 124.14 29.04 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.76 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.562 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -88.66 160.26 17.45 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.55 -166.86 1.36 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 110.266 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.0 -24.27 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.838 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 4.1 ttm180 -64.79 -15.34 61.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.566 ' OE1' ' HG3' ' A' ' 87' ' ' GLN . 3.0 tp10 -100.28 -3.61 31.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -90.91 -59.3 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 111.445 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.88 -47.54 24.89 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.725 ' HB3' HD13 ' A' ' 84' ' ' LEU 0.33 1.3 ttp -48.79 -52.3 24.66 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 123.497 1.618 . . . . 0.0 108.666 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.558 ' CB ' ' O ' ' A' ' 67' ' ' GLU 0.293 0.0 OUTLIER -68.39 -33.85 74.98 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.043 -179.21 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HB2' ' CD2' ' A' ' 78' ' ' LEU . 6.7 tt0 -90.56 7.64 38.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 69' ' ' GLY . 5.5 m -48.83 -49.47 39.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.85 -1.156 . . . . 0.0 108.342 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 74' ' ' VAL . 4.3 m -90.48 113.35 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.02 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.9 t -48.57 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.823 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -125.2 44.82 2.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.558 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.7 pt-20 39.56 60.53 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.43 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 72' ' ' GLU . 2.5 tp -32.17 133.59 0.1 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.679 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 21.3 mtmt -110.44 172.01 3.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.708 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -66.26 -32.06 42.79 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.507 1.267 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.536 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 14.5 p-10 -98.79 -10.84 22.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.542 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 50.2 m -48.92 150.51 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 0.0 109.724 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.555 ' CD ' ' OE1' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -157.59 151.43 24.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.725 HD13 ' HB3' ' A' ' 70' ' ' MET . 0.4 OUTLIER -73.17 130.45 40.29 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.577 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -44.81 -20.98 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.991 -1.068 . . . . 0.0 112.149 -176.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 1.225 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 26.1 m -107.02 39.29 1.9 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.578 -1.326 . . . . 0.0 111.168 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.588 ' CG ' ' CB ' ' A' ' 84' ' ' LEU . 34.6 mm-40 -125.06 -45.26 1.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 110.634 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.598 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.88 143.25 12.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.9 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.0 mm -110.68 158.71 10.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.416 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.53 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 1.9 tpt -110.21 103.89 12.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -98.58 167.61 11.17 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.754 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -72.6 -0.36 8.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.584 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 3.7 pt-20 -110.04 -32.08 7.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 109.55 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.539 HD21 ' N ' ' A' ' 94' ' ' LEU . 6.8 mt -94.66 35.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.16 0.981 . . . . 0.0 109.187 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.538 ' CB ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -87.94 154.58 20.39 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.667 0.746 . . . . 0.0 112.101 -177.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.642 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.37 24.14 19.75 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.657 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -80.5 152.24 4.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.274 1.035 . . . . 0.0 112.577 -177.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.566 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 17.6 t -112.68 123.56 68.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -103.91 -175.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.86 -1.15 . . . . 0.0 109.933 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.9 m-20 -162.11 130.14 4.06 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.989 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 54.0 t -89.19 110.36 37.86 Favored Pre-proline 0 C--N 1.277 -2.549 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.615 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.4 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 124.029 1.542 . . . . 0.0 112.139 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.543 0.687 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -90.25 121.44 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.652 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 3.4 t -122.55 143.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.719 -1.238 . . . . 0.0 110.098 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 24.4 t -130.18 122.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.998 0.904 . . . . 0.0 109.147 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.652 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 42.1 m-85 -96.95 142.07 29.36 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.802 0.81 . . . . 0.0 111.035 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.53 HG12 ' CG ' ' A' ' 12' ' ' ARG . 2.9 t -113.48 114.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.39 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -79.6 124.56 28.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -32.4 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.005 -0.434 . . . . 0.0 112.144 -178.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 7' ' ' SER . 2.6 p-10 -66.99 -9.51 39.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.682 -1.261 . . . . 0.0 110.141 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . 110.0 -31.73 7.25 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.496 HG21 ' CB ' ' A' ' 7' ' ' SER . 2.7 t -61.58 133.61 55.86 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.965 -1.315 . . . . 0.0 109.272 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' CG ' HG12 ' A' ' 6' ' ' VAL . 13.4 mtm180 -118.53 132.3 56.21 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.169 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.534 ' CG ' HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.03 149.15 24.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 179.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 22.9 mt-10 -130.41 120.1 23.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.771 -1.206 . . . . 0.0 110.949 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.68 ' CD2' ' ND2' ' A' ' 30' ' ' ASN . 1.4 mp -116.87 177.62 4.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.257 1.027 . . . . 0.0 111.914 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -106.75 83.14 1.8 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 58.6 t -98.54 129.22 49.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.538 -0.726 . . . . 0.0 110.305 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' HB3' ' N ' ' A' ' 1' ' ' SER . . . -140.0 -171.47 3.18 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.523 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 90' ' ' MET . 1.9 p30 -41.23 115.4 0.6 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.856 0.836 . . . . 0.0 110.324 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.34 -22.23 22.89 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HA ' ' NE2' ' A' ' 25' ' ' GLN . 2.4 t -107.88 157.49 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.849 -1.383 . . . . 0.0 110.86 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -120.96 166.69 13.47 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 5.1 mp -58.42 -22.09 53.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.368 -1.457 . . . . 0.0 107.897 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.87 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.93 -72.12 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.643 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.555 ' NE2' ' HA ' ' A' ' 21' ' ' VAL . 4.8 tt0 -37.67 -67.6 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.877 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB2' HD21 ' A' ' 15' ' ' LEU . . . -42.37 -73.95 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.499 -1.376 . . . . 0.0 108.613 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -44.85 -44.74 9.76 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.9 OUTLIER -47.09 -60.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.587 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -50.27 -45.87 54.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.993 0.901 . . . . 0.0 108.748 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.68 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 1.5 m-80 -64.93 -2.34 2.58 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.789 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 79.54 11.68 84.54 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 27' ' ' ALA 0.268 3.8 mt -70.67 -31.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.568 -0.96 . . . . 0.0 109.134 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.715 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.4 m-85 . . . . . 0 N--CA 1.498 1.937 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.622 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.3 p . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.035 0.445 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.44 28.07 3.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.28 35.47 26.6 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.0 p -140.11 8.38 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -1.204 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.621 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 70.3 53.41 0.33 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.149 -0.969 . . . . 0.0 111.935 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.418 ' H ' ' HA ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -133.19 38.44 3.33 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.708 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.62 153.9 24.55 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.95 -2.22 16.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.658 -1.276 . . . . 0.0 108.789 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 p -110.02 -34.49 6.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 111.363 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.569 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 3.2 m -74.53 63.7 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.561 -1.337 . . . . 0.0 109.794 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.611 ' CD2' HD22 ' A' ' 71' ' ' LEU . 17.1 t-160 -91.78 133.13 35.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.477 HG12 ' OH ' ' A' ' 33' ' ' TYR . 16.9 m -144.58 154.82 14.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.808 -1.182 . . . . 0.0 109.943 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.707 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 7.7 m-30 -116.84 109.57 17.26 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' VAL . 16.4 t -86.28 158.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.372 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.6 ' ND2' ' CG2' ' A' ' 98' ' ' VAL . 11.5 p-10 -78.81 132.43 36.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 119.997 -1.689 . . . . 0.0 109.918 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 53' ' ' ASN . 12.1 pt-20 -38.65 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.98 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -63.87 -23.13 67.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.643 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 24.9 m-85 -122.71 -15.27 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.926 -1.109 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -78.65 -26.44 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.937 -1.105 . . . . 0.0 108.796 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.0 p-10 -81.83 -26.2 34.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.533 -0.729 . . . . 0.0 109.692 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.519 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . 12.5 mmtt -79.79 -52.04 8.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.498 -0.751 . . . . 0.0 109.492 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 57' ' ' THR . 10.3 m -40.76 162.55 0.1 Allowed Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.602 -0.686 . . . . 0.0 110.515 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.524 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.6 Cg_endo -66.74 165.57 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.068 1.562 . . . . 0.0 111.454 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.62 27.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.622 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.519 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -69.21 166.3 18.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.439 -0.788 . . . . 0.0 109.71 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -100.45 -158.2 0.66 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.977 -1.077 . . . . 0.0 110.929 -179.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 1.2 pp20? -78.38 -23.16 46.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.694 -0.628 . . . . 0.0 111.069 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.563 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.84 -48.46 74.28 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.801 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.591 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.11 -6.27 0.84 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.262 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.523 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.2 mp -91.39 -30.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.617 -1.302 . . . . 0.0 110.668 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.28 -63.22 1.25 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.637 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -48.08 -42.64 29.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 109.222 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 49' ' ' HIS 0.26 0.0 OUTLIER -69.45 -23.84 63.72 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.934 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -89.95 -18.68 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.511 -0.743 . . . . 0.0 110.029 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' GLU . 2.1 m -48.51 -31.43 6.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.578 ' CG2' ' ND1' ' A' ' 49' ' ' HIS . 20.4 m -90.32 87.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.547 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.3 t -48.41 82.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.269 -0.894 . . . . 0.0 111.506 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.39 40.85 3.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 10.0 pt-20 39.2 60.14 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.764 -0.585 . . . . 0.0 109.754 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.542 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.6 OUTLIER -19.93 125.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.264 0.554 . . . . 0.0 112.104 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.598 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -80.05 170.69 14.78 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.4 Cg_endo -65.85 -25.71 52.7 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.477 1.251 . . . . 0.0 109.564 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.542 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 20.6 p-10 -107.79 -8.25 16.09 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 111.33 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.592 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 45.7 m -49.44 158.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.614 -1.304 . . . . 0.0 111.205 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.524 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 2.3 ttp180 -175.51 156.48 1.96 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -73.29 135.47 44.42 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.571 ' CB ' ' HB2' ' A' ' 24' ' ' MET . 0.8 OUTLIER -45.46 -24.3 0.3 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.585 -177.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.87 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 14.3 m -104.79 42.64 1.18 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.894 -1.128 . . . . 0.0 111.401 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.585 ' NE2' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -125.07 -42.53 2.01 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.717 0.77 . . . . 0.0 110.501 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.531 HG23 ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -89.0 140.04 16.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.354 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 90' ' ' MET . 5.3 mm -110.68 172.56 2.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.534 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 1.2 tpt -110.15 115.85 30.48 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.13 -0.982 . . . . 0.0 111.029 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.468 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -96.8 169.56 8.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.664 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.9 -5.65 17.58 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.885 1.466 . . . . 0.0 110.556 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 10.8 pt-20 -110.29 -23.94 10.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.701 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' CE ' ' A' ' 90' ' ' MET . 7.2 mt -96.39 55.9 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -0.995 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -100.84 146.51 27.21 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.066 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.643 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.59 21.73 10.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.627 ' CG1' ' CB ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -62.48 150.47 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.183 0.992 . . . . 0.0 113.243 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.6 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 10.9 t -127.61 89.82 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.586 HG13 HG22 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -104.72 162.49 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.441 1.115 . . . . 0.0 110.51 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -145.51 170.13 17.01 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.913 -178.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 8' ' ' HIS . 42.3 t -110.17 128.84 24.69 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.707 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 37.5 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 O-C-N 123.771 1.406 . . . . 0.0 112.942 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.522 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.366 0.603 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' O ' HG21 ' A' ' 97' ' ' ILE . 1.6 ttmm -76.63 135.12 39.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.903 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.77 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 14.8 t -123.43 140.39 47.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.614 -1.304 . . . . 0.0 110.865 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 41.4 t -121.5 117.91 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 122.052 0.93 . . . . 0.0 111.504 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.77 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 22.5 m-30 -97.55 135.26 39.64 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.837 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 100' ' ' ASP . 14.4 t -120.05 154.09 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.48 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.529 ' CB ' HG21 ' A' ' 11' ' ' THR . 10.7 p -117.06 138.64 51.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -44.39 -24.28 0.17 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.151 -0.968 . . . . 0.0 110.338 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.5 p30 -85.03 -5.82 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.007 . . . . 0.0 110.401 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.19 -45.61 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.529 HG21 ' CB ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.73 124.52 9.84 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.877 -1.366 . . . . 0.0 110.011 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' CA ' ' O ' ' A' ' 5' ' ' TYR . 30.7 mtm180 -110.34 156.91 20.1 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.479 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.616 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -134.75 67.78 1.49 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 0.0 109.438 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 1.4 mp0 -69.48 131.49 44.82 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.563 0.697 . . . . 0.0 110.335 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.712 ' CD2' ' ND2' ' A' ' 30' ' ' ASN . 2.3 mp -114.77 173.5 6.45 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.236 1.017 . . . . 0.0 112.012 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.78 90.76 4.56 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.578 HG11 ' CG1' ' A' ' 21' ' ' VAL . 95.7 t -98.58 166.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.469 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -133.01 -160.74 1.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.757 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.487 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -82.41 123.75 29.41 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.564 0.697 . . . . 0.0 110.696 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.37 37.08 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.867 HG11 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -106.29 170.2 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 110.65 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.604 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -120.51 175.94 5.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -76.16 -3.67 37.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.216 -1.553 . . . . 0.0 108.218 178.049 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.589 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.18 -77.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 112.022 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.867 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -38.03 -23.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.905 -0.497 . . . . 0.0 111.176 -177.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.593 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -87.7 -45.06 10.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB1' ' CE2' ' A' ' 5' ' ' TYR 0.265 . . -66.33 -46.13 77.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.887 1.327 . . . . 0.0 107.492 176.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 29' ' ' SER 0.263 0.8 OUTLIER -45.92 -58.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.197 178.64 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.556 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.72 -35.79 75.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.031 178.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.712 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -72.87 12.15 0.56 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.444 0.64 . . . . 0.0 109.831 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 70.08 4.96 51.51 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.57 HG13 ' HB3' ' A' ' 30' ' ' ASN . 4.2 mt -66.43 -42.43 90.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -1.109 . . . . 0.0 109.459 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 23.5 m-85 . . . . . 0 C--N 1.301 -1.536 0 C-N-CA 119.183 -1.007 . . . . 0.0 113.448 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.61 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 21.7 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.066 0.46 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 42.59 35.28 1.98 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.27 28.25 49.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 39' ' ' CYS . 6.2 m -128.58 -3.65 5.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -1.092 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.567 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 72.81 51.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.765 0.793 . . . . 0.0 112.321 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.573 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -131.55 38.91 3.55 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -110.88 150.41 29.22 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.531 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -111.01 -4.4 15.14 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.554 -0.717 . . . . 0.0 109.667 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.463 ' HA ' HG12 ' A' ' 74' ' ' VAL . 6.2 t -110.56 -21.49 12.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.947 . . . . 0.0 112.754 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.63 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 34.9 m -75.02 11.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.367 -1.458 . . . . 0.0 111.243 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.629 ' CE1' ' CB ' ' A' ' 76' ' ' ALA . 3.3 t-160 -43.69 124.45 3.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 15.6 m -143.35 163.12 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 120.928 -1.107 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.648 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.8 m-30 -118.47 124.63 48.07 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.704 0.764 . . . . 0.0 111.147 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 t -99.58 165.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.571 ' O ' ' CG2' ' A' ' 57' ' ' THR . 9.7 p30 -82.85 134.58 35.09 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 119.892 -1.755 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.1 pt-20 -37.58 -25.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.455 -0.778 . . . . 0.0 111.765 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.535 ' CB ' ' OD1' ' A' ' 53' ' ' ASN . . . -70.68 -40.33 73.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.838 -1.163 . . . . 0.0 111.587 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.724 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 61.1 m-85 -102.71 -17.95 15.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.733 -1.229 . . . . 0.0 111.258 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.571 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -80.63 -23.43 39.75 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.927 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 55' ' ' ALA . 23.4 p-10 -82.95 -24.11 33.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.566 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.533 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 3.4 mmtp -79.85 -49.05 12.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.556 ' CG2' ' O ' ' A' ' 57' ' ' THR . 3.0 m -43.54 168.25 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 110.05 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.6 Cg_endo -62.17 164.71 16.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.029 1.541 . . . . 0.0 111.589 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.67 112.79 18.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.898 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . . . -69.58 147.24 50.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.763 . . . . 0.0 110.366 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.477 ' O ' HD11 ' A' ' 68' ' ' ILE . 23.6 p30 -100.07 -173.38 2.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 110.555 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -53.63 -26.92 24.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 70' ' ' MET . 5.4 ttm180 -64.83 -18.11 64.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 tm-20 -99.96 1.51 42.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.57 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.1 mp -91.89 -59.05 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 111.194 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -77.01 -47.77 9.01 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.702 ' HE1' HD11 ' A' ' 84' ' ' LEU 0.323 2.8 ttp -48.58 -50.72 31.26 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 123.547 1.641 . . . . 0.0 108.022 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.599 HD22 ' CD2' ' A' ' 49' ' ' HIS 0.296 0.0 OUTLIER -70.87 -32.44 69.43 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.709 -179.408 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 4.3 tt0 -89.16 -0.15 57.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.893 -1.129 . . . . 0.0 110.453 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -49.08 -52.34 26.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.631 -1.293 . . . . 0.0 108.438 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 31.1 m -90.48 107.95 19.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.481 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.15 103.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.838 -1.164 . . . . 0.0 109.254 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.629 ' CB ' ' CE1' ' A' ' 49' ' ' HIS . . . -120.07 22.51 11.41 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.608 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 71.7 38.27 0.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.672 1.225 . . . . 0.0 108.338 -178.408 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 77' ' ' GLU . 11.3 tp -19.26 134.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.979 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.609 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 2.4 mtpt -128.09 -169.24 0.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 46.2 Cg_endo -81.92 -30.64 1.26 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.697 1.367 . . . . 0.0 109.743 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.536 ' CB ' ' OG1' ' A' ' 57' ' ' THR . 13.7 p-10 -93.7 -12.17 29.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.731 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.577 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 18.6 m -49.23 155.52 0.68 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.042 . . . . 0.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.539 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 2.4 mtp180 -175.29 153.92 1.63 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.702 HD11 ' HE1' ' A' ' 70' ' ' MET . 11.1 mt -74.61 150.84 39.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 46.6 p -46.71 -25.94 0.83 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.528 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 2.8 m -110.13 44.95 1.15 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.732 0.777 . . . . 0.0 109.556 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -125.44 -32.77 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.595 ' CD1' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.35 147.18 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.628 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 90' ' ' MET . 5.0 mm -110.3 160.62 9.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.552 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.9 tpt -110.25 112.86 25.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.539 -0.726 . . . . 0.0 110.425 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -97.48 172.66 4.7 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.2 Cg_endo -72.67 -31.87 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.92 1.484 . . . . 0.0 110.558 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 2.4 pp20? -81.04 -44.96 17.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.883 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' CE ' ' A' ' 90' ' ' MET . 1.1 mt -75.81 52.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.115 -0.991 . . . . 0.0 111.018 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 4.3 p-10 -101.33 152.86 20.2 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.032 -1.042 . . . . 0.0 111.764 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.626 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.32 22.42 10.56 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.724 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 3.6 tt -72.55 154.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 123.175 1.464 . . . . 0.0 113.555 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.546 ' H ' ' ND2' ' A' ' 53' ' ' ASN 0.252 8.1 t -125.37 98.27 4.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.566 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -104.74 174.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.134 -1.427 . . . . 0.0 109.726 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.572 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.87 174.03 16.12 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.914 0.864 . . . . 0.0 111.024 -178.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 18.0 t -111.09 130.96 22.43 Favored Pre-proline 0 N--CA 1.498 1.956 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.429 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.648 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 49.7 Cg_endo . . . . . 0 N--CA 1.495 1.615 0 C-N-CA 121.695 1.597 . . . . 0.0 112.683 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.568 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.38 0.609 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -74.8 120.11 19.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.743 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.645 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 25.1 t -119.67 146.5 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.769 -1.207 . . . . 0.0 110.983 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 16.9 t -131.06 125.83 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.695 0.76 . . . . 0.0 109.856 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 49.2 m-85 -101.52 137.91 39.22 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.486 0.66 . . . . 0.0 111.922 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 2.5 t -120.77 132.73 69.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.023 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.503 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 67.6 p -79.39 -153.01 0.07 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.426 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -110.2 -8.13 14.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 120.97 -1.081 . . . . 0.0 108.98 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -100.37 1.65 41.64 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.41 -21.75 23.54 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.87 138.89 14.32 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.024 -1.28 . . . . 0.0 109.449 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 24.6 mtt180 -130.06 148.66 51.93 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.401 0.62 . . . . 0.0 111.215 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.538 ' CD ' HG12 ' A' ' 32' ' ' ILE . 1.4 ttm-85 -140.11 118.9 12.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.43 -0.794 . . . . 0.0 109.888 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 3.0 mp0 -100.42 124.43 45.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.797 -1.189 . . . . 0.0 110.835 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 10.8 mt -110.57 151.83 27.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 110.507 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.11 90.37 3.92 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 1' ' ' SER . 50.6 t -98.61 174.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 110.298 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.494 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -125.32 -133.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.518 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.482 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -110.03 124.04 50.75 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.51 -10.78 30.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 70.0 t -93.87 169.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.33 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.36 169.26 10.78 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.473 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 10.7 mt -60.91 -35.15 75.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.721 -1.237 . . . . 0.0 108.934 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.716 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.9 ttp -66.65 -62.47 1.44 Allowed 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.927 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.4 tt0 -38.14 -76.72 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.557 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -43.15 -56.39 3.44 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.331 -1.481 . . . . 0.0 109.754 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -56.74 -53.62 55.69 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.012 0.91 . . . . 0.0 109.412 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.638 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.284 1.2 t -35.47 -63.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.152 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.581 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.37 -46.67 85.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.112 0.958 . . . . 0.0 108.884 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.578 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.8 m-80 -59.93 -8.6 2.35 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 88.02 -14.64 58.37 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 7.6 mt -42.75 -38.41 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.692 -0.887 . . . . 0.0 108.643 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.716 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 72.3 m-85 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.498 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 1.3 p . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.026 0.441 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.4 42.92 7.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.8 39.59 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 9.8 p -120.9 -32.35 3.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.155 -1.203 . . . . 0.0 110.386 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 72.53 60.97 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.222 -0.924 . . . . 0.0 111.596 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -132.38 9.27 4.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.203 -0.936 . . . . 0.0 110.998 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.702 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.31 162.03 15.97 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.715 -1.241 . . . . 0.0 114.195 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.601 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -110.14 -22.27 11.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.813 -1.179 . . . . 0.0 110.463 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 t -69.83 -14.96 63.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.64 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -94.72 14.05 22.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 0.0 108.581 178.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.593 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 3.9 t-160 -46.98 138.52 6.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.531 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 15.7 m -144.78 157.09 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.817 -1.177 . . . . 0.0 109.923 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.682 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.8 m-30 -119.87 122.06 40.45 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.582 0.706 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.532 ' CG1' HG21 ' A' ' 57' ' ' THR . 38.7 t -99.44 151.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.12 -0.988 . . . . 0.0 110.354 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -74.57 125.32 28.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.133 -1.605 . . . . 0.0 109.414 178.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CA ' HG22 ' A' ' 57' ' ' THR . 2.7 pm0 -34.07 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.702 -0.624 . . . . 0.0 112.19 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . . . -62.7 -17.25 60.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.881 -1.137 . . . . 0.0 111.301 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.724 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 65.7 m-85 -125.35 -8.98 6.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.869 -1.145 . . . . 0.0 110.193 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.545 HG23 ' HB2' ' A' ' 81' ' ' ASN . 1.3 p -80.35 -34.76 36.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 108.914 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 -17.68 60.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.546 -0.721 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' CB ' HD11 ' A' ' 94' ' ' LEU 0.278 0.5 OUTLIER -79.34 -55.97 4.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 123.643 1.687 . . . . 0.0 109.423 179.584 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG13 ' CG2' ' A' ' 88' ' ' ILE 0.323 0.3 OUTLIER -77.62 145.4 71.2 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.068 -177.707 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD2' HG21 ' A' ' 60' ' ' VAL . 35.8 Cg_endo -61.75 160.0 30.62 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.847 1.446 . . . . 0.0 111.704 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.546 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -171.42 3.12 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.151 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 67' ' ' GLU . . . -100.2 158.92 15.52 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.186 0.517 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' HD11 ' A' ' 68' ' ' ILE . 24.8 p30 -100.45 -173.64 2.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 111.117 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 21.5 pt-20 -47.8 -24.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.0 ttm180 -64.5 -59.45 4.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.382 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' OE2' ' CG ' ' A' ' 83' ' ' ARG . 2.4 tt0 -66.96 14.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.558 -0.714 . . . . 0.0 111.975 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.2 mp -90.83 -37.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 119.282 -2.136 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.35 -57.28 1.68 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.673 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -48.0 -44.96 31.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.161 -1.199 . . . . 0.0 109.087 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.593 ' CD2' ' CE1' ' A' ' 49' ' ' HIS 0.3 0.0 OUTLIER -70.95 -30.96 67.4 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.531 -179.27 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 1.2 tt0 -90.9 -11.36 39.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.374 -0.829 . . . . 0.0 110.479 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.601 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.6 -50.98 30.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.706 -1.246 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 74' ' ' VAL . 16.3 m -90.21 96.28 6.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 108.878 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.8 t -48.05 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -126.87 45.96 2.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.799 . . . . 0.0 109.91 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.6 pt-20 39.34 58.31 1.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.764 0.792 . . . . 0.0 109.467 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.541 ' CD1' HD12 ' A' ' 71' ' ' LEU . 12.7 tp -29.72 131.72 0.07 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.56 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.637 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 6.8 mtpt -98.96 170.85 6.36 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.084 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.7 Cg_endo -67.4 -28.68 38.89 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.553 1.291 . . . . 0.0 109.768 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.545 ' HB2' HG23 ' A' ' 57' ' ' THR . 21.7 p-10 -105.01 -5.05 21.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 111.025 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 72.7 m -48.54 164.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.795 -1.191 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.594 ' CG ' ' OE2' ' A' ' 67' ' ' GLU . 3.1 mtt180 -175.33 174.81 2.29 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.608 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.702 ' CD1' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -96.69 142.25 28.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.44 -0.788 . . . . 0.0 109.341 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 24' ' ' MET . 15.2 m -45.54 -29.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.526 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 1.1 p -98.68 38.83 1.31 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.619 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.499 ' NE2' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -126.79 -44.72 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.189 -1.57 . . . . 0.0 113.289 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.541 ' CG2' HG13 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -85.54 150.99 3.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.715 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.452 HG21 ' N ' ' A' ' 90' ' ' MET . 5.4 mm -111.02 161.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.535 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.6 tpt -110.25 111.46 22.79 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.812 -1.18 . . . . 0.0 111.043 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.494 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -91.32 156.6 43.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 41.6 Cg_endo -68.95 -1.42 7.76 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.805 1.423 . . . . 0.0 111.264 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' C ' HD21 ' A' ' 94' ' ' LEU . 6.3 pm0 -110.09 -27.72 9.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.981 -1.075 . . . . 0.0 110.072 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.537 HD11 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -97.24 58.48 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.267 -0.896 . . . . 0.0 109.78 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.75 151.1 22.07 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.859 0.838 . . . . 0.0 112.612 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.0 21.08 12.32 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.724 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -76.26 142.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.079 . . . . 0.0 113.42 -176.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.523 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 21.2 t -107.97 128.82 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.592 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.8 t -104.07 -176.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.789 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 51' ' ' TYR . 9.5 m-20 -161.42 138.11 8.45 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.703 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 40.0 t -96.72 109.29 47.75 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.803 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.682 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 46.5 Cg_endo . . . . . 0 C--N 1.308 -1.583 0 C-N-CA 121.962 1.775 . . . . 0.0 112.309 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.523 ' OG ' ' CG ' ' A' ' 90' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.332 0.587 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.06 117.21 28.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.655 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 3.5 t -120.69 144.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 7.9 t -128.53 130.22 68.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 121.803 0.811 . . . . 0.0 109.386 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 44.9 m-85 -106.48 137.61 44.16 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.479 0.657 . . . . 0.0 112.263 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.596 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 3.5 t -120.17 127.97 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.713 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 11' ' ' THR . 87.4 p -79.47 154.29 29.0 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.213 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.611 ' ND1' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -67.6 -5.28 14.8 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.262 0.553 . . . . 0.0 109.827 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -93.33 -13.2 28.43 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.146 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 28.19 4.19 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.167 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.527 ' CG2' ' OG ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -109.83 144.42 38.3 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.835 -1.391 . . . . 0.0 108.064 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.529 ' CG ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -123.71 147.65 47.27 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.856 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.594 ' CD ' ' CD1' ' A' ' 32' ' ' ILE . 2.6 ttm-85 -140.04 146.96 39.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.601 -0.687 . . . . 0.0 109.205 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 12.1 mp0 -130.51 117.26 19.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.633 -1.292 . . . . 0.0 110.965 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.689 ' CD2' ' ND2' ' A' ' 30' ' ' ASN . 1.3 mp -115.15 -172.64 2.17 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.215 1.007 . . . . 0.0 111.974 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -115.74 98.53 6.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 41.4 t -98.48 99.89 9.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.61 -165.75 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.734 0.778 . . . . 0.0 111.281 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -72.02 121.9 19.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.684 0.754 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.73 -8.17 29.87 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.399 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 22' ' ' SER . 58.2 t -103.77 166.78 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.461 . . . . 0.0 110.637 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.521 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.92 153.3 37.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' O ' ' CE1' ' A' ' 5' ' ' TYR . 6.5 mt -46.37 -31.39 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.303 . . . . 0.0 109.949 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 1.465 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 11.5 ttt -77.69 -57.89 3.57 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.861 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.517 ' CG ' HG11 ' A' ' 21' ' ' VAL . 6.3 tt0 -37.23 -68.8 0.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.99 -0.444 . . . . 0.0 111.203 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 15' ' ' LEU . . . -44.37 -68.69 0.18 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.65 -1.281 . . . . 0.0 108.429 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB3' HD13 ' A' ' 32' ' ' ILE . . . -47.33 -46.71 25.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.907 0.861 . . . . 0.0 109.638 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 24' ' ' MET . 1.2 t -46.56 -62.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.586 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -48.24 -46.86 35.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.206 1.003 . . . . 0.0 108.674 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.689 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 1.3 m-80 -66.02 -2.38 3.99 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.11 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 82.34 -8.82 60.14 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.602 HD13 ' HB3' ' A' ' 27' ' ' ALA . 1.4 mt -42.51 -33.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -1.021 . . . . 0.0 109.422 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.706 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 61.2 m-85 -111.21 61.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.374 -0.93 . . . . 0.0 112.849 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.53 48.85 0.82 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.931 -1.106 . . . . 0.0 108.023 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.461 HD13 HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -83.43 -141.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.745 . . . . 0.0 110.698 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.461 HG23 HD13 ' A' ' 35' ' ' ILE . 13.3 m -93.18 -158.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' OD1' ' A' ' 38' ' ' ASP . . . -120.05 79.82 0.32 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.9 m-20 -120.16 -69.18 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 109.651 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.644 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 23.7 p -69.84 -33.49 72.36 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.14 33.45 2.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.91 31.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' CYS . 43.7 t -140.09 7.98 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.375 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 65.67 56.75 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.316 1.055 . . . . 0.0 110.997 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.543 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -132.28 31.6 4.07 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -110.77 153.13 25.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -111.39 -4.44 14.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.543 -0.723 . . . . 0.0 109.101 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.453 ' OG1' HD11 ' A' ' 35' ' ' ILE . 16.5 p -110.34 -22.77 11.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.325 -0.859 . . . . 0.0 112.551 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.641 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 61.6 m -74.72 7.64 2.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.271 -1.518 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.605 ' CD2' HD22 ' A' ' 71' ' ' LEU . 2.2 t-160 -43.13 120.2 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.014 . . . . 0.0 108.339 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 14.9 m -142.96 164.71 16.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.011 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.728 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 12.5 m-30 -115.05 119.23 35.74 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.588 0.708 . . . . 0.0 110.293 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 97' ' ' ILE . 29.3 t -85.53 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -59.13 131.59 51.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.548 -1.97 . . . . 0.0 109.711 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CA ' HG22 ' A' ' 57' ' ' THR . 11.3 pt-20 -36.69 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.55 -42.39 67.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.454 -1.404 . . . . 0.0 112.172 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.652 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 49.6 m-85 -93.85 -4.56 49.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.748 -1.22 . . . . 0.0 109.956 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.533 HG22 ' CA ' ' A' ' 54' ' ' GLU . 4.5 p -81.06 -24.78 37.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -86.04 -30.24 22.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -0.803 . . . . 0.0 109.966 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . 7.6 mmtt -79.74 -50.04 11.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' A' ' 88' ' ' ILE . 4.5 m -39.73 162.92 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 110.975 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' HG21 ' A' ' 88' ' ' ILE . 38.8 Cg_endo -67.49 166.51 23.57 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.352 1.712 . . . . 0.0 110.957 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 115.18 20.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.822 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.53 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -69.44 146.63 51.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.484 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' O ' HD12 ' A' ' 68' ' ' ILE . 22.7 p30 -99.9 174.0 6.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.95 -1.094 . . . . 0.0 111.458 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 1.7 pp20? -43.31 -29.18 0.39 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.884 -0.51 . . . . 0.0 110.913 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.1 OUTLIER -64.69 -21.46 66.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.013 -1.054 . . . . 0.0 109.774 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' CG ' ' HG3' ' A' ' 83' ' ' ARG . 3.4 tm-20 -95.88 1.96 53.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.513 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -91.78 -61.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 111.297 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -73.24 -48.52 19.04 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.725 ' HE1' HD11 ' A' ' 84' ' ' LEU 0.308 3.3 ttp -48.63 -49.26 38.0 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 123.312 1.53 . . . . 0.0 108.496 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.605 HD22 ' CD2' ' A' ' 49' ' ' HIS 0.298 0.0 OUTLIER -72.35 -33.02 66.97 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.269 -179.547 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 3.2 tt0 -86.15 8.59 20.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.091 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' SG ' ' CB ' ' A' ' 46' ' ' ALA . 34.4 m -49.03 -49.44 41.13 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.66 -1.275 . . . . 0.0 108.216 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 76' ' ' ALA . 13.2 m -90.52 115.88 30.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.574 ' O ' ' CG2' ' A' ' 75' ' ' THR . 13.1 t -48.76 85.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 111.203 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 49' ' ' HIS . . . -117.17 36.38 4.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.931 -1.106 . . . . 0.0 109.977 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.23 52.55 2.15 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.526 0.679 . . . . 0.0 110.192 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -19.79 119.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.553 0.692 . . . . 0.0 112.13 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.588 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -83.46 -168.01 0.17 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.371 -0.831 . . . . 0.0 108.762 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 42.8 Cg_endo -81.07 -27.17 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.584 1.307 . . . . 0.0 109.395 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.512 ' HB2' HG23 ' A' ' 57' ' ' THR . 16.4 p30 -107.73 -5.55 17.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 111.319 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.6 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 21.5 m -48.97 153.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.617 -1.302 . . . . 0.0 110.409 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.665 ' HG2' ' OE1' ' A' ' 87' ' ' GLN . 4.9 mtp180 -175.03 153.28 1.61 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.484 -0.76 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.902 ' O ' ' NE2' ' A' ' 87' ' ' GLN . 11.0 mt -74.6 137.62 42.43 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.641 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 24.3 p -39.58 -22.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.137 -1.602 . . . . 0.0 113.257 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 1.465 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 11.5 m -110.82 43.43 1.43 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.6 -33.26 2.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.217 -1.552 . . . . 0.0 111.731 178.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.617 ' CG1' ' OE1' ' A' ' 87' ' ' GLN . 2.3 mt -85.73 148.37 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.007 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mm -111.43 156.04 12.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.616 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 20.6 tpp -108.37 128.59 54.9 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 120.668 -1.27 . . . . 0.0 111.525 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.491 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -97.13 167.78 11.38 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.56 -0.71 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.743 1.391 . . . . 0.0 111.261 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.6 pp20? -110.32 -40.75 4.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.636 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.616 ' O ' ' CE ' ' A' ' 90' ' ' MET . 1.5 mt -73.65 58.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.28 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.495 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.71 146.52 27.12 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.442 -1.411 . . . . 0.0 112.087 -178.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 105.46 20.14 9.86 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.652 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -73.04 136.56 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 122.365 1.079 . . . . 0.0 111.833 -177.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.514 ' N ' HD13 ' A' ' 97' ' ' ILE . 60.8 t -110.94 122.8 66.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.209 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.596 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 1.5 t -104.27 169.1 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.709 -1.244 . . . . 0.0 109.881 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.3 m-20 -162.06 138.84 8.13 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.73 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 8' ' ' HIS . 4.1 t -90.69 135.34 29.22 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.728 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 33.6 Cg_endo -66.92 126.53 15.4 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.757 1.398 . . . . 0.0 114.767 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.611 ' HA ' ' ND1' ' A' ' 8' ' ' HIS . 7.6 p-10 -103.5 27.34 7.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.534 ' CZ ' ' O ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -49.47 -18.64 0.43 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.193 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.412 ' N ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 pt20 -75.91 1.54 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.286 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.556 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.06 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 110.27 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -52.88 122.99 10.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 108.667 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.644 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 42.1 t -138.36 144.98 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 117.889 -1.524 . . . . 0.0 112.24 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 2.9 t -130.7 130.4 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.662 ' HE2' ' CG ' ' A' ' 15' ' ' LEU . 42.6 m-85 -103.33 141.46 35.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.82 0.819 . . . . 0.0 112.436 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 2.4 t -120.34 157.75 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.194 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.555 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.9 152.19 31.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.38 -13.41 5.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.945 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -96.84 -2.8 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 110.323 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.34 -36.45 4.26 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.154 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.511 HG23 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.5 133.18 20.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.768 -1.431 . . . . 0.0 109.229 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' CG ' HG12 ' A' ' 6' ' ' VAL . 37.4 mtm105 -124.38 162.24 24.26 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.669 0.747 . . . . 0.0 111.288 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.54 ' CD ' HG12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -140.17 156.7 46.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.649 -0.657 . . . . 0.0 109.266 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -130.69 127.19 38.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.787 -1.195 . . . . 0.0 110.471 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.662 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 12.6 mt -120.45 150.77 40.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 110.744 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -104.0 92.32 4.34 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.556 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 46.6 t -98.54 167.23 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 111.002 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -116.01 -133.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.449 -0.782 . . . . 0.0 110.738 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -110.24 123.01 49.0 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.279 -0.888 . . . . 0.0 110.671 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.29 -6.27 30.31 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.481 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 63.2 t -98.18 169.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.868 -1.372 . . . . 0.0 110.742 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.68 159.42 25.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HG ' ' HB ' ' A' ' 88' ' ' ILE . 10.9 mt -50.48 -35.8 30.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 109.616 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 1.187 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -73.33 -59.72 2.58 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.63 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.5 tt0 -37.85 -69.66 0.11 Allowed 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.763 -0.586 . . . . 0.0 111.691 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.503 ' CB ' HD11 ' A' ' 15' ' ' LEU . . . -47.27 -52.03 17.27 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.303 -1.498 . . . . 0.0 108.863 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.616 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -59.05 -59.51 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.766 0.793 . . . . 0.0 109.527 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.287 1.1 t -29.97 -60.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.584 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.53 -47.51 81.31 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.038 0.923 . . . . 0.0 108.872 179.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.578 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.4 m-80 -59.61 -10.67 3.76 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 81.71 -5.54 69.24 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 38.0 mt -42.92 -30.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.537 -0.978 . . . . 0.0 108.905 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.713 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 57.3 m-85 -109.14 60.58 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.364 -0.835 . . . . 0.0 111.576 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' TYR . 9.4 p-10 -49.34 -22.99 1.24 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.017 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' CG1' ' HB ' ' A' ' 47' ' ' THR . 18.1 tt -79.86 105.62 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.18 0.514 . . . . 0.0 109.745 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.02 142.77 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.866 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.17 -137.62 5.46 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.8 m-20 -106.67 5.13 28.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.274 . . . . 0.0 110.315 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.609 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 25.1 p -69.96 -40.02 75.67 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.732 -0.605 . . . . 0.0 111.423 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.5 31.3 1.59 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.73 35.34 25.48 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.579 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 8.3 t -140.12 -0.8 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -1.128 . . . . 0.0 111.711 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 42' ' ' SER . . . 77.57 57.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.922 0.868 . . . . 0.0 113.336 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -133.55 27.39 4.04 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 5.9 p -111.04 142.28 43.4 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.562 ' CB ' ' HB3' ' A' ' 73' ' ' CYS . . . -110.61 8.97 22.99 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.541 ' HB ' ' CG1' ' A' ' 35' ' ' ILE . 7.4 p -111.01 -30.09 7.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.01 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 1.3 m -84.24 32.42 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.966 -1.084 . . . . 0.0 110.631 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.664 ' CE1' ' O ' ' A' ' 71' ' ' LEU . 6.0 t-160 -57.94 134.2 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.602 -1.311 . . . . 0.0 109.673 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 34.6 m -150.12 159.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.775 -1.203 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 30.2 m-85 -122.75 134.66 54.43 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.3 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 88' ' ' ILE . 15.1 t -91.57 156.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.824 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.586 ' O ' ' CG2' ' A' ' 57' ' ' THR . 4.4 p30 -59.23 -157.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.058 -1.651 . . . . 0.0 108.941 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.27 -7.25 23.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 110.309 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.72 -39.68 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 113.05 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.698 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 67.4 m-85 -84.7 1.94 44.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.739 -1.225 . . . . 0.0 111.772 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.586 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 8.3 p -80.56 -54.37 5.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.886 -1.134 . . . . 0.0 109.526 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 57' ' ' THR . 4.9 p-10 -62.29 -12.01 18.34 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.762 0.791 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.285 0.1 OUTLIER -79.67 -55.1 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 123.458 1.599 . . . . 0.0 109.553 180.0 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 61' ' ' PRO 0.321 0.4 OUTLIER -84.6 155.61 62.19 Favored Pre-proline 0 C--N 1.28 -2.43 0 CA-C-N 112.975 -1.92 . . . . 0.0 110.101 -177.552 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 60' ' ' VAL . 36.5 Cg_endo -62.65 159.13 38.3 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.919 1.484 . . . . 0.0 111.858 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.73 -169.99 2.43 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.547 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.582 ' CB ' ' NH2' ' A' ' 83' ' ' ARG . . . -110.11 162.73 14.28 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.763 -0.586 . . . . 0.0 110.918 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.531 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 54.8 p30 -100.33 -156.41 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 111.343 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 6.4 pt-20 -73.73 -28.71 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 110.286 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.6 ttm180 -64.57 -50.76 66.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.293 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 32.9 tt0 -72.53 14.55 0.24 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.856 -0.528 . . . . 0.0 111.903 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -91.65 -46.17 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.385 -1.447 . . . . 0.0 110.2 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -85.32 -60.27 1.84 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.717 ' HE1' HD11 ' A' ' 84' ' ' LEU . 2.8 ptm -48.13 -43.93 31.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.904 -1.351 . . . . 0.0 108.295 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.664 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -62.62 -38.56 90.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.597 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 2.8 tt0 -83.75 29.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.903 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -48.79 -81.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.418 -1.426 . . . . 0.0 107.931 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 76' ' ' ALA . 2.3 m -81.35 129.13 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.25 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.9 t -49.11 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.903 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -104.54 48.41 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 110.202 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.552 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 18.1 pt-20 39.3 60.73 1.47 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.507 -0.746 . . . . 0.0 110.786 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.1 tp -30.28 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.541 . . . . 0.0 111.466 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HD3' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -145.35 -166.56 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.314 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 46.1 Cg_endo -80.76 -32.59 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.334 1.176 . . . . 0.0 110.942 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.524 ' CB ' HG23 ' A' ' 57' ' ' THR . 39.7 p-10 -102.52 4.38 38.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 111.429 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -62.96 135.61 57.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.93 -1.106 . . . . 0.0 109.827 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.607 ' HG3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.07 169.28 23.9 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 118.455 -1.298 . . . . 0.0 110.759 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.717 HD11 ' HE1' ' A' ' 70' ' ' MET . 1.4 mt -90.81 148.35 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.9 m -46.8 -27.53 1.25 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.677 -1.265 . . . . 0.0 110.526 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 1.187 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 3.9 m -102.38 40.31 1.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.287 -0.883 . . . . 0.0 111.511 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.646 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.9 mm100 -126.25 -41.54 1.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 112.187 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.607 ' CD1' ' HG3' ' A' ' 83' ' ' ARG . 3.3 mm -79.39 147.71 6.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.2 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mm -112.31 151.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.535 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -110.46 111.72 23.16 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.482 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -100.65 170.86 6.08 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 42.3 Cg_endo -73.37 -5.21 16.75 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.824 1.434 . . . . 0.0 110.634 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.31 -29.54 8.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.117 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.512 ' O ' ' CE ' ' A' ' 90' ' ' MET . 7.3 mt -97.0 54.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 109.872 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.528 ' HB3' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.39 148.41 25.19 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.278 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.649 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.25 23.32 9.12 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.698 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.03 117.94 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.405 1.098 . . . . 0.0 113.324 -176.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 9.5 t -82.55 124.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.826 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.529 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 1.9 t -104.31 -179.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.673 -1.267 . . . . 0.0 109.547 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.542 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 9.5 m-20 -161.82 142.47 10.64 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.521 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.58 HG13 ' CE1' ' A' ' 8' ' ' HIS . 50.6 t -92.06 148.01 35.94 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.621 ' HG3' ' CG ' ' A' ' 49' ' ' HIS . 39.6 Cg_endo -65.71 125.33 14.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.521 1.274 . . . . 0.0 112.611 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 8' ' ' HIS . 6.9 p-10 -110.58 77.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.738 . . . . 0.0 109.884 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.53 ' HD3' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -70.38 -77.41 0.09 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -99.7 107.45 19.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.278 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.241 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.531 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.287 0.565 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -81.08 115.69 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.855 . . . . 0.0 109.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.614 HG13 ' CE2' ' A' ' 5' ' ' TYR . 3.8 t -109.85 137.37 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.913 -1.117 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 3.5 t -131.98 128.63 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.2 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 71.1 m-85 -104.75 146.98 28.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.571 0.7 . . . . 0.0 112.385 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 5.2 t -121.24 133.55 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.185 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 62.8 p -79.56 -152.56 0.07 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.612 ' ND1' ' CB ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -110.06 -10.6 14.68 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.059 -1.025 . . . . 0.0 108.677 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.472 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 17.6 p-10 -100.55 3.66 42.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.357 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.57 -39.24 2.97 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.491 HG21 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.8 138.13 15.24 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.866 -1.373 . . . . 0.0 109.974 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 54.4 mtt180 -130.25 164.24 24.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.387 0.613 . . . . 0.0 111.215 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -128.2 161.04 30.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.316 -0.865 . . . . 0.0 109.09 179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 1.1 mp0 -131.11 139.64 49.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.7 -1.25 . . . . 0.0 110.856 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.577 ' CD2' ' ND2' ' A' ' 30' ' ' ASN . 10.8 mt -128.08 144.89 51.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.902 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.87 84.08 2.09 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 18.0 t -98.63 172.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.661 0.743 . . . . 0.0 111.526 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.541 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -123.43 -159.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.809 0.814 . . . . 0.0 111.537 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -87.26 125.56 34.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.312 -179.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.01 -5.13 30.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.831 HG11 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -102.3 172.1 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 122.442 1.115 . . . . 0.0 110.338 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.619 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -118.47 -169.72 1.76 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 18.0 mt -87.99 -14.07 40.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.832 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.65 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 2.3 ttp -90.9 -65.86 0.98 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.802 -1.186 . . . . 0.0 112.327 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.831 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.32 -26.42 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 111.44 -178.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -92.35 -34.83 14.03 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.642 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -77.28 -41.84 39.29 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.017 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.531 ' CG2' ' HE2' ' A' ' 24' ' ' MET . 62.8 t -55.17 -60.42 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.861 -1.15 . . . . 0.0 108.413 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -51.39 -38.31 52.76 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.577 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 2.8 m-80 -70.48 1.64 4.86 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 84.34 -15.63 38.93 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 1.2 mt -41.55 -42.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.323 -1.104 . . . . 0.0 108.122 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CE1' ' HA ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -161.72 101.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.549 -0.719 . . . . 0.0 109.778 175.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.46 ' HA ' HG11 ' A' ' 28' ' ' VAL . 2.2 p30 -70.66 53.85 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.577 ' CD1' ' CG2' ' A' ' 47' ' ' THR . 2.3 tt -107.7 87.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.243 0.544 . . . . 0.0 110.871 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 3.2 m -120.37 32.47 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -0.86 . . . . 0.0 110.567 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.46 -48.6 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -79.81 -41.62 26.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -1.165 . . . . 0.0 110.339 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.66 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.9 p -110.84 -48.09 3.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.81 -0.556 . . . . 0.0 110.906 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . 44.53 36.64 4.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.16 28.44 49.29 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.9 m -124.71 -13.67 6.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -1.105 . . . . 0.0 110.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.614 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 75.51 55.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.797 0.808 . . . . 0.0 112.689 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -132.14 37.12 3.59 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 1.3 p -111.23 157.12 20.47 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -111.89 -10.24 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.016 . . . . 0.0 110.925 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.577 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 6.3 t -110.56 -19.01 13.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.857 -1.152 . . . . 0.0 113.257 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 1.8 m -80.36 20.31 0.7 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.316 -1.49 . . . . 0.0 110.994 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.611 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.7 t-160 -48.23 139.86 8.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.56 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 14.2 m -143.97 156.17 15.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.627 -1.296 . . . . 0.0 109.81 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.658 ' CD2' ' HB3' ' A' ' 102' ' ' PRO . 2.9 m-30 -119.8 119.02 32.36 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.998 0.904 . . . . 0.0 109.367 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 97' ' ' ILE . 21.4 t -100.8 152.0 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 111.009 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' OD1' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -74.29 130.92 40.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.398 -1.439 . . . . 0.0 109.324 178.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.523 ' CA ' HG22 ' A' ' 57' ' ' THR . 0.5 OUTLIER -36.79 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.505 -0.747 . . . . 0.0 111.519 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.09 -19.82 63.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.03 -1.043 . . . . 0.0 111.273 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.687 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 43.7 m-85 -127.66 -11.36 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.881 -1.137 . . . . 0.0 110.572 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.53 ' CB ' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -81.14 -17.86 48.4 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.191 -0.943 . . . . 0.0 108.975 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.2 p-10 -89.68 -30.83 17.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 3.5 mmmm -82.81 12.01 5.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.833 . . . . 0.0 110.259 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -116.78 155.45 49.03 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.4 Cg_endo -62.94 156.76 52.36 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.084 1.57 . . . . 0.0 111.859 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.14 128.09 33.37 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.754 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.541 ' CB ' ' CD ' ' A' ' 67' ' ' GLU . . . -69.38 156.24 39.13 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.551 -0.718 . . . . 0.0 110.064 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.48 ' O ' HD11 ' A' ' 68' ' ' ILE . 27.5 p30 -100.57 -172.34 2.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 111.648 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.56 -21.49 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 110.711 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.3 ttm180 -64.12 -59.07 4.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.003 -1.061 . . . . 0.0 109.253 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.589 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 20.1 tt0 -65.55 10.71 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.656 . . . . 0.0 112.436 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.529 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -91.18 -40.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 119.453 -2.029 . . . . 0.0 110.952 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.18 -57.95 1.62 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.631 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 6.1 ptm -48.14 -43.05 30.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.222 -1.164 . . . . 0.0 109.173 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 67' ' ' GLU 0.281 0.0 OUTLIER -70.29 -33.2 71.27 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.935 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 4.4 tt0 -90.78 3.53 54.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.23 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 46' ' ' ALA . 1.6 m -49.11 -54.73 14.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.665 -1.272 . . . . 0.0 109.457 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 74' ' ' VAL . 34.8 m -90.04 105.72 16.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.9 t -48.53 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.384 -0.823 . . . . 0.0 110.888 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.2 50.9 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.67 60.45 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 110.309 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' A' ' 77' ' ' GLU . 2.3 tp -29.87 144.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 111.787 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 14.5 mtmt -120.6 170.76 6.65 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.747 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.6 Cg_endo -69.48 -30.7 23.16 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.649 1.341 . . . . 0.0 109.926 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.53 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 8.3 p-10 -97.35 -6.39 34.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.562 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 13.1 m -49.12 165.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.767 -1.208 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.531 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.27 167.45 3.39 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.638 -0.664 . . . . 0.0 109.48 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.631 ' CD1' ' CE ' ' A' ' 70' ' ' MET . 0.8 OUTLIER -95.7 141.4 29.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.589 ' CB ' ' HG3' ' A' ' 24' ' ' MET . 4.7 m -41.67 -27.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 110.462 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 84' ' ' LEU . 2.0 m -108.32 43.78 1.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.589 -0.694 . . . . 0.0 111.034 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.658 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 3.2 mm-40 -126.08 -33.83 2.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 111.845 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -92.03 149.97 3.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 110.267 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 5.2 mm -110.34 156.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 1.1 tpt -110.02 113.54 26.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 0.0 110.792 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.452 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -106.51 171.44 4.75 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -72.85 -1.62 10.71 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.908 1.478 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 4.7 pt-20 -110.19 -30.66 7.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 59' ' ' LYS . 7.3 mt -94.14 52.94 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.949 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 4.5 p-10 -100.48 145.66 28.0 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.017 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.32 22.0 10.22 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.687 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -70.9 130.05 34.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.994 0.902 . . . . 0.0 113.162 -176.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.536 ' CG2' ' OD1' ' A' ' 53' ' ' ASN . 11.0 t -103.75 122.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.655 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -103.98 -174.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 51' ' ' TYR . 7.2 m-20 -161.7 139.79 9.17 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.065 176.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 9.6 t -98.13 103.02 15.6 Favored Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.0 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.658 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 41.8 Cg_endo -69.62 80.99 0.81 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.155 1.904 . . . . 0.0 112.772 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.612 ' CB ' ' ND1' ' A' ' 8' ' ' HIS . 12.8 t70 -111.05 39.89 2.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.593 -1.317 . . . . 0.0 110.438 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -56.41 -172.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.082 -1.011 . . . . 0.0 111.326 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 2.1 mt-30 -120.22 -9.13 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.0 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.259 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.542 ' HA ' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.317 0.58 . . . . 0.0 110.475 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -88.86 134.46 33.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.852 . . . . 0.0 109.928 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.607 HG13 ' CE2' ' A' ' 5' ' ' TYR . 14.0 t -122.61 147.43 26.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.883 -1.136 . . . . 0.0 111.155 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.585 ' CG2' ' CG ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -131.18 130.86 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.652 ' CE1' ' HB3' ' A' ' 23' ' ' LEU . 83.4 m-85 -111.46 123.73 50.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.462 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 99' ' ' VAL . 2.3 t -92.27 151.86 3.51 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.84 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.532 ' OG ' ' CB ' ' A' ' 11' ' ' THR . 17.1 p -113.53 141.36 47.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.981 -1.074 . . . . 0.0 109.403 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.636 ' CE1' ' CB ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -41.81 -23.88 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.607 -0.683 . . . . 0.0 110.723 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 6.2 p-10 -93.44 -1.22 55.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.878 -1.139 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.36 -32.05 6.93 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.949 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.532 ' CB ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.62 141.35 9.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.874 -1.368 . . . . 0.0 109.476 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.7 mtm180 -127.45 124.93 39.6 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.791 -0.568 . . . . 0.0 111.042 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -102.34 157.6 16.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' CG ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -130.58 135.31 47.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.989 -1.069 . . . . 0.0 110.804 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 7.3 mt -124.55 142.0 51.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 111.035 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -99.92 82.38 2.57 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.588 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 40.5 t -98.17 169.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.575 -0.703 . . . . 0.0 110.413 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.491 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -126.09 -149.95 0.43 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.521 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -90.85 122.65 33.74 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.617 0.722 . . . . 0.0 110.498 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -8.57 30.89 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 22' ' ' SER . 18.5 t -96.57 170.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.0 -1.294 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.572 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 166.51 13.91 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.652 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 4.8 mt -69.98 -5.34 25.69 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.083 -1.847 . . . . 0.0 108.332 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.587 ' HG3' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -84.22 -72.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.587 ' N ' ' HG3' ' A' ' 24' ' ' MET . 0.0 OUTLIER -42.87 -57.7 2.7 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 121.783 -0.573 . . . . 0.0 112.242 -176.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.588 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -57.95 -57.78 11.29 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.57 -1.956 . . . . 0.0 108.386 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -51.48 -57.96 7.6 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.516 0.674 . . . . 0.0 109.97 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.572 ' CG2' ' CG2' ' A' ' 35' ' ' ILE . 13.4 t -39.79 -71.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.302 0.572 . . . . 0.0 109.627 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -48.71 -46.41 40.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -0.835 . . . . 0.0 109.387 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.534 ' ND2' HD23 ' A' ' 15' ' ' LEU . 4.2 m-80 -59.67 -8.57 2.09 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.92 -5.96 76.86 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CG2' ' CE1' ' A' ' 33' ' ' TYR . 2.9 mt -44.68 -35.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.636 ' CE1' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.79 111.01 6.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -66.47 54.18 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.011 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.572 ' CG2' ' CG2' ' A' ' 28' ' ' VAL . 1.2 tp -103.75 115.51 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.867 -0.52 . . . . 0.0 109.882 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.73 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 111.083 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.88 53.21 4.32 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . 1.8 m-20 -120.27 -63.95 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -1.193 . . . . 0.0 110.055 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.6 p -110.32 -54.3 2.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.045 -1.034 . . . . 0.0 110.15 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.54 47.54 7.19 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.36 59.38 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 8.0 t -116.93 -36.74 3.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -1.078 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 72.04 60.68 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 111.331 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' C ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -131.3 14.01 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.237 -0.914 . . . . 0.0 110.438 178.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.621 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.94 124.28 52.26 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.586 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -79.14 4.55 14.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.689 -1.257 . . . . 0.0 109.885 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.6 p -91.38 -22.83 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.702 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.593 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -95.53 13.63 25.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.049 -1.032 . . . . 0.0 110.029 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.586 ' CE1' HD22 ' A' ' 71' ' ' LEU . 22.3 t-160 -50.51 137.33 19.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.505 -1.372 . . . . 0.0 108.733 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -142.67 158.93 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.635 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 3.5 m-30 -117.71 109.98 17.29 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.624 0.726 . . . . 0.0 109.694 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 99' ' ' VAL . 10.7 t -85.61 162.27 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' O ' ' CG2' ' A' ' 57' ' ' THR . 10.1 p30 -82.92 139.0 33.64 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 119.947 -1.72 . . . . 0.0 109.273 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 53' ' ' ASN . 5.1 pt-20 -41.68 -21.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.995 -1.065 . . . . 0.0 111.503 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.526 ' CB ' ' OD1' ' A' ' 53' ' ' ASN . . . -72.93 -53.02 12.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.756 -1.215 . . . . 0.0 111.637 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 48.3 m-85 -85.03 -4.75 59.27 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.841 -1.162 . . . . 0.0 111.072 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.56 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 10.2 p -80.28 -51.24 9.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.873 -1.142 . . . . 0.0 109.501 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD2' ' CE ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.05 -12.03 16.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' CB ' HD11 ' A' ' 94' ' ' LEU 0.284 8.8 mmpt? -79.29 -52.42 8.14 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.876 1.798 . . . . 0.0 108.208 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' CG1' ' CG2' ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -84.75 144.59 42.54 Favored Pre-proline 0 C--N 1.279 -2.458 0 CA-C-N 112.201 -2.272 . . . . 0.0 110.435 -177.494 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.7 Cg_endo -62.53 162.97 22.45 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.934 1.492 . . . . 0.0 112.145 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -168.64 1.84 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.352 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -110.9 171.52 7.42 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.379 0.609 . . . . 0.0 111.056 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.481 ' O ' HD11 ' A' ' 68' ' ' ILE . 48.1 p-10 -100.81 -153.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.605 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -71.67 -18.52 62.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 110.217 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -64.51 -52.16 59.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 109.241 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -63.55 0.09 0.82 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.865 -0.522 . . . . 0.0 111.33 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.552 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.1 mp -91.16 -18.78 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 119.79 -1.819 . . . . 0.0 111.359 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.52 -79.58 1.37 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 120.753 -1.217 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.668 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.58 -32.16 7.68 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.169 -1.195 . . . . 0.0 110.134 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.631 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -68.64 -30.63 69.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.251 -0.905 . . . . 0.0 108.783 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -85.07 -29.51 24.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 109.691 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.586 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -49.29 -44.26 43.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 109.491 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 13.4 m -90.17 70.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.531 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.2 t -48.92 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 0.0 111.11 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' CB ' ' HG3' ' A' ' 104' ' ' ARG . . . -118.12 66.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.02 -1.05 . . . . 0.0 109.529 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 1.7 pm0 39.88 49.08 2.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.814 0.816 . . . . 0.0 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD13 ' CD2' ' A' ' 71' ' ' LEU . 2.4 tp -23.46 142.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.363 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.03 170.48 5.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.755 . . . . 0.0 108.978 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.3 Cg_endo -69.2 -29.39 26.59 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.649 1.341 . . . . 0.0 109.481 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.521 ' HB2' HG23 ' A' ' 57' ' ' THR . 23.0 p-10 -99.58 -7.98 25.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.657 -0.652 . . . . 0.0 110.522 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.635 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 67.0 m -48.98 153.58 0.86 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.089 -1.007 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -175.45 161.67 2.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.898 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.668 ' CD1' ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -78.38 140.22 38.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 179.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.518 ' C ' ' HB2' ' A' ' 24' ' ' MET . 47.4 m -42.27 -28.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.542 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -92.53 35.6 1.02 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.636 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.9 tp-100 -126.49 -41.93 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.465 -1.397 . . . . 0.0 112.374 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 1.3 mt -94.65 154.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-O 122.099 0.952 . . . . 0.0 111.583 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 90' ' ' MET . 5.2 mm -110.88 160.85 9.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 21' ' ' VAL . 3.4 tpt -110.17 113.62 26.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 110.083 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.5 OUTLIER -92.92 166.12 17.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.5 Cg_endo -73.02 -25.46 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.502 . . . . 0.0 110.538 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' C ' HD21 ' A' ' 94' ' ' LEU . 1.4 pm0 -91.32 -26.76 18.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.813 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' A' ' 59' ' ' LYS . 7.3 mt -94.9 51.0 1.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.058 0.932 . . . . 0.0 109.417 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.542 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 4.6 p-10 -100.49 152.53 20.28 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.677 0.751 . . . . 0.0 112.203 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.64 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 97.06 28.1 8.93 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.656 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 9.8 tt -74.2 155.02 6.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 123.259 1.504 . . . . 0.0 113.533 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.524 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 6.4 t -120.79 91.55 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.362 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.603 HG12 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -104.66 171.35 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.644 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -145.69 172.79 12.76 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.32 1.057 . . . . 0.0 112.083 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 6' ' ' VAL . 13.1 t -105.69 111.94 64.62 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 42.8 Cg_endo -70.39 -0.3 7.23 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.906 1.477 . . . . 0.0 111.754 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.636 ' CB ' ' CE1' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -53.28 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.962 . . . . 0.0 110.281 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -110.31 -172.33 2.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.414 -0.804 . . . . 0.0 111.504 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 30.4 tp60 -120.2 103.03 8.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.243 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.553 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.544 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.502 0.667 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' CB ' ' HA2' ' A' ' 96' ' ' GLY . 0.8 OUTLIER -82.96 109.64 17.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.728 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 2.5 t -109.5 134.54 51.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.921 -1.112 . . . . 0.0 110.634 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.676 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 93.4 t -124.11 107.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.259 1.028 . . . . 0.0 111.807 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.728 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 22.6 m-30 -83.46 130.26 35.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.583 ' O ' ' N ' ' A' ' 101' ' ' VAL . 3.4 t -120.18 134.07 64.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.393 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.545 ' HB3' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -79.58 -167.28 1.17 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 108.51 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.508 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -97.94 -9.95 25.35 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.952 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.433 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.3 p30 -100.43 -6.68 25.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 19.48 8.07 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.541 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.545 ' CG2' ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -87.88 153.72 21.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.844 -1.386 . . . . 0.0 107.754 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 mtm180 -130.13 139.32 50.92 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.229 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.701 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.36 67.87 1.36 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.7 0.762 . . . . 0.0 108.991 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.676 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.6 mt-10 -67.96 140.21 56.41 Favored 'General case' 0 C--N 1.288 -2.065 0 O-C-N 120.767 -1.208 . . . . 0.0 110.896 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 8.0 mt -110.99 147.1 35.45 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.646 -0.659 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.59 86.43 3.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.578 HG13 HG13 ' A' ' 21' ' ' VAL . 25.3 t -98.88 172.32 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.697 0.761 . . . . 0.0 111.833 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.541 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -112.57 -144.78 0.39 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.603 0.716 . . . . 0.0 111.525 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -104.07 124.69 49.5 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.46 0.648 . . . . 0.0 110.346 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.3 3.19 38.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.825 HG11 ' NE2' ' A' ' 25' ' ' GLN . 2.5 t -107.65 172.36 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.613 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.65 179.85 4.21 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.876 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.48 ' CD2' ' SD ' ' A' ' 90' ' ' MET . 14.5 mt -79.06 -6.84 57.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.637 -1.289 . . . . 0.0 109.085 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.628 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.73 -76.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.904 0.859 . . . . 0.0 111.597 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.825 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.78 -24.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.075 -177.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -91.75 -33.18 15.12 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.631 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -77.48 -51.35 10.9 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.065 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.587 ' CG2' ' CE ' ' A' ' 24' ' ' MET . 96.5 t -45.04 -57.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -58.24 -37.72 75.47 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.026 0.917 . . . . 0.0 108.688 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 1.1 m-80 -68.92 1.81 3.12 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.279 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 85.78 -14.42 52.27 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 1.3 mt -44.76 -54.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -1.196 . . . . 0.0 107.826 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.607 ' CE1' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.84 94.6 2.1 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.257 176.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HA ' HG11 ' A' ' 28' ' ' VAL . 1.6 p30 -70.4 53.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.782 -1.199 . . . . 0.0 108.48 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.619 ' CG2' ' CE ' ' A' ' 24' ' ' MET . 5.2 tt -89.57 104.1 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.583 . . . . 0.0 111.852 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 61.5 t -120.87 37.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.138 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.23 -53.62 0.25 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.735 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 44' ' ' SER . 5.1 m-20 -79.41 -78.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.066 -1.255 . . . . 0.0 110.363 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.6 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.8 p -68.96 -39.25 79.58 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.771 -0.581 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.21 32.61 3.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.769 -2.133 . . . . 0.0 107.769 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.53 35.15 26.64 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 48.2 m -137.98 0.63 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -1.153 . . . . 0.0 111.473 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 71.82 57.4 0.17 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 112.416 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 3.8 t -133.01 32.11 3.8 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.734 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.6 p -111.87 131.59 55.26 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -91.77 5.4 49.99 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.063 -1.648 . . . . 0.0 109.109 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.59 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 5.9 t -110.55 -40.47 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.221 -0.924 . . . . 0.0 111.897 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.603 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.0 m -74.87 10.61 1.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.495 -1.378 . . . . 0.0 110.976 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.611 ' N ' HD22 ' A' ' 84' ' ' LEU . 18.1 t-160 -45.88 138.83 4.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.355 -1.466 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.532 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 17.7 m -140.94 160.38 23.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.037 -1.039 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.655 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 10.1 m-30 -119.28 122.19 41.34 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.545 0.688 . . . . 0.0 109.398 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 88' ' ' ILE . 41.2 t -96.31 169.66 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.339 -0.85 . . . . 0.0 110.079 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CG2' ' A' ' 57' ' ' THR . 11.9 p30 -86.45 137.41 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.648 -1.283 . . . . 0.0 108.854 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.0 pt-20 -40.3 -22.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.996 -1.065 . . . . 0.0 111.748 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.09 -53.87 11.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.81 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.733 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 55.5 m-85 -84.89 -4.78 59.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 0.0 111.286 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 6.5 p -80.35 -52.32 7.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 109.99 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -63.79 -9.32 13.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.412 -0.805 . . . . 0.0 110.178 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.566 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.299 1.9 mmtp -79.29 -53.23 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.796 1.76 . . . . 0.0 109.086 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.562 ' CG2' ' HD2' ' A' ' 61' ' ' PRO 0.336 0.3 OUTLIER -79.28 161.13 68.9 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 112.372 -2.195 . . . . 0.0 110.146 -177.56 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 36.1 Cg_endo -60.63 163.64 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.774 1.407 . . . . 0.0 112.638 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.51 -148.23 0.06 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.831 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.558 ' CB ' ' OE2' ' A' ' 67' ' ' GLU . . . -110.09 144.37 38.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.473 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 49.8 p30 -100.43 -153.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.535 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.433 ' OE2' ' HB2' ' A' ' 66' ' ' ARG . 1.2 pm0 -80.39 -27.37 38.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 110.065 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -75.21 -50.0 17.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.616 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 30.9 tt0 -63.84 -5.31 4.14 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.49 -0.756 . . . . 0.0 110.996 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.533 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -90.63 -13.47 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.28 -1.512 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -88.84 -80.32 1.3 Allowed Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.256 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.667 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.23 -34.77 10.74 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.977 -1.308 . . . . 0.0 109.528 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -70.29 -18.02 63.11 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.791 0.805 . . . . 0.0 109.269 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -90.95 -53.09 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.105 -0.997 . . . . 0.0 109.654 178.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.41 -24.08 1.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.807 . . . . 0.0 109.248 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.6 ' O ' ' NH2' ' A' ' 104' ' ' ARG . 34.5 m -79.74 57.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.299 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.517 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.0 t -48.97 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.0 112.534 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.621 ' CB ' ' NH2' ' A' ' 104' ' ' ARG . . . -130.52 63.37 1.57 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.798 -1.189 . . . . 0.0 108.938 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.55 58.17 2.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.732 0.777 . . . . 0.0 109.413 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.497 HD13 HD21 ' A' ' 71' ' ' LEU . 2.5 tp -30.64 138.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.523 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 51' ' ' TYR . 5.4 mmmt -93.03 168.69 11.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 109.067 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.57 -25.44 40.89 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.71 1.374 . . . . 0.0 109.155 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.531 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 3.3 p30 -113.06 5.46 17.16 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.67 -0.644 . . . . 0.0 111.652 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.595 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 72.7 m -48.52 144.32 4.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.546 -1.346 . . . . 0.0 111.292 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.586 ' CD ' ' OE2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -154.93 160.0 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -85.02 142.61 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 110.132 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.603 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 2.4 p -44.66 -25.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.3 m -108.65 40.71 1.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.444 0.64 . . . . 0.0 110.012 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.55 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 7.3 tp-100 -122.22 -48.47 2.09 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.491 -0.756 . . . . 0.0 111.965 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.535 ' CG2' HG23 ' A' ' 60' ' ' VAL . 1.2 mt -87.46 153.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 121.944 0.878 . . . . 0.0 111.104 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mm -111.26 156.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.544 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -110.5 92.49 4.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.099 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.473 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.72 171.73 11.69 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -78.86 -0.77 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.863 1.454 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.53 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 2.6 pt-20 -110.08 -31.22 7.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 109.403 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.53 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.3 mt -98.16 51.72 1.03 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.975 0.893 . . . . 0.0 108.791 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 8.0 p-10 -100.48 147.05 26.32 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 121.976 0.893 . . . . 0.0 113.189 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.647 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.57 28.1 7.69 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.733 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.9 125.52 38.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 8.6 t -82.49 120.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.754 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -104.55 -175.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.639 -1.288 . . . . 0.0 110.039 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 51' ' ' TYR . 13.9 m-20 -161.4 136.19 7.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.253 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 6' ' ' VAL . 2.6 t -95.71 115.7 65.7 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.626 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo -61.86 177.33 1.03 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.894 1.729 . . . . 0.0 112.486 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 2.6 p-10 -110.5 100.13 9.01 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.017 0.913 . . . . 0.0 111.503 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.621 ' NH2' ' CB ' ' A' ' 76' ' ' ALA . 8.5 mmp_? -87.76 -51.74 5.7 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' O ' ' CG ' ' A' ' 105' ' ' GLN . 5.8 pt20 -69.2 96.73 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.561 0.696 . . . . 0.0 110.494 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.472 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 5.9 ttmt -85.25 113.34 21.52 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.571 HG12 ' CZ ' ' A' ' 5' ' ' TYR . 5.0 t -109.16 137.05 43.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 2.2 t -131.21 125.38 57.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.992 0.901 . . . . 0.0 108.667 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.709 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.273 52.1 m-85 -105.08 140.21 38.6 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 -177.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 3.4 t -121.49 157.06 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.455 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.586 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 78.3 p -116.41 140.56 49.22 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.57 ' CE1' HG13 ' A' ' 101' ' ' VAL . 1.6 p-80 -48.0 -20.75 0.36 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.067 -1.02 . . . . 0.0 109.687 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 1.8 p30 -89.9 -3.89 57.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 -35.98 4.52 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.896 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.547 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.28 132.58 19.97 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.788 -1.419 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -130.32 153.05 49.06 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.709 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.83 163.45 27.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.916 . . . . 0.0 109.006 177.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 32.8 mt-10 -130.64 120.87 24.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.614 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 7.4 mt -109.72 145.45 36.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.872 -1.142 . . . . 0.0 112.123 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.7 92.09 5.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 HG11 ' CG1' ' A' ' 21' ' ' VAL . 96.2 t -98.77 170.75 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 112.029 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.456 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -119.67 -151.65 0.49 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.424 0.63 . . . . 0.0 110.623 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.19 121.2 42.18 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.381 -0.824 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 5.95 28.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.822 HG11 ' NE2' ' A' ' 25' ' ' GLN . 1.4 t -110.04 174.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.593 ' N ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.07 -177.25 3.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.19 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.506 HD11 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.84 -13.31 59.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 109.269 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.678 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -90.13 -73.58 0.52 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.822 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -36.75 -24.8 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 122.048 -0.408 . . . . 0.0 111.64 -177.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.623 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -91.11 -46.37 8.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.606 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -61.81 -54.27 44.48 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.283 0.8 OUTLIER -36.38 -60.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.66 177.607 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.583 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -65.14 -42.48 93.79 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.134 0.968 . . . . 0.0 109.148 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.558 ' ND2' HD23 ' A' ' 15' ' ' LEU . 4.8 m-80 -63.85 -3.27 2.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.97 -20.58 24.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.566 HD12 ' CD2' ' A' ' 5' ' ' TYR . 10.3 mt -42.06 -39.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.445 -1.033 . . . . 0.0 109.281 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.62 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 25.5 m-85 -111.78 67.54 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.149 -0.969 . . . . 0.0 113.036 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -87.81 38.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.507 HD11 ' N ' ' A' ' 36' ' ' VAL . 1.5 pp -79.67 -158.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.346 0.593 . . . . 0.0 110.443 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.507 ' N ' HD11 ' A' ' 35' ' ' ILE . 2.9 t -79.89 -174.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 110.011 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.8 83.9 0.34 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 44' ' ' SER . 4.3 t0 -119.91 -17.05 8.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -1.141 . . . . 0.0 110.348 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.61 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.6 p -110.31 -42.5 4.12 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.768 -0.583 . . . . 0.0 110.452 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.75 34.62 5.46 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.18 30.05 43.36 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 1.1 t -128.56 -6.79 5.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.137 . . . . 0.0 111.057 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.674 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 73.25 57.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.433 -0.792 . . . . 0.0 112.913 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -133.58 36.98 3.33 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.581 -1.636 . . . . 0.0 106.581 176.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.725 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -111.6 150.06 30.6 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -175.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.37 2.07 18.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.518 -1.364 . . . . 0.0 109.076 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.465 ' OG1' HD12 ' A' ' 35' ' ' ILE . 16.7 p -110.07 -34.52 6.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 111.3 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 1.8 m -77.92 8.06 5.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.544 -1.347 . . . . 0.0 110.203 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.642 ' CG ' ' CG ' ' A' ' 102' ' ' PRO . 21.5 t-160 -53.13 150.42 5.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.596 -1.315 . . . . 0.0 108.929 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 49' ' ' HIS . 12.5 m -160.39 164.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.852 0.834 . . . . 0.0 110.919 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 82' ' ' SER . 4.1 m-85 -118.68 122.87 43.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 15.8 t -92.75 151.61 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.241 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -75.18 130.62 39.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.137 -1.602 . . . . 0.0 109.664 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.549 ' CA ' HG22 ' A' ' 57' ' ' THR . 4.9 pt-20 -35.28 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.792 -0.568 . . . . 0.0 111.984 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -65.92 -18.1 65.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.891 -1.131 . . . . 0.0 111.558 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.709 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 46.9 m-85 -127.89 -11.62 5.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.845 -1.159 . . . . 0.0 110.444 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.585 HG23 ' CB ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -80.96 -50.91 9.13 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' ' HD2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.31 -20.98 64.88 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 0.0 109.224 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.578 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.279 20.5 mmmt -79.4 -56.22 4.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.602 1.668 . . . . 0.0 108.923 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.541 HG13 ' CG2' ' A' ' 88' ' ' ILE 0.314 0.3 OUTLIER -75.64 138.12 70.44 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 112.856 -1.974 . . . . 0.0 109.854 -178.263 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' HG21 ' A' ' 60' ' ' VAL . 36.8 Cg_endo -64.22 159.75 41.84 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 124.116 1.587 . . . . 0.0 111.982 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 -167.59 1.44 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.733 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.594 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.73 -169.13 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.377 0.608 . . . . 0.0 110.625 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 66' ' ' ARG . 53.4 p30 -100.27 -144.64 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -80.01 -23.81 41.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.768 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.9 ttm-85 -64.74 -50.98 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 11.4 tp10 -59.55 -11.48 4.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.3 mp -89.97 -16.59 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.658 -1.276 . . . . 0.0 109.813 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -90.6 -63.32 1.23 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.674 ' CE ' ' O ' ' A' ' 43' ' ' ALA 0.289 2.9 mpp? -48.6 -48.52 39.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.335 1.541 . . . . 0.0 108.149 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.624 ' CD2' ' NE2' ' A' ' 49' ' ' HIS 0.269 0.0 OUTLIER -66.01 -32.04 73.29 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.961 -178.323 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -70.0 -41.98 73.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 109.997 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -41.88 41.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 109.797 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.56 HG22 ' ND1' ' A' ' 49' ' ' HIS . 9.9 m -90.22 63.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 110.181 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.523 ' O ' ' CG2' ' A' ' 75' ' ' THR . 10.2 t -49.66 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.726 . . . . 0.0 111.113 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.27 74.93 1.62 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -0.999 . . . . 0.0 110.126 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.2 pt-20 39.17 60.46 1.49 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.495 1.141 . . . . 0.0 109.525 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.557 ' CD1' HD21 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -59.02 120.02 8.35 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.531 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -104.92 -167.01 0.11 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.604 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 41.7 Cg_endo -74.95 -28.27 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.041 1.021 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.585 ' CB ' HG23 ' A' ' 57' ' ' THR . 44.6 p-10 -87.16 -28.24 22.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.513 -0.742 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.684 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.9 m -49.9 106.37 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.834 -1.166 . . . . 0.0 108.796 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.509 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -145.68 171.91 14.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.796 -1.19 . . . . 0.0 111.48 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -84.32 136.52 33.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.467 0.651 . . . . 0.0 111.332 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.599 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 3.0 p -42.38 -29.93 0.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 110.832 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.678 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.9 m -98.78 35.24 1.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 111.304 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.665 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 5.0 mm-40 -126.75 -48.02 1.52 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 113.066 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.541 ' CG2' HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -79.86 151.36 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.643 -1.286 . . . . 0.0 110.534 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 90' ' ' MET . 3.9 mm -111.85 160.05 11.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 110.159 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.609 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.63 118.21 35.59 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 110.454 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -94.89 167.22 13.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.848 . . . . 0.0 109.713 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.8 Cg_endo -78.65 -2.07 12.15 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.868 1.457 . . . . 0.0 110.714 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.458 ' OE2' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.09 -29.94 7.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.1 -1.0 . . . . 0.0 109.765 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.609 ' O ' ' CE ' ' A' ' 90' ' ' MET . 4.6 mt -88.28 66.03 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 110.351 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.515 ' HA ' ' CB ' ' A' ' 1' ' ' SER . 10.3 p30 -101.72 148.38 25.34 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.735 -1.228 . . . . 0.0 113.174 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.669 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.03 30.49 6.68 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.709 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -80.2 135.28 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.177 0.989 . . . . 0.0 112.779 -177.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.53 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 12.7 t -102.78 125.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.67 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -104.25 -179.69 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.996 -1.065 . . . . 0.0 108.971 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-20 -162.07 145.56 12.0 Favored 'General case' 0 C--N 1.276 -2.616 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.547 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 55.0 t -83.86 149.79 57.41 Favored Pre-proline 0 C--N 1.289 -2.033 0 C-N-CA 117.449 -1.7 . . . . 0.0 107.514 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.642 ' CG ' ' CG ' ' A' ' 49' ' ' HIS . 42.1 Cg_endo -92.95 124.4 0.58 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.464 1.443 . . . . 0.0 111.956 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 3.3 t70 -110.4 115.2 29.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.27 0.11 17.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.921 . . . . 0.0 110.284 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -119.97 60.81 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.21 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.528 ' CA ' ' O ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.518 0.675 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.32 127.86 33.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.72 . . . . 0.0 109.605 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.655 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 23.0 t -139.5 148.07 23.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.856 -1.152 . . . . 0.0 112.033 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 13.8 t -131.41 126.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 54.5 m-85 -100.16 140.36 34.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.636 0.731 . . . . 0.0 112.509 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 2.6 t -120.52 134.98 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.21 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.486 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 36.0 p -79.51 -152.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.619 ' ND1' ' CB ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 -10.43 14.59 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.913 -1.117 . . . . 0.0 108.965 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 58.2 p30 -100.45 3.34 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.52 -0.737 . . . . 0.0 109.602 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.47 -29.6 8.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.466 ' HB ' ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -49.81 134.88 20.27 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.953 -1.322 . . . . 0.0 109.224 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HG2' ' CG1' ' A' ' 6' ' ' VAL . 12.8 mtm180 -130.11 161.72 30.42 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.612 0.72 . . . . 0.0 111.504 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 5' ' ' TYR . 2.8 ttp180 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 20.0 mt-10 -130.62 124.23 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.833 -1.167 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.643 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 12.3 mt -117.95 151.54 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.77 90.55 3.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.584 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 42.9 t -98.7 163.63 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.854 . . . . 0.0 110.557 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -112.97 -136.78 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.356 -0.84 . . . . 0.0 110.916 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -108.32 124.43 50.32 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.309 -0.869 . . . . 0.0 110.494 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -7.11 30.52 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 83.0 t -95.69 168.0 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.027 -1.278 . . . . 0.0 110.543 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.517 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.62 160.14 25.0 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 18.4 mt -57.77 -36.04 71.59 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.673 -1.267 . . . . 0.0 109.254 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 1.298 ' SD ' ' SG ' ' A' ' 39' ' ' CYS . 4.7 ttp -79.33 7.24 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.062 -1.024 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.535 ' CG ' HG11 ' A' ' 21' ' ' VAL . 4.9 tt0 -102.29 -71.13 0.73 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.54 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.584 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -46.48 -55.43 7.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.758 -1.214 . . . . 0.0 108.614 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -53.55 -53.05 57.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG2' ' O ' ' A' ' 24' ' ' MET 0.277 0.7 OUTLIER -37.8 -57.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.422 177.769 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.582 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.76 -47.14 85.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.075 0.941 . . . . 0.0 108.821 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.588 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 6.1 m-80 -64.42 -4.03 3.54 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.499 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.03 -14.94 51.37 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 10.2 mt -44.04 -37.9 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.505 -0.997 . . . . 0.0 108.542 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.661 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 72.0 m-85 -114.42 76.93 1.02 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.162 -0.961 . . . . 0.0 111.201 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 33' ' ' TYR . 3.0 p30 -49.13 -22.21 0.91 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.638 -1.289 . . . . 0.0 107.852 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.52 90.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' CG2' HG23 ' A' ' 28' ' ' VAL . 4.1 t -118.55 -25.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 111.104 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.73 30.95 4.77 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.2 t0 -120.3 -45.9 2.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 110.638 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 1.298 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -110.46 -58.04 2.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.072 -1.018 . . . . 0.0 110.165 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.1 46.24 10.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 29.72 44.44 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 66.9 m -116.4 -39.42 3.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -1.129 . . . . 0.0 110.583 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' CB ' ' NE2' ' A' ' 87' ' ' GLN . . . 72.79 59.19 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 111.66 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.492 ' C ' ' HG2' ' A' ' 70' ' ' MET . 58.3 m -131.91 11.29 4.7 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 110.196 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.625 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -113.01 120.61 41.97 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -177.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.55 ' N ' ' HB3' ' A' ' 70' ' ' MET . . . -77.16 -0.87 26.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.434 -1.416 . . . . 0.0 109.564 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.452 ' OG1' ' CD1' ' A' ' 35' ' ' ILE . 1.3 p -83.65 -21.18 32.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 111.188 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.601 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -98.44 16.69 20.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.824 -1.172 . . . . 0.0 110.095 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.64 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 5.9 t-160 -46.16 134.32 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.604 -1.31 . . . . 0.0 108.054 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 18.1 m -138.27 156.24 30.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.766 -1.209 . . . . 0.0 110.037 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.669 ' CZ ' ' CG ' ' A' ' 79' ' ' LYS . 3.1 m-30 -118.29 116.67 27.23 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.597 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 88' ' ' ILE . 22.2 t -94.33 166.09 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 108.909 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.551 ' O ' ' CG2' ' A' ' 57' ' ' THR . 12.5 p30 -84.97 137.2 33.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.278 -1.514 . . . . 0.0 109.023 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 53' ' ' ASN . 6.7 pt-20 -41.05 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.169 -0.957 . . . . 0.0 112.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 59' ' ' LYS . . . -75.61 -51.03 13.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.639 -1.288 . . . . 0.0 111.762 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.769 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 64.4 m-85 -84.96 -5.06 59.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.079 -1.013 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 9.7 p -80.3 -55.04 5.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.884 -1.135 . . . . 0.0 109.815 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.452 ' N ' ' OG1' ' A' ' 57' ' ' THR . 1.6 p30 -60.89 -12.42 11.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.429 -0.794 . . . . 0.0 110.769 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 56' ' ' PHE 0.295 13.5 mtpt -79.4 -54.49 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.724 1.726 . . . . 0.0 109.336 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.545 HG12 ' CG2' ' A' ' 88' ' ' ILE 0.324 0.3 OUTLIER -76.51 155.06 83.8 Favored Pre-proline 0 C--N 1.278 -2.506 0 CA-C-N 112.546 -2.115 . . . . 0.0 110.593 -177.441 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 37.5 Cg_endo -63.58 168.09 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.024 1.539 . . . . 0.0 111.758 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.518 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -80.34 -170.22 2.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.543 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.567 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -110.74 157.85 19.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.555 -0.715 . . . . 0.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.537 ' ND2' ' HG3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -79.47 -161.84 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.496 -0.752 . . . . 0.0 110.884 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.11 -22.59 41.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 111.343 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.537 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -69.73 -42.44 73.95 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.612 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.616 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.31 -7.54 1.33 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.819 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.547 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -90.41 -15.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.608 -1.307 . . . . 0.0 109.642 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.84 -79.75 1.38 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.524 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.679 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.9 -35.17 14.22 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.881 -1.364 . . . . 0.0 109.778 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.64 ' CD2' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -65.35 -30.18 70.99 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 108.575 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.15 -29.08 18.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.474 -0.766 . . . . 0.0 109.561 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.545 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -49.02 -48.87 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.046 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 16.5 m -90.07 76.53 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.425 -0.797 . . . . 0.0 109.098 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.563 ' O ' ' CG2' ' A' ' 75' ' ' THR . 13.1 t -48.25 87.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.782 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HA ' ' CD ' ' A' ' 104' ' ' ARG . . . -105.5 41.04 1.43 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.745 -1.222 . . . . 0.0 109.748 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.596 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER 66.78 44.47 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.219 1.009 . . . . 0.0 109.207 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.509 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.5 tp -19.42 134.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.53 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.669 ' CG ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.42 172.48 3.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.1 Cg_endo -69.83 -26.69 26.97 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.585 1.308 . . . . 0.0 108.828 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.6 p-10 -104.67 -9.16 18.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.704 -0.622 . . . . 0.0 111.399 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.596 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 42.7 m -47.86 158.62 0.21 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.524 -1.36 . . . . 0.0 111.406 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.538 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 0.8 OUTLIER -175.6 161.87 2.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.683 -0.636 . . . . 0.0 109.822 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.679 ' CD1' ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -80.33 139.53 36.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.93 . . . . 0.0 109.625 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.596 ' C ' ' HB2' ' A' ' 24' ' ' MET . 20.0 m -38.54 -31.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.515 1.15 . . . . 0.0 108.496 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.53 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -91.44 37.11 0.94 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.184 -178.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.621 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.1 mm-40 -127.43 -40.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.409 -1.432 . . . . 0.0 113.444 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.545 ' CG2' HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -92.61 150.9 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.551 -178.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.484 HG21 ' N ' ' A' ' 90' ' ' MET . 5.5 mm -111.35 163.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.547 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.5 tpt -110.28 108.74 18.94 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.905 -1.122 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -88.14 159.64 47.62 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.0 Cg_endo -72.16 -1.08 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.977 1.514 . . . . 0.0 110.82 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -110.1 -27.27 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.022 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.547 ' O ' ' CE ' ' A' ' 90' ' ' MET . 8.8 mt -98.38 60.5 1.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 109.931 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.517 ' HB3' ' CB ' ' A' ' 1' ' ' SER . 3.8 p-10 -100.54 145.02 28.83 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.443 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.81 23.68 8.57 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.769 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -76.19 115.07 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.357 1.075 . . . . 0.0 113.486 -176.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.461 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 10.5 t -77.25 123.32 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.273 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.571 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 1.7 t -104.29 -176.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.863 -1.148 . . . . 0.0 109.275 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.4 m-20 -162.1 141.58 9.7 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.907 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 8' ' ' HIS . 49.4 t -97.48 102.86 13.94 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.5 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.652 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 41.0 Cg_endo -68.71 79.26 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.306 2.004 . . . . 0.0 113.342 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.619 ' CB ' ' ND1' ' A' ' 8' ' ' HIS . 27.0 t70 -111.49 38.97 2.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.582 -1.324 . . . . 0.0 110.095 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.561 ' CD ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -48.85 -179.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.121 -0.987 . . . . 0.0 111.724 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.26 63.15 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.336 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.224 -179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.569 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.249 0.547 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.498 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.91 124.14 19.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.642 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 11.8 t -121.44 145.81 27.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 4.3 t -130.98 125.65 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.913 0.863 . . . . 0.0 109.158 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.696 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.265 43.3 m-85 -101.07 135.9 41.79 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 3.2 t -121.97 119.9 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.27 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.524 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 77.7 p -79.78 128.58 33.6 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 1.5 t60 -41.74 -24.31 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -79.45 -3.52 46.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.06 -1.025 . . . . 0.0 110.073 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' SER . . . 110.22 -36.48 4.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.493 ' CB ' ' OG ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.54 137.06 15.8 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.838 -1.39 . . . . 0.0 108.776 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 12.1 mtm180 -130.15 147.35 51.87 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.712 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.696 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -131.58 119.32 21.31 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 177.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.7 mt-10 -94.92 123.98 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.141 -0.974 . . . . 0.0 110.261 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 8.1 mt -109.78 146.81 34.34 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.071 -1.018 . . . . 0.0 110.741 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.63 88.17 3.76 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.574 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 42.8 t -98.96 165.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.769 . . . . 0.0 110.974 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -118.94 -141.44 0.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 110.547 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -101.14 126.46 47.85 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.508 -0.745 . . . . 0.0 110.49 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -9.74 30.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.547 HG11 ' CG ' ' A' ' 25' ' ' GLN . 55.4 t -99.67 170.73 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.843 -1.387 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.504 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.58 167.68 12.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 9.2 mt -59.29 -27.96 66.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.699 -1.25 . . . . 0.0 109.447 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 1.226 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -80.26 -58.22 3.24 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.547 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.2 tt0 -37.98 -68.97 0.13 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.402 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.574 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -47.8 -57.27 5.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.349 -1.469 . . . . 0.0 108.813 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.645 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -52.78 -56.92 12.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.936 0.874 . . . . 0.0 108.911 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.281 1.2 t -35.34 -63.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.219 178.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.584 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.34 -49.64 71.71 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.074 0.94 . . . . 0.0 109.034 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.587 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 m-80 -61.36 -6.94 2.52 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.379 0.609 . . . . 0.0 109.445 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.28 -7.3 64.57 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.54 ' HB ' ' CA ' ' A' ' 27' ' ' ALA . 3.9 mt -44.66 -31.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.305 -1.115 . . . . 0.0 109.323 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.706 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 47.4 m-85 -108.71 58.39 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 113.204 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -74.14 51.39 0.41 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.609 -1.307 . . . . 0.0 107.503 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.531 ' CD1' ' OG1' ' A' ' 47' ' ' THR . 1.7 pp -112.73 178.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.55 -0.719 . . . . 0.0 109.959 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 47' ' ' THR . 1.3 p -120.72 101.35 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 109.741 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.48 179.01 16.48 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -100.23 0.92 41.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -1.023 . . . . 0.0 110.325 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.578 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 19.5 p -69.57 -36.03 75.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.355 -0.841 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.87 31.82 4.26 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.36 37.27 21.47 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 20.2 t -138.84 5.67 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -1.122 . . . . 0.0 111.822 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 42' ' ' SER . . . 73.14 42.58 0.44 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.309 -0.87 . . . . 0.0 113.298 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.2 t -132.35 44.7 2.85 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.744 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.1 p -111.76 130.09 55.91 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -92.13 6.47 46.44 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.258 -1.526 . . . . 0.0 108.178 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.531 ' OG1' ' CD1' ' A' ' 35' ' ' ILE . 19.0 p -110.65 -40.06 4.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.374 -0.828 . . . . 0.0 111.714 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.6 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 1.9 m -79.26 24.04 0.36 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.662 -1.274 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.688 ' NE2' ' CD2' ' A' ' 71' ' ' LEU . 6.9 t-160 -46.32 137.01 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.737 -1.227 . . . . 0.0 108.214 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.525 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 19.3 m -145.86 152.82 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.027 -1.046 . . . . 0.0 110.873 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 102' ' ' PRO . 31.1 m-85 -122.87 128.66 50.64 Favored 'General case' 0 C--N 1.281 -2.413 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.895 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.564 ' CG1' HG21 ' A' ' 57' ' ' THR . 13.6 t -93.88 168.43 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.279 -0.888 . . . . 0.0 109.873 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.61 ' O ' ' CG2' ' A' ' 57' ' ' THR . 6.8 p30 -67.94 -147.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.609 -1.307 . . . . 0.0 109.518 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -103.34 -16.52 15.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.856 -1.152 . . . . 0.0 111.836 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.457 ' O ' ' OD2' ' A' ' 58' ' ' ASP . . . -100.52 -36.82 9.06 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.703 -1.248 . . . . 0.0 114.146 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.72 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.4 m-85 -84.11 -11.0 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.308 -1.495 . . . . 0.0 110.839 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.61 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -81.73 -29.25 33.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 2.1 p30 -79.84 -26.89 40.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.513 ' CB ' HD11 ' A' ' 94' ' ' LEU . 21.1 mmtm -79.65 -51.43 9.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.611 ' CG1' ' CG2' ' A' ' 88' ' ' ILE . 11.5 m -41.78 153.51 0.27 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.411 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -65.18 160.92 39.67 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.114 1.586 . . . . 0.0 112.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 118.01 22.19 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.885 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -69.82 163.89 24.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 109.821 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 24.5 p-10 -100.1 -167.61 1.48 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.19 -20.93 29.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.474 -0.766 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' SD ' ' A' ' 70' ' ' MET . 1.1 ttt-85 -64.53 -53.36 49.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.855 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 6.9 tp10 -59.14 -12.61 5.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 64' ' ' ASN . 1.8 mp -90.92 -9.83 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.826 -1.171 . . . . 0.0 111.244 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.05 -79.3 1.35 Allowed Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.224 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.649 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.09 -37.31 14.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.761 -1.435 . . . . 0.0 109.107 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.688 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -67.82 -23.54 65.19 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.09 -39.49 12.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.811 178.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.78 -43.53 38.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.024 . . . . 0.0 108.344 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 1.7 m -90.42 72.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' A' ' 75' ' ' THR . 10.5 t -48.18 104.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.763 0.792 . . . . 0.0 111.27 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.58 ' CB ' ' CD ' ' A' ' 104' ' ' ARG . . . -126.16 60.8 1.29 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.545 -0.722 . . . . 0.0 109.335 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.542 ' O ' ' CE ' ' A' ' 79' ' ' LYS . 11.3 pt-20 39.28 56.22 2.16 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.995 0.902 . . . . 0.0 109.784 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -33.99 143.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.661 0.743 . . . . 0.0 112.052 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.576 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -134.44 -176.44 0.58 Allowed Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.2 -25.56 43.03 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.146 1.077 . . . . 0.0 111.765 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' HG23 ' A' ' 57' ' ' THR . 24.6 p-10 -111.85 6.5 19.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.831 -1.168 . . . . 0.0 113.308 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.575 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -57.26 149.29 20.38 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.204 -1.56 . . . . 0.0 109.143 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.531 ' HG3' ' CD1' ' A' ' 88' ' ' ILE . 11.3 mmt-85 -154.15 179.7 8.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.737 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -114.94 134.93 54.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.6 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 9.1 m -40.31 -27.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.882 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 1.226 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.2 m -106.93 45.66 0.97 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.994 -1.067 . . . . 0.0 112.053 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.608 ' NE2' ' CE ' ' A' ' 70' ' ' MET . 90.3 mm-40 -125.34 -47.83 1.72 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.043 0.925 . . . . 0.0 111.394 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.611 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -84.35 149.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.932 0.872 . . . . 0.0 111.538 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 90' ' ' MET . 4.4 mm -110.9 160.96 9.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.569 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -110.1 104.21 13.05 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 110.224 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.454 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -91.1 164.24 26.03 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.86 . . . . 0.0 109.442 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 39.7 Cg_endo -71.88 -0.69 8.81 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.648 1.341 . . . . 0.0 110.503 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.1 pt-20 -110.06 -27.61 9.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.513 HD11 ' CB ' ' A' ' 59' ' ' LYS . 9.5 mt -100.25 54.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.363 -0.835 . . . . 0.0 109.824 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.62 143.96 30.16 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.623 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.23 23.33 8.56 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.72 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.79 118.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.339 1.066 . . . . 0.0 113.166 -176.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 21.1 t -82.03 127.08 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.7 t -104.21 -175.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.782 -1.199 . . . . 0.0 109.345 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.1 m-20 -161.34 136.66 7.64 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.527 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -90.84 137.95 26.56 Favored Pre-proline 0 C--N 1.289 -2.049 0 C-N-CA 118.896 -1.121 . . . . 0.0 108.987 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.632 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 56.3 Cg_endo -82.0 110.09 2.02 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.172 1.617 . . . . 0.0 111.892 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.574 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 2.4 m-20 -110.8 79.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.695 -1.253 . . . . 0.0 110.413 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.58 ' CD ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.27 99.94 8.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 0.0 109.95 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -119.98 24.05 10.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.166 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.182 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.521 ' HB2' ' CB ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.643 0.735 . . . . 0.0 110.482 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -90.29 101.11 13.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.657 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 48.6 t -109.64 145.52 16.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.677 -1.264 . . . . 0.0 111.118 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 6.0 t -130.95 127.81 61.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.45 0.643 . . . . 0.0 109.356 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 49.8 m-85 -102.51 136.53 42.17 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.778 0.799 . . . . 0.0 112.184 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.0 t -120.55 133.54 66.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.429 -0.909 . . . . 0.0 109.642 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.522 ' HB3' ' CG2' ' A' ' 11' ' ' THR . 24.0 p -79.73 -159.07 0.19 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.576 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.94 -6.72 21.0 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.894 -1.129 . . . . 0.0 108.916 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -100.44 1.61 41.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.45 -22.95 21.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.9 137.13 17.18 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.986 -1.302 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.503 ' CG ' HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -130.1 149.98 51.57 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.232 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' TYR . 2.6 tpp180 -140.15 155.93 46.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.796 . . . . 0.0 109.714 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 3.9 mt-10 -130.92 128.0 39.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.922 -1.112 . . . . 0.0 110.328 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.648 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 14.1 mt -120.43 -170.53 2.0 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.899 -1.126 . . . . 0.0 110.778 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -133.45 81.71 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 39.9 t -98.4 130.62 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.384 -0.823 . . . . 0.0 110.487 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 90' ' ' MET . . . -110.53 -160.29 0.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.799 0.809 . . . . 0.0 111.523 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.6 OUTLIER -70.53 124.13 23.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.642 0.734 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.71 -14.41 29.57 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 21.9 t -108.11 166.57 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.832 -1.393 . . . . 0.0 110.373 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -121.21 153.77 37.15 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 3' ' ' VAL . 16.8 mt -47.09 -27.37 1.35 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.686 -1.258 . . . . 0.0 107.919 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.684 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -72.42 -67.28 0.56 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.096 0.951 . . . . 0.0 110.609 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' CG ' HG11 ' A' ' 21' ' ' VAL 0.255 5.9 tt0 -37.75 -73.41 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.33 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -43.08 -56.21 3.48 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.558 -1.338 . . . . 0.0 109.264 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.616 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -56.88 -60.42 3.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.644 0.735 . . . . 0.0 109.08 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.586 ' CG2' ' HG3' ' A' ' 24' ' ' MET 0.288 0.9 OUTLIER -33.09 -66.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.658 0.742 . . . . 0.0 109.221 178.041 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.515 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -51.02 -51.87 48.69 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.924 0.869 . . . . 0.0 109.285 178.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.572 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.9 m-80 -60.43 -7.29 1.98 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.33 0.586 . . . . 0.0 109.77 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.93 63.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 27.5 mt -43.82 -36.45 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.417 -1.049 . . . . 0.0 108.687 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.684 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 44.5 m-85 -104.5 64.26 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.099 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.94 50.97 0.11 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.704 -1.248 . . . . 0.0 108.382 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.548 HG13 ' N ' ' A' ' 36' ' ' VAL . 3.4 pt -104.55 -147.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.596 -0.69 . . . . 0.0 109.899 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.548 ' N ' HG13 ' A' ' 35' ' ' ILE . 6.6 t -96.88 174.77 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.91 . . . . 0.0 109.704 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.06 85.98 0.39 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -120.33 6.45 10.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -1.184 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.563 ' SG ' ' CE ' ' A' ' 24' ' ' MET . 1.7 p -110.52 -54.09 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.056 -1.028 . . . . 0.0 111.09 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.28 40.43 10.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.49 40.42 12.98 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 39.3 t -131.22 -34.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 0.0 111.261 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.593 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 75.81 61.42 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.321 -0.862 . . . . 0.0 111.354 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -131.34 8.52 4.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.373 -0.829 . . . . 0.0 110.124 179.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.554 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.88 117.77 33.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.242 -0.911 . . . . 0.0 112.423 -178.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . . . -75.41 0.26 17.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.454 HG21 ' HB2' ' A' ' 45' ' ' CYS . 8.4 t -83.73 -32.41 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.575 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.606 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.3 11.68 16.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 179.277 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 18.0 t-160 -49.16 152.39 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.709 -1.244 . . . . 0.0 109.791 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 13.9 m -156.02 160.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.221 -0.924 . . . . 0.0 109.622 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.9 m-30 -119.97 118.06 29.71 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.555 HG12 ' CD1' ' A' ' 97' ' ' ILE . 29.1 t -98.53 155.02 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.365 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' OD1' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.22 131.69 40.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.325 -1.485 . . . . 0.0 109.364 178.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pt-20 -37.49 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.435 -0.791 . . . . 0.0 111.476 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.77 -24.9 67.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.018 . . . . 0.0 111.356 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.677 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 33.2 m-85 -123.02 -11.0 8.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.871 -1.143 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.549 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -80.57 -29.42 37.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 108.888 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.8 p-10 -76.41 -26.87 55.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 109.666 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.528 ' CB ' HD11 ' A' ' 94' ' ' LEU . 23.1 mmtm -80.85 -52.44 7.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.554 -0.716 . . . . 0.0 110.192 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 88' ' ' ILE . 6.0 m -40.91 153.75 0.22 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.535 -0.728 . . . . 0.0 110.48 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.3 Cg_endo -65.79 168.22 15.7 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.061 1.559 . . . . 0.0 111.352 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.66 125.88 30.58 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.392 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -69.35 170.93 9.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.455 ' O ' HD11 ' A' ' 68' ' ' ILE . 31.3 p30 -96.83 -161.72 0.9 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 111.131 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -73.37 -24.76 60.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.512 -0.742 . . . . 0.0 110.543 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.514 ' NE ' ' O ' ' A' ' 42' ' ' SER . 1.7 mtm-85 -64.71 -43.07 94.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.405 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 4.2 tp10 -66.64 -7.03 17.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.532 -0.73 . . . . 0.0 109.517 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.51 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -91.94 -30.16 4.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.579 -1.326 . . . . 0.0 111.006 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.03 -64.89 1.57 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.854 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.885 ' HG3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.77 -46.89 42.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.828 -1.395 . . . . 0.0 108.43 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.606 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -57.13 -25.2 58.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.483 -175.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -36.39 17.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.5 -0.75 . . . . 0.0 108.981 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.35 -32.01 10.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 108.809 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.585 ' CG1' ' CB ' ' A' ' 46' ' ' ALA . 14.7 m -90.12 65.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 104' ' ' ARG . 4.8 t -48.87 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.445 0.64 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.27 69.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -0.808 . . . . 0.0 109.109 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.62 46.27 1.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.695 0.76 . . . . 0.0 109.905 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.525 ' C ' ' O ' ' A' ' 77' ' ' GLU . 9.8 tp -23.93 134.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.601 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' HD2' ' CD2' ' A' ' 51' ' ' TYR . 5.5 mtpt -110.0 167.92 8.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.751 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.6 Cg_endo -68.19 -28.88 33.6 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.854 1.45 . . . . 0.0 109.379 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 11.8 p-10 -97.54 -11.93 23.14 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.643 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 50.4 m -48.99 153.74 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.831 -1.168 . . . . 0.0 110.665 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.537 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 3.8 ttp180 -175.5 158.48 2.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.416 -0.802 . . . . 0.0 110.086 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.885 HD13 ' HG3' ' A' ' 70' ' ' MET . 0.5 OUTLIER -76.38 142.38 41.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.933 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 17.3 p -44.88 -26.24 0.39 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.582 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -93.0 29.87 1.74 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.899 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.6 tp-100 -126.59 -38.32 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.394 -1.441 . . . . 0.0 112.687 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.584 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -92.6 142.79 12.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.001 -1.079 . . . . 0.0 110.85 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.516 HG21 ' N ' ' A' ' 90' ' ' MET . 7.2 mm -110.52 168.19 4.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.543 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 3.5 tpt -109.93 110.65 21.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.866 -1.147 . . . . 0.0 111.137 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.481 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -89.93 165.64 23.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.86 -6.36 18.87 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.864 1.455 . . . . 0.0 110.901 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.7 pt-20 -110.26 -28.48 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.007 . . . . 0.0 110.429 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.543 ' O ' ' CE ' ' A' ' 90' ' ' MET . 8.1 mt -93.78 55.92 2.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.521 ' CB ' ' HB2' ' A' ' 1' ' ' SER . 2.8 p30 -100.53 148.98 24.18 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.327 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.677 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.72 34.02 6.46 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.643 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 5.0 tt -83.96 157.41 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.214 1.007 . . . . 0.0 113.127 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.534 ' CG2' ' OD1' ' A' ' 53' ' ' ASN . 18.1 t -117.84 124.76 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.214 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -104.4 -177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.858 -1.151 . . . . 0.0 109.996 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 51' ' ' TYR . 16.5 m-20 -162.26 145.84 11.83 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.29 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.576 HG13 ' CE1' ' A' ' 8' ' ' HIS . 71.7 t -98.27 111.89 60.79 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 120.678 -1.264 . . . . 0.0 108.716 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.621 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.2 Cg_endo -67.77 133.82 30.65 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.057 1.556 . . . . 0.0 110.941 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 36.3 p-10 -110.19 106.99 16.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 109.938 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.53 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -99.14 110.47 23.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.116 -0.99 . . . . 0.0 109.929 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -149.27 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.626 ' N ' ' CE3' ' A' ' 106' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.106 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.544 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.445 0.641 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.09 109.69 20.73 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.424 -0.797 . . . . 0.0 109.546 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.654 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 30.3 t -109.73 144.81 17.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.914 -1.116 . . . . 0.0 110.706 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 15.8 t -130.93 124.78 56.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.554 0.692 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 54.1 m-85 -100.38 138.6 37.22 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.702 0.763 . . . . 0.0 112.552 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.6 t -120.88 127.51 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.904 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.493 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 10.2 p -79.78 -159.25 0.2 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.979 -1.076 . . . . 0.0 108.315 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.44 -1.07 31.41 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.98 -1.075 . . . . 0.0 109.177 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -100.4 -4.63 28.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.483 -0.761 . . . . 0.0 109.389 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.27 -31.8 7.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.478 HG21 ' CB ' ' A' ' 7' ' ' SER . 1.1 t -49.94 130.58 22.01 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.899 -1.353 . . . . 0.0 109.802 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 16.2 mtm180 -120.04 134.29 55.29 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.484 0.659 . . . . 0.0 110.864 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -111.62 156.77 21.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 0.0 109.682 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 32.2 mt-10 -130.89 125.34 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.382 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 11.1 mt -118.72 149.36 41.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.056 . . . . 0.0 111.434 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.72 87.77 3.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.572 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 41.7 t -98.7 171.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.692 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -121.44 -139.52 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.925 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.7 OUTLIER -104.73 125.74 51.11 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.41 -0.806 . . . . 0.0 110.224 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -8.74 30.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 69.7 t -98.86 169.49 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.07 -1.253 . . . . 0.0 110.322 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.51 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 -175.1 2.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.508 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 19.9 mt -79.9 -36.87 35.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.749 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.7 ttp -79.64 9.02 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' CG ' HG11 ' A' ' 21' ' ' VAL . 4.7 tt0 -102.03 -70.94 0.73 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.348 -0.845 . . . . 0.0 109.362 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -49.39 -53.65 21.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.723 -1.236 . . . . 0.0 108.516 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.639 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -53.81 -51.77 62.42 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.604 ' CG2' ' O ' ' A' ' 24' ' ' MET 0.272 0.7 OUTLIER -38.91 -57.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 177.8 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.588 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.84 -50.34 74.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.056 0.931 . . . . 0.0 109.101 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.581 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.8 m-80 -60.04 -7.88 2.05 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.418 0.628 . . . . 0.0 109.642 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.47 -13.04 59.29 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 12.7 mt -41.76 -39.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.534 -0.98 . . . . 0.0 109.58 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.749 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 45.8 m-85 -99.04 56.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.108 -0.995 . . . . 0.0 111.012 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.45 -2.7 4.89 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.466 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 36' ' ' VAL . 1.1 tt -79.07 -141.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.374 -0.829 . . . . 0.0 109.56 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.556 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 32.7 m -80.37 134.71 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.778 -1.201 . . . . 0.0 110.527 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.07 57.55 0.57 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -80.59 7.4 10.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -1.146 . . . . 0.0 110.313 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.576 ' HB2' ' CB ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -110.75 -64.4 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.176 -0.953 . . . . 0.0 110.481 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.29 52.63 8.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.33 34.8 28.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.7 t -125.73 -42.84 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -1.113 . . . . 0.0 110.281 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 72.15 57.22 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.369 -0.832 . . . . 0.0 111.342 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 p -132.65 8.24 4.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.884 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.661 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.29 151.55 29.54 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.74 -1.225 . . . . 0.0 113.647 -177.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -106.61 8.84 31.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.627 -1.296 . . . . 0.0 111.372 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.533 ' OG1' ' CG2' ' A' ' 36' ' ' VAL . 7.4 p -103.25 9.79 37.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -115.43 14.51 16.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.382 -0.824 . . . . 0.0 109.309 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.619 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 3.5 t-160 -41.83 141.17 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.525 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 16.1 m -147.04 155.81 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.9 -1.125 . . . . 0.0 109.326 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.638 ' CE2' ' HD2' ' A' ' 79' ' ' LYS . 7.9 m-30 -120.9 121.39 37.96 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.638 0.732 . . . . 0.0 110.67 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' CG1' HG21 ' A' ' 57' ' ' THR . 16.5 t -91.88 170.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.595 ' O ' ' CG2' ' A' ' 57' ' ' THR . 6.7 p30 -72.76 -148.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.526 -1.359 . . . . 0.0 109.222 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -102.85 -14.84 16.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.913 -1.117 . . . . 0.0 111.507 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.438 ' N ' ' OD1' ' A' ' 53' ' ' ASN . . . -100.56 -38.24 8.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.802 -1.186 . . . . 0.0 114.072 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.661 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 78.6 m-85 -84.24 -11.24 56.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.332 -1.48 . . . . 0.0 111.464 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.595 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -81.44 -49.16 10.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.934 -1.104 . . . . 0.0 109.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 3.7 p-10 -61.33 -13.53 20.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -93.46 -52.7 4.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.532 -0.73 . . . . 0.0 110.163 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.581 ' CG2' ' O ' ' A' ' 57' ' ' THR . 6.2 m -46.25 165.81 0.18 Allowed Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.7 Cg_endo -67.36 161.08 44.77 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.102 1.58 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.18 126.29 31.32 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.529 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -69.53 157.9 36.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 31.1 p-10 -100.24 -168.17 1.55 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.897 -1.127 . . . . 0.0 112.067 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -65.05 -19.68 66.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.818 -0.551 . . . . 0.0 110.493 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -64.14 -53.12 54.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.955 . . . . 0.0 108.809 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.1 tt0 -58.95 -47.37 85.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.535 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.4 mp -47.97 -26.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.016 -1.052 . . . . 0.0 111.281 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.67 -67.91 1.19 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.668 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.12 -44.05 31.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.35 -1.088 . . . . 0.0 109.279 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.619 ' CD2' ' CE1' ' A' ' 49' ' ' HIS 0.255 0.0 OUTLIER -68.63 -25.14 64.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.644 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -91.01 -25.89 19.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.499 -0.751 . . . . 0.0 110.769 178.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.578 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.09 -41.41 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.777 -1.202 . . . . 0.0 109.052 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 104' ' ' ARG . 3.6 m -90.51 87.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.802 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.54 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.6 t -47.84 96.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.817 0.818 . . . . 0.0 111.475 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -125.17 47.38 2.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.222 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.563 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.3 pt-20 39.75 60.16 1.71 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.732 0.777 . . . . 0.0 109.384 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.8 tp -27.24 134.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.578 0.704 . . . . 0.0 112.089 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.638 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 5.1 mtpt -104.85 173.71 3.14 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.7 Cg_endo -69.32 -29.26 26.24 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.393 1.207 . . . . 0.0 110.054 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.8 p-10 -106.97 -2.32 21.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 111.061 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.568 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 69.6 m -49.21 161.83 0.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.813 -1.18 . . . . 0.0 111.069 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.516 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -175.32 166.39 3.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.668 ' CD1' ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -83.16 148.56 27.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.549 ' C ' ' HB2' ' A' ' 24' ' ' MET . 66.1 m -49.07 -27.36 3.28 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.576 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 4.7 p -106.95 43.65 1.14 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.878 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.57 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.4 tp-100 -125.57 -38.06 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.919 -1.113 . . . . 0.0 111.212 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -96.15 147.99 5.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.605 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 90' ' ' MET . 5.5 mm -110.61 161.67 8.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.576 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.29 124.31 51.41 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.789 -1.194 . . . . 0.0 110.792 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.499 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 3.9 p -110.02 168.07 8.18 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.63 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 43.9 Cg_endo -73.27 -1.75 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.823 1.433 . . . . 0.0 111.59 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -110.08 -24.13 10.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.812 -1.18 . . . . 0.0 110.233 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.576 ' O ' ' CE ' ' A' ' 90' ' ' MET . 4.8 mt -93.73 33.57 1.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 6.0 p-10 -80.65 144.39 32.34 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.822 0.82 . . . . 0.0 112.501 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.657 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.25 21.59 11.52 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.661 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 13.2 tt -74.17 157.49 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 123.131 1.443 . . . . 0.0 113.8 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 23.2 t -122.92 121.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.261 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -103.76 -176.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.0 109.531 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.8 m-20 -160.95 138.86 9.51 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.028 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 6' ' ' VAL . 12.7 t -102.05 116.68 62.84 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.984 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.637 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo -64.55 169.34 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 109.953 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.519 ' O ' ' NE ' ' A' ' 104' ' ' ARG . 3.0 p-10 -110.33 78.56 1.13 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.777 -1.202 . . . . 0.0 112.009 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.538 ' CD ' ' HB3' ' A' ' 76' ' ' ALA . 11.9 mmp_? -110.46 87.89 2.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -119.87 8.47 11.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 110.22 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.274 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.523 ' HA ' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.341 0.591 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -80.73 137.56 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.812 . . . . 0.0 109.422 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.612 HG13 ' CZ ' ' A' ' 5' ' ' TYR . 2.5 t -125.74 135.94 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.823 -1.173 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 44.3 t -129.19 124.89 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.496 1.141 . . . . 0.0 110.324 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.669 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.29 30.1 m-85 -98.46 139.96 33.43 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.976 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 4.5 t -121.05 155.86 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.032 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.509 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 97.4 p -119.38 142.05 48.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.437 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -44.65 -23.72 0.15 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.421 -0.799 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.459 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.3 p30 -89.64 -4.07 57.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.067 -1.021 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.13 -32.22 7.23 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.459 ' HB ' ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -49.53 131.49 21.02 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.082 -1.246 . . . . 0.0 109.061 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -125.67 151.31 46.73 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.439 0.638 . . . . 0.0 111.122 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.669 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.41 118.41 17.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.325 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 6.9 mp0 -116.29 125.37 52.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 0.0 111.845 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.724 ' CD2' ' ND2' ' A' ' 30' ' ' ASN 0.25 6.7 mp -110.42 -175.23 2.67 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.225 1.012 . . . . 0.0 111.198 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -119.23 92.35 3.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.576 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 5.9 t -98.63 170.07 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.496 -0.752 . . . . 0.0 110.948 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.513 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -134.03 -143.64 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' MET . 1.3 p-10 -95.02 123.57 38.57 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.591 -0.693 . . . . 0.0 110.546 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.52 -7.67 30.21 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.579 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.576 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 46.0 t -98.4 167.91 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.776 -1.426 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.519 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.66 165.14 16.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.49 HD21 HG12 ' A' ' 3' ' ' VAL . 2.9 mt -59.69 -17.19 32.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.481 -1.387 . . . . 0.0 108.474 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.644 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -82.53 -66.5 0.88 Allowed 'General case' 0 C--O 1.204 -1.34 0 O-C-N 121.479 -0.763 . . . . 0.0 109.03 178.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' CG ' HG11 ' A' ' 21' ' ' VAL 0.27 6.4 tt0 -37.03 -71.15 0.08 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.366 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.532 ' C ' ' CD2' ' A' ' 15' ' ' LEU . . . -43.21 -66.3 0.39 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.683 -1.261 . . . . 0.0 108.518 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . . . -46.84 -49.9 19.34 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.065 0.936 . . . . 0.0 109.152 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.257 0.8 OUTLIER -43.68 -56.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.63 0.729 . . . . 0.0 109.137 179.033 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.28 -49.42 72.16 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.885 0.85 . . . . 0.0 108.879 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.724 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 1.5 m-80 -59.75 -10.65 3.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.62 -10.56 73.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CD1' ' CD2' ' A' ' 5' ' ' TYR . 4.1 mt -39.92 -41.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.694 -0.886 . . . . 0.0 110.038 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 25.6 m-85 -108.68 59.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.045 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -60.46 -15.98 32.03 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CD1' ' CG2' ' A' ' 47' ' ' THR . 10.1 tt -79.71 77.34 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.304 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 33' ' ' TYR . 3.9 t -120.15 73.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.055 -1.028 . . . . 0.0 110.493 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.28 -2.47 12.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -120.1 -64.28 1.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.157 -1.202 . . . . 0.0 110.039 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 7.3 p -69.11 -37.47 78.38 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.707 -0.621 . . . . 0.0 111.105 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.83 29.44 6.17 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.56 34.76 27.56 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 4.6 p -140.15 7.31 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -1.211 . . . . 0.0 111.752 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.608 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 71.21 58.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.12 -0.987 . . . . 0.0 112.514 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -133.61 30.78 3.76 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.685 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.5 p -111.25 150.41 29.63 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB2' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.11 16.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.086 -1.009 . . . . 0.0 108.672 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.582 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 14.1 t -110.35 -32.36 6.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 111.908 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.9 m -74.73 8.32 2.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.398 -1.439 . . . . 0.0 110.41 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.64 ' NE2' HD23 ' A' ' 71' ' ' LEU . 23.6 t-160 -46.03 140.53 3.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.65 -1.281 . . . . 0.0 109.292 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG11 ' O ' ' A' ' 49' ' ' HIS . 13.5 m -144.89 159.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.563 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.6 m-30 -118.4 120.76 38.54 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.56 ' CG1' HG21 ' A' ' 57' ' ' THR . 24.2 t -84.45 167.84 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' O ' ' CG2' ' A' ' 57' ' ' THR . 8.1 p-10 -80.27 -142.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.232 -1.543 . . . . 0.0 110.229 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -101.92 -28.02 12.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.253 -1.53 . . . . 0.0 113.384 -177.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -100.2 23.83 9.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.349 -1.469 . . . . 0.0 113.313 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.658 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 73.5 m-85 -140.58 -19.48 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.627 -1.296 . . . . 0.0 110.939 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.584 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -81.18 -50.67 9.3 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -64.92 -15.47 62.12 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' CB ' ' CD2' ' A' ' 94' ' ' LEU 0.296 0.8 OUTLIER -79.28 -53.9 6.48 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.797 1.76 . . . . 0.0 108.942 179.154 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG13 ' CG2' ' A' ' 88' ' ' ILE 0.319 0.3 OUTLIER -77.42 139.44 63.84 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 112.519 -2.128 . . . . 0.0 110.22 -177.817 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -66.67 162.25 38.03 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.092 1.575 . . . . 0.0 112.011 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 -173.42 4.14 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.564 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.589 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -170.41 1.63 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.415 0.626 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.64 -164.4 1.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.0 110.671 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 1.1 pt-20 -61.37 -22.0 64.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 6.2 ttm180 -64.24 -57.93 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 0.0 109.164 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 15.6 tp10 -59.97 1.15 0.12 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.749 -0.594 . . . . 0.0 111.956 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 6.7 mm -90.9 -39.55 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 110.225 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -83.2 -60.5 2.02 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.647 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -47.65 -43.7 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.195 -1.179 . . . . 0.0 108.738 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.64 HD23 ' NE2' ' A' ' 49' ' ' HIS 0.257 0.0 OUTLIER -73.11 -34.31 66.09 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.819 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -70.29 -21.1 62.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 46' ' ' ALA . 74.4 m -48.99 -24.24 1.44 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.088 -1.008 . . . . 0.0 108.696 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' A' ' 76' ' ' ALA . 17.4 m -90.12 76.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.662 -0.649 . . . . 0.0 109.786 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 75' ' ' THR . 12.9 t -50.99 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.008 -0.432 . . . . 0.0 111.829 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -131.09 52.35 2.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.867 -1.146 . . . . 0.0 110.443 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 38.93 60.17 1.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.631 -0.668 . . . . 0.0 110.151 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.573 HD13 ' CE1' ' A' ' 49' ' ' HIS . 2.3 tp -22.91 141.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.44 0.638 . . . . 0.0 112.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -90.7 168.87 13.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.004 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.32 -26.37 41.58 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.653 1.344 . . . . 0.0 109.346 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.559 ' HB2' HG23 ' A' ' 57' ' ' THR . 14.2 p30 -105.38 -6.74 19.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.752 -0.593 . . . . 0.0 110.958 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.622 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.3 m -48.95 156.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 0.0 111.085 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.52 ' CD ' HG12 ' A' ' 88' ' ' ILE . 1.2 ttt180 -175.18 158.79 2.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.73 0.776 . . . . 0.0 110.8 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER -78.85 138.94 38.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.689 -0.632 . . . . 0.0 109.809 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 1.6 p -44.84 -31.85 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.886 -1.134 . . . . 0.0 110.005 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 3.7 m -101.08 39.58 1.38 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.433 -0.792 . . . . 0.0 111.17 -177.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.7 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 1.8 mm-40 -126.48 -43.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 112.608 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.544 ' CG2' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -83.75 149.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 118.634 -1.227 . . . . 0.0 110.656 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 22' ' ' SER . 4.9 mm -110.87 160.15 10.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.318 0.58 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 1.9 tpt -110.3 113.91 26.95 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.079 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -91.37 169.15 11.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 109.508 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 41.8 Cg_endo -72.73 -8.83 23.07 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.782 1.412 . . . . 0.0 111.291 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 1.9 pp20? -110.04 -41.58 4.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.863 -1.148 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.599 ' CD2' ' CB ' ' A' ' 59' ' ' LYS . 1.2 mt -72.56 54.28 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.541 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.523 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 50.0 p-10 -101.53 156.18 17.63 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.106 -0.997 . . . . 0.0 112.646 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.658 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.6 27.07 12.03 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.653 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 4.9 tt -79.99 157.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 122.219 1.009 . . . . 0.0 112.21 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.528 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 19.0 t -124.13 125.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.559 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.1 t -103.73 -176.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.0 m-20 -162.18 139.24 8.21 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.885 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 6' ' ' VAL . 16.4 t -90.67 117.18 67.77 Favored Pre-proline 0 C--N 1.285 -2.223 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.245 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.632 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.2 Cg_endo -64.59 154.69 70.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.855 1.45 . . . . 0.0 110.312 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.501 ' OD1' ' NH2' ' A' ' 104' ' ' ARG . 6.1 p-10 -105.59 91.06 3.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 0.0 111.302 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.624 ' NE ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.1 44.57 1.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.723 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.07 2.82 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.188 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.343 0.592 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -80.02 138.6 37.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -0.793 . . . . 0.0 109.873 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.644 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 4.0 t -127.95 146.73 33.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.012 -1.055 . . . . 0.0 110.141 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 3.4 t -130.5 130.06 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.592 0.71 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.683 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.266 46.3 m-85 -106.09 138.83 41.6 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.523 ' HA ' ' CG ' ' A' ' 12' ' ' ARG . 11.3 t -121.71 152.17 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.738 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.525 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 80.5 p -114.97 138.0 51.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' CD2' ' HB3' ' A' ' 103' ' ' ASP . 1.3 t60 -46.59 -22.38 0.28 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.943 -1.098 . . . . 0.0 110.016 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 7' ' ' SER . 2.1 p30 -85.03 -6.22 59.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.049 . . . . 0.0 110.156 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.25 -36.1 4.46 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.73 133.28 21.66 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.817 -1.402 . . . . 0.0 109.226 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 16.9 mtm105 -129.04 154.9 46.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.283 0.563 . . . . 0.0 111.247 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.683 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -135.58 121.3 19.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 36.4 mt-10 -94.64 123.35 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.62 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 8.2 mt -109.79 147.23 33.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.979 . . . . 0.0 110.57 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -99.55 88.07 3.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.572 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 56.6 t -98.97 168.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.517 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -125.28 -133.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -108.1 123.98 49.53 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.248 -0.907 . . . . 0.0 110.382 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.32 -8.47 30.78 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 22' ' ' SER . 60.8 t -97.81 170.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.917 -1.343 . . . . 0.0 110.465 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.534 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.48 154.4 35.31 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 10.0 mt -48.78 -23.35 1.04 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.505 -1.372 . . . . 0.0 109.329 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.665 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.6 ttt -83.51 -62.73 1.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.621 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.6 tt0 -36.57 -54.22 0.87 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.257 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -61.39 -49.91 74.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.035 -1.665 . . . . 0.0 107.664 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.62 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -58.16 -61.2 2.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.308 1.051 . . . . 0.0 108.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.293 0.8 OUTLIER -29.63 -59.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.744 178.22 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.586 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -48.18 78.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.108 0.956 . . . . 0.0 108.871 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.589 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.3 m-80 -59.64 -11.42 4.89 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.07 -10.32 73.4 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 27' ' ' ALA . 4.8 mt -42.83 -30.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.395 -1.062 . . . . 0.0 108.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.665 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 26.4 m-85 -118.08 67.4 0.76 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.457 -0.897 . . . . 0.0 113.09 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -89.93 26.53 1.8 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.512 ' CD1' ' SG ' ' A' ' 48' ' ' CYS . 5.2 pt -79.67 -162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.427 0.632 . . . . 0.0 110.191 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -120.64 87.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.25 150.69 17.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER -86.76 6.1 33.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.609 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.7 p -69.36 -35.35 75.78 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.768 -0.583 . . . . 0.0 111.291 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.68 31.39 2.57 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.35 35.61 25.97 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 39' ' ' CYS . 0.4 OUTLIER -140.17 8.95 2.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -1.179 . . . . 0.0 111.024 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.58 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 68.49 54.28 0.53 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.283 1.039 . . . . 0.0 111.285 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.586 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -131.77 30.8 4.31 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -111.39 149.9 30.55 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB2' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.88 16.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.951 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.468 HG22 HG13 ' A' ' 35' ' ' ILE . 1.7 t -110.22 -25.13 10.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 112.152 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.599 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 19.0 m -76.71 15.16 0.68 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.509 -1.369 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.72 ' CD2' ' CD2' ' A' ' 71' ' ' LEU . 6.5 t-80 -49.97 136.32 18.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.833 -1.167 . . . . 0.0 108.036 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 9.9 m -160.27 170.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.668 -1.27 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CE2' ' HD2' ' A' ' 79' ' ' LYS . 11.4 m-30 -120.4 123.09 42.19 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.563 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' A' ' 97' ' ' ILE . 46.6 t -90.48 151.15 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.527 ' OD1' ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -73.25 133.77 44.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 119.835 -1.791 . . . . 0.0 109.863 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HA ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -40.95 -26.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.724 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.528 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -61.34 -17.23 52.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.875 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.699 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 50.1 m-85 -131.02 -9.19 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.011 -1.056 . . . . 0.0 110.835 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 81' ' ' ASN . 1.3 p -80.52 -39.44 27.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -12.11 60.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 109.57 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.281 22.0 mmmt -79.43 -54.64 5.73 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.669 1.7 . . . . 0.0 108.678 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' CG2' ' A' ' 88' ' ' ILE 0.326 0.3 OUTLIER -81.09 134.23 52.92 Favored Pre-proline 0 C--N 1.279 -2.47 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.943 -178.005 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.67 159.9 50.58 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.079 1.568 . . . . 0.0 112.212 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -81.07 177.44 9.04 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.614 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -152.41 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.403 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' O ' HD11 ' A' ' 68' ' ' ILE . 47.8 p-10 -100.04 -139.85 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.11 -18.05 50.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 110.109 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.7 OUTLIER -70.05 -52.55 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.614 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 1.7 tm-20 -58.35 -15.54 10.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.838 -1.164 . . . . 0.0 110.16 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.608 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.5 mp -91.31 -65.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.39 -48.01 26.14 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.271 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.664 ' CE ' HD11 ' A' ' 84' ' ' LEU 0.296 12.3 ttp -48.61 -52.34 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 123.207 1.479 . . . . 0.0 107.744 178.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.72 ' CD2' ' CD2' ' A' ' 49' ' ' HIS 0.284 0.0 OUTLIER -62.26 -52.56 63.24 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.379 179.609 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.621 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 7.4 tt0 -82.17 20.53 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.519 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' GLY . 1.3 m -49.18 -25.42 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.149 -1.594 . . . . 0.0 108.069 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.527 ' CG2' ' N ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -89.93 -148.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.527 ' N ' ' CG2' ' A' ' 74' ' ' VAL . 9.6 t -130.78 55.52 1.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.174 -1.579 . . . . 0.0 110.076 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -98.6 32.27 2.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 110.745 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.553 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.1 pt-20 39.19 60.48 1.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 77' ' ' GLU . 12.4 tp -19.77 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.579 0.704 . . . . 0.0 112.544 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.646 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 3.6 mtpt -97.53 -167.55 0.13 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 43.9 Cg_endo -82.58 -28.23 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.491 1.258 . . . . 0.0 109.777 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 9.8 p-10 -105.89 -7.21 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.52 -0.737 . . . . 0.0 111.508 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.568 ' CB ' HD12 ' A' ' 71' ' ' LEU . 1.5 m -49.56 143.68 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.59 -1.319 . . . . 0.0 110.326 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.594 ' CD ' ' CG ' ' A' ' 67' ' ' GLU . 1.5 mmt-85 -158.85 151.76 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 110.158 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.664 HD11 ' CE ' ' A' ' 70' ' ' MET . 12.2 mt -74.34 148.51 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.599 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 18.1 m -47.1 -25.38 0.85 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 2.8 m -110.08 48.18 0.91 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.837 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.528 ' NE2' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -125.24 -38.95 2.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 110.863 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.585 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -101.7 155.93 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.462 HG21 ' N ' ' A' ' 90' ' ' MET . 4.6 mm -110.3 163.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.513 -0.742 . . . . 0.0 109.369 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.7 tpt -110.07 106.73 16.32 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 110.438 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.1 p -89.4 163.79 32.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.7 Cg_endo -74.34 -6.88 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.956 1.503 . . . . 0.0 110.54 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.472 ' HG3' HD22 ' A' ' 94' ' ' LEU . 2.7 pt-20 -103.47 -27.76 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' A' ' 59' ' ' LYS . 9.9 mt -99.97 57.29 0.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 4.8 p-10 -100.43 149.89 23.19 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.662 0.744 . . . . 0.0 112.242 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.646 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.61 22.36 11.36 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.699 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 8.3 tt -72.84 154.49 7.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.747 1.261 . . . . 0.0 113.325 -177.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.527 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 5.8 t -122.57 127.76 75.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.334 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.65 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.8 t -103.81 -179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.015 -1.053 . . . . 0.0 108.578 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.519 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.6 m-20 -161.17 138.53 9.02 Favored 'General case' 0 C--N 1.274 -2.711 0 C-N-CA 118.408 -1.317 . . . . 0.0 110.726 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 15.2 t -97.38 117.75 65.18 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.644 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 37.2 Cg_endo -65.23 -166.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.95 1.5 . . . . 0.0 110.613 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.584 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 4.5 p-10 -110.03 -0.14 18.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.992 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.525 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -110.29 78.51 1.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.191 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.7 2.34 15.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.546 ' CE3' ' C ' ' A' ' 106' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 95' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.563 0.697 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.4 OUTLIER -80.13 119.66 23.22 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.641 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 20.3 t -124.46 148.6 28.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.871 -1.143 . . . . 0.0 111.53 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 4.7 t -131.14 128.8 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.699 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.273 42.2 m-85 -107.68 140.99 39.89 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 3.2 t -122.16 129.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.05 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 77.6 p -79.36 -151.44 0.06 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.61 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.33 -10.51 14.6 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 120.874 -1.141 . . . . 0.0 108.915 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.443 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.7 p30 -100.41 1.99 41.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.34 -31.05 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.481 HG21 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.7 135.99 18.14 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.935 -1.332 . . . . 0.0 109.092 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.7 mtm180 -130.16 152.74 49.27 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.411 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.699 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -132.78 121.24 22.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 2.5 mm-40 -94.64 124.14 38.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.146 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 7.2 mt -109.67 147.98 32.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.009 -1.057 . . . . 0.0 111.851 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.02 84.89 2.31 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.548 HG11 ' CG1' ' A' ' 21' ' ' VAL . 16.6 t -98.89 172.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -177.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -120.3 -144.2 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.418 -0.801 . . . . 0.0 111.252 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -102.06 133.73 46.41 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.62 -0.675 . . . . 0.0 110.307 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.47 -3.09 57.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.831 HG11 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -100.43 172.48 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -1.105 . . . . 0.0 110.406 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.617 ' H ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.97 179.26 4.32 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.791 178.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 16.1 mt -76.63 -14.82 59.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.782 -1.199 . . . . 0.0 109.534 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.725 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.1 tmt? -90.6 -71.45 0.62 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.679 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.831 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -37.9 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.707 -0.621 . . . . 0.0 112.132 -176.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.607 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -88.37 -52.5 5.16 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -59.86 -45.43 92.47 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.624 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.262 0.8 OUTLIER -42.9 -61.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.72 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.613 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.55 -32.73 70.6 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.45 1.119 . . . . 0.0 108.163 178.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.583 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 3.7 m-80 -77.36 10.41 2.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.046 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 61.06 13.91 36.62 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' HB ' ' CB ' ' A' ' 27' ' ' ALA . 5.1 mt -72.1 -33.93 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.343 -1.092 . . . . 0.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.725 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.3 m-85 -103.8 52.26 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.0 111.888 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -79.1 48.72 0.88 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 36' ' ' VAL . 6.3 pt -79.98 -144.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.334 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.51 ' N ' HG13 ' A' ' 35' ' ' ILE . 30.4 t -85.26 -89.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 110.343 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.489 ' N ' ' CG1' ' A' ' 36' ' ' VAL . . . -79.97 178.19 53.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -119.55 162.19 19.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -1.1 . . . . 0.0 110.206 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -110.46 -26.38 9.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 0.0 109.938 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 40.94 28.06 0.22 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . 80.09 30.54 41.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' CYS . 7.8 t -117.58 -36.13 3.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -1.14 . . . . 0.0 109.881 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 70' ' ' MET . . . 73.33 60.36 0.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.632 0.729 . . . . 0.0 111.762 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -131.95 22.02 4.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -112.56 161.15 17.11 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.495 0.664 . . . . 0.0 111.761 -177.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -110.95 -2.99 15.78 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.576 -1.328 . . . . 0.0 112.623 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 18.0 p -110.32 28.36 8.71 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.284 -1.51 . . . . 0.0 112.656 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -115.96 -3.4 12.14 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.616 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 2.7 t-160 -43.46 127.6 4.74 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 17.4 m -139.17 161.26 28.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.566 -1.334 . . . . 0.0 110.211 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.701 ' CE2' ' HD2' ' A' ' 79' ' ' LYS . 5.8 m-30 -116.9 121.8 42.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.69 0.757 . . . . 0.0 110.381 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.555 ' CG1' HG21 ' A' ' 57' ' ' THR . 14.6 t -91.41 172.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.598 ' O ' ' CG2' ' A' ' 57' ' ' THR . 6.6 p30 -75.84 -148.39 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.445 -1.41 . . . . 0.0 109.21 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 -16.02 16.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.878 -1.139 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.65 -36.12 9.25 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.853 -1.154 . . . . 0.0 113.832 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.676 ' CD2' ' HA ' ' A' ' 97' ' ' ILE . 70.0 m-85 -84.37 -13.21 52.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.338 -1.477 . . . . 0.0 111.608 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.598 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -80.79 -27.67 36.56 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.717 -1.239 . . . . 0.0 109.818 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -24.43 21.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . 15.3 mmtm -79.57 -52.12 8.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 56' ' ' PHE . 9.1 m -42.19 166.31 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.616 -0.678 . . . . 0.0 110.044 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 38.1 Cg_endo -66.34 165.29 25.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.027 1.541 . . . . 0.0 111.448 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 114.17 19.35 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.261 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.575 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -69.1 163.81 23.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.879 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.459 ' O ' HD12 ' A' ' 68' ' ' ILE . 44.3 p-10 -100.3 -146.45 0.34 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 0.0 111.335 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' HG3' ' CZ ' ' A' ' 66' ' ' ARG . 3.6 pt-20 -72.72 -27.76 62.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.55 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.616 ' O ' ' CB ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.37 -46.83 81.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 108.509 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.578 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 3.0 tm-20 -58.08 -16.05 11.64 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.43 -1.419 . . . . 0.0 109.298 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.518 HG21 ' N ' ' A' ' 69' ' ' GLY . 1.2 mp -92.14 -68.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 110.436 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.518 ' N ' HG21 ' A' ' 68' ' ' ILE . . . -77.38 -49.23 7.51 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.702 ' HE3' HD12 ' A' ' 84' ' ' LEU 0.253 0.0 OUTLIER -48.91 -41.4 33.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.029 1.395 . . . . 0.0 108.268 179.187 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.612 HD23 ' CD2' ' A' ' 49' ' ' HIS 0.323 0.0 OUTLIER -77.29 -30.34 54.17 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.737 -179.217 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 6.1 tt0 -86.33 10.24 15.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.868 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 46' ' ' ALA . 33.9 m -48.92 -52.88 22.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.648 -1.283 . . . . 0.0 108.039 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 18.3 m -90.48 116.45 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.565 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.8 OUTLIER -48.49 98.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.557 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -128.27 38.77 3.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.865 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.24 60.45 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.633 0.73 . . . . 0.0 110.038 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 72' ' ' GLU . 0.4 OUTLIER -27.98 119.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.494 0.664 . . . . 0.0 111.927 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.701 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 1.1 mttp -85.35 -167.68 0.15 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.568 ' CD ' ' HB3' ' A' ' 79' ' ' LYS . 43.1 Cg_endo -82.81 -29.02 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.305 1.161 . . . . 0.0 109.135 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.523 ' HB2' HG23 ' A' ' 57' ' ' THR . 42.0 p-10 -106.15 -7.3 18.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.597 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 13.9 m -48.08 128.7 14.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.555 -1.34 . . . . 0.0 110.072 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.572 ' CG ' ' HG3' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -142.29 164.17 30.86 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.82 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.702 HD12 ' HE3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -74.94 136.83 41.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.824 -0.548 . . . . 0.0 111.943 -178.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 1.9 p -55.99 -22.7 28.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.598 ' HB3' ' CB ' ' A' ' 39' ' ' CYS . 1.1 p -107.13 28.95 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.309 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.561 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 2.7 mm-40 -126.08 -41.28 1.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.175 . . . . 0.0 112.103 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -79.85 146.21 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.689 -178.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 5.9 mm -111.1 158.86 11.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 4.0 tpt -110.14 114.47 28.0 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.072 -1.017 . . . . 0.0 110.488 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.486 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -95.7 165.83 15.8 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.326 -0.858 . . . . 0.0 109.669 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.3 Cg_endo -70.51 -30.01 19.46 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.837 1.441 . . . . 0.0 110.965 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.5 pp20? -83.46 -41.39 18.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.982 -1.074 . . . . 0.0 109.911 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.531 ' O ' ' CE ' ' A' ' 90' ' ' MET . 1.6 mt -79.42 60.82 3.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.524 ' OD1' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -101.16 153.61 19.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.862 -1.149 . . . . 0.0 111.652 -178.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.48 19.52 12.2 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.676 ' HA ' ' CD2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -59.32 126.72 17.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.453 1.12 . . . . 0.0 112.537 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 2.8 t -105.73 116.63 49.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.637 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.5 t -104.11 -178.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 122.354 1.074 . . . . 0.0 110.542 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 51' ' ' TYR . 5.1 m-20 -162.05 140.24 8.98 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.035 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.58 HG13 ' CE1' ' A' ' 8' ' ' HIS . 52.5 t -96.59 112.08 59.07 Favored Pre-proline 0 N--CA 1.499 1.999 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.017 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.672 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 44.7 Cg_endo -73.57 98.32 1.03 Allowed 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.105 1.87 . . . . 0.0 113.928 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.61 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -111.6 87.39 2.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.713 -1.242 . . . . 0.0 109.522 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.552 ' NE ' ' C ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -110.19 22.6 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.866 -1.146 . . . . 0.0 111.683 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.489 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 5.5 tp60 -64.02 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.226 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.512 ' N ' ' O ' ' A' ' 104' ' ' ARG . 98.6 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.231 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.41 0.624 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.484 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 6.2 tmtm? -79.98 109.32 14.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.669 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 4.9 t -111.37 143.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.997 -1.064 . . . . 0.0 110.75 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 3.1 t -130.89 125.09 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.232 1.015 . . . . 0.0 109.519 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.67 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.284 36.6 m-85 -101.02 138.32 38.22 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.585 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 100' ' ' ASP . 3.5 t -121.79 158.02 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.454 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 60.7 p -120.03 137.86 53.85 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.578 ' CE1' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -43.84 -23.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.018 -1.051 . . . . 0.0 110.409 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD2' ' HB ' ' A' ' 11' ' ' THR . 6.6 p-10 -85.94 -3.5 58.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.086 -1.009 . . . . 0.0 110.577 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.22 -42.01 2.08 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.832 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.53 ' CG2' ' CZ ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -49.56 134.48 19.58 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 120.968 -1.313 . . . . 0.0 109.869 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.8 mtm180 -130.08 160.68 32.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.036 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.67 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -138.4 123.06 18.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 178.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 3.2 mp0 -95.36 128.27 42.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.644 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 9.0 mt -121.13 146.2 47.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.048 -1.032 . . . . 0.0 111.718 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 16.2 p30 -100.86 90.05 4.07 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.578 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 42.5 t -98.85 171.49 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 111.064 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -118.82 -134.16 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 0.0 110.546 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -110.13 124.36 51.39 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.276 -0.89 . . . . 0.0 110.527 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.39 -8.28 30.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.383 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 95.9 t -96.07 170.13 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.288 . . . . 0.0 110.651 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.526 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.98 171.72 8.44 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.88 -28.19 67.31 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.21 179.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.639 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -86.86 4.7 40.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.583 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.545 ' CG ' HG11 ' A' ' 21' ' ' VAL . 5.9 tt0 -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.15 -0.969 . . . . 0.0 109.372 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.578 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -51.24 -47.79 62.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 108.212 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.644 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -60.36 -53.28 59.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.279 0.8 OUTLIER -36.84 -58.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.65 0.738 . . . . 0.0 109.011 178.006 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.569 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.137 0.97 . . . . 0.0 108.459 178.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.587 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.1 m-80 -64.55 -5.0 4.62 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.506 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 74.29 2.06 61.98 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.577 ' HB ' ' CB ' ' A' ' 27' ' ' ALA . 3.0 mt -50.22 -30.1 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.329 -1.1 . . . . 0.0 109.393 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 54.0 m-85 -105.98 53.39 0.71 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 112.064 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.24 45.85 0.39 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 108.599 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.539 ' CG1' ' N ' ' A' ' 36' ' ' VAL . 1.3 tt -120.26 173.24 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 121.459 -0.776 . . . . 0.0 109.072 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.539 ' N ' ' CG1' ' A' ' 35' ' ' ILE . 2.5 p -79.8 87.58 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 110.159 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 126.98 6.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 12.1 p30 -107.57 59.97 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.2 p -110.65 -57.35 2.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.307 -0.871 . . . . 0.0 110.797 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.13 41.96 11.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.32 37.03 22.32 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 10.2 t -126.96 -22.24 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 111.152 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.589 ' CB ' ' NE2' ' A' ' 87' ' ' GLN . . . 58.22 60.72 2.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.381 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.61 7.18 4.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.349 -0.845 . . . . 0.0 110.455 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.554 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.68 116.36 30.64 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.254 -0.904 . . . . 0.0 112.069 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.533 ' CB ' HG12 ' A' ' 74' ' ' VAL . . . -74.98 0.31 16.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 36' ' ' VAL . 9.4 t -85.42 -29.55 24.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.903 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.585 ' CB ' ' OG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -89.38 11.79 18.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.017 -1.052 . . . . 0.0 109.384 179.12 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.655 ' CG ' ' CG ' ' A' ' 102' ' ' PRO . 11.1 t-160 -42.5 139.83 1.41 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 83' ' ' ARG . 34.9 m -146.51 154.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 122.09 0.948 . . . . 0.0 109.929 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 11.9 m-85 -121.67 129.34 52.7 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.264 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 19.1 t -96.12 167.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.772 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.555 ' ND2' ' CG2' ' A' ' 98' ' ' VAL . 25.3 p-10 -91.97 136.1 33.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.722 -1.237 . . . . 0.0 109.337 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.8 pt-20 -37.1 -26.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.81 . . . . 0.0 111.989 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -69.81 -16.52 63.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.871 -1.143 . . . . 0.0 111.681 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.682 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 68.1 m-85 -131.11 -10.81 3.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.729 -1.232 . . . . 0.0 110.945 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.556 HG23 ' HB2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -80.57 -26.82 37.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 109.018 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.4 -31.59 63.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.983 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . 1.5 mmtt -79.92 -53.0 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' HB ' ' CG2' ' A' ' 88' ' ' ILE . 5.4 m -40.43 147.04 0.4 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.514 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 41.3 Cg_endo -68.52 170.7 14.43 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.397 1.735 . . . . 0.0 111.146 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 135.4 36.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.33 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -69.2 177.09 2.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 110.884 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -100.22 -156.13 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.338 -0.851 . . . . 0.0 111.015 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.7 pp20? -80.34 -30.79 38.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.514 ' NE ' ' O ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -65.0 -37.8 88.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.126 -0.984 . . . . 0.0 109.449 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.587 ' HG3' ' HG2' ' A' ' 87' ' ' GLN . 2.3 tm-20 -67.73 -6.89 23.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.684 -0.635 . . . . 0.0 109.478 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.573 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -91.47 -35.57 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 110.909 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -77.36 -65.31 1.95 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.174 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.864 ' HG3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.71 -48.55 40.27 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.017 1.389 . . . . 0.0 108.333 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.65 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -58.91 -30.47 67.84 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.184 -176.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -81.26 -39.58 25.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.6 -0.688 . . . . 0.0 109.476 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.32 -41.53 38.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.816 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG22 ' ND1' ' A' ' 49' ' ' HIS . 2.8 m -90.42 67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.464 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.0 t -48.79 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.685 -0.635 . . . . 0.0 111.349 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.554 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.16 64.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.49 60.16 1.64 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.241 1.02 . . . . 0.0 109.813 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' CD1' HD21 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -46.87 134.65 9.91 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.991 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -125.36 -176.86 0.5 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.0 Cg_endo -67.04 -25.53 44.04 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.173 1.091 . . . . 0.0 111.297 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB2' HG23 ' A' ' 57' ' ' THR . 26.0 p-10 -97.91 -13.13 21.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.813 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 1.4 m -54.44 151.34 7.83 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.596 -1.315 . . . . 0.0 109.761 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.562 ' CG ' ' HG2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -175.63 163.76 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.188 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.864 HD13 ' HG3' ' A' ' 70' ' ' MET . 0.4 OUTLIER -83.16 145.09 29.39 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.489 -0.757 . . . . 0.0 109.986 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 60.3 p -40.83 -32.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 123.116 1.436 . . . . 0.0 107.973 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.588 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -94.35 46.39 1.15 Allowed 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.589 ' NE2' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -127.43 -43.29 1.61 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.493 -1.379 . . . . 0.0 113.374 -178.44 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.28 152.88 5.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 122.044 0.926 . . . . 0.0 112.341 -176.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 90' ' ' MET . 6.9 mm -106.35 165.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.541 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tpt -110.17 117.7 34.39 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.385 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 10.4 p -95.41 165.67 16.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.648 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.9 Cg_endo -73.25 -1.38 10.52 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.929 1.489 . . . . 0.0 110.345 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -110.08 -51.79 2.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 109.097 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.541 ' O ' ' CE ' ' A' ' 90' ' ' MET . 1.3 mt -65.85 57.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.501 -0.749 . . . . 0.0 110.474 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.523 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 1.8 p30 -101.74 142.9 32.37 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.967 -1.083 . . . . 0.0 112.721 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.654 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.68 23.82 8.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.682 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.78 149.99 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.344 1.068 . . . . 0.0 112.904 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.555 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 22.1 t -115.09 123.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.788 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.59 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.1 t -103.94 176.7 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.828 -1.17 . . . . 0.0 109.423 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 51' ' ' TYR . 3.0 m-20 -162.53 143.85 10.31 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.349 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.578 HG13 ' CE1' ' A' ' 8' ' ' HIS . 53.2 t -94.26 132.98 28.0 Favored Pre-proline 0 C--N 1.287 -2.128 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.608 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.655 ' CG ' ' CG ' ' A' ' 49' ' ' HIS . 37.8 Cg_endo -79.42 135.21 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.548 1.289 . . . . 0.0 112.852 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.543 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 3.9 t70 -110.79 103.81 12.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 109.638 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.527 ' CD ' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -110.33 25.21 12.04 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.345 -0.847 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -120.0 -159.17 0.77 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 110.165 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.552 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.259 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.313 0.578 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.34 123.07 21.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.666 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 35.1 t -124.3 144.15 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.515 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 14.8 t -131.9 124.54 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.486 0.66 . . . . 0.0 109.317 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.666 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 69.6 m-85 -102.73 141.6 35.28 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.652 -0.655 . . . . 0.0 111.434 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.7 t -120.84 148.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.901 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 2.2 p -110.15 139.33 45.41 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 103' ' ' ASP . 0.3 OUTLIER -45.36 -22.11 0.12 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.085 -1.009 . . . . 0.0 110.023 -179.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 9.9 p-10 -82.46 -7.66 59.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.987 -1.071 . . . . 0.0 110.374 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . 110.54 -36.87 4.02 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.173 -0.954 . . . . 0.0 111.673 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.493 HG23 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.64 145.33 5.16 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.586 -1.538 . . . . 0.0 109.499 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 9.8 mtt180 -130.05 158.03 40.75 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.573 -0.704 . . . . 0.0 111.187 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HG2' ' CD1' ' A' ' 32' ' ' ILE . 2.6 ttp180 -140.19 122.07 15.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 1.1 mp0 -98.86 123.19 42.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.725 -1.234 . . . . 0.0 110.79 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.631 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 9.4 mt -110.4 147.92 33.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -99.96 90.16 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.559 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 55.9 t -98.83 172.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 111.045 -177.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -124.64 -140.77 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.682 . . . . 0.0 110.324 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.91 123.42 47.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.63 -3.07 29.15 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.59 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 58.1 t -102.52 169.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.732 -1.451 . . . . 0.0 110.519 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.515 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.53 165.29 15.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.808 -0.557 . . . . 0.0 109.553 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -55.57 -33.94 64.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.637 -1.289 . . . . 0.0 107.602 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.738 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.5 ttt -68.43 -65.83 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.547 ' CG ' HG11 ' A' ' 21' ' ' VAL . 6.4 tt0 -38.05 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' CB ' HD11 ' A' ' 15' ' ' LEU . . . -43.8 -56.7 3.67 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.418 -1.426 . . . . 0.0 109.187 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -54.3 -58.71 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.929 0.871 . . . . 0.0 109.535 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.582 ' CG1' ' N ' ' A' ' 29' ' ' SER 0.277 1.2 t -31.37 -63.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.563 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.582 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.64 -47.04 87.15 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.119 0.961 . . . . 0.0 109.042 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.584 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 4.9 m-80 -59.67 -9.69 2.93 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.89 63.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 7.8 mt -41.99 -34.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.591 -0.947 . . . . 0.0 109.058 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.738 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.2 m-85 -106.81 61.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.858 . . . . 0.0 111.9 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.43 43.45 0.18 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.672 -1.267 . . . . 0.0 109.147 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' HB ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -120.76 126.64 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.311 -0.868 . . . . 0.0 109.48 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -80.0 117.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.44 -156.96 10.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -115.25 3.37 14.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.231 -1.158 . . . . 0.0 110.116 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.619 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 8.5 p -69.53 -39.91 77.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.534 -0.729 . . . . 0.0 111.683 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.33 29.94 5.52 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.08 23.32 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.33 7.24 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.165 -1.197 . . . . 0.0 111.915 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' CB ' ' NE2' ' A' ' 87' ' ' GLN . . . 71.44 53.28 0.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 0.0 112.329 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.532 ' CA ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -132.57 34.35 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.762 ' O ' HD12 ' A' ' 84' ' ' LEU . 1.2 p -111.39 122.26 47.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -85.82 7.85 22.29 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.127 -1.608 . . . . 0.0 107.887 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.538 ' HB ' ' CG1' ' A' ' 35' ' ' ILE . 10.2 p -110.84 -42.47 4.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.757 . . . . 0.0 112.121 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.595 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.6 m -75.34 19.16 0.18 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.54 -1.35 . . . . 0.0 111.791 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.616 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 5.0 t-160 -45.58 137.25 5.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.576 -1.327 . . . . 0.0 108.225 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 17.3 m -139.63 155.2 25.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.775 -1.203 . . . . 0.0 109.952 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.644 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.1 m-30 -119.02 122.18 41.57 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.153 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.562 ' CG1' HD12 ' A' ' 97' ' ' ILE . 5.2 t -100.55 174.66 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.325 -0.859 . . . . 0.0 109.859 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.563 ' O ' ' CG2' ' A' ' 57' ' ' THR . 10.2 p30 -94.68 137.36 33.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.768 -1.208 . . . . 0.0 109.075 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 53' ' ' ASN . 8.9 pm0 -37.98 -25.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.342 -0.849 . . . . 0.0 111.625 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.49 -44.74 64.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 111.875 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.645 ' CD2' ' HA ' ' A' ' 97' ' ' ILE . 53.4 m-85 -99.12 -9.45 23.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.658 -1.277 . . . . 0.0 111.831 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -80.29 -33.11 37.95 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.521 -1.362 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.91 -27.02 57.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -79.93 -53.72 6.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 57' ' ' THR . 11.9 m -41.17 163.49 0.1 Allowed Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 121.472 -0.767 . . . . 0.0 110.337 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -64.89 161.86 34.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.032 1.543 . . . . 0.0 111.915 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.63 26.27 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.815 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -69.59 152.72 44.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 27.6 p-10 -100.18 -173.04 2.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.102 -0.999 . . . . 0.0 111.187 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -54.43 -18.63 4.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.51 -55.77 18.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.1 tm-20 -59.55 -5.1 0.75 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.837 -0.539 . . . . 0.0 111.4 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -91.25 -16.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.344 -1.472 . . . . 0.0 111.488 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.29 -82.45 1.37 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.666 -1.271 . . . . 0.0 110.388 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.663 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -47.84 -33.74 7.81 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.005 -1.291 . . . . 0.0 109.755 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' CD2' ' CE1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -65.09 -29.32 70.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -90.32 -23.8 21.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.541 -0.724 . . . . 0.0 109.575 178.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.537 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 16.2 m -48.94 -44.72 40.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 108.779 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -90.53 80.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.042 178.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.8 t -47.9 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.423 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.544 ' HB3' ' CG ' ' A' ' 104' ' ' ARG . . . -118.83 55.41 0.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.777 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 78' ' ' LEU . 1.6 pm0 39.54 48.64 1.84 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 109.457 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' CD1' HD21 ' A' ' 71' ' ' LEU . 1.7 tp -19.81 133.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.524 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -100.81 170.66 6.31 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -68.16 -27.77 34.98 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.559 1.294 . . . . 0.0 109.46 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.526 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 24.4 p-10 -105.77 -4.65 20.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.6 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.9 m -48.83 158.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 0.0 111.036 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.513 ' NH2' ' HB1' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -175.11 167.57 3.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.634 -0.666 . . . . 0.0 109.627 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -88.68 143.82 26.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.982 . . . . 0.0 110.368 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 6.4 p -46.57 -36.39 6.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 110.576 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.469 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 12.1 m -94.04 37.43 1.09 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 111.386 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.675 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 2.9 mm-40 -126.65 -43.27 1.74 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 112.259 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.481 HD13 HG23 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -84.18 148.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.549 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 90' ' ' MET . 5.8 mm -111.07 164.17 7.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.762 -0.586 . . . . 0.0 109.788 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.576 ' HE3' ' CG1' ' A' ' 97' ' ' ILE . 2.0 tpt -110.28 86.96 2.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.303 -0.873 . . . . 0.0 110.028 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.47 ' O ' ' OG ' ' A' ' 1' ' ' SER . 1.3 p -70.54 163.41 63.6 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.46 -0.775 . . . . 0.0 109.858 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -76.93 0.84 9.26 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.9 1.474 . . . . 0.0 110.144 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.528 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 22.8 pt-20 -110.03 -21.28 12.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 109.47 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.528 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 10.5 mt -103.98 63.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 109.826 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.55 147.45 25.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.476 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.12 24.36 9.05 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.645 ' HA ' ' CD2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -65.05 122.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 122.748 1.261 . . . . 0.0 113.045 -176.33 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.455 ' N ' HD11 ' A' ' 97' ' ' ILE . 3.8 t -98.75 116.03 40.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.486 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -104.34 -175.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.38 1.086 . . . . 0.0 110.381 -179.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 51' ' ' TYR . 11.5 m-20 -161.99 139.81 8.81 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.128 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 6' ' ' VAL . 5.3 t -96.06 108.04 38.57 Favored Pre-proline 0 C--N 1.289 -2.048 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.644 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.1 Cg_endo -68.02 91.96 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.175 1.619 . . . . 0.0 110.904 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . 0.5 OUTLIER -110.16 108.11 18.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.969 -1.082 . . . . 0.0 110.401 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.31 140.17 44.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.238 -0.914 . . . . 0.0 110.066 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.12 2.85 10.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 11.4 m95 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.202 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' CA ' ' O ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.513 0.673 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 105.91 4.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.65 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 4.8 t -109.94 145.92 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.051 -1.031 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 6.7 t -131.19 132.55 63.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.438 -0.789 . . . . 0.0 109.538 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.684 ' HE1' ' HB3' ' A' ' 23' ' ' LEU . 70.9 m-85 -110.21 129.04 55.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.011 0.91 . . . . 0.0 112.02 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 100' ' ' ASP . 2.2 t -102.08 119.46 50.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.762 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.524 ' OG ' ' CB ' ' A' ' 11' ' ' THR . 91.5 p -79.62 130.29 35.23 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.585 ' CG ' ' HB3' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -38.18 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.749 -0.594 . . . . 0.0 111.049 -179.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.8 p30 -79.36 -3.07 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.989 -1.069 . . . . 0.0 110.672 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 7' ' ' SER . . . 109.99 -33.48 5.99 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.524 ' CB ' ' OG ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.71 142.06 9.06 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.946 -1.326 . . . . 0.0 109.29 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 27.8 mtt180 -126.98 120.84 30.04 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.345 0.593 . . . . 0.0 111.074 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 5' ' ' TYR . 3.0 ttp180 -99.94 153.04 19.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 5.3 mt-10 -130.51 134.09 46.77 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.852 -1.155 . . . . 0.0 110.238 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 27' ' ' ALA . 7.4 mt -122.13 144.32 49.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -99.91 86.28 3.24 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.584 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 43.8 t -98.43 172.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.59 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' N ' HG13 ' A' ' 17' ' ' VAL . . . -125.78 -146.52 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 111.282 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -96.71 122.07 39.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.594 0.712 . . . . 0.0 110.354 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.23 -13.14 31.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' SER . 32.7 t -88.26 169.74 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.018 -1.284 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.49 152.24 39.37 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.684 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 5.4 mt -52.17 -23.29 5.28 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.336 -1.746 . . . . 0.0 107.788 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.721 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -73.17 -66.05 0.73 Allowed 'General case' 0 C--O 1.202 -1.421 0 CA-C-O 121.595 0.712 . . . . 0.0 109.887 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' NE2' ' HA ' ' A' ' 21' ' ' VAL 0.256 6.7 tt0 -37.13 -70.29 0.1 Allowed 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.735 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.584 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -49.66 -58.93 4.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.94 -1.725 . . . . 0.0 108.666 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.67 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -47.91 -58.74 4.0 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 108.888 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.284 1.0 OUTLIER -34.29 -64.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.715 178.176 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.577 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.03 -46.96 86.9 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.872 0.844 . . . . 0.0 109.6 179.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.542 ' ND2' HD21 ' A' ' 15' ' ' LEU . 2.8 m-80 -59.87 -7.01 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.419 0.628 . . . . 0.0 109.735 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.59 -18.82 44.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 59.5 mt -40.79 -38.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -1.028 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.721 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 23.4 m-85 -109.55 59.79 0.6 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.96 . . . . 0.0 113.224 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -66.76 -10.9 52.15 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 47' ' ' THR . 2.4 tt -80.02 106.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.322 0.582 . . . . 0.0 110.294 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.9 t -85.85 131.55 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.05 -135.05 4.89 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -114.47 37.98 3.22 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.185 -1.186 . . . . 0.0 109.99 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p -110.04 -36.0 5.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.781 -0.575 . . . . 0.0 109.792 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.26 31.2 4.52 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.0 32.03 37.33 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 9.6 m -131.45 5.32 4.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 0.0 111.172 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.657 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 71.09 47.93 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.242 -0.911 . . . . 0.0 112.312 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 3.2 m -133.16 44.53 2.82 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.709 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.96 153.5 25.43 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.497 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -111.55 -3.45 15.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.229 -0.92 . . . . 0.0 108.826 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.413 ' HB ' ' CD1' ' A' ' 35' ' ' ILE . 21.6 p -110.18 -30.49 7.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.272 -0.892 . . . . 0.0 112.039 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.567 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.1 m -80.32 34.0 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.545 -1.347 . . . . 0.0 110.964 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.576 ' NE2' HD22 ' A' ' 71' ' ' LEU . 8.0 t-160 -60.7 132.8 55.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.923 -1.111 . . . . 0.0 108.091 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.527 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 19.0 m -139.44 155.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.783 -1.198 . . . . 0.0 109.939 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.618 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.3 m-30 -116.21 106.34 13.58 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.928 0.871 . . . . 0.0 109.587 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 99' ' ' VAL . 15.8 t -88.09 148.47 4.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.547 ' OD1' ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -73.08 127.4 32.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 119.516 -1.99 . . . . 0.0 109.661 178.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' CA ' HG22 ' A' ' 57' ' ' THR . 16.8 pt-20 -34.38 -35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.698 -0.626 . . . . 0.0 111.621 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -55.26 -16.61 3.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.704 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 60.4 m-85 -128.66 -16.17 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.683 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.576 ' CG2' ' HB2' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -80.29 -32.01 38.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 108.984 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.1 p-10 -74.52 -27.28 60.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . 2.2 mmtt -79.88 -53.7 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.498 -0.752 . . . . 0.0 109.763 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 57' ' ' THR . 12.3 m -42.98 166.83 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 110.029 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.7 Cg_endo -62.26 162.16 24.4 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.966 1.508 . . . . 0.0 111.96 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.91 125.32 29.97 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.044 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HB1' ' NH1' ' A' ' 83' ' ' ARG . . . -69.78 146.28 51.56 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 109.768 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.547 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.65 -172.37 2.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.108 -0.995 . . . . 0.0 111.972 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -53.97 -20.81 6.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.59 . . . . 0.0 110.869 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.547 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 4.3 ttm180 -64.09 -55.59 20.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.47 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.3 tt0 -58.64 -49.97 75.55 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.716 -0.615 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 72' ' ' GLU . 1.3 mp -48.01 -26.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 111.457 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.75 -68.7 1.19 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.657 ' CE ' ' O ' ' A' ' 43' ' ' ALA . 2.2 ptm -48.51 -41.47 30.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.83 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' CB ' ' O ' ' A' ' 67' ' ' GLU 0.25 0.0 OUTLIER -71.1 -24.19 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.925 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 2.5 tt0 -90.78 -13.41 33.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.731 -0.605 . . . . 0.0 109.87 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 46' ' ' ALA . 9.7 m -48.52 -49.68 35.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 108.861 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 4.3 m -90.32 92.9 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.1 t -48.29 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.369 -0.832 . . . . 0.0 110.757 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' CB ' ' CD ' ' A' ' 104' ' ' ARG . . . -124.49 50.59 1.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.1 pt-20 39.39 60.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.634 0.73 . . . . 0.0 109.609 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.8 OUTLIER -30.54 122.06 0.2 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.573 0.702 . . . . 0.0 111.806 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.606 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -86.05 171.21 10.87 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.8 Cg_endo -66.72 -25.91 46.05 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.46 1.242 . . . . 0.0 109.485 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.576 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 6.7 p-10 -109.87 -4.13 16.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.619 -0.676 . . . . 0.0 111.394 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.594 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.2 m -48.71 143.9 4.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.674 -1.266 . . . . 0.0 110.588 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.536 ' HD2' ' CG ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -154.86 165.53 36.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.0 110.046 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -88.4 143.08 27.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.362 -0.836 . . . . 0.0 109.369 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.567 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 5.7 p -46.64 -46.37 19.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.74 -1.225 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 2.8 m -91.91 38.82 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.598 -0.689 . . . . 0.0 109.893 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.538 ' NE2' ' HE3' ' A' ' 70' ' ' MET . 4.5 tp-100 -123.28 -40.99 2.33 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.41 -0.806 . . . . 0.0 111.318 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.531 ' CD1' ' CB ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -92.73 149.73 4.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.31 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.483 HG21 ' N ' ' A' ' 90' ' ' MET . 4.6 mm -110.7 164.28 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.533 ' HE1' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -110.4 126.37 54.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.96 -1.088 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.482 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.55 159.86 28.06 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.722 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -72.71 -1.61 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.915 1.481 . . . . 0.0 110.514 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -110.06 -28.59 8.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.588 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.53 ' O ' ' CE ' ' A' ' 90' ' ' MET . 7.5 mt -93.48 37.77 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.073 0.94 . . . . 0.0 109.286 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' CB ' ' OG ' ' A' ' 1' ' ' SER . 1.6 p-10 -82.06 142.83 31.98 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.707 0.765 . . . . 0.0 112.196 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.36 28.33 7.23 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.704 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.99 133.7 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 122.173 0.987 . . . . 0.0 112.483 -177.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.547 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 16.5 t -102.44 101.63 12.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.373 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -104.59 170.15 2.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.063 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -144.32 172.19 13.27 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.197 0.999 . . . . 0.0 111.57 -176.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.56 HG13 ' CE1' ' A' ' 8' ' ' HIS . 98.9 t -107.08 109.4 62.99 Favored Pre-proline 0 C--N 1.297 -1.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.264 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.618 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 47.0 Cg_endo -71.09 94.99 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.981 1.516 . . . . 0.0 111.585 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.585 ' HB3' ' CG ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -110.33 112.9 25.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 0.0 109.876 178.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.573 ' CD ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.66 113.62 26.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.61 5.32 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 110.251 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.21 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -70.18 125.28 26.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.698 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.663 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 3.2 t -121.76 136.88 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.975 -1.078 . . . . 0.0 110.231 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 95.1 t -121.14 110.75 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 112.197 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.663 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 19.6 m-30 -82.27 131.4 35.23 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.423 0.63 . . . . 0.0 111.708 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 4.4 t -120.49 128.78 76.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.064 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 26.8 p -79.33 -159.78 0.21 Allowed 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.95 -1.1 . . . . 0.0 108.5 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 103' ' ' ASP . 0.3 OUTLIER -101.5 -11.33 19.39 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.895 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.55 -0.75 37.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 0.0 109.565 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 -19.9 26.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.464 ' CB ' ' OG ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.82 143.04 7.99 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.958 -1.319 . . . . 0.0 109.223 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 17.2 mtt180 -124.1 139.21 54.16 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.428 0.633 . . . . 0.0 111.329 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.655 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.25 67.82 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 4.0 mp0 -67.51 140.97 57.05 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.919 -1.113 . . . . 0.0 110.849 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 5' ' ' TYR . 8.8 mt -109.72 150.76 27.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.691 -0.631 . . . . 0.0 110.043 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.35 85.78 3.26 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.562 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 40.7 t -98.76 171.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.666 0.746 . . . . 0.0 111.337 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -118.57 -139.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.454 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -105.58 125.73 51.33 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.452 -0.78 . . . . 0.0 110.198 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.67 29.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 61.1 t -102.18 170.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.933 -1.333 . . . . 0.0 110.199 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.504 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.73 160.33 23.56 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' CD2' ' SD ' ' A' ' 90' ' ' MET . 16.8 mt -54.97 -18.4 4.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.694 -1.254 . . . . 0.0 109.448 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 1.225 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -90.23 -58.18 2.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.257 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.7 tt0 -38.63 -64.77 0.41 Allowed 'General case' 0 C--N 1.289 -2.062 0 O-C-N 122.127 -0.358 . . . . 0.0 110.762 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . . . -48.38 -55.97 9.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.437 -1.415 . . . . 0.0 108.283 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -52.72 -55.92 19.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' ' 33' ' ' TYR 0.264 0.7 OUTLIER -37.32 -47.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.472 177.592 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.519 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.8 -43.81 21.76 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.516 ' ND2' HD23 ' A' ' 15' ' ' LEU . 1.7 m-80 -59.86 -8.08 2.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 109.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.34 -18.4 18.53 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' A' ' 5' ' ' TYR . 58.2 mt -48.92 -29.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.851 -1.382 . . . . 0.0 107.643 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.677 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 3.1 m-85 -100.54 56.42 0.9 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 21.4 p-10 -70.81 56.17 0.18 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.512 -1.367 . . . . 0.0 107.397 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.467 HD11 ' SG ' ' A' ' 48' ' ' CYS . 6.0 pt -79.65 -151.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.09 -142.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.417 -0.802 . . . . 0.0 110.143 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.48 83.9 0.36 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.743 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.474 ' CB ' ' HA ' ' A' ' 45' ' ' CYS . 6.5 m-20 -120.23 -66.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.126 -1.22 . . . . 0.0 109.159 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.644 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.1 p -69.07 -14.13 62.84 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.741 -0.599 . . . . 0.0 110.23 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 48.26 25.48 4.22 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.03 28.81 61.71 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 39' ' ' CYS . 10.3 p -140.23 28.09 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.3 . . . . 0.0 111.998 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 66.56 45.29 2.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.547 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -130.6 46.79 2.61 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.078 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.664 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -111.72 157.06 20.95 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -177.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -112.0 -9.76 13.98 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.677 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.2 p -110.48 -30.11 7.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -0.78 . . . . 0.0 112.618 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 3.4 m -73.99 66.88 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.31 -1.494 . . . . 0.0 110.197 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.564 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 4.0 t-160 -87.85 132.74 34.08 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 17.1 m -142.29 155.24 18.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 109.277 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.679 ' CD1' ' HE2' ' A' ' 79' ' ' LYS . 5.1 m-30 -120.2 118.11 29.65 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 121.675 0.75 . . . . 0.0 111.015 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 42.2 t -97.96 165.71 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.346 -0.846 . . . . 0.0 109.643 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' ND2' ' CG2' ' A' ' 98' ' ' VAL . 21.1 p-10 -89.41 138.31 31.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.38 -1.45 . . . . 0.0 109.388 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -38.38 -26.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.382 -0.824 . . . . 0.0 111.441 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -68.31 -18.0 64.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.965 -1.084 . . . . 0.0 111.551 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.657 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 38.5 m-85 -129.62 -14.44 4.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.776 -1.203 . . . . 0.0 110.796 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -80.88 -22.69 39.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.906 -1.121 . . . . 0.0 108.746 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -85.96 -23.97 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.825 . . . . 0.0 110.028 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.468 ' HB3' HD23 ' A' ' 94' ' ' LEU . 9.2 mmtt -79.5 -47.66 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.452 -0.78 . . . . 0.0 109.111 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.598 ' CG1' ' CG2' ' A' ' 88' ' ' ILE . 6.3 m -45.3 161.39 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.786 -0.571 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.512 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -65.19 163.34 29.43 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 112.325 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.21 124.14 29.04 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.76 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.562 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -88.66 160.26 17.45 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.55 -166.86 1.36 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 110.266 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.0 -24.27 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.838 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 4.1 ttm180 -64.79 -15.34 61.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.566 ' OE1' ' HG3' ' A' ' 87' ' ' GLN . 3.0 tp10 -100.28 -3.61 31.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -90.91 -59.3 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 111.445 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.88 -47.54 24.89 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.725 ' HB3' HD13 ' A' ' 84' ' ' LEU 0.33 1.3 ttp -48.79 -52.3 24.66 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 123.497 1.618 . . . . 0.0 108.666 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.558 ' CB ' ' O ' ' A' ' 67' ' ' GLU 0.293 0.0 OUTLIER -68.39 -33.85 74.98 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.043 -179.21 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HB2' ' CD2' ' A' ' 78' ' ' LEU . 6.7 tt0 -90.56 7.64 38.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 69' ' ' GLY . 5.5 m -48.83 -49.47 39.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.85 -1.156 . . . . 0.0 108.342 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 74' ' ' VAL . 4.3 m -90.48 113.35 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.02 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.9 t -48.57 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.823 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -125.2 44.82 2.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.558 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.7 pt-20 39.56 60.53 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.43 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 72' ' ' GLU . 2.5 tp -32.17 133.59 0.1 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.679 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 21.3 mtmt -110.44 172.01 3.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.708 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -66.26 -32.06 42.79 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.507 1.267 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.536 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 14.5 p-10 -98.79 -10.84 22.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.542 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 50.2 m -48.92 150.51 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 0.0 109.724 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.555 ' CD ' ' OE1' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -157.59 151.43 24.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.725 HD13 ' HB3' ' A' ' 70' ' ' MET . 0.4 OUTLIER -73.17 130.45 40.29 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.577 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -44.81 -20.98 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.991 -1.068 . . . . 0.0 112.149 -176.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 1.225 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 26.1 m -107.02 39.29 1.9 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.578 -1.326 . . . . 0.0 111.168 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.588 ' CG ' ' CB ' ' A' ' 84' ' ' LEU . 34.6 mm-40 -125.06 -45.26 1.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 110.634 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.598 ' CG2' ' CG1' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.88 143.25 12.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.9 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.0 mm -110.68 158.71 10.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.416 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.53 ' HG2' ' CG2' ' A' ' 3' ' ' VAL . 1.9 tpt -110.21 103.89 12.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -98.58 167.61 11.17 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.754 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -72.6 -0.36 8.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.584 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 3.7 pt-20 -110.04 -32.08 7.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 109.55 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.539 HD21 ' N ' ' A' ' 94' ' ' LEU . 6.8 mt -94.66 35.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.16 0.981 . . . . 0.0 109.187 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.538 ' CB ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -87.94 154.58 20.39 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.667 0.746 . . . . 0.0 112.101 -177.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.642 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.37 24.14 19.75 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.657 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -80.5 152.24 4.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.274 1.035 . . . . 0.0 112.577 -177.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.566 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 17.6 t -112.68 123.56 68.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -103.91 -175.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.86 -1.15 . . . . 0.0 109.933 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.9 m-20 -162.11 130.14 4.06 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.989 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 54.0 t -89.19 110.36 37.86 Favored Pre-proline 0 C--N 1.277 -2.549 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.615 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.4 Cg_endo -65.03 134.7 40.78 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.029 1.542 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 6.2 t0 -110.41 115.59 29.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HG2' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.09 70.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.082 -1.011 . . . . 0.0 110.136 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.13 41.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.219 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.543 0.687 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -90.25 121.44 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.652 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 3.4 t -122.55 143.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.719 -1.238 . . . . 0.0 110.098 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 24.4 t -130.18 122.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.998 0.904 . . . . 0.0 109.147 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.652 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 42.1 m-85 -96.95 142.07 29.36 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.802 0.81 . . . . 0.0 111.035 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.53 HG12 ' CG ' ' A' ' 12' ' ' ARG . 2.9 t -113.48 114.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.39 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -79.6 124.56 28.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.596 ' CB ' ' CB ' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -32.4 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.005 -0.434 . . . . 0.0 112.144 -178.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 7' ' ' SER . 2.6 p-10 -66.99 -9.51 39.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.682 -1.261 . . . . 0.0 110.141 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . 110.0 -31.73 7.25 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.496 HG21 ' CB ' ' A' ' 7' ' ' SER . 2.7 t -61.58 133.61 55.86 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.965 -1.315 . . . . 0.0 109.272 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' CG ' HG12 ' A' ' 6' ' ' VAL . 13.4 mtm180 -118.53 132.3 56.21 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.169 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' CG ' HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.03 149.15 24.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 179.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 22.9 mt-10 -130.41 120.1 23.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.771 -1.206 . . . . 0.0 110.949 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.68 ' CD2' ' ND2' ' A' ' 30' ' ' ASN . 1.4 mp -116.87 177.62 4.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.257 1.027 . . . . 0.0 111.914 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -106.75 83.14 1.8 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 58.6 t -98.54 129.22 49.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.538 -0.726 . . . . 0.0 110.305 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' HB3' ' N ' ' A' ' 1' ' ' SER . . . -140.0 -171.47 3.18 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.523 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 90' ' ' MET . 1.9 p30 -41.23 115.4 0.6 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.856 0.836 . . . . 0.0 110.324 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.34 -22.23 22.89 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HA ' ' NE2' ' A' ' 25' ' ' GLN . 2.4 t -107.88 157.49 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.849 -1.383 . . . . 0.0 110.86 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -120.96 166.69 13.47 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 5.1 mp -58.42 -22.09 53.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.368 -1.457 . . . . 0.0 107.897 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.87 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.93 -72.12 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.643 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.555 ' NE2' ' HA ' ' A' ' 21' ' ' VAL . 4.8 tt0 -37.67 -67.6 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.877 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB2' HD21 ' A' ' 15' ' ' LEU . . . -42.37 -73.95 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.499 -1.376 . . . . 0.0 108.613 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -44.85 -44.74 9.76 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' ' 24' ' ' MET . 0.9 OUTLIER -47.09 -60.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.587 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -50.27 -45.87 54.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.993 0.901 . . . . 0.0 108.748 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.68 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 1.5 m-80 -64.93 -2.34 2.58 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.789 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 79.54 11.68 84.54 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 27' ' ' ALA 0.268 3.8 mt -70.67 -31.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.568 -0.96 . . . . 0.0 109.134 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.715 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.4 m-85 -108.7 56.47 0.62 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.369 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -73.88 50.7 0.36 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.932 -1.105 . . . . 0.0 108.522 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 36' ' ' VAL . 1.1 pp -81.74 -146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.565 -0.709 . . . . 0.0 110.862 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.513 ' N ' HD13 ' A' ' 35' ' ' ILE . 1.4 p -99.15 -156.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 0.0 110.46 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 36' ' ' VAL . . . -120.19 83.91 0.36 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' CB ' ' HA ' ' A' ' 45' ' ' CYS . 61.4 m-20 -120.15 -58.24 1.88 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.621 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.3 p -69.31 -28.0 65.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.798 -0.564 . . . . 0.0 110.709 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.44 28.07 3.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.28 35.47 26.6 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.0 p -140.11 8.38 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -1.204 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.621 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 70.3 53.41 0.33 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.149 -0.969 . . . . 0.0 111.935 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -133.19 38.44 3.33 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.708 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.62 153.9 24.55 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.95 -2.22 16.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.658 -1.276 . . . . 0.0 108.789 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.46 ' OG1' HD11 ' A' ' 35' ' ' ILE . 15.0 p -110.02 -34.49 6.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 111.363 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.569 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 3.2 m -74.53 63.7 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.561 -1.337 . . . . 0.0 109.794 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.611 ' CD2' HD22 ' A' ' 71' ' ' LEU . 17.1 t-160 -91.78 133.13 35.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.477 HG12 ' OH ' ' A' ' 33' ' ' TYR . 16.9 m -144.58 154.82 14.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.808 -1.182 . . . . 0.0 109.943 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.707 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 7.7 m-30 -116.84 109.57 17.26 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' VAL . 16.4 t -86.28 158.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.372 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.6 ' ND2' ' CG2' ' A' ' 98' ' ' VAL . 11.5 p-10 -78.81 132.43 36.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 119.997 -1.689 . . . . 0.0 109.918 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 53' ' ' ASN . 12.1 pt-20 -38.65 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.98 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -63.87 -23.13 67.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.643 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 24.9 m-85 -122.71 -15.27 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.926 -1.109 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -78.65 -26.44 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.937 -1.105 . . . . 0.0 108.796 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.0 p-10 -81.83 -26.2 34.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.533 -0.729 . . . . 0.0 109.692 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.519 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . 12.5 mmtt -79.79 -52.04 8.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.498 -0.751 . . . . 0.0 109.492 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 57' ' ' THR . 10.3 m -40.76 162.55 0.1 Allowed Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.602 -0.686 . . . . 0.0 110.515 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.524 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.6 Cg_endo -66.74 165.57 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.068 1.562 . . . . 0.0 111.454 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.62 27.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.622 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -69.21 166.3 18.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.439 -0.788 . . . . 0.0 109.71 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -100.45 -158.2 0.66 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.977 -1.077 . . . . 0.0 110.929 -179.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 1.2 pp20? -78.38 -23.16 46.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.694 -0.628 . . . . 0.0 111.069 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.563 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.84 -48.46 74.28 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.801 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.591 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.11 -6.27 0.84 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.262 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.523 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.2 mp -91.39 -30.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.617 -1.302 . . . . 0.0 110.668 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.28 -63.22 1.25 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.637 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -48.08 -42.64 29.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 109.222 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 49' ' ' HIS 0.26 0.0 OUTLIER -69.45 -23.84 63.72 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.934 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -89.95 -18.68 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.511 -0.743 . . . . 0.0 110.029 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' GLU . 2.1 m -48.51 -31.43 6.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.578 ' CG2' ' ND1' ' A' ' 49' ' ' HIS . 20.4 m -90.32 87.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.547 ' O ' ' CG2' ' A' ' 75' ' ' THR . 9.3 t -48.41 82.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.269 -0.894 . . . . 0.0 111.506 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.39 40.85 3.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 10.0 pt-20 39.2 60.14 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.764 -0.585 . . . . 0.0 109.754 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.542 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.6 OUTLIER -19.93 125.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.264 0.554 . . . . 0.0 112.104 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.598 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -80.05 170.69 14.78 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.4 Cg_endo -65.85 -25.71 52.7 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.477 1.251 . . . . 0.0 109.564 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.542 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 20.6 p-10 -107.79 -8.25 16.09 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 111.33 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.592 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 45.7 m -49.44 158.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.614 -1.304 . . . . 0.0 111.205 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.524 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 2.3 ttp180 -175.51 156.48 1.96 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -73.29 135.47 44.42 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.571 ' CB ' ' HB2' ' A' ' 24' ' ' MET . 0.8 OUTLIER -45.46 -24.3 0.3 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.585 -177.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.87 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 14.3 m -104.79 42.64 1.18 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.894 -1.128 . . . . 0.0 111.401 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.585 ' NE2' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -125.07 -42.53 2.01 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.717 0.77 . . . . 0.0 110.501 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.531 HG23 ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -89.0 140.04 16.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.354 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 90' ' ' MET . 5.3 mm -110.68 172.56 2.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.534 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 1.2 tpt -110.15 115.85 30.48 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.13 -0.982 . . . . 0.0 111.029 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.468 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -96.8 169.56 8.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.664 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.9 -5.65 17.58 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.885 1.466 . . . . 0.0 110.556 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 10.8 pt-20 -110.29 -23.94 10.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.701 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' CE ' ' A' ' 90' ' ' MET . 7.2 mt -96.39 55.9 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -0.995 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -100.84 146.51 27.21 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.066 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.643 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.59 21.73 10.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.627 ' CG1' ' CB ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -62.48 150.47 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.183 0.992 . . . . 0.0 113.243 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.6 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 10.9 t -127.61 89.82 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.586 HG13 HG22 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -104.72 162.49 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.441 1.115 . . . . 0.0 110.51 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -145.51 170.13 17.01 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.913 -178.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 8' ' ' HIS . 42.3 t -110.17 128.84 24.69 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.707 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 37.5 Cg_endo -71.73 106.38 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.771 1.406 . . . . 0.0 112.942 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.596 ' CB ' ' CB ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.81 10.01 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.553 ' C ' ' CD ' ' A' ' 104' ' ' ARG 0.265 0.0 OUTLIER -29.59 143.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.087 178.883 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.7 mm100 -120.17 94.62 4.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 75' ' ' THR . 6.7 m95 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.522 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.366 0.603 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' O ' HG21 ' A' ' 97' ' ' ILE . 1.6 ttmm -76.63 135.12 39.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.903 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.77 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 14.8 t -123.43 140.39 47.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.614 -1.304 . . . . 0.0 110.865 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 41.4 t -121.5 117.91 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 122.052 0.93 . . . . 0.0 111.504 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.77 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 22.5 m-30 -97.55 135.26 39.64 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.837 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 100' ' ' ASP . 14.4 t -120.05 154.09 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.48 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.529 ' CB ' HG21 ' A' ' 11' ' ' THR . 10.7 p -117.06 138.64 51.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.593 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 0.5 OUTLIER -44.39 -24.28 0.17 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.151 -0.968 . . . . 0.0 110.338 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.5 p30 -85.03 -5.82 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.007 . . . . 0.0 110.401 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.19 -45.61 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.529 HG21 ' CB ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.73 124.52 9.84 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.877 -1.366 . . . . 0.0 110.011 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' CA ' ' O ' ' A' ' 5' ' ' TYR . 30.7 mtm180 -110.34 156.91 20.1 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.479 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.616 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -134.75 67.78 1.49 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 0.0 109.438 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 1.4 mp0 -69.48 131.49 44.82 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.563 0.697 . . . . 0.0 110.335 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.712 ' CD2' ' ND2' ' A' ' 30' ' ' ASN . 2.3 mp -114.77 173.5 6.45 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.236 1.017 . . . . 0.0 112.012 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.78 90.76 4.56 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.578 HG11 ' CG1' ' A' ' 21' ' ' VAL . 95.7 t -98.58 166.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.469 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -133.01 -160.74 1.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.757 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.487 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -82.41 123.75 29.41 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.564 0.697 . . . . 0.0 110.696 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.37 37.08 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.867 HG11 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -106.29 170.2 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 110.65 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.604 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -120.51 175.94 5.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -76.16 -3.67 37.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.216 -1.553 . . . . 0.0 108.218 178.049 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.589 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.18 -77.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 112.022 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.867 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -38.03 -23.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.905 -0.497 . . . . 0.0 111.176 -177.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.593 ' N ' ' CD ' ' A' ' 25' ' ' GLN . . . -87.7 -45.06 10.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB1' ' CE2' ' A' ' 5' ' ' TYR 0.265 . . -66.33 -46.13 77.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.887 1.327 . . . . 0.0 107.492 176.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 29' ' ' SER 0.263 0.8 OUTLIER -45.92 -58.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.197 178.64 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.556 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.72 -35.79 75.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.031 178.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.712 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -72.87 12.15 0.56 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.444 0.64 . . . . 0.0 109.831 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 70.08 4.96 51.51 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.57 HG13 ' HB3' ' A' ' 30' ' ' ASN . 4.2 mt -66.43 -42.43 90.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -1.109 . . . . 0.0 109.459 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 23.5 m-85 -108.82 61.19 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.183 -1.007 . . . . 0.0 113.448 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 11.0 p-10 -84.62 43.33 0.97 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.597 ' CD1' ' CG2' ' A' ' 47' ' ' THR . 30.4 pt -79.86 -146.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.321 0.582 . . . . 0.0 110.784 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' N ' HG13 ' A' ' 35' ' ' ILE . 6.6 m -92.19 -155.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 110.52 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.1 84.42 0.37 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 44' ' ' SER . 13.9 m-20 -120.12 -35.3 3.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -1.179 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 21.7 p -110.29 -36.25 5.86 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.852 -0.53 . . . . 0.0 110.116 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 42.59 35.28 1.98 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.27 28.25 49.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 39' ' ' CYS . 6.2 m -128.58 -3.65 5.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -1.092 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.567 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 72.81 51.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.765 0.793 . . . . 0.0 112.321 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.573 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -131.55 38.91 3.55 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 39' ' ' CYS . 1.8 p -110.88 150.41 29.22 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -111.01 -4.4 15.14 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.554 -0.717 . . . . 0.0 109.667 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.597 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 6.2 t -110.56 -21.49 12.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.947 . . . . 0.0 112.754 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.63 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 34.9 m -75.02 11.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.367 -1.458 . . . . 0.0 111.243 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.629 ' CE1' ' CB ' ' A' ' 76' ' ' ALA . 3.3 t-160 -43.69 124.45 3.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 83' ' ' ARG . 15.6 m -143.35 163.12 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 120.928 -1.107 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.648 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.8 m-30 -118.47 124.63 48.07 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.704 0.764 . . . . 0.0 111.147 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 t -99.58 165.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.571 ' O ' ' CG2' ' A' ' 57' ' ' THR . 9.7 p30 -82.85 134.58 35.09 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 119.892 -1.755 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.1 pt-20 -37.58 -25.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.455 -0.778 . . . . 0.0 111.765 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.535 ' CB ' ' OD1' ' A' ' 53' ' ' ASN . . . -70.68 -40.33 73.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.838 -1.163 . . . . 0.0 111.587 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.724 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 61.1 m-85 -102.71 -17.95 15.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.733 -1.229 . . . . 0.0 111.258 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.571 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -80.63 -23.43 39.75 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.927 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 55' ' ' ALA . 23.4 p-10 -82.95 -24.11 33.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.566 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 3.4 mmtp -79.85 -49.05 12.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.556 ' CG2' ' O ' ' A' ' 57' ' ' THR . 3.0 m -43.54 168.25 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 110.05 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.6 Cg_endo -62.17 164.71 16.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.029 1.541 . . . . 0.0 111.589 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.67 112.79 18.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.898 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . . . -69.58 147.24 50.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.763 . . . . 0.0 110.366 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.477 ' O ' HD11 ' A' ' 68' ' ' ILE . 23.6 p30 -100.07 -173.38 2.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 110.555 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -53.63 -26.92 24.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 70' ' ' MET . 5.4 ttm180 -64.83 -18.11 64.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 tm-20 -99.96 1.51 42.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.57 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.1 mp -91.89 -59.05 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 111.194 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -77.01 -47.77 9.01 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.702 ' HE1' HD11 ' A' ' 84' ' ' LEU 0.323 2.8 ttp -48.58 -50.72 31.26 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 123.547 1.641 . . . . 0.0 108.022 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.599 HD22 ' CD2' ' A' ' 49' ' ' HIS 0.296 0.0 OUTLIER -70.87 -32.44 69.43 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.709 -179.408 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 4.3 tt0 -89.16 -0.15 57.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.893 -1.129 . . . . 0.0 110.453 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -49.08 -52.34 26.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.631 -1.293 . . . . 0.0 108.438 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 46' ' ' ALA . 31.1 m -90.48 107.95 19.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.481 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 104' ' ' ARG . 1.0 OUTLIER -48.15 103.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.838 -1.164 . . . . 0.0 109.254 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.629 ' CB ' ' CE1' ' A' ' 49' ' ' HIS . . . -120.07 22.51 11.41 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.608 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 71.7 38.27 0.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.672 1.225 . . . . 0.0 108.338 -178.408 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 77' ' ' GLU . 11.3 tp -19.26 134.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.979 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.609 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 2.4 mtpt -128.09 -169.24 0.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 46.2 Cg_endo -81.92 -30.64 1.26 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.697 1.367 . . . . 0.0 109.743 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.536 ' CB ' ' OG1' ' A' ' 57' ' ' THR . 13.7 p-10 -93.7 -12.17 29.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.731 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.577 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 18.6 m -49.23 155.52 0.68 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.042 . . . . 0.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.539 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 2.4 mtp180 -175.29 153.92 1.63 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.702 HD11 ' HE1' ' A' ' 70' ' ' MET . 11.1 mt -74.61 150.84 39.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 46.6 p -46.71 -25.94 0.83 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.528 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 2.8 m -110.13 44.95 1.15 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.732 0.777 . . . . 0.0 109.556 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -125.44 -32.77 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.595 ' CD1' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.35 147.18 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.628 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 90' ' ' MET . 5.0 mm -110.3 160.62 9.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.552 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.9 tpt -110.25 112.86 25.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.539 -0.726 . . . . 0.0 110.425 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -97.48 172.66 4.7 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.2 Cg_endo -72.67 -31.87 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.92 1.484 . . . . 0.0 110.558 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 2.4 pp20? -81.04 -44.96 17.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.883 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' CE ' ' A' ' 90' ' ' MET . 1.1 mt -75.81 52.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.115 -0.991 . . . . 0.0 111.018 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 4.3 p-10 -101.33 152.86 20.2 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.032 -1.042 . . . . 0.0 111.764 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.626 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.32 22.42 10.56 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.724 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 3.6 tt -72.55 154.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 123.175 1.464 . . . . 0.0 113.555 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.546 ' H ' ' ND2' ' A' ' 53' ' ' ASN 0.252 8.1 t -125.37 98.27 4.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.566 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -104.74 174.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.134 -1.427 . . . . 0.0 109.726 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.572 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.87 174.03 16.12 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.914 0.864 . . . . 0.0 111.024 -178.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 18.0 t -111.09 130.96 22.43 Favored Pre-proline 0 N--CA 1.498 1.956 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.429 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.648 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 49.7 Cg_endo -73.36 134.67 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.695 1.597 . . . . 0.0 112.683 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.593 ' HB3' ' CB ' ' A' ' 8' ' ' HIS . 0.6 OUTLIER -111.83 107.44 16.49 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.272 -0.892 . . . . 0.0 111.624 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -110.75 53.87 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.007 -1.058 . . . . 0.0 110.039 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -104.99 73.72 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.161 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 97.8 m95 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.234 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.568 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.38 0.609 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -74.8 120.11 19.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.743 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.645 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 25.1 t -119.67 146.5 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.769 -1.207 . . . . 0.0 110.983 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 16.9 t -131.06 125.83 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.695 0.76 . . . . 0.0 109.856 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 49.2 m-85 -101.52 137.91 39.22 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.486 0.66 . . . . 0.0 111.922 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 99' ' ' VAL . 2.5 t -120.77 132.73 69.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.023 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.503 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 67.6 p -79.39 -153.01 0.07 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.596 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.2 -8.13 14.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 120.97 -1.081 . . . . 0.0 108.98 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -100.37 1.65 41.64 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.41 -21.75 23.54 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.87 138.89 14.32 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.024 -1.28 . . . . 0.0 109.449 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 24.6 mtt180 -130.06 148.66 51.93 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.401 0.62 . . . . 0.0 111.215 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.538 ' CD ' HG12 ' A' ' 32' ' ' ILE . 1.4 ttm-85 -140.11 118.9 12.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.43 -0.794 . . . . 0.0 109.888 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 3.0 mp0 -100.42 124.43 45.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.797 -1.189 . . . . 0.0 110.835 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CG ' ' HE2' ' A' ' 5' ' ' TYR . 10.8 mt -110.57 151.83 27.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 110.507 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.11 90.37 3.92 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 1' ' ' SER . 50.6 t -98.61 174.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 110.298 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.494 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -125.32 -133.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.518 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -110.03 124.04 50.75 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.51 -10.78 30.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 70.0 t -93.87 169.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.33 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.36 169.26 10.78 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.473 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 10.7 mt -60.91 -35.15 75.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.721 -1.237 . . . . 0.0 108.934 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.716 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.9 ttp -66.65 -62.47 1.44 Allowed 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.927 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG11 ' A' ' 21' ' ' VAL . 7.4 tt0 -38.14 -76.72 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -43.15 -56.39 3.44 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.331 -1.481 . . . . 0.0 109.754 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -56.74 -53.62 55.69 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.012 0.91 . . . . 0.0 109.412 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.638 ' HB ' ' O ' ' A' ' 24' ' ' MET 0.284 1.2 t -35.47 -63.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.152 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.581 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.37 -46.67 85.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.112 0.958 . . . . 0.0 108.884 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.578 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.8 m-80 -59.93 -8.6 2.35 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 88.02 -14.64 58.37 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 27' ' ' ALA . 7.6 mt -42.75 -38.41 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.692 -0.887 . . . . 0.0 108.643 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.716 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 72.3 m-85 -112.79 76.81 1.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 19.4 p30 -49.01 -20.4 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.604 -1.238 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.589 ' CD1' ' CG2' ' A' ' 47' ' ' THR . 1.7 tt -78.95 90.28 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.0 9.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.042 -1.036 . . . . 0.0 110.692 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.75 21.77 27.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.53 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 1.4 m-20 -120.07 -50.06 2.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 0.0 110.615 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.493 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 1.3 p -110.39 -50.99 2.91 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.4 42.92 7.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.8 39.59 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 9.8 p -120.9 -32.35 3.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.155 -1.203 . . . . 0.0 110.386 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' O ' ' CE ' ' A' ' 70' ' ' MET . . . 72.53 60.97 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.222 -0.924 . . . . 0.0 111.596 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -132.38 9.27 4.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.203 -0.936 . . . . 0.0 110.998 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.702 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.31 162.03 15.97 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.715 -1.241 . . . . 0.0 114.195 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.601 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -110.14 -22.27 11.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.813 -1.179 . . . . 0.0 110.463 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.589 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 1.6 t -69.83 -14.96 63.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.64 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -94.72 14.05 22.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 0.0 108.581 178.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.593 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 3.9 t-160 -46.98 138.52 6.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.531 ' HA ' ' CD ' ' A' ' 102' ' ' PRO . 15.7 m -144.78 157.09 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.817 -1.177 . . . . 0.0 109.923 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.682 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.8 m-30 -119.87 122.06 40.45 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.582 0.706 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.532 ' CG1' HG21 ' A' ' 57' ' ' THR . 38.7 t -99.44 151.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.12 -0.988 . . . . 0.0 110.354 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -74.57 125.32 28.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.133 -1.605 . . . . 0.0 109.414 178.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CA ' HG22 ' A' ' 57' ' ' THR . 2.7 pm0 -34.07 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.702 -0.624 . . . . 0.0 112.19 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . . . -62.7 -17.25 60.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.881 -1.137 . . . . 0.0 111.301 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.724 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 65.7 m-85 -125.35 -8.98 6.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.869 -1.145 . . . . 0.0 110.193 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.545 HG23 ' HB2' ' A' ' 81' ' ' ASN . 1.3 p -80.35 -34.76 36.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 108.914 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 -17.68 60.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.546 -0.721 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' CB ' HD11 ' A' ' 94' ' ' LEU 0.278 0.5 OUTLIER -79.34 -55.97 4.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 123.643 1.687 . . . . 0.0 109.423 179.584 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.541 HG13 ' CG2' ' A' ' 88' ' ' ILE 0.323 0.3 OUTLIER -77.62 145.4 71.2 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.068 -177.707 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD2' HG21 ' A' ' 60' ' ' VAL . 35.8 Cg_endo -61.75 160.0 30.62 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.847 1.446 . . . . 0.0 111.704 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.546 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -171.42 3.12 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.151 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 67' ' ' GLU . . . -100.2 158.92 15.52 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.186 0.517 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' HD11 ' A' ' 68' ' ' ILE . 24.8 p30 -100.45 -173.64 2.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 111.117 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 21.5 pt-20 -47.8 -24.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.0 ttm180 -64.5 -59.45 4.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.382 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' OE2' ' CG ' ' A' ' 83' ' ' ARG . 2.4 tt0 -66.96 14.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.558 -0.714 . . . . 0.0 111.975 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.2 mp -90.83 -37.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 119.282 -2.136 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.35 -57.28 1.68 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.673 ' CE ' ' CD1' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -48.0 -44.96 31.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.161 -1.199 . . . . 0.0 109.087 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.593 ' CD2' ' CE1' ' A' ' 49' ' ' HIS 0.3 0.0 OUTLIER -70.95 -30.96 67.4 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.531 -179.27 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 1.2 tt0 -90.9 -11.36 39.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.374 -0.829 . . . . 0.0 110.479 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.601 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.6 -50.98 30.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.706 -1.246 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 74' ' ' VAL . 16.3 m -90.21 96.28 6.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 108.878 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.8 t -48.05 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.588 ' CB ' ' CD ' ' A' ' 104' ' ' ARG . . . -126.87 45.96 2.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.799 . . . . 0.0 109.91 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.6 pt-20 39.34 58.31 1.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.764 0.792 . . . . 0.0 109.467 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.541 ' CD1' HD12 ' A' ' 71' ' ' LEU . 12.7 tp -29.72 131.72 0.07 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.56 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.637 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 6.8 mtpt -98.96 170.85 6.36 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.084 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.7 Cg_endo -67.4 -28.68 38.89 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.553 1.291 . . . . 0.0 109.768 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.545 ' HB2' HG23 ' A' ' 57' ' ' THR . 21.7 p-10 -105.01 -5.05 21.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 111.025 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 72.7 m -48.54 164.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.795 -1.191 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.594 ' CG ' ' OE2' ' A' ' 67' ' ' GLU . 3.1 mtt180 -175.33 174.81 2.29 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.608 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.702 ' CD1' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -96.69 142.25 28.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.44 -0.788 . . . . 0.0 109.341 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 24' ' ' MET . 15.2 m -45.54 -29.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.526 ' SG ' ' CD1' ' A' ' 84' ' ' LEU . 1.1 p -98.68 38.83 1.31 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.619 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.499 ' NE2' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -126.79 -44.72 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.189 -1.57 . . . . 0.0 113.289 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.541 ' CG2' HG13 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -85.54 150.99 3.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.715 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.452 HG21 ' N ' ' A' ' 90' ' ' MET . 5.4 mm -111.02 161.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.535 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.6 tpt -110.25 111.46 22.79 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.812 -1.18 . . . . 0.0 111.043 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.494 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -91.32 156.6 43.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 41.6 Cg_endo -68.95 -1.42 7.76 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.805 1.423 . . . . 0.0 111.264 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' C ' HD21 ' A' ' 94' ' ' LEU . 6.3 pm0 -110.09 -27.72 9.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.981 -1.075 . . . . 0.0 110.072 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.537 HD11 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -97.24 58.48 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.267 -0.896 . . . . 0.0 109.78 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.75 151.1 22.07 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.859 0.838 . . . . 0.0 112.612 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.0 21.08 12.32 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.724 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -76.26 142.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.079 . . . . 0.0 113.42 -176.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.523 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 21.2 t -107.97 128.82 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.592 HG22 ' CD1' ' A' ' 5' ' ' TYR . 1.8 t -104.07 -176.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.789 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 51' ' ' TYR . 9.5 m-20 -161.42 138.11 8.45 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.703 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 40.0 t -96.72 109.29 47.75 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.803 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.682 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 46.5 Cg_endo -69.65 107.8 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.962 1.775 . . . . 0.0 112.309 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.596 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -111.32 109.98 20.24 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.802 -1.186 . . . . 0.0 110.729 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.588 ' CD ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.6 86.62 2.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.934 -1.103 . . . . 0.0 109.887 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -108.44 16.82 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.258 179.926 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 95' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.332 0.587 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.06 117.21 28.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.915 HG22 HG23 ' A' ' 97' ' ' ILE . 3.5 t -120.69 144.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.903 HG22 ' CG ' ' A' ' 14' ' ' GLU . 7.9 t -128.53 130.22 68.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 121.803 0.811 . . . . 0.0 109.386 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.856 ' CE2' HD13 ' A' ' 15' ' ' LEU . 44.9 m-85 -106.48 137.61 44.16 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.479 0.657 . . . . 0.0 112.263 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.5 t -120.17 127.97 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.713 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.923 ' CB ' HG22 ' A' ' 11' ' ' THR . 87.4 p -79.47 154.29 29.0 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.213 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.593 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -67.6 -5.28 14.8 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.262 0.553 . . . . 0.0 109.827 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -93.33 -13.2 28.43 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.146 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 28.19 4.19 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.167 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.923 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -109.83 144.42 38.3 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.835 -1.391 . . . . 0.0 108.064 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.759 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -123.71 147.65 47.27 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.856 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.594 ' CD ' ' CD1' ' A' ' 32' ' ' ILE . 2.6 ttm-85 -140.04 146.96 39.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.601 -0.687 . . . . 0.0 109.205 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.903 ' CG ' HG22 ' A' ' 4' ' ' VAL . 12.1 mp0 -130.51 117.26 19.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.633 -1.292 . . . . 0.0 110.965 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.856 HD13 ' CE2' ' A' ' 5' ' ' TYR . 1.3 mp -115.15 -172.64 2.17 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.215 1.007 . . . . 0.0 111.974 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -115.74 98.53 6.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.885 HG12 ' HB3' ' A' ' 90' ' ' MET . 41.4 t -98.48 99.89 9.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.61 -165.75 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.734 0.778 . . . . 0.0 111.281 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -72.02 121.9 19.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.684 0.754 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.73 -8.17 29.87 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.399 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 22' ' ' SER . 58.2 t -103.77 166.78 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.461 . . . . 0.0 110.637 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.598 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.92 153.3 37.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 99' ' ' VAL . 6.5 mt -46.37 -31.39 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.303 . . . . 0.0 109.949 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 1.465 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 11.5 ttt -77.69 -57.89 3.57 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.861 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.526 ' CG ' HG13 ' A' ' 21' ' ' VAL . 34.8 tt0 -37.23 -68.8 0.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.99 -0.444 . . . . 0.0 111.203 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.59 ' C ' HD22 ' A' ' 15' ' ' LEU . . . -44.37 -68.69 0.18 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.65 -1.281 . . . . 0.0 108.429 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -47.33 -46.71 25.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.907 0.861 . . . . 0.0 109.638 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.767 HG12 ' N ' ' A' ' 29' ' ' SER . 1.2 t -46.56 -62.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.767 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -48.24 -46.86 35.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.206 1.003 . . . . 0.0 108.674 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.809 ' OD1' HD21 ' A' ' 15' ' ' LEU . 1.2 m120 -66.02 -2.38 3.99 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.11 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.34 -8.82 60.14 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 15' ' ' LEU . 1.4 mt -42.51 -33.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -1.021 . . . . 0.0 109.422 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.731 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 61.2 m-85 . . . . . 0 N--CA 1.496 1.843 0 C-N-CA 119.374 -0.93 . . . . 0.0 112.849 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.685 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 23.7 p . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.053 0.454 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.14 33.45 2.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.421 ' H ' ' HE1' ' A' ' 24' ' ' MET . . . 80.13 33.91 31.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.644 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 43.7 t -140.09 7.98 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.375 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.886 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 65.67 56.75 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.316 1.055 . . . . 0.0 110.997 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.581 ' H ' ' CB ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -132.28 31.6 4.07 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.796 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -110.77 153.13 25.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.39 -4.44 14.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.543 -0.723 . . . . 0.0 109.101 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -110.34 -22.77 11.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.325 -0.859 . . . . 0.0 112.551 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.888 ' O ' HG13 ' A' ' 50' ' ' VAL . 61.6 m -74.72 7.64 2.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.271 -1.518 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.896 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.2 t-160 -43.13 120.2 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.014 . . . . 0.0 108.339 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.888 HG13 ' O ' ' A' ' 48' ' ' CYS . 14.9 m -142.96 164.71 16.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.011 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.758 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 12.5 m-30 -115.05 119.23 35.74 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.588 0.708 . . . . 0.0 110.293 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.918 ' HB ' HG22 ' A' ' 57' ' ' THR . 29.3 t -85.53 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.919 ' O ' HG23 ' A' ' 57' ' ' THR . 20.5 p-10 -59.13 131.59 51.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.548 -1.97 . . . . 0.0 109.711 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 11.3 pt-20 -36.69 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.55 -42.39 67.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.454 -1.404 . . . . 0.0 112.172 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.753 ' O ' HG13 ' A' ' 60' ' ' VAL . 49.6 m-85 -93.85 -4.56 49.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.748 -1.22 . . . . 0.0 109.956 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.919 HG23 ' O ' ' A' ' 53' ' ' ASN . 4.5 p -81.06 -24.78 37.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -86.04 -30.24 22.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -0.803 . . . . 0.0 109.966 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.84 ' CB ' HD11 ' A' ' 94' ' ' LEU . 7.6 mmtt -79.74 -50.04 11.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.5 m -39.73 162.92 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 110.975 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 88' ' ' ILE . 38.8 Cg_endo -67.49 166.51 23.57 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.352 1.712 . . . . 0.0 110.957 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 115.18 20.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.822 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.534 ' HB1' ' CG ' ' A' ' 67' ' ' GLU . . . -69.44 146.63 51.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.484 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.494 ' O ' HD13 ' A' ' 68' ' ' ILE . 22.7 p30 -99.9 174.0 6.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.95 -1.094 . . . . 0.0 111.458 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 1.7 pp20? -43.31 -29.18 0.39 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.884 -0.51 . . . . 0.0 110.913 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.1 OUTLIER -64.69 -21.46 66.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.013 -1.054 . . . . 0.0 109.774 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.4 tm-20 -95.88 1.96 53.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.513 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -91.78 -61.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 111.297 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -73.24 -48.52 19.04 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.735 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.308 3.3 ttp -48.63 -49.26 38.0 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 123.312 1.53 . . . . 0.0 108.496 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.649 HD12 ' OE2' ' A' ' 67' ' ' GLU 0.298 0.0 OUTLIER -72.35 -33.02 66.97 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.269 -179.547 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.931 ' HB2' HD13 ' A' ' 78' ' ' LEU . 3.2 tt0 -86.15 8.59 20.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.091 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.571 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 34.4 m -49.03 -49.44 41.13 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.66 -1.275 . . . . 0.0 108.216 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.2 m -90.52 115.88 30.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 75' ' ' THR . 13.1 t -48.76 85.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 111.203 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -117.17 36.38 4.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.931 -1.106 . . . . 0.0 109.977 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.23 52.55 2.15 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.526 0.679 . . . . 0.0 110.192 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.931 HD13 ' HB2' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -19.79 119.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.553 0.692 . . . . 0.0 112.13 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -83.46 -168.01 0.17 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.371 -0.831 . . . . 0.0 108.762 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 42.8 Cg_endo -81.07 -27.17 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.584 1.307 . . . . 0.0 109.395 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.51 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 16.4 p30 -107.73 -5.55 17.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 111.319 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 21.5 m -48.97 153.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.617 -1.302 . . . . 0.0 110.409 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.67 ' HG2' ' OE1' ' A' ' 87' ' ' GLN . 4.9 mtp180 -175.03 153.28 1.61 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.484 -0.76 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.902 ' O ' ' NE2' ' A' ' 87' ' ' GLN . 11.0 mt -74.6 137.62 42.43 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.679 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 24.3 p -39.58 -22.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.137 -1.602 . . . . 0.0 113.257 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.465 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 11.5 m -110.82 43.43 1.43 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.6 -33.26 2.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.217 -1.552 . . . . 0.0 111.731 178.197 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.716 HG21 ' CG1' ' A' ' 60' ' ' VAL . 2.3 mt -85.73 148.37 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.007 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -111.43 156.04 12.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.885 ' HB3' HG12 ' A' ' 17' ' ' VAL . 20.6 tpp -108.37 128.59 54.9 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 120.668 -1.27 . . . . 0.0 111.525 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.466 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -97.13 167.78 11.38 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.56 -0.71 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.743 1.391 . . . . 0.0 111.261 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.6 pp20? -110.32 -40.75 4.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.636 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.84 HD11 ' CB ' ' A' ' 59' ' ' LYS . 1.5 mt -73.65 58.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.28 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.71 146.52 27.12 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.442 -1.411 . . . . 0.0 112.087 -178.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 105.46 20.14 9.86 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.915 HG23 HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -73.04 136.56 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 122.365 1.079 . . . . 0.0 111.833 -177.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.802 ' N ' HD12 ' A' ' 97' ' ' ILE . 60.8 t -110.94 122.8 66.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.209 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.5 t -104.27 169.1 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.709 -1.244 . . . . 0.0 109.881 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.3 m-20 -162.06 138.84 8.13 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.73 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 6' ' ' VAL . 4.1 t -90.69 135.34 29.22 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.75 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 33.6 Cg_endo . . . . . 0 C--N 1.304 -1.792 0 O-C-N 123.757 1.398 . . . . 0.0 114.767 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.656 ' H2 ' ' C ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 110.27 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -52.88 122.99 10.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 108.667 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.129 HG22 ' CG2' ' A' ' 97' ' ' ILE . 42.1 t -138.36 144.98 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 117.889 -1.524 . . . . 0.0 112.24 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.692 HG13 ' HG3' ' A' ' 14' ' ' GLU . 2.9 t -130.7 130.4 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.799 ' CD1' HG21 ' A' ' 99' ' ' VAL . 42.6 m-85 -103.33 141.46 35.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.82 0.819 . . . . 0.0 112.436 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.852 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.4 t -120.34 157.75 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.194 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.617 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.9 152.19 31.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.732 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.38 -13.41 5.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.945 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -96.84 -2.8 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 110.323 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.34 -36.45 4.26 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.154 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.603 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.5 133.18 20.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.768 -1.431 . . . . 0.0 109.229 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.852 ' HG2' HG13 ' A' ' 6' ' ' VAL . 37.4 mtm105 -124.38 162.24 24.26 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.669 0.747 . . . . 0.0 111.288 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' CD ' HG12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -140.17 156.7 46.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.649 -0.657 . . . . 0.0 109.266 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.692 ' HG3' HG13 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -130.69 127.19 38.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.787 -1.195 . . . . 0.0 110.471 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.025 HD11 HD12 ' A' ' 32' ' ' ILE . 12.6 mt -120.45 150.77 40.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 110.744 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -104.0 92.32 4.34 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.874 HG22 ' HB2' ' A' ' 26' ' ' ALA . 46.6 t -98.54 167.23 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 111.002 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -116.01 -133.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.449 -0.782 . . . . 0.0 110.738 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.528 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -110.24 123.01 49.0 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.279 -0.888 . . . . 0.0 110.671 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.29 -6.27 30.31 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.481 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 22' ' ' SER . 63.2 t -98.18 169.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.868 -1.372 . . . . 0.0 110.742 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.605 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.68 159.42 25.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.701 HD21 ' SD ' ' A' ' 90' ' ' MET . 10.9 mt -50.48 -35.8 30.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 109.616 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 1.187 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -73.33 -59.72 2.58 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.63 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.594 ' CG ' HG13 ' A' ' 21' ' ' VAL . 46.4 tt0 -37.85 -69.66 0.11 Allowed 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.763 -0.586 . . . . 0.0 111.691 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.874 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -47.27 -52.03 17.27 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.303 -1.498 . . . . 0.0 108.863 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -59.05 -59.51 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.766 0.793 . . . . 0.0 109.527 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG23 ' HG3' ' A' ' 24' ' ' MET 0.287 1.1 t -29.97 -60.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.723 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.53 -47.51 81.31 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.038 0.923 . . . . 0.0 108.872 179.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.492 ' HB3' HG13 ' A' ' 32' ' ' ILE . 1.5 m120 -59.61 -10.67 3.76 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 81.71 -5.54 69.24 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.025 HD12 HD11 ' A' ' 15' ' ' LEU . 38.0 mt -42.92 -30.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.537 -0.978 . . . . 0.0 108.905 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.732 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 57.3 m-85 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.364 -0.835 . . . . 0.0 111.576 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.641 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 25.1 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 111.423 0.156 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.5 31.3 1.59 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.73 35.34 25.48 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.793 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 8.3 t -140.12 -0.8 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -1.128 . . . . 0.0 111.711 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.801 ' HB1' ' HE1' ' A' ' 70' ' ' MET . . . 77.57 57.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.922 0.868 . . . . 0.0 113.336 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -133.55 27.39 4.04 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.025 ' SG ' HD22 ' A' ' 84' ' ' LEU . 5.9 p -111.04 142.28 43.4 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -110.61 8.97 22.99 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.4 p -111.01 -30.09 7.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.01 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.654 ' C ' HD23 ' A' ' 84' ' ' LEU . 1.3 m -84.24 32.42 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.966 -1.084 . . . . 0.0 110.631 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.664 ' CE1' ' O ' ' A' ' 71' ' ' LEU . 6.0 t-160 -57.94 134.2 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.602 -1.311 . . . . 0.0 109.673 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 83' ' ' ARG . 34.6 m -150.12 159.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.775 -1.203 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 30.2 m-85 -122.75 134.66 54.43 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.3 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.632 ' HB ' HG22 ' A' ' 57' ' ' THR . 15.1 t -91.57 156.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.824 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.586 ' O ' ' CG2' ' A' ' 57' ' ' THR . 4.4 p30 -59.23 -157.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.058 -1.651 . . . . 0.0 108.941 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.27 -7.25 23.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 110.309 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.72 -39.68 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 113.05 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.649 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 67.4 m-85 -84.7 1.94 44.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.739 -1.225 . . . . 0.0 111.772 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.632 HG22 ' HB ' ' A' ' 52' ' ' VAL . 8.3 p -80.56 -54.37 5.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.886 -1.134 . . . . 0.0 109.526 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 57' ' ' THR . 4.9 p-10 -62.29 -12.01 18.34 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.762 0.791 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.599 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.285 0.1 OUTLIER -79.67 -55.1 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 123.458 1.599 . . . . 0.0 109.553 180.0 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 HG23 ' A' ' 88' ' ' ILE 0.321 0.4 OUTLIER -84.6 155.61 62.19 Favored Pre-proline 0 C--N 1.28 -2.43 0 CA-C-N 112.975 -1.92 . . . . 0.0 110.101 -177.552 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 60' ' ' VAL . 36.5 Cg_endo -62.65 159.13 38.3 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.919 1.484 . . . . 0.0 111.858 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.73 -169.99 2.43 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.547 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 83' ' ' ARG . . . -110.11 162.73 14.28 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.763 -0.586 . . . . 0.0 110.918 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 1.024 ' O ' HD13 ' A' ' 68' ' ' ILE . 54.8 p30 -100.33 -156.41 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 111.343 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 6.4 pt-20 -73.73 -28.71 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 110.286 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.6 ttm180 -64.57 -50.76 66.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.293 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 32.9 tt0 -72.53 14.55 0.24 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.856 -0.528 . . . . 0.0 111.903 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.024 HD13 ' O ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -91.65 -46.17 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.385 -1.447 . . . . 0.0 110.2 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -85.32 -60.27 1.84 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.801 ' HE1' ' HB1' ' A' ' 43' ' ' ALA . 2.8 ptm -48.13 -43.93 31.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.904 -1.351 . . . . 0.0 108.295 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.67 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -62.62 -38.56 90.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.597 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 2.8 tt0 -83.75 29.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.903 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.911 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -48.79 -81.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.418 -1.426 . . . . 0.0 107.931 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 76' ' ' ALA . 2.3 m -81.35 129.13 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.25 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 75' ' ' THR . 8.9 t -49.11 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.903 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -104.54 48.41 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 110.202 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.552 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 18.1 pt-20 39.3 60.73 1.47 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.507 -0.746 . . . . 0.0 110.786 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.511 HD22 ' CD ' ' A' ' 72' ' ' GLU . 1.1 tp -30.28 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.541 . . . . 0.0 111.466 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -145.35 -166.56 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.314 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.1 Cg_endo -80.76 -32.59 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.334 1.176 . . . . 0.0 110.942 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.519 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 39.7 p-10 -102.52 4.38 38.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 111.429 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -62.96 135.61 57.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.93 -1.106 . . . . 0.0 109.827 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 1.018 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.07 169.28 23.9 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 118.455 -1.298 . . . . 0.0 110.759 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.025 HD22 ' SG ' ' A' ' 45' ' ' CYS . 1.4 mt -90.81 148.35 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.611 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 4.9 m -46.8 -27.53 1.25 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.677 -1.265 . . . . 0.0 110.526 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.187 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 3.9 m -102.38 40.31 1.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.287 -0.883 . . . . 0.0 111.511 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.665 HE22 ' HB2' ' A' ' 43' ' ' ALA . 6.9 mm100 -126.25 -41.54 1.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 112.187 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.018 HD11 ' HG3' ' A' ' 83' ' ' ARG . 3.3 mm -79.39 147.71 6.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.2 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.4 mm -112.31 151.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.804 ' HG2' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -110.46 111.72 23.16 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -100.65 170.86 6.08 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 42.3 Cg_endo -73.37 -5.21 16.75 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.824 1.434 . . . . 0.0 110.634 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.506 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.31 -29.54 8.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.117 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 59' ' ' LYS . 7.3 mt -97.0 54.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 109.872 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' HB3' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.39 148.41 25.19 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.278 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.649 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.25 23.32 9.12 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.129 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -78.03 117.94 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.405 1.098 . . . . 0.0 113.324 -176.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 9.5 t -82.55 124.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.826 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.799 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.9 t -104.31 -179.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.673 -1.267 . . . . 0.0 109.547 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 99' ' ' VAL . 9.5 m-20 -161.82 142.47 10.64 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.521 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.765 HG13 ' HD2' ' A' ' 102' ' ' PRO . 50.6 t -92.06 148.01 35.94 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.765 ' HD2' HG13 ' A' ' 101' ' ' VAL . 39.6 Cg_endo . . . . . 0 C--N 1.301 -1.938 0 O-C-N 123.521 1.274 . . . . 0.0 112.611 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.553 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.287 0.565 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -81.08 115.69 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.855 . . . . 0.0 109.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.708 ' HA ' HG23 ' A' ' 97' ' ' ILE . 3.8 t -109.85 137.37 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.913 -1.117 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.5 t -131.98 128.63 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.2 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.984 ' CE1' HG21 ' A' ' 99' ' ' VAL . 71.1 m-85 -104.75 146.98 28.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.571 0.7 . . . . 0.0 112.385 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.724 HG13 ' HG2' ' A' ' 12' ' ' ARG . 5.2 t -121.24 133.55 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.185 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.632 ' CB ' HG22 ' A' ' 11' ' ' THR . 62.8 p -79.56 -152.56 0.07 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.06 -10.6 14.68 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.059 -1.025 . . . . 0.0 108.677 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 17.6 p-10 -100.55 3.66 42.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.357 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.57 -39.24 2.97 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.632 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.8 138.13 15.24 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.866 -1.373 . . . . 0.0 109.974 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.724 ' HG2' HG13 ' A' ' 6' ' ' VAL . 54.4 mtt180 -130.25 164.24 24.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.387 0.613 . . . . 0.0 111.215 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -128.2 161.04 30.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.316 -0.865 . . . . 0.0 109.09 179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' CG ' HG22 ' A' ' 4' ' ' VAL . 1.1 mp0 -131.11 139.64 49.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.7 -1.25 . . . . 0.0 110.856 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.727 HD11 ' CA ' ' A' ' 27' ' ' ALA . 10.8 mt -128.08 144.89 51.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.902 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.87 84.08 2.09 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.679 HG13 HG11 ' A' ' 21' ' ' VAL . 18.0 t -98.63 172.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.661 0.743 . . . . 0.0 111.526 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.541 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -123.43 -159.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.809 0.814 . . . . 0.0 111.537 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.511 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -87.26 125.56 34.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.312 -179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.01 -5.13 30.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.912 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.6 t -102.3 172.1 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 122.442 1.115 . . . . 0.0 110.338 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.619 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -118.47 -169.72 1.76 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.829 HD21 ' SD ' ' A' ' 90' ' ' MET . 18.0 mt -87.99 -14.07 40.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.832 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.86 ' HE2' HG21 ' A' ' 28' ' ' VAL . 2.3 ttp -90.9 -65.86 0.98 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.802 -1.186 . . . . 0.0 112.327 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.912 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.32 -26.42 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 111.44 -178.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.649 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -92.35 -34.83 14.03 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.859 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . . . -77.28 -41.84 39.29 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.017 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.86 HG21 ' HE2' ' A' ' 24' ' ' MET . 62.8 t -55.17 -60.42 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.861 -1.15 . . . . 0.0 108.413 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -51.39 -38.31 52.76 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.588 ' CG ' HD21 ' A' ' 15' ' ' LEU . 2.8 m-80 -70.48 1.64 4.86 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 84.34 -15.63 38.93 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 mt -41.55 -42.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.323 -1.104 . . . . 0.0 108.122 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.549 -0.719 . . . . 0.0 109.778 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.9 p . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 120.853 0.359 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.53 36.64 4.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.16 28.44 49.29 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.9 m -124.71 -13.67 6.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -1.105 . . . . 0.0 110.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.834 ' HB1' ' HE1' ' A' ' 70' ' ' MET . . . 75.51 55.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.797 0.808 . . . . 0.0 112.689 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.14 37.12 3.59 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.966 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.3 p -111.23 157.12 20.47 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -111.89 -10.24 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.016 . . . . 0.0 110.925 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.3 t -110.56 -19.01 13.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.857 -1.152 . . . . 0.0 113.257 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.812 ' HB2' HD22 ' A' ' 84' ' ' LEU . 1.8 m -80.36 20.31 0.7 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.316 -1.49 . . . . 0.0 110.994 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.651 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.7 t-160 -48.23 139.86 8.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 48' ' ' CYS . 14.2 m -143.97 156.17 15.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.627 -1.296 . . . . 0.0 109.81 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 2.9 m-30 -119.8 119.02 32.36 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.998 0.904 . . . . 0.0 109.367 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 97' ' ' ILE . 21.4 t -100.8 152.0 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 111.009 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -74.29 130.92 40.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.398 -1.439 . . . . 0.0 109.324 178.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -36.79 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.505 -0.747 . . . . 0.0 111.519 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.09 -19.82 63.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.03 -1.043 . . . . 0.0 111.273 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.97 ' CB ' HD13 ' A' ' 97' ' ' ILE . 43.7 m-85 -127.66 -11.36 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.881 -1.137 . . . . 0.0 110.572 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.14 -17.86 48.4 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.191 -0.943 . . . . 0.0 108.975 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.2 p-10 -89.68 -30.83 17.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.589 ' O ' HD11 ' A' ' 94' ' ' LEU . 3.5 mmmm -82.81 12.01 5.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.833 . . . . 0.0 110.259 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.881 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -116.78 155.45 49.03 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.4 Cg_endo -62.94 156.76 52.36 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.084 1.57 . . . . 0.0 111.859 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.14 128.09 33.37 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.754 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -69.38 156.24 39.13 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.551 -0.718 . . . . 0.0 110.064 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.685 ' O ' HD13 ' A' ' 68' ' ' ILE . 27.5 p30 -100.57 -172.34 2.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 111.648 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.56 -21.49 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 110.711 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.3 ttm180 -64.12 -59.07 4.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.003 -1.061 . . . . 0.0 109.253 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.79 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 20.1 tt0 -65.55 10.71 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.656 . . . . 0.0 112.436 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.18 -40.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 119.453 -2.029 . . . . 0.0 110.952 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.18 -57.95 1.62 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.024 ' HE2' HD12 ' A' ' 84' ' ' LEU . 6.1 ptm -48.14 -43.05 30.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.222 -1.164 . . . . 0.0 109.173 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.749 HD22 HD11 ' A' ' 78' ' ' LEU 0.281 0.0 OUTLIER -70.29 -33.2 71.27 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.935 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 4.4 tt0 -90.78 3.53 54.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.23 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 46' ' ' ALA . 1.6 m -49.11 -54.73 14.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.665 -1.272 . . . . 0.0 109.457 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 74' ' ' VAL . 34.8 m -90.04 105.72 16.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 75' ' ' THR . 8.9 t -48.53 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.384 -0.823 . . . . 0.0 110.888 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.2 50.9 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.67 60.45 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 110.309 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.749 HD11 HD22 ' A' ' 71' ' ' LEU . 2.3 tp -29.87 144.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 111.787 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 14.5 mtmt -120.6 170.76 6.65 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.747 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.6 Cg_endo -69.48 -30.7 23.16 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.649 1.341 . . . . 0.0 109.926 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 8.3 p-10 -97.35 -6.39 34.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 13.1 m -49.12 165.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.767 -1.208 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.695 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.27 167.45 3.39 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.638 -0.664 . . . . 0.0 109.48 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.024 HD12 ' HE2' ' A' ' 70' ' ' MET . 0.8 OUTLIER -95.7 141.4 29.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . 4.7 m -41.67 -27.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 110.462 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 84' ' ' LEU . 2.0 m -108.32 43.78 1.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.589 -0.694 . . . . 0.0 111.034 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.752 HE21 ' HB2' ' A' ' 67' ' ' GLU . 4.5 mm100 -126.08 -33.83 2.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 111.845 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.941 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -92.03 149.97 3.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 110.267 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 5.2 mm -110.34 156.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.829 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.1 tpt -110.02 113.54 26.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 0.0 110.792 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.455 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -106.51 171.44 4.75 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -72.85 -1.62 10.71 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.908 1.478 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 4.7 pt-20 -110.19 -30.66 7.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 59' ' ' LYS . 7.3 mt -94.14 52.94 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.949 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 4.5 p-10 -100.48 145.66 28.0 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.017 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.32 22.0 10.22 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.011 HD11 HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -70.9 130.05 34.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.994 0.902 . . . . 0.0 113.162 -176.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.739 ' N ' HD12 ' A' ' 97' ' ' ILE . 11.0 t -103.75 122.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.984 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.4 t -103.98 -174.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.66 ' H ' HG12 ' A' ' 99' ' ' VAL . 7.2 m-20 -161.7 139.79 9.17 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.065 176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' VAL . 9.6 t -98.13 103.02 15.6 Favored Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.0 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.68 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 41.8 Cg_endo . . . . . 0 C--N 1.309 -1.53 0 C-N-CA 122.155 1.904 . . . . 0.0 112.772 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.55 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.317 0.58 . . . . 0.0 110.475 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -88.86 134.46 33.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.852 . . . . 0.0 109.928 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.98 HG22 ' CG2' ' A' ' 97' ' ' ILE . 14.0 t -122.61 147.43 26.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.883 -1.136 . . . . 0.0 111.155 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.996 HG23 ' HG2' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -131.18 130.86 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 23' ' ' LEU . 83.4 m-85 -111.46 123.73 50.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.462 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.3 t -92.27 151.86 3.51 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.84 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.571 ' CB ' HG22 ' A' ' 11' ' ' THR . 17.1 p -113.53 141.36 47.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.981 -1.074 . . . . 0.0 109.403 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' SER . 1.0 OUTLIER -41.81 -23.88 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.607 -0.683 . . . . 0.0 110.723 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' SER . 6.2 p-10 -93.44 -1.22 55.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.878 -1.139 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.36 -32.05 6.93 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.949 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.571 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.62 141.35 9.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.874 -1.368 . . . . 0.0 109.476 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.7 mtm180 -127.45 124.93 39.6 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.791 -0.568 . . . . 0.0 111.042 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -102.34 157.6 16.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.996 ' HG2' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -130.58 135.31 47.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.989 -1.069 . . . . 0.0 110.804 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.858 HD11 ' CA ' ' A' ' 27' ' ' ALA . 7.3 mt -124.55 142.0 51.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 111.035 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -99.92 82.38 2.57 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 26' ' ' ALA . 40.5 t -98.17 169.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.575 -0.703 . . . . 0.0 110.413 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.542 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -126.09 -149.95 0.43 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.521 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -90.85 122.65 33.74 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.617 0.722 . . . . 0.0 110.498 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -8.57 30.89 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.623 HG22 ' NE2' ' A' ' 25' ' ' GLN . 18.5 t -96.57 170.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.0 -1.294 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.572 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 166.51 13.91 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.7 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 4.8 mt -69.98 -5.34 25.69 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.083 -1.847 . . . . 0.0 108.332 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.695 ' HE3' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.22 -72.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.623 ' NE2' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -42.87 -57.7 2.7 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 121.783 -0.573 . . . . 0.0 112.242 -176.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.813 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -57.95 -57.78 11.29 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.57 -1.956 . . . . 0.0 108.386 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.858 ' CA ' HD11 ' A' ' 15' ' ' LEU . . . -51.48 -57.96 7.6 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.516 0.674 . . . . 0.0 109.97 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 29' ' ' SER . 13.4 t -39.79 -71.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.302 0.572 . . . . 0.0 109.627 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -48.71 -46.41 40.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -0.835 . . . . 0.0 109.387 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.523 ' ND2' HD22 ' A' ' 15' ' ' LEU . 4.2 m-80 -59.67 -8.57 2.09 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.92 -5.96 76.86 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.8 HG22 ' CE1' ' A' ' 33' ' ' TYR . 2.9 mt -44.68 -35.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.8 ' CE1' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.6 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 120.981 0.419 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.54 47.54 7.19 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.36 59.38 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 8.0 t -116.93 -36.74 3.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -1.078 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.04 60.68 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 111.331 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.574 ' C ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -131.3 14.01 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.237 -0.914 . . . . 0.0 110.438 178.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.975 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.94 124.28 52.26 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.625 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -79.14 4.55 14.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.689 -1.257 . . . . 0.0 109.885 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.6 p -91.38 -22.83 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.702 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.81 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -95.53 13.63 25.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.049 -1.032 . . . . 0.0 110.029 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.755 ' NE2' HD21 ' A' ' 71' ' ' LEU . 22.3 t-160 -50.51 137.33 19.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.505 -1.372 . . . . 0.0 108.733 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -142.67 158.93 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 102' ' ' PRO . 3.5 m-30 -117.71 109.98 17.29 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.624 0.726 . . . . 0.0 109.694 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.913 ' CG1' HD11 ' A' ' 97' ' ' ILE . 10.7 t -85.61 162.27 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 1.047 ' O ' HG23 ' A' ' 57' ' ' THR . 10.1 p30 -82.92 139.0 33.64 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 119.947 -1.72 . . . . 0.0 109.273 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 53' ' ' ASN . 5.1 pt-20 -41.68 -21.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.995 -1.065 . . . . 0.0 111.503 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.921 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -72.93 -53.02 12.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.756 -1.215 . . . . 0.0 111.637 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.853 ' HB3' HD12 ' A' ' 97' ' ' ILE . 48.3 m-85 -85.03 -4.75 59.27 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.841 -1.162 . . . . 0.0 111.072 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.047 HG23 ' O ' ' A' ' 53' ' ' ASN . 10.2 p -80.28 -51.24 9.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.873 -1.142 . . . . 0.0 109.501 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD2' ' CE ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.05 -12.03 16.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.735 ' HB3' HD13 ' A' ' 94' ' ' LEU 0.284 8.8 mmpt? -79.29 -52.42 8.14 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.876 1.798 . . . . 0.0 108.208 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -84.75 144.59 42.54 Favored Pre-proline 0 C--N 1.279 -2.458 0 CA-C-N 112.201 -2.272 . . . . 0.0 110.435 -177.494 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.7 Cg_endo -62.53 162.97 22.45 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.934 1.492 . . . . 0.0 112.145 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -168.64 1.84 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.352 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 87' ' ' GLN . . . -110.9 171.52 7.42 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.379 0.609 . . . . 0.0 111.056 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.693 ' O ' HD13 ' A' ' 68' ' ' ILE . 48.1 p-10 -100.81 -153.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.605 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -71.67 -18.52 62.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 110.217 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -64.51 -52.16 59.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 109.241 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.631 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -63.55 0.09 0.82 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.865 -0.522 . . . . 0.0 111.33 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.1 mp -91.16 -18.78 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 119.79 -1.819 . . . . 0.0 111.359 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.52 -79.58 1.37 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 120.753 -1.217 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.215 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.58 -32.16 7.68 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.169 -1.195 . . . . 0.0 110.134 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.934 HD22 HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.64 -30.63 69.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.251 -0.905 . . . . 0.0 108.783 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -85.07 -29.51 24.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 109.691 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -49.29 -44.26 43.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 109.491 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.625 HG11 ' O ' ' A' ' 46' ' ' ALA . 13.4 m -90.17 70.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.531 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 75' ' ' THR . 9.2 t -48.92 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 0.0 111.11 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -118.12 66.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.02 -1.05 . . . . 0.0 109.529 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 1.7 pm0 39.88 49.08 2.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.814 0.816 . . . . 0.0 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.934 HD11 HD22 ' A' ' 71' ' ' LEU . 2.4 tp -23.46 142.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.363 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.03 170.48 5.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.755 . . . . 0.0 108.978 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.3 Cg_endo -69.2 -29.39 26.59 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.649 1.341 . . . . 0.0 109.481 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 57' ' ' THR . 23.0 p-10 -99.58 -7.98 25.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.657 -0.652 . . . . 0.0 110.522 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.62 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 67.0 m -48.98 153.58 0.86 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.089 -1.007 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -175.45 161.67 2.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.898 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.215 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -78.38 140.22 38.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 179.021 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.695 ' HB2' ' HE3' ' A' ' 24' ' ' MET . 47.4 m -42.27 -28.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.023 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -92.53 35.6 1.02 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.636 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.681 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 6.9 tp-100 -126.49 -41.93 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.465 -1.397 . . . . 0.0 112.374 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.908 ' CD1' HG21 ' A' ' 52' ' ' VAL . 1.3 mt -94.65 154.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-O 122.099 0.952 . . . . 0.0 111.583 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.2 mm -110.88 160.85 9.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.55 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 3.4 tpt -110.17 113.62 26.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 110.083 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.5 OUTLIER -92.92 166.12 17.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.5 Cg_endo -73.02 -25.46 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.502 . . . . 0.0 110.538 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.4 pm0 -91.32 -26.76 18.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.813 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 59' ' ' LYS . 7.3 mt -94.9 51.0 1.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.058 0.932 . . . . 0.0 109.417 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 4.6 p-10 -100.49 152.53 20.28 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.677 0.751 . . . . 0.0 112.203 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.64 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 97.06 28.1 8.93 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.98 ' CG2' HG22 ' A' ' 3' ' ' VAL . 9.8 tt -74.2 155.02 6.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 123.259 1.504 . . . . 0.0 113.533 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.653 ' HA ' HG12 ' A' ' 4' ' ' VAL . 6.4 t -120.79 91.55 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.362 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -104.66 171.35 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.644 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -145.69 172.79 12.76 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.32 1.057 . . . . 0.0 112.083 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 6' ' ' VAL . 13.1 t -105.69 111.94 64.62 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 42.8 Cg_endo . . . . . 0 C--N 1.303 -1.83 0 O-C-N 123.906 1.477 . . . . 0.0 111.754 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.562 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.502 0.667 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.8 OUTLIER -82.96 109.64 17.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.728 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 2.5 t -109.5 134.54 51.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.921 -1.112 . . . . 0.0 110.634 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.965 HG22 ' OE1' ' A' ' 14' ' ' GLU . 93.4 t -124.11 107.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.259 1.028 . . . . 0.0 111.807 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.774 ' OH ' HD12 ' A' ' 15' ' ' LEU . 22.6 m-30 -83.46 130.26 35.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.4 t -120.18 134.07 64.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.393 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.667 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -79.58 -167.28 1.17 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 108.51 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.508 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -97.94 -9.95 25.35 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.952 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.43 -6.68 25.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 19.48 8.07 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.541 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.667 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -87.88 153.72 21.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.844 -1.386 . . . . 0.0 107.754 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 mtm180 -130.13 139.32 50.92 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.229 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.701 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.36 67.87 1.36 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.7 0.762 . . . . 0.0 108.991 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.965 ' OE1' HG22 ' A' ' 4' ' ' VAL . 18.6 mt-10 -67.96 140.21 56.41 Favored 'General case' 0 C--N 1.288 -2.065 0 O-C-N 120.767 -1.208 . . . . 0.0 110.896 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.774 HD12 ' OH ' ' A' ' 5' ' ' TYR . 8.0 mt -110.99 147.1 35.45 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.646 -0.659 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.59 86.43 3.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG13 HG11 ' A' ' 21' ' ' VAL . 25.3 t -98.88 172.32 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.697 0.761 . . . . 0.0 111.833 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.545 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -112.57 -144.78 0.39 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.603 0.716 . . . . 0.0 111.525 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -104.07 124.69 49.5 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.46 0.648 . . . . 0.0 110.346 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.3 3.19 38.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.912 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.5 t -107.65 172.36 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.613 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.65 179.85 4.21 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.876 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.919 HD21 ' SD ' ' A' ' 90' ' ' MET . 14.5 mt -79.06 -6.84 57.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.637 -1.289 . . . . 0.0 109.085 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.628 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.73 -76.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.904 0.859 . . . . 0.0 111.597 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.912 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.78 -24.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.075 -177.165 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.772 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -91.75 -33.18 15.12 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . . . -77.48 -51.35 10.9 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.065 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 33' ' ' TYR . 96.5 t -45.04 -57.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -58.24 -37.72 75.47 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.026 0.917 . . . . 0.0 108.688 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.655 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.1 m-80 -68.92 1.81 3.12 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.279 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 85.78 -14.42 52.27 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 27' ' ' ALA . 1.3 mt -44.76 -54.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -1.196 . . . . 0.0 107.826 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.891 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.504 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.257 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.8 p . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.21 32.61 3.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.769 -2.133 . . . . 0.0 107.769 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.53 35.15 26.64 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 48.2 m -137.98 0.63 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -1.153 . . . . 0.0 111.473 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.875 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 71.82 57.4 0.17 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 112.416 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.464 ' C ' ' HG2' ' A' ' 70' ' ' MET . 3.8 t -133.01 32.11 3.8 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.006 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.6 p -111.87 131.59 55.26 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -91.77 5.4 49.99 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.063 -1.648 . . . . 0.0 109.109 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.491 HG23 ' N ' ' A' ' 48' ' ' CYS . 5.9 t -110.55 -40.47 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.221 -0.924 . . . . 0.0 111.897 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.776 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.0 m -74.87 10.61 1.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.495 -1.378 . . . . 0.0 110.976 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.786 ' ND1' HG21 ' A' ' 74' ' ' VAL . 18.1 t-160 -45.88 138.83 4.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.355 -1.466 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.7 m -140.94 160.38 23.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.037 -1.039 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.675 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 10.1 m-30 -119.28 122.19 41.34 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.545 0.688 . . . . 0.0 109.398 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.898 HG21 ' CD1' ' A' ' 88' ' ' ILE . 41.2 t -96.31 169.66 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.339 -0.85 . . . . 0.0 110.079 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 1.041 ' O ' HG23 ' A' ' 57' ' ' THR . 11.9 p30 -86.45 137.41 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.648 -1.283 . . . . 0.0 108.854 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.0 pt-20 -40.3 -22.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.996 -1.065 . . . . 0.0 111.748 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.811 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -72.09 -53.87 11.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.81 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.679 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 55.5 m-85 -84.89 -4.78 59.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 0.0 111.286 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.041 HG23 ' O ' ' A' ' 53' ' ' ASN . 6.5 p -80.35 -52.32 7.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 109.99 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -63.79 -9.32 13.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.412 -0.805 . . . . 0.0 110.178 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.631 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.299 1.9 mmtp -79.29 -53.23 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.796 1.76 . . . . 0.0 109.086 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.019 HG21 HG22 ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -79.28 161.13 68.9 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 112.372 -2.195 . . . . 0.0 110.146 -177.56 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 60' ' ' VAL . 36.1 Cg_endo -60.63 163.64 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.774 1.407 . . . . 0.0 112.638 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.51 -148.23 0.06 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.831 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.796 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . . . -110.09 144.37 38.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.897 ' O ' HD13 ' A' ' 68' ' ' ILE . 49.8 p30 -100.43 -153.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.535 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 66' ' ' ARG . 1.2 pm0 -80.39 -27.37 38.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 110.065 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -75.21 -50.0 17.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.796 ' OE2' ' HB2' ' A' ' 63' ' ' ALA . 30.9 tt0 -63.84 -5.31 4.14 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.49 -0.756 . . . . 0.0 110.996 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.63 -13.47 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.28 -1.512 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -88.84 -80.32 1.3 Allowed Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.256 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.137 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.23 -34.77 10.74 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.977 -1.308 . . . . 0.0 109.528 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.682 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.29 -18.02 63.11 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.791 0.805 . . . . 0.0 109.269 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -90.95 -53.09 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.105 -0.997 . . . . 0.0 109.654 178.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.41 -24.08 1.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.807 . . . . 0.0 109.248 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.786 HG21 ' ND1' ' A' ' 49' ' ' HIS . 34.5 m -79.74 57.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.299 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 75' ' ' THR . 9.0 t -48.97 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.0 112.534 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.52 63.37 1.57 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.798 -1.189 . . . . 0.0 108.938 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.55 58.17 2.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.732 0.777 . . . . 0.0 109.413 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.682 HD11 HD22 ' A' ' 71' ' ' LEU . 2.5 tp -30.64 138.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.523 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.675 ' HG2' ' CZ ' ' A' ' 51' ' ' TYR . 5.4 mmmt -93.03 168.69 11.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 109.067 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.57 -25.44 40.89 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.71 1.374 . . . . 0.0 109.155 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.549 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 3.3 p30 -113.06 5.46 17.16 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.67 -0.644 . . . . 0.0 111.652 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.595 ' HG ' ' HG2' ' A' ' 79' ' ' LYS . 72.7 m -48.52 144.32 4.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.546 -1.346 . . . . 0.0 111.292 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.651 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -154.93 160.0 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.137 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -85.02 142.61 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 110.132 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.663 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 2.4 p -44.66 -25.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.875 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 5.3 m -108.65 40.71 1.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.444 0.64 . . . . 0.0 110.012 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.61 ' NE2' ' OE1' ' A' ' 67' ' ' GLU . 46.4 tp60 -122.22 -48.47 2.09 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.491 -0.756 . . . . 0.0 111.965 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.019 HG22 HG21 ' A' ' 60' ' ' VAL . 1.2 mt -87.46 153.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 121.944 0.878 . . . . 0.0 111.104 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.7 mm -111.26 156.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.919 ' SD ' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -110.5 92.49 4.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.099 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.72 171.73 11.69 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -78.86 -0.77 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.863 1.454 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 2.6 pt-20 -110.08 -31.22 7.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 109.403 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.554 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.3 mt -98.16 51.72 1.03 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.975 0.893 . . . . 0.0 108.791 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 8.0 p-10 -100.48 147.05 26.32 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 121.976 0.893 . . . . 0.0 113.189 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.647 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.57 28.1 7.69 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.679 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.9 125.52 38.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 8.6 t -82.49 120.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.754 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -104.55 -175.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.639 -1.288 . . . . 0.0 110.039 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.665 ' H ' HG12 ' A' ' 99' ' ' VAL . 13.9 m-20 -161.4 136.19 7.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.253 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 6' ' ' VAL . 2.6 t -95.71 115.7 65.7 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.655 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo . . . . . 0 C--N 1.304 -1.775 0 C-N-CA 121.894 1.729 . . . . 0.0 112.486 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.561 0.696 . . . . 0.0 110.494 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 5.9 ttmt -85.25 113.34 21.52 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 5.0 t -109.16 137.05 43.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.914 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 t -131.21 125.38 57.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.992 0.901 . . . . 0.0 108.667 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.006 ' CD1' HG21 ' A' ' 99' ' ' VAL 0.273 52.1 m-85 -105.08 140.21 38.6 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 -177.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.929 HG13 ' HG3' ' A' ' 12' ' ' ARG . 3.4 t -121.49 157.06 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.455 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.641 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 78.3 p -116.41 140.56 49.22 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.441 ' ND1' HG12 ' A' ' 101' ' ' VAL . 1.6 p-80 -48.0 -20.75 0.36 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.067 -1.02 . . . . 0.0 109.687 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.461 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 1.8 p30 -89.9 -3.89 57.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 -35.98 4.52 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.896 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.28 132.58 19.97 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.788 -1.419 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.929 ' HG3' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -130.32 153.05 49.06 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.767 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.83 163.45 27.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.916 . . . . 0.0 109.006 177.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.731 ' HG2' HG22 ' A' ' 4' ' ' VAL . 32.8 mt-10 -130.64 120.87 24.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.863 HD21 ' CG ' ' A' ' 30' ' ' ASN . 7.4 mt -109.72 145.45 36.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.872 -1.142 . . . . 0.0 112.123 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.7 92.09 5.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.83 HG13 HG11 ' A' ' 21' ' ' VAL . 96.2 t -98.77 170.75 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 112.029 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.597 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -119.67 -151.65 0.49 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.424 0.63 . . . . 0.0 110.623 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' HB2' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.19 121.2 42.18 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.381 -0.824 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 5.95 28.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.886 HG13 ' NE2' ' A' ' 25' ' ' GLN . 1.4 t -110.04 174.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.585 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.07 -177.25 3.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.19 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -77.84 -13.31 59.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 109.269 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.678 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -90.13 -73.58 0.52 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.886 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -36.75 -24.8 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 122.048 -0.408 . . . . 0.0 111.64 -177.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.66 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -91.11 -46.37 8.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.827 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -61.81 -54.27 44.48 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.734 HG12 ' N ' ' A' ' 29' ' ' SER 0.283 0.8 OUTLIER -36.38 -60.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.66 177.607 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.734 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -65.14 -42.48 93.79 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.134 0.968 . . . . 0.0 109.148 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.863 ' CG ' HD21 ' A' ' 15' ' ' LEU . 4.8 m-80 -63.85 -3.27 2.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.97 -20.58 24.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.827 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 10.3 mt -42.06 -39.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.445 -1.033 . . . . 0.0 109.281 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.716 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 25.5 m-85 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.149 -0.969 . . . . 0.0 113.036 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.631 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.6 p . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 121.18 0.514 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.75 34.62 5.46 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.18 30.05 43.36 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 1.1 t -128.56 -6.79 5.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.137 . . . . 0.0 111.057 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.25 57.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.433 -0.792 . . . . 0.0 112.913 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.484 ' C ' ' HG2' ' A' ' 70' ' ' MET . 0.4 OUTLIER -133.58 36.98 3.33 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.581 -1.636 . . . . 0.0 106.581 176.559 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.076 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -111.6 150.06 30.6 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -175.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.37 2.07 18.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.518 -1.364 . . . . 0.0 109.076 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -110.07 -34.52 6.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 111.3 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.634 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 1.8 m -77.92 8.06 5.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.544 -1.347 . . . . 0.0 110.203 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.771 ' NE2' HD21 ' A' ' 71' ' ' LEU . 21.5 t-160 -53.13 150.42 5.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.596 -1.315 . . . . 0.0 108.929 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 49' ' ' HIS . 12.5 m -160.39 164.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.852 0.834 . . . . 0.0 110.919 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.689 ' CE1' ' HB3' ' A' ' 82' ' ' SER . 4.1 m-85 -118.68 122.87 43.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.816 HG21 ' CD1' ' A' ' 88' ' ' ILE . 15.8 t -92.75 151.61 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.241 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -75.18 130.62 39.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.137 -1.602 . . . . 0.0 109.664 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 4.9 pt-20 -35.28 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.792 -0.568 . . . . 0.0 111.984 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -65.92 -18.1 65.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.891 -1.131 . . . . 0.0 111.558 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.669 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 46.9 m-85 -127.89 -11.62 5.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.845 -1.159 . . . . 0.0 110.444 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -80.96 -50.91 9.13 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' OD1' ' HD2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.31 -20.98 64.88 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 0.0 109.224 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.879 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.279 20.5 mmmt -79.4 -56.22 4.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.602 1.668 . . . . 0.0 108.923 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 88' ' ' ILE 0.314 0.3 OUTLIER -75.64 138.12 70.44 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 112.856 -1.974 . . . . 0.0 109.854 -178.263 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.22 159.75 41.84 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 124.116 1.587 . . . . 0.0 111.982 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 -167.59 1.44 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.733 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.634 ' HB1' ' OE1' ' A' ' 87' ' ' GLN . . . -110.73 -169.13 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.377 0.608 . . . . 0.0 110.625 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.722 ' O ' HD13 ' A' ' 68' ' ' ILE . 53.4 p30 -100.27 -144.64 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -80.01 -23.81 41.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.768 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.9 ttm-85 -64.74 -50.98 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.627 ' OE2' HD12 ' A' ' 71' ' ' LEU . 11.4 tp10 -59.55 -11.48 4.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.3 mp -89.97 -16.59 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.658 -1.276 . . . . 0.0 109.813 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -90.6 -63.32 1.23 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.001 ' CE ' HD12 ' A' ' 84' ' ' LEU 0.289 2.9 mpp? -48.6 -48.52 39.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.335 1.541 . . . . 0.0 108.149 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.096 HD13 HD21 ' A' ' 78' ' ' LEU 0.269 0.0 OUTLIER -66.01 -32.04 73.29 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.961 -178.323 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -70.0 -41.98 73.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 109.997 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -41.88 41.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 109.797 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 74' ' ' VAL . 9.9 m -90.22 63.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 110.181 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 75' ' ' THR . 10.2 t -49.66 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.726 . . . . 0.0 111.113 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.27 74.93 1.62 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -0.999 . . . . 0.0 110.126 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.2 pt-20 39.17 60.46 1.49 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.495 1.141 . . . . 0.0 109.525 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.096 HD21 HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -59.02 120.02 8.35 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.531 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.652 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -104.92 -167.01 0.11 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 41.7 Cg_endo -74.95 -28.27 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.041 1.021 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.575 ' HB3' ' CB ' ' A' ' 57' ' ' THR . 44.6 p-10 -87.16 -28.24 22.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.513 -0.742 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.689 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.9 m -49.9 106.37 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.834 -1.166 . . . . 0.0 108.796 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.53 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -145.68 171.91 14.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.796 -1.19 . . . . 0.0 111.48 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.076 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -84.32 136.52 33.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.467 0.651 . . . . 0.0 111.332 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.634 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 3.0 p -42.38 -29.93 0.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 110.832 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.678 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.9 m -98.78 35.24 1.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 111.304 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.711 HE21 ' HB2' ' A' ' 43' ' ' ALA . 5.0 mm-40 -126.75 -48.02 1.52 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 113.066 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.816 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -79.86 151.36 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.643 -1.286 . . . . 0.0 110.534 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 89' ' ' ILE . 3.9 mm -111.85 160.05 11.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 110.159 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.823 ' HE1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.63 118.21 35.59 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 110.454 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -94.89 167.22 13.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.848 . . . . 0.0 109.713 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' CD ' ' HB2' ' A' ' 19' ' ' ASP . 43.8 Cg_endo -78.65 -2.07 12.15 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.868 1.457 . . . . 0.0 110.714 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' OE2' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.09 -29.94 7.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.1 -1.0 . . . . 0.0 109.765 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.879 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.6 mt -88.28 66.03 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 110.351 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' HA ' ' OG ' ' A' ' 1' ' ' SER . 10.3 p30 -101.72 148.38 25.34 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.735 -1.228 . . . . 0.0 113.174 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.669 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.03 30.49 6.68 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.664 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -80.2 135.28 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.177 0.989 . . . . 0.0 112.779 -177.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.535 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 12.7 t -102.78 125.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.006 HG21 ' CD1' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -104.25 -179.69 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.996 -1.065 . . . . 0.0 108.971 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-20 -162.07 145.56 12.0 Favored 'General case' 0 C--N 1.276 -2.616 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.547 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 55.0 t -83.86 149.79 57.41 Favored Pre-proline 0 C--N 1.289 -2.033 0 C-N-CA 117.449 -1.7 . . . . 0.0 107.514 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.67 ' HG3' ' CG ' ' A' ' 49' ' ' HIS . 42.1 Cg_endo . . . . . 0 C--N 1.3 -2.01 0 C-N-CA 121.464 1.443 . . . . 0.0 111.956 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 95' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.518 0.675 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -77.32 127.86 33.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.72 . . . . 0.0 109.605 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.137 HG22 ' CG2' ' A' ' 97' ' ' ILE . 23.0 t -139.5 148.07 23.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.856 -1.152 . . . . 0.0 112.033 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 99' ' ' VAL . 13.8 t -131.41 126.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.835 ' CD1' HG21 ' A' ' 99' ' ' VAL . 54.5 m-85 -100.16 140.36 34.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.636 0.731 . . . . 0.0 112.509 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.939 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.6 t -120.52 134.98 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.21 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.638 ' HB3' HG22 ' A' ' 11' ' ' THR . 36.0 p -79.51 -152.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.519 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.36 -10.43 14.59 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.913 -1.117 . . . . 0.0 108.965 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 58.2 p30 -100.45 3.34 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.52 -0.737 . . . . 0.0 109.602 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.47 -29.6 8.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.81 134.88 20.27 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.953 -1.322 . . . . 0.0 109.224 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.939 ' HG2' HG13 ' A' ' 6' ' ' VAL . 12.8 mtm180 -130.11 161.72 30.42 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.612 0.72 . . . . 0.0 111.504 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.849 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.8 ttp180 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.744 ' HG2' HG22 ' A' ' 4' ' ' VAL . 20.0 mt-10 -130.62 124.23 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.833 -1.167 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.941 HD11 ' HA ' ' A' ' 27' ' ' ALA . 12.3 mt -117.95 151.54 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.77 90.55 3.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.9 t -98.7 163.63 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.854 . . . . 0.0 110.557 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -112.97 -136.78 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.356 -0.84 . . . . 0.0 110.916 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -108.32 124.43 50.32 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.309 -0.869 . . . . 0.0 110.494 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -7.11 30.52 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 22' ' ' SER . 83.0 t -95.69 168.0 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.027 -1.278 . . . . 0.0 110.543 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.596 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.62 160.14 25.0 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 3' ' ' VAL . 18.4 mt -57.77 -36.04 71.59 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.673 -1.267 . . . . 0.0 109.254 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 1.298 ' SD ' ' SG ' ' A' ' 39' ' ' CYS . 4.7 ttp -79.33 7.24 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.062 -1.024 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.566 ' CG ' HG13 ' A' ' 21' ' ' VAL . 24.7 tt0 -102.29 -71.13 0.73 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.54 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.993 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -46.48 -55.43 7.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.758 -1.214 . . . . 0.0 108.614 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -53.55 -53.05 57.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.692 HG12 ' N ' ' A' ' 29' ' ' SER 0.277 0.7 OUTLIER -37.8 -57.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.422 177.769 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.692 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.76 -47.14 85.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.075 0.941 . . . . 0.0 108.821 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.528 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.8 m120 -64.42 -4.03 3.54 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.499 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.03 -14.94 51.37 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.908 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 mt -44.04 -37.9 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.505 -0.997 . . . . 0.0 108.542 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.74 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 72.0 m-85 . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.162 -0.961 . . . . 0.0 111.201 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.298 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 121.116 0.484 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.1 46.24 10.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 29.72 44.44 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 66.9 m -116.4 -39.42 3.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -1.129 . . . . 0.0 110.583 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.8 ' HB2' ' NE2' ' A' ' 87' ' ' GLN . . . 72.79 59.19 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 111.66 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.534 ' C ' ' HG2' ' A' ' 70' ' ' MET . 58.3 m -131.91 11.29 4.7 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 110.196 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.969 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -113.01 120.61 41.97 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -177.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -77.16 -0.87 26.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.434 -1.416 . . . . 0.0 109.564 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -83.65 -21.18 32.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 111.188 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.833 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -98.44 16.69 20.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.824 -1.172 . . . . 0.0 110.095 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.856 ' HD1' HG23 ' A' ' 74' ' ' VAL . 5.9 t-160 -46.16 134.32 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.604 -1.31 . . . . 0.0 108.054 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 48' ' ' CYS . 18.1 m -138.27 156.24 30.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.766 -1.209 . . . . 0.0 110.037 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.681 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.1 m-30 -118.29 116.67 27.23 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.597 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.849 HG21 ' CD1' ' A' ' 88' ' ' ILE . 22.2 t -94.33 166.09 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 108.909 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 1.009 ' O ' HG23 ' A' ' 57' ' ' THR . 12.5 p30 -84.97 137.2 33.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.278 -1.514 . . . . 0.0 109.023 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 53' ' ' ASN . 6.7 pt-20 -41.05 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.169 -0.957 . . . . 0.0 112.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.654 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -75.61 -51.03 13.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.639 -1.288 . . . . 0.0 111.762 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.726 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 64.4 m-85 -84.96 -5.06 59.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.079 -1.013 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.009 HG23 ' O ' ' A' ' 53' ' ' ASN . 9.7 p -80.3 -55.04 5.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.884 -1.135 . . . . 0.0 109.815 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.452 ' N ' ' OG1' ' A' ' 57' ' ' THR . 1.6 p30 -60.89 -12.42 11.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.429 -0.794 . . . . 0.0 110.769 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.734 ' CB ' HD13 ' A' ' 94' ' ' LEU 0.295 13.5 mtpt -79.4 -54.49 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.724 1.726 . . . . 0.0 109.336 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.815 HG22 ' HD2' ' A' ' 61' ' ' PRO 0.324 0.3 OUTLIER -76.51 155.06 83.8 Favored Pre-proline 0 C--N 1.278 -2.506 0 CA-C-N 112.546 -2.115 . . . . 0.0 110.593 -177.441 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.815 ' HD2' HG22 ' A' ' 60' ' ' VAL . 37.5 Cg_endo -63.58 168.09 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.024 1.539 . . . . 0.0 111.758 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -80.34 -170.22 2.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.543 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.684 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -110.74 157.85 19.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.555 -0.715 . . . . 0.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.473 ' CG ' ' HG3' ' A' ' 66' ' ' ARG . 5.1 p30 -79.47 -161.84 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.496 -0.752 . . . . 0.0 110.884 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.11 -22.59 41.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 111.343 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.531 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -69.73 -42.44 73.95 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.612 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.7 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.31 -7.54 1.33 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.819 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.64 HD13 ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -90.41 -15.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.608 -1.307 . . . . 0.0 109.642 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.84 -79.75 1.38 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.524 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.237 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.9 -35.17 14.22 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.881 -1.364 . . . . 0.0 109.778 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -65.35 -30.18 70.99 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 108.575 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.15 -29.08 18.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.474 -0.766 . . . . 0.0 109.561 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -49.02 -48.87 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.046 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.856 HG23 ' HD1' ' A' ' 49' ' ' HIS . 16.5 m -90.07 76.53 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.425 -0.797 . . . . 0.0 109.098 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 75' ' ' THR . 13.1 t -48.25 87.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.782 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 77' ' ' GLU . . . -105.5 41.04 1.43 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.745 -1.222 . . . . 0.0 109.748 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.596 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER 66.78 44.47 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.219 1.009 . . . . 0.0 109.207 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.835 HD11 HD22 ' A' ' 71' ' ' LEU . 1.5 tp -19.42 134.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.53 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.669 ' CG ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.42 172.48 3.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.1 Cg_endo -69.83 -26.69 26.97 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.585 1.308 . . . . 0.0 108.828 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.6 p-10 -104.67 -9.16 18.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.704 -0.622 . . . . 0.0 111.399 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.583 ' OG ' ' CG ' ' A' ' 79' ' ' LYS . 42.7 m -47.86 158.62 0.21 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.524 -1.36 . . . . 0.0 111.406 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.773 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -175.6 161.87 2.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.683 -0.636 . . . . 0.0 109.822 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.237 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -80.33 139.53 36.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.93 . . . . 0.0 109.625 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.627 ' C ' ' HB2' ' A' ' 24' ' ' MET . 20.0 m -38.54 -31.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.515 1.15 . . . . 0.0 108.496 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.032 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -91.44 37.11 0.94 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.184 -178.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.8 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 6.1 mm-40 -127.43 -40.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.409 -1.432 . . . . 0.0 113.444 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -92.61 150.9 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.551 -178.024 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.5 mm -111.35 163.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.603 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.5 tpt -110.28 108.74 18.94 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.905 -1.122 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -88.14 159.64 47.62 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.0 Cg_endo -72.16 -1.08 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.977 1.514 . . . . 0.0 110.82 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' C ' HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -110.1 -27.27 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.022 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 59' ' ' LYS . 8.8 mt -98.38 60.5 1.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 109.931 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 1' ' ' SER . 3.8 p-10 -100.54 145.02 28.83 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.443 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.81 23.68 8.57 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.137 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.19 115.07 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.357 1.075 . . . . 0.0 113.486 -176.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.488 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 10.5 t -77.25 123.32 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.273 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.835 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.7 t -104.29 -176.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.863 -1.148 . . . . 0.0 109.275 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.653 ' H ' HG12 ' A' ' 99' ' ' VAL . 6.4 m-20 -162.1 141.58 9.7 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.907 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 49.4 t -97.48 102.86 13.94 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.5 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.681 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 41.0 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 C-N-CA 122.306 2.004 . . . . 0.0 113.342 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.586 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.249 0.547 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.498 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.91 124.14 19.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 11.8 t -121.44 145.81 27.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.011 ' O ' HG23 ' A' ' 99' ' ' VAL . 4.3 t -130.98 125.65 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.913 0.863 . . . . 0.0 109.158 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.265 43.3 m-85 -101.07 135.9 41.79 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.2 t -121.97 119.9 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.27 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.649 ' CB ' HG22 ' A' ' 11' ' ' THR . 77.7 p -79.78 128.58 33.6 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 1.5 t60 -41.74 -24.31 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -79.45 -3.52 46.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.06 -1.025 . . . . 0.0 110.073 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.22 -36.48 4.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.649 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.54 137.06 15.8 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.838 -1.39 . . . . 0.0 108.776 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 12.1 mtm180 -130.15 147.35 51.87 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.712 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.75 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -131.58 119.32 21.31 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 177.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.7 mt-10 -94.92 123.98 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.141 -0.974 . . . . 0.0 110.261 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 27' ' ' ALA . 8.1 mt -109.78 146.81 34.34 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.071 -1.018 . . . . 0.0 110.741 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.63 88.17 3.76 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.89 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.8 t -98.96 165.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.769 . . . . 0.0 110.974 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -118.94 -141.44 0.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 110.547 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -101.14 126.46 47.85 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.508 -0.745 . . . . 0.0 110.49 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -9.74 30.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 22' ' ' SER . 55.4 t -99.67 170.73 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.843 -1.387 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.618 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.58 167.68 12.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD21 ' SD ' ' A' ' 90' ' ' MET . 9.2 mt -59.29 -27.96 66.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.699 -1.25 . . . . 0.0 109.447 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 1.226 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -80.26 -58.22 3.24 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.556 ' CG ' HG13 ' A' ' 21' ' ' VAL . 42.7 tt0 -37.98 -68.97 0.13 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.402 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.89 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -47.8 -57.27 5.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.349 -1.469 . . . . 0.0 108.813 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.829 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -52.78 -56.92 12.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.936 0.874 . . . . 0.0 108.911 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.768 HG12 ' N ' ' A' ' 29' ' ' SER 0.281 1.2 t -35.34 -63.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.219 178.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.768 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.34 -49.64 71.71 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.074 0.94 . . . . 0.0 109.034 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.509 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.2 m120 -61.36 -6.94 2.52 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.379 0.609 . . . . 0.0 109.445 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.28 -7.3 64.57 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.829 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 3.9 mt -44.66 -31.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.305 -1.115 . . . . 0.0 109.323 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 47.4 m-85 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 113.204 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.594 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 19.5 p . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.87 31.82 4.26 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.36 37.27 21.47 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.779 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 20.2 t -138.84 5.67 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -1.122 . . . . 0.0 111.822 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.14 42.58 0.44 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.309 -0.87 . . . . 0.0 113.298 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.2 t -132.35 44.7 2.85 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.981 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.1 p -111.76 130.09 55.91 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.714 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -92.13 6.47 46.44 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.258 -1.526 . . . . 0.0 108.178 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 p -110.65 -40.06 4.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.374 -0.828 . . . . 0.0 111.714 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.861 ' O ' HG13 ' A' ' 50' ' ' VAL . 1.9 m -79.26 24.04 0.36 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.662 -1.274 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.688 ' NE2' ' CD2' ' A' ' 71' ' ' LEU . 6.9 t-160 -46.32 137.01 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.737 -1.227 . . . . 0.0 108.214 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 48' ' ' CYS . 19.3 m -145.86 152.82 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.027 -1.046 . . . . 0.0 110.873 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE1' ' HB3' ' A' ' 102' ' ' PRO . 31.1 m-85 -122.87 128.66 50.64 Favored 'General case' 0 C--N 1.281 -2.413 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.895 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.781 ' HB ' HG22 ' A' ' 57' ' ' THR . 13.6 t -93.88 168.43 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.279 -0.888 . . . . 0.0 109.873 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.763 ' O ' HG21 ' A' ' 57' ' ' THR . 6.8 p30 -67.94 -147.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.609 -1.307 . . . . 0.0 109.518 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -103.34 -16.52 15.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.856 -1.152 . . . . 0.0 111.836 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . . . -100.52 -36.82 9.06 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.703 -1.248 . . . . 0.0 114.146 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.4 m-85 -84.11 -11.0 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.308 -1.495 . . . . 0.0 110.839 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.781 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -81.73 -29.25 33.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD2' ' HA ' ' A' ' 55' ' ' ALA . 2.1 p30 -79.84 -26.89 40.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.522 ' CB ' HD13 ' A' ' 94' ' ' LEU . 21.1 mmtm -79.65 -51.43 9.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.775 HG11 HG21 ' A' ' 88' ' ' ILE . 11.5 m -41.78 153.51 0.27 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.411 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -65.18 160.92 39.67 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.114 1.586 . . . . 0.0 112.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 118.01 22.19 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.885 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.694 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.82 163.89 24.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 109.821 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 24.5 p-10 -100.1 -167.61 1.48 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.19 -20.93 29.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.474 -0.766 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' SD ' ' A' ' 70' ' ' MET . 1.1 ttt-85 -64.53 -53.36 49.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.855 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.694 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 6.9 tp10 -59.14 -12.61 5.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.8 mp -90.92 -9.83 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.826 -1.171 . . . . 0.0 111.244 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.05 -79.3 1.35 Allowed Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.224 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.073 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.09 -37.31 14.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.761 -1.435 . . . . 0.0 109.107 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.688 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -67.82 -23.54 65.19 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.09 -39.49 12.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.811 178.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.78 -43.53 38.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.024 . . . . 0.0 108.344 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 46' ' ' ALA . 1.7 m -90.42 72.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 75' ' ' THR . 10.5 t -48.18 104.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.763 0.792 . . . . 0.0 111.27 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.604 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -126.16 60.8 1.29 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.545 -0.722 . . . . 0.0 109.335 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.542 ' O ' ' CE ' ' A' ' 79' ' ' LYS . 11.3 pt-20 39.28 56.22 2.16 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.995 0.902 . . . . 0.0 109.784 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -33.99 143.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.661 0.743 . . . . 0.0 112.052 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.672 ' H ' ' HG ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -134.44 -176.44 0.58 Allowed Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.2 -25.56 43.03 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.146 1.077 . . . . 0.0 111.765 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 24.6 p-10 -111.85 6.5 19.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.831 -1.168 . . . . 0.0 113.308 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -57.26 149.29 20.38 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.204 -1.56 . . . . 0.0 109.143 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HG3' HD11 ' A' ' 88' ' ' ILE . 11.3 mmt-85 -154.15 179.7 8.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.737 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.073 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -114.94 134.93 54.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.657 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 9.1 m -40.31 -27.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.882 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.226 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.2 m -106.93 45.66 0.97 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.994 -1.067 . . . . 0.0 112.053 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.654 ' NE2' ' HB2' ' A' ' 67' ' ' GLU . 25.5 mm100 -125.34 -47.83 1.72 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.043 0.925 . . . . 0.0 111.394 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.775 HG21 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -84.35 149.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.932 0.872 . . . . 0.0 111.538 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.4 mm -110.9 160.96 9.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.699 ' SD ' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -110.1 104.21 13.05 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 110.224 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.8 OUTLIER -91.1 164.24 26.03 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.86 . . . . 0.0 109.442 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 39.7 Cg_endo -71.88 -0.69 8.81 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.648 1.341 . . . . 0.0 110.503 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.1 pt-20 -110.06 -27.61 9.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.522 HD13 ' CB ' ' A' ' 59' ' ' LYS . 9.5 mt -100.25 54.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.363 -0.835 . . . . 0.0 109.824 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.62 143.96 30.16 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.623 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.23 23.33 8.56 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.696 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.79 118.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.339 1.066 . . . . 0.0 113.166 -176.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 21.1 t -82.03 127.08 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.011 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.7 t -104.21 -175.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.782 -1.199 . . . . 0.0 109.345 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.1 m-20 -161.34 136.66 7.64 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.527 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -90.84 137.95 26.56 Favored Pre-proline 0 C--N 1.289 -2.049 0 C-N-CA 118.896 -1.121 . . . . 0.0 108.987 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 56.3 Cg_endo . . . . . 0 C--N 1.301 -1.954 0 O-C-N 124.172 1.617 . . . . 0.0 111.892 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.643 0.735 . . . . 0.0 110.482 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -90.29 101.11 13.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.133 HG22 ' CG2' ' A' ' 97' ' ' ILE . 48.6 t -109.64 145.52 16.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.677 -1.264 . . . . 0.0 111.118 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.808 ' O ' HG23 ' A' ' 99' ' ' VAL . 6.0 t -130.95 127.81 61.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.45 0.643 . . . . 0.0 109.356 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.949 ' CD1' HG21 ' A' ' 99' ' ' VAL . 49.8 m-85 -102.51 136.53 42.17 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.778 0.799 . . . . 0.0 112.184 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.0 t -120.55 133.54 66.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.429 -0.909 . . . . 0.0 109.642 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.762 ' CB ' HG22 ' A' ' 11' ' ' THR . 24.0 p -79.73 -159.07 0.19 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.642 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.94 -6.72 21.0 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.894 -1.129 . . . . 0.0 108.916 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -100.44 1.61 41.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.45 -22.95 21.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.762 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.9 137.13 17.18 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.986 -1.302 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.1 149.98 51.57 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.232 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 2.6 tpp180 -140.15 155.93 46.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.796 . . . . 0.0 109.714 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.602 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.9 mt-10 -130.92 128.0 39.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.922 -1.112 . . . . 0.0 110.328 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.001 HD11 HD12 ' A' ' 32' ' ' ILE . 14.1 mt -120.43 -170.53 2.0 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.899 -1.126 . . . . 0.0 110.778 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -133.45 81.71 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.899 HG22 ' CB ' ' A' ' 26' ' ' ALA . 39.9 t -98.4 130.62 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.384 -0.823 . . . . 0.0 110.487 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 90' ' ' MET . . . -110.53 -160.29 0.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.799 0.809 . . . . 0.0 111.523 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.6 OUTLIER -70.53 124.13 23.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.642 0.734 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.71 -14.41 29.57 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 17' ' ' VAL . 21.9 t -108.11 166.57 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.832 -1.393 . . . . 0.0 110.373 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.531 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.21 153.77 37.15 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.459 HD22 HG11 ' A' ' 3' ' ' VAL . 16.8 mt -47.09 -27.37 1.35 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.686 -1.258 . . . . 0.0 107.919 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.726 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -72.42 -67.28 0.56 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.096 0.951 . . . . 0.0 110.609 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.528 ' HB3' ' CG1' ' A' ' 21' ' ' VAL 0.255 32.4 tt0 -37.75 -73.41 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.33 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.899 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -43.08 -56.21 3.48 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.558 -1.338 . . . . 0.0 109.264 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.942 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -56.88 -60.42 3.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.644 0.735 . . . . 0.0 109.08 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.744 HG12 ' N ' ' A' ' 29' ' ' SER 0.288 0.9 OUTLIER -33.09 -66.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.658 0.742 . . . . 0.0 109.221 178.041 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.744 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -51.02 -51.87 48.69 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.924 0.869 . . . . 0.0 109.285 178.147 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.487 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.7 m120 -60.43 -7.29 1.98 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.33 0.586 . . . . 0.0 109.77 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.93 63.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.001 HD12 HD11 ' A' ' 15' ' ' LEU . 27.5 mt -43.82 -36.45 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.417 -1.049 . . . . 0.0 108.687 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.726 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 44.5 m-85 . . . . . 0 N--CA 1.49 1.573 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.099 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.563 ' SG ' ' CE ' ' A' ' 24' ' ' MET . 1.7 p . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 120.706 0.289 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.28 40.43 10.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.49 40.42 12.98 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.779 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 39.3 t -131.22 -34.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 0.0 111.261 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 75.81 61.42 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.321 -0.862 . . . . 0.0 111.354 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.34 8.52 4.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.373 -0.829 . . . . 0.0 110.124 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.876 ' O ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.88 117.77 33.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.242 -0.911 . . . . 0.0 112.423 -178.327 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 1.098 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -75.41 0.26 17.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 45' ' ' CYS . 8.4 t -83.73 -32.41 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.575 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.835 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.3 11.68 16.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 179.277 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.735 ' NE2' HD21 ' A' ' 71' ' ' LEU . 18.0 t-160 -49.16 152.39 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.709 -1.244 . . . . 0.0 109.791 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 83' ' ' ARG . 13.9 m -156.02 160.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.221 -0.924 . . . . 0.0 109.622 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.9 m-30 -119.97 118.06 29.71 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.863 HG21 ' CD1' ' A' ' 88' ' ' ILE . 29.1 t -98.53 155.02 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.365 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.755 ' O ' HG23 ' A' ' 57' ' ' THR . 28.0 p30 -75.22 131.69 40.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.325 -1.485 . . . . 0.0 109.364 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pt-20 -37.49 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.435 -0.791 . . . . 0.0 111.476 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.77 -24.9 67.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.018 . . . . 0.0 111.356 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.979 ' HB3' HD12 ' A' ' 97' ' ' ILE . 33.2 m-85 -123.02 -11.0 8.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.871 -1.143 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.84 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -80.57 -29.42 37.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 108.888 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.8 p-10 -76.41 -26.87 55.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 109.666 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.692 ' CB ' HD13 ' A' ' 94' ' ' LEU . 23.1 mmtm -80.85 -52.44 7.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.554 -0.716 . . . . 0.0 110.192 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.722 HG11 ' CG2' ' A' ' 88' ' ' ILE . 6.0 m -40.91 153.75 0.22 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.535 -0.728 . . . . 0.0 110.48 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.3 Cg_endo -65.79 168.22 15.7 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.061 1.559 . . . . 0.0 111.352 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.66 125.88 30.58 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.392 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.548 ' HB1' ' OE1' ' A' ' 87' ' ' GLN . . . -69.35 170.93 9.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 68' ' ' ILE . 31.3 p30 -96.83 -161.72 0.9 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 111.131 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -73.37 -24.76 60.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.512 -0.742 . . . . 0.0 110.543 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.514 ' NE ' ' O ' ' A' ' 42' ' ' SER . 1.7 mtm-85 -64.71 -43.07 94.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.405 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 4.2 tp10 -66.64 -7.03 17.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.532 -0.73 . . . . 0.0 109.517 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.94 -30.16 4.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.579 -1.326 . . . . 0.0 111.006 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.03 -64.89 1.57 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.854 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.233 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.77 -46.89 42.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.828 -1.395 . . . . 0.0 108.43 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.735 HD21 ' NE2' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -57.13 -25.2 58.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.483 -175.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -36.39 17.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.5 -0.75 . . . . 0.0 108.981 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.35 -32.01 10.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 108.809 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.098 ' CG1' ' HB1' ' A' ' 46' ' ' ALA . 14.7 m -90.12 65.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 75' ' ' THR . 4.8 t -48.87 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.445 0.64 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 77' ' ' GLU . . . -130.27 69.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -0.808 . . . . 0.0 109.109 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.62 46.27 1.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.695 0.76 . . . . 0.0 109.905 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.572 HD13 HD22 ' A' ' 71' ' ' LEU . 9.8 tp -23.93 134.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.601 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.627 ' HD2' ' CD2' ' A' ' 51' ' ' TYR . 5.5 mtpt -110.0 167.92 8.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.751 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.6 Cg_endo -68.19 -28.88 33.6 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.854 1.45 . . . . 0.0 109.379 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.588 ' HB2' HG21 ' A' ' 57' ' ' THR . 11.8 p-10 -97.54 -11.93 23.14 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.643 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 50.4 m -48.99 153.74 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.831 -1.168 . . . . 0.0 110.665 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.8 ttp180 -175.5 158.48 2.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.416 -0.802 . . . . 0.0 110.086 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.233 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -76.38 142.38 41.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.933 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 48' ' ' CYS . 17.3 p -44.88 -26.24 0.39 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.028 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -93.0 29.87 1.74 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.899 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 6.6 tp-100 -126.59 -38.32 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.394 -1.441 . . . . 0.0 112.687 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.863 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -92.6 142.79 12.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.001 -1.079 . . . . 0.0 110.85 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 90' ' ' MET . 7.2 mm -110.52 168.19 4.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.643 ' CB ' HG12 ' A' ' 17' ' ' VAL . 3.5 tpt -109.93 110.65 21.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.866 -1.147 . . . . 0.0 111.137 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -89.93 165.64 23.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.86 -6.36 18.87 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.864 1.455 . . . . 0.0 110.901 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.7 pt-20 -110.26 -28.48 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.007 . . . . 0.0 110.429 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.692 HD13 ' CB ' ' A' ' 59' ' ' LYS . 8.1 mt -93.78 55.92 2.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 2.8 p30 -100.53 148.98 24.18 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.327 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.677 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.72 34.02 6.46 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.133 ' CG2' HG22 ' A' ' 3' ' ' VAL . 5.0 tt -83.96 157.41 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.214 1.007 . . . . 0.0 113.127 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.687 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 18.1 t -117.84 124.76 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.214 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.949 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -104.4 -177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.858 -1.151 . . . . 0.0 109.996 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.647 ' H ' HG12 ' A' ' 99' ' ' VAL . 16.5 m-20 -162.26 145.84 11.83 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.29 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.642 HG12 ' ND1' ' A' ' 8' ' ' HIS . 71.7 t -98.27 111.89 60.79 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 120.678 -1.264 . . . . 0.0 108.716 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.649 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.2 Cg_endo . . . . . 0 C--N 1.306 -1.707 0 O-C-N 124.057 1.556 . . . . 0.0 110.941 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.544 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.445 0.641 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.09 109.69 20.73 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.424 -0.797 . . . . 0.0 109.546 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.982 HG22 ' CG2' ' A' ' 97' ' ' ILE . 30.3 t -109.73 144.81 17.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.914 -1.116 . . . . 0.0 110.706 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.891 ' O ' HG23 ' A' ' 99' ' ' VAL . 15.8 t -130.93 124.78 56.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.554 0.692 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.976 ' CD1' HG21 ' A' ' 99' ' ' VAL . 54.1 m-85 -100.38 138.6 37.22 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.702 0.763 . . . . 0.0 112.552 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.6 t -120.88 127.51 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.904 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 11' ' ' THR . 10.2 p -79.78 -159.25 0.2 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.979 -1.076 . . . . 0.0 108.315 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.408 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -102.44 -1.07 31.41 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.98 -1.075 . . . . 0.0 109.177 178.421 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.44 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -100.4 -4.63 28.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.483 -0.761 . . . . 0.0 109.389 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.27 -31.8 7.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.628 HG22 ' OG ' ' A' ' 7' ' ' SER . 1.1 t -49.94 130.58 22.01 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.899 -1.353 . . . . 0.0 109.802 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.826 ' HG2' HG13 ' A' ' 6' ' ' VAL . 16.2 mtm180 -120.04 134.29 55.29 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.484 0.659 . . . . 0.0 110.864 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.571 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -111.62 156.77 21.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 0.0 109.682 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.725 ' HG2' HG22 ' A' ' 4' ' ' VAL . 32.2 mt-10 -130.89 125.34 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.382 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.831 HD11 ' CA ' ' A' ' 27' ' ' ALA . 11.1 mt -118.72 149.36 41.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.056 . . . . 0.0 111.434 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.72 87.77 3.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 26' ' ' ALA . 41.7 t -98.7 171.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.692 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -121.44 -139.52 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.925 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.7 OUTLIER -104.73 125.74 51.11 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.41 -0.806 . . . . 0.0 110.224 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -8.74 30.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 22' ' ' SER . 69.7 t -98.86 169.49 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.07 -1.253 . . . . 0.0 110.322 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 -175.1 2.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.515 HD22 HG11 ' A' ' 3' ' ' VAL . 19.9 mt -79.9 -36.87 35.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.763 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.7 ttp -79.64 9.02 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.581 ' CG ' HG13 ' A' ' 21' ' ' VAL . 22.0 tt0 -102.03 -70.94 0.73 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.348 -0.845 . . . . 0.0 109.362 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -49.39 -53.65 21.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.723 -1.236 . . . . 0.0 108.516 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.831 ' CA ' HD11 ' A' ' 15' ' ' LEU . . . -53.81 -51.77 62.42 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.714 HG12 ' N ' ' A' ' 29' ' ' SER 0.272 0.7 OUTLIER -38.91 -57.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 177.8 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.714 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.84 -50.34 74.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.056 0.931 . . . . 0.0 109.101 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.535 ' HB3' HG13 ' A' ' 32' ' ' ILE . 1.7 m120 -60.04 -7.88 2.05 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.418 0.628 . . . . 0.0 109.642 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.47 -13.04 59.29 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.793 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 12.7 mt -41.76 -39.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.534 -0.98 . . . . 0.0 109.58 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.763 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 45.8 m-85 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.108 -0.995 . . . . 0.0 111.012 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.582 ' HB2' ' CB ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.023 0.439 . . . . 0.0 110.481 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.29 52.63 8.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.33 34.8 28.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.736 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.7 t -125.73 -42.84 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -1.113 . . . . 0.0 110.281 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.15 57.22 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.369 -0.832 . . . . 0.0 111.342 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 p -132.65 8.24 4.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.884 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.173 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.29 151.55 29.54 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.74 -1.225 . . . . 0.0 113.647 -177.383 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.578 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -106.61 8.84 31.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.627 -1.296 . . . . 0.0 111.372 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.4 p -103.25 9.79 37.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.794 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.43 14.51 16.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.382 -0.824 . . . . 0.0 109.309 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.786 ' HE2' ' HE1' ' A' ' 51' ' ' TYR . 3.5 t-160 -41.83 141.17 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 48' ' ' CYS . 16.1 m -147.04 155.81 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.9 -1.125 . . . . 0.0 109.326 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.786 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 7.9 m-30 -120.9 121.39 37.96 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.638 0.732 . . . . 0.0 110.67 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.779 ' HB ' HG22 ' A' ' 57' ' ' THR . 16.5 t -91.88 170.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 57' ' ' THR . 6.7 p30 -72.76 -148.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.526 -1.359 . . . . 0.0 109.222 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -102.85 -14.84 16.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.913 -1.117 . . . . 0.0 111.507 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.403 ' N ' ' OD1' ' A' ' 53' ' ' ASN . . . -100.56 -38.24 8.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.802 -1.186 . . . . 0.0 114.072 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.846 ' HB3' HD12 ' A' ' 97' ' ' ILE . 78.6 m-85 -84.24 -11.24 56.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.332 -1.48 . . . . 0.0 111.464 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.779 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.44 -49.16 10.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.934 -1.104 . . . . 0.0 109.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 3.7 p-10 -61.33 -13.53 20.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HB2' HD13 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -93.46 -52.7 4.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.532 -0.73 . . . . 0.0 110.163 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 57' ' ' THR . 6.2 m -46.25 165.81 0.18 Allowed Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.7 Cg_endo -67.36 161.08 44.77 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.102 1.58 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.18 126.29 31.32 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.529 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -69.53 157.9 36.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 31.1 p-10 -100.24 -168.17 1.55 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.897 -1.127 . . . . 0.0 112.067 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -65.05 -19.68 66.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.818 -0.551 . . . . 0.0 110.493 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.14 -53.12 54.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.955 . . . . 0.0 108.809 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 2.1 tt0 -58.95 -47.37 85.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.4 mp -47.97 -26.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.016 -1.052 . . . . 0.0 111.281 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.67 -67.91 1.19 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.059 ' HE2' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.12 -44.05 31.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.35 -1.088 . . . . 0.0 109.279 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.855 HD22 HD11 ' A' ' 78' ' ' LEU 0.255 0.0 OUTLIER -68.63 -25.14 64.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.644 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -91.01 -25.89 19.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.499 -0.751 . . . . 0.0 110.769 178.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.578 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.09 -41.41 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.777 -1.202 . . . . 0.0 109.052 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 49' ' ' HIS . 3.6 m -90.51 87.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.802 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 75' ' ' THR . 9.6 t -47.84 96.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.817 0.818 . . . . 0.0 111.475 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -125.17 47.38 2.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.222 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.563 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.3 pt-20 39.75 60.16 1.71 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.732 0.777 . . . . 0.0 109.384 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.855 HD11 HD22 ' A' ' 71' ' ' LEU . 1.8 tp -27.24 134.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.578 0.704 . . . . 0.0 112.089 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.636 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 5.1 mtpt -104.85 173.71 3.14 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.7 Cg_endo -69.32 -29.26 26.24 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.393 1.207 . . . . 0.0 110.054 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.8 p-10 -106.97 -2.32 21.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 111.061 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.57 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 69.6 m -49.21 161.83 0.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.813 -1.18 . . . . 0.0 111.069 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.721 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.32 166.39 3.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.173 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -83.16 148.56 27.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.58 ' C ' ' HB2' ' A' ' 24' ' ' MET . 66.1 m -49.07 -27.36 3.28 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.1 ' SG ' HD13 ' A' ' 84' ' ' LEU . 4.7 p -106.95 43.65 1.14 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.878 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.4 tp-100 -125.57 -38.06 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.919 -1.113 . . . . 0.0 111.212 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -96.15 147.99 5.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.605 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.5 mm -110.61 161.67 8.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.924 ' HE1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.29 124.31 51.41 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.789 -1.194 . . . . 0.0 110.792 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 3.9 p -110.02 168.07 8.18 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.63 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 43.9 Cg_endo -73.27 -1.75 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.823 1.433 . . . . 0.0 111.59 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -110.08 -24.13 10.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.812 -1.18 . . . . 0.0 110.233 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.924 ' O ' ' HE1' ' A' ' 90' ' ' MET . 4.8 mt -93.73 33.57 1.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.536 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 6.0 p-10 -80.65 144.39 32.34 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.822 0.82 . . . . 0.0 112.501 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.657 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.25 21.59 11.52 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.982 ' CG2' HG22 ' A' ' 3' ' ' VAL . 13.2 tt -74.17 157.49 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 123.131 1.443 . . . . 0.0 113.8 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.569 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 23.2 t -122.92 121.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.261 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.976 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -103.76 -176.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.0 109.531 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.643 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.8 m-20 -160.95 138.86 9.51 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.028 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 6' ' ' VAL . 12.7 t -102.05 116.68 62.84 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.984 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo . . . . . 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 109.953 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.341 0.591 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -80.73 137.56 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.812 . . . . 0.0 109.422 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.544 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 2.5 t -125.74 135.94 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.823 -1.173 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.033 HG13 ' HG3' ' A' ' 14' ' ' GLU . 44.3 t -129.19 124.89 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.496 1.141 . . . . 0.0 110.324 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.894 ' CE2' HD13 ' A' ' 15' ' ' LEU 0.29 30.1 m-85 -98.46 139.96 33.43 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.976 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.021 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.5 t -121.05 155.86 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.032 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.593 ' HB3' HG22 ' A' ' 11' ' ' THR . 97.4 p -119.38 142.05 48.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.437 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -44.65 -23.72 0.15 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.421 -0.799 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.458 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.3 p30 -89.64 -4.07 57.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.067 -1.021 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.13 -32.22 7.23 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.53 131.49 21.02 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.082 -1.246 . . . . 0.0 109.061 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.729 ' HG3' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.67 151.31 46.73 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.439 0.638 . . . . 0.0 111.122 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.722 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.41 118.41 17.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.325 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 1.033 ' HG3' HG13 ' A' ' 4' ' ' VAL . 6.9 mp0 -116.29 125.37 52.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 0.0 111.845 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.894 HD13 ' CE2' ' A' ' 5' ' ' TYR 0.25 6.7 mp -110.42 -175.23 2.67 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.225 1.012 . . . . 0.0 111.198 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -119.23 92.35 3.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 5.9 t -98.63 170.07 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.496 -0.752 . . . . 0.0 110.948 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.549 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -134.03 -143.64 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 90' ' ' MET . 1.3 p-10 -95.02 123.57 38.57 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.591 -0.693 . . . . 0.0 110.546 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.52 -7.67 30.21 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.579 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 22' ' ' SER . 46.0 t -98.4 167.91 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.776 -1.426 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.595 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.66 165.14 16.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.9 mt -59.69 -17.19 32.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.481 -1.387 . . . . 0.0 108.474 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.67 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -82.53 -66.5 0.88 Allowed 'General case' 0 C--O 1.204 -1.34 0 O-C-N 121.479 -0.763 . . . . 0.0 109.03 178.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.535 ' CG ' HG13 ' A' ' 21' ' ' VAL 0.27 35.7 tt0 -37.03 -71.15 0.08 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.366 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.57 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -43.21 -66.3 0.39 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.683 -1.261 . . . . 0.0 108.518 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . . . -46.84 -49.9 19.34 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.065 0.936 . . . . 0.0 109.152 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 29' ' ' SER 0.257 0.8 OUTLIER -43.68 -56.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.63 0.729 . . . . 0.0 109.137 179.033 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.696 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.28 -49.42 72.16 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.885 0.85 . . . . 0.0 108.879 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.603 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.9 m120 -59.75 -10.65 3.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.62 -10.56 73.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.712 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 4.1 mt -39.92 -41.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.694 -0.886 . . . . 0.0 110.038 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.67 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 25.6 m-85 . . . . . 0 C--N 1.3 -1.585 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.045 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 7.3 p . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.902 0.382 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.83 29.44 6.17 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.56 34.76 27.56 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.741 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 4.6 p -140.15 7.31 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -1.211 . . . . 0.0 111.752 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.21 58.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.12 -0.987 . . . . 0.0 112.514 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -133.61 30.78 3.76 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.196 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.038 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.5 p -111.25 150.41 29.63 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.11 16.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.086 -1.009 . . . . 0.0 108.672 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -110.35 -32.36 6.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 111.908 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.722 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.9 m -74.73 8.32 2.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.398 -1.439 . . . . 0.0 110.41 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.074 ' ND1' HG21 ' A' ' 74' ' ' VAL . 23.6 t-160 -46.03 140.53 3.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.65 -1.281 . . . . 0.0 109.292 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 48' ' ' CYS . 13.5 m -144.89 159.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.563 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.6 m-30 -118.4 120.76 38.54 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.767 HG13 HD11 ' A' ' 97' ' ' ILE . 24.2 t -84.45 167.84 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.595 ' ND2' HG23 ' A' ' 98' ' ' VAL . 8.1 p-10 -80.27 -142.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.232 -1.543 . . . . 0.0 110.229 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -101.92 -28.02 12.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.253 -1.53 . . . . 0.0 113.384 -177.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -100.2 23.83 9.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.349 -1.469 . . . . 0.0 113.313 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.945 ' HB3' HD12 ' A' ' 97' ' ' ILE . 73.5 m-85 -140.58 -19.48 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.627 -1.296 . . . . 0.0 110.939 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.703 HG22 ' CG1' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.18 -50.67 9.3 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.189 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -64.92 -15.47 62.12 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.969 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.296 0.8 OUTLIER -79.28 -53.9 6.48 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.797 1.76 . . . . 0.0 108.942 179.154 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.812 HG21 HG22 ' A' ' 88' ' ' ILE 0.319 0.3 OUTLIER -77.42 139.44 63.84 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 112.519 -2.128 . . . . 0.0 110.22 -177.817 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -66.67 162.25 38.03 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.092 1.575 . . . . 0.0 112.011 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 -173.42 4.14 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.564 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.589 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -170.41 1.63 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.415 0.626 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.587 HD22 ' NH1' ' A' ' 66' ' ' ARG . 3.3 p30 -100.64 -164.4 1.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.0 110.671 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 1.1 pt-20 -61.37 -22.0 64.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.587 ' NH1' HD22 ' A' ' 64' ' ' ASN . 6.2 ttm180 -64.24 -57.93 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 0.0 109.164 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 15.6 tp10 -59.97 1.15 0.12 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.749 -0.594 . . . . 0.0 111.956 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 6.7 mm -90.9 -39.55 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 110.225 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -83.2 -60.5 2.02 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.104 ' HE2' HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -47.65 -43.7 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.195 -1.179 . . . . 0.0 108.738 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.007 ' O ' HG22 ' A' ' 74' ' ' VAL 0.257 0.0 OUTLIER -73.11 -34.31 66.09 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.819 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -70.29 -21.1 62.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.67 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 74.4 m -48.99 -24.24 1.44 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.088 -1.008 . . . . 0.0 108.696 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.074 HG21 ' ND1' ' A' ' 49' ' ' HIS . 17.4 m -90.12 76.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.662 -0.649 . . . . 0.0 109.786 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 75' ' ' THR . 12.9 t -50.99 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.008 -0.432 . . . . 0.0 111.829 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -131.09 52.35 2.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.867 -1.146 . . . . 0.0 110.443 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 38.93 60.17 1.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.631 -0.668 . . . . 0.0 110.151 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.995 HD21 HD13 ' A' ' 71' ' ' LEU . 2.3 tp -22.91 141.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.44 0.638 . . . . 0.0 112.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -90.7 168.87 13.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.004 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.32 -26.37 41.58 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.653 1.344 . . . . 0.0 109.346 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 14.2 p30 -105.38 -6.74 19.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.752 -0.593 . . . . 0.0 110.958 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.622 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.3 m -48.95 156.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 0.0 111.085 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.59 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.2 ttt180 -175.18 158.79 2.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.73 0.776 . . . . 0.0 110.8 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.104 HD12 ' HE2' ' A' ' 70' ' ' MET . 1.0 OUTLIER -78.85 138.94 38.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.689 -0.632 . . . . 0.0 109.809 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.6 p -44.84 -31.85 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.886 -1.134 . . . . 0.0 110.005 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 3.7 m -101.08 39.58 1.38 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.433 -0.792 . . . . 0.0 111.17 -177.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.717 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 1.8 mm-40 -126.48 -43.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 112.608 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.812 HG22 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -83.75 149.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 118.634 -1.227 . . . . 0.0 110.656 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.9 mm -110.87 160.15 10.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.318 0.58 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 1.9 tpt -110.3 113.91 26.95 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.079 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -91.37 169.15 11.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 109.508 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.508 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 41.8 Cg_endo -72.73 -8.83 23.07 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.782 1.412 . . . . 0.0 111.291 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 1.9 pp20? -110.04 -41.58 4.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.863 -1.148 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.969 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.2 mt -72.56 54.28 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.541 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 50.0 p-10 -101.53 156.18 17.63 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.106 -0.997 . . . . 0.0 112.646 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.658 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.6 27.07 12.03 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.945 HD12 ' HB3' ' A' ' 56' ' ' PHE . 4.9 tt -79.99 157.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 122.219 1.009 . . . . 0.0 112.21 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG23 ' ND2' ' A' ' 53' ' ' ASN . 19.0 t -124.13 125.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.1 t -103.73 -176.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.0 m-20 -162.18 139.24 8.21 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.885 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 6' ' ' VAL . 16.4 t -90.67 117.18 67.77 Favored Pre-proline 0 C--N 1.285 -2.223 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.245 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.2 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 123.855 1.45 . . . . 0.0 110.312 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.56 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.343 0.592 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -80.02 138.6 37.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -0.793 . . . . 0.0 109.873 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.013 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.0 t -127.95 146.73 33.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.012 -1.055 . . . . 0.0 110.141 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.874 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.4 t -130.5 130.06 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.592 0.71 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.98 ' CE1' HG21 ' A' ' 99' ' ' VAL 0.266 46.3 m-85 -106.09 138.83 41.6 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.024 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.3 t -121.71 152.17 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.738 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.57 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 80.5 p -114.97 138.0 51.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.478 ' ND1' ' HA ' ' A' ' 102' ' ' PRO . 1.3 t60 -46.59 -22.38 0.28 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.943 -1.098 . . . . 0.0 110.016 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.1 p30 -85.03 -6.22 59.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.049 . . . . 0.0 110.156 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.25 -36.1 4.46 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.73 133.28 21.66 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.817 -1.402 . . . . 0.0 109.226 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.847 ' HG2' HG22 ' A' ' 6' ' ' VAL . 16.9 mtm105 -129.04 154.9 46.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.283 0.563 . . . . 0.0 111.247 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.743 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -135.58 121.3 19.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 36.4 mt-10 -94.64 123.35 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.875 HD11 ' HA ' ' A' ' 27' ' ' ALA . 8.2 mt -109.79 147.23 33.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.979 . . . . 0.0 110.57 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -99.55 88.07 3.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.954 HG22 ' HB2' ' A' ' 26' ' ' ALA . 56.6 t -98.97 168.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.56 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -125.28 -133.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -108.1 123.98 49.53 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.248 -0.907 . . . . 0.0 110.382 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.32 -8.47 30.78 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 22' ' ' SER . 60.8 t -97.81 170.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.917 -1.343 . . . . 0.0 110.465 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.48 154.4 35.31 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.622 HD21 ' SD ' ' A' ' 90' ' ' MET . 10.0 mt -48.78 -23.35 1.04 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.505 -1.372 . . . . 0.0 109.329 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.776 ' HE2' HG21 ' A' ' 28' ' ' VAL . 1.6 ttt -83.51 -62.73 1.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.621 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG13 ' A' ' 21' ' ' VAL . 47.1 tt0 -36.57 -54.22 0.87 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.257 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.954 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -61.39 -49.91 74.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.035 -1.665 . . . . 0.0 107.664 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.875 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -58.16 -61.2 2.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.308 1.051 . . . . 0.0 108.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.776 HG21 ' HE2' ' A' ' 24' ' ' MET 0.293 0.8 OUTLIER -29.63 -59.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.744 178.22 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.73 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -48.18 78.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.108 0.956 . . . . 0.0 108.871 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.501 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.5 m120 -59.64 -11.42 4.89 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.07 -10.32 73.4 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.867 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 4.8 mt -42.83 -30.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.395 -1.062 . . . . 0.0 108.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.681 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 26.4 m-85 . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 119.457 -0.897 . . . . 0.0 113.09 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.7 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.68 31.39 2.57 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.35 35.61 25.97 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.699 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.17 8.95 2.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -1.179 . . . . 0.0 111.024 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 68.49 54.28 0.53 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.283 1.039 . . . . 0.0 111.285 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.601 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -131.77 30.8 4.31 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.004 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.812 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -111.39 149.9 30.55 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.644 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.88 16.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.951 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 t -110.22 -25.13 10.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 112.152 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.635 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 19.0 m -76.71 15.16 0.68 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.509 -1.369 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.727 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 4.2 t60 -49.97 136.32 18.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.833 -1.167 . . . . 0.0 108.036 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 49' ' ' HIS . 9.9 m -160.27 170.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.668 -1.27 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 11.4 m-30 -120.4 123.09 42.19 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.563 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.856 HG21 ' CD1' ' A' ' 88' ' ' ILE . 46.6 t -90.48 151.15 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.768 ' O ' HG23 ' A' ' 57' ' ' THR . 35.6 p-10 -73.25 133.77 44.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 119.835 -1.791 . . . . 0.0 109.863 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -40.95 -26.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.724 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.528 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -61.34 -17.23 52.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.875 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.91 ' HB3' HD12 ' A' ' 97' ' ' ILE . 50.1 m-85 -131.02 -9.19 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.011 -1.056 . . . . 0.0 110.835 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 53' ' ' ASN . 1.3 p -80.52 -39.44 27.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -12.11 60.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 109.57 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.615 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.281 22.0 mmmt -79.43 -54.64 5.73 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.669 1.7 . . . . 0.0 108.678 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.964 HG11 HG21 ' A' ' 88' ' ' ILE 0.326 0.3 OUTLIER -81.09 134.23 52.92 Favored Pre-proline 0 C--N 1.279 -2.47 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.943 -178.005 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.67 159.9 50.58 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.079 1.568 . . . . 0.0 112.212 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -81.07 177.44 9.04 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.936 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -152.41 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.403 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.778 ' O ' HD13 ' A' ' 68' ' ' ILE . 47.8 p-10 -100.04 -139.85 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.11 -18.05 50.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 110.109 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.7 OUTLIER -70.05 -52.55 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.936 ' CB ' ' HB3' ' A' ' 63' ' ' ALA . 1.7 tm-20 -58.35 -15.54 10.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.838 -1.164 . . . . 0.0 110.16 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.778 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.5 mp -91.31 -65.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.39 -48.01 26.14 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.271 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.728 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.296 12.3 ttp -48.61 -52.34 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 123.207 1.479 . . . . 0.0 107.744 178.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.941 HD13 HD11 ' A' ' 78' ' ' LEU 0.284 0.0 OUTLIER -62.26 -52.56 63.24 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.379 179.609 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.954 ' HB2' HD13 ' A' ' 78' ' ' LEU . 7.4 tt0 -82.17 20.53 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.519 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.644 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 1.3 m -49.18 -25.42 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.149 -1.594 . . . . 0.0 108.069 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.793 HG23 ' N ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -89.93 -148.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.793 ' N ' HG23 ' A' ' 74' ' ' VAL . 9.6 t -130.78 55.52 1.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.174 -1.579 . . . . 0.0 110.076 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -98.6 32.27 2.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 110.745 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.553 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.1 pt-20 39.19 60.48 1.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.954 HD13 ' HB2' ' A' ' 72' ' ' GLU . 12.4 tp -19.77 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.579 0.704 . . . . 0.0 112.544 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.642 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 3.6 mtpt -97.53 -167.55 0.13 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 43.9 Cg_endo -82.58 -28.23 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.491 1.258 . . . . 0.0 109.777 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 9.8 p-10 -105.89 -7.21 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.52 -0.737 . . . . 0.0 111.508 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.755 ' C ' HD11 ' A' ' 71' ' ' LEU . 1.5 m -49.56 143.68 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.59 -1.319 . . . . 0.0 110.326 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.614 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmt-85 -158.85 151.76 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 110.158 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.812 HD22 ' SG ' ' A' ' 45' ' ' CYS . 12.2 mt -74.34 148.51 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.635 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 18.1 m -47.1 -25.38 0.85 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -110.08 48.18 0.91 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.837 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.542 ' HG2' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -125.24 -38.95 2.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 110.863 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.964 HG21 HG11 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -101.7 155.93 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -110.3 163.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.513 -0.742 . . . . 0.0 109.369 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.622 ' SD ' HD21 ' A' ' 23' ' ' LEU . 2.7 tpt -110.07 106.73 16.32 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 110.438 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.1 p -89.4 163.79 32.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.7 Cg_endo -74.34 -6.88 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.956 1.503 . . . . 0.0 110.54 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.498 ' HG2' ' HG ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -103.47 -27.76 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.597 HD13 ' CB ' ' A' ' 59' ' ' LYS . 9.9 mt -99.97 57.29 0.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 4.8 p-10 -100.43 149.89 23.19 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.662 0.744 . . . . 0.0 112.242 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.646 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.61 22.36 11.36 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.013 ' CG2' HG22 ' A' ' 3' ' ' VAL . 8.3 tt -72.84 154.49 7.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.747 1.261 . . . . 0.0 113.325 -177.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.687 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 5.8 t -122.57 127.76 75.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.334 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.98 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.8 t -103.81 -179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.015 -1.053 . . . . 0.0 108.578 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.578 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.6 m-20 -161.17 138.53 9.02 Favored 'General case' 0 C--N 1.274 -2.711 0 C-N-CA 118.408 -1.317 . . . . 0.0 110.726 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 6' ' ' VAL . 15.2 t -97.38 117.75 65.18 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.727 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 37.2 Cg_endo . . . . . 0 C--N 1.302 -1.873 0 O-C-N 123.95 1.5 . . . . 0.0 110.613 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.611 ' H1 ' ' C ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.563 0.697 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.524 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.4 OUTLIER -80.13 119.66 23.22 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.79 HG22 ' CG2' ' A' ' 97' ' ' ILE . 20.3 t -124.46 148.6 28.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.871 -1.143 . . . . 0.0 111.53 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 ' OE1' ' A' ' 14' ' ' GLU . 4.7 t -131.14 128.8 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.972 ' CE1' HG21 ' A' ' 99' ' ' VAL 0.273 42.2 m-85 -107.68 140.99 39.89 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.2 t -122.16 129.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.05 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.637 ' HB3' HG22 ' A' ' 11' ' ' THR . 77.6 p -79.36 -151.44 0.06 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.553 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.33 -10.51 14.6 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 120.874 -1.141 . . . . 0.0 108.915 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.445 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.7 p30 -100.41 1.99 41.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.34 -31.05 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.637 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.7 135.99 18.14 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.935 -1.332 . . . . 0.0 109.092 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.7 mtm180 -130.16 152.74 49.27 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.411 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.756 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -132.78 121.24 22.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.857 ' OE1' HG22 ' A' ' 4' ' ' VAL . 2.5 mm-40 -94.64 124.14 38.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.146 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.878 HD11 ' CA ' ' A' ' 27' ' ' ALA . 7.2 mt -109.67 147.98 32.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.009 -1.057 . . . . 0.0 111.851 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.02 84.89 2.31 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.698 HG13 HG11 ' A' ' 21' ' ' VAL . 16.6 t -98.89 172.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -177.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -120.3 -144.2 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.418 -0.801 . . . . 0.0 111.252 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.504 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -102.06 133.73 46.41 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.62 -0.675 . . . . 0.0 110.307 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.47 -3.09 57.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.917 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.6 t -100.43 172.48 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -1.105 . . . . 0.0 110.406 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.609 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.97 179.26 4.32 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.791 178.283 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.518 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 16.1 mt -76.63 -14.82 59.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.782 -1.199 . . . . 0.0 109.534 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.733 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.1 tmt? -90.6 -71.45 0.62 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.679 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.917 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -37.9 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.707 -0.621 . . . . 0.0 112.132 -176.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.645 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -88.37 -52.5 5.16 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.992 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -59.86 -45.43 92.47 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.732 HG21 ' SD ' ' A' ' 24' ' ' MET 0.262 0.8 OUTLIER -42.9 -61.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.72 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.726 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.55 -32.73 70.6 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.45 1.119 . . . . 0.0 108.163 178.475 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.691 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.2 m120 -77.36 10.41 2.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.046 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.06 13.91 36.62 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.992 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 5.1 mt -72.1 -33.93 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.343 -1.092 . . . . 0.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.3 m-85 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.0 111.888 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.639 ' CB ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.032 0.444 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 40.94 28.06 0.22 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . 80.09 30.54 41.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.75 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.8 t -117.58 -36.13 3.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -1.14 . . . . 0.0 109.881 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.33 60.36 0.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.632 0.729 . . . . 0.0 111.762 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -131.95 22.02 4.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -112.56 161.15 17.11 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.495 0.664 . . . . 0.0 111.761 -177.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -110.95 -2.99 15.78 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.576 -1.328 . . . . 0.0 112.623 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -110.32 28.36 8.71 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.284 -1.51 . . . . 0.0 112.656 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 1.016 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.96 -3.4 12.14 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.965 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -43.46 127.6 4.74 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.016 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.4 m -139.17 161.26 28.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.566 -1.334 . . . . 0.0 110.211 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.842 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 5.8 m-30 -116.9 121.8 42.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.69 0.757 . . . . 0.0 110.381 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.743 ' HB ' HG22 ' A' ' 57' ' ' THR . 14.6 t -91.41 172.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.603 ' O ' HG21 ' A' ' 57' ' ' THR . 6.6 p30 -75.84 -148.39 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.445 -1.41 . . . . 0.0 109.21 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 -16.02 16.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.878 -1.139 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.65 -36.12 9.25 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.853 -1.154 . . . . 0.0 113.832 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.745 ' O ' HG13 ' A' ' 60' ' ' VAL . 70.0 m-85 -84.37 -13.21 52.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.338 -1.477 . . . . 0.0 111.608 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.743 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -80.79 -27.67 36.56 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.717 -1.239 . . . . 0.0 109.818 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -24.43 21.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.898 ' CB ' HD21 ' A' ' 94' ' ' LEU . 15.3 mmtm -79.57 -52.12 8.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 56' ' ' PHE . 9.1 m -42.19 166.31 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.616 -0.678 . . . . 0.0 110.044 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 38.1 Cg_endo -66.34 165.29 25.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.027 1.541 . . . . 0.0 111.448 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 114.17 19.35 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.261 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.935 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.1 163.81 23.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.879 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.45 ' O ' HD13 ' A' ' 68' ' ' ILE . 44.3 p-10 -100.3 -146.45 0.34 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 0.0 111.335 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 66' ' ' ARG . 3.6 pt-20 -72.72 -27.76 62.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.55 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.684 ' HG3' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -64.37 -46.83 81.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 108.509 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.935 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 3.0 tm-20 -58.08 -16.05 11.64 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.43 -1.419 . . . . 0.0 109.298 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -92.14 -68.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 110.436 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 68' ' ' ILE . . . -77.38 -49.23 7.51 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.942 ' CE ' HD11 ' A' ' 84' ' ' LEU 0.253 0.0 OUTLIER -48.91 -41.4 33.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.029 1.395 . . . . 0.0 108.268 179.187 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 67' ' ' GLU 0.323 0.0 OUTLIER -77.29 -30.34 54.17 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.737 -179.217 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.841 ' HB2' HD13 ' A' ' 78' ' ' LEU . 6.1 tt0 -86.33 10.24 15.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.868 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 46' ' ' ALA . 33.9 m -48.92 -52.88 22.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.648 -1.283 . . . . 0.0 108.039 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 74' ' ' VAL . 18.3 m -90.48 116.45 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -48.49 98.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.965 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -128.27 38.77 3.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.865 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.24 60.45 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.633 0.73 . . . . 0.0 110.038 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 72' ' ' GLU . 0.4 OUTLIER -27.98 119.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.494 0.664 . . . . 0.0 111.927 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.714 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 1.1 mttp -85.35 -167.68 0.15 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.1 Cg_endo -82.81 -29.02 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.305 1.161 . . . . 0.0 109.135 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.52 ' HB2' HG21 ' A' ' 57' ' ' THR . 42.0 p-10 -106.15 -7.3 18.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.61 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 13.9 m -48.08 128.7 14.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.555 -1.34 . . . . 0.0 110.072 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.649 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -142.29 164.17 30.86 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.82 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.942 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -74.94 136.83 41.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.824 -0.548 . . . . 0.0 111.943 -178.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.605 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 1.9 p -55.99 -22.7 28.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.882 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.1 p -107.13 28.95 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.309 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.558 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 2.7 mm-40 -126.08 -41.28 1.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.175 . . . . 0.0 112.103 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -79.85 146.21 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.689 -178.641 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.9 mm -111.1 158.86 11.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 4.0 tpt -110.14 114.47 28.0 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.072 -1.017 . . . . 0.0 110.488 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -95.7 165.83 15.8 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.326 -0.858 . . . . 0.0 109.669 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.3 Cg_endo -70.51 -30.01 19.46 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.837 1.441 . . . . 0.0 110.965 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.5 pp20? -83.46 -41.39 18.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.982 -1.074 . . . . 0.0 109.911 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.898 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.6 mt -79.42 60.82 3.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB2' ' CB ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.16 153.61 19.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.862 -1.149 . . . . 0.0 111.652 -178.776 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.48 19.52 12.2 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.79 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -59.32 126.72 17.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.453 1.12 . . . . 0.0 112.537 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.517 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 2.8 t -105.73 116.63 49.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.972 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.5 t -104.11 -178.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 122.354 1.074 . . . . 0.0 110.542 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.618 ' H ' HG12 ' A' ' 99' ' ' VAL . 5.1 m-20 -162.05 140.24 8.98 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.035 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 52.5 t -96.59 112.08 59.07 Favored Pre-proline 0 N--CA 1.499 1.999 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.017 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.709 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 44.7 Cg_endo . . . . . 0 N--CA 1.496 1.636 0 C-N-CA 122.105 1.87 . . . . 0.0 113.928 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.41 0.624 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 6.2 tmtm? -79.98 109.32 14.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.012 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.9 t -111.37 143.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.997 -1.064 . . . . 0.0 110.75 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.863 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.1 t -130.89 125.09 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.232 1.015 . . . . 0.0 109.519 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.96 ' CD1' HG21 ' A' ' 99' ' ' VAL 0.284 36.6 m-85 -101.02 138.32 38.22 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.585 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG13 ' HG2' ' A' ' 12' ' ' ARG . 3.5 t -121.79 158.02 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.454 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.534 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 60.7 p -120.03 137.86 53.85 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.573 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -43.84 -23.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.018 -1.051 . . . . 0.0 110.409 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' OD2' ' HB ' ' A' ' 11' ' ' THR . 6.6 p-10 -85.94 -3.5 58.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.086 -1.009 . . . . 0.0 110.577 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.22 -42.01 2.08 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.832 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.53 ' CG2' ' CZ ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -49.56 134.48 19.58 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 120.968 -1.313 . . . . 0.0 109.869 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.765 ' HG2' HG13 ' A' ' 6' ' ' VAL . 4.8 mtm180 -130.08 160.68 32.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.036 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.73 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -138.4 123.06 18.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 178.581 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.57 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.2 mp0 -95.36 128.27 42.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.85 HD11 ' CA ' ' A' ' 27' ' ' ALA . 9.0 mt -121.13 146.2 47.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.048 -1.032 . . . . 0.0 111.718 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 16.2 p30 -100.86 90.05 4.07 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.971 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.5 t -98.85 171.49 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 111.064 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.557 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -118.82 -134.16 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 0.0 110.546 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -110.13 124.36 51.39 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.276 -0.89 . . . . 0.0 110.527 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.39 -8.28 30.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.383 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 22' ' ' SER . 95.9 t -96.07 170.13 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.288 . . . . 0.0 110.651 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.599 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.98 171.72 8.44 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.666 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.88 -28.19 67.31 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.21 179.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.781 ' SD ' HG23 ' A' ' 28' ' ' VAL . 0.7 OUTLIER -86.86 4.7 40.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.583 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.569 ' CG ' HG13 ' A' ' 21' ' ' VAL . 32.2 tt0 -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.15 -0.969 . . . . 0.0 109.372 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.971 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -51.24 -47.79 62.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 108.212 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.934 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -60.36 -53.28 59.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.781 HG23 ' SD ' ' A' ' 24' ' ' MET 0.279 0.8 OUTLIER -36.84 -58.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.65 0.738 . . . . 0.0 109.011 178.006 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.704 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.137 0.97 . . . . 0.0 108.459 178.055 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 1.4 m120 -64.55 -5.0 4.62 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.506 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 74.29 2.06 61.98 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.934 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 3.0 mt -50.22 -30.1 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.329 -1.1 . . . . 0.0 109.393 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.66 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 54.0 m-85 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 112.064 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.2 p . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.852 0.358 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.13 41.96 11.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.32 37.03 22.32 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 10.2 t -126.96 -22.24 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 111.152 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB1' ' NE2' ' A' ' 87' ' ' GLN . . . 58.22 60.72 2.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.381 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.61 7.18 4.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.349 -0.845 . . . . 0.0 110.455 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.871 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.68 116.36 30.64 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.254 -0.904 . . . . 0.0 112.069 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.826 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . -74.98 0.31 16.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.4 t -85.42 -29.55 24.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.903 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.833 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -89.38 11.79 18.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.017 -1.052 . . . . 0.0 109.384 179.12 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.67 ' NE2' HD21 ' A' ' 71' ' ' LEU . 11.1 t-160 -42.5 139.83 1.41 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 48' ' ' CYS . 34.9 m -146.51 154.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 122.09 0.948 . . . . 0.0 109.929 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.703 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 11.9 m-85 -121.67 129.34 52.7 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.264 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.872 ' HB ' HG22 ' A' ' 57' ' ' THR . 19.1 t -96.12 167.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.772 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.783 ' O ' HG23 ' A' ' 57' ' ' THR . 25.3 p-10 -91.97 136.1 33.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.722 -1.237 . . . . 0.0 109.337 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.8 pt-20 -37.1 -26.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.81 . . . . 0.0 111.989 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -69.81 -16.52 63.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.871 -1.143 . . . . 0.0 111.681 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 68.1 m-85 -131.11 -10.81 3.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.729 -1.232 . . . . 0.0 110.945 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.872 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -80.57 -26.82 37.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 109.018 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 5.7 p-10 -73.4 -31.59 63.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.983 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.829 ' HB2' HD11 ' A' ' 94' ' ' LEU . 1.5 mmtt -79.92 -53.0 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.804 HG11 HG21 ' A' ' 88' ' ' ILE . 5.4 m -40.43 147.04 0.4 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.514 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 41.3 Cg_endo -68.52 170.7 14.43 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.397 1.735 . . . . 0.0 111.146 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 135.4 36.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.33 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -69.2 177.09 2.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 110.884 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -100.22 -156.13 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.338 -0.851 . . . . 0.0 111.015 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.7 pp20? -80.34 -30.79 38.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' O ' ' HE3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -65.0 -37.8 88.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.126 -0.984 . . . . 0.0 109.449 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.705 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 2.3 tm-20 -67.73 -6.89 23.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.684 -0.635 . . . . 0.0 109.478 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -91.47 -35.57 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 110.909 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -77.36 -65.31 1.95 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.174 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.192 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.71 -48.55 40.27 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.017 1.389 . . . . 0.0 108.333 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.113 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -58.91 -30.47 67.84 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.184 -176.004 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -81.26 -39.58 25.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.6 -0.688 . . . . 0.0 109.476 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.32 -41.53 38.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.816 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.826 HG13 ' HB1' ' A' ' 46' ' ' ALA . 2.8 m -90.42 67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 75' ' ' THR . 8.0 t -48.79 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.685 -0.635 . . . . 0.0 111.349 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.16 64.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.49 60.16 1.64 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.241 1.02 . . . . 0.0 109.813 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.113 HD11 HD22 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -46.87 134.65 9.91 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.991 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -125.36 -176.86 0.5 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.0 Cg_endo -67.04 -25.53 44.04 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.173 1.091 . . . . 0.0 111.297 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 26.0 p-10 -97.91 -13.13 21.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.813 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.703 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 1.4 m -54.44 151.34 7.83 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.596 -1.315 . . . . 0.0 109.761 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.733 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -175.63 163.76 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.188 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.192 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -83.16 145.09 29.39 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.489 -0.757 . . . . 0.0 109.986 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 60.3 p -40.83 -32.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 123.116 1.436 . . . . 0.0 107.973 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.062 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -94.35 46.39 1.15 Allowed 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.655 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -127.43 -43.29 1.61 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.493 -1.379 . . . . 0.0 113.374 -178.44 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.804 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -103.28 152.88 5.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 122.044 0.926 . . . . 0.0 112.341 -176.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 6.9 mm -106.35 165.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.541 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tpt -110.17 117.7 34.39 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.385 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 10.4 p -95.41 165.67 16.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.648 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.9 Cg_endo -73.25 -1.38 10.52 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.929 1.489 . . . . 0.0 110.345 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -110.08 -51.79 2.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 109.097 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 59' ' ' LYS . 1.3 mt -65.85 57.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.501 -0.749 . . . . 0.0 110.474 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.528 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 1.8 p30 -101.74 142.9 32.37 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.967 -1.083 . . . . 0.0 112.721 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.654 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.68 23.82 8.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.012 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.78 149.99 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.344 1.068 . . . . 0.0 112.904 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.62 HG23 ' ND2' ' A' ' 53' ' ' ASN . 22.1 t -115.09 123.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.788 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.96 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.1 t -103.94 176.7 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.828 -1.17 . . . . 0.0 109.423 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 51' ' ' TYR . 3.0 m-20 -162.53 143.85 10.31 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.349 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG12 ' ND1' ' A' ' 8' ' ' HIS . 53.2 t -94.26 132.98 28.0 Favored Pre-proline 0 C--N 1.287 -2.128 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.608 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.679 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 37.8 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 O-C-N 123.548 1.289 . . . . 0.0 112.852 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.513 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.313 0.578 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -71.34 123.07 21.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.827 HG22 ' CG2' ' A' ' 97' ' ' ILE . 35.1 t -124.3 144.15 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.515 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.788 ' O ' HG23 ' A' ' 99' ' ' VAL . 14.8 t -131.9 124.54 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.486 0.66 . . . . 0.0 109.317 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.03 ' CD1' HG21 ' A' ' 99' ' ' VAL . 69.6 m-85 -102.73 141.6 35.28 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.652 -0.655 . . . . 0.0 111.434 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.074 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.7 t -120.84 148.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.901 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 2.2 p -110.15 139.33 45.41 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -45.36 -22.11 0.12 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.085 -1.009 . . . . 0.0 110.023 -179.514 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 7' ' ' SER . 9.9 p-10 -82.46 -7.66 59.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.987 -1.071 . . . . 0.0 110.374 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.54 -36.87 4.02 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.173 -0.954 . . . . 0.0 111.673 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.525 HG22 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.64 145.33 5.16 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.586 -1.538 . . . . 0.0 109.499 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.717 ' HG2' HG13 ' A' ' 6' ' ' VAL . 9.8 mtt180 -130.05 158.03 40.75 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.573 -0.704 . . . . 0.0 111.187 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.683 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.6 ttp180 -140.19 122.07 15.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.573 ' CG ' HG22 ' A' ' 4' ' ' VAL . 1.1 mp0 -98.86 123.19 42.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.725 -1.234 . . . . 0.0 110.79 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.793 HD12 ' CE2' ' A' ' 5' ' ' TYR . 9.4 mt -110.4 147.92 33.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -99.96 90.16 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.861 HG22 ' HB2' ' A' ' 26' ' ' ALA . 55.9 t -98.83 172.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 111.045 -177.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.582 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -124.64 -140.77 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.682 . . . . 0.0 110.324 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.91 123.42 47.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.63 -3.07 29.15 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.59 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 22' ' ' SER . 58.1 t -102.52 169.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.732 -1.451 . . . . 0.0 110.519 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.594 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.53 165.29 15.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.808 -0.557 . . . . 0.0 109.553 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -55.57 -33.94 64.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.637 -1.289 . . . . 0.0 107.602 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.773 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.5 ttt -68.43 -65.83 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.553 ' CG ' HG13 ' A' ' 21' ' ' VAL . 36.1 tt0 -38.05 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.861 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -43.8 -56.7 3.67 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.418 -1.426 . . . . 0.0 109.187 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -54.3 -58.71 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.929 0.871 . . . . 0.0 109.535 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.774 HG12 ' N ' ' A' ' 29' ' ' SER 0.277 1.2 t -31.37 -63.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.563 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.774 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.64 -47.04 87.15 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.119 0.961 . . . . 0.0 109.042 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.3 m120 -59.67 -9.69 2.93 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.89 63.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.799 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 7.8 mt -41.99 -34.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.591 -0.947 . . . . 0.0 109.058 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.773 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.2 m-85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.858 . . . . 0.0 111.9 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 8.5 p . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.671 0.272 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.33 29.94 5.52 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.08 23.32 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.751 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.33 7.24 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.165 -1.197 . . . . 0.0 111.915 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.44 53.28 0.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 0.0 112.329 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.569 ' CA ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -132.57 34.35 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.43 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.933 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.2 p -111.39 122.26 47.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -85.82 7.85 22.29 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.127 -1.608 . . . . 0.0 107.887 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.2 p -110.84 -42.47 4.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.757 . . . . 0.0 112.121 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.856 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.6 m -75.34 19.16 0.18 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.54 -1.35 . . . . 0.0 111.791 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.638 ' HD1' HG23 ' A' ' 74' ' ' VAL . 5.0 t-160 -45.58 137.25 5.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.576 -1.327 . . . . 0.0 108.225 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.3 m -139.63 155.2 25.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.775 -1.203 . . . . 0.0 109.952 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.1 m-30 -119.02 122.18 41.57 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.153 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.2 t -100.55 174.66 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.325 -0.859 . . . . 0.0 109.859 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.95 ' O ' HG23 ' A' ' 57' ' ' THR . 10.2 p30 -94.68 137.36 33.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.768 -1.208 . . . . 0.0 109.075 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 53' ' ' ASN . 8.9 pm0 -37.98 -25.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.342 -0.849 . . . . 0.0 111.625 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.923 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -71.49 -44.74 64.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 111.875 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.648 ' O ' HG13 ' A' ' 60' ' ' VAL . 53.4 m-85 -99.12 -9.45 23.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.658 -1.277 . . . . 0.0 111.831 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.95 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -80.29 -33.11 37.95 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.521 -1.362 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.91 -27.02 57.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.67 ' CB ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -79.93 -53.72 6.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 56' ' ' PHE . 11.9 m -41.17 163.49 0.1 Allowed Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 121.472 -0.767 . . . . 0.0 110.337 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -64.89 161.86 34.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.032 1.543 . . . . 0.0 111.915 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.63 26.27 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.815 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.59 152.72 44.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.59 ' O ' HD13 ' A' ' 68' ' ' ILE . 27.6 p-10 -100.18 -173.04 2.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.102 -0.999 . . . . 0.0 111.187 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -54.43 -18.63 4.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.529 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.51 -55.77 18.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.894 ' HB2' HE21 ' A' ' 87' ' ' GLN . 2.1 tm-20 -59.55 -5.1 0.75 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.837 -0.539 . . . . 0.0 111.4 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.3 mp -91.25 -16.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.344 -1.472 . . . . 0.0 111.488 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.29 -82.45 1.37 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.666 -1.271 . . . . 0.0 110.388 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.095 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -47.84 -33.74 7.81 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.005 -1.291 . . . . 0.0 109.755 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.019 HD22 HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.09 -29.32 70.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -90.32 -23.8 21.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.541 -0.724 . . . . 0.0 109.575 178.699 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.576 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 16.2 m -48.94 -44.72 40.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 108.779 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.638 HG23 ' HD1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -90.53 80.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.042 178.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 75' ' ' THR . 8.8 t -47.9 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.423 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -118.83 55.41 0.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.777 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 78' ' ' LEU . 1.6 pm0 39.54 48.64 1.84 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 109.457 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.019 HD11 HD22 ' A' ' 71' ' ' LEU . 1.7 tp -19.81 133.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.524 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.633 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -100.81 170.66 6.31 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -68.16 -27.77 34.98 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.559 1.294 . . . . 0.0 109.46 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 57' ' ' THR . 24.4 p-10 -105.77 -4.65 20.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.579 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.9 m -48.83 158.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 0.0 111.036 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.605 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -175.11 167.57 3.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.634 -0.666 . . . . 0.0 109.627 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.095 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -88.68 143.82 26.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.982 . . . . 0.0 110.368 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.654 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 6.4 p -46.57 -36.39 6.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 110.576 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.469 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 12.1 m -94.04 37.43 1.09 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 111.386 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.894 HE21 ' HB2' ' A' ' 67' ' ' GLU . 3.8 mm100 -126.65 -43.27 1.74 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 112.259 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.795 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -84.18 148.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.549 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.8 mm -111.07 164.17 7.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.762 -0.586 . . . . 0.0 109.788 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.608 ' HE2' ' HB ' ' A' ' 97' ' ' ILE . 2.0 tpt -110.28 86.96 2.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.303 -0.873 . . . . 0.0 110.028 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.469 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 1.3 p -70.54 163.41 63.6 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.46 -0.775 . . . . 0.0 109.858 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -76.93 0.84 9.26 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.9 1.474 . . . . 0.0 110.144 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.541 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 22.8 pt-20 -110.03 -21.28 12.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 109.47 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.67 HD13 ' CB ' ' A' ' 59' ' ' LYS . 10.5 mt -103.98 63.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 109.826 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.55 147.45 25.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.476 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.12 24.36 9.05 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.827 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -65.05 122.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 122.748 1.261 . . . . 0.0 113.045 -176.33 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.469 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 3.8 t -98.75 116.03 40.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.486 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.03 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -104.34 -175.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.38 1.086 . . . . 0.0 110.381 -179.334 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.659 ' H ' HG12 ' A' ' 99' ' ' VAL . 11.5 m-20 -161.99 139.81 8.81 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.128 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 1.074 HG23 ' O ' ' A' ' 6' ' ' VAL . 5.3 t -96.06 108.04 38.57 Favored Pre-proline 0 C--N 1.289 -2.048 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.1 Cg_endo . . . . . 0 C--N 1.304 -1.768 0 O-C-N 124.175 1.619 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' CA ' ' O ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.513 0.673 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 105.91 4.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.007 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.8 t -109.94 145.92 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.051 -1.031 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 6.7 t -131.19 132.55 63.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.438 -0.789 . . . . 0.0 109.538 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.732 ' HE1' ' HB3' ' A' ' 23' ' ' LEU . 70.9 m-85 -110.21 129.04 55.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.011 0.91 . . . . 0.0 112.02 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.2 t -102.08 119.46 50.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.762 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.663 ' CB ' HG22 ' A' ' 11' ' ' THR . 91.5 p -79.62 130.29 35.23 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -38.18 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.749 -0.594 . . . . 0.0 111.049 -179.414 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.8 p30 -79.36 -3.07 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.989 -1.069 . . . . 0.0 110.672 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' SER . . . 109.99 -33.48 5.99 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.663 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.71 142.06 9.06 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.946 -1.326 . . . . 0.0 109.29 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HG2' HG13 ' A' ' 6' ' ' VAL . 27.8 mtt180 -126.98 120.84 30.04 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.345 0.593 . . . . 0.0 111.074 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 3.0 ttp180 -99.94 153.04 19.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 5.3 mt-10 -130.51 134.09 46.77 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.852 -1.155 . . . . 0.0 110.238 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.835 HD13 ' CB ' ' A' ' 26' ' ' ALA . 7.4 mt -122.13 144.32 49.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -99.91 86.28 3.24 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.996 HG22 ' HB2' ' A' ' 26' ' ' ALA . 43.8 t -98.43 172.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.59 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.575 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -125.78 -146.52 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 111.282 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -96.71 122.07 39.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.594 0.712 . . . . 0.0 110.354 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.23 -13.14 31.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 22' ' ' SER . 32.7 t -88.26 169.74 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.018 -1.284 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.581 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.49 152.24 39.37 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.072 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.813 HD13 HG11 ' A' ' 99' ' ' VAL . 5.4 mt -52.17 -23.29 5.28 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.336 -1.746 . . . . 0.0 107.788 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.755 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -73.17 -66.05 0.73 Allowed 'General case' 0 C--O 1.202 -1.421 0 CA-C-O 121.595 0.712 . . . . 0.0 109.887 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.507 ' HB3' HG13 ' A' ' 21' ' ' VAL 0.256 38.7 tt0 -37.13 -70.29 0.1 Allowed 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.735 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.996 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -49.66 -58.93 4.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.94 -1.725 . . . . 0.0 108.666 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.917 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -47.91 -58.74 4.0 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 108.888 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.801 HG12 ' N ' ' A' ' 29' ' ' SER 0.284 1.0 OUTLIER -34.29 -64.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.715 178.176 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.801 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.03 -46.96 86.9 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.872 0.844 . . . . 0.0 109.6 179.097 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.503 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.1 m120 -59.87 -7.01 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.419 0.628 . . . . 0.0 109.735 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.59 -18.82 44.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 27' ' ' ALA . 59.5 mt -40.79 -38.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -1.028 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.755 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 23.4 m-85 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.96 . . . . 0.0 113.224 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 121.258 0.552 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.26 31.2 4.52 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.0 32.03 37.33 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.738 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.6 m -131.45 5.32 4.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 0.0 111.172 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.09 47.93 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.242 -0.911 . . . . 0.0 112.312 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.43 ' HB2' ' HA ' ' A' ' 39' ' ' CYS . 3.2 m -133.16 44.53 2.82 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.053 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.96 153.5 25.43 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -111.55 -3.45 15.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.229 -0.92 . . . . 0.0 108.826 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 p -110.18 -30.49 7.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.272 -0.892 . . . . 0.0 112.039 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.623 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.1 m -80.32 34.0 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.545 -1.347 . . . . 0.0 110.964 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HD1' HG23 ' A' ' 74' ' ' VAL . 8.0 t-160 -60.7 132.8 55.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.923 -1.111 . . . . 0.0 108.091 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 83' ' ' ARG . 19.0 m -139.44 155.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.783 -1.198 . . . . 0.0 109.939 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.3 m-30 -116.21 106.34 13.58 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.928 0.871 . . . . 0.0 109.587 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.064 HG13 HD11 ' A' ' 97' ' ' ILE . 15.8 t -88.09 148.47 4.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.691 ' ND2' ' HB ' ' A' ' 98' ' ' VAL . 36.1 p-10 -73.08 127.4 32.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 119.516 -1.99 . . . . 0.0 109.661 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 16.8 pt-20 -34.38 -35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.698 -0.626 . . . . 0.0 111.621 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -55.26 -16.61 3.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 60.4 m-85 -128.66 -16.17 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.683 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.845 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -80.29 -32.01 38.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 108.984 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.1 p-10 -74.52 -27.28 60.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.763 ' CB ' HD13 ' A' ' 94' ' ' LEU . 2.2 mmtt -79.88 -53.7 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.498 -0.752 . . . . 0.0 109.763 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 57' ' ' THR . 12.3 m -42.98 166.83 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 110.029 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.7 Cg_endo -62.26 162.16 24.4 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.966 1.508 . . . . 0.0 111.96 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.91 125.32 29.97 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.044 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . . . -69.78 146.28 51.56 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 109.768 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 3.7 p30 -100.65 -172.37 2.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.108 -0.995 . . . . 0.0 111.972 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -53.97 -20.81 6.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.59 . . . . 0.0 110.869 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 70' ' ' MET . 4.3 ttm180 -64.09 -55.59 20.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.47 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 3.3 tt0 -58.64 -49.97 75.55 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.716 -0.615 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.3 mp -48.01 -26.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 111.457 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.75 -68.7 1.19 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.028 ' CE ' HD12 ' A' ' 84' ' ' LEU . 2.2 ptm -48.51 -41.47 30.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.83 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 71' ' ' LEU 0.25 0.0 OUTLIER -71.1 -24.19 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.925 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 2.5 tt0 -90.78 -13.41 33.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.731 -0.605 . . . . 0.0 109.87 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.748 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 9.7 m -48.52 -49.68 35.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 108.861 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.616 HG23 ' HD1' ' A' ' 49' ' ' HIS . 4.3 m -90.32 92.9 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 75' ' ' THR . 9.1 t -48.29 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.369 -0.832 . . . . 0.0 110.757 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -124.49 50.59 1.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.1 pt-20 39.39 60.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.634 0.73 . . . . 0.0 109.609 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.571 HD11 HD13 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -30.54 122.06 0.2 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.573 0.702 . . . . 0.0 111.806 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -86.05 171.21 10.87 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.8 Cg_endo -66.72 -25.91 46.05 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.46 1.242 . . . . 0.0 109.485 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' A' ' 57' ' ' THR . 6.7 p-10 -109.87 -4.13 16.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.619 -0.676 . . . . 0.0 111.394 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CG ' ' A' ' 79' ' ' LYS . 69.2 m -48.71 143.9 4.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.674 -1.266 . . . . 0.0 110.588 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.831 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.86 165.53 36.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.0 110.046 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.053 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -88.4 143.08 27.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.362 -0.836 . . . . 0.0 109.369 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.623 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 5.7 p -46.64 -46.37 19.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.74 -1.225 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -91.91 38.82 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.598 -0.689 . . . . 0.0 109.893 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.584 ' OE1' ' HB1' ' A' ' 43' ' ' ALA . 38.6 tp60 -123.28 -40.99 2.33 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.41 -0.806 . . . . 0.0 111.318 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.902 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -92.73 149.73 4.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.31 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -110.7 164.28 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.603 ' HE3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.4 126.37 54.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.96 -1.088 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.482 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.55 159.86 28.06 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.722 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -72.71 -1.61 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.915 1.481 . . . . 0.0 110.514 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -110.06 -28.59 8.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.588 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.763 HD13 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -93.48 37.77 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.073 0.94 . . . . 0.0 109.286 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' CB ' ' OG ' ' A' ' 1' ' ' SER . 1.6 p-10 -82.06 142.83 31.98 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.707 0.765 . . . . 0.0 112.196 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.36 28.33 7.23 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.064 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -77.99 133.7 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 122.173 0.987 . . . . 0.0 112.483 -177.235 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.691 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 16.5 t -102.44 101.63 12.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.373 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.95 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.59 170.15 2.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.063 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -144.32 172.19 13.27 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.197 0.999 . . . . 0.0 111.57 -176.483 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 102' ' ' PRO . 98.9 t -107.08 109.4 62.99 Favored Pre-proline 0 C--N 1.297 -1.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.264 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.646 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 47.0 Cg_endo . . . . . 0 C--N 1.305 -1.728 0 O-C-N 123.981 1.516 . . . . 0.0 111.585 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.543 ' HB3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -70.18 125.28 26.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.698 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.663 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 3.2 t -121.76 136.88 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.975 -1.078 . . . . 0.0 110.231 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.911 HG13 ' CG ' ' A' ' 14' ' ' GLU . 95.1 t -121.14 110.75 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 112.197 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.108 ' OH ' HD12 ' A' ' 15' ' ' LEU . 19.6 m-30 -82.27 131.4 35.23 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.423 0.63 . . . . 0.0 111.708 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 99' ' ' VAL . 4.4 t -120.49 128.78 76.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.064 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.666 ' HB3' HG22 ' A' ' 11' ' ' THR . 26.8 p -79.33 -159.78 0.21 Allowed 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.95 -1.1 . . . . 0.0 108.5 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -11.33 19.39 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.895 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.55 -0.75 37.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 0.0 109.565 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 -19.9 26.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.82 143.04 7.99 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.958 -1.319 . . . . 0.0 109.223 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 17.2 mtt180 -124.1 139.21 54.16 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.428 0.633 . . . . 0.0 111.329 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.655 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.25 67.82 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.911 ' CG ' HG13 ' A' ' 4' ' ' VAL . 4.0 mp0 -67.51 140.97 57.05 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.919 -1.113 . . . . 0.0 110.849 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.108 HD12 ' OH ' ' A' ' 5' ' ' TYR . 8.8 mt -109.72 150.76 27.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.691 -0.631 . . . . 0.0 110.043 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.35 85.78 3.26 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 26' ' ' ALA . 40.7 t -98.76 171.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.666 0.746 . . . . 0.0 111.337 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.578 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -118.57 -139.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.454 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -105.58 125.73 51.33 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.452 -0.78 . . . . 0.0 110.198 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.67 29.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 22' ' ' SER . 61.1 t -102.18 170.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.933 -1.333 . . . . 0.0 110.199 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.616 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.73 160.33 23.56 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.762 HD21 ' SD ' ' A' ' 90' ' ' MET . 16.8 mt -54.97 -18.4 4.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.694 -1.254 . . . . 0.0 109.448 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . 1.225 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -90.23 -58.18 2.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.257 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG13 ' A' ' 21' ' ' VAL . 46.9 tt0 -38.63 -64.77 0.41 Allowed 'General case' 0 C--N 1.289 -2.062 0 O-C-N 122.127 -0.358 . . . . 0.0 110.762 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.953 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -48.38 -55.97 9.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.437 -1.415 . . . . 0.0 108.283 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.777 ' HB1' ' CD1' ' A' ' 33' ' ' TYR . . . -52.72 -55.92 19.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.89 ' CG2' ' HE2' ' A' ' 24' ' ' MET 0.264 0.7 OUTLIER -37.32 -47.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.472 177.592 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.8 -43.81 21.76 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.582 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.7 m-80 -59.86 -8.08 2.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 109.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.34 -18.4 18.53 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.592 HD13 ' HD2' ' A' ' 5' ' ' TYR . 58.2 mt -48.92 -29.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.851 -1.382 . . . . 0.0 107.643 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 3.1 m-85 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.675 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.1 p . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.106 0.479 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 48.26 25.48 4.22 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.03 28.81 61.71 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.3 p -140.23 28.09 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.3 . . . . 0.0 111.998 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 66.56 45.29 2.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.577 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -130.6 46.79 2.61 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.078 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.054 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -111.72 157.06 20.95 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -177.047 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.692 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -112.0 -9.76 13.98 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.677 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.2 p -110.48 -30.11 7.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -0.78 . . . . 0.0 112.618 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.863 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.4 m -73.99 66.88 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.31 -1.494 . . . . 0.0 110.197 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.619 ' HE2' ' HE1' ' A' ' 51' ' ' TYR . 4.0 t-160 -87.85 132.74 34.08 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 83' ' ' ARG . 17.1 m -142.29 155.24 18.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 109.277 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.694 ' CD1' ' HE2' ' A' ' 79' ' ' LYS . 5.1 m-30 -120.2 118.11 29.65 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 121.675 0.75 . . . . 0.0 111.015 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.791 ' HB ' HG22 ' A' ' 57' ' ' THR . 42.2 t -97.96 165.71 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.346 -0.846 . . . . 0.0 109.643 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.763 ' O ' HG23 ' A' ' 57' ' ' THR . 21.1 p-10 -89.41 138.31 31.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.38 -1.45 . . . . 0.0 109.388 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -38.38 -26.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.382 -0.824 . . . . 0.0 111.441 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . . . -68.31 -18.0 64.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.965 -1.084 . . . . 0.0 111.551 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 38.5 m-85 -129.62 -14.44 4.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.776 -1.203 . . . . 0.0 110.796 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.791 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -80.88 -22.69 39.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.906 -1.121 . . . . 0.0 108.746 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -85.96 -23.97 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.825 . . . . 0.0 110.028 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HB3' HD22 ' A' ' 94' ' ' LEU . 9.2 mmtt -79.5 -47.66 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.452 -0.78 . . . . 0.0 109.111 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.897 HG11 ' CG2' ' A' ' 88' ' ' ILE . 6.3 m -45.3 161.39 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.786 -0.571 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.512 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -65.19 163.34 29.43 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 112.325 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.21 124.14 29.04 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.76 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.631 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -88.66 160.26 17.45 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.621 ' O ' HD13 ' A' ' 68' ' ' ILE . 3.3 p30 -100.55 -166.86 1.36 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 110.266 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.0 -24.27 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.838 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' MET . 4.1 ttm180 -64.79 -15.34 61.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.741 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.0 tp10 -100.28 -3.61 31.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.91 -59.3 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 111.445 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.88 -47.54 24.89 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.988 ' CE ' HD12 ' A' ' 84' ' ' LEU 0.33 1.3 ttp -48.79 -52.3 24.66 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 123.497 1.618 . . . . 0.0 108.666 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD12 ' OE2' ' A' ' 67' ' ' GLU 0.293 0.0 OUTLIER -68.39 -33.85 74.98 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.043 -179.21 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.684 ' HB2' HD22 ' A' ' 78' ' ' LEU . 6.7 tt0 -90.56 7.64 38.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.573 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 5.5 m -48.83 -49.47 39.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.85 -1.156 . . . . 0.0 108.342 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.694 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.3 m -90.48 113.35 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.02 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 75' ' ' THR . 8.9 t -48.57 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.823 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -125.2 44.82 2.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.558 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.7 pt-20 39.56 60.53 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.43 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 72' ' ' GLU . 2.5 tp -32.17 133.59 0.1 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 21.3 mtmt -110.44 172.01 3.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.708 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -66.26 -32.06 42.79 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.507 1.267 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.732 ' HB2' HG21 ' A' ' 57' ' ' THR . 14.5 p-10 -98.79 -10.84 22.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.501 ' OG ' ' HB2' ' A' ' 79' ' ' LYS . 50.2 m -48.92 150.51 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 0.0 109.724 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.666 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -157.59 151.43 24.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.054 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -73.17 130.45 40.29 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.62 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -44.81 -20.98 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.991 -1.068 . . . . 0.0 112.149 -176.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.225 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 26.1 m -107.02 39.29 1.9 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.578 -1.326 . . . . 0.0 111.168 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.589 ' HG3' ' HB2' ' A' ' 84' ' ' LEU . 7.7 mm100 -125.06 -45.26 1.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 110.634 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.897 ' CG2' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.88 143.25 12.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.9 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.0 mm -110.68 158.71 10.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.416 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.762 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.9 tpt -110.21 103.89 12.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -98.58 167.61 11.17 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.754 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -72.6 -0.36 8.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.584 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 3.7 pt-20 -110.04 -32.08 7.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 109.55 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' CE ' ' A' ' 90' ' ' MET . 6.8 mt -94.66 35.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.16 0.981 . . . . 0.0 109.187 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -87.94 154.58 20.39 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.667 0.746 . . . . 0.0 112.101 -177.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.642 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.37 24.14 19.75 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.765 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -80.5 152.24 4.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.274 1.035 . . . . 0.0 112.577 -177.399 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG23 ' ND2' ' A' ' 53' ' ' ASN . 17.6 t -112.68 123.56 68.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -103.91 -175.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.86 -1.15 . . . . 0.0 109.933 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.675 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.9 m-20 -162.11 130.14 4.06 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.989 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 6' ' ' VAL . 54.0 t -89.19 110.36 37.86 Favored Pre-proline 0 C--N 1.277 -2.549 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.642 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.4 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 124.029 1.542 . . . . 0.0 112.139 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.522 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.543 0.687 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -90.25 121.44 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.817 HG22 ' CG2' ' A' ' 97' ' ' ILE . 3.4 t -122.55 143.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.719 -1.238 . . . . 0.0 110.098 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.85 HG22 ' CG ' ' A' ' 14' ' ' GLU . 24.4 t -130.18 122.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.998 0.904 . . . . 0.0 109.147 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.913 ' HE2' HD13 ' A' ' 15' ' ' LEU . 42.1 m-85 -96.95 142.07 29.36 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.802 0.81 . . . . 0.0 111.035 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.002 HG13 ' HG3' ' A' ' 12' ' ' ARG . 2.9 t -113.48 114.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.39 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -79.6 124.56 28.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.504 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -32.4 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.005 -0.434 . . . . 0.0 112.144 -178.133 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.589 ' OD1' HG22 ' A' ' 11' ' ' THR . 2.6 p-10 -66.99 -9.51 39.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.682 -1.261 . . . . 0.0 110.141 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . 110.0 -31.73 7.25 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.589 HG22 ' OD1' ' A' ' 9' ' ' ASP . 2.7 t -61.58 133.61 55.86 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.965 -1.315 . . . . 0.0 109.272 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 1.002 ' HG3' HG13 ' A' ' 6' ' ' VAL . 13.4 mtm180 -118.53 132.3 56.21 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.169 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.687 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.03 149.15 24.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 179.002 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.85 ' CG ' HG22 ' A' ' 4' ' ' VAL . 22.9 mt-10 -130.41 120.1 23.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.771 -1.206 . . . . 0.0 110.949 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.913 HD13 ' HE2' ' A' ' 5' ' ' TYR . 1.4 mp -116.87 177.62 4.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.257 1.027 . . . . 0.0 111.914 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -106.75 83.14 1.8 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.986 HG22 ' CB ' ' A' ' 26' ' ' ALA . 58.6 t -98.54 129.22 49.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.538 -0.726 . . . . 0.0 110.305 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.477 ' HA ' ' OG ' ' A' ' 1' ' ' SER . . . -140.0 -171.47 3.18 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.523 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 90' ' ' MET . 1.9 p30 -41.23 115.4 0.6 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.856 0.836 . . . . 0.0 110.324 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.34 -22.23 22.89 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.661 ' HB ' HG13 ' A' ' 17' ' ' VAL . 2.4 t -107.88 157.49 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.849 -1.383 . . . . 0.0 110.86 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -120.96 166.69 13.47 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.671 HD22 HD12 ' A' ' 88' ' ' ILE . 5.1 mp -58.42 -22.09 53.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.368 -1.457 . . . . 0.0 107.897 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.87 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.93 -72.12 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.643 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.608 ' HG2' HG13 ' A' ' 21' ' ' VAL . 28.8 tt0 -37.67 -67.6 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.877 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.986 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -42.37 -73.95 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.499 -1.376 . . . . 0.0 108.613 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.826 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . . . -44.85 -44.74 9.76 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -47.09 -60.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.714 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -50.27 -45.87 54.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.993 0.901 . . . . 0.0 108.748 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.654 ' OD1' HD21 ' A' ' 15' ' ' LEU . 1.3 m120 -64.93 -2.34 2.58 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.789 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 11.68 84.54 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 15' ' ' LEU 0.268 3.8 mt -70.67 -31.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.568 -0.96 . . . . 0.0 109.134 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.751 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.4 m-85 . . . . . 0 N--CA 1.498 1.937 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.3 p . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.035 0.445 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.44 28.07 3.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.28 35.47 26.6 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.729 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.0 p -140.11 8.38 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -1.204 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 70.3 53.41 0.33 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.149 -0.969 . . . . 0.0 111.935 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.461 ' H ' ' HA ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -133.19 38.44 3.33 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.108 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.62 153.9 24.55 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.95 -2.22 16.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.658 -1.276 . . . . 0.0 108.789 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 p -110.02 -34.49 6.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 111.363 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.84 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.2 m -74.53 63.7 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.561 -1.337 . . . . 0.0 109.794 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.957 ' ND1' HG21 ' A' ' 74' ' ' VAL . 17.1 t-160 -91.78 133.13 35.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.601 HG11 ' OH ' ' A' ' 33' ' ' TYR . 16.9 m -144.58 154.82 14.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.808 -1.182 . . . . 0.0 109.943 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.727 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 7.7 m-30 -116.84 109.57 17.26 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.891 HG21 ' CD1' ' A' ' 88' ' ' ILE . 16.4 t -86.28 158.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.372 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 57' ' ' THR . 11.5 p-10 -78.81 132.43 36.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 119.997 -1.689 . . . . 0.0 109.918 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 53' ' ' ASN . 12.1 pt-20 -38.65 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.98 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -63.87 -23.13 67.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.643 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 24.9 m-85 -122.71 -15.27 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.926 -1.109 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.874 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -78.65 -26.44 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.937 -1.105 . . . . 0.0 108.796 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.0 p-10 -81.83 -26.2 34.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.533 -0.729 . . . . 0.0 109.692 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . 12.5 mmtt -79.79 -52.04 8.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.498 -0.751 . . . . 0.0 109.492 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 56' ' ' PHE . 10.3 m -40.76 162.55 0.1 Allowed Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.602 -0.686 . . . . 0.0 110.515 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.524 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.6 Cg_endo -66.74 165.57 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.068 1.562 . . . . 0.0 111.454 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.62 27.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.622 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.519 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -69.21 166.3 18.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.439 -0.788 . . . . 0.0 109.71 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.71 ' O ' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -100.45 -158.2 0.66 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.977 -1.077 . . . . 0.0 110.929 -179.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 pp20? -78.38 -23.16 46.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.694 -0.628 . . . . 0.0 111.069 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.565 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.84 -48.46 74.28 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.801 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.591 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.11 -6.27 0.84 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.262 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.39 -30.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.617 -1.302 . . . . 0.0 110.668 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.28 -63.22 1.25 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.106 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -48.08 -42.64 29.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 109.222 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.911 HD13 HD11 ' A' ' 78' ' ' LEU 0.26 0.0 OUTLIER -69.45 -23.84 63.72 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.934 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -89.95 -18.68 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.511 -0.743 . . . . 0.0 110.029 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' GLU . 2.1 m -48.51 -31.43 6.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.957 HG21 ' ND1' ' A' ' 49' ' ' HIS . 20.4 m -90.32 87.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 75' ' ' THR . 9.3 t -48.41 82.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.269 -0.894 . . . . 0.0 111.506 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.39 40.85 3.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 10.0 pt-20 39.2 60.14 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.764 -0.585 . . . . 0.0 109.754 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.911 HD11 HD13 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -19.93 125.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.264 0.554 . . . . 0.0 112.104 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.626 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -80.05 170.69 14.78 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.4 Cg_endo -65.85 -25.71 52.7 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.477 1.251 . . . . 0.0 109.564 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.675 ' HB2' HG21 ' A' ' 57' ' ' THR . 20.6 p-10 -107.79 -8.25 16.09 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 111.33 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 45.7 m -49.44 158.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.614 -1.304 . . . . 0.0 111.205 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' NH2' HG23 ' A' ' 88' ' ' ILE . 2.3 ttp180 -175.51 156.48 1.96 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.108 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -73.29 135.47 44.42 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.624 ' HG ' ' HE1' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -45.46 -24.3 0.3 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.585 -177.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.3 m -104.79 42.64 1.18 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.894 -1.128 . . . . 0.0 111.401 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.823 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -125.07 -42.53 2.01 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.717 0.77 . . . . 0.0 110.501 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.891 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -89.0 140.04 16.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.354 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 90' ' ' MET . 5.3 mm -110.68 172.56 2.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.933 ' CB ' HG12 ' A' ' 17' ' ' VAL . 1.2 tpt -110.15 115.85 30.48 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.13 -0.982 . . . . 0.0 111.029 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.471 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -96.8 169.56 8.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.664 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.9 -5.65 17.58 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.885 1.466 . . . . 0.0 110.556 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 10.8 pt-20 -110.29 -23.94 10.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.701 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 7.2 mt -96.39 55.9 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -0.995 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -100.84 146.51 27.21 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.066 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.643 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.59 21.73 10.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.817 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -62.48 150.47 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.183 0.992 . . . . 0.0 113.243 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.668 HG23 ' ND2' ' A' ' 53' ' ' ASN . 10.9 t -127.61 89.82 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.977 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.72 162.49 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.441 1.115 . . . . 0.0 110.51 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.571 ' OD2' HG21 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -145.51 170.13 17.01 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.913 -178.076 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.504 HG12 ' ND1' ' A' ' 8' ' ' HIS . 42.3 t -110.17 128.84 24.69 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.727 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 37.5 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 O-C-N 123.771 1.406 . . . . 0.0 112.942 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.559 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.366 0.603 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.6 ttmm -76.63 135.12 39.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.903 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.77 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 14.8 t -123.43 140.39 47.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.614 -1.304 . . . . 0.0 110.865 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.866 HG13 ' HG2' ' A' ' 14' ' ' GLU . 41.4 t -121.5 117.91 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 122.052 0.93 . . . . 0.0 111.504 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.097 ' CE2' HD13 ' A' ' 15' ' ' LEU . 22.5 m-30 -97.55 135.26 39.64 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.837 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 99' ' ' VAL . 14.4 t -120.05 154.09 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.48 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 11' ' ' THR . 10.7 p -117.06 138.64 51.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.452 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -44.39 -24.28 0.17 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.151 -0.968 . . . . 0.0 110.338 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.5 p30 -85.03 -5.82 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.007 . . . . 0.0 110.401 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.19 -45.61 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.529 HG22 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.73 124.52 9.84 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.877 -1.366 . . . . 0.0 110.011 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.708 ' HD2' HG22 ' A' ' 6' ' ' VAL . 30.7 mtm180 -110.34 156.91 20.1 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.479 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.763 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -134.75 67.78 1.49 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 0.0 109.438 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.866 ' HG2' HG13 ' A' ' 4' ' ' VAL . 1.4 mp0 -69.48 131.49 44.82 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.563 0.697 . . . . 0.0 110.335 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.097 HD13 ' CE2' ' A' ' 5' ' ' TYR . 2.3 mp -114.77 173.5 6.45 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.236 1.017 . . . . 0.0 112.012 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.78 90.76 4.56 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.9 HG13 HG11 ' A' ' 21' ' ' VAL . 95.7 t -98.58 166.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.469 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.559 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -133.01 -160.74 1.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.757 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -82.41 123.75 29.41 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.564 0.697 . . . . 0.0 110.696 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.37 37.08 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.923 HG13 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -106.29 170.2 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 110.65 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.604 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -120.51 175.94 5.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -76.16 -3.67 37.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.216 -1.553 . . . . 0.0 108.218 178.049 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.612 ' HE3' ' H ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -91.18 -77.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 112.022 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.923 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -38.03 -23.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.905 -0.497 . . . . 0.0 111.176 -177.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.635 ' C ' HD22 ' A' ' 15' ' ' LEU . . . -87.7 -45.06 10.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.791 ' HA ' HD12 ' A' ' 32' ' ' ILE 0.265 . . -66.33 -46.13 77.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.887 1.327 . . . . 0.0 107.492 176.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 29' ' ' SER 0.263 0.8 OUTLIER -45.92 -58.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.197 178.64 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.7 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.72 -35.79 75.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.031 178.653 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.709 ' OD1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -72.87 12.15 0.56 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.444 0.64 . . . . 0.0 109.831 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 70.08 4.96 51.51 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 27' ' ' ALA . 4.2 mt -66.43 -42.43 90.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -1.109 . . . . 0.0 109.459 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.63 ' HB2' HG23 ' A' ' 28' ' ' VAL . 23.5 m-85 . . . . . 0 C--N 1.301 -1.536 0 C-N-CA 119.183 -1.007 . . . . 0.0 113.448 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.638 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 21.7 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.066 0.46 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 42.59 35.28 1.98 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' H ' ' HE3' ' A' ' 24' ' ' MET . . . 80.27 28.25 49.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 6.2 m -128.58 -3.65 5.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -1.092 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.81 51.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.765 0.793 . . . . 0.0 112.321 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.567 ' OG ' ' HA ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -131.55 38.91 3.55 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.733 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -110.88 150.41 29.22 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.87 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -111.01 -4.4 15.14 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.554 -0.717 . . . . 0.0 109.667 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.2 t -110.56 -21.49 12.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.947 . . . . 0.0 112.754 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.819 ' O ' HG13 ' A' ' 50' ' ' VAL . 34.9 m -75.02 11.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.367 -1.458 . . . . 0.0 111.243 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.103 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 3.3 t-160 -43.69 124.45 3.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.6 m -143.35 163.12 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 120.928 -1.107 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.774 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -118.47 124.63 48.07 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.704 0.764 . . . . 0.0 111.147 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.932 HG21 ' CD1' ' A' ' 88' ' ' ILE . 2.7 t -99.58 165.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.943 ' OD1' ' HB3' ' A' ' 55' ' ' ALA . 9.7 p30 -82.85 134.58 35.09 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 119.892 -1.755 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.1 pt-20 -37.58 -25.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.455 -0.778 . . . . 0.0 111.765 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.943 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -70.68 -40.33 73.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.838 -1.163 . . . . 0.0 111.587 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.845 ' HB3' HD12 ' A' ' 97' ' ' ILE . 61.1 m-85 -102.71 -17.95 15.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.733 -1.229 . . . . 0.0 111.258 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -80.63 -23.43 39.75 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.927 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 55' ' ' ALA . 23.4 p-10 -82.95 -24.11 33.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.566 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.897 ' CB ' HD21 ' A' ' 94' ' ' LEU . 3.4 mmtp -79.85 -49.05 12.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.675 ' N ' HD11 ' A' ' 94' ' ' LEU . 3.0 m -43.54 168.25 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 110.05 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.6 Cg_endo -62.17 164.71 16.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.029 1.541 . . . . 0.0 111.589 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.67 112.79 18.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.898 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.587 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.58 147.24 50.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.763 . . . . 0.0 110.366 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' O ' HD13 ' A' ' 68' ' ' ILE . 23.6 p30 -100.07 -173.38 2.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 110.555 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.63 -26.92 24.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 70' ' ' MET . 5.4 ttm180 -64.83 -18.11 64.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.587 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 3.3 tm-20 -99.96 1.51 42.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.1 mp -91.89 -59.05 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 111.194 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -77.01 -47.77 9.01 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.695 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.323 2.8 ttp -48.58 -50.72 31.26 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 123.547 1.641 . . . . 0.0 108.022 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.626 HD11 ' C ' ' A' ' 82' ' ' SER 0.296 0.0 OUTLIER -70.87 -32.44 69.43 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.709 -179.408 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.649 ' HB2' HD22 ' A' ' 78' ' ' LEU . 4.3 tt0 -89.16 -0.15 57.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.893 -1.129 . . . . 0.0 110.453 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.692 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -49.08 -52.34 26.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.631 -1.293 . . . . 0.0 108.438 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 46' ' ' ALA . 31.1 m -90.48 107.95 19.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.481 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -48.15 103.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.838 -1.164 . . . . 0.0 109.254 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.103 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -120.07 22.51 11.41 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.608 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 71.7 38.27 0.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.672 1.225 . . . . 0.0 108.338 -178.408 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 72' ' ' GLU . 11.3 tp -19.26 134.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.979 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' N ' HD12 ' A' ' 78' ' ' LEU . 2.4 mtpt -128.09 -169.24 0.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 46.2 Cg_endo -81.92 -30.64 1.26 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.697 1.367 . . . . 0.0 109.743 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.7 p-10 -93.7 -12.17 29.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.731 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.626 ' C ' HD11 ' A' ' 71' ' ' LEU . 18.6 m -49.23 155.52 0.68 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.042 . . . . 0.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.85 ' NE ' HG23 ' A' ' 88' ' ' ILE . 2.4 mtp180 -175.29 153.92 1.63 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.733 HD22 ' SG ' ' A' ' 45' ' ' CYS . 11.1 mt -74.61 150.84 39.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.672 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 46.6 p -46.71 -25.94 0.83 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.725 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -110.13 44.95 1.15 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.732 0.777 . . . . 0.0 109.556 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.564 ' HG2' ' CG ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -125.44 -32.77 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.932 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.35 147.18 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.628 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.0 mm -110.3 160.62 9.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 21' ' ' VAL . 2.9 tpt -110.25 112.86 25.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.539 -0.726 . . . . 0.0 110.425 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -97.48 172.66 4.7 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.2 Cg_endo -72.67 -31.87 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.92 1.484 . . . . 0.0 110.558 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 2.4 pp20? -81.04 -44.96 17.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.883 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.897 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.1 mt -75.81 52.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.115 -0.991 . . . . 0.0 111.018 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 4.3 p-10 -101.33 152.86 20.2 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.032 -1.042 . . . . 0.0 111.764 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.626 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.32 22.42 10.56 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.845 HD12 ' HB3' ' A' ' 56' ' ' PHE . 3.6 tt -72.55 154.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 123.175 1.464 . . . . 0.0 113.555 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.636 ' H ' ' ND2' ' A' ' 53' ' ' ASN 0.252 8.1 t -125.37 98.27 4.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.566 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.891 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.74 174.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.134 -1.427 . . . . 0.0 109.726 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.586 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.87 174.03 16.12 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.914 0.864 . . . . 0.0 111.024 -178.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 18.0 t -111.09 130.96 22.43 Favored Pre-proline 0 N--CA 1.498 1.956 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.429 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.937 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 49.7 Cg_endo . . . . . 0 N--CA 1.495 1.615 0 C-N-CA 121.695 1.597 . . . . 0.0 112.683 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.546 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.38 0.609 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -74.8 120.11 19.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.743 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.769 HG22 ' CG2' ' A' ' 97' ' ' ILE . 25.1 t -119.67 146.5 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.769 -1.207 . . . . 0.0 110.983 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 99' ' ' VAL . 16.9 t -131.06 125.83 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.695 0.76 . . . . 0.0 109.856 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.902 ' CD1' HG21 ' A' ' 99' ' ' VAL . 49.2 m-85 -101.52 137.91 39.22 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.486 0.66 . . . . 0.0 111.922 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.5 t -120.77 132.73 69.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.023 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.693 ' HB3' HG22 ' A' ' 11' ' ' THR . 67.6 p -79.39 -153.01 0.07 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.523 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -110.2 -8.13 14.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 120.97 -1.081 . . . . 0.0 108.98 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -100.37 1.65 41.64 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.41 -21.75 23.54 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.87 138.89 14.32 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.024 -1.28 . . . . 0.0 109.449 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 24.6 mtt180 -130.06 148.66 51.93 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.401 0.62 . . . . 0.0 111.215 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.696 ' HG2' HD11 ' A' ' 32' ' ' ILE . 1.4 ttm-85 -140.11 118.9 12.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.43 -0.794 . . . . 0.0 109.888 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.0 mp0 -100.42 124.43 45.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.797 -1.189 . . . . 0.0 110.835 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 27' ' ' ALA . 10.8 mt -110.57 151.83 27.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 110.507 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.11 90.37 3.92 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.911 HG22 ' HB2' ' A' ' 26' ' ' ALA . 50.6 t -98.61 174.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 110.298 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -125.32 -133.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.518 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -110.03 124.04 50.75 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.51 -10.78 30.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 22' ' ' SER . 70.0 t -93.87 169.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.33 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.618 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.36 169.26 10.78 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 3' ' ' VAL . 10.7 mt -60.91 -35.15 75.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.721 -1.237 . . . . 0.0 108.934 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.754 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.9 ttp -66.65 -62.47 1.44 Allowed 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.927 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.614 ' CG ' HG13 ' A' ' 21' ' ' VAL . 45.5 tt0 -38.14 -76.72 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.911 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -43.15 -56.39 3.44 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.331 -1.481 . . . . 0.0 109.754 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.879 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -56.74 -53.62 55.69 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.012 0.91 . . . . 0.0 109.412 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.756 HG12 ' N ' ' A' ' 29' ' ' SER 0.284 1.2 t -35.47 -63.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.152 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.756 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.37 -46.67 85.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.112 0.958 . . . . 0.0 108.884 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.508 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.6 m120 -59.93 -8.6 2.35 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 88.02 -14.64 58.37 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.866 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 7.6 mt -42.75 -38.41 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.692 -0.887 . . . . 0.0 108.643 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.754 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 72.3 m-85 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.511 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 1.3 p . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.026 0.441 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.4 42.92 7.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.8 39.59 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.735 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.8 p -120.9 -32.35 3.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.155 -1.203 . . . . 0.0 110.386 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.53 60.97 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.222 -0.924 . . . . 0.0 111.596 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -132.38 9.27 4.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.203 -0.936 . . . . 0.0 110.998 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.182 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.31 162.03 15.97 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.715 -1.241 . . . . 0.0 114.195 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 73' ' ' CYS . . . -110.14 -22.27 11.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.813 -1.179 . . . . 0.0 110.463 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.462 ' H ' HG22 ' A' ' 47' ' ' THR . 1.6 t -69.83 -14.96 63.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.64 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.833 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -94.72 14.05 22.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 0.0 108.581 178.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.619 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.9 t-160 -46.98 138.52 6.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -144.78 157.09 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.817 -1.177 . . . . 0.0 109.923 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.8 m-30 -119.87 122.06 40.45 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.582 0.706 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.849 HG21 ' CD1' ' A' ' 88' ' ' ILE . 38.7 t -99.44 151.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.12 -0.988 . . . . 0.0 110.354 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.673 ' ND2' ' HB ' ' A' ' 98' ' ' VAL . 33.2 p-10 -74.57 125.32 28.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.133 -1.605 . . . . 0.0 109.414 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' A' ' 55' ' ' ALA . 2.7 pm0 -34.07 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.702 -0.624 . . . . 0.0 112.19 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.7 -17.25 60.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.881 -1.137 . . . . 0.0 111.301 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.67 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 65.7 m-85 -125.35 -8.98 6.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.869 -1.145 . . . . 0.0 110.193 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.699 HG22 ' HB ' ' A' ' 52' ' ' VAL . 1.3 p -80.35 -34.76 36.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 108.914 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 -17.68 60.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.546 -0.721 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.766 ' CB ' HD13 ' A' ' 94' ' ' LEU 0.278 0.5 OUTLIER -79.34 -55.97 4.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 123.643 1.687 . . . . 0.0 109.423 179.584 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 88' ' ' ILE 0.323 0.3 OUTLIER -77.62 145.4 71.2 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.068 -177.707 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 60' ' ' VAL . 35.8 Cg_endo -61.75 160.0 30.62 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.847 1.446 . . . . 0.0 111.704 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -171.42 3.12 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.151 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.0 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -100.2 158.92 15.52 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.186 0.517 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 68' ' ' ILE . 24.8 p30 -100.45 -173.64 2.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 111.117 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.436 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 21.5 pt-20 -47.8 -24.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.0 ttm180 -64.5 -59.45 4.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.382 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 1.0 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 2.4 tt0 -66.96 14.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.558 -0.714 . . . . 0.0 111.975 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.83 -37.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 119.282 -2.136 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.35 -57.28 1.68 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 1.142 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -48.0 -44.96 31.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.161 -1.199 . . . . 0.0 109.087 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HB2' ' HG3' ' A' ' 67' ' ' GLU 0.3 0.0 OUTLIER -70.95 -30.96 67.4 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.531 -179.27 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 1.2 tt0 -90.9 -11.36 39.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.374 -0.829 . . . . 0.0 110.479 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.6 -50.98 30.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.706 -1.246 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.779 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.3 m -90.21 96.28 6.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 108.878 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 75' ' ' THR . 8.8 t -48.05 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -126.87 45.96 2.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.799 . . . . 0.0 109.91 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.6 pt-20 39.34 58.31 1.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.764 0.792 . . . . 0.0 109.467 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.546 ' CD1' ' HB2' ' A' ' 82' ' ' SER . 12.7 tp -29.72 131.72 0.07 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.56 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 6.8 mtpt -98.96 170.85 6.36 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.084 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.7 Cg_endo -67.4 -28.68 38.89 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.553 1.291 . . . . 0.0 109.768 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 21.7 p-10 -105.01 -5.05 21.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 111.025 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.577 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 72.7 m -48.54 164.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.795 -1.191 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.594 ' CG ' ' OE2' ' A' ' 67' ' ' GLU . 3.1 mtt180 -175.33 174.81 2.29 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.608 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.182 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -96.69 142.25 28.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.44 -0.788 . . . . 0.0 109.341 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 24' ' ' MET . 15.2 m -45.54 -29.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.037 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.1 p -98.68 38.83 1.31 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.619 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -126.79 -44.72 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.189 -1.57 . . . . 0.0 113.289 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.54 150.99 3.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.715 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.4 mm -111.02 161.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.546 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 2.6 tpt -110.25 111.46 22.79 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.812 -1.18 . . . . 0.0 111.043 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.472 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -91.32 156.6 43.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.6 Cg_endo -68.95 -1.42 7.76 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.805 1.423 . . . . 0.0 111.264 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.509 ' C ' HD23 ' A' ' 94' ' ' LEU . 6.3 pm0 -110.09 -27.72 9.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.981 -1.075 . . . . 0.0 110.072 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.766 HD13 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -97.24 58.48 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.267 -0.896 . . . . 0.0 109.78 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.543 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.75 151.1 22.07 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.859 0.838 . . . . 0.0 112.612 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.0 21.08 12.32 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.769 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.26 142.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.079 . . . . 0.0 113.42 -176.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.673 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 21.2 t -107.97 128.82 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.902 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.8 t -104.07 -176.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.789 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 99' ' ' VAL . 9.5 m-20 -161.42 138.11 8.45 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.703 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 40.0 t -96.72 109.29 47.75 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.803 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.72 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 46.5 Cg_endo . . . . . 0 C--N 1.308 -1.583 0 C-N-CA 121.962 1.775 . . . . 0.0 112.309 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 95' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.332 0.587 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.06 117.21 28.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.915 HG22 HG23 ' A' ' 97' ' ' ILE . 3.5 t -120.69 144.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.903 HG22 ' CG ' ' A' ' 14' ' ' GLU . 7.9 t -128.53 130.22 68.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 121.803 0.811 . . . . 0.0 109.386 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.856 ' CE2' HD13 ' A' ' 15' ' ' LEU . 44.9 m-85 -106.48 137.61 44.16 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.479 0.657 . . . . 0.0 112.263 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.5 t -120.17 127.97 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.713 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.923 ' CB ' HG22 ' A' ' 11' ' ' THR . 87.4 p -79.47 154.29 29.0 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.213 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.609 ' CE1' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -67.6 -5.28 14.8 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.262 0.553 . . . . 0.0 109.827 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -93.33 -13.2 28.43 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.146 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 28.19 4.19 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.167 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.923 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -109.83 144.42 38.3 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.835 -1.391 . . . . 0.0 108.064 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.759 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -123.71 147.65 47.27 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.856 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.594 ' CD ' ' CD1' ' A' ' 32' ' ' ILE . 2.6 ttm-85 -140.04 146.96 39.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.601 -0.687 . . . . 0.0 109.205 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.903 ' CG ' HG22 ' A' ' 4' ' ' VAL . 12.1 mp0 -130.51 117.26 19.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.633 -1.292 . . . . 0.0 110.965 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.856 HD13 ' CE2' ' A' ' 5' ' ' TYR . 1.3 mp -115.15 -172.64 2.17 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.215 1.007 . . . . 0.0 111.974 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -115.74 98.53 6.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.885 HG12 ' HB3' ' A' ' 90' ' ' MET . 41.4 t -98.48 99.89 9.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.61 -165.75 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.734 0.778 . . . . 0.0 111.281 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -72.02 121.9 19.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.684 0.754 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.73 -8.17 29.87 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.399 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 22' ' ' SER . 58.2 t -103.77 166.78 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.461 . . . . 0.0 110.637 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.598 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.92 153.3 37.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 99' ' ' VAL . 6.5 mt -46.37 -31.39 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.303 . . . . 0.0 109.949 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 1.465 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 11.5 ttt -77.69 -57.89 3.57 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.861 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.526 ' CG ' HG13 ' A' ' 21' ' ' VAL . 34.8 tt0 -37.23 -68.8 0.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.99 -0.444 . . . . 0.0 111.203 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.59 ' C ' HD22 ' A' ' 15' ' ' LEU . . . -44.37 -68.69 0.18 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.65 -1.281 . . . . 0.0 108.429 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -47.33 -46.71 25.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.907 0.861 . . . . 0.0 109.638 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.767 HG12 ' N ' ' A' ' 29' ' ' SER . 1.2 t -46.56 -62.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.767 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -48.24 -46.86 35.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.206 1.003 . . . . 0.0 108.674 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.809 ' OD1' HD21 ' A' ' 15' ' ' LEU . 1.2 m120 -66.02 -2.38 3.99 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.11 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.34 -8.82 60.14 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 15' ' ' LEU . 1.4 mt -42.51 -33.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -1.021 . . . . 0.0 109.422 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.731 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 61.2 m-85 -111.21 61.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.374 -0.93 . . . . 0.0 112.849 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.53 48.85 0.82 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.931 -1.106 . . . . 0.0 108.023 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.827 HD12 HG22 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -83.43 -141.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.745 . . . . 0.0 110.698 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.827 HG22 HD12 ' A' ' 35' ' ' ILE . 13.3 m -93.18 -158.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' OD1' ' A' ' 38' ' ' ASP . . . -120.05 79.82 0.32 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.9 m-20 -120.16 -69.18 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 109.651 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.676 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 23.7 p -69.84 -33.49 72.36 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.14 33.45 2.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.91 31.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.644 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 43.7 t -140.09 7.98 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.375 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.886 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 65.67 56.75 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.316 1.055 . . . . 0.0 110.997 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.581 ' H ' ' CB ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -132.28 31.6 4.07 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.796 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -110.77 153.13 25.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.39 -4.44 14.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.543 -0.723 . . . . 0.0 109.101 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -110.34 -22.77 11.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.325 -0.859 . . . . 0.0 112.551 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.888 ' O ' HG13 ' A' ' 50' ' ' VAL . 61.6 m -74.72 7.64 2.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.271 -1.518 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.896 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.2 t-160 -43.13 120.2 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.014 . . . . 0.0 108.339 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.888 HG13 ' O ' ' A' ' 48' ' ' CYS . 14.9 m -142.96 164.71 16.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.011 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.758 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 12.5 m-30 -115.05 119.23 35.74 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.588 0.708 . . . . 0.0 110.293 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.918 ' HB ' HG22 ' A' ' 57' ' ' THR . 29.3 t -85.53 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.919 ' O ' HG23 ' A' ' 57' ' ' THR . 20.5 p-10 -59.13 131.59 51.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.548 -1.97 . . . . 0.0 109.711 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 11.3 pt-20 -36.69 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.55 -42.39 67.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.454 -1.404 . . . . 0.0 112.172 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.753 ' O ' HG13 ' A' ' 60' ' ' VAL . 49.6 m-85 -93.85 -4.56 49.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.748 -1.22 . . . . 0.0 109.956 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.919 HG23 ' O ' ' A' ' 53' ' ' ASN . 4.5 p -81.06 -24.78 37.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -86.04 -30.24 22.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -0.803 . . . . 0.0 109.966 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.84 ' CB ' HD11 ' A' ' 94' ' ' LEU . 7.6 mmtt -79.74 -50.04 11.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.5 m -39.73 162.92 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 110.975 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 88' ' ' ILE . 38.8 Cg_endo -67.49 166.51 23.57 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.352 1.712 . . . . 0.0 110.957 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 115.18 20.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.822 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.534 ' HB1' ' CG ' ' A' ' 67' ' ' GLU . . . -69.44 146.63 51.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.484 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.494 ' O ' HD13 ' A' ' 68' ' ' ILE . 22.7 p30 -99.9 174.0 6.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.95 -1.094 . . . . 0.0 111.458 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 1.7 pp20? -43.31 -29.18 0.39 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.884 -0.51 . . . . 0.0 110.913 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.1 OUTLIER -64.69 -21.46 66.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.013 -1.054 . . . . 0.0 109.774 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.4 tm-20 -95.88 1.96 53.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.513 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -91.78 -61.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 111.297 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -73.24 -48.52 19.04 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.735 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.308 3.3 ttp -48.63 -49.26 38.0 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 123.312 1.53 . . . . 0.0 108.496 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.649 HD12 ' OE2' ' A' ' 67' ' ' GLU 0.298 0.0 OUTLIER -72.35 -33.02 66.97 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.269 -179.547 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.931 ' HB2' HD13 ' A' ' 78' ' ' LEU . 3.2 tt0 -86.15 8.59 20.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.091 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.571 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 34.4 m -49.03 -49.44 41.13 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.66 -1.275 . . . . 0.0 108.216 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.2 m -90.52 115.88 30.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 75' ' ' THR . 13.1 t -48.76 85.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 111.203 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -117.17 36.38 4.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.931 -1.106 . . . . 0.0 109.977 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.23 52.55 2.15 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.526 0.679 . . . . 0.0 110.192 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.931 HD13 ' HB2' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -19.79 119.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.553 0.692 . . . . 0.0 112.13 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -83.46 -168.01 0.17 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.371 -0.831 . . . . 0.0 108.762 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 42.8 Cg_endo -81.07 -27.17 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.584 1.307 . . . . 0.0 109.395 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.51 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 16.4 p30 -107.73 -5.55 17.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 111.319 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 21.5 m -48.97 153.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.617 -1.302 . . . . 0.0 110.409 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.67 ' HG2' ' OE1' ' A' ' 87' ' ' GLN . 4.9 mtp180 -175.03 153.28 1.61 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.484 -0.76 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.902 ' O ' ' NE2' ' A' ' 87' ' ' GLN . 11.0 mt -74.6 137.62 42.43 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.679 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 24.3 p -39.58 -22.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.137 -1.602 . . . . 0.0 113.257 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.465 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 11.5 m -110.82 43.43 1.43 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.6 -33.26 2.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.217 -1.552 . . . . 0.0 111.731 178.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.716 HG21 ' CG1' ' A' ' 60' ' ' VAL . 2.3 mt -85.73 148.37 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.007 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -111.43 156.04 12.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.885 ' HB3' HG12 ' A' ' 17' ' ' VAL . 20.6 tpp -108.37 128.59 54.9 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 120.668 -1.27 . . . . 0.0 111.525 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.466 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -97.13 167.78 11.38 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.56 -0.71 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.743 1.391 . . . . 0.0 111.261 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.6 pp20? -110.32 -40.75 4.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.636 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.84 HD11 ' CB ' ' A' ' 59' ' ' LYS . 1.5 mt -73.65 58.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.28 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.71 146.52 27.12 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.442 -1.411 . . . . 0.0 112.087 -178.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 105.46 20.14 9.86 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.915 HG23 HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -73.04 136.56 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 122.365 1.079 . . . . 0.0 111.833 -177.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.802 ' N ' HD12 ' A' ' 97' ' ' ILE . 60.8 t -110.94 122.8 66.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.209 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.5 t -104.27 169.1 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.709 -1.244 . . . . 0.0 109.881 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.3 m-20 -162.06 138.84 8.13 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.73 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 6' ' ' VAL . 4.1 t -90.69 135.34 29.22 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.75 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 33.6 Cg_endo -66.92 126.53 15.4 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.757 1.398 . . . . 0.0 114.767 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.609 ' HA ' ' CE1' ' A' ' 8' ' ' HIS . 7.6 p-10 -103.5 27.34 7.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.653 HH21 ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -49.47 -18.64 0.43 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.193 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' N ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 pt20 -75.91 1.54 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.286 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.556 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.06 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.656 ' H2 ' ' C ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 110.27 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -52.88 122.99 10.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 108.667 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.129 HG22 ' CG2' ' A' ' 97' ' ' ILE . 42.1 t -138.36 144.98 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 117.889 -1.524 . . . . 0.0 112.24 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.692 HG13 ' HG3' ' A' ' 14' ' ' GLU . 2.9 t -130.7 130.4 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.799 ' CD1' HG21 ' A' ' 99' ' ' VAL . 42.6 m-85 -103.33 141.46 35.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.82 0.819 . . . . 0.0 112.436 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.852 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.4 t -120.34 157.75 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.194 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.617 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.9 152.19 31.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.732 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.38 -13.41 5.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.945 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -96.84 -2.8 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 110.323 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.34 -36.45 4.26 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.154 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.603 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.5 133.18 20.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.768 -1.431 . . . . 0.0 109.229 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.852 ' HG2' HG13 ' A' ' 6' ' ' VAL . 37.4 mtm105 -124.38 162.24 24.26 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.669 0.747 . . . . 0.0 111.288 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' CD ' HG12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -140.17 156.7 46.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.649 -0.657 . . . . 0.0 109.266 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.692 ' HG3' HG13 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -130.69 127.19 38.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.787 -1.195 . . . . 0.0 110.471 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.025 HD11 HD12 ' A' ' 32' ' ' ILE . 12.6 mt -120.45 150.77 40.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 110.744 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -104.0 92.32 4.34 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.874 HG22 ' HB2' ' A' ' 26' ' ' ALA . 46.6 t -98.54 167.23 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 111.002 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -116.01 -133.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.449 -0.782 . . . . 0.0 110.738 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.528 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -110.24 123.01 49.0 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.279 -0.888 . . . . 0.0 110.671 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.29 -6.27 30.31 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.481 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 22' ' ' SER . 63.2 t -98.18 169.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.868 -1.372 . . . . 0.0 110.742 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.605 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.68 159.42 25.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.701 HD21 ' SD ' ' A' ' 90' ' ' MET . 10.9 mt -50.48 -35.8 30.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 109.616 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 1.187 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -73.33 -59.72 2.58 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.63 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.594 ' CG ' HG13 ' A' ' 21' ' ' VAL . 46.4 tt0 -37.85 -69.66 0.11 Allowed 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.763 -0.586 . . . . 0.0 111.691 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.874 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -47.27 -52.03 17.27 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.303 -1.498 . . . . 0.0 108.863 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -59.05 -59.51 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.766 0.793 . . . . 0.0 109.527 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG23 ' HG3' ' A' ' 24' ' ' MET 0.287 1.1 t -29.97 -60.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.723 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.53 -47.51 81.31 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.038 0.923 . . . . 0.0 108.872 179.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.492 ' HB3' HG13 ' A' ' 32' ' ' ILE . 1.5 m120 -59.61 -10.67 3.76 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 81.71 -5.54 69.24 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.025 HD12 HD11 ' A' ' 15' ' ' LEU . 38.0 mt -42.92 -30.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.537 -0.978 . . . . 0.0 108.905 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.732 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 57.3 m-85 -109.14 60.58 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.364 -0.835 . . . . 0.0 111.576 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' TYR . 9.4 p-10 -49.34 -22.99 1.24 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.017 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.762 ' O ' HG23 ' A' ' 35' ' ' ILE . 18.1 tt -79.86 105.62 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.18 0.514 . . . . 0.0 109.745 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.02 142.77 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.866 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.17 -137.62 5.46 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 2.8 m-20 -106.67 5.13 28.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.274 . . . . 0.0 110.315 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.641 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 25.1 p -69.96 -40.02 75.67 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.732 -0.605 . . . . 0.0 111.423 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.5 31.3 1.59 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.73 35.34 25.48 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.793 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 8.3 t -140.12 -0.8 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -1.128 . . . . 0.0 111.711 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.801 ' HB1' ' HE1' ' A' ' 70' ' ' MET . . . 77.57 57.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.922 0.868 . . . . 0.0 113.336 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -133.55 27.39 4.04 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.025 ' SG ' HD22 ' A' ' 84' ' ' LEU . 5.9 p -111.04 142.28 43.4 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -110.61 8.97 22.99 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.562 ' HB ' HD11 ' A' ' 35' ' ' ILE . 7.4 p -111.01 -30.09 7.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.01 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.654 ' C ' HD23 ' A' ' 84' ' ' LEU . 1.3 m -84.24 32.42 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.966 -1.084 . . . . 0.0 110.631 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.664 ' CE1' ' O ' ' A' ' 71' ' ' LEU . 6.0 t-160 -57.94 134.2 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.602 -1.311 . . . . 0.0 109.673 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 83' ' ' ARG . 34.6 m -150.12 159.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.775 -1.203 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 30.2 m-85 -122.75 134.66 54.43 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.3 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.632 ' HB ' HG22 ' A' ' 57' ' ' THR . 15.1 t -91.57 156.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.824 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.586 ' O ' ' CG2' ' A' ' 57' ' ' THR . 4.4 p30 -59.23 -157.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.058 -1.651 . . . . 0.0 108.941 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.27 -7.25 23.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 110.309 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.72 -39.68 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 113.05 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.649 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 67.4 m-85 -84.7 1.94 44.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.739 -1.225 . . . . 0.0 111.772 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.632 HG22 ' HB ' ' A' ' 52' ' ' VAL . 8.3 p -80.56 -54.37 5.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.886 -1.134 . . . . 0.0 109.526 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 57' ' ' THR . 4.9 p-10 -62.29 -12.01 18.34 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.762 0.791 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.285 0.1 OUTLIER -79.67 -55.1 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 123.458 1.599 . . . . 0.0 109.553 180.0 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 HG23 ' A' ' 88' ' ' ILE 0.321 0.4 OUTLIER -84.6 155.61 62.19 Favored Pre-proline 0 C--N 1.28 -2.43 0 CA-C-N 112.975 -1.92 . . . . 0.0 110.101 -177.552 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 60' ' ' VAL . 36.5 Cg_endo -62.65 159.13 38.3 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.919 1.484 . . . . 0.0 111.858 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.73 -169.99 2.43 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.547 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 83' ' ' ARG . . . -110.11 162.73 14.28 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.763 -0.586 . . . . 0.0 110.918 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 1.024 ' O ' HD13 ' A' ' 68' ' ' ILE . 54.8 p30 -100.33 -156.41 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 111.343 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 6.4 pt-20 -73.73 -28.71 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 110.286 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.6 ttm180 -64.57 -50.76 66.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.293 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 32.9 tt0 -72.53 14.55 0.24 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.856 -0.528 . . . . 0.0 111.903 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.024 HD13 ' O ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -91.65 -46.17 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.385 -1.447 . . . . 0.0 110.2 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -85.32 -60.27 1.84 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.801 ' HE1' ' HB1' ' A' ' 43' ' ' ALA . 2.8 ptm -48.13 -43.93 31.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.904 -1.351 . . . . 0.0 108.295 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.67 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -62.62 -38.56 90.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.597 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 2.8 tt0 -83.75 29.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.903 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.911 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -48.79 -81.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.418 -1.426 . . . . 0.0 107.931 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.611 HG21 ' HD3' ' A' ' 104' ' ' ARG . 2.3 m -81.35 129.13 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.25 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 75' ' ' THR . 8.9 t -49.11 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.903 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -104.54 48.41 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 110.202 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.552 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 18.1 pt-20 39.3 60.73 1.47 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.507 -0.746 . . . . 0.0 110.786 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.511 HD22 ' CD ' ' A' ' 72' ' ' GLU . 1.1 tp -30.28 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.541 . . . . 0.0 111.466 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -145.35 -166.56 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.314 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.1 Cg_endo -80.76 -32.59 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.334 1.176 . . . . 0.0 110.942 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.519 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 39.7 p-10 -102.52 4.38 38.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 111.429 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -62.96 135.61 57.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.93 -1.106 . . . . 0.0 109.827 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 1.018 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.07 169.28 23.9 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 118.455 -1.298 . . . . 0.0 110.759 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.025 HD22 ' SG ' ' A' ' 45' ' ' CYS . 1.4 mt -90.81 148.35 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.611 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 4.9 m -46.8 -27.53 1.25 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.677 -1.265 . . . . 0.0 110.526 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.187 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 3.9 m -102.38 40.31 1.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.287 -0.883 . . . . 0.0 111.511 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.665 HE22 ' HB2' ' A' ' 43' ' ' ALA . 6.9 mm100 -126.25 -41.54 1.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 112.187 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.018 HD11 ' HG3' ' A' ' 83' ' ' ARG . 3.3 mm -79.39 147.71 6.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.2 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.4 mm -112.31 151.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.804 ' HG2' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -110.46 111.72 23.16 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -100.65 170.86 6.08 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 42.3 Cg_endo -73.37 -5.21 16.75 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.824 1.434 . . . . 0.0 110.634 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.506 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.31 -29.54 8.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.117 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 59' ' ' LYS . 7.3 mt -97.0 54.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 109.872 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' HB3' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.39 148.41 25.19 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.278 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.649 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.25 23.32 9.12 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.129 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -78.03 117.94 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.405 1.098 . . . . 0.0 113.324 -176.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 9.5 t -82.55 124.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.826 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.799 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.9 t -104.31 -179.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.673 -1.267 . . . . 0.0 109.547 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 99' ' ' VAL . 9.5 m-20 -161.82 142.47 10.64 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.521 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.765 HG13 ' HD2' ' A' ' 102' ' ' PRO . 50.6 t -92.06 148.01 35.94 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.765 ' HD2' HG13 ' A' ' 101' ' ' VAL . 39.6 Cg_endo -65.71 125.33 14.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.521 1.274 . . . . 0.0 112.611 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.562 ' HB3' ' CB ' ' A' ' 8' ' ' HIS . 6.9 p-10 -110.58 77.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.738 . . . . 0.0 109.884 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.611 ' HD3' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -70.38 -77.41 0.09 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -99.7 107.45 19.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.278 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.241 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.553 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.287 0.565 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -81.08 115.69 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.855 . . . . 0.0 109.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.708 ' HA ' HG23 ' A' ' 97' ' ' ILE . 3.8 t -109.85 137.37 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.913 -1.117 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.5 t -131.98 128.63 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.2 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.984 ' CE1' HG21 ' A' ' 99' ' ' VAL . 71.1 m-85 -104.75 146.98 28.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.571 0.7 . . . . 0.0 112.385 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.724 HG13 ' HG2' ' A' ' 12' ' ' ARG . 5.2 t -121.24 133.55 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.185 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.632 ' CB ' HG22 ' A' ' 11' ' ' THR . 62.8 p -79.56 -152.56 0.07 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.612 ' ND1' ' CB ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -110.06 -10.6 14.68 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.059 -1.025 . . . . 0.0 108.677 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 17.6 p-10 -100.55 3.66 42.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.357 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.57 -39.24 2.97 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.632 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.8 138.13 15.24 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.866 -1.373 . . . . 0.0 109.974 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.724 ' HG2' HG13 ' A' ' 6' ' ' VAL . 54.4 mtt180 -130.25 164.24 24.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.387 0.613 . . . . 0.0 111.215 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -128.2 161.04 30.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.316 -0.865 . . . . 0.0 109.09 179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' CG ' HG22 ' A' ' 4' ' ' VAL . 1.1 mp0 -131.11 139.64 49.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.7 -1.25 . . . . 0.0 110.856 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.727 HD11 ' CA ' ' A' ' 27' ' ' ALA . 10.8 mt -128.08 144.89 51.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.902 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.87 84.08 2.09 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.679 HG13 HG11 ' A' ' 21' ' ' VAL . 18.0 t -98.63 172.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.661 0.743 . . . . 0.0 111.526 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.541 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -123.43 -159.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.809 0.814 . . . . 0.0 111.537 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.511 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -87.26 125.56 34.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.312 -179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.01 -5.13 30.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.912 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.6 t -102.3 172.1 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 122.442 1.115 . . . . 0.0 110.338 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.619 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -118.47 -169.72 1.76 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.829 HD21 ' SD ' ' A' ' 90' ' ' MET . 18.0 mt -87.99 -14.07 40.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.832 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.828 ' HE3' HG23 ' A' ' 35' ' ' ILE . 2.3 ttp -90.9 -65.86 0.98 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.802 -1.186 . . . . 0.0 112.327 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.912 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.32 -26.42 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 111.44 -178.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -92.35 -34.83 14.03 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.859 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . . . -77.28 -41.84 39.29 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.017 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 33' ' ' TYR . 62.8 t -55.17 -60.42 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.861 -1.15 . . . . 0.0 108.413 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -51.39 -38.31 52.76 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.588 ' CG ' HD21 ' A' ' 15' ' ' LEU . 2.8 m-80 -70.48 1.64 4.86 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 84.34 -15.63 38.93 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 mt -41.55 -42.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.323 -1.104 . . . . 0.0 108.122 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -161.72 101.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.549 -0.719 . . . . 0.0 109.778 175.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 2.2 p30 -70.66 53.85 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.828 HG23 ' HE3' ' A' ' 24' ' ' MET . 2.3 tt -107.7 87.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.243 0.544 . . . . 0.0 110.871 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.646 HG13 HG11 ' A' ' 28' ' ' VAL . 3.2 m -120.37 32.47 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -0.86 . . . . 0.0 110.567 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.46 -48.6 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -79.81 -41.62 26.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -1.165 . . . . 0.0 110.339 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.9 p -110.84 -48.09 3.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.81 -0.556 . . . . 0.0 110.906 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . 44.53 36.64 4.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.16 28.44 49.29 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.9 m -124.71 -13.67 6.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -1.105 . . . . 0.0 110.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.834 ' HB1' ' HE1' ' A' ' 70' ' ' MET . . . 75.51 55.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.797 0.808 . . . . 0.0 112.689 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -132.14 37.12 3.59 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.966 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.3 p -111.23 157.12 20.47 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -111.89 -10.24 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.016 . . . . 0.0 110.925 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.58 ' CG2' HD13 ' A' ' 35' ' ' ILE . 6.3 t -110.56 -19.01 13.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.857 -1.152 . . . . 0.0 113.257 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.812 ' HB2' HD22 ' A' ' 84' ' ' LEU . 1.8 m -80.36 20.31 0.7 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.316 -1.49 . . . . 0.0 110.994 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.651 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.7 t-160 -48.23 139.86 8.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 48' ' ' CYS . 14.2 m -143.97 156.17 15.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.627 -1.296 . . . . 0.0 109.81 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 2.9 m-30 -119.8 119.02 32.36 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.998 0.904 . . . . 0.0 109.367 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 97' ' ' ILE . 21.4 t -100.8 152.0 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 111.009 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -74.29 130.92 40.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.398 -1.439 . . . . 0.0 109.324 178.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -36.79 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.505 -0.747 . . . . 0.0 111.519 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.09 -19.82 63.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.03 -1.043 . . . . 0.0 111.273 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.97 ' CB ' HD13 ' A' ' 97' ' ' ILE . 43.7 m-85 -127.66 -11.36 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.881 -1.137 . . . . 0.0 110.572 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.14 -17.86 48.4 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.191 -0.943 . . . . 0.0 108.975 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.2 p-10 -89.68 -30.83 17.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.589 ' O ' HD11 ' A' ' 94' ' ' LEU . 3.5 mmmm -82.81 12.01 5.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.833 . . . . 0.0 110.259 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.881 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -116.78 155.45 49.03 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.4 Cg_endo -62.94 156.76 52.36 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.084 1.57 . . . . 0.0 111.859 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.14 128.09 33.37 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.754 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -69.38 156.24 39.13 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.551 -0.718 . . . . 0.0 110.064 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.685 ' O ' HD13 ' A' ' 68' ' ' ILE . 27.5 p30 -100.57 -172.34 2.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 111.648 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.56 -21.49 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 110.711 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.3 ttm180 -64.12 -59.07 4.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.003 -1.061 . . . . 0.0 109.253 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.79 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 20.1 tt0 -65.55 10.71 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.656 . . . . 0.0 112.436 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.18 -40.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 119.453 -2.029 . . . . 0.0 110.952 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.18 -57.95 1.62 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.024 ' HE2' HD12 ' A' ' 84' ' ' LEU . 6.1 ptm -48.14 -43.05 30.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.222 -1.164 . . . . 0.0 109.173 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.749 HD22 HD11 ' A' ' 78' ' ' LEU 0.281 0.0 OUTLIER -70.29 -33.2 71.27 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.935 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 4.4 tt0 -90.78 3.53 54.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.23 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 46' ' ' ALA . 1.6 m -49.11 -54.73 14.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.665 -1.272 . . . . 0.0 109.457 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 74' ' ' VAL . 34.8 m -90.04 105.72 16.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 75' ' ' THR . 8.9 t -48.53 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.384 -0.823 . . . . 0.0 110.888 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.2 50.9 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.67 60.45 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 110.309 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.749 HD11 HD22 ' A' ' 71' ' ' LEU . 2.3 tp -29.87 144.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 111.787 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 14.5 mtmt -120.6 170.76 6.65 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.747 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.6 Cg_endo -69.48 -30.7 23.16 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.649 1.341 . . . . 0.0 109.926 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 8.3 p-10 -97.35 -6.39 34.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 13.1 m -49.12 165.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.767 -1.208 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.695 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.27 167.45 3.39 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.638 -0.664 . . . . 0.0 109.48 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.024 HD12 ' HE2' ' A' ' 70' ' ' MET . 0.8 OUTLIER -95.7 141.4 29.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . 4.7 m -41.67 -27.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 110.462 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 84' ' ' LEU . 2.0 m -108.32 43.78 1.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.589 -0.694 . . . . 0.0 111.034 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.752 HE21 ' HB2' ' A' ' 67' ' ' GLU . 4.5 mm100 -126.08 -33.83 2.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 111.845 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.941 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -92.03 149.97 3.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 110.267 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 5.2 mm -110.34 156.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.829 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.1 tpt -110.02 113.54 26.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 0.0 110.792 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.455 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -106.51 171.44 4.75 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -72.85 -1.62 10.71 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.908 1.478 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 4.7 pt-20 -110.19 -30.66 7.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 59' ' ' LYS . 7.3 mt -94.14 52.94 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.949 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 4.5 p-10 -100.48 145.66 28.0 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.017 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.32 22.0 10.22 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.011 HD11 HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -70.9 130.05 34.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.994 0.902 . . . . 0.0 113.162 -176.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.739 ' N ' HD12 ' A' ' 97' ' ' ILE . 11.0 t -103.75 122.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.984 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.4 t -103.98 -174.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.66 ' H ' HG12 ' A' ' 99' ' ' VAL . 7.2 m-20 -161.7 139.79 9.17 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.065 176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' VAL . 9.6 t -98.13 103.02 15.6 Favored Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.0 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.68 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 41.8 Cg_endo -69.62 80.99 0.81 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.155 1.904 . . . . 0.0 112.772 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.612 ' CB ' ' ND1' ' A' ' 8' ' ' HIS . 12.8 t70 -111.05 39.89 2.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.593 -1.317 . . . . 0.0 110.438 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -56.41 -172.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.082 -1.011 . . . . 0.0 111.326 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.44 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 2.1 mt-30 -120.22 -9.13 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.412 ' OXT' HG23 ' A' ' 75' ' ' THR . 60.0 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.259 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.55 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.317 0.58 . . . . 0.0 110.475 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -88.86 134.46 33.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.852 . . . . 0.0 109.928 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.98 HG22 ' CG2' ' A' ' 97' ' ' ILE . 14.0 t -122.61 147.43 26.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.883 -1.136 . . . . 0.0 111.155 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.996 HG23 ' HG2' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -131.18 130.86 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 23' ' ' LEU . 83.4 m-85 -111.46 123.73 50.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.462 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.3 t -92.27 151.86 3.51 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.84 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.571 ' CB ' HG22 ' A' ' 11' ' ' THR . 17.1 p -113.53 141.36 47.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.981 -1.074 . . . . 0.0 109.403 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.636 ' CE1' ' CB ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -41.81 -23.88 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.607 -0.683 . . . . 0.0 110.723 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' SER . 6.2 p-10 -93.44 -1.22 55.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.878 -1.139 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.36 -32.05 6.93 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.949 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.571 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.62 141.35 9.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.874 -1.368 . . . . 0.0 109.476 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.7 mtm180 -127.45 124.93 39.6 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.791 -0.568 . . . . 0.0 111.042 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -102.34 157.6 16.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.996 ' HG2' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -130.58 135.31 47.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.989 -1.069 . . . . 0.0 110.804 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.858 HD11 ' CA ' ' A' ' 27' ' ' ALA . 7.3 mt -124.55 142.0 51.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 111.035 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -99.92 82.38 2.57 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 26' ' ' ALA . 40.5 t -98.17 169.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.575 -0.703 . . . . 0.0 110.413 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.542 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -126.09 -149.95 0.43 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.521 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -90.85 122.65 33.74 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.617 0.722 . . . . 0.0 110.498 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -8.57 30.89 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.623 HG22 ' NE2' ' A' ' 25' ' ' GLN . 18.5 t -96.57 170.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.0 -1.294 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.572 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 166.51 13.91 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.7 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 4.8 mt -69.98 -5.34 25.69 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.083 -1.847 . . . . 0.0 108.332 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.826 ' HE1' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -84.22 -72.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.623 ' NE2' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -42.87 -57.7 2.7 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 121.783 -0.573 . . . . 0.0 112.242 -176.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.813 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -57.95 -57.78 11.29 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.57 -1.956 . . . . 0.0 108.386 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.858 ' CA ' HD11 ' A' ' 15' ' ' LEU . . . -51.48 -57.96 7.6 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.516 0.674 . . . . 0.0 109.97 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.068 HG22 ' CG2' ' A' ' 35' ' ' ILE . 13.4 t -39.79 -71.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.302 0.572 . . . . 0.0 109.627 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -48.71 -46.41 40.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -0.835 . . . . 0.0 109.387 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.523 ' ND2' HD22 ' A' ' 15' ' ' LEU . 4.2 m-80 -59.67 -8.57 2.09 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.92 -5.96 76.86 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.8 HG22 ' CE1' ' A' ' 33' ' ' TYR . 2.9 mt -44.68 -35.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.8 ' CE1' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.79 111.01 6.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.025 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -66.47 54.18 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.011 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.068 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.2 tp -103.75 115.51 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.867 -0.52 . . . . 0.0 109.882 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 37' ' ' GLY . 41.1 t -111.73 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 111.083 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -79.88 53.21 4.32 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' CB ' HD11 ' A' ' 35' ' ' ILE . 1.8 m-20 -120.27 -63.95 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -1.193 . . . . 0.0 110.055 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.6 p -110.32 -54.3 2.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.045 -1.034 . . . . 0.0 110.15 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.54 47.54 7.19 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.36 59.38 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 8.0 t -116.93 -36.74 3.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -1.078 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.04 60.68 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 111.331 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.574 ' C ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -131.3 14.01 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.237 -0.914 . . . . 0.0 110.438 178.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.975 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.94 124.28 52.26 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.625 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -79.14 4.55 14.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.689 -1.257 . . . . 0.0 109.885 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.6 p -91.38 -22.83 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.702 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.81 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -95.53 13.63 25.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.049 -1.032 . . . . 0.0 110.029 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.755 ' NE2' HD21 ' A' ' 71' ' ' LEU . 22.3 t-160 -50.51 137.33 19.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.505 -1.372 . . . . 0.0 108.733 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -142.67 158.93 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 102' ' ' PRO . 3.5 m-30 -117.71 109.98 17.29 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.624 0.726 . . . . 0.0 109.694 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.913 ' CG1' HD11 ' A' ' 97' ' ' ILE . 10.7 t -85.61 162.27 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 1.047 ' O ' HG23 ' A' ' 57' ' ' THR . 10.1 p30 -82.92 139.0 33.64 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 119.947 -1.72 . . . . 0.0 109.273 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 53' ' ' ASN . 5.1 pt-20 -41.68 -21.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.995 -1.065 . . . . 0.0 111.503 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.921 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -72.93 -53.02 12.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.756 -1.215 . . . . 0.0 111.637 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.853 ' HB3' HD12 ' A' ' 97' ' ' ILE . 48.3 m-85 -85.03 -4.75 59.27 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.841 -1.162 . . . . 0.0 111.072 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.047 HG23 ' O ' ' A' ' 53' ' ' ASN . 10.2 p -80.28 -51.24 9.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.873 -1.142 . . . . 0.0 109.501 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD2' ' CE ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.05 -12.03 16.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.735 ' HB3' HD13 ' A' ' 94' ' ' LEU 0.284 8.8 mmpt? -79.29 -52.42 8.14 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.876 1.798 . . . . 0.0 108.208 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -84.75 144.59 42.54 Favored Pre-proline 0 C--N 1.279 -2.458 0 CA-C-N 112.201 -2.272 . . . . 0.0 110.435 -177.494 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.7 Cg_endo -62.53 162.97 22.45 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.934 1.492 . . . . 0.0 112.145 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -168.64 1.84 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.352 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 87' ' ' GLN . . . -110.9 171.52 7.42 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.379 0.609 . . . . 0.0 111.056 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.693 ' O ' HD13 ' A' ' 68' ' ' ILE . 48.1 p-10 -100.81 -153.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.605 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -71.67 -18.52 62.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 110.217 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -64.51 -52.16 59.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 109.241 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -63.55 0.09 0.82 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.865 -0.522 . . . . 0.0 111.33 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.1 mp -91.16 -18.78 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 119.79 -1.819 . . . . 0.0 111.359 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.52 -79.58 1.37 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 120.753 -1.217 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.215 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.58 -32.16 7.68 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.169 -1.195 . . . . 0.0 110.134 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.934 HD22 HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.64 -30.63 69.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.251 -0.905 . . . . 0.0 108.783 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -85.07 -29.51 24.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 109.691 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -49.29 -44.26 43.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 109.491 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.625 HG11 ' O ' ' A' ' 46' ' ' ALA . 13.4 m -90.17 70.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.531 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 75' ' ' THR . 9.2 t -48.92 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 0.0 111.11 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.588 ' HB1' ' HG3' ' A' ' 104' ' ' ARG . . . -118.12 66.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.02 -1.05 . . . . 0.0 109.529 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 1.7 pm0 39.88 49.08 2.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.814 0.816 . . . . 0.0 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.934 HD11 HD22 ' A' ' 71' ' ' LEU . 2.4 tp -23.46 142.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.363 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.03 170.48 5.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.755 . . . . 0.0 108.978 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.3 Cg_endo -69.2 -29.39 26.59 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.649 1.341 . . . . 0.0 109.481 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 57' ' ' THR . 23.0 p-10 -99.58 -7.98 25.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.657 -0.652 . . . . 0.0 110.522 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.62 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 67.0 m -48.98 153.58 0.86 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.089 -1.007 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -175.45 161.67 2.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.898 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.215 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -78.38 140.22 38.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 179.021 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.747 ' HB2' ' HE3' ' A' ' 24' ' ' MET . 47.4 m -42.27 -28.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.023 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -92.53 35.6 1.02 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.636 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.681 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 6.9 tp-100 -126.49 -41.93 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.465 -1.397 . . . . 0.0 112.374 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.908 ' CD1' HG21 ' A' ' 52' ' ' VAL . 1.3 mt -94.65 154.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-O 122.099 0.952 . . . . 0.0 111.583 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.2 mm -110.88 160.85 9.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.55 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 3.4 tpt -110.17 113.62 26.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 110.083 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.5 OUTLIER -92.92 166.12 17.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.5 Cg_endo -73.02 -25.46 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.502 . . . . 0.0 110.538 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.4 pm0 -91.32 -26.76 18.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.813 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 59' ' ' LYS . 7.3 mt -94.9 51.0 1.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.058 0.932 . . . . 0.0 109.417 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 4.6 p-10 -100.49 152.53 20.28 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.677 0.751 . . . . 0.0 112.203 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.64 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 97.06 28.1 8.93 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.98 ' CG2' HG22 ' A' ' 3' ' ' VAL . 9.8 tt -74.2 155.02 6.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 123.259 1.504 . . . . 0.0 113.533 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.653 ' HA ' HG12 ' A' ' 4' ' ' VAL . 6.4 t -120.79 91.55 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.362 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -104.66 171.35 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.644 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -145.69 172.79 12.76 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.32 1.057 . . . . 0.0 112.083 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 6' ' ' VAL . 13.1 t -105.69 111.94 64.62 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 42.8 Cg_endo -70.39 -0.3 7.23 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.906 1.477 . . . . 0.0 111.754 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.636 ' CB ' ' CE1' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -53.28 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.962 . . . . 0.0 110.281 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.588 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.31 -172.33 2.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.414 -0.804 . . . . 0.0 111.504 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 30.4 tp60 -120.2 103.03 8.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.243 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.575 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.562 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.502 0.667 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.8 OUTLIER -82.96 109.64 17.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.728 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 2.5 t -109.5 134.54 51.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.921 -1.112 . . . . 0.0 110.634 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.965 HG22 ' OE1' ' A' ' 14' ' ' GLU . 93.4 t -124.11 107.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.259 1.028 . . . . 0.0 111.807 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.774 ' OH ' HD12 ' A' ' 15' ' ' LEU . 22.6 m-30 -83.46 130.26 35.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.4 t -120.18 134.07 64.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.393 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.667 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -79.58 -167.28 1.17 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 108.51 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.508 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -97.94 -9.95 25.35 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.952 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.43 -6.68 25.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 19.48 8.07 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.541 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.667 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -87.88 153.72 21.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.844 -1.386 . . . . 0.0 107.754 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 mtm180 -130.13 139.32 50.92 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.229 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.701 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.36 67.87 1.36 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.7 0.762 . . . . 0.0 108.991 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.965 ' OE1' HG22 ' A' ' 4' ' ' VAL . 18.6 mt-10 -67.96 140.21 56.41 Favored 'General case' 0 C--N 1.288 -2.065 0 O-C-N 120.767 -1.208 . . . . 0.0 110.896 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.774 HD12 ' OH ' ' A' ' 5' ' ' TYR . 8.0 mt -110.99 147.1 35.45 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.646 -0.659 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.59 86.43 3.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG13 HG11 ' A' ' 21' ' ' VAL . 25.3 t -98.88 172.32 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.697 0.761 . . . . 0.0 111.833 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.545 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -112.57 -144.78 0.39 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.603 0.716 . . . . 0.0 111.525 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -104.07 124.69 49.5 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.46 0.648 . . . . 0.0 110.346 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.3 3.19 38.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.912 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.5 t -107.65 172.36 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.613 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.65 179.85 4.21 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.876 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.919 HD21 ' SD ' ' A' ' 90' ' ' MET . 14.5 mt -79.06 -6.84 57.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.637 -1.289 . . . . 0.0 109.085 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.628 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.73 -76.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.904 0.859 . . . . 0.0 111.597 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.912 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.78 -24.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.075 -177.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.772 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -91.75 -33.18 15.12 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . . . -77.48 -51.35 10.9 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.065 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG13 ' HA ' ' A' ' 34' ' ' ASP . 96.5 t -45.04 -57.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -58.24 -37.72 75.47 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.026 0.917 . . . . 0.0 108.688 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.655 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.1 m-80 -68.92 1.81 3.12 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.279 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 85.78 -14.42 52.27 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 27' ' ' ALA . 1.3 mt -44.76 -54.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -1.196 . . . . 0.0 107.826 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.891 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.84 94.6 2.1 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.257 176.003 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.641 ' HA ' HG13 ' A' ' 28' ' ' VAL . 1.6 p30 -70.4 53.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.782 -1.199 . . . . 0.0 108.48 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.071 HD13 ' SG ' ' A' ' 48' ' ' CYS . 5.2 tt -89.57 104.1 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.583 . . . . 0.0 111.852 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 36' ' ' VAL . 61.5 t -120.87 37.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.138 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.23 -53.62 0.25 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.735 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 44' ' ' SER . 5.1 m-20 -79.41 -78.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.066 -1.255 . . . . 0.0 110.363 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.8 p -68.96 -39.25 79.58 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.771 -0.581 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.21 32.61 3.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.769 -2.133 . . . . 0.0 107.769 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.53 35.15 26.64 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 48.2 m -137.98 0.63 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -1.153 . . . . 0.0 111.473 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.875 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 71.82 57.4 0.17 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 112.416 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.464 ' C ' ' HG2' ' A' ' 70' ' ' MET . 3.8 t -133.01 32.11 3.8 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.006 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.6 p -111.87 131.59 55.26 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -91.77 5.4 49.99 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.063 -1.648 . . . . 0.0 109.109 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.791 HG21 HD12 ' A' ' 35' ' ' ILE . 5.9 t -110.55 -40.47 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.221 -0.924 . . . . 0.0 111.897 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 1.071 ' SG ' HD13 ' A' ' 35' ' ' ILE . 2.0 m -74.87 10.61 1.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.495 -1.378 . . . . 0.0 110.976 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.786 ' ND1' HG21 ' A' ' 74' ' ' VAL . 18.1 t-160 -45.88 138.83 4.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.355 -1.466 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.7 m -140.94 160.38 23.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.037 -1.039 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.675 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 10.1 m-30 -119.28 122.19 41.34 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.545 0.688 . . . . 0.0 109.398 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.898 HG21 ' CD1' ' A' ' 88' ' ' ILE . 41.2 t -96.31 169.66 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.339 -0.85 . . . . 0.0 110.079 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 1.041 ' O ' HG23 ' A' ' 57' ' ' THR . 11.9 p30 -86.45 137.41 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.648 -1.283 . . . . 0.0 108.854 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.0 pt-20 -40.3 -22.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.996 -1.065 . . . . 0.0 111.748 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.811 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -72.09 -53.87 11.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.81 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.679 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 55.5 m-85 -84.89 -4.78 59.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 0.0 111.286 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.041 HG23 ' O ' ' A' ' 53' ' ' ASN . 6.5 p -80.35 -52.32 7.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 109.99 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -63.79 -9.32 13.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.412 -0.805 . . . . 0.0 110.178 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.631 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.299 1.9 mmtp -79.29 -53.23 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.796 1.76 . . . . 0.0 109.086 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.019 HG21 HG22 ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -79.28 161.13 68.9 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 112.372 -2.195 . . . . 0.0 110.146 -177.56 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 60' ' ' VAL . 36.1 Cg_endo -60.63 163.64 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.774 1.407 . . . . 0.0 112.638 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.51 -148.23 0.06 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.831 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.796 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . . . -110.09 144.37 38.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.897 ' O ' HD13 ' A' ' 68' ' ' ILE . 49.8 p30 -100.43 -153.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.535 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 66' ' ' ARG . 1.2 pm0 -80.39 -27.37 38.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 110.065 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -75.21 -50.0 17.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.796 ' OE2' ' HB2' ' A' ' 63' ' ' ALA . 30.9 tt0 -63.84 -5.31 4.14 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.49 -0.756 . . . . 0.0 110.996 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.63 -13.47 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.28 -1.512 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -88.84 -80.32 1.3 Allowed Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.256 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.137 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.23 -34.77 10.74 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.977 -1.308 . . . . 0.0 109.528 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.682 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.29 -18.02 63.11 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.791 0.805 . . . . 0.0 109.269 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -90.95 -53.09 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.105 -0.997 . . . . 0.0 109.654 178.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.41 -24.08 1.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.807 . . . . 0.0 109.248 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.786 HG21 ' ND1' ' A' ' 49' ' ' HIS . 34.5 m -79.74 57.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.299 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 75' ' ' THR . 9.0 t -48.97 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.0 112.534 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.888 ' HB3' ' NH2' ' A' ' 104' ' ' ARG . . . -130.52 63.37 1.57 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.798 -1.189 . . . . 0.0 108.938 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.55 58.17 2.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.732 0.777 . . . . 0.0 109.413 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.682 HD11 HD22 ' A' ' 71' ' ' LEU . 2.5 tp -30.64 138.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.523 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.675 ' HG2' ' CZ ' ' A' ' 51' ' ' TYR . 5.4 mmmt -93.03 168.69 11.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 109.067 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.57 -25.44 40.89 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.71 1.374 . . . . 0.0 109.155 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.549 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 3.3 p30 -113.06 5.46 17.16 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.67 -0.644 . . . . 0.0 111.652 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.595 ' HG ' ' HG2' ' A' ' 79' ' ' LYS . 72.7 m -48.52 144.32 4.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.546 -1.346 . . . . 0.0 111.292 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.651 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -154.93 160.0 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.137 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -85.02 142.61 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 110.132 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.663 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 2.4 p -44.66 -25.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.875 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 5.3 m -108.65 40.71 1.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.444 0.64 . . . . 0.0 110.012 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.61 ' NE2' ' OE1' ' A' ' 67' ' ' GLU . 46.4 tp60 -122.22 -48.47 2.09 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.491 -0.756 . . . . 0.0 111.965 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.019 HG22 HG21 ' A' ' 60' ' ' VAL . 1.2 mt -87.46 153.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 121.944 0.878 . . . . 0.0 111.104 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.7 mm -111.26 156.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.919 ' SD ' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -110.5 92.49 4.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.099 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.72 171.73 11.69 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -78.86 -0.77 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.863 1.454 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 2.6 pt-20 -110.08 -31.22 7.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 109.403 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.554 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.3 mt -98.16 51.72 1.03 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.975 0.893 . . . . 0.0 108.791 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 8.0 p-10 -100.48 147.05 26.32 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 121.976 0.893 . . . . 0.0 113.189 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.647 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.57 28.1 7.69 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.679 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.9 125.52 38.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 8.6 t -82.49 120.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.754 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -104.55 -175.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.639 -1.288 . . . . 0.0 110.039 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.665 ' H ' HG12 ' A' ' 99' ' ' VAL . 13.9 m-20 -161.4 136.19 7.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.253 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 6' ' ' VAL . 2.6 t -95.71 115.7 65.7 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.655 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo -61.86 177.33 1.03 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.894 1.729 . . . . 0.0 112.486 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 2.6 p-10 -110.5 100.13 9.01 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.017 0.913 . . . . 0.0 111.503 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.888 ' NH2' ' HB3' ' A' ' 76' ' ' ALA . 8.5 mmp_? -87.76 -51.74 5.7 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' O ' ' CG ' ' A' ' 105' ' ' GLN . 5.8 pt20 -69.2 96.73 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.561 0.696 . . . . 0.0 110.494 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 5.9 ttmt -85.25 113.34 21.52 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 5.0 t -109.16 137.05 43.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.914 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 t -131.21 125.38 57.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.992 0.901 . . . . 0.0 108.667 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.006 ' CD1' HG21 ' A' ' 99' ' ' VAL 0.273 52.1 m-85 -105.08 140.21 38.6 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 -177.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.929 HG13 ' HG3' ' A' ' 12' ' ' ARG . 3.4 t -121.49 157.06 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.455 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.641 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 78.3 p -116.41 140.56 49.22 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.548 ' CB ' ' HB2' ' A' ' 103' ' ' ASP . 1.6 p-80 -48.0 -20.75 0.36 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.067 -1.02 . . . . 0.0 109.687 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.461 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 1.8 p30 -89.9 -3.89 57.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 -35.98 4.52 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.896 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.28 132.58 19.97 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.788 -1.419 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.929 ' HG3' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -130.32 153.05 49.06 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.767 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.83 163.45 27.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.916 . . . . 0.0 109.006 177.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.731 ' HG2' HG22 ' A' ' 4' ' ' VAL . 32.8 mt-10 -130.64 120.87 24.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.863 HD21 ' CG ' ' A' ' 30' ' ' ASN . 7.4 mt -109.72 145.45 36.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.872 -1.142 . . . . 0.0 112.123 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.7 92.09 5.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.83 HG13 HG11 ' A' ' 21' ' ' VAL . 96.2 t -98.77 170.75 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 112.029 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.597 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -119.67 -151.65 0.49 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.424 0.63 . . . . 0.0 110.623 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' HB2' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.19 121.2 42.18 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.381 -0.824 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 5.95 28.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.886 HG13 ' NE2' ' A' ' 25' ' ' GLN . 1.4 t -110.04 174.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.585 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.07 -177.25 3.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.19 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -77.84 -13.31 59.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 109.269 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.678 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -90.13 -73.58 0.52 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.886 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -36.75 -24.8 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 122.048 -0.408 . . . . 0.0 111.64 -177.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.66 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -91.11 -46.37 8.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.827 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -61.81 -54.27 44.48 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.734 HG12 ' N ' ' A' ' 29' ' ' SER 0.283 0.8 OUTLIER -36.38 -60.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.66 177.607 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.734 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -65.14 -42.48 93.79 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.134 0.968 . . . . 0.0 109.148 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.863 ' CG ' HD21 ' A' ' 15' ' ' LEU . 4.8 m-80 -63.85 -3.27 2.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.97 -20.58 24.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.827 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 10.3 mt -42.06 -39.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.445 -1.033 . . . . 0.0 109.281 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.716 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 25.5 m-85 -111.78 67.54 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.149 -0.969 . . . . 0.0 113.036 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -87.81 38.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.848 HD13 ' OG1' ' A' ' 47' ' ' THR . 1.5 pp -79.67 -158.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.346 0.593 . . . . 0.0 110.443 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG12 ' H ' ' A' ' 37' ' ' GLY . 2.9 t -79.89 -174.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 110.011 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -109.8 83.9 0.34 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 44' ' ' SER . 4.3 t0 -119.91 -17.05 8.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -1.141 . . . . 0.0 110.348 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.631 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.6 p -110.31 -42.5 4.12 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.768 -0.583 . . . . 0.0 110.452 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.75 34.62 5.46 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.18 30.05 43.36 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 1.1 t -128.56 -6.79 5.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.137 . . . . 0.0 111.057 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.25 57.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.433 -0.792 . . . . 0.0 112.913 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -133.58 36.98 3.33 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.581 -1.636 . . . . 0.0 106.581 176.559 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.076 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -111.6 150.06 30.6 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -175.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.37 2.07 18.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.518 -1.364 . . . . 0.0 109.076 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.848 ' OG1' HD13 ' A' ' 35' ' ' ILE . 16.7 p -110.07 -34.52 6.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 111.3 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.634 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 1.8 m -77.92 8.06 5.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.544 -1.347 . . . . 0.0 110.203 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.771 ' NE2' HD21 ' A' ' 71' ' ' LEU . 21.5 t-160 -53.13 150.42 5.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.596 -1.315 . . . . 0.0 108.929 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 49' ' ' HIS . 12.5 m -160.39 164.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.852 0.834 . . . . 0.0 110.919 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.689 ' CE1' ' HB3' ' A' ' 82' ' ' SER . 4.1 m-85 -118.68 122.87 43.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.816 HG21 ' CD1' ' A' ' 88' ' ' ILE . 15.8 t -92.75 151.61 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.241 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -75.18 130.62 39.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.137 -1.602 . . . . 0.0 109.664 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 4.9 pt-20 -35.28 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.792 -0.568 . . . . 0.0 111.984 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -65.92 -18.1 65.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.891 -1.131 . . . . 0.0 111.558 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.669 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 46.9 m-85 -127.89 -11.62 5.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.845 -1.159 . . . . 0.0 110.444 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -80.96 -50.91 9.13 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' OD1' ' HD2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.31 -20.98 64.88 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 0.0 109.224 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.879 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.279 20.5 mmmt -79.4 -56.22 4.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.602 1.668 . . . . 0.0 108.923 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 88' ' ' ILE 0.314 0.3 OUTLIER -75.64 138.12 70.44 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 112.856 -1.974 . . . . 0.0 109.854 -178.263 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.22 159.75 41.84 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 124.116 1.587 . . . . 0.0 111.982 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 -167.59 1.44 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.733 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.634 ' HB1' ' OE1' ' A' ' 87' ' ' GLN . . . -110.73 -169.13 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.377 0.608 . . . . 0.0 110.625 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.722 ' O ' HD13 ' A' ' 68' ' ' ILE . 53.4 p30 -100.27 -144.64 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -80.01 -23.81 41.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.768 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.9 ttm-85 -64.74 -50.98 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.627 ' OE2' HD12 ' A' ' 71' ' ' LEU . 11.4 tp10 -59.55 -11.48 4.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.3 mp -89.97 -16.59 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.658 -1.276 . . . . 0.0 109.813 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -90.6 -63.32 1.23 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.001 ' CE ' HD12 ' A' ' 84' ' ' LEU 0.289 2.9 mpp? -48.6 -48.52 39.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.335 1.541 . . . . 0.0 108.149 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.096 HD13 HD21 ' A' ' 78' ' ' LEU 0.269 0.0 OUTLIER -66.01 -32.04 73.29 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.961 -178.323 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -70.0 -41.98 73.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 109.997 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -41.88 41.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 109.797 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 9.9 m -90.22 63.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 110.181 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 75' ' ' THR . 10.2 t -49.66 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.726 . . . . 0.0 111.113 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.007 ' HB2' ' CG ' ' A' ' 104' ' ' ARG . . . -130.27 74.93 1.62 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -0.999 . . . . 0.0 110.126 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.2 pt-20 39.17 60.46 1.49 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.495 1.141 . . . . 0.0 109.525 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.096 HD21 HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -59.02 120.02 8.35 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.531 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.652 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -104.92 -167.01 0.11 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 41.7 Cg_endo -74.95 -28.27 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.041 1.021 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.575 ' HB3' ' CB ' ' A' ' 57' ' ' THR . 44.6 p-10 -87.16 -28.24 22.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.513 -0.742 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.689 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.9 m -49.9 106.37 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.834 -1.166 . . . . 0.0 108.796 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.53 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -145.68 171.91 14.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.796 -1.19 . . . . 0.0 111.48 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.076 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -84.32 136.52 33.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.467 0.651 . . . . 0.0 111.332 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.634 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 3.0 p -42.38 -29.93 0.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 110.832 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.678 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.9 m -98.78 35.24 1.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 111.304 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.711 HE21 ' HB2' ' A' ' 43' ' ' ALA . 5.0 mm-40 -126.75 -48.02 1.52 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 113.066 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.816 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -79.86 151.36 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.643 -1.286 . . . . 0.0 110.534 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 89' ' ' ILE . 3.9 mm -111.85 160.05 11.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 110.159 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.823 ' HE1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.63 118.21 35.59 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 110.454 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -94.89 167.22 13.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.848 . . . . 0.0 109.713 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' CD ' ' HB2' ' A' ' 19' ' ' ASP . 43.8 Cg_endo -78.65 -2.07 12.15 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.868 1.457 . . . . 0.0 110.714 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' OE2' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.09 -29.94 7.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.1 -1.0 . . . . 0.0 109.765 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.879 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.6 mt -88.28 66.03 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 110.351 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' HA ' ' OG ' ' A' ' 1' ' ' SER . 10.3 p30 -101.72 148.38 25.34 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.735 -1.228 . . . . 0.0 113.174 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.669 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.03 30.49 6.68 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.664 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -80.2 135.28 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.177 0.989 . . . . 0.0 112.779 -177.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.535 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 12.7 t -102.78 125.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.006 HG21 ' CD1' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -104.25 -179.69 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.996 -1.065 . . . . 0.0 108.971 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-20 -162.07 145.56 12.0 Favored 'General case' 0 C--N 1.276 -2.616 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.547 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 55.0 t -83.86 149.79 57.41 Favored Pre-proline 0 C--N 1.289 -2.033 0 C-N-CA 117.449 -1.7 . . . . 0.0 107.514 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.67 ' HG3' ' CG ' ' A' ' 49' ' ' HIS . 42.1 Cg_endo -92.95 124.4 0.58 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.464 1.443 . . . . 0.0 111.956 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 3.3 t70 -110.4 115.2 29.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 1.007 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.27 0.11 17.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.921 . . . . 0.0 110.284 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -119.97 60.81 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.21 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 95' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.518 0.675 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -77.32 127.86 33.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.72 . . . . 0.0 109.605 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.137 HG22 ' CG2' ' A' ' 97' ' ' ILE . 23.0 t -139.5 148.07 23.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.856 -1.152 . . . . 0.0 112.033 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 99' ' ' VAL . 13.8 t -131.41 126.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.835 ' CD1' HG21 ' A' ' 99' ' ' VAL . 54.5 m-85 -100.16 140.36 34.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.636 0.731 . . . . 0.0 112.509 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.939 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.6 t -120.52 134.98 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.21 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.638 ' HB3' HG22 ' A' ' 11' ' ' THR . 36.0 p -79.51 -152.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.619 ' ND1' ' CB ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 -10.43 14.59 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.913 -1.117 . . . . 0.0 108.965 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 58.2 p30 -100.45 3.34 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.52 -0.737 . . . . 0.0 109.602 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.47 -29.6 8.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.81 134.88 20.27 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.953 -1.322 . . . . 0.0 109.224 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.939 ' HG2' HG13 ' A' ' 6' ' ' VAL . 12.8 mtm180 -130.11 161.72 30.42 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.612 0.72 . . . . 0.0 111.504 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.849 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.8 ttp180 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.744 ' HG2' HG22 ' A' ' 4' ' ' VAL . 20.0 mt-10 -130.62 124.23 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.833 -1.167 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.941 HD11 ' HA ' ' A' ' 27' ' ' ALA . 12.3 mt -117.95 151.54 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.77 90.55 3.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.9 t -98.7 163.63 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.854 . . . . 0.0 110.557 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -112.97 -136.78 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.356 -0.84 . . . . 0.0 110.916 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -108.32 124.43 50.32 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.309 -0.869 . . . . 0.0 110.494 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -7.11 30.52 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 22' ' ' SER . 83.0 t -95.69 168.0 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.027 -1.278 . . . . 0.0 110.543 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.596 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.62 160.14 25.0 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 3' ' ' VAL . 18.4 mt -57.77 -36.04 71.59 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.673 -1.267 . . . . 0.0 109.254 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 1.298 ' SD ' ' SG ' ' A' ' 39' ' ' CYS . 4.7 ttp -79.33 7.24 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.062 -1.024 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.566 ' CG ' HG13 ' A' ' 21' ' ' VAL . 24.7 tt0 -102.29 -71.13 0.73 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.54 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.993 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -46.48 -55.43 7.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.758 -1.214 . . . . 0.0 108.614 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -53.55 -53.05 57.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 36' ' ' VAL 0.277 0.7 OUTLIER -37.8 -57.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.422 177.769 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.692 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.76 -47.14 85.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.075 0.941 . . . . 0.0 108.821 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.8 m120 -64.42 -4.03 3.54 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.499 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.03 -14.94 51.37 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.908 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 mt -44.04 -37.9 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.505 -0.997 . . . . 0.0 108.542 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.74 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 72.0 m-85 -114.42 76.93 1.02 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.162 -0.961 . . . . 0.0 111.201 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 33' ' ' TYR . 3.0 p30 -49.13 -22.21 0.91 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.638 -1.289 . . . . 0.0 107.852 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.753 ' O ' HG23 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.52 90.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 28' ' ' VAL . 4.1 t -118.55 -25.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 111.104 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.73 30.95 4.77 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.468 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.2 t0 -120.3 -45.9 2.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 110.638 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.298 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -110.46 -58.04 2.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.072 -1.018 . . . . 0.0 110.165 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.1 46.24 10.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 29.72 44.44 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 66.9 m -116.4 -39.42 3.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -1.129 . . . . 0.0 110.583 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.8 ' HB2' ' NE2' ' A' ' 87' ' ' GLN . . . 72.79 59.19 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 111.66 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.534 ' C ' ' HG2' ' A' ' 70' ' ' MET . 58.3 m -131.91 11.29 4.7 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 110.196 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.969 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -113.01 120.61 41.97 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -177.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -77.16 -0.87 26.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.434 -1.416 . . . . 0.0 109.564 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.452 ' OG1' ' CD1' ' A' ' 35' ' ' ILE . 1.3 p -83.65 -21.18 32.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 111.188 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.833 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -98.44 16.69 20.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.824 -1.172 . . . . 0.0 110.095 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.856 ' HD1' HG23 ' A' ' 74' ' ' VAL . 5.9 t-160 -46.16 134.32 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.604 -1.31 . . . . 0.0 108.054 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 48' ' ' CYS . 18.1 m -138.27 156.24 30.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.766 -1.209 . . . . 0.0 110.037 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.681 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.1 m-30 -118.29 116.67 27.23 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.597 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.849 HG21 ' CD1' ' A' ' 88' ' ' ILE . 22.2 t -94.33 166.09 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 108.909 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 1.009 ' O ' HG23 ' A' ' 57' ' ' THR . 12.5 p30 -84.97 137.2 33.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.278 -1.514 . . . . 0.0 109.023 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 53' ' ' ASN . 6.7 pt-20 -41.05 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.169 -0.957 . . . . 0.0 112.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.654 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -75.61 -51.03 13.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.639 -1.288 . . . . 0.0 111.762 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.726 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 64.4 m-85 -84.96 -5.06 59.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.079 -1.013 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.009 HG23 ' O ' ' A' ' 53' ' ' ASN . 9.7 p -80.3 -55.04 5.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.884 -1.135 . . . . 0.0 109.815 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.452 ' N ' ' OG1' ' A' ' 57' ' ' THR . 1.6 p30 -60.89 -12.42 11.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.429 -0.794 . . . . 0.0 110.769 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.734 ' CB ' HD13 ' A' ' 94' ' ' LEU 0.295 13.5 mtpt -79.4 -54.49 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.724 1.726 . . . . 0.0 109.336 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.815 HG22 ' HD2' ' A' ' 61' ' ' PRO 0.324 0.3 OUTLIER -76.51 155.06 83.8 Favored Pre-proline 0 C--N 1.278 -2.506 0 CA-C-N 112.546 -2.115 . . . . 0.0 110.593 -177.441 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.815 ' HD2' HG22 ' A' ' 60' ' ' VAL . 37.5 Cg_endo -63.58 168.09 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.024 1.539 . . . . 0.0 111.758 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -80.34 -170.22 2.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.543 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.684 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -110.74 157.85 19.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.555 -0.715 . . . . 0.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.473 ' CG ' ' HG3' ' A' ' 66' ' ' ARG . 5.1 p30 -79.47 -161.84 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.496 -0.752 . . . . 0.0 110.884 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.11 -22.59 41.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 111.343 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.531 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -69.73 -42.44 73.95 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.612 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.7 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.31 -7.54 1.33 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.819 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.64 HD13 ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -90.41 -15.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.608 -1.307 . . . . 0.0 109.642 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.84 -79.75 1.38 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.524 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.237 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.9 -35.17 14.22 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.881 -1.364 . . . . 0.0 109.778 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -65.35 -30.18 70.99 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 108.575 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.15 -29.08 18.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.474 -0.766 . . . . 0.0 109.561 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -49.02 -48.87 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.046 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.856 HG23 ' HD1' ' A' ' 49' ' ' HIS . 16.5 m -90.07 76.53 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.425 -0.797 . . . . 0.0 109.098 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 75' ' ' THR . 13.1 t -48.25 87.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.782 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.606 ' HA ' ' CD ' ' A' ' 104' ' ' ARG . . . -105.5 41.04 1.43 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.745 -1.222 . . . . 0.0 109.748 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.596 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER 66.78 44.47 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.219 1.009 . . . . 0.0 109.207 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.835 HD11 HD22 ' A' ' 71' ' ' LEU . 1.5 tp -19.42 134.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.53 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.669 ' CG ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.42 172.48 3.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.1 Cg_endo -69.83 -26.69 26.97 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.585 1.308 . . . . 0.0 108.828 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.6 p-10 -104.67 -9.16 18.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.704 -0.622 . . . . 0.0 111.399 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.583 ' OG ' ' CG ' ' A' ' 79' ' ' LYS . 42.7 m -47.86 158.62 0.21 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.524 -1.36 . . . . 0.0 111.406 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.773 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -175.6 161.87 2.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.683 -0.636 . . . . 0.0 109.822 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.237 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -80.33 139.53 36.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.93 . . . . 0.0 109.625 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.627 ' C ' ' HB2' ' A' ' 24' ' ' MET . 20.0 m -38.54 -31.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.515 1.15 . . . . 0.0 108.496 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.032 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -91.44 37.11 0.94 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.184 -178.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.8 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 6.1 mm-40 -127.43 -40.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.409 -1.432 . . . . 0.0 113.444 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -92.61 150.9 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.551 -178.024 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.5 mm -111.35 163.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.603 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.5 tpt -110.28 108.74 18.94 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.905 -1.122 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -88.14 159.64 47.62 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.0 Cg_endo -72.16 -1.08 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.977 1.514 . . . . 0.0 110.82 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' C ' HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -110.1 -27.27 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.022 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 59' ' ' LYS . 8.8 mt -98.38 60.5 1.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 109.931 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 1' ' ' SER . 3.8 p-10 -100.54 145.02 28.83 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.443 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.81 23.68 8.57 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.137 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.19 115.07 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.357 1.075 . . . . 0.0 113.486 -176.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.488 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 10.5 t -77.25 123.32 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.273 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.835 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.7 t -104.29 -176.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.863 -1.148 . . . . 0.0 109.275 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.653 ' H ' HG12 ' A' ' 99' ' ' VAL . 6.4 m-20 -162.1 141.58 9.7 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.907 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 49.4 t -97.48 102.86 13.94 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.5 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.681 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 41.0 Cg_endo -68.71 79.26 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.306 2.004 . . . . 0.0 113.342 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.619 ' CB ' ' ND1' ' A' ' 8' ' ' HIS . 27.0 t70 -111.49 38.97 2.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.582 -1.324 . . . . 0.0 110.095 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.606 ' CD ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -48.85 -179.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.121 -0.987 . . . . 0.0 111.724 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.26 63.15 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.336 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.42 ' H ' ' NH1' ' A' ' 104' ' ' ARG . 3.6 t-105 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.224 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.586 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.249 0.547 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.498 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.91 124.14 19.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 11.8 t -121.44 145.81 27.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.011 ' O ' HG23 ' A' ' 99' ' ' VAL . 4.3 t -130.98 125.65 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.913 0.863 . . . . 0.0 109.158 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.265 43.3 m-85 -101.07 135.9 41.79 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.2 t -121.97 119.9 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.27 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.649 ' CB ' HG22 ' A' ' 11' ' ' THR . 77.7 p -79.78 128.58 33.6 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 1.5 t60 -41.74 -24.31 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -79.45 -3.52 46.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.06 -1.025 . . . . 0.0 110.073 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.22 -36.48 4.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.649 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.54 137.06 15.8 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.838 -1.39 . . . . 0.0 108.776 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 12.1 mtm180 -130.15 147.35 51.87 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.712 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.75 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -131.58 119.32 21.31 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 177.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.7 mt-10 -94.92 123.98 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.141 -0.974 . . . . 0.0 110.261 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 27' ' ' ALA . 8.1 mt -109.78 146.81 34.34 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.071 -1.018 . . . . 0.0 110.741 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.63 88.17 3.76 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.89 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.8 t -98.96 165.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.769 . . . . 0.0 110.974 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -118.94 -141.44 0.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 110.547 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -101.14 126.46 47.85 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.508 -0.745 . . . . 0.0 110.49 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -9.74 30.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 22' ' ' SER . 55.4 t -99.67 170.73 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.843 -1.387 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.618 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.58 167.68 12.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD21 ' SD ' ' A' ' 90' ' ' MET . 9.2 mt -59.29 -27.96 66.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.699 -1.25 . . . . 0.0 109.447 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 1.226 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -80.26 -58.22 3.24 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.556 ' CG ' HG13 ' A' ' 21' ' ' VAL . 42.7 tt0 -37.98 -68.97 0.13 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.402 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.89 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -47.8 -57.27 5.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.349 -1.469 . . . . 0.0 108.813 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.829 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -52.78 -56.92 12.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.936 0.874 . . . . 0.0 108.911 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.768 HG12 ' N ' ' A' ' 29' ' ' SER 0.281 1.2 t -35.34 -63.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.219 178.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.768 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.34 -49.64 71.71 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.074 0.94 . . . . 0.0 109.034 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.509 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.2 m120 -61.36 -6.94 2.52 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.379 0.609 . . . . 0.0 109.445 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.28 -7.3 64.57 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.829 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 3.9 mt -44.66 -31.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.305 -1.115 . . . . 0.0 109.323 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 47.4 m-85 -108.71 58.39 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 113.204 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -74.14 51.39 0.41 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.609 -1.307 . . . . 0.0 107.503 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 36' ' ' VAL . 1.7 pp -112.73 178.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.55 -0.719 . . . . 0.0 109.959 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.781 ' O ' HG21 ' A' ' 47' ' ' THR . 1.3 p -120.72 101.35 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 109.741 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.48 179.01 16.48 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -100.23 0.92 41.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -1.023 . . . . 0.0 110.325 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.594 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 19.5 p -69.57 -36.03 75.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.355 -0.841 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.87 31.82 4.26 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.36 37.27 21.47 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.779 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 20.2 t -138.84 5.67 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -1.122 . . . . 0.0 111.822 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.14 42.58 0.44 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.309 -0.87 . . . . 0.0 113.298 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.2 t -132.35 44.7 2.85 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.981 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.1 p -111.76 130.09 55.91 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.714 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -92.13 6.47 46.44 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.258 -1.526 . . . . 0.0 108.178 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.781 HG21 ' O ' ' A' ' 36' ' ' VAL . 19.0 p -110.65 -40.06 4.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.374 -0.828 . . . . 0.0 111.714 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.861 ' O ' HG13 ' A' ' 50' ' ' VAL . 1.9 m -79.26 24.04 0.36 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.662 -1.274 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.688 ' NE2' ' CD2' ' A' ' 71' ' ' LEU . 6.9 t-160 -46.32 137.01 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.737 -1.227 . . . . 0.0 108.214 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 48' ' ' CYS . 19.3 m -145.86 152.82 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.027 -1.046 . . . . 0.0 110.873 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE1' ' HB3' ' A' ' 102' ' ' PRO . 31.1 m-85 -122.87 128.66 50.64 Favored 'General case' 0 C--N 1.281 -2.413 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.895 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.781 ' HB ' HG22 ' A' ' 57' ' ' THR . 13.6 t -93.88 168.43 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.279 -0.888 . . . . 0.0 109.873 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.763 ' O ' HG21 ' A' ' 57' ' ' THR . 6.8 p30 -67.94 -147.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.609 -1.307 . . . . 0.0 109.518 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -103.34 -16.52 15.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.856 -1.152 . . . . 0.0 111.836 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . . . -100.52 -36.82 9.06 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.703 -1.248 . . . . 0.0 114.146 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.4 m-85 -84.11 -11.0 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.308 -1.495 . . . . 0.0 110.839 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.781 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -81.73 -29.25 33.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD2' ' HA ' ' A' ' 55' ' ' ALA . 2.1 p30 -79.84 -26.89 40.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.522 ' CB ' HD13 ' A' ' 94' ' ' LEU . 21.1 mmtm -79.65 -51.43 9.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.775 HG11 HG21 ' A' ' 88' ' ' ILE . 11.5 m -41.78 153.51 0.27 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.411 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -65.18 160.92 39.67 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.114 1.586 . . . . 0.0 112.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 118.01 22.19 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.885 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.694 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.82 163.89 24.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 109.821 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 24.5 p-10 -100.1 -167.61 1.48 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.19 -20.93 29.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.474 -0.766 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' SD ' ' A' ' 70' ' ' MET . 1.1 ttt-85 -64.53 -53.36 49.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.855 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.694 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 6.9 tp10 -59.14 -12.61 5.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.8 mp -90.92 -9.83 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.826 -1.171 . . . . 0.0 111.244 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.05 -79.3 1.35 Allowed Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.224 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.073 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.09 -37.31 14.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.761 -1.435 . . . . 0.0 109.107 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.688 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -67.82 -23.54 65.19 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.09 -39.49 12.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.811 178.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.78 -43.53 38.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.024 . . . . 0.0 108.344 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 46' ' ' ALA . 1.7 m -90.42 72.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 75' ' ' THR . 10.5 t -48.18 104.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.763 0.792 . . . . 0.0 111.27 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.835 ' HB2' ' CD ' ' A' ' 104' ' ' ARG . . . -126.16 60.8 1.29 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.545 -0.722 . . . . 0.0 109.335 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.542 ' O ' ' CE ' ' A' ' 79' ' ' LYS . 11.3 pt-20 39.28 56.22 2.16 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.995 0.902 . . . . 0.0 109.784 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -33.99 143.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.661 0.743 . . . . 0.0 112.052 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.672 ' H ' ' HG ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -134.44 -176.44 0.58 Allowed Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.2 -25.56 43.03 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.146 1.077 . . . . 0.0 111.765 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 24.6 p-10 -111.85 6.5 19.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.831 -1.168 . . . . 0.0 113.308 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -57.26 149.29 20.38 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.204 -1.56 . . . . 0.0 109.143 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HG3' HD11 ' A' ' 88' ' ' ILE . 11.3 mmt-85 -154.15 179.7 8.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.737 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.073 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -114.94 134.93 54.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.657 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 9.1 m -40.31 -27.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.882 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.226 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.2 m -106.93 45.66 0.97 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.994 -1.067 . . . . 0.0 112.053 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.654 ' NE2' ' HB2' ' A' ' 67' ' ' GLU . 25.5 mm100 -125.34 -47.83 1.72 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.043 0.925 . . . . 0.0 111.394 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.775 HG21 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -84.35 149.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.932 0.872 . . . . 0.0 111.538 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.4 mm -110.9 160.96 9.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.699 ' SD ' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -110.1 104.21 13.05 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 110.224 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.8 OUTLIER -91.1 164.24 26.03 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.86 . . . . 0.0 109.442 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 39.7 Cg_endo -71.88 -0.69 8.81 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.648 1.341 . . . . 0.0 110.503 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.1 pt-20 -110.06 -27.61 9.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.522 HD13 ' CB ' ' A' ' 59' ' ' LYS . 9.5 mt -100.25 54.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.363 -0.835 . . . . 0.0 109.824 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.62 143.96 30.16 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.623 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.23 23.33 8.56 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.696 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.79 118.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.339 1.066 . . . . 0.0 113.166 -176.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 21.1 t -82.03 127.08 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.011 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.7 t -104.21 -175.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.782 -1.199 . . . . 0.0 109.345 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.1 m-20 -161.34 136.66 7.64 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.527 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -90.84 137.95 26.56 Favored Pre-proline 0 C--N 1.289 -2.049 0 C-N-CA 118.896 -1.121 . . . . 0.0 108.987 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 56.3 Cg_endo -82.0 110.09 2.02 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.172 1.617 . . . . 0.0 111.892 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.577 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 2.4 m-20 -110.8 79.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.695 -1.253 . . . . 0.0 110.413 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.835 ' CD ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.27 99.94 8.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 0.0 109.95 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -119.98 24.05 10.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.166 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.182 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.643 0.735 . . . . 0.0 110.482 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -90.29 101.11 13.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.133 HG22 ' CG2' ' A' ' 97' ' ' ILE . 48.6 t -109.64 145.52 16.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.677 -1.264 . . . . 0.0 111.118 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.808 ' O ' HG23 ' A' ' 99' ' ' VAL . 6.0 t -130.95 127.81 61.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.45 0.643 . . . . 0.0 109.356 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.949 ' CD1' HG21 ' A' ' 99' ' ' VAL . 49.8 m-85 -102.51 136.53 42.17 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.778 0.799 . . . . 0.0 112.184 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.0 t -120.55 133.54 66.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.429 -0.909 . . . . 0.0 109.642 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.762 ' CB ' HG22 ' A' ' 11' ' ' THR . 24.0 p -79.73 -159.07 0.19 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.642 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.94 -6.72 21.0 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.894 -1.129 . . . . 0.0 108.916 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -100.44 1.61 41.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.45 -22.95 21.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.762 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.9 137.13 17.18 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.986 -1.302 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.1 149.98 51.57 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.232 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 2.6 tpp180 -140.15 155.93 46.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.796 . . . . 0.0 109.714 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.602 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.9 mt-10 -130.92 128.0 39.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.922 -1.112 . . . . 0.0 110.328 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.001 HD11 HD12 ' A' ' 32' ' ' ILE . 14.1 mt -120.43 -170.53 2.0 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.899 -1.126 . . . . 0.0 110.778 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -133.45 81.71 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.899 HG22 ' CB ' ' A' ' 26' ' ' ALA . 39.9 t -98.4 130.62 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.384 -0.823 . . . . 0.0 110.487 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 90' ' ' MET . . . -110.53 -160.29 0.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.799 0.809 . . . . 0.0 111.523 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.6 OUTLIER -70.53 124.13 23.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.642 0.734 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.71 -14.41 29.57 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 17' ' ' VAL . 21.9 t -108.11 166.57 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.832 -1.393 . . . . 0.0 110.373 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.531 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.21 153.77 37.15 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.459 HD22 HG11 ' A' ' 3' ' ' VAL . 16.8 mt -47.09 -27.37 1.35 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.686 -1.258 . . . . 0.0 107.919 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.726 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -72.42 -67.28 0.56 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.096 0.951 . . . . 0.0 110.609 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.528 ' HB3' ' CG1' ' A' ' 21' ' ' VAL 0.255 32.4 tt0 -37.75 -73.41 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.33 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.899 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -43.08 -56.21 3.48 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.558 -1.338 . . . . 0.0 109.264 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.942 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -56.88 -60.42 3.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.644 0.735 . . . . 0.0 109.08 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.744 HG12 ' N ' ' A' ' 29' ' ' SER 0.288 0.9 OUTLIER -33.09 -66.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.658 0.742 . . . . 0.0 109.221 178.041 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.744 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -51.02 -51.87 48.69 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.924 0.869 . . . . 0.0 109.285 178.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.487 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.7 m120 -60.43 -7.29 1.98 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.33 0.586 . . . . 0.0 109.77 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.93 63.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.001 HD12 HD11 ' A' ' 15' ' ' LEU . 27.5 mt -43.82 -36.45 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.417 -1.049 . . . . 0.0 108.687 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.726 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 44.5 m-85 -104.5 64.26 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.099 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.94 50.97 0.11 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.704 -1.248 . . . . 0.0 108.382 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 36' ' ' VAL . 3.4 pt -104.55 -147.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.596 -0.69 . . . . 0.0 109.899 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' N ' HG13 ' A' ' 35' ' ' ILE . 6.6 t -96.88 174.77 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.91 . . . . 0.0 109.704 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -120.06 85.98 0.39 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' C ' ' SG ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -120.33 6.45 10.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -1.184 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.563 ' SG ' ' CE ' ' A' ' 24' ' ' MET . 1.7 p -110.52 -54.09 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.056 -1.028 . . . . 0.0 111.09 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.28 40.43 10.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.49 40.42 12.98 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.779 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 39.3 t -131.22 -34.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 0.0 111.261 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 75.81 61.42 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.321 -0.862 . . . . 0.0 111.354 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.34 8.52 4.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.373 -0.829 . . . . 0.0 110.124 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.876 ' O ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.88 117.77 33.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.242 -0.911 . . . . 0.0 112.423 -178.327 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.098 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -75.41 0.26 17.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 45' ' ' CYS . 8.4 t -83.73 -32.41 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.575 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.835 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.3 11.68 16.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 179.277 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.735 ' NE2' HD21 ' A' ' 71' ' ' LEU . 18.0 t-160 -49.16 152.39 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.709 -1.244 . . . . 0.0 109.791 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 83' ' ' ARG . 13.9 m -156.02 160.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.221 -0.924 . . . . 0.0 109.622 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.9 m-30 -119.97 118.06 29.71 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.863 HG21 ' CD1' ' A' ' 88' ' ' ILE . 29.1 t -98.53 155.02 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.365 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.755 ' O ' HG23 ' A' ' 57' ' ' THR . 28.0 p30 -75.22 131.69 40.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.325 -1.485 . . . . 0.0 109.364 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pt-20 -37.49 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.435 -0.791 . . . . 0.0 111.476 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.77 -24.9 67.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.018 . . . . 0.0 111.356 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.979 ' HB3' HD12 ' A' ' 97' ' ' ILE . 33.2 m-85 -123.02 -11.0 8.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.871 -1.143 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.84 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -80.57 -29.42 37.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 108.888 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.8 p-10 -76.41 -26.87 55.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 109.666 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.692 ' CB ' HD13 ' A' ' 94' ' ' LEU . 23.1 mmtm -80.85 -52.44 7.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.554 -0.716 . . . . 0.0 110.192 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.722 HG11 ' CG2' ' A' ' 88' ' ' ILE . 6.0 m -40.91 153.75 0.22 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.535 -0.728 . . . . 0.0 110.48 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.3 Cg_endo -65.79 168.22 15.7 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.061 1.559 . . . . 0.0 111.352 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.66 125.88 30.58 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.392 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.548 ' HB1' ' OE1' ' A' ' 87' ' ' GLN . . . -69.35 170.93 9.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 68' ' ' ILE . 31.3 p30 -96.83 -161.72 0.9 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 111.131 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -73.37 -24.76 60.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.512 -0.742 . . . . 0.0 110.543 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.514 ' NE ' ' O ' ' A' ' 42' ' ' SER . 1.7 mtm-85 -64.71 -43.07 94.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.405 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 4.2 tp10 -66.64 -7.03 17.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.532 -0.73 . . . . 0.0 109.517 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.94 -30.16 4.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.579 -1.326 . . . . 0.0 111.006 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.03 -64.89 1.57 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.854 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.233 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.77 -46.89 42.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.828 -1.395 . . . . 0.0 108.43 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.735 HD21 ' NE2' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -57.13 -25.2 58.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.483 -175.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -36.39 17.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.5 -0.75 . . . . 0.0 108.981 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.35 -32.01 10.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 108.809 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.098 ' CG1' ' HB1' ' A' ' 46' ' ' ALA . 14.7 m -90.12 65.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 75' ' ' THR . 4.8 t -48.87 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.445 0.64 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.005 ' HB2' ' CG ' ' A' ' 104' ' ' ARG . . . -130.27 69.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -0.808 . . . . 0.0 109.109 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.62 46.27 1.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.695 0.76 . . . . 0.0 109.905 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD13 HD22 ' A' ' 71' ' ' LEU . 9.8 tp -23.93 134.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.601 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.627 ' HD2' ' CD2' ' A' ' 51' ' ' TYR . 5.5 mtpt -110.0 167.92 8.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.751 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.6 Cg_endo -68.19 -28.88 33.6 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.854 1.45 . . . . 0.0 109.379 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.588 ' HB2' HG21 ' A' ' 57' ' ' THR . 11.8 p-10 -97.54 -11.93 23.14 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.643 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 50.4 m -48.99 153.74 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.831 -1.168 . . . . 0.0 110.665 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.8 ttp180 -175.5 158.48 2.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.416 -0.802 . . . . 0.0 110.086 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.233 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -76.38 142.38 41.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.933 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 48' ' ' CYS . 17.3 p -44.88 -26.24 0.39 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.028 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -93.0 29.87 1.74 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.899 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 6.6 tp-100 -126.59 -38.32 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.394 -1.441 . . . . 0.0 112.687 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.863 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -92.6 142.79 12.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.001 -1.079 . . . . 0.0 110.85 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 90' ' ' MET . 7.2 mm -110.52 168.19 4.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.643 ' CB ' HG12 ' A' ' 17' ' ' VAL . 3.5 tpt -109.93 110.65 21.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.866 -1.147 . . . . 0.0 111.137 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -89.93 165.64 23.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.86 -6.36 18.87 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.864 1.455 . . . . 0.0 110.901 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.7 pt-20 -110.26 -28.48 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.007 . . . . 0.0 110.429 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.692 HD13 ' CB ' ' A' ' 59' ' ' LYS . 8.1 mt -93.78 55.92 2.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 2.8 p30 -100.53 148.98 24.18 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.327 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.677 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.72 34.02 6.46 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.133 ' CG2' HG22 ' A' ' 3' ' ' VAL . 5.0 tt -83.96 157.41 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.214 1.007 . . . . 0.0 113.127 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.687 ' CG2' ' ND2' ' A' ' 53' ' ' ASN . 18.1 t -117.84 124.76 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.214 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.949 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -104.4 -177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.858 -1.151 . . . . 0.0 109.996 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.647 ' H ' HG12 ' A' ' 99' ' ' VAL . 16.5 m-20 -162.26 145.84 11.83 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.29 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.642 HG12 ' ND1' ' A' ' 8' ' ' HIS . 71.7 t -98.27 111.89 60.79 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 120.678 -1.264 . . . . 0.0 108.716 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.649 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.2 Cg_endo -67.77 133.82 30.65 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.057 1.556 . . . . 0.0 110.941 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 36.3 p-10 -110.19 106.99 16.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 109.938 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 1.005 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -99.14 110.47 23.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.116 -0.99 . . . . 0.0 109.929 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -149.27 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.626 ' N ' ' CE3' ' A' ' 106' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.106 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.544 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.445 0.641 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.09 109.69 20.73 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.424 -0.797 . . . . 0.0 109.546 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.982 HG22 ' CG2' ' A' ' 97' ' ' ILE . 30.3 t -109.73 144.81 17.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.914 -1.116 . . . . 0.0 110.706 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.891 ' O ' HG23 ' A' ' 99' ' ' VAL . 15.8 t -130.93 124.78 56.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.554 0.692 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.976 ' CD1' HG21 ' A' ' 99' ' ' VAL . 54.1 m-85 -100.38 138.6 37.22 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.702 0.763 . . . . 0.0 112.552 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.6 t -120.88 127.51 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.904 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 11' ' ' THR . 10.2 p -79.78 -159.25 0.2 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.979 -1.076 . . . . 0.0 108.315 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.408 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -102.44 -1.07 31.41 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.98 -1.075 . . . . 0.0 109.177 178.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.44 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -100.4 -4.63 28.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.483 -0.761 . . . . 0.0 109.389 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.27 -31.8 7.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.628 HG22 ' OG ' ' A' ' 7' ' ' SER . 1.1 t -49.94 130.58 22.01 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.899 -1.353 . . . . 0.0 109.802 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.826 ' HG2' HG13 ' A' ' 6' ' ' VAL . 16.2 mtm180 -120.04 134.29 55.29 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.484 0.659 . . . . 0.0 110.864 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.571 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -111.62 156.77 21.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 0.0 109.682 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.725 ' HG2' HG22 ' A' ' 4' ' ' VAL . 32.2 mt-10 -130.89 125.34 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.382 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.831 HD11 ' CA ' ' A' ' 27' ' ' ALA . 11.1 mt -118.72 149.36 41.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.056 . . . . 0.0 111.434 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.72 87.77 3.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 26' ' ' ALA . 41.7 t -98.7 171.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.692 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -121.44 -139.52 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.925 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.7 OUTLIER -104.73 125.74 51.11 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.41 -0.806 . . . . 0.0 110.224 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -8.74 30.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 22' ' ' SER . 69.7 t -98.86 169.49 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.07 -1.253 . . . . 0.0 110.322 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 -175.1 2.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.515 HD22 HG11 ' A' ' 3' ' ' VAL . 19.9 mt -79.9 -36.87 35.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.763 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.7 ttp -79.64 9.02 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.581 ' CG ' HG13 ' A' ' 21' ' ' VAL . 22.0 tt0 -102.03 -70.94 0.73 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.348 -0.845 . . . . 0.0 109.362 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -49.39 -53.65 21.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.723 -1.236 . . . . 0.0 108.516 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.831 ' CA ' HD11 ' A' ' 15' ' ' LEU . . . -53.81 -51.77 62.42 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.714 HG12 ' N ' ' A' ' 29' ' ' SER 0.272 0.7 OUTLIER -38.91 -57.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 177.8 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.714 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.84 -50.34 74.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.056 0.931 . . . . 0.0 109.101 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.535 ' HB3' HG13 ' A' ' 32' ' ' ILE . 1.7 m120 -60.04 -7.88 2.05 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.418 0.628 . . . . 0.0 109.642 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.47 -13.04 59.29 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.793 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 12.7 mt -41.76 -39.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.534 -0.98 . . . . 0.0 109.58 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.763 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 45.8 m-85 -99.04 56.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.108 -0.995 . . . . 0.0 111.012 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.45 -2.7 4.89 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.466 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.808 HG23 ' N ' ' A' ' 36' ' ' VAL . 1.1 tt -79.07 -141.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.374 -0.829 . . . . 0.0 109.56 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.909 HG21 ' OG1' ' A' ' 47' ' ' THR . 32.7 m -80.37 134.71 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.778 -1.201 . . . . 0.0 110.527 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.07 57.55 0.57 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -80.59 7.4 10.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -1.146 . . . . 0.0 110.313 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.582 ' HB2' ' CB ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -110.75 -64.4 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.176 -0.953 . . . . 0.0 110.481 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.29 52.63 8.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.33 34.8 28.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.736 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.7 t -125.73 -42.84 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -1.113 . . . . 0.0 110.281 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.15 57.22 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.369 -0.832 . . . . 0.0 111.342 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 p -132.65 8.24 4.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.884 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.173 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.29 151.55 29.54 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.74 -1.225 . . . . 0.0 113.647 -177.383 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -106.61 8.84 31.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.627 -1.296 . . . . 0.0 111.372 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.909 ' OG1' HG21 ' A' ' 36' ' ' VAL . 7.4 p -103.25 9.79 37.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.794 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.43 14.51 16.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.382 -0.824 . . . . 0.0 109.309 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.786 ' HE2' ' HE1' ' A' ' 51' ' ' TYR . 3.5 t-160 -41.83 141.17 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 48' ' ' CYS . 16.1 m -147.04 155.81 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.9 -1.125 . . . . 0.0 109.326 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.786 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 7.9 m-30 -120.9 121.39 37.96 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.638 0.732 . . . . 0.0 110.67 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.779 ' HB ' HG22 ' A' ' 57' ' ' THR . 16.5 t -91.88 170.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 57' ' ' THR . 6.7 p30 -72.76 -148.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.526 -1.359 . . . . 0.0 109.222 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -102.85 -14.84 16.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.913 -1.117 . . . . 0.0 111.507 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.403 ' N ' ' OD1' ' A' ' 53' ' ' ASN . . . -100.56 -38.24 8.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.802 -1.186 . . . . 0.0 114.072 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.846 ' HB3' HD12 ' A' ' 97' ' ' ILE . 78.6 m-85 -84.24 -11.24 56.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.332 -1.48 . . . . 0.0 111.464 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.779 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.44 -49.16 10.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.934 -1.104 . . . . 0.0 109.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 3.7 p-10 -61.33 -13.53 20.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HB2' HD13 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -93.46 -52.7 4.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.532 -0.73 . . . . 0.0 110.163 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 57' ' ' THR . 6.2 m -46.25 165.81 0.18 Allowed Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.7 Cg_endo -67.36 161.08 44.77 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.102 1.58 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.18 126.29 31.32 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.529 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -69.53 157.9 36.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 31.1 p-10 -100.24 -168.17 1.55 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.897 -1.127 . . . . 0.0 112.067 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -65.05 -19.68 66.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.818 -0.551 . . . . 0.0 110.493 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.14 -53.12 54.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.955 . . . . 0.0 108.809 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 2.1 tt0 -58.95 -47.37 85.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.4 mp -47.97 -26.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.016 -1.052 . . . . 0.0 111.281 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.67 -67.91 1.19 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.059 ' HE2' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.12 -44.05 31.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.35 -1.088 . . . . 0.0 109.279 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.855 HD22 HD11 ' A' ' 78' ' ' LEU 0.255 0.0 OUTLIER -68.63 -25.14 64.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.644 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -91.01 -25.89 19.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.499 -0.751 . . . . 0.0 110.769 178.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.578 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.09 -41.41 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.777 -1.202 . . . . 0.0 109.052 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 49' ' ' HIS . 3.6 m -90.51 87.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.802 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 75' ' ' THR . 9.6 t -47.84 96.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.817 0.818 . . . . 0.0 111.475 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 104' ' ' ARG . . . -125.17 47.38 2.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.222 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.563 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.3 pt-20 39.75 60.16 1.71 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.732 0.777 . . . . 0.0 109.384 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.855 HD11 HD22 ' A' ' 71' ' ' LEU . 1.8 tp -27.24 134.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.578 0.704 . . . . 0.0 112.089 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.636 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 5.1 mtpt -104.85 173.71 3.14 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.7 Cg_endo -69.32 -29.26 26.24 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.393 1.207 . . . . 0.0 110.054 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.8 p-10 -106.97 -2.32 21.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 111.061 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.57 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 69.6 m -49.21 161.83 0.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.813 -1.18 . . . . 0.0 111.069 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.721 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.32 166.39 3.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.173 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -83.16 148.56 27.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.58 ' C ' ' HB2' ' A' ' 24' ' ' MET . 66.1 m -49.07 -27.36 3.28 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.1 ' SG ' HD13 ' A' ' 84' ' ' LEU . 4.7 p -106.95 43.65 1.14 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.878 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.4 tp-100 -125.57 -38.06 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.919 -1.113 . . . . 0.0 111.212 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -96.15 147.99 5.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.605 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.5 mm -110.61 161.67 8.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.924 ' HE1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.29 124.31 51.41 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.789 -1.194 . . . . 0.0 110.792 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 3.9 p -110.02 168.07 8.18 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.63 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 43.9 Cg_endo -73.27 -1.75 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.823 1.433 . . . . 0.0 111.59 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -110.08 -24.13 10.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.812 -1.18 . . . . 0.0 110.233 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.924 ' O ' ' HE1' ' A' ' 90' ' ' MET . 4.8 mt -93.73 33.57 1.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.536 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 6.0 p-10 -80.65 144.39 32.34 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.822 0.82 . . . . 0.0 112.501 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.657 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.25 21.59 11.52 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.982 ' CG2' HG22 ' A' ' 3' ' ' VAL . 13.2 tt -74.17 157.49 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 123.131 1.443 . . . . 0.0 113.8 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.569 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 23.2 t -122.92 121.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.261 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.976 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -103.76 -176.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.0 109.531 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.643 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.8 m-20 -160.95 138.86 9.51 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.028 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 6' ' ' VAL . 12.7 t -102.05 116.68 62.84 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.984 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo -64.55 169.34 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 109.953 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.519 ' O ' ' NE ' ' A' ' 104' ' ' ARG . 3.0 p-10 -110.33 78.56 1.13 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.777 -1.202 . . . . 0.0 112.009 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.752 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 11.9 mmp_? -110.46 87.89 2.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -119.87 8.47 11.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 110.22 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.274 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.341 0.591 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -80.73 137.56 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.812 . . . . 0.0 109.422 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.544 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 2.5 t -125.74 135.94 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.823 -1.173 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.033 HG13 ' HG3' ' A' ' 14' ' ' GLU . 44.3 t -129.19 124.89 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.496 1.141 . . . . 0.0 110.324 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.894 ' CE2' HD13 ' A' ' 15' ' ' LEU 0.29 30.1 m-85 -98.46 139.96 33.43 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.976 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.021 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.5 t -121.05 155.86 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.032 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.593 ' HB3' HG22 ' A' ' 11' ' ' THR . 97.4 p -119.38 142.05 48.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.437 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -44.65 -23.72 0.15 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.421 -0.799 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.458 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.3 p30 -89.64 -4.07 57.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.067 -1.021 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.13 -32.22 7.23 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.53 131.49 21.02 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.082 -1.246 . . . . 0.0 109.061 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.729 ' HG3' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.67 151.31 46.73 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.439 0.638 . . . . 0.0 111.122 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.722 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.41 118.41 17.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.325 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 1.033 ' HG3' HG13 ' A' ' 4' ' ' VAL . 6.9 mp0 -116.29 125.37 52.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 0.0 111.845 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.894 HD13 ' CE2' ' A' ' 5' ' ' TYR 0.25 6.7 mp -110.42 -175.23 2.67 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.225 1.012 . . . . 0.0 111.198 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -119.23 92.35 3.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 5.9 t -98.63 170.07 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.496 -0.752 . . . . 0.0 110.948 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.549 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -134.03 -143.64 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 90' ' ' MET . 1.3 p-10 -95.02 123.57 38.57 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.591 -0.693 . . . . 0.0 110.546 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.52 -7.67 30.21 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.579 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 22' ' ' SER . 46.0 t -98.4 167.91 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.776 -1.426 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.595 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.66 165.14 16.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.9 mt -59.69 -17.19 32.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.481 -1.387 . . . . 0.0 108.474 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.67 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -82.53 -66.5 0.88 Allowed 'General case' 0 C--O 1.204 -1.34 0 O-C-N 121.479 -0.763 . . . . 0.0 109.03 178.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.535 ' CG ' HG13 ' A' ' 21' ' ' VAL 0.27 35.7 tt0 -37.03 -71.15 0.08 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.366 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.57 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -43.21 -66.3 0.39 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.683 -1.261 . . . . 0.0 108.518 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . . . -46.84 -49.9 19.34 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.065 0.936 . . . . 0.0 109.152 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 29' ' ' SER 0.257 0.8 OUTLIER -43.68 -56.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.63 0.729 . . . . 0.0 109.137 179.033 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.696 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.28 -49.42 72.16 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.885 0.85 . . . . 0.0 108.879 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.603 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.9 m120 -59.75 -10.65 3.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.62 -10.56 73.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.712 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 4.1 mt -39.92 -41.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.694 -0.886 . . . . 0.0 110.038 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.67 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 25.6 m-85 -108.68 59.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.045 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -60.46 -15.98 32.03 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.794 ' CD1' HG21 ' A' ' 47' ' ' THR . 10.1 tt -79.71 77.34 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.304 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.639 HG12 ' HA2' ' A' ' 40' ' ' GLY . 3.9 t -120.15 73.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.055 -1.028 . . . . 0.0 110.493 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.28 -2.47 12.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -120.1 -64.28 1.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.157 -1.202 . . . . 0.0 110.039 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 7.3 p -69.11 -37.47 78.38 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.707 -0.621 . . . . 0.0 111.105 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.639 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 47.83 29.44 6.17 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.56 34.76 27.56 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.741 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 4.6 p -140.15 7.31 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -1.211 . . . . 0.0 111.752 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.21 58.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.12 -0.987 . . . . 0.0 112.514 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -133.61 30.78 3.76 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.038 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.5 p -111.25 150.41 29.63 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.11 16.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.086 -1.009 . . . . 0.0 108.672 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.794 HG21 ' CD1' ' A' ' 35' ' ' ILE . 14.1 t -110.35 -32.36 6.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 111.908 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.722 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.9 m -74.73 8.32 2.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.398 -1.439 . . . . 0.0 110.41 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.074 ' ND1' HG21 ' A' ' 74' ' ' VAL . 23.6 t-160 -46.03 140.53 3.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.65 -1.281 . . . . 0.0 109.292 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 48' ' ' CYS . 13.5 m -144.89 159.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.563 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.6 m-30 -118.4 120.76 38.54 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.767 HG13 HD11 ' A' ' 97' ' ' ILE . 24.2 t -84.45 167.84 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.595 ' ND2' HG23 ' A' ' 98' ' ' VAL . 8.1 p-10 -80.27 -142.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.232 -1.543 . . . . 0.0 110.229 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -101.92 -28.02 12.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.253 -1.53 . . . . 0.0 113.384 -177.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -100.2 23.83 9.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.349 -1.469 . . . . 0.0 113.313 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.945 ' HB3' HD12 ' A' ' 97' ' ' ILE . 73.5 m-85 -140.58 -19.48 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.627 -1.296 . . . . 0.0 110.939 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.703 HG22 ' CG1' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.18 -50.67 9.3 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.189 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -64.92 -15.47 62.12 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.969 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.296 0.8 OUTLIER -79.28 -53.9 6.48 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.797 1.76 . . . . 0.0 108.942 179.154 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.812 HG21 HG22 ' A' ' 88' ' ' ILE 0.319 0.3 OUTLIER -77.42 139.44 63.84 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 112.519 -2.128 . . . . 0.0 110.22 -177.817 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -66.67 162.25 38.03 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.092 1.575 . . . . 0.0 112.011 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 -173.42 4.14 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.564 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.589 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -170.41 1.63 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.415 0.626 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.587 HD22 ' NH1' ' A' ' 66' ' ' ARG . 3.3 p30 -100.64 -164.4 1.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.0 110.671 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 1.1 pt-20 -61.37 -22.0 64.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.587 ' NH1' HD22 ' A' ' 64' ' ' ASN . 6.2 ttm180 -64.24 -57.93 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 0.0 109.164 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 15.6 tp10 -59.97 1.15 0.12 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.749 -0.594 . . . . 0.0 111.956 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 6.7 mm -90.9 -39.55 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 110.225 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -83.2 -60.5 2.02 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.104 ' HE2' HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -47.65 -43.7 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.195 -1.179 . . . . 0.0 108.738 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.007 ' O ' HG22 ' A' ' 74' ' ' VAL 0.257 0.0 OUTLIER -73.11 -34.31 66.09 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.819 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -70.29 -21.1 62.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.67 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 74.4 m -48.99 -24.24 1.44 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.088 -1.008 . . . . 0.0 108.696 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.074 HG21 ' ND1' ' A' ' 49' ' ' HIS . 17.4 m -90.12 76.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.662 -0.649 . . . . 0.0 109.786 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 75' ' ' THR . 12.9 t -50.99 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.008 -0.432 . . . . 0.0 111.829 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -131.09 52.35 2.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.867 -1.146 . . . . 0.0 110.443 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 38.93 60.17 1.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.631 -0.668 . . . . 0.0 110.151 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.995 HD21 HD13 ' A' ' 71' ' ' LEU . 2.3 tp -22.91 141.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.44 0.638 . . . . 0.0 112.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -90.7 168.87 13.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.004 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.32 -26.37 41.58 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.653 1.344 . . . . 0.0 109.346 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 14.2 p30 -105.38 -6.74 19.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.752 -0.593 . . . . 0.0 110.958 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.622 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.3 m -48.95 156.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 0.0 111.085 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.59 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.2 ttt180 -175.18 158.79 2.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.73 0.776 . . . . 0.0 110.8 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.104 HD12 ' HE2' ' A' ' 70' ' ' MET . 1.0 OUTLIER -78.85 138.94 38.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.689 -0.632 . . . . 0.0 109.809 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.6 p -44.84 -31.85 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.886 -1.134 . . . . 0.0 110.005 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 3.7 m -101.08 39.58 1.38 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.433 -0.792 . . . . 0.0 111.17 -177.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.717 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 1.8 mm-40 -126.48 -43.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 112.608 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.812 HG22 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -83.75 149.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 118.634 -1.227 . . . . 0.0 110.656 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.9 mm -110.87 160.15 10.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.318 0.58 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 1.9 tpt -110.3 113.91 26.95 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.079 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -91.37 169.15 11.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 109.508 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.508 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 41.8 Cg_endo -72.73 -8.83 23.07 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.782 1.412 . . . . 0.0 111.291 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 1.9 pp20? -110.04 -41.58 4.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.863 -1.148 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.969 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.2 mt -72.56 54.28 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.541 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 50.0 p-10 -101.53 156.18 17.63 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.106 -0.997 . . . . 0.0 112.646 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.658 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.6 27.07 12.03 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.945 HD12 ' HB3' ' A' ' 56' ' ' PHE . 4.9 tt -79.99 157.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 122.219 1.009 . . . . 0.0 112.21 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG23 ' ND2' ' A' ' 53' ' ' ASN . 19.0 t -124.13 125.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.1 t -103.73 -176.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.0 m-20 -162.18 139.24 8.21 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.885 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 6' ' ' VAL . 16.4 t -90.67 117.18 67.77 Favored Pre-proline 0 C--N 1.285 -2.223 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.245 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.2 Cg_endo -64.59 154.69 70.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.855 1.45 . . . . 0.0 110.312 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.501 ' OD1' ' NH2' ' A' ' 104' ' ' ARG . 6.1 p-10 -105.59 91.06 3.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 0.0 111.302 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.629 ' NE ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.1 44.57 1.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.723 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.07 2.82 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.188 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.56 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.343 0.592 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -80.02 138.6 37.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -0.793 . . . . 0.0 109.873 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.013 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.0 t -127.95 146.73 33.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.012 -1.055 . . . . 0.0 110.141 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.874 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.4 t -130.5 130.06 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.592 0.71 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.98 ' CE1' HG21 ' A' ' 99' ' ' VAL 0.266 46.3 m-85 -106.09 138.83 41.6 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.024 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.3 t -121.71 152.17 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.738 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.57 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 80.5 p -114.97 138.0 51.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' CD2' ' HB3' ' A' ' 103' ' ' ASP . 1.3 t60 -46.59 -22.38 0.28 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.943 -1.098 . . . . 0.0 110.016 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.1 p30 -85.03 -6.22 59.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.049 . . . . 0.0 110.156 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.25 -36.1 4.46 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.73 133.28 21.66 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.817 -1.402 . . . . 0.0 109.226 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.847 ' HG2' HG22 ' A' ' 6' ' ' VAL . 16.9 mtm105 -129.04 154.9 46.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.283 0.563 . . . . 0.0 111.247 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.743 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -135.58 121.3 19.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 36.4 mt-10 -94.64 123.35 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.875 HD11 ' HA ' ' A' ' 27' ' ' ALA . 8.2 mt -109.79 147.23 33.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.979 . . . . 0.0 110.57 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -99.55 88.07 3.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.954 HG22 ' HB2' ' A' ' 26' ' ' ALA . 56.6 t -98.97 168.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.56 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -125.28 -133.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -108.1 123.98 49.53 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.248 -0.907 . . . . 0.0 110.382 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.32 -8.47 30.78 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 22' ' ' SER . 60.8 t -97.81 170.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.917 -1.343 . . . . 0.0 110.465 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.48 154.4 35.31 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.622 HD21 ' SD ' ' A' ' 90' ' ' MET . 10.0 mt -48.78 -23.35 1.04 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.505 -1.372 . . . . 0.0 109.329 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.681 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.6 ttt -83.51 -62.73 1.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.621 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG13 ' A' ' 21' ' ' VAL . 47.1 tt0 -36.57 -54.22 0.87 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.257 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.954 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -61.39 -49.91 74.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.035 -1.665 . . . . 0.0 107.664 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.875 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -58.16 -61.2 2.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.308 1.051 . . . . 0.0 108.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.73 HG12 ' N ' ' A' ' 29' ' ' SER 0.293 0.8 OUTLIER -29.63 -59.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.744 178.22 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.73 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -48.18 78.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.108 0.956 . . . . 0.0 108.871 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.501 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.5 m120 -59.64 -11.42 4.89 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.07 -10.32 73.4 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.867 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 4.8 mt -42.83 -30.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.395 -1.062 . . . . 0.0 108.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.681 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 26.4 m-85 -118.08 67.4 0.76 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.457 -0.897 . . . . 0.0 113.09 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -89.93 26.53 1.8 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.045 HD11 ' SG ' ' A' ' 48' ' ' CYS . 5.2 pt -79.67 -162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.427 0.632 . . . . 0.0 110.191 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.629 ' C ' HG21 ' A' ' 47' ' ' THR . 9.1 m -120.64 87.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.25 150.69 17.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER -86.76 6.1 33.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.7 p -69.36 -35.35 75.78 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.768 -0.583 . . . . 0.0 111.291 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.68 31.39 2.57 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.35 35.61 25.97 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.699 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.17 8.95 2.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -1.179 . . . . 0.0 111.024 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 68.49 54.28 0.53 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.283 1.039 . . . . 0.0 111.285 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.601 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -131.77 30.8 4.31 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.004 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.812 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -111.39 149.9 30.55 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.644 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.88 16.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.951 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.629 HG21 ' C ' ' A' ' 36' ' ' VAL . 1.7 t -110.22 -25.13 10.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 112.152 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 1.045 ' SG ' HD11 ' A' ' 35' ' ' ILE . 19.0 m -76.71 15.16 0.68 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.509 -1.369 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.727 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 4.2 t60 -49.97 136.32 18.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.833 -1.167 . . . . 0.0 108.036 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 49' ' ' HIS . 9.9 m -160.27 170.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.668 -1.27 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 11.4 m-30 -120.4 123.09 42.19 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.563 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.856 HG21 ' CD1' ' A' ' 88' ' ' ILE . 46.6 t -90.48 151.15 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.768 ' O ' HG23 ' A' ' 57' ' ' THR . 35.6 p-10 -73.25 133.77 44.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 119.835 -1.791 . . . . 0.0 109.863 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -40.95 -26.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.724 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.528 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -61.34 -17.23 52.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.875 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.91 ' HB3' HD12 ' A' ' 97' ' ' ILE . 50.1 m-85 -131.02 -9.19 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.011 -1.056 . . . . 0.0 110.835 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 53' ' ' ASN . 1.3 p -80.52 -39.44 27.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -12.11 60.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 109.57 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.615 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.281 22.0 mmmt -79.43 -54.64 5.73 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.669 1.7 . . . . 0.0 108.678 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.964 HG11 HG21 ' A' ' 88' ' ' ILE 0.326 0.3 OUTLIER -81.09 134.23 52.92 Favored Pre-proline 0 C--N 1.279 -2.47 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.943 -178.005 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.67 159.9 50.58 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.079 1.568 . . . . 0.0 112.212 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -81.07 177.44 9.04 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.936 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -152.41 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.403 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.778 ' O ' HD13 ' A' ' 68' ' ' ILE . 47.8 p-10 -100.04 -139.85 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.11 -18.05 50.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 110.109 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.7 OUTLIER -70.05 -52.55 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.936 ' CB ' ' HB3' ' A' ' 63' ' ' ALA . 1.7 tm-20 -58.35 -15.54 10.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.838 -1.164 . . . . 0.0 110.16 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.778 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.5 mp -91.31 -65.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.39 -48.01 26.14 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.271 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.728 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.296 12.3 ttp -48.61 -52.34 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 123.207 1.479 . . . . 0.0 107.744 178.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.941 HD13 HD11 ' A' ' 78' ' ' LEU 0.284 0.0 OUTLIER -62.26 -52.56 63.24 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.379 179.609 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.954 ' HB2' HD13 ' A' ' 78' ' ' LEU . 7.4 tt0 -82.17 20.53 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.519 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.644 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 1.3 m -49.18 -25.42 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.149 -1.594 . . . . 0.0 108.069 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.823 HG21 ' O ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -89.93 -148.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.793 ' N ' HG23 ' A' ' 74' ' ' VAL . 9.6 t -130.78 55.52 1.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.174 -1.579 . . . . 0.0 110.076 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.924 ' HB2' ' HB2' ' A' ' 104' ' ' ARG . . . -98.6 32.27 2.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 110.745 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.553 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.1 pt-20 39.19 60.48 1.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.954 HD13 ' HB2' ' A' ' 72' ' ' GLU . 12.4 tp -19.77 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.579 0.704 . . . . 0.0 112.544 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.642 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 3.6 mtpt -97.53 -167.55 0.13 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 43.9 Cg_endo -82.58 -28.23 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.491 1.258 . . . . 0.0 109.777 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 9.8 p-10 -105.89 -7.21 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.52 -0.737 . . . . 0.0 111.508 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.755 ' C ' HD11 ' A' ' 71' ' ' LEU . 1.5 m -49.56 143.68 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.59 -1.319 . . . . 0.0 110.326 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.614 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmt-85 -158.85 151.76 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 110.158 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.812 HD22 ' SG ' ' A' ' 45' ' ' CYS . 12.2 mt -74.34 148.51 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.635 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 18.1 m -47.1 -25.38 0.85 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -110.08 48.18 0.91 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.837 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.542 ' HG2' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -125.24 -38.95 2.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 110.863 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.964 HG21 HG11 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -101.7 155.93 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -110.3 163.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.513 -0.742 . . . . 0.0 109.369 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.622 ' SD ' HD21 ' A' ' 23' ' ' LEU . 2.7 tpt -110.07 106.73 16.32 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 110.438 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.1 p -89.4 163.79 32.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.7 Cg_endo -74.34 -6.88 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.956 1.503 . . . . 0.0 110.54 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.498 ' HG2' ' HG ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -103.47 -27.76 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.597 HD13 ' CB ' ' A' ' 59' ' ' LYS . 9.9 mt -99.97 57.29 0.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 4.8 p-10 -100.43 149.89 23.19 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.662 0.744 . . . . 0.0 112.242 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.646 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.61 22.36 11.36 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.013 ' CG2' HG22 ' A' ' 3' ' ' VAL . 8.3 tt -72.84 154.49 7.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.747 1.261 . . . . 0.0 113.325 -177.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.687 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 5.8 t -122.57 127.76 75.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.334 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.98 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.8 t -103.81 -179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.015 -1.053 . . . . 0.0 108.578 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.578 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.6 m-20 -161.17 138.53 9.02 Favored 'General case' 0 C--N 1.274 -2.711 0 C-N-CA 118.408 -1.317 . . . . 0.0 110.726 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 6' ' ' VAL . 15.2 t -97.38 117.75 65.18 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.727 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 37.2 Cg_endo -65.23 -166.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.95 1.5 . . . . 0.0 110.613 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.589 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 4.5 p-10 -110.03 -0.14 18.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.992 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.924 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -110.29 78.51 1.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.191 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.7 2.34 15.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.546 ' CE3' ' C ' ' A' ' 106' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.611 ' H1 ' ' C ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.563 0.697 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.4 OUTLIER -80.13 119.66 23.22 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.79 HG22 ' CG2' ' A' ' 97' ' ' ILE . 20.3 t -124.46 148.6 28.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.871 -1.143 . . . . 0.0 111.53 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 ' OE1' ' A' ' 14' ' ' GLU . 4.7 t -131.14 128.8 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.972 ' CE1' HG21 ' A' ' 99' ' ' VAL 0.273 42.2 m-85 -107.68 140.99 39.89 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.2 t -122.16 129.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.05 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.637 ' HB3' HG22 ' A' ' 11' ' ' THR . 77.6 p -79.36 -151.44 0.06 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.629 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.33 -10.51 14.6 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 120.874 -1.141 . . . . 0.0 108.915 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.445 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.7 p30 -100.41 1.99 41.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.34 -31.05 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.637 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.7 135.99 18.14 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.935 -1.332 . . . . 0.0 109.092 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.7 mtm180 -130.16 152.74 49.27 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.411 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.756 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -132.78 121.24 22.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.857 ' OE1' HG22 ' A' ' 4' ' ' VAL . 2.5 mm-40 -94.64 124.14 38.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.146 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.878 HD11 ' CA ' ' A' ' 27' ' ' ALA . 7.2 mt -109.67 147.98 32.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.009 -1.057 . . . . 0.0 111.851 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.02 84.89 2.31 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.698 HG13 HG11 ' A' ' 21' ' ' VAL . 16.6 t -98.89 172.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -177.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -120.3 -144.2 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.418 -0.801 . . . . 0.0 111.252 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.504 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -102.06 133.73 46.41 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.62 -0.675 . . . . 0.0 110.307 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.47 -3.09 57.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.917 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.6 t -100.43 172.48 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -1.105 . . . . 0.0 110.406 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.609 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.97 179.26 4.32 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.791 178.283 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.518 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 16.1 mt -76.63 -14.82 59.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.782 -1.199 . . . . 0.0 109.534 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.733 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.1 tmt? -90.6 -71.45 0.62 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.679 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.917 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -37.9 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.707 -0.621 . . . . 0.0 112.132 -176.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.645 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -88.37 -52.5 5.16 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.992 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -59.86 -45.43 92.47 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.732 HG21 ' SD ' ' A' ' 24' ' ' MET 0.262 0.8 OUTLIER -42.9 -61.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.72 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.726 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.55 -32.73 70.6 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.45 1.119 . . . . 0.0 108.163 178.475 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.691 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.2 m120 -77.36 10.41 2.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.046 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.06 13.91 36.62 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.992 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 5.1 mt -72.1 -33.93 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.343 -1.092 . . . . 0.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.3 m-85 -103.8 52.26 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.0 111.888 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -79.1 48.72 0.88 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 36' ' ' VAL . 6.3 pt -79.98 -144.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.334 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.724 HG12 ' N ' ' A' ' 37' ' ' GLY . 30.4 t -85.26 -89.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 110.343 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.724 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -79.97 178.19 53.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -119.55 162.19 19.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -1.1 . . . . 0.0 110.206 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.639 ' CB ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -110.46 -26.38 9.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 0.0 109.938 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 40.94 28.06 0.22 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . 80.09 30.54 41.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.75 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.8 t -117.58 -36.13 3.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -1.14 . . . . 0.0 109.881 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.33 60.36 0.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.632 0.729 . . . . 0.0 111.762 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -131.95 22.02 4.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.529 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -112.56 161.15 17.11 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.495 0.664 . . . . 0.0 111.761 -177.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -110.95 -2.99 15.78 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.576 -1.328 . . . . 0.0 112.623 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 18.0 p -110.32 28.36 8.71 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.284 -1.51 . . . . 0.0 112.656 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 1.016 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.96 -3.4 12.14 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.965 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -43.46 127.6 4.74 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.016 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.4 m -139.17 161.26 28.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.566 -1.334 . . . . 0.0 110.211 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.842 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 5.8 m-30 -116.9 121.8 42.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.69 0.757 . . . . 0.0 110.381 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.743 ' HB ' HG22 ' A' ' 57' ' ' THR . 14.6 t -91.41 172.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.603 ' O ' HG21 ' A' ' 57' ' ' THR . 6.6 p30 -75.84 -148.39 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.445 -1.41 . . . . 0.0 109.21 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 -16.02 16.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.878 -1.139 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.65 -36.12 9.25 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.853 -1.154 . . . . 0.0 113.832 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.745 ' O ' HG13 ' A' ' 60' ' ' VAL . 70.0 m-85 -84.37 -13.21 52.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.338 -1.477 . . . . 0.0 111.608 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.743 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -80.79 -27.67 36.56 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.717 -1.239 . . . . 0.0 109.818 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -24.43 21.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.898 ' CB ' HD21 ' A' ' 94' ' ' LEU . 15.3 mmtm -79.57 -52.12 8.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 56' ' ' PHE . 9.1 m -42.19 166.31 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.616 -0.678 . . . . 0.0 110.044 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 38.1 Cg_endo -66.34 165.29 25.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.027 1.541 . . . . 0.0 111.448 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 114.17 19.35 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.261 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.935 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.1 163.81 23.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.879 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.45 ' O ' HD13 ' A' ' 68' ' ' ILE . 44.3 p-10 -100.3 -146.45 0.34 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 0.0 111.335 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 66' ' ' ARG . 3.6 pt-20 -72.72 -27.76 62.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.55 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.684 ' HG3' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -64.37 -46.83 81.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 108.509 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.935 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 3.0 tm-20 -58.08 -16.05 11.64 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.43 -1.419 . . . . 0.0 109.298 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -92.14 -68.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 110.436 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 68' ' ' ILE . . . -77.38 -49.23 7.51 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.942 ' CE ' HD11 ' A' ' 84' ' ' LEU 0.253 0.0 OUTLIER -48.91 -41.4 33.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.029 1.395 . . . . 0.0 108.268 179.187 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 67' ' ' GLU 0.323 0.0 OUTLIER -77.29 -30.34 54.17 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.737 -179.217 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.841 ' HB2' HD13 ' A' ' 78' ' ' LEU . 6.1 tt0 -86.33 10.24 15.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.868 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 46' ' ' ALA . 33.9 m -48.92 -52.88 22.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.648 -1.283 . . . . 0.0 108.039 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 74' ' ' VAL . 18.3 m -90.48 116.45 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -48.49 98.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.965 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -128.27 38.77 3.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.865 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.24 60.45 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.633 0.73 . . . . 0.0 110.038 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 72' ' ' GLU . 0.4 OUTLIER -27.98 119.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.494 0.664 . . . . 0.0 111.927 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.714 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 1.1 mttp -85.35 -167.68 0.15 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.1 Cg_endo -82.81 -29.02 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.305 1.161 . . . . 0.0 109.135 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.52 ' HB2' HG21 ' A' ' 57' ' ' THR . 42.0 p-10 -106.15 -7.3 18.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.61 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 13.9 m -48.08 128.7 14.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.555 -1.34 . . . . 0.0 110.072 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.649 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -142.29 164.17 30.86 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.82 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.942 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -74.94 136.83 41.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.824 -0.548 . . . . 0.0 111.943 -178.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.605 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 1.9 p -55.99 -22.7 28.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.882 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.1 p -107.13 28.95 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.309 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.558 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 2.7 mm-40 -126.08 -41.28 1.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.175 . . . . 0.0 112.103 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -79.85 146.21 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.689 -178.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.9 mm -111.1 158.86 11.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 4.0 tpt -110.14 114.47 28.0 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.072 -1.017 . . . . 0.0 110.488 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -95.7 165.83 15.8 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.326 -0.858 . . . . 0.0 109.669 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.3 Cg_endo -70.51 -30.01 19.46 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.837 1.441 . . . . 0.0 110.965 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.5 pp20? -83.46 -41.39 18.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.982 -1.074 . . . . 0.0 109.911 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.898 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.6 mt -79.42 60.82 3.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB2' ' CB ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.16 153.61 19.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.862 -1.149 . . . . 0.0 111.652 -178.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.48 19.52 12.2 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.79 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -59.32 126.72 17.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.453 1.12 . . . . 0.0 112.537 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.517 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 2.8 t -105.73 116.63 49.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.972 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.5 t -104.11 -178.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 122.354 1.074 . . . . 0.0 110.542 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.618 ' H ' HG12 ' A' ' 99' ' ' VAL . 5.1 m-20 -162.05 140.24 8.98 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.035 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 52.5 t -96.59 112.08 59.07 Favored Pre-proline 0 N--CA 1.499 1.999 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.017 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.709 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 44.7 Cg_endo -73.57 98.32 1.03 Allowed 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.105 1.87 . . . . 0.0 113.928 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.629 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -111.6 87.39 2.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.713 -1.242 . . . . 0.0 109.522 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.552 ' NE ' ' C ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -110.19 22.6 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.866 -1.146 . . . . 0.0 111.683 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.457 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 5.5 tp60 -64.02 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.226 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.512 ' N ' ' O ' ' A' ' 104' ' ' ARG . 98.6 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.231 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.41 0.624 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 6.2 tmtm? -79.98 109.32 14.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.012 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.9 t -111.37 143.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.997 -1.064 . . . . 0.0 110.75 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.863 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.1 t -130.89 125.09 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.232 1.015 . . . . 0.0 109.519 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.96 ' CD1' HG21 ' A' ' 99' ' ' VAL 0.284 36.6 m-85 -101.02 138.32 38.22 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.585 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG13 ' HG2' ' A' ' 12' ' ' ARG . 3.5 t -121.79 158.02 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.454 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.534 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 60.7 p -120.03 137.86 53.85 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.573 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -43.84 -23.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.018 -1.051 . . . . 0.0 110.409 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' OD2' ' HB ' ' A' ' 11' ' ' THR . 6.6 p-10 -85.94 -3.5 58.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.086 -1.009 . . . . 0.0 110.577 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.22 -42.01 2.08 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.832 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.53 ' CG2' ' CZ ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -49.56 134.48 19.58 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 120.968 -1.313 . . . . 0.0 109.869 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.765 ' HG2' HG13 ' A' ' 6' ' ' VAL . 4.8 mtm180 -130.08 160.68 32.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.036 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.73 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -138.4 123.06 18.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 178.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.57 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.2 mp0 -95.36 128.27 42.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.85 HD11 ' CA ' ' A' ' 27' ' ' ALA . 9.0 mt -121.13 146.2 47.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.048 -1.032 . . . . 0.0 111.718 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 16.2 p30 -100.86 90.05 4.07 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.971 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.5 t -98.85 171.49 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 111.064 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -118.82 -134.16 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 0.0 110.546 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -110.13 124.36 51.39 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.276 -0.89 . . . . 0.0 110.527 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.39 -8.28 30.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.383 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 22' ' ' SER . 95.9 t -96.07 170.13 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.288 . . . . 0.0 110.651 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.599 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.98 171.72 8.44 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.666 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.88 -28.19 67.31 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.21 179.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.781 ' SD ' HG23 ' A' ' 28' ' ' VAL . 0.7 OUTLIER -86.86 4.7 40.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.583 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.569 ' CG ' HG13 ' A' ' 21' ' ' VAL . 32.2 tt0 -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.15 -0.969 . . . . 0.0 109.372 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.971 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -51.24 -47.79 62.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 108.212 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.934 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -60.36 -53.28 59.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.781 HG23 ' SD ' ' A' ' 24' ' ' MET 0.279 0.8 OUTLIER -36.84 -58.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.65 0.738 . . . . 0.0 109.011 178.006 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.704 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.137 0.97 . . . . 0.0 108.459 178.055 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 1.4 m120 -64.55 -5.0 4.62 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.506 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 74.29 2.06 61.98 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.934 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 3.0 mt -50.22 -30.1 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.329 -1.1 . . . . 0.0 109.393 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.66 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 54.0 m-85 -105.98 53.39 0.71 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 112.064 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.24 45.85 0.39 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 108.599 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.935 HD11 ' OG1' ' A' ' 47' ' ' THR . 1.3 tt -120.26 173.24 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 121.459 -0.776 . . . . 0.0 109.072 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.923 ' O ' HG21 ' A' ' 47' ' ' THR . 2.5 p -79.8 87.58 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 110.159 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 126.98 6.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 12.1 p30 -107.57 59.97 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.2 p -110.65 -57.35 2.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.307 -0.871 . . . . 0.0 110.797 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.13 41.96 11.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.32 37.03 22.32 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 10.2 t -126.96 -22.24 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 111.152 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB1' ' NE2' ' A' ' 87' ' ' GLN . . . 58.22 60.72 2.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.381 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.61 7.18 4.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.349 -0.845 . . . . 0.0 110.455 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.871 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.68 116.36 30.64 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.254 -0.904 . . . . 0.0 112.069 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.826 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . -74.98 0.31 16.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.935 ' OG1' HD11 ' A' ' 35' ' ' ILE . 9.4 t -85.42 -29.55 24.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.903 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.833 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -89.38 11.79 18.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.017 -1.052 . . . . 0.0 109.384 179.12 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.67 ' NE2' HD21 ' A' ' 71' ' ' LEU . 11.1 t-160 -42.5 139.83 1.41 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 48' ' ' CYS . 34.9 m -146.51 154.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 122.09 0.948 . . . . 0.0 109.929 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.703 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 11.9 m-85 -121.67 129.34 52.7 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.264 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.872 ' HB ' HG22 ' A' ' 57' ' ' THR . 19.1 t -96.12 167.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.772 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.783 ' O ' HG23 ' A' ' 57' ' ' THR . 25.3 p-10 -91.97 136.1 33.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.722 -1.237 . . . . 0.0 109.337 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.8 pt-20 -37.1 -26.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.81 . . . . 0.0 111.989 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -69.81 -16.52 63.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.871 -1.143 . . . . 0.0 111.681 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 68.1 m-85 -131.11 -10.81 3.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.729 -1.232 . . . . 0.0 110.945 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.872 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -80.57 -26.82 37.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 109.018 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 5.7 p-10 -73.4 -31.59 63.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.983 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.829 ' HB2' HD11 ' A' ' 94' ' ' LEU . 1.5 mmtt -79.92 -53.0 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.804 HG11 HG21 ' A' ' 88' ' ' ILE . 5.4 m -40.43 147.04 0.4 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.514 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 41.3 Cg_endo -68.52 170.7 14.43 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.397 1.735 . . . . 0.0 111.146 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 135.4 36.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.33 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -69.2 177.09 2.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 110.884 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -100.22 -156.13 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.338 -0.851 . . . . 0.0 111.015 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.7 pp20? -80.34 -30.79 38.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' O ' ' HE3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -65.0 -37.8 88.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.126 -0.984 . . . . 0.0 109.449 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.705 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 2.3 tm-20 -67.73 -6.89 23.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.684 -0.635 . . . . 0.0 109.478 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -91.47 -35.57 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 110.909 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -77.36 -65.31 1.95 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.174 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.192 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.71 -48.55 40.27 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.017 1.389 . . . . 0.0 108.333 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.113 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -58.91 -30.47 67.84 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.184 -176.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -81.26 -39.58 25.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.6 -0.688 . . . . 0.0 109.476 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.32 -41.53 38.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.816 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.826 HG13 ' HB1' ' A' ' 46' ' ' ALA . 2.8 m -90.42 67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 75' ' ' THR . 8.0 t -48.79 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.685 -0.635 . . . . 0.0 111.349 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.02 ' HB2' ' HG2' ' A' ' 104' ' ' ARG . . . -130.16 64.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.49 60.16 1.64 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.241 1.02 . . . . 0.0 109.813 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.113 HD11 HD22 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -46.87 134.65 9.91 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.991 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -125.36 -176.86 0.5 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.0 Cg_endo -67.04 -25.53 44.04 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.173 1.091 . . . . 0.0 111.297 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 26.0 p-10 -97.91 -13.13 21.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.813 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.703 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 1.4 m -54.44 151.34 7.83 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.596 -1.315 . . . . 0.0 109.761 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.733 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -175.63 163.76 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.188 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.192 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -83.16 145.09 29.39 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.489 -0.757 . . . . 0.0 109.986 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 60.3 p -40.83 -32.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 123.116 1.436 . . . . 0.0 107.973 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.062 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -94.35 46.39 1.15 Allowed 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.655 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -127.43 -43.29 1.61 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.493 -1.379 . . . . 0.0 113.374 -178.44 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.804 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -103.28 152.88 5.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 122.044 0.926 . . . . 0.0 112.341 -176.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 6.9 mm -106.35 165.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.541 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tpt -110.17 117.7 34.39 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.385 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 10.4 p -95.41 165.67 16.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.648 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.9 Cg_endo -73.25 -1.38 10.52 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.929 1.489 . . . . 0.0 110.345 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -110.08 -51.79 2.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 109.097 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 59' ' ' LYS . 1.3 mt -65.85 57.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.501 -0.749 . . . . 0.0 110.474 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.528 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 1.8 p30 -101.74 142.9 32.37 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.967 -1.083 . . . . 0.0 112.721 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.654 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.68 23.82 8.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.012 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.78 149.99 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.344 1.068 . . . . 0.0 112.904 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.62 HG23 ' ND2' ' A' ' 53' ' ' ASN . 22.1 t -115.09 123.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.788 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.96 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.1 t -103.94 176.7 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.828 -1.17 . . . . 0.0 109.423 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 51' ' ' TYR . 3.0 m-20 -162.53 143.85 10.31 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.349 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG12 ' ND1' ' A' ' 8' ' ' HIS . 53.2 t -94.26 132.98 28.0 Favored Pre-proline 0 C--N 1.287 -2.128 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.608 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.679 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 37.8 Cg_endo -79.42 135.21 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.548 1.289 . . . . 0.0 112.852 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.564 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 3.9 t70 -110.79 103.81 12.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 109.638 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 1.02 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.33 25.21 12.04 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.345 -0.847 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -120.0 -159.17 0.77 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.57 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.259 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.513 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.313 0.578 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -71.34 123.07 21.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.827 HG22 ' CG2' ' A' ' 97' ' ' ILE . 35.1 t -124.3 144.15 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.515 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.788 ' O ' HG23 ' A' ' 99' ' ' VAL . 14.8 t -131.9 124.54 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.486 0.66 . . . . 0.0 109.317 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.03 ' CD1' HG21 ' A' ' 99' ' ' VAL . 69.6 m-85 -102.73 141.6 35.28 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.652 -0.655 . . . . 0.0 111.434 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.074 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.7 t -120.84 148.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.901 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 2.2 p -110.15 139.33 45.41 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 103' ' ' ASP . 0.3 OUTLIER -45.36 -22.11 0.12 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.085 -1.009 . . . . 0.0 110.023 -179.514 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 7' ' ' SER . 9.9 p-10 -82.46 -7.66 59.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.987 -1.071 . . . . 0.0 110.374 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.54 -36.87 4.02 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.173 -0.954 . . . . 0.0 111.673 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.525 HG22 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.64 145.33 5.16 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.586 -1.538 . . . . 0.0 109.499 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.717 ' HG2' HG13 ' A' ' 6' ' ' VAL . 9.8 mtt180 -130.05 158.03 40.75 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.573 -0.704 . . . . 0.0 111.187 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.683 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.6 ttp180 -140.19 122.07 15.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.573 ' CG ' HG22 ' A' ' 4' ' ' VAL . 1.1 mp0 -98.86 123.19 42.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.725 -1.234 . . . . 0.0 110.79 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.793 HD12 ' CE2' ' A' ' 5' ' ' TYR . 9.4 mt -110.4 147.92 33.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -99.96 90.16 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.861 HG22 ' HB2' ' A' ' 26' ' ' ALA . 55.9 t -98.83 172.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 111.045 -177.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.582 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -124.64 -140.77 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.682 . . . . 0.0 110.324 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.91 123.42 47.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.63 -3.07 29.15 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.59 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 22' ' ' SER . 58.1 t -102.52 169.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.732 -1.451 . . . . 0.0 110.519 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.594 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.53 165.29 15.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.808 -0.557 . . . . 0.0 109.553 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -55.57 -33.94 64.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.637 -1.289 . . . . 0.0 107.602 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.773 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.5 ttt -68.43 -65.83 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.553 ' CG ' HG13 ' A' ' 21' ' ' VAL . 36.1 tt0 -38.05 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.861 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -43.8 -56.7 3.67 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.418 -1.426 . . . . 0.0 109.187 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -54.3 -58.71 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.929 0.871 . . . . 0.0 109.535 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.774 HG12 ' N ' ' A' ' 29' ' ' SER 0.277 1.2 t -31.37 -63.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.563 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.774 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.64 -47.04 87.15 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.119 0.961 . . . . 0.0 109.042 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.3 m120 -59.67 -9.69 2.93 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.89 63.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.799 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 7.8 mt -41.99 -34.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.591 -0.947 . . . . 0.0 109.058 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.773 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.2 m-85 -106.81 61.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.858 . . . . 0.0 111.9 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.43 43.45 0.18 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.672 -1.267 . . . . 0.0 109.147 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.614 HD11 ' HB ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -120.76 126.64 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.311 -0.868 . . . . 0.0 109.48 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' H ' HG12 ' A' ' 36' ' ' VAL . 3.0 p -80.0 117.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.44 -156.96 10.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -115.25 3.37 14.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.231 -1.158 . . . . 0.0 110.116 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 8.5 p -69.53 -39.91 77.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.534 -0.729 . . . . 0.0 111.683 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.33 29.94 5.52 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.08 23.32 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.751 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.33 7.24 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.165 -1.197 . . . . 0.0 111.915 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.44 53.28 0.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 0.0 112.329 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.569 ' CA ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -132.57 34.35 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.43 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.933 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.2 p -111.39 122.26 47.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -85.82 7.85 22.29 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.127 -1.608 . . . . 0.0 107.887 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.614 ' HB ' HD11 ' A' ' 35' ' ' ILE . 10.2 p -110.84 -42.47 4.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.757 . . . . 0.0 112.121 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.856 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.6 m -75.34 19.16 0.18 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.54 -1.35 . . . . 0.0 111.791 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.638 ' HD1' HG23 ' A' ' 74' ' ' VAL . 5.0 t-160 -45.58 137.25 5.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.576 -1.327 . . . . 0.0 108.225 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.3 m -139.63 155.2 25.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.775 -1.203 . . . . 0.0 109.952 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.1 m-30 -119.02 122.18 41.57 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.153 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.2 t -100.55 174.66 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.325 -0.859 . . . . 0.0 109.859 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.95 ' O ' HG23 ' A' ' 57' ' ' THR . 10.2 p30 -94.68 137.36 33.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.768 -1.208 . . . . 0.0 109.075 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 53' ' ' ASN . 8.9 pm0 -37.98 -25.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.342 -0.849 . . . . 0.0 111.625 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.923 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -71.49 -44.74 64.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 111.875 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.648 ' O ' HG13 ' A' ' 60' ' ' VAL . 53.4 m-85 -99.12 -9.45 23.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.658 -1.277 . . . . 0.0 111.831 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.95 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -80.29 -33.11 37.95 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.521 -1.362 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.91 -27.02 57.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.67 ' CB ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -79.93 -53.72 6.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 56' ' ' PHE . 11.9 m -41.17 163.49 0.1 Allowed Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 121.472 -0.767 . . . . 0.0 110.337 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -64.89 161.86 34.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.032 1.543 . . . . 0.0 111.915 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.63 26.27 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.815 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.59 152.72 44.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.59 ' O ' HD13 ' A' ' 68' ' ' ILE . 27.6 p-10 -100.18 -173.04 2.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.102 -0.999 . . . . 0.0 111.187 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -54.43 -18.63 4.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.529 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.51 -55.77 18.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.894 ' HB2' HE21 ' A' ' 87' ' ' GLN . 2.1 tm-20 -59.55 -5.1 0.75 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.837 -0.539 . . . . 0.0 111.4 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.3 mp -91.25 -16.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.344 -1.472 . . . . 0.0 111.488 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.29 -82.45 1.37 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.666 -1.271 . . . . 0.0 110.388 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.095 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -47.84 -33.74 7.81 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.005 -1.291 . . . . 0.0 109.755 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.019 HD22 HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.09 -29.32 70.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -90.32 -23.8 21.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.541 -0.724 . . . . 0.0 109.575 178.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.576 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 16.2 m -48.94 -44.72 40.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 108.779 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.638 HG23 ' HD1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -90.53 80.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.042 178.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 75' ' ' THR . 8.8 t -47.9 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.423 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.914 ' HB2' ' HD3' ' A' ' 104' ' ' ARG . . . -118.83 55.41 0.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.777 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 78' ' ' LEU . 1.6 pm0 39.54 48.64 1.84 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 109.457 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.019 HD11 HD22 ' A' ' 71' ' ' LEU . 1.7 tp -19.81 133.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.524 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.633 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -100.81 170.66 6.31 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -68.16 -27.77 34.98 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.559 1.294 . . . . 0.0 109.46 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 57' ' ' THR . 24.4 p-10 -105.77 -4.65 20.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.579 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.9 m -48.83 158.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 0.0 111.036 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.605 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -175.11 167.57 3.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.634 -0.666 . . . . 0.0 109.627 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.095 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -88.68 143.82 26.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.982 . . . . 0.0 110.368 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.654 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 6.4 p -46.57 -36.39 6.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 110.576 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.469 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 12.1 m -94.04 37.43 1.09 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 111.386 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.894 HE21 ' HB2' ' A' ' 67' ' ' GLU . 3.8 mm100 -126.65 -43.27 1.74 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 112.259 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.795 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -84.18 148.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.549 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.8 mm -111.07 164.17 7.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.762 -0.586 . . . . 0.0 109.788 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.608 ' HE2' ' HB ' ' A' ' 97' ' ' ILE . 2.0 tpt -110.28 86.96 2.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.303 -0.873 . . . . 0.0 110.028 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.469 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 1.3 p -70.54 163.41 63.6 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.46 -0.775 . . . . 0.0 109.858 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -76.93 0.84 9.26 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.9 1.474 . . . . 0.0 110.144 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.541 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 22.8 pt-20 -110.03 -21.28 12.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 109.47 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.67 HD13 ' CB ' ' A' ' 59' ' ' LYS . 10.5 mt -103.98 63.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 109.826 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.55 147.45 25.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.476 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.12 24.36 9.05 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.827 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -65.05 122.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 122.748 1.261 . . . . 0.0 113.045 -176.33 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.469 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 3.8 t -98.75 116.03 40.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.486 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.03 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -104.34 -175.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.38 1.086 . . . . 0.0 110.381 -179.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.659 ' H ' HG12 ' A' ' 99' ' ' VAL . 11.5 m-20 -161.99 139.81 8.81 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.128 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.074 HG23 ' O ' ' A' ' 6' ' ' VAL . 5.3 t -96.06 108.04 38.57 Favored Pre-proline 0 C--N 1.289 -2.048 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.1 Cg_endo -68.02 91.96 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.175 1.619 . . . . 0.0 110.904 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . 0.5 OUTLIER -110.16 108.11 18.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.969 -1.082 . . . . 0.0 110.401 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.914 ' HD3' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.31 140.17 44.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.238 -0.914 . . . . 0.0 110.066 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.12 2.85 10.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 11.4 m95 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.202 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' CA ' ' O ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.513 0.673 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 105.91 4.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.007 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.8 t -109.94 145.92 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.051 -1.031 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 6.7 t -131.19 132.55 63.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.438 -0.789 . . . . 0.0 109.538 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.732 ' HE1' ' HB3' ' A' ' 23' ' ' LEU . 70.9 m-85 -110.21 129.04 55.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.011 0.91 . . . . 0.0 112.02 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.2 t -102.08 119.46 50.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.762 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.663 ' CB ' HG22 ' A' ' 11' ' ' THR . 91.5 p -79.62 130.29 35.23 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.607 ' CG ' ' HB3' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -38.18 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.749 -0.594 . . . . 0.0 111.049 -179.414 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.8 p30 -79.36 -3.07 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.989 -1.069 . . . . 0.0 110.672 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' SER . . . 109.99 -33.48 5.99 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.663 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.71 142.06 9.06 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.946 -1.326 . . . . 0.0 109.29 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HG2' HG13 ' A' ' 6' ' ' VAL . 27.8 mtt180 -126.98 120.84 30.04 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.345 0.593 . . . . 0.0 111.074 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 3.0 ttp180 -99.94 153.04 19.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 5.3 mt-10 -130.51 134.09 46.77 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.852 -1.155 . . . . 0.0 110.238 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.835 HD13 ' CB ' ' A' ' 26' ' ' ALA . 7.4 mt -122.13 144.32 49.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -99.91 86.28 3.24 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.996 HG22 ' HB2' ' A' ' 26' ' ' ALA . 43.8 t -98.43 172.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.59 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.575 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -125.78 -146.52 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 111.282 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -96.71 122.07 39.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.594 0.712 . . . . 0.0 110.354 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.23 -13.14 31.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 22' ' ' SER . 32.7 t -88.26 169.74 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.018 -1.284 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.581 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.49 152.24 39.37 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.072 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.813 HD13 HG11 ' A' ' 99' ' ' VAL . 5.4 mt -52.17 -23.29 5.28 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.336 -1.746 . . . . 0.0 107.788 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.755 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -73.17 -66.05 0.73 Allowed 'General case' 0 C--O 1.202 -1.421 0 CA-C-O 121.595 0.712 . . . . 0.0 109.887 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.507 ' HB3' HG13 ' A' ' 21' ' ' VAL 0.256 38.7 tt0 -37.13 -70.29 0.1 Allowed 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.735 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.996 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -49.66 -58.93 4.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.94 -1.725 . . . . 0.0 108.666 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.917 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -47.91 -58.74 4.0 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 108.888 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.801 HG12 ' N ' ' A' ' 29' ' ' SER 0.284 1.0 OUTLIER -34.29 -64.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.715 178.176 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.801 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.03 -46.96 86.9 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.872 0.844 . . . . 0.0 109.6 179.097 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.503 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.1 m120 -59.87 -7.01 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.419 0.628 . . . . 0.0 109.735 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.59 -18.82 44.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 27' ' ' ALA . 59.5 mt -40.79 -38.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -1.028 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.755 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 23.4 m-85 -109.55 59.79 0.6 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.96 . . . . 0.0 113.224 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -66.76 -10.9 52.15 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.4 tt -80.02 106.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.322 0.582 . . . . 0.0 110.294 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.9 t -85.85 131.55 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.05 -135.05 4.89 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -114.47 37.98 3.22 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.185 -1.186 . . . . 0.0 109.99 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p -110.04 -36.0 5.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.781 -0.575 . . . . 0.0 109.792 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.26 31.2 4.52 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.0 32.03 37.33 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.738 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.6 m -131.45 5.32 4.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 0.0 111.172 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.09 47.93 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.242 -0.911 . . . . 0.0 112.312 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 3.2 m -133.16 44.53 2.82 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.053 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.96 153.5 25.43 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -111.55 -3.45 15.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.229 -0.92 . . . . 0.0 108.826 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.59 ' HB ' HD11 ' A' ' 35' ' ' ILE . 21.6 p -110.18 -30.49 7.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.272 -0.892 . . . . 0.0 112.039 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.623 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.1 m -80.32 34.0 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.545 -1.347 . . . . 0.0 110.964 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HD1' HG23 ' A' ' 74' ' ' VAL . 8.0 t-160 -60.7 132.8 55.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.923 -1.111 . . . . 0.0 108.091 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 83' ' ' ARG . 19.0 m -139.44 155.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.783 -1.198 . . . . 0.0 109.939 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.3 m-30 -116.21 106.34 13.58 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.928 0.871 . . . . 0.0 109.587 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.064 HG13 HD11 ' A' ' 97' ' ' ILE . 15.8 t -88.09 148.47 4.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.691 ' ND2' ' HB ' ' A' ' 98' ' ' VAL . 36.1 p-10 -73.08 127.4 32.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 119.516 -1.99 . . . . 0.0 109.661 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 16.8 pt-20 -34.38 -35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.698 -0.626 . . . . 0.0 111.621 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -55.26 -16.61 3.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 60.4 m-85 -128.66 -16.17 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.683 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.845 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -80.29 -32.01 38.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 108.984 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.1 p-10 -74.52 -27.28 60.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.763 ' CB ' HD13 ' A' ' 94' ' ' LEU . 2.2 mmtt -79.88 -53.7 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.498 -0.752 . . . . 0.0 109.763 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 57' ' ' THR . 12.3 m -42.98 166.83 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 110.029 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.7 Cg_endo -62.26 162.16 24.4 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.966 1.508 . . . . 0.0 111.96 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.91 125.32 29.97 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.044 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . . . -69.78 146.28 51.56 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 109.768 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 66' ' ' ARG . 3.7 p30 -100.65 -172.37 2.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.108 -0.995 . . . . 0.0 111.972 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -53.97 -20.81 6.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.59 . . . . 0.0 110.869 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 70' ' ' MET . 4.3 ttm180 -64.09 -55.59 20.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.47 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 3.3 tt0 -58.64 -49.97 75.55 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.716 -0.615 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.3 mp -48.01 -26.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 111.457 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.75 -68.7 1.19 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.028 ' CE ' HD12 ' A' ' 84' ' ' LEU . 2.2 ptm -48.51 -41.47 30.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.83 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 71' ' ' LEU 0.25 0.0 OUTLIER -71.1 -24.19 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.925 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 2.5 tt0 -90.78 -13.41 33.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.731 -0.605 . . . . 0.0 109.87 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.748 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 9.7 m -48.52 -49.68 35.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 108.861 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.616 HG23 ' HD1' ' A' ' 49' ' ' HIS . 4.3 m -90.32 92.9 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 75' ' ' THR . 9.1 t -48.29 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.369 -0.832 . . . . 0.0 110.757 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.869 ' HB2' ' HD3' ' A' ' 104' ' ' ARG . . . -124.49 50.59 1.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.1 pt-20 39.39 60.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.634 0.73 . . . . 0.0 109.609 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.571 HD11 HD13 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -30.54 122.06 0.2 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.573 0.702 . . . . 0.0 111.806 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -86.05 171.21 10.87 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.8 Cg_endo -66.72 -25.91 46.05 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.46 1.242 . . . . 0.0 109.485 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' A' ' 57' ' ' THR . 6.7 p-10 -109.87 -4.13 16.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.619 -0.676 . . . . 0.0 111.394 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CG ' ' A' ' 79' ' ' LYS . 69.2 m -48.71 143.9 4.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.674 -1.266 . . . . 0.0 110.588 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.831 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.86 165.53 36.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.0 110.046 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.053 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -88.4 143.08 27.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.362 -0.836 . . . . 0.0 109.369 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.623 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 5.7 p -46.64 -46.37 19.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.74 -1.225 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -91.91 38.82 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.598 -0.689 . . . . 0.0 109.893 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.584 ' OE1' ' HB1' ' A' ' 43' ' ' ALA . 38.6 tp60 -123.28 -40.99 2.33 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.41 -0.806 . . . . 0.0 111.318 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.902 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -92.73 149.73 4.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.31 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -110.7 164.28 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.603 ' HE3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.4 126.37 54.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.96 -1.088 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.482 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.55 159.86 28.06 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.722 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -72.71 -1.61 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.915 1.481 . . . . 0.0 110.514 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -110.06 -28.59 8.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.588 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.763 HD13 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -93.48 37.77 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.073 0.94 . . . . 0.0 109.286 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' CB ' ' OG ' ' A' ' 1' ' ' SER . 1.6 p-10 -82.06 142.83 31.98 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.707 0.765 . . . . 0.0 112.196 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.36 28.33 7.23 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.064 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -77.99 133.7 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 122.173 0.987 . . . . 0.0 112.483 -177.235 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.691 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 16.5 t -102.44 101.63 12.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.373 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.95 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.59 170.15 2.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.063 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -144.32 172.19 13.27 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.197 0.999 . . . . 0.0 111.57 -176.483 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 102' ' ' PRO . 98.9 t -107.08 109.4 62.99 Favored Pre-proline 0 C--N 1.297 -1.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.264 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.646 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 47.0 Cg_endo -71.09 94.99 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.981 1.516 . . . . 0.0 111.585 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.607 ' HB3' ' CG ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -110.33 112.9 25.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 0.0 109.876 178.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.869 ' HD3' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.66 113.62 26.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -118.61 5.32 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 110.251 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.21 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.543 ' HB3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -70.18 125.28 26.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.698 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.663 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 3.2 t -121.76 136.88 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.975 -1.078 . . . . 0.0 110.231 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.911 HG13 ' CG ' ' A' ' 14' ' ' GLU . 95.1 t -121.14 110.75 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 112.197 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.108 ' OH ' HD12 ' A' ' 15' ' ' LEU . 19.6 m-30 -82.27 131.4 35.23 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.423 0.63 . . . . 0.0 111.708 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 99' ' ' VAL . 4.4 t -120.49 128.78 76.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.064 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.666 ' HB3' HG22 ' A' ' 11' ' ' THR . 26.8 p -79.33 -159.78 0.21 Allowed 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.95 -1.1 . . . . 0.0 108.5 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.551 ' CB ' ' HB2' ' A' ' 103' ' ' ASP . 0.3 OUTLIER -101.5 -11.33 19.39 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.895 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.55 -0.75 37.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 0.0 109.565 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 -19.9 26.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.82 143.04 7.99 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.958 -1.319 . . . . 0.0 109.223 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 17.2 mtt180 -124.1 139.21 54.16 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.428 0.633 . . . . 0.0 111.329 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.655 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.25 67.82 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.911 ' CG ' HG13 ' A' ' 4' ' ' VAL . 4.0 mp0 -67.51 140.97 57.05 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.919 -1.113 . . . . 0.0 110.849 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.108 HD12 ' OH ' ' A' ' 5' ' ' TYR . 8.8 mt -109.72 150.76 27.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.691 -0.631 . . . . 0.0 110.043 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.35 85.78 3.26 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 26' ' ' ALA . 40.7 t -98.76 171.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.666 0.746 . . . . 0.0 111.337 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.578 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -118.57 -139.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.454 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -105.58 125.73 51.33 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.452 -0.78 . . . . 0.0 110.198 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.67 29.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 22' ' ' SER . 61.1 t -102.18 170.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.933 -1.333 . . . . 0.0 110.199 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.616 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.73 160.33 23.56 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.762 HD21 ' SD ' ' A' ' 90' ' ' MET . 16.8 mt -54.97 -18.4 4.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.694 -1.254 . . . . 0.0 109.448 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . 1.225 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -90.23 -58.18 2.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.257 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG13 ' A' ' 21' ' ' VAL . 46.9 tt0 -38.63 -64.77 0.41 Allowed 'General case' 0 C--N 1.289 -2.062 0 O-C-N 122.127 -0.358 . . . . 0.0 110.762 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.953 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -48.38 -55.97 9.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.437 -1.415 . . . . 0.0 108.283 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.777 ' HB1' ' CD1' ' A' ' 33' ' ' TYR . . . -52.72 -55.92 19.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 33' ' ' TYR 0.264 0.7 OUTLIER -37.32 -47.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.472 177.592 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.8 -43.81 21.76 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.582 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.7 m-80 -59.86 -8.08 2.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 109.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.34 -18.4 18.53 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.592 HD13 ' HD2' ' A' ' 5' ' ' TYR . 58.2 mt -48.92 -29.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.851 -1.382 . . . . 0.0 107.643 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 3.1 m-85 -100.54 56.42 0.9 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 21.4 p-10 -70.81 56.17 0.18 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.512 -1.367 . . . . 0.0 107.397 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 33' ' ' TYR . 6.0 pt -79.65 -151.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 37' ' ' GLY . 2.0 t -118.09 -142.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.417 -0.802 . . . . 0.0 110.143 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -120.48 83.9 0.36 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.743 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.463 ' CB ' ' HA ' ' A' ' 45' ' ' CYS . 6.5 m-20 -120.23 -66.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.126 -1.22 . . . . 0.0 109.159 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.662 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.1 p -69.07 -14.13 62.84 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.741 -0.599 . . . . 0.0 110.23 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 48.26 25.48 4.22 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.03 28.81 61.71 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.3 p -140.23 28.09 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.3 . . . . 0.0 111.998 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 66.56 45.29 2.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.577 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -130.6 46.79 2.61 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.078 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.054 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -111.72 157.06 20.95 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -177.047 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.692 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -112.0 -9.76 13.98 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.677 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.2 p -110.48 -30.11 7.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -0.78 . . . . 0.0 112.618 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.863 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.4 m -73.99 66.88 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.31 -1.494 . . . . 0.0 110.197 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.619 ' HE2' ' HE1' ' A' ' 51' ' ' TYR . 4.0 t-160 -87.85 132.74 34.08 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 83' ' ' ARG . 17.1 m -142.29 155.24 18.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 109.277 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.694 ' CD1' ' HE2' ' A' ' 79' ' ' LYS . 5.1 m-30 -120.2 118.11 29.65 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 121.675 0.75 . . . . 0.0 111.015 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.791 ' HB ' HG22 ' A' ' 57' ' ' THR . 42.2 t -97.96 165.71 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.346 -0.846 . . . . 0.0 109.643 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.763 ' O ' HG23 ' A' ' 57' ' ' THR . 21.1 p-10 -89.41 138.31 31.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.38 -1.45 . . . . 0.0 109.388 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -38.38 -26.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.382 -0.824 . . . . 0.0 111.441 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . . . -68.31 -18.0 64.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.965 -1.084 . . . . 0.0 111.551 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 38.5 m-85 -129.62 -14.44 4.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.776 -1.203 . . . . 0.0 110.796 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.791 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -80.88 -22.69 39.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.906 -1.121 . . . . 0.0 108.746 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -85.96 -23.97 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.825 . . . . 0.0 110.028 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HB3' HD22 ' A' ' 94' ' ' LEU . 9.2 mmtt -79.5 -47.66 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.452 -0.78 . . . . 0.0 109.111 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.897 HG11 ' CG2' ' A' ' 88' ' ' ILE . 6.3 m -45.3 161.39 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.786 -0.571 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.512 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -65.19 163.34 29.43 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 112.325 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.21 124.14 29.04 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.76 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.631 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -88.66 160.26 17.45 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.621 ' O ' HD13 ' A' ' 68' ' ' ILE . 3.3 p30 -100.55 -166.86 1.36 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 110.266 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.0 -24.27 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.838 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' MET . 4.1 ttm180 -64.79 -15.34 61.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.741 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.0 tp10 -100.28 -3.61 31.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.91 -59.3 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 111.445 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.88 -47.54 24.89 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.988 ' CE ' HD12 ' A' ' 84' ' ' LEU 0.33 1.3 ttp -48.79 -52.3 24.66 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 123.497 1.618 . . . . 0.0 108.666 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD12 ' OE2' ' A' ' 67' ' ' GLU 0.293 0.0 OUTLIER -68.39 -33.85 74.98 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.043 -179.21 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.684 ' HB2' HD22 ' A' ' 78' ' ' LEU . 6.7 tt0 -90.56 7.64 38.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.573 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 5.5 m -48.83 -49.47 39.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.85 -1.156 . . . . 0.0 108.342 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.694 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.3 m -90.48 113.35 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.02 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 75' ' ' THR . 8.9 t -48.57 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.823 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.006 ' HB2' ' HG2' ' A' ' 104' ' ' ARG . . . -125.2 44.82 2.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.558 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.7 pt-20 39.56 60.53 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.43 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 72' ' ' GLU . 2.5 tp -32.17 133.59 0.1 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 21.3 mtmt -110.44 172.01 3.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.708 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -66.26 -32.06 42.79 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.507 1.267 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.732 ' HB2' HG21 ' A' ' 57' ' ' THR . 14.5 p-10 -98.79 -10.84 22.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.501 ' OG ' ' HB2' ' A' ' 79' ' ' LYS . 50.2 m -48.92 150.51 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 0.0 109.724 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.666 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -157.59 151.43 24.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.054 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -73.17 130.45 40.29 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.62 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -44.81 -20.98 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.991 -1.068 . . . . 0.0 112.149 -176.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.225 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 26.1 m -107.02 39.29 1.9 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.578 -1.326 . . . . 0.0 111.168 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.589 ' HG3' ' HB2' ' A' ' 84' ' ' LEU . 7.7 mm100 -125.06 -45.26 1.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 110.634 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.897 ' CG2' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.88 143.25 12.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.9 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.0 mm -110.68 158.71 10.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.416 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.762 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.9 tpt -110.21 103.89 12.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -98.58 167.61 11.17 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.754 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -72.6 -0.36 8.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.584 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 3.7 pt-20 -110.04 -32.08 7.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 109.55 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' CE ' ' A' ' 90' ' ' MET . 6.8 mt -94.66 35.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.16 0.981 . . . . 0.0 109.187 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -87.94 154.58 20.39 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.667 0.746 . . . . 0.0 112.101 -177.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.642 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.37 24.14 19.75 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.765 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -80.5 152.24 4.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.274 1.035 . . . . 0.0 112.577 -177.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG23 ' ND2' ' A' ' 53' ' ' ASN . 17.6 t -112.68 123.56 68.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -103.91 -175.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.86 -1.15 . . . . 0.0 109.933 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.675 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.9 m-20 -162.11 130.14 4.06 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.989 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 6' ' ' VAL . 54.0 t -89.19 110.36 37.86 Favored Pre-proline 0 C--N 1.277 -2.549 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.642 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.4 Cg_endo -65.03 134.7 40.78 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.029 1.542 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 6.2 t0 -110.41 115.59 29.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 1.006 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.09 70.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.082 -1.011 . . . . 0.0 110.136 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.13 41.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.219 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.522 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.543 0.687 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -90.25 121.44 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.817 HG22 ' CG2' ' A' ' 97' ' ' ILE . 3.4 t -122.55 143.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.719 -1.238 . . . . 0.0 110.098 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.85 HG22 ' CG ' ' A' ' 14' ' ' GLU . 24.4 t -130.18 122.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.998 0.904 . . . . 0.0 109.147 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.913 ' HE2' HD13 ' A' ' 15' ' ' LEU . 42.1 m-85 -96.95 142.07 29.36 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.802 0.81 . . . . 0.0 111.035 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.002 HG13 ' HG3' ' A' ' 12' ' ' ARG . 2.9 t -113.48 114.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.39 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -79.6 124.56 28.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.611 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -32.4 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.005 -0.434 . . . . 0.0 112.144 -178.133 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.589 ' OD1' HG22 ' A' ' 11' ' ' THR . 2.6 p-10 -66.99 -9.51 39.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.682 -1.261 . . . . 0.0 110.141 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . 110.0 -31.73 7.25 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.589 HG22 ' OD1' ' A' ' 9' ' ' ASP . 2.7 t -61.58 133.61 55.86 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.965 -1.315 . . . . 0.0 109.272 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 1.002 ' HG3' HG13 ' A' ' 6' ' ' VAL . 13.4 mtm180 -118.53 132.3 56.21 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.169 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.687 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.03 149.15 24.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 179.002 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.85 ' CG ' HG22 ' A' ' 4' ' ' VAL . 22.9 mt-10 -130.41 120.1 23.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.771 -1.206 . . . . 0.0 110.949 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.913 HD13 ' HE2' ' A' ' 5' ' ' TYR . 1.4 mp -116.87 177.62 4.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.257 1.027 . . . . 0.0 111.914 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -106.75 83.14 1.8 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.986 HG22 ' CB ' ' A' ' 26' ' ' ALA . 58.6 t -98.54 129.22 49.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.538 -0.726 . . . . 0.0 110.305 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.477 ' HA ' ' OG ' ' A' ' 1' ' ' SER . . . -140.0 -171.47 3.18 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.523 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 90' ' ' MET . 1.9 p30 -41.23 115.4 0.6 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.856 0.836 . . . . 0.0 110.324 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.34 -22.23 22.89 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.661 ' HB ' HG13 ' A' ' 17' ' ' VAL . 2.4 t -107.88 157.49 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.849 -1.383 . . . . 0.0 110.86 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -120.96 166.69 13.47 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.671 HD22 HD12 ' A' ' 88' ' ' ILE . 5.1 mp -58.42 -22.09 53.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.368 -1.457 . . . . 0.0 107.897 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.87 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.93 -72.12 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.643 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.608 ' HG2' HG13 ' A' ' 21' ' ' VAL . 28.8 tt0 -37.67 -67.6 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.877 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.986 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -42.37 -73.95 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.499 -1.376 . . . . 0.0 108.613 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.826 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . . . -44.85 -44.74 9.76 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -47.09 -60.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.714 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -50.27 -45.87 54.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.993 0.901 . . . . 0.0 108.748 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.654 ' OD1' HD21 ' A' ' 15' ' ' LEU . 1.3 m120 -64.93 -2.34 2.58 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.789 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 11.68 84.54 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 15' ' ' LEU 0.268 3.8 mt -70.67 -31.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.568 -0.96 . . . . 0.0 109.134 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.751 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.4 m-85 -108.7 56.47 0.62 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.369 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -73.88 50.7 0.36 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.932 -1.105 . . . . 0.0 108.522 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.76 HD13 ' SG ' ' A' ' 48' ' ' CYS . 1.1 pp -81.74 -146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.565 -0.709 . . . . 0.0 110.862 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 37' ' ' GLY . 1.4 p -99.15 -156.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 0.0 110.46 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.67 ' N ' HG13 ' A' ' 36' ' ' VAL . . . -120.19 83.91 0.36 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 44' ' ' SER . 61.4 m-20 -120.15 -58.24 1.88 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.3 p -69.31 -28.0 65.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.798 -0.564 . . . . 0.0 110.709 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.44 28.07 3.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.28 35.47 26.6 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.729 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.0 p -140.11 8.38 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -1.204 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 70.3 53.41 0.33 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.149 -0.969 . . . . 0.0 111.935 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -133.19 38.44 3.33 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.108 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.62 153.9 24.55 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.95 -2.22 16.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.658 -1.276 . . . . 0.0 108.789 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 p -110.02 -34.49 6.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 111.363 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.84 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.2 m -74.53 63.7 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.561 -1.337 . . . . 0.0 109.794 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.957 ' ND1' HG21 ' A' ' 74' ' ' VAL . 17.1 t-160 -91.78 133.13 35.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.601 HG11 ' OH ' ' A' ' 33' ' ' TYR . 16.9 m -144.58 154.82 14.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.808 -1.182 . . . . 0.0 109.943 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.727 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 7.7 m-30 -116.84 109.57 17.26 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.891 HG21 ' CD1' ' A' ' 88' ' ' ILE . 16.4 t -86.28 158.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.372 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 57' ' ' THR . 11.5 p-10 -78.81 132.43 36.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 119.997 -1.689 . . . . 0.0 109.918 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 53' ' ' ASN . 12.1 pt-20 -38.65 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.98 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -63.87 -23.13 67.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.643 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 24.9 m-85 -122.71 -15.27 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.926 -1.109 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.874 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -78.65 -26.44 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.937 -1.105 . . . . 0.0 108.796 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.0 p-10 -81.83 -26.2 34.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.533 -0.729 . . . . 0.0 109.692 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . 12.5 mmtt -79.79 -52.04 8.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.498 -0.751 . . . . 0.0 109.492 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 56' ' ' PHE . 10.3 m -40.76 162.55 0.1 Allowed Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.602 -0.686 . . . . 0.0 110.515 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.524 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.6 Cg_endo -66.74 165.57 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.068 1.562 . . . . 0.0 111.454 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.62 27.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.622 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -69.21 166.3 18.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.439 -0.788 . . . . 0.0 109.71 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.71 ' O ' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -100.45 -158.2 0.66 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.977 -1.077 . . . . 0.0 110.929 -179.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 pp20? -78.38 -23.16 46.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.694 -0.628 . . . . 0.0 111.069 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.565 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.84 -48.46 74.28 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.801 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.591 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.11 -6.27 0.84 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.262 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.39 -30.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.617 -1.302 . . . . 0.0 110.668 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.28 -63.22 1.25 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.106 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -48.08 -42.64 29.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 109.222 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.911 HD13 HD11 ' A' ' 78' ' ' LEU 0.26 0.0 OUTLIER -69.45 -23.84 63.72 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.934 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -89.95 -18.68 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.511 -0.743 . . . . 0.0 110.029 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' GLU . 2.1 m -48.51 -31.43 6.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.957 HG21 ' ND1' ' A' ' 49' ' ' HIS . 20.4 m -90.32 87.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 75' ' ' THR . 9.3 t -48.41 82.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.269 -0.894 . . . . 0.0 111.506 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.901 ' HB2' ' NH2' ' A' ' 104' ' ' ARG . . . -130.39 40.85 3.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 10.0 pt-20 39.2 60.14 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.764 -0.585 . . . . 0.0 109.754 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.911 HD11 HD13 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -19.93 125.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.264 0.554 . . . . 0.0 112.104 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.626 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -80.05 170.69 14.78 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.4 Cg_endo -65.85 -25.71 52.7 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.477 1.251 . . . . 0.0 109.564 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.675 ' HB2' HG21 ' A' ' 57' ' ' THR . 20.6 p-10 -107.79 -8.25 16.09 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 111.33 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 45.7 m -49.44 158.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.614 -1.304 . . . . 0.0 111.205 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' NH2' HG23 ' A' ' 88' ' ' ILE . 2.3 ttp180 -175.51 156.48 1.96 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.108 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -73.29 135.47 44.42 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.624 ' HG ' ' HE1' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -45.46 -24.3 0.3 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.585 -177.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.3 m -104.79 42.64 1.18 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.894 -1.128 . . . . 0.0 111.401 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.823 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -125.07 -42.53 2.01 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.717 0.77 . . . . 0.0 110.501 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.891 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -89.0 140.04 16.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.354 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 90' ' ' MET . 5.3 mm -110.68 172.56 2.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.933 ' CB ' HG12 ' A' ' 17' ' ' VAL . 1.2 tpt -110.15 115.85 30.48 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.13 -0.982 . . . . 0.0 111.029 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.471 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -96.8 169.56 8.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.664 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.9 -5.65 17.58 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.885 1.466 . . . . 0.0 110.556 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 10.8 pt-20 -110.29 -23.94 10.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.701 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 7.2 mt -96.39 55.9 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -0.995 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -100.84 146.51 27.21 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.066 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.643 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.59 21.73 10.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.817 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -62.48 150.47 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.183 0.992 . . . . 0.0 113.243 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.668 HG23 ' ND2' ' A' ' 53' ' ' ASN . 10.9 t -127.61 89.82 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.977 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.72 162.49 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.441 1.115 . . . . 0.0 110.51 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.571 ' OD2' HG21 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -145.51 170.13 17.01 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.913 -178.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.504 HG12 ' ND1' ' A' ' 8' ' ' HIS . 42.3 t -110.17 128.84 24.69 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.727 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 37.5 Cg_endo -71.73 106.38 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.771 1.406 . . . . 0.0 112.942 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.611 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.81 10.01 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.901 ' NH2' ' HB2' ' A' ' 76' ' ' ALA 0.265 0.0 OUTLIER -29.59 143.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.087 178.883 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.471 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.7 mm100 -120.17 94.62 4.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 75' ' ' THR . 6.7 m95 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.559 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.366 0.603 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.6 ttmm -76.63 135.12 39.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.903 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.77 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 14.8 t -123.43 140.39 47.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.614 -1.304 . . . . 0.0 110.865 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.866 HG13 ' HG2' ' A' ' 14' ' ' GLU . 41.4 t -121.5 117.91 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 122.052 0.93 . . . . 0.0 111.504 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.097 ' CE2' HD13 ' A' ' 15' ' ' LEU . 22.5 m-30 -97.55 135.26 39.64 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.837 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 99' ' ' VAL . 14.4 t -120.05 154.09 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.48 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 11' ' ' THR . 10.7 p -117.06 138.64 51.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 0.5 OUTLIER -44.39 -24.28 0.17 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.151 -0.968 . . . . 0.0 110.338 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.5 p30 -85.03 -5.82 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.007 . . . . 0.0 110.401 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.19 -45.61 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.529 HG22 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.73 124.52 9.84 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.877 -1.366 . . . . 0.0 110.011 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.708 ' HD2' HG22 ' A' ' 6' ' ' VAL . 30.7 mtm180 -110.34 156.91 20.1 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.479 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.763 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -134.75 67.78 1.49 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 0.0 109.438 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.866 ' HG2' HG13 ' A' ' 4' ' ' VAL . 1.4 mp0 -69.48 131.49 44.82 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.563 0.697 . . . . 0.0 110.335 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.097 HD13 ' CE2' ' A' ' 5' ' ' TYR . 2.3 mp -114.77 173.5 6.45 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.236 1.017 . . . . 0.0 112.012 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.78 90.76 4.56 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.9 HG13 HG11 ' A' ' 21' ' ' VAL . 95.7 t -98.58 166.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.469 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.559 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -133.01 -160.74 1.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.757 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -82.41 123.75 29.41 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.564 0.697 . . . . 0.0 110.696 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.37 37.08 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.923 HG13 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -106.29 170.2 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 110.65 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.604 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -120.51 175.94 5.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -76.16 -3.67 37.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.216 -1.553 . . . . 0.0 108.218 178.049 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.59 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.18 -77.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 112.022 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.923 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -38.03 -23.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.905 -0.497 . . . . 0.0 111.176 -177.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.635 ' C ' HD22 ' A' ' 15' ' ' LEU . . . -87.7 -45.06 10.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.791 ' HA ' HD12 ' A' ' 32' ' ' ILE 0.265 . . -66.33 -46.13 77.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.887 1.327 . . . . 0.0 107.492 176.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 29' ' ' SER 0.263 0.8 OUTLIER -45.92 -58.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.197 178.64 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.7 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.72 -35.79 75.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.031 178.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.709 ' OD1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -72.87 12.15 0.56 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.444 0.64 . . . . 0.0 109.831 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 70.08 4.96 51.51 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 27' ' ' ALA . 4.2 mt -66.43 -42.43 90.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -1.109 . . . . 0.0 109.459 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.63 ' HB2' HG23 ' A' ' 28' ' ' VAL . 23.5 m-85 -108.82 61.19 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.183 -1.007 . . . . 0.0 113.448 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 11.0 p-10 -84.62 43.33 0.97 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.813 HD12 ' CG2' ' A' ' 47' ' ' THR . 30.4 pt -79.86 -146.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.321 0.582 . . . . 0.0 110.784 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.503 ' N ' HG13 ' A' ' 35' ' ' ILE . 6.6 m -92.19 -155.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 110.52 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.1 84.42 0.37 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 44' ' ' SER . 13.9 m-20 -120.12 -35.3 3.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -1.179 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 21.7 p -110.29 -36.25 5.86 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.852 -0.53 . . . . 0.0 110.116 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 42.59 35.28 1.98 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.55 ' H ' ' HE3' ' A' ' 24' ' ' MET . . . 80.27 28.25 49.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 6.2 m -128.58 -3.65 5.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -1.092 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.81 51.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.765 0.793 . . . . 0.0 112.321 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.567 ' OG ' ' HA ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -131.55 38.91 3.55 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.733 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -110.88 150.41 29.22 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.87 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -111.01 -4.4 15.14 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.554 -0.717 . . . . 0.0 109.667 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.813 ' CG2' HD12 ' A' ' 35' ' ' ILE . 6.2 t -110.56 -21.49 12.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.947 . . . . 0.0 112.754 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.819 ' O ' HG13 ' A' ' 50' ' ' VAL . 34.9 m -75.02 11.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.367 -1.458 . . . . 0.0 111.243 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.103 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 3.3 t-160 -43.69 124.45 3.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.6 m -143.35 163.12 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 120.928 -1.107 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.774 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -118.47 124.63 48.07 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.704 0.764 . . . . 0.0 111.147 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.932 HG21 ' CD1' ' A' ' 88' ' ' ILE . 2.7 t -99.58 165.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.943 ' OD1' ' HB3' ' A' ' 55' ' ' ALA . 9.7 p30 -82.85 134.58 35.09 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 119.892 -1.755 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.1 pt-20 -37.58 -25.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.455 -0.778 . . . . 0.0 111.765 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.943 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -70.68 -40.33 73.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.838 -1.163 . . . . 0.0 111.587 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.845 ' HB3' HD12 ' A' ' 97' ' ' ILE . 61.1 m-85 -102.71 -17.95 15.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.733 -1.229 . . . . 0.0 111.258 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -80.63 -23.43 39.75 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.927 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 55' ' ' ALA . 23.4 p-10 -82.95 -24.11 33.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.566 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.897 ' CB ' HD21 ' A' ' 94' ' ' LEU . 3.4 mmtp -79.85 -49.05 12.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.675 ' N ' HD11 ' A' ' 94' ' ' LEU . 3.0 m -43.54 168.25 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 110.05 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.6 Cg_endo -62.17 164.71 16.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.029 1.541 . . . . 0.0 111.589 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.67 112.79 18.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.898 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.587 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.58 147.24 50.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.763 . . . . 0.0 110.366 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' O ' HD13 ' A' ' 68' ' ' ILE . 23.6 p30 -100.07 -173.38 2.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 110.555 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.63 -26.92 24.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 70' ' ' MET . 5.4 ttm180 -64.83 -18.11 64.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.587 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 3.3 tm-20 -99.96 1.51 42.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.1 mp -91.89 -59.05 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 111.194 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -77.01 -47.77 9.01 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.695 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.323 2.8 ttp -48.58 -50.72 31.26 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 123.547 1.641 . . . . 0.0 108.022 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.626 HD11 ' C ' ' A' ' 82' ' ' SER 0.296 0.0 OUTLIER -70.87 -32.44 69.43 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.709 -179.408 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.649 ' HB2' HD22 ' A' ' 78' ' ' LEU . 4.3 tt0 -89.16 -0.15 57.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.893 -1.129 . . . . 0.0 110.453 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.692 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -49.08 -52.34 26.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.631 -1.293 . . . . 0.0 108.438 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 46' ' ' ALA . 31.1 m -90.48 107.95 19.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.481 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -48.15 103.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.838 -1.164 . . . . 0.0 109.254 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.103 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -120.07 22.51 11.41 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.608 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 71.7 38.27 0.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.672 1.225 . . . . 0.0 108.338 -178.408 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 72' ' ' GLU . 11.3 tp -19.26 134.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.979 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' N ' HD12 ' A' ' 78' ' ' LEU . 2.4 mtpt -128.09 -169.24 0.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 46.2 Cg_endo -81.92 -30.64 1.26 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.697 1.367 . . . . 0.0 109.743 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.7 p-10 -93.7 -12.17 29.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.731 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.626 ' C ' HD11 ' A' ' 71' ' ' LEU . 18.6 m -49.23 155.52 0.68 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.042 . . . . 0.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.85 ' NE ' HG23 ' A' ' 88' ' ' ILE . 2.4 mtp180 -175.29 153.92 1.63 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.733 HD22 ' SG ' ' A' ' 45' ' ' CYS . 11.1 mt -74.61 150.84 39.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.672 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 46.6 p -46.71 -25.94 0.83 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.725 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -110.13 44.95 1.15 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.732 0.777 . . . . 0.0 109.556 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.564 ' HG2' ' CG ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -125.44 -32.77 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.932 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.35 147.18 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.628 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.0 mm -110.3 160.62 9.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 21' ' ' VAL . 2.9 tpt -110.25 112.86 25.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.539 -0.726 . . . . 0.0 110.425 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -97.48 172.66 4.7 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.2 Cg_endo -72.67 -31.87 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.92 1.484 . . . . 0.0 110.558 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 2.4 pp20? -81.04 -44.96 17.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.883 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.897 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.1 mt -75.81 52.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.115 -0.991 . . . . 0.0 111.018 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 4.3 p-10 -101.33 152.86 20.2 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.032 -1.042 . . . . 0.0 111.764 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.626 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.32 22.42 10.56 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.845 HD12 ' HB3' ' A' ' 56' ' ' PHE . 3.6 tt -72.55 154.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 123.175 1.464 . . . . 0.0 113.555 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.636 ' H ' ' ND2' ' A' ' 53' ' ' ASN 0.252 8.1 t -125.37 98.27 4.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.566 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.891 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.74 174.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.134 -1.427 . . . . 0.0 109.726 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.586 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.87 174.03 16.12 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.914 0.864 . . . . 0.0 111.024 -178.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 18.0 t -111.09 130.96 22.43 Favored Pre-proline 0 N--CA 1.498 1.956 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.429 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.937 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 49.7 Cg_endo -73.36 134.67 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.695 1.597 . . . . 0.0 112.683 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.598 ' HB3' ' CB ' ' A' ' 8' ' ' HIS . 0.6 OUTLIER -111.83 107.44 16.49 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.272 -0.892 . . . . 0.0 111.624 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.642 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -110.75 53.87 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.007 -1.058 . . . . 0.0 110.039 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -104.99 73.72 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.161 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 97.8 m95 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.234 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.546 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.38 0.609 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -74.8 120.11 19.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.743 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.769 HG22 ' CG2' ' A' ' 97' ' ' ILE . 25.1 t -119.67 146.5 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.769 -1.207 . . . . 0.0 110.983 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 99' ' ' VAL . 16.9 t -131.06 125.83 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.695 0.76 . . . . 0.0 109.856 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.902 ' CD1' HG21 ' A' ' 99' ' ' VAL . 49.2 m-85 -101.52 137.91 39.22 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.486 0.66 . . . . 0.0 111.922 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.5 t -120.77 132.73 69.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.023 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.693 ' HB3' HG22 ' A' ' 11' ' ' THR . 67.6 p -79.39 -153.01 0.07 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.617 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.2 -8.13 14.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 120.97 -1.081 . . . . 0.0 108.98 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -100.37 1.65 41.64 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.41 -21.75 23.54 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.87 138.89 14.32 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.024 -1.28 . . . . 0.0 109.449 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 24.6 mtt180 -130.06 148.66 51.93 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.401 0.62 . . . . 0.0 111.215 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.696 ' HG2' HD11 ' A' ' 32' ' ' ILE . 1.4 ttm-85 -140.11 118.9 12.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.43 -0.794 . . . . 0.0 109.888 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.0 mp0 -100.42 124.43 45.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.797 -1.189 . . . . 0.0 110.835 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 27' ' ' ALA . 10.8 mt -110.57 151.83 27.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 110.507 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.11 90.37 3.92 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.911 HG22 ' HB2' ' A' ' 26' ' ' ALA . 50.6 t -98.61 174.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 110.298 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -125.32 -133.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.518 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -110.03 124.04 50.75 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.51 -10.78 30.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 22' ' ' SER . 70.0 t -93.87 169.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.33 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.618 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.36 169.26 10.78 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 3' ' ' VAL . 10.7 mt -60.91 -35.15 75.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.721 -1.237 . . . . 0.0 108.934 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.754 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.9 ttp -66.65 -62.47 1.44 Allowed 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.927 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.614 ' CG ' HG13 ' A' ' 21' ' ' VAL . 45.5 tt0 -38.14 -76.72 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.911 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -43.15 -56.39 3.44 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.331 -1.481 . . . . 0.0 109.754 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.879 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -56.74 -53.62 55.69 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.012 0.91 . . . . 0.0 109.412 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.756 HG12 ' N ' ' A' ' 29' ' ' SER 0.284 1.2 t -35.47 -63.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.152 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.756 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.37 -46.67 85.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.112 0.958 . . . . 0.0 108.884 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.508 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.6 m120 -59.93 -8.6 2.35 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 88.02 -14.64 58.37 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.866 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 7.6 mt -42.75 -38.41 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.692 -0.887 . . . . 0.0 108.643 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.754 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 72.3 m-85 -112.79 76.81 1.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 19.4 p30 -49.01 -20.4 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.604 -1.238 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.822 ' CD1' HG23 ' A' ' 47' ' ' THR . 1.7 tt -78.95 90.28 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.0 9.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.042 -1.036 . . . . 0.0 110.692 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.75 21.77 27.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.53 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 1.4 m-20 -120.07 -50.06 2.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 0.0 110.615 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.511 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 1.3 p -110.39 -50.99 2.91 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.4 42.92 7.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.8 39.59 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.735 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.8 p -120.9 -32.35 3.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.155 -1.203 . . . . 0.0 110.386 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.53 60.97 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.222 -0.924 . . . . 0.0 111.596 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -132.38 9.27 4.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.203 -0.936 . . . . 0.0 110.998 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.182 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.31 162.03 15.97 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.715 -1.241 . . . . 0.0 114.195 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 73' ' ' CYS . . . -110.14 -22.27 11.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.813 -1.179 . . . . 0.0 110.463 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.822 HG23 ' CD1' ' A' ' 35' ' ' ILE . 1.6 t -69.83 -14.96 63.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.64 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.833 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -94.72 14.05 22.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 0.0 108.581 178.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.619 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.9 t-160 -46.98 138.52 6.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -144.78 157.09 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.817 -1.177 . . . . 0.0 109.923 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.8 m-30 -119.87 122.06 40.45 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.582 0.706 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.849 HG21 ' CD1' ' A' ' 88' ' ' ILE . 38.7 t -99.44 151.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.12 -0.988 . . . . 0.0 110.354 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.673 ' ND2' ' HB ' ' A' ' 98' ' ' VAL . 33.2 p-10 -74.57 125.32 28.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.133 -1.605 . . . . 0.0 109.414 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' A' ' 55' ' ' ALA . 2.7 pm0 -34.07 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.702 -0.624 . . . . 0.0 112.19 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.7 -17.25 60.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.881 -1.137 . . . . 0.0 111.301 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.67 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 65.7 m-85 -125.35 -8.98 6.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.869 -1.145 . . . . 0.0 110.193 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.699 HG22 ' HB ' ' A' ' 52' ' ' VAL . 1.3 p -80.35 -34.76 36.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 108.914 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 -17.68 60.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.546 -0.721 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.766 ' CB ' HD13 ' A' ' 94' ' ' LEU 0.278 0.5 OUTLIER -79.34 -55.97 4.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 123.643 1.687 . . . . 0.0 109.423 179.584 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 88' ' ' ILE 0.323 0.3 OUTLIER -77.62 145.4 71.2 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.068 -177.707 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 60' ' ' VAL . 35.8 Cg_endo -61.75 160.0 30.62 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.847 1.446 . . . . 0.0 111.704 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -171.42 3.12 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.151 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.0 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -100.2 158.92 15.52 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.186 0.517 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 68' ' ' ILE . 24.8 p30 -100.45 -173.64 2.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 111.117 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.436 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 21.5 pt-20 -47.8 -24.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.0 ttm180 -64.5 -59.45 4.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.382 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 1.0 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 2.4 tt0 -66.96 14.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.558 -0.714 . . . . 0.0 111.975 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.83 -37.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 119.282 -2.136 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.35 -57.28 1.68 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 1.142 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -48.0 -44.96 31.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.161 -1.199 . . . . 0.0 109.087 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HB2' ' HG3' ' A' ' 67' ' ' GLU 0.3 0.0 OUTLIER -70.95 -30.96 67.4 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.531 -179.27 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 1.2 tt0 -90.9 -11.36 39.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.374 -0.829 . . . . 0.0 110.479 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.6 -50.98 30.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.706 -1.246 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.779 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.3 m -90.21 96.28 6.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 108.878 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 75' ' ' THR . 8.8 t -48.05 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.888 ' HB2' ' CD ' ' A' ' 104' ' ' ARG . . . -126.87 45.96 2.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.799 . . . . 0.0 109.91 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.6 pt-20 39.34 58.31 1.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.764 0.792 . . . . 0.0 109.467 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.546 ' CD1' ' HB2' ' A' ' 82' ' ' SER . 12.7 tp -29.72 131.72 0.07 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.56 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 6.8 mtpt -98.96 170.85 6.36 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.084 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.7 Cg_endo -67.4 -28.68 38.89 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.553 1.291 . . . . 0.0 109.768 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 21.7 p-10 -105.01 -5.05 21.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 111.025 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.577 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 72.7 m -48.54 164.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.795 -1.191 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.594 ' CG ' ' OE2' ' A' ' 67' ' ' GLU . 3.1 mtt180 -175.33 174.81 2.29 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.608 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.182 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -96.69 142.25 28.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.44 -0.788 . . . . 0.0 109.341 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 24' ' ' MET . 15.2 m -45.54 -29.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.037 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.1 p -98.68 38.83 1.31 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.619 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -126.79 -44.72 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.189 -1.57 . . . . 0.0 113.289 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.54 150.99 3.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.715 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.4 mm -111.02 161.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.546 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 2.6 tpt -110.25 111.46 22.79 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.812 -1.18 . . . . 0.0 111.043 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.472 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -91.32 156.6 43.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.6 Cg_endo -68.95 -1.42 7.76 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.805 1.423 . . . . 0.0 111.264 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.509 ' C ' HD23 ' A' ' 94' ' ' LEU . 6.3 pm0 -110.09 -27.72 9.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.981 -1.075 . . . . 0.0 110.072 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.766 HD13 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -97.24 58.48 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.267 -0.896 . . . . 0.0 109.78 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.543 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.75 151.1 22.07 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.859 0.838 . . . . 0.0 112.612 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.0 21.08 12.32 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.769 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.26 142.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.079 . . . . 0.0 113.42 -176.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.673 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 21.2 t -107.97 128.82 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.902 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.8 t -104.07 -176.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.789 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 99' ' ' VAL . 9.5 m-20 -161.42 138.11 8.45 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.703 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 40.0 t -96.72 109.29 47.75 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.803 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.72 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 46.5 Cg_endo -69.65 107.8 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.962 1.775 . . . . 0.0 112.309 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.617 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -111.32 109.98 20.24 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.802 -1.186 . . . . 0.0 110.729 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.888 ' CD ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.6 86.62 2.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.934 -1.103 . . . . 0.0 109.887 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -108.44 16.82 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.258 179.926 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 95' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.332 0.587 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.06 117.21 28.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.915 HG22 HG23 ' A' ' 97' ' ' ILE . 3.5 t -120.69 144.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.903 HG22 ' CG ' ' A' ' 14' ' ' GLU . 7.9 t -128.53 130.22 68.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 121.803 0.811 . . . . 0.0 109.386 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.856 ' CE2' HD13 ' A' ' 15' ' ' LEU . 44.9 m-85 -106.48 137.61 44.16 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.479 0.657 . . . . 0.0 112.263 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.5 t -120.17 127.97 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.713 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.923 ' CB ' HG22 ' A' ' 11' ' ' THR . 87.4 p -79.47 154.29 29.0 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.213 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.593 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -67.6 -5.28 14.8 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.262 0.553 . . . . 0.0 109.827 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -93.33 -13.2 28.43 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.146 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 28.19 4.19 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.167 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.923 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -109.83 144.42 38.3 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.835 -1.391 . . . . 0.0 108.064 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.759 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -123.71 147.65 47.27 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.856 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.594 ' CD ' ' CD1' ' A' ' 32' ' ' ILE . 2.6 ttm-85 -140.04 146.96 39.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.601 -0.687 . . . . 0.0 109.205 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.903 ' CG ' HG22 ' A' ' 4' ' ' VAL . 12.1 mp0 -130.51 117.26 19.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.633 -1.292 . . . . 0.0 110.965 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.954 HD21 ' ND2' ' A' ' 30' ' ' ASN . 1.3 mp -115.15 -172.64 2.17 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.215 1.007 . . . . 0.0 111.974 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -115.74 98.53 6.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.885 HG12 ' HB3' ' A' ' 90' ' ' MET . 41.4 t -98.48 99.89 9.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.61 -165.75 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.734 0.778 . . . . 0.0 111.281 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -72.02 121.9 19.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.684 0.754 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.73 -8.17 29.87 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.399 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 22' ' ' SER . 58.2 t -103.77 166.78 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.461 . . . . 0.0 110.637 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.598 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.92 153.3 37.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 99' ' ' VAL . 6.5 mt -46.37 -31.39 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.303 . . . . 0.0 109.949 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 1.465 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 11.5 ttt -77.69 -57.89 3.57 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.861 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 21' ' ' VAL . 6.3 tt0 -37.23 -68.8 0.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.99 -0.444 . . . . 0.0 111.203 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.59 ' C ' HD22 ' A' ' 15' ' ' LEU . . . -44.37 -68.69 0.18 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.65 -1.281 . . . . 0.0 108.429 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -47.33 -46.71 25.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.907 0.861 . . . . 0.0 109.638 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.767 HG12 ' N ' ' A' ' 29' ' ' SER . 1.2 t -46.56 -62.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.767 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -48.24 -46.86 35.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.206 1.003 . . . . 0.0 108.674 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.954 ' ND2' HD21 ' A' ' 15' ' ' LEU . 1.3 m-80 -66.02 -2.38 3.99 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.11 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.34 -8.82 60.14 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 15' ' ' LEU . 1.4 mt -42.51 -33.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -1.021 . . . . 0.0 109.422 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.731 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 61.2 m-85 . . . . . 0 N--CA 1.496 1.843 0 C-N-CA 119.374 -0.93 . . . . 0.0 112.849 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.685 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 23.7 p . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.053 0.454 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.14 33.45 2.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.421 ' H ' ' HE1' ' A' ' 24' ' ' MET . . . 80.13 33.91 31.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.644 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 43.7 t -140.09 7.98 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.375 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.886 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 65.67 56.75 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.316 1.055 . . . . 0.0 110.997 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.581 ' H ' ' CB ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -132.28 31.6 4.07 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.796 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -110.77 153.13 25.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.39 -4.44 14.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.543 -0.723 . . . . 0.0 109.101 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -110.34 -22.77 11.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.325 -0.859 . . . . 0.0 112.551 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.888 ' O ' HG13 ' A' ' 50' ' ' VAL . 61.6 m -74.72 7.64 2.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.271 -1.518 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.896 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.2 t-160 -43.13 120.2 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.014 . . . . 0.0 108.339 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.888 HG13 ' O ' ' A' ' 48' ' ' CYS . 14.9 m -142.96 164.71 16.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.011 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.758 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 12.5 m-30 -115.05 119.23 35.74 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.588 0.708 . . . . 0.0 110.293 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.918 ' HB ' HG22 ' A' ' 57' ' ' THR . 29.3 t -85.53 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.919 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -59.13 131.59 51.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.548 -1.97 . . . . 0.0 109.711 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 11.3 pt-20 -36.69 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.55 -42.39 67.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.454 -1.404 . . . . 0.0 112.172 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.753 ' O ' HG13 ' A' ' 60' ' ' VAL . 49.6 m-85 -93.85 -4.56 49.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.748 -1.22 . . . . 0.0 109.956 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.919 HG23 ' O ' ' A' ' 53' ' ' ASN . 4.5 p -81.06 -24.78 37.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -86.04 -30.24 22.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -0.803 . . . . 0.0 109.966 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.84 ' CB ' HD11 ' A' ' 94' ' ' LEU . 7.6 mmtt -79.74 -50.04 11.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.5 m -39.73 162.92 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 110.975 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 88' ' ' ILE . 38.8 Cg_endo -67.49 166.51 23.57 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.352 1.712 . . . . 0.0 110.957 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 115.18 20.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.822 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.534 ' HB1' ' CG ' ' A' ' 67' ' ' GLU . . . -69.44 146.63 51.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.484 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.494 ' O ' HD13 ' A' ' 68' ' ' ILE . 22.7 p30 -99.9 174.0 6.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.95 -1.094 . . . . 0.0 111.458 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 1.7 pp20? -43.31 -29.18 0.39 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.884 -0.51 . . . . 0.0 110.913 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.1 OUTLIER -64.69 -21.46 66.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.013 -1.054 . . . . 0.0 109.774 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.4 tm-20 -95.88 1.96 53.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.513 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -91.78 -61.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 111.297 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -73.24 -48.52 19.04 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.735 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.308 3.3 ttp -48.63 -49.26 38.0 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 123.312 1.53 . . . . 0.0 108.496 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.649 HD12 ' OE2' ' A' ' 67' ' ' GLU 0.298 0.0 OUTLIER -72.35 -33.02 66.97 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.269 -179.547 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.931 ' HB2' HD13 ' A' ' 78' ' ' LEU . 3.2 tt0 -86.15 8.59 20.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.091 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.571 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 34.4 m -49.03 -49.44 41.13 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.66 -1.275 . . . . 0.0 108.216 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.2 m -90.52 115.88 30.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.837 ' O ' HG23 ' A' ' 75' ' ' THR . 13.1 t -48.76 85.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 111.203 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -117.17 36.38 4.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.931 -1.106 . . . . 0.0 109.977 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.23 52.55 2.15 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.526 0.679 . . . . 0.0 110.192 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.931 HD13 ' HB2' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -19.79 119.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.553 0.692 . . . . 0.0 112.13 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -83.46 -168.01 0.17 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.371 -0.831 . . . . 0.0 108.762 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 42.8 Cg_endo -81.07 -27.17 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.584 1.307 . . . . 0.0 109.395 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.51 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 16.4 p30 -107.73 -5.55 17.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 111.319 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 21.5 m -48.97 153.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.617 -1.302 . . . . 0.0 110.409 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.67 ' HG2' ' OE1' ' A' ' 87' ' ' GLN . 4.9 mtp180 -175.03 153.28 1.61 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.484 -0.76 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.902 ' O ' ' NE2' ' A' ' 87' ' ' GLN . 11.0 mt -74.6 137.62 42.43 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.679 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 24.3 p -39.58 -22.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.137 -1.602 . . . . 0.0 113.257 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.465 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 11.5 m -110.82 43.43 1.43 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.6 -33.26 2.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.217 -1.552 . . . . 0.0 111.731 178.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.716 HG21 ' CG1' ' A' ' 60' ' ' VAL . 2.3 mt -85.73 148.37 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.007 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -111.43 156.04 12.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.885 ' HB3' HG12 ' A' ' 17' ' ' VAL . 20.6 tpp -108.37 128.59 54.9 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 120.668 -1.27 . . . . 0.0 111.525 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.466 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -97.13 167.78 11.38 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.56 -0.71 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.743 1.391 . . . . 0.0 111.261 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.6 pp20? -110.32 -40.75 4.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.636 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.84 HD11 ' CB ' ' A' ' 59' ' ' LYS . 1.5 mt -73.65 58.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.28 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.71 146.52 27.12 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.442 -1.411 . . . . 0.0 112.087 -178.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 105.46 20.14 9.86 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.915 HG23 HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -73.04 136.56 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 122.365 1.079 . . . . 0.0 111.833 -177.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.802 ' N ' HD12 ' A' ' 97' ' ' ILE . 60.8 t -110.94 122.8 66.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.209 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.5 t -104.27 169.1 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.709 -1.244 . . . . 0.0 109.881 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.3 m-20 -162.06 138.84 8.13 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.73 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 6' ' ' VAL . 4.1 t -90.69 135.34 29.22 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.75 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 33.6 Cg_endo . . . . . 0 C--N 1.304 -1.792 0 O-C-N 123.757 1.398 . . . . 0.0 114.767 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.656 ' H2 ' ' C ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 110.27 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -52.88 122.99 10.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 108.667 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.129 HG22 ' CG2' ' A' ' 97' ' ' ILE . 42.1 t -138.36 144.98 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 117.889 -1.524 . . . . 0.0 112.24 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.692 HG13 ' HG3' ' A' ' 14' ' ' GLU . 2.9 t -130.7 130.4 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.799 ' CD1' HG21 ' A' ' 99' ' ' VAL . 42.6 m-85 -103.33 141.46 35.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.82 0.819 . . . . 0.0 112.436 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.852 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.4 t -120.34 157.75 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.194 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.617 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.9 152.19 31.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.732 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.38 -13.41 5.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.945 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -96.84 -2.8 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 110.323 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.34 -36.45 4.26 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.154 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.603 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.5 133.18 20.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.768 -1.431 . . . . 0.0 109.229 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.852 ' HG2' HG13 ' A' ' 6' ' ' VAL . 37.4 mtm105 -124.38 162.24 24.26 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.669 0.747 . . . . 0.0 111.288 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' CD ' HG12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -140.17 156.7 46.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.649 -0.657 . . . . 0.0 109.266 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.692 ' HG3' HG13 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -130.69 127.19 38.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.787 -1.195 . . . . 0.0 110.471 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.025 HD11 HD12 ' A' ' 32' ' ' ILE . 12.6 mt -120.45 150.77 40.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 110.744 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -104.0 92.32 4.34 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.874 HG22 ' HB2' ' A' ' 26' ' ' ALA . 46.6 t -98.54 167.23 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 111.002 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -116.01 -133.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.449 -0.782 . . . . 0.0 110.738 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.528 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -110.24 123.01 49.0 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.279 -0.888 . . . . 0.0 110.671 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.29 -6.27 30.31 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.481 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 22' ' ' SER . 63.2 t -98.18 169.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.868 -1.372 . . . . 0.0 110.742 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.605 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.68 159.42 25.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.701 HD21 ' SD ' ' A' ' 90' ' ' MET . 10.9 mt -50.48 -35.8 30.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 109.616 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 1.187 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -73.33 -59.72 2.58 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.63 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.594 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.5 tt0 -37.85 -69.66 0.11 Allowed 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.763 -0.586 . . . . 0.0 111.691 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.874 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -47.27 -52.03 17.27 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.303 -1.498 . . . . 0.0 108.863 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -59.05 -59.51 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.766 0.793 . . . . 0.0 109.527 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG23 ' HG3' ' A' ' 24' ' ' MET 0.287 1.1 t -29.97 -60.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.723 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.53 -47.51 81.31 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.038 0.923 . . . . 0.0 108.872 179.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.578 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.4 m-80 -59.61 -10.67 3.76 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 81.71 -5.54 69.24 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.025 HD12 HD11 ' A' ' 15' ' ' LEU . 38.0 mt -42.92 -30.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.537 -0.978 . . . . 0.0 108.905 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.732 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 57.3 m-85 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.364 -0.835 . . . . 0.0 111.576 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.641 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 25.1 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 111.423 0.156 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.5 31.3 1.59 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.73 35.34 25.48 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.793 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 8.3 t -140.12 -0.8 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -1.128 . . . . 0.0 111.711 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.801 ' HB1' ' HE1' ' A' ' 70' ' ' MET . . . 77.57 57.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.922 0.868 . . . . 0.0 113.336 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -133.55 27.39 4.04 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.025 ' SG ' HD22 ' A' ' 84' ' ' LEU . 5.9 p -111.04 142.28 43.4 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -110.61 8.97 22.99 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.4 p -111.01 -30.09 7.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.01 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.654 ' C ' HD23 ' A' ' 84' ' ' LEU . 1.3 m -84.24 32.42 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.966 -1.084 . . . . 0.0 110.631 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.664 ' CE1' ' O ' ' A' ' 71' ' ' LEU . 6.0 t-160 -57.94 134.2 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.602 -1.311 . . . . 0.0 109.673 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 83' ' ' ARG . 34.6 m -150.12 159.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.775 -1.203 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 30.2 m-85 -122.75 134.66 54.43 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.3 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.632 ' HB ' HG22 ' A' ' 57' ' ' THR . 15.1 t -91.57 156.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.824 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.586 ' O ' ' CG2' ' A' ' 57' ' ' THR . 4.4 p30 -59.23 -157.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.058 -1.651 . . . . 0.0 108.941 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.27 -7.25 23.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 110.309 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.72 -39.68 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 113.05 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.649 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 67.4 m-85 -84.7 1.94 44.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.739 -1.225 . . . . 0.0 111.772 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.632 HG22 ' HB ' ' A' ' 52' ' ' VAL . 8.3 p -80.56 -54.37 5.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.886 -1.134 . . . . 0.0 109.526 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 57' ' ' THR . 4.9 p-10 -62.29 -12.01 18.34 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.762 0.791 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.599 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.285 0.1 OUTLIER -79.67 -55.1 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 123.458 1.599 . . . . 0.0 109.553 180.0 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 HG23 ' A' ' 88' ' ' ILE 0.321 0.4 OUTLIER -84.6 155.61 62.19 Favored Pre-proline 0 C--N 1.28 -2.43 0 CA-C-N 112.975 -1.92 . . . . 0.0 110.101 -177.552 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 60' ' ' VAL . 36.5 Cg_endo -62.65 159.13 38.3 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.919 1.484 . . . . 0.0 111.858 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.73 -169.99 2.43 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.547 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 83' ' ' ARG . . . -110.11 162.73 14.28 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.763 -0.586 . . . . 0.0 110.918 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 1.024 ' O ' HD13 ' A' ' 68' ' ' ILE . 54.8 p30 -100.33 -156.41 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 111.343 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 6.4 pt-20 -73.73 -28.71 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 110.286 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.6 ttm180 -64.57 -50.76 66.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.293 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 32.9 tt0 -72.53 14.55 0.24 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.856 -0.528 . . . . 0.0 111.903 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.024 HD13 ' O ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -91.65 -46.17 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.385 -1.447 . . . . 0.0 110.2 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -85.32 -60.27 1.84 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.801 ' HE1' ' HB1' ' A' ' 43' ' ' ALA . 2.8 ptm -48.13 -43.93 31.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.904 -1.351 . . . . 0.0 108.295 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.67 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -62.62 -38.56 90.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.597 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 2.8 tt0 -83.75 29.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.903 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.911 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -48.79 -81.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.418 -1.426 . . . . 0.0 107.931 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 76' ' ' ALA . 2.3 m -81.35 129.13 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.25 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.784 ' O ' HG23 ' A' ' 75' ' ' THR . 8.9 t -49.11 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.903 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -104.54 48.41 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 110.202 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.552 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 18.1 pt-20 39.3 60.73 1.47 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.507 -0.746 . . . . 0.0 110.786 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.511 HD22 ' CD ' ' A' ' 72' ' ' GLU . 1.1 tp -30.28 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.541 . . . . 0.0 111.466 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -145.35 -166.56 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.314 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.1 Cg_endo -80.76 -32.59 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.334 1.176 . . . . 0.0 110.942 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.519 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 39.7 p-10 -102.52 4.38 38.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 111.429 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -62.96 135.61 57.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.93 -1.106 . . . . 0.0 109.827 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 1.018 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.07 169.28 23.9 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 118.455 -1.298 . . . . 0.0 110.759 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.025 HD22 ' SG ' ' A' ' 45' ' ' CYS . 1.4 mt -90.81 148.35 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.611 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 4.9 m -46.8 -27.53 1.25 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.677 -1.265 . . . . 0.0 110.526 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.187 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 3.9 m -102.38 40.31 1.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.287 -0.883 . . . . 0.0 111.511 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.665 HE22 ' HB2' ' A' ' 43' ' ' ALA . 6.9 mm100 -126.25 -41.54 1.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 112.187 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.018 HD11 ' HG3' ' A' ' 83' ' ' ARG . 3.3 mm -79.39 147.71 6.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.2 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.4 mm -112.31 151.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.804 ' HG2' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -110.46 111.72 23.16 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -100.65 170.86 6.08 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 42.3 Cg_endo -73.37 -5.21 16.75 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.824 1.434 . . . . 0.0 110.634 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.506 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.31 -29.54 8.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.117 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 59' ' ' LYS . 7.3 mt -97.0 54.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 109.872 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' HB3' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.39 148.41 25.19 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.278 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.649 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.25 23.32 9.12 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.129 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -78.03 117.94 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.405 1.098 . . . . 0.0 113.324 -176.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 9.5 t -82.55 124.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.826 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.799 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.9 t -104.31 -179.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.673 -1.267 . . . . 0.0 109.547 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 99' ' ' VAL . 9.5 m-20 -161.82 142.47 10.64 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.521 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.765 HG13 ' HD2' ' A' ' 102' ' ' PRO . 50.6 t -92.06 148.01 35.94 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.765 ' HD2' HG13 ' A' ' 101' ' ' VAL . 39.6 Cg_endo . . . . . 0 C--N 1.301 -1.938 0 O-C-N 123.521 1.274 . . . . 0.0 112.611 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.553 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.287 0.565 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -81.08 115.69 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.855 . . . . 0.0 109.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.708 ' HA ' HG23 ' A' ' 97' ' ' ILE . 3.8 t -109.85 137.37 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.913 -1.117 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.5 t -131.98 128.63 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.2 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.984 ' CE1' HG21 ' A' ' 99' ' ' VAL . 71.1 m-85 -104.75 146.98 28.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.571 0.7 . . . . 0.0 112.385 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.724 HG13 ' HG2' ' A' ' 12' ' ' ARG . 5.2 t -121.24 133.55 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.185 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.632 ' CB ' HG22 ' A' ' 11' ' ' THR . 62.8 p -79.56 -152.56 0.07 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.06 -10.6 14.68 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.059 -1.025 . . . . 0.0 108.677 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 17.6 p-10 -100.55 3.66 42.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.357 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.57 -39.24 2.97 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.632 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.8 138.13 15.24 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.866 -1.373 . . . . 0.0 109.974 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.724 ' HG2' HG13 ' A' ' 6' ' ' VAL . 54.4 mtt180 -130.25 164.24 24.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.387 0.613 . . . . 0.0 111.215 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -128.2 161.04 30.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.316 -0.865 . . . . 0.0 109.09 179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' CG ' HG22 ' A' ' 4' ' ' VAL . 1.1 mp0 -131.11 139.64 49.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.7 -1.25 . . . . 0.0 110.856 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.727 HD11 ' CA ' ' A' ' 27' ' ' ALA . 10.8 mt -128.08 144.89 51.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.902 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.87 84.08 2.09 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.679 HG13 HG11 ' A' ' 21' ' ' VAL . 18.0 t -98.63 172.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.661 0.743 . . . . 0.0 111.526 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.541 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -123.43 -159.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.809 0.814 . . . . 0.0 111.537 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.511 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -87.26 125.56 34.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.312 -179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.01 -5.13 30.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.912 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.6 t -102.3 172.1 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 122.442 1.115 . . . . 0.0 110.338 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.619 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -118.47 -169.72 1.76 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.829 HD21 ' SD ' ' A' ' 90' ' ' MET . 18.0 mt -87.99 -14.07 40.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.832 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.86 ' HE2' HG21 ' A' ' 28' ' ' VAL . 2.3 ttp -90.9 -65.86 0.98 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.802 -1.186 . . . . 0.0 112.327 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.912 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.32 -26.42 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 111.44 -178.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.649 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -92.35 -34.83 14.03 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.859 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . . . -77.28 -41.84 39.29 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.017 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.86 HG21 ' HE2' ' A' ' 24' ' ' MET . 62.8 t -55.17 -60.42 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.861 -1.15 . . . . 0.0 108.413 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -51.39 -38.31 52.76 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.588 ' CG ' HD21 ' A' ' 15' ' ' LEU . 2.8 m-80 -70.48 1.64 4.86 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 84.34 -15.63 38.93 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 mt -41.55 -42.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.323 -1.104 . . . . 0.0 108.122 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.549 -0.719 . . . . 0.0 109.778 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.9 p . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 120.853 0.359 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.53 36.64 4.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.16 28.44 49.29 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.9 m -124.71 -13.67 6.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -1.105 . . . . 0.0 110.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.834 ' HB1' ' HE1' ' A' ' 70' ' ' MET . . . 75.51 55.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.797 0.808 . . . . 0.0 112.689 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -132.14 37.12 3.59 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.966 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.3 p -111.23 157.12 20.47 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -111.89 -10.24 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.016 . . . . 0.0 110.925 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.3 t -110.56 -19.01 13.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.857 -1.152 . . . . 0.0 113.257 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.812 ' HB2' HD22 ' A' ' 84' ' ' LEU . 1.8 m -80.36 20.31 0.7 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.316 -1.49 . . . . 0.0 110.994 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.651 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.7 t-160 -48.23 139.86 8.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 48' ' ' CYS . 14.2 m -143.97 156.17 15.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.627 -1.296 . . . . 0.0 109.81 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 2.9 m-30 -119.8 119.02 32.36 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.998 0.904 . . . . 0.0 109.367 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 97' ' ' ILE . 21.4 t -100.8 152.0 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 111.009 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -74.29 130.92 40.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.398 -1.439 . . . . 0.0 109.324 178.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -36.79 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.505 -0.747 . . . . 0.0 111.519 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.09 -19.82 63.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.03 -1.043 . . . . 0.0 111.273 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.97 ' CB ' HD13 ' A' ' 97' ' ' ILE . 43.7 m-85 -127.66 -11.36 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.881 -1.137 . . . . 0.0 110.572 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.14 -17.86 48.4 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.191 -0.943 . . . . 0.0 108.975 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.2 p-10 -89.68 -30.83 17.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.589 ' O ' HD11 ' A' ' 94' ' ' LEU . 3.5 mmmm -82.81 12.01 5.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.833 . . . . 0.0 110.259 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.881 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -116.78 155.45 49.03 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.4 Cg_endo -62.94 156.76 52.36 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.084 1.57 . . . . 0.0 111.859 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.14 128.09 33.37 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.754 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -69.38 156.24 39.13 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.551 -0.718 . . . . 0.0 110.064 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.685 ' O ' HD13 ' A' ' 68' ' ' ILE . 27.5 p30 -100.57 -172.34 2.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 111.648 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.56 -21.49 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 110.711 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.3 ttm180 -64.12 -59.07 4.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.003 -1.061 . . . . 0.0 109.253 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.79 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 20.1 tt0 -65.55 10.71 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.656 . . . . 0.0 112.436 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.18 -40.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 119.453 -2.029 . . . . 0.0 110.952 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.18 -57.95 1.62 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.024 ' HE2' HD12 ' A' ' 84' ' ' LEU . 6.1 ptm -48.14 -43.05 30.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.222 -1.164 . . . . 0.0 109.173 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.749 HD22 HD11 ' A' ' 78' ' ' LEU 0.281 0.0 OUTLIER -70.29 -33.2 71.27 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.935 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 4.4 tt0 -90.78 3.53 54.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.23 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 46' ' ' ALA . 1.6 m -49.11 -54.73 14.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.665 -1.272 . . . . 0.0 109.457 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 74' ' ' VAL . 34.8 m -90.04 105.72 16.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.786 ' O ' HG23 ' A' ' 75' ' ' THR . 8.9 t -48.53 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.384 -0.823 . . . . 0.0 110.888 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.2 50.9 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.67 60.45 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 110.309 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.749 HD11 HD22 ' A' ' 71' ' ' LEU . 2.3 tp -29.87 144.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 111.787 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 14.5 mtmt -120.6 170.76 6.65 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.747 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.6 Cg_endo -69.48 -30.7 23.16 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.649 1.341 . . . . 0.0 109.926 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 8.3 p-10 -97.35 -6.39 34.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 13.1 m -49.12 165.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.767 -1.208 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.695 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.27 167.45 3.39 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.638 -0.664 . . . . 0.0 109.48 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.024 HD12 ' HE2' ' A' ' 70' ' ' MET . 0.8 OUTLIER -95.7 141.4 29.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . 4.7 m -41.67 -27.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 110.462 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 84' ' ' LEU . 2.0 m -108.32 43.78 1.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.589 -0.694 . . . . 0.0 111.034 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.714 HE21 ' HB2' ' A' ' 43' ' ' ALA . 3.2 mm-40 -126.08 -33.83 2.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 111.845 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.941 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -92.03 149.97 3.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 110.267 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 5.2 mm -110.34 156.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.829 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.1 tpt -110.02 113.54 26.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 0.0 110.792 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.455 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -106.51 171.44 4.75 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -72.85 -1.62 10.71 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.908 1.478 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 4.7 pt-20 -110.19 -30.66 7.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 59' ' ' LYS . 7.3 mt -94.14 52.94 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.949 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 4.5 p-10 -100.48 145.66 28.0 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.017 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.32 22.0 10.22 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.011 HD11 HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -70.9 130.05 34.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.994 0.902 . . . . 0.0 113.162 -176.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.739 ' N ' HD12 ' A' ' 97' ' ' ILE . 11.0 t -103.75 122.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.984 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.4 t -103.98 -174.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.66 ' H ' HG12 ' A' ' 99' ' ' VAL . 7.2 m-20 -161.7 139.79 9.17 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.065 176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' VAL . 9.6 t -98.13 103.02 15.6 Favored Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.0 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.68 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 41.8 Cg_endo . . . . . 0 C--N 1.309 -1.53 0 C-N-CA 122.155 1.904 . . . . 0.0 112.772 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.55 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.317 0.58 . . . . 0.0 110.475 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -88.86 134.46 33.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.852 . . . . 0.0 109.928 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.98 HG22 ' CG2' ' A' ' 97' ' ' ILE . 14.0 t -122.61 147.43 26.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.883 -1.136 . . . . 0.0 111.155 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.996 HG23 ' HG2' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -131.18 130.86 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 23' ' ' LEU . 83.4 m-85 -111.46 123.73 50.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.462 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.3 t -92.27 151.86 3.51 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.84 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.571 ' CB ' HG22 ' A' ' 11' ' ' THR . 17.1 p -113.53 141.36 47.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.981 -1.074 . . . . 0.0 109.403 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' SER . 1.0 OUTLIER -41.81 -23.88 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.607 -0.683 . . . . 0.0 110.723 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' SER . 6.2 p-10 -93.44 -1.22 55.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.878 -1.139 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.36 -32.05 6.93 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.949 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.571 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.62 141.35 9.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.874 -1.368 . . . . 0.0 109.476 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.7 mtm180 -127.45 124.93 39.6 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.791 -0.568 . . . . 0.0 111.042 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -102.34 157.6 16.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.996 ' HG2' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -130.58 135.31 47.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.989 -1.069 . . . . 0.0 110.804 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.858 HD11 ' CA ' ' A' ' 27' ' ' ALA . 7.3 mt -124.55 142.0 51.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 111.035 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -99.92 82.38 2.57 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 26' ' ' ALA . 40.5 t -98.17 169.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.575 -0.703 . . . . 0.0 110.413 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.542 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -126.09 -149.95 0.43 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.521 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -90.85 122.65 33.74 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.617 0.722 . . . . 0.0 110.498 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -8.57 30.89 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HA ' ' NE2' ' A' ' 25' ' ' GLN . 18.5 t -96.57 170.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.0 -1.294 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.572 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 166.51 13.91 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.7 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 4.8 mt -69.98 -5.34 25.69 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.083 -1.847 . . . . 0.0 108.332 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.695 ' HE3' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.22 -72.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.617 ' N ' ' HG3' ' A' ' 24' ' ' MET . 0.0 OUTLIER -42.87 -57.7 2.7 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 121.783 -0.573 . . . . 0.0 112.242 -176.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.813 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -57.95 -57.78 11.29 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.57 -1.956 . . . . 0.0 108.386 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.858 ' CA ' HD11 ' A' ' 15' ' ' LEU . . . -51.48 -57.96 7.6 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.516 0.674 . . . . 0.0 109.97 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 29' ' ' SER . 13.4 t -39.79 -71.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.302 0.572 . . . . 0.0 109.627 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -48.71 -46.41 40.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -0.835 . . . . 0.0 109.387 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.523 ' ND2' HD22 ' A' ' 15' ' ' LEU . 4.2 m-80 -59.67 -8.57 2.09 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.92 -5.96 76.86 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.8 HG22 ' CE1' ' A' ' 33' ' ' TYR . 2.9 mt -44.68 -35.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.8 ' CE1' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.6 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 120.981 0.419 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.54 47.54 7.19 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.36 59.38 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 8.0 t -116.93 -36.74 3.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -1.078 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.04 60.68 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 111.331 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.574 ' C ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -131.3 14.01 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.237 -0.914 . . . . 0.0 110.438 178.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.975 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.94 124.28 52.26 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.625 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -79.14 4.55 14.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.689 -1.257 . . . . 0.0 109.885 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.6 p -91.38 -22.83 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.702 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.81 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -95.53 13.63 25.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.049 -1.032 . . . . 0.0 110.029 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.755 ' NE2' HD21 ' A' ' 71' ' ' LEU . 22.3 t-160 -50.51 137.33 19.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.505 -1.372 . . . . 0.0 108.733 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -142.67 158.93 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 102' ' ' PRO . 3.5 m-30 -117.71 109.98 17.29 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.624 0.726 . . . . 0.0 109.694 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.913 ' CG1' HD11 ' A' ' 97' ' ' ILE . 10.7 t -85.61 162.27 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 1.047 ' O ' HG23 ' A' ' 57' ' ' THR . 10.1 p30 -82.92 139.0 33.64 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 119.947 -1.72 . . . . 0.0 109.273 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 53' ' ' ASN . 5.1 pt-20 -41.68 -21.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.995 -1.065 . . . . 0.0 111.503 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.921 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -72.93 -53.02 12.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.756 -1.215 . . . . 0.0 111.637 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.853 ' HB3' HD12 ' A' ' 97' ' ' ILE . 48.3 m-85 -85.03 -4.75 59.27 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.841 -1.162 . . . . 0.0 111.072 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.047 HG23 ' O ' ' A' ' 53' ' ' ASN . 10.2 p -80.28 -51.24 9.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.873 -1.142 . . . . 0.0 109.501 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD2' ' CE ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.05 -12.03 16.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.735 ' HB3' HD13 ' A' ' 94' ' ' LEU 0.284 8.8 mmpt? -79.29 -52.42 8.14 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.876 1.798 . . . . 0.0 108.208 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -84.75 144.59 42.54 Favored Pre-proline 0 C--N 1.279 -2.458 0 CA-C-N 112.201 -2.272 . . . . 0.0 110.435 -177.494 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.7 Cg_endo -62.53 162.97 22.45 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.934 1.492 . . . . 0.0 112.145 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -168.64 1.84 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.352 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 87' ' ' GLN . . . -110.9 171.52 7.42 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.379 0.609 . . . . 0.0 111.056 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.693 ' O ' HD13 ' A' ' 68' ' ' ILE . 48.1 p-10 -100.81 -153.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.605 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -71.67 -18.52 62.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 110.217 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -64.51 -52.16 59.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 109.241 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.631 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -63.55 0.09 0.82 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.865 -0.522 . . . . 0.0 111.33 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.1 mp -91.16 -18.78 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 119.79 -1.819 . . . . 0.0 111.359 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.52 -79.58 1.37 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 120.753 -1.217 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.215 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.58 -32.16 7.68 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.169 -1.195 . . . . 0.0 110.134 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.934 HD22 HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.64 -30.63 69.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.251 -0.905 . . . . 0.0 108.783 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -85.07 -29.51 24.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 109.691 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -49.29 -44.26 43.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 109.491 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.625 HG11 ' O ' ' A' ' 46' ' ' ALA . 13.4 m -90.17 70.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.531 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 75' ' ' THR . 9.2 t -48.92 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 0.0 111.11 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -118.12 66.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.02 -1.05 . . . . 0.0 109.529 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 1.7 pm0 39.88 49.08 2.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.814 0.816 . . . . 0.0 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.934 HD11 HD22 ' A' ' 71' ' ' LEU . 2.4 tp -23.46 142.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.363 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.03 170.48 5.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.755 . . . . 0.0 108.978 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.3 Cg_endo -69.2 -29.39 26.59 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.649 1.341 . . . . 0.0 109.481 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 57' ' ' THR . 23.0 p-10 -99.58 -7.98 25.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.657 -0.652 . . . . 0.0 110.522 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.62 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 67.0 m -48.98 153.58 0.86 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.089 -1.007 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -175.45 161.67 2.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.898 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.215 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -78.38 140.22 38.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 179.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.695 ' HB2' ' HE3' ' A' ' 24' ' ' MET . 47.4 m -42.27 -28.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.023 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -92.53 35.6 1.02 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.636 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.681 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 6.9 tp-100 -126.49 -41.93 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.465 -1.397 . . . . 0.0 112.374 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.908 ' CD1' HG21 ' A' ' 52' ' ' VAL . 1.3 mt -94.65 154.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-O 122.099 0.952 . . . . 0.0 111.583 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.2 mm -110.88 160.85 9.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.55 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 3.4 tpt -110.17 113.62 26.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 110.083 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.5 OUTLIER -92.92 166.12 17.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.5 Cg_endo -73.02 -25.46 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.502 . . . . 0.0 110.538 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.4 pm0 -91.32 -26.76 18.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.813 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 59' ' ' LYS . 7.3 mt -94.9 51.0 1.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.058 0.932 . . . . 0.0 109.417 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 4.6 p-10 -100.49 152.53 20.28 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.677 0.751 . . . . 0.0 112.203 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.64 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 97.06 28.1 8.93 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.98 ' CG2' HG22 ' A' ' 3' ' ' VAL . 9.8 tt -74.2 155.02 6.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 123.259 1.504 . . . . 0.0 113.533 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.653 ' HA ' HG12 ' A' ' 4' ' ' VAL . 6.4 t -120.79 91.55 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.362 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -104.66 171.35 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.644 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -145.69 172.79 12.76 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.32 1.057 . . . . 0.0 112.083 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 6' ' ' VAL . 13.1 t -105.69 111.94 64.62 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 42.8 Cg_endo . . . . . 0 C--N 1.303 -1.83 0 O-C-N 123.906 1.477 . . . . 0.0 111.754 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.562 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.502 0.667 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.8 OUTLIER -82.96 109.64 17.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.728 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 2.5 t -109.5 134.54 51.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.921 -1.112 . . . . 0.0 110.634 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.965 HG22 ' OE1' ' A' ' 14' ' ' GLU . 93.4 t -124.11 107.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.259 1.028 . . . . 0.0 111.807 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.774 ' OH ' HD12 ' A' ' 15' ' ' LEU . 22.6 m-30 -83.46 130.26 35.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.4 t -120.18 134.07 64.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.393 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.667 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -79.58 -167.28 1.17 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 108.51 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.508 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -97.94 -9.95 25.35 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.952 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.43 -6.68 25.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 19.48 8.07 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.541 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.667 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -87.88 153.72 21.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.844 -1.386 . . . . 0.0 107.754 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 mtm180 -130.13 139.32 50.92 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.229 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.701 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.36 67.87 1.36 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.7 0.762 . . . . 0.0 108.991 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.965 ' OE1' HG22 ' A' ' 4' ' ' VAL . 18.6 mt-10 -67.96 140.21 56.41 Favored 'General case' 0 C--N 1.288 -2.065 0 O-C-N 120.767 -1.208 . . . . 0.0 110.896 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.774 HD12 ' OH ' ' A' ' 5' ' ' TYR . 8.0 mt -110.99 147.1 35.45 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.646 -0.659 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.59 86.43 3.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG13 HG11 ' A' ' 21' ' ' VAL . 25.3 t -98.88 172.32 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.697 0.761 . . . . 0.0 111.833 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.545 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -112.57 -144.78 0.39 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.603 0.716 . . . . 0.0 111.525 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -104.07 124.69 49.5 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.46 0.648 . . . . 0.0 110.346 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.3 3.19 38.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.912 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.5 t -107.65 172.36 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.613 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.65 179.85 4.21 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.876 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.919 HD21 ' SD ' ' A' ' 90' ' ' MET . 14.5 mt -79.06 -6.84 57.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.637 -1.289 . . . . 0.0 109.085 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.628 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.73 -76.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.904 0.859 . . . . 0.0 111.597 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.912 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.78 -24.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.075 -177.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.772 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -91.75 -33.18 15.12 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . . . -77.48 -51.35 10.9 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.065 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 33' ' ' TYR . 96.5 t -45.04 -57.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -58.24 -37.72 75.47 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.026 0.917 . . . . 0.0 108.688 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.655 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.1 m-80 -68.92 1.81 3.12 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.279 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 85.78 -14.42 52.27 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 27' ' ' ALA . 1.3 mt -44.76 -54.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -1.196 . . . . 0.0 107.826 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.891 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.504 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.257 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.8 p . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.21 32.61 3.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.769 -2.133 . . . . 0.0 107.769 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.53 35.15 26.64 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 48.2 m -137.98 0.63 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -1.153 . . . . 0.0 111.473 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.875 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 71.82 57.4 0.17 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 112.416 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.464 ' C ' ' HG2' ' A' ' 70' ' ' MET . 3.8 t -133.01 32.11 3.8 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.006 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.6 p -111.87 131.59 55.26 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -91.77 5.4 49.99 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.063 -1.648 . . . . 0.0 109.109 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.491 HG23 ' N ' ' A' ' 48' ' ' CYS . 5.9 t -110.55 -40.47 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.221 -0.924 . . . . 0.0 111.897 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.776 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.0 m -74.87 10.61 1.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.495 -1.378 . . . . 0.0 110.976 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.786 ' ND1' HG21 ' A' ' 74' ' ' VAL . 18.1 t-160 -45.88 138.83 4.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.355 -1.466 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.7 m -140.94 160.38 23.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.037 -1.039 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.675 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 10.1 m-30 -119.28 122.19 41.34 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.545 0.688 . . . . 0.0 109.398 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.898 HG21 ' CD1' ' A' ' 88' ' ' ILE . 41.2 t -96.31 169.66 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.339 -0.85 . . . . 0.0 110.079 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 1.041 ' O ' HG23 ' A' ' 57' ' ' THR . 11.9 p30 -86.45 137.41 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.648 -1.283 . . . . 0.0 108.854 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.0 pt-20 -40.3 -22.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.996 -1.065 . . . . 0.0 111.748 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.811 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -72.09 -53.87 11.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.81 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.679 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 55.5 m-85 -84.89 -4.78 59.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 0.0 111.286 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.041 HG23 ' O ' ' A' ' 53' ' ' ASN . 6.5 p -80.35 -52.32 7.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 109.99 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -63.79 -9.32 13.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.412 -0.805 . . . . 0.0 110.178 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.631 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.299 1.9 mmtp -79.29 -53.23 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.796 1.76 . . . . 0.0 109.086 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.019 HG21 HG22 ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -79.28 161.13 68.9 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 112.372 -2.195 . . . . 0.0 110.146 -177.56 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 60' ' ' VAL . 36.1 Cg_endo -60.63 163.64 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.774 1.407 . . . . 0.0 112.638 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.51 -148.23 0.06 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.831 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.796 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . . . -110.09 144.37 38.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.897 ' O ' HD13 ' A' ' 68' ' ' ILE . 49.8 p30 -100.43 -153.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.535 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 66' ' ' ARG . 1.2 pm0 -80.39 -27.37 38.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 110.065 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -75.21 -50.0 17.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.796 ' OE2' ' HB2' ' A' ' 63' ' ' ALA . 30.9 tt0 -63.84 -5.31 4.14 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.49 -0.756 . . . . 0.0 110.996 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.63 -13.47 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.28 -1.512 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -88.84 -80.32 1.3 Allowed Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.256 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.137 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.23 -34.77 10.74 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.977 -1.308 . . . . 0.0 109.528 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.682 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.29 -18.02 63.11 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.791 0.805 . . . . 0.0 109.269 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -90.95 -53.09 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.105 -0.997 . . . . 0.0 109.654 178.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.41 -24.08 1.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.807 . . . . 0.0 109.248 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.786 HG21 ' ND1' ' A' ' 49' ' ' HIS . 34.5 m -79.74 57.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.299 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.777 ' O ' HG23 ' A' ' 75' ' ' THR . 9.0 t -48.97 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.0 112.534 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.52 63.37 1.57 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.798 -1.189 . . . . 0.0 108.938 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.55 58.17 2.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.732 0.777 . . . . 0.0 109.413 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.682 HD11 HD22 ' A' ' 71' ' ' LEU . 2.5 tp -30.64 138.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.523 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.675 ' HG2' ' CZ ' ' A' ' 51' ' ' TYR . 5.4 mmmt -93.03 168.69 11.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 109.067 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.57 -25.44 40.89 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.71 1.374 . . . . 0.0 109.155 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.549 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 3.3 p30 -113.06 5.46 17.16 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.67 -0.644 . . . . 0.0 111.652 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.595 ' HG ' ' HG2' ' A' ' 79' ' ' LYS . 72.7 m -48.52 144.32 4.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.546 -1.346 . . . . 0.0 111.292 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.651 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -154.93 160.0 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.137 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -85.02 142.61 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 110.132 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.663 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 2.4 p -44.66 -25.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.875 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 5.3 m -108.65 40.71 1.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.444 0.64 . . . . 0.0 110.012 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.538 ' CG ' ' OE1' ' A' ' 67' ' ' GLU . 7.3 tp-100 -122.22 -48.47 2.09 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.491 -0.756 . . . . 0.0 111.965 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.019 HG22 HG21 ' A' ' 60' ' ' VAL . 1.2 mt -87.46 153.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 121.944 0.878 . . . . 0.0 111.104 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.7 mm -111.26 156.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.919 ' SD ' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -110.5 92.49 4.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.099 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.72 171.73 11.69 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -78.86 -0.77 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.863 1.454 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 2.6 pt-20 -110.08 -31.22 7.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 109.403 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.554 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.3 mt -98.16 51.72 1.03 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.975 0.893 . . . . 0.0 108.791 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 8.0 p-10 -100.48 147.05 26.32 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 121.976 0.893 . . . . 0.0 113.189 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.647 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.57 28.1 7.69 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.679 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.9 125.52 38.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 8.6 t -82.49 120.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.754 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -104.55 -175.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.639 -1.288 . . . . 0.0 110.039 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.665 ' H ' HG12 ' A' ' 99' ' ' VAL . 13.9 m-20 -161.4 136.19 7.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.253 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 6' ' ' VAL . 2.6 t -95.71 115.7 65.7 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.655 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo . . . . . 0 C--N 1.304 -1.775 0 C-N-CA 121.894 1.729 . . . . 0.0 112.486 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.561 0.696 . . . . 0.0 110.494 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 5.9 ttmt -85.25 113.34 21.52 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 5.0 t -109.16 137.05 43.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.914 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 t -131.21 125.38 57.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.992 0.901 . . . . 0.0 108.667 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.006 ' CD1' HG21 ' A' ' 99' ' ' VAL 0.273 52.1 m-85 -105.08 140.21 38.6 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 -177.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.929 HG13 ' HG3' ' A' ' 12' ' ' ARG . 3.4 t -121.49 157.06 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.455 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.641 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 78.3 p -116.41 140.56 49.22 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.441 ' ND1' HG12 ' A' ' 101' ' ' VAL . 1.6 p-80 -48.0 -20.75 0.36 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.067 -1.02 . . . . 0.0 109.687 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.461 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 1.8 p30 -89.9 -3.89 57.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 -35.98 4.52 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.896 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.28 132.58 19.97 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.788 -1.419 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.929 ' HG3' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -130.32 153.05 49.06 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.767 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.83 163.45 27.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.916 . . . . 0.0 109.006 177.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.731 ' HG2' HG22 ' A' ' 4' ' ' VAL . 32.8 mt-10 -130.64 120.87 24.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.863 HD21 ' CG ' ' A' ' 30' ' ' ASN . 7.4 mt -109.72 145.45 36.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.872 -1.142 . . . . 0.0 112.123 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.7 92.09 5.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.83 HG13 HG11 ' A' ' 21' ' ' VAL . 96.2 t -98.77 170.75 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 112.029 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.597 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -119.67 -151.65 0.49 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.424 0.63 . . . . 0.0 110.623 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' HB2' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.19 121.2 42.18 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.381 -0.824 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 5.95 28.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.886 HG13 ' NE2' ' A' ' 25' ' ' GLN . 1.4 t -110.04 174.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.585 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.07 -177.25 3.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.19 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -77.84 -13.31 59.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 109.269 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.678 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -90.13 -73.58 0.52 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.886 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -36.75 -24.8 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 122.048 -0.408 . . . . 0.0 111.64 -177.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.66 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -91.11 -46.37 8.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.827 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -61.81 -54.27 44.48 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.734 HG12 ' N ' ' A' ' 29' ' ' SER 0.283 0.8 OUTLIER -36.38 -60.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.66 177.607 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.734 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -65.14 -42.48 93.79 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.134 0.968 . . . . 0.0 109.148 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.863 ' CG ' HD21 ' A' ' 15' ' ' LEU . 4.8 m-80 -63.85 -3.27 2.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.97 -20.58 24.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.827 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 10.3 mt -42.06 -39.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.445 -1.033 . . . . 0.0 109.281 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.716 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 25.5 m-85 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.149 -0.969 . . . . 0.0 113.036 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.631 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.6 p . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 121.18 0.514 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.75 34.62 5.46 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.18 30.05 43.36 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 1.1 t -128.56 -6.79 5.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.137 . . . . 0.0 111.057 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.25 57.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.433 -0.792 . . . . 0.0 112.913 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.484 ' C ' ' HG2' ' A' ' 70' ' ' MET . 0.4 OUTLIER -133.58 36.98 3.33 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.581 -1.636 . . . . 0.0 106.581 176.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.076 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -111.6 150.06 30.6 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -175.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.37 2.07 18.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.518 -1.364 . . . . 0.0 109.076 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 p -110.07 -34.52 6.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 111.3 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.634 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 1.8 m -77.92 8.06 5.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.544 -1.347 . . . . 0.0 110.203 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.771 ' NE2' HD21 ' A' ' 71' ' ' LEU . 21.5 t-160 -53.13 150.42 5.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.596 -1.315 . . . . 0.0 108.929 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 49' ' ' HIS . 12.5 m -160.39 164.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.852 0.834 . . . . 0.0 110.919 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.689 ' CE1' ' HB3' ' A' ' 82' ' ' SER . 4.1 m-85 -118.68 122.87 43.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.816 HG21 ' CD1' ' A' ' 88' ' ' ILE . 15.8 t -92.75 151.61 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.241 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -75.18 130.62 39.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.137 -1.602 . . . . 0.0 109.664 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 4.9 pt-20 -35.28 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.792 -0.568 . . . . 0.0 111.984 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -65.92 -18.1 65.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.891 -1.131 . . . . 0.0 111.558 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.669 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 46.9 m-85 -127.89 -11.62 5.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.845 -1.159 . . . . 0.0 110.444 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -80.96 -50.91 9.13 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' OD1' ' HD2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.31 -20.98 64.88 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 0.0 109.224 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.879 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.279 20.5 mmmt -79.4 -56.22 4.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.602 1.668 . . . . 0.0 108.923 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 88' ' ' ILE 0.314 0.3 OUTLIER -75.64 138.12 70.44 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 112.856 -1.974 . . . . 0.0 109.854 -178.263 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.22 159.75 41.84 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 124.116 1.587 . . . . 0.0 111.982 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 -167.59 1.44 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.733 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.634 ' HB1' ' OE1' ' A' ' 87' ' ' GLN . . . -110.73 -169.13 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.377 0.608 . . . . 0.0 110.625 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.722 ' O ' HD13 ' A' ' 68' ' ' ILE . 53.4 p30 -100.27 -144.64 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -80.01 -23.81 41.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.768 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.9 ttm-85 -64.74 -50.98 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.627 ' OE2' HD12 ' A' ' 71' ' ' LEU . 11.4 tp10 -59.55 -11.48 4.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.3 mp -89.97 -16.59 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.658 -1.276 . . . . 0.0 109.813 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -90.6 -63.32 1.23 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.001 ' CE ' HD12 ' A' ' 84' ' ' LEU 0.289 2.9 mpp? -48.6 -48.52 39.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.335 1.541 . . . . 0.0 108.149 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.096 HD13 HD21 ' A' ' 78' ' ' LEU 0.269 0.0 OUTLIER -66.01 -32.04 73.29 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.961 -178.323 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -70.0 -41.98 73.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 109.997 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -41.88 41.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 109.797 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 74' ' ' VAL . 9.9 m -90.22 63.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 110.181 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.782 ' O ' HG23 ' A' ' 75' ' ' THR . 10.2 t -49.66 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.726 . . . . 0.0 111.113 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.27 74.93 1.62 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -0.999 . . . . 0.0 110.126 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.2 pt-20 39.17 60.46 1.49 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.495 1.141 . . . . 0.0 109.525 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.096 HD21 HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -59.02 120.02 8.35 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.531 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.652 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -104.92 -167.01 0.11 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 41.7 Cg_endo -74.95 -28.27 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.041 1.021 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.575 ' HB3' ' CB ' ' A' ' 57' ' ' THR . 44.6 p-10 -87.16 -28.24 22.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.513 -0.742 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.689 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.9 m -49.9 106.37 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.834 -1.166 . . . . 0.0 108.796 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.53 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -145.68 171.91 14.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.796 -1.19 . . . . 0.0 111.48 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.076 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -84.32 136.52 33.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.467 0.651 . . . . 0.0 111.332 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.634 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 3.0 p -42.38 -29.93 0.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 110.832 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.678 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.9 m -98.78 35.24 1.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 111.304 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.711 HE21 ' HB2' ' A' ' 43' ' ' ALA . 5.0 mm-40 -126.75 -48.02 1.52 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 113.066 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.816 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -79.86 151.36 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.643 -1.286 . . . . 0.0 110.534 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 89' ' ' ILE . 3.9 mm -111.85 160.05 11.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 110.159 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.823 ' HE1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.63 118.21 35.59 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 110.454 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -94.89 167.22 13.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.848 . . . . 0.0 109.713 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' CD ' ' HB2' ' A' ' 19' ' ' ASP . 43.8 Cg_endo -78.65 -2.07 12.15 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.868 1.457 . . . . 0.0 110.714 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' OE2' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.09 -29.94 7.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.1 -1.0 . . . . 0.0 109.765 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.879 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.6 mt -88.28 66.03 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 110.351 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' HA ' ' OG ' ' A' ' 1' ' ' SER . 10.3 p30 -101.72 148.38 25.34 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.735 -1.228 . . . . 0.0 113.174 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.669 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.03 30.49 6.68 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.664 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -80.2 135.28 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.177 0.989 . . . . 0.0 112.779 -177.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.535 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 12.7 t -102.78 125.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.006 HG21 ' CD1' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -104.25 -179.69 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.996 -1.065 . . . . 0.0 108.971 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-20 -162.07 145.56 12.0 Favored 'General case' 0 C--N 1.276 -2.616 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.547 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 55.0 t -83.86 149.79 57.41 Favored Pre-proline 0 C--N 1.289 -2.033 0 C-N-CA 117.449 -1.7 . . . . 0.0 107.514 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.67 ' HG3' ' CG ' ' A' ' 49' ' ' HIS . 42.1 Cg_endo . . . . . 0 C--N 1.3 -2.01 0 C-N-CA 121.464 1.443 . . . . 0.0 111.956 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 95' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.518 0.675 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -77.32 127.86 33.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.72 . . . . 0.0 109.605 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.137 HG22 ' CG2' ' A' ' 97' ' ' ILE . 23.0 t -139.5 148.07 23.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.856 -1.152 . . . . 0.0 112.033 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 99' ' ' VAL . 13.8 t -131.41 126.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.835 ' CD1' HG21 ' A' ' 99' ' ' VAL . 54.5 m-85 -100.16 140.36 34.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.636 0.731 . . . . 0.0 112.509 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.939 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.6 t -120.52 134.98 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.21 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.638 ' HB3' HG22 ' A' ' 11' ' ' THR . 36.0 p -79.51 -152.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.519 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.36 -10.43 14.59 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.913 -1.117 . . . . 0.0 108.965 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 58.2 p30 -100.45 3.34 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.52 -0.737 . . . . 0.0 109.602 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.47 -29.6 8.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.81 134.88 20.27 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.953 -1.322 . . . . 0.0 109.224 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.939 ' HG2' HG13 ' A' ' 6' ' ' VAL . 12.8 mtm180 -130.11 161.72 30.42 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.612 0.72 . . . . 0.0 111.504 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.849 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.8 ttp180 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.744 ' HG2' HG22 ' A' ' 4' ' ' VAL . 20.0 mt-10 -130.62 124.23 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.833 -1.167 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.941 HD11 ' HA ' ' A' ' 27' ' ' ALA . 12.3 mt -117.95 151.54 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.77 90.55 3.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.9 t -98.7 163.63 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.854 . . . . 0.0 110.557 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -112.97 -136.78 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.356 -0.84 . . . . 0.0 110.916 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -108.32 124.43 50.32 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.309 -0.869 . . . . 0.0 110.494 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -7.11 30.52 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 22' ' ' SER . 83.0 t -95.69 168.0 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.027 -1.278 . . . . 0.0 110.543 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.596 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.62 160.14 25.0 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 3' ' ' VAL . 18.4 mt -57.77 -36.04 71.59 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.673 -1.267 . . . . 0.0 109.254 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 1.298 ' SD ' ' SG ' ' A' ' 39' ' ' CYS . 4.7 ttp -79.33 7.24 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.062 -1.024 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.566 ' CG ' HG13 ' A' ' 21' ' ' VAL . 4.9 tt0 -102.29 -71.13 0.73 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.54 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.993 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -46.48 -55.43 7.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.758 -1.214 . . . . 0.0 108.614 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -53.55 -53.05 57.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.692 HG12 ' N ' ' A' ' 29' ' ' SER 0.277 0.7 OUTLIER -37.8 -57.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.422 177.769 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.692 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.76 -47.14 85.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.075 0.941 . . . . 0.0 108.821 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.588 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 6.1 m-80 -64.42 -4.03 3.54 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.499 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.03 -14.94 51.37 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.908 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 mt -44.04 -37.9 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.505 -0.997 . . . . 0.0 108.542 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.74 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 72.0 m-85 . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.162 -0.961 . . . . 0.0 111.201 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.298 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 121.116 0.484 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.1 46.24 10.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 29.72 44.44 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 66.9 m -116.4 -39.42 3.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -1.129 . . . . 0.0 110.583 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.8 ' HB2' ' NE2' ' A' ' 87' ' ' GLN . . . 72.79 59.19 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 111.66 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.534 ' C ' ' HG2' ' A' ' 70' ' ' MET . 58.3 m -131.91 11.29 4.7 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 110.196 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.969 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -113.01 120.61 41.97 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -177.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -77.16 -0.87 26.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.434 -1.416 . . . . 0.0 109.564 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -83.65 -21.18 32.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 111.188 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.833 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -98.44 16.69 20.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.824 -1.172 . . . . 0.0 110.095 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.856 ' HD1' HG23 ' A' ' 74' ' ' VAL . 5.9 t-160 -46.16 134.32 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.604 -1.31 . . . . 0.0 108.054 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 48' ' ' CYS . 18.1 m -138.27 156.24 30.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.766 -1.209 . . . . 0.0 110.037 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.681 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.1 m-30 -118.29 116.67 27.23 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.597 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.849 HG21 ' CD1' ' A' ' 88' ' ' ILE . 22.2 t -94.33 166.09 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 108.909 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 1.009 ' O ' HG23 ' A' ' 57' ' ' THR . 12.5 p30 -84.97 137.2 33.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.278 -1.514 . . . . 0.0 109.023 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 53' ' ' ASN . 6.7 pt-20 -41.05 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.169 -0.957 . . . . 0.0 112.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.654 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -75.61 -51.03 13.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.639 -1.288 . . . . 0.0 111.762 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.726 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 64.4 m-85 -84.96 -5.06 59.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.079 -1.013 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.009 HG23 ' O ' ' A' ' 53' ' ' ASN . 9.7 p -80.3 -55.04 5.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.884 -1.135 . . . . 0.0 109.815 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.452 ' N ' ' OG1' ' A' ' 57' ' ' THR . 1.6 p30 -60.89 -12.42 11.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.429 -0.794 . . . . 0.0 110.769 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.734 ' CB ' HD13 ' A' ' 94' ' ' LEU 0.295 13.5 mtpt -79.4 -54.49 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.724 1.726 . . . . 0.0 109.336 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.815 HG22 ' HD2' ' A' ' 61' ' ' PRO 0.324 0.3 OUTLIER -76.51 155.06 83.8 Favored Pre-proline 0 C--N 1.278 -2.506 0 CA-C-N 112.546 -2.115 . . . . 0.0 110.593 -177.441 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.815 ' HD2' HG22 ' A' ' 60' ' ' VAL . 37.5 Cg_endo -63.58 168.09 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.024 1.539 . . . . 0.0 111.758 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -80.34 -170.22 2.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.543 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.684 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -110.74 157.85 19.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.555 -0.715 . . . . 0.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -79.47 -161.84 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.496 -0.752 . . . . 0.0 110.884 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.11 -22.59 41.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 111.343 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.554 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -69.73 -42.44 73.95 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.612 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.7 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.31 -7.54 1.33 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.819 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.64 HD13 ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -90.41 -15.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.608 -1.307 . . . . 0.0 109.642 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.84 -79.75 1.38 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.524 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.237 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.9 -35.17 14.22 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.881 -1.364 . . . . 0.0 109.778 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -65.35 -30.18 70.99 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 108.575 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.15 -29.08 18.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.474 -0.766 . . . . 0.0 109.561 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -49.02 -48.87 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.046 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.856 HG23 ' HD1' ' A' ' 49' ' ' HIS . 16.5 m -90.07 76.53 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.425 -0.797 . . . . 0.0 109.098 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.828 ' O ' HG23 ' A' ' 75' ' ' THR . 13.1 t -48.25 87.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.782 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 77' ' ' GLU . . . -105.5 41.04 1.43 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.745 -1.222 . . . . 0.0 109.748 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.596 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER 66.78 44.47 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.219 1.009 . . . . 0.0 109.207 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.835 HD11 HD22 ' A' ' 71' ' ' LEU . 1.5 tp -19.42 134.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.53 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.669 ' CG ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.42 172.48 3.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.1 Cg_endo -69.83 -26.69 26.97 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.585 1.308 . . . . 0.0 108.828 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.6 p-10 -104.67 -9.16 18.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.704 -0.622 . . . . 0.0 111.399 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.583 ' OG ' ' CG ' ' A' ' 79' ' ' LYS . 42.7 m -47.86 158.62 0.21 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.524 -1.36 . . . . 0.0 111.406 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.773 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -175.6 161.87 2.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.683 -0.636 . . . . 0.0 109.822 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.237 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -80.33 139.53 36.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.93 . . . . 0.0 109.625 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.627 ' C ' ' HB2' ' A' ' 24' ' ' MET . 20.0 m -38.54 -31.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.515 1.15 . . . . 0.0 108.496 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.032 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -91.44 37.11 0.94 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.184 -178.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.8 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 6.1 mm-40 -127.43 -40.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.409 -1.432 . . . . 0.0 113.444 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -92.61 150.9 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.551 -178.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.5 mm -111.35 163.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.603 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.5 tpt -110.28 108.74 18.94 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.905 -1.122 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -88.14 159.64 47.62 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.0 Cg_endo -72.16 -1.08 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.977 1.514 . . . . 0.0 110.82 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' C ' HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -110.1 -27.27 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.022 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 59' ' ' LYS . 8.8 mt -98.38 60.5 1.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 109.931 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 1' ' ' SER . 3.8 p-10 -100.54 145.02 28.83 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.443 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.81 23.68 8.57 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.137 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.19 115.07 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.357 1.075 . . . . 0.0 113.486 -176.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.488 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 10.5 t -77.25 123.32 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.273 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.835 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.7 t -104.29 -176.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.863 -1.148 . . . . 0.0 109.275 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.653 ' H ' HG12 ' A' ' 99' ' ' VAL . 6.4 m-20 -162.1 141.58 9.7 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.907 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 49.4 t -97.48 102.86 13.94 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.5 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.681 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 41.0 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 C-N-CA 122.306 2.004 . . . . 0.0 113.342 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.586 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.249 0.547 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.498 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.91 124.14 19.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 11.8 t -121.44 145.81 27.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.011 ' O ' HG23 ' A' ' 99' ' ' VAL . 4.3 t -130.98 125.65 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.913 0.863 . . . . 0.0 109.158 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.265 43.3 m-85 -101.07 135.9 41.79 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.2 t -121.97 119.9 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.27 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.649 ' CB ' HG22 ' A' ' 11' ' ' THR . 77.7 p -79.78 128.58 33.6 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 1.5 t60 -41.74 -24.31 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -79.45 -3.52 46.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.06 -1.025 . . . . 0.0 110.073 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.22 -36.48 4.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.649 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.54 137.06 15.8 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.838 -1.39 . . . . 0.0 108.776 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 12.1 mtm180 -130.15 147.35 51.87 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.712 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.75 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -131.58 119.32 21.31 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 177.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.7 mt-10 -94.92 123.98 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.141 -0.974 . . . . 0.0 110.261 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 27' ' ' ALA . 8.1 mt -109.78 146.81 34.34 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.071 -1.018 . . . . 0.0 110.741 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.63 88.17 3.76 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.89 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.8 t -98.96 165.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.769 . . . . 0.0 110.974 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -118.94 -141.44 0.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 110.547 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -101.14 126.46 47.85 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.508 -0.745 . . . . 0.0 110.49 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -9.74 30.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 22' ' ' SER . 55.4 t -99.67 170.73 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.843 -1.387 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.618 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.58 167.68 12.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD21 ' SD ' ' A' ' 90' ' ' MET . 9.2 mt -59.29 -27.96 66.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.699 -1.25 . . . . 0.0 109.447 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 1.226 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -80.26 -58.22 3.24 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.556 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.2 tt0 -37.98 -68.97 0.13 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.402 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.89 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -47.8 -57.27 5.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.349 -1.469 . . . . 0.0 108.813 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.829 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -52.78 -56.92 12.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.936 0.874 . . . . 0.0 108.911 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.768 HG12 ' N ' ' A' ' 29' ' ' SER 0.281 1.2 t -35.34 -63.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.219 178.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.768 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.34 -49.64 71.71 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.074 0.94 . . . . 0.0 109.034 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.587 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 m-80 -61.36 -6.94 2.52 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.379 0.609 . . . . 0.0 109.445 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.28 -7.3 64.57 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.829 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 3.9 mt -44.66 -31.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.305 -1.115 . . . . 0.0 109.323 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 47.4 m-85 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 113.204 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.594 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 19.5 p . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.87 31.82 4.26 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.36 37.27 21.47 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.779 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 20.2 t -138.84 5.67 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -1.122 . . . . 0.0 111.822 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.14 42.58 0.44 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.309 -0.87 . . . . 0.0 113.298 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.2 t -132.35 44.7 2.85 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.981 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.1 p -111.76 130.09 55.91 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.714 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -92.13 6.47 46.44 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.258 -1.526 . . . . 0.0 108.178 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 p -110.65 -40.06 4.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.374 -0.828 . . . . 0.0 111.714 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.861 ' O ' HG13 ' A' ' 50' ' ' VAL . 1.9 m -79.26 24.04 0.36 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.662 -1.274 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.688 ' NE2' ' CD2' ' A' ' 71' ' ' LEU . 6.9 t-160 -46.32 137.01 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.737 -1.227 . . . . 0.0 108.214 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 48' ' ' CYS . 19.3 m -145.86 152.82 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.027 -1.046 . . . . 0.0 110.873 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE1' ' HB3' ' A' ' 102' ' ' PRO . 31.1 m-85 -122.87 128.66 50.64 Favored 'General case' 0 C--N 1.281 -2.413 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.895 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.781 ' HB ' HG22 ' A' ' 57' ' ' THR . 13.6 t -93.88 168.43 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.279 -0.888 . . . . 0.0 109.873 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.763 ' O ' HG21 ' A' ' 57' ' ' THR . 6.8 p30 -67.94 -147.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.609 -1.307 . . . . 0.0 109.518 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -103.34 -16.52 15.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.856 -1.152 . . . . 0.0 111.836 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . . . -100.52 -36.82 9.06 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.703 -1.248 . . . . 0.0 114.146 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.4 m-85 -84.11 -11.0 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.308 -1.495 . . . . 0.0 110.839 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.781 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -81.73 -29.25 33.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD2' ' HA ' ' A' ' 55' ' ' ALA . 2.1 p30 -79.84 -26.89 40.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.522 ' CB ' HD13 ' A' ' 94' ' ' LEU . 21.1 mmtm -79.65 -51.43 9.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.775 HG11 HG21 ' A' ' 88' ' ' ILE . 11.5 m -41.78 153.51 0.27 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.411 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -65.18 160.92 39.67 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.114 1.586 . . . . 0.0 112.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 118.01 22.19 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.885 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.694 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.82 163.89 24.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 109.821 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 24.5 p-10 -100.1 -167.61 1.48 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.19 -20.93 29.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.474 -0.766 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' SD ' ' A' ' 70' ' ' MET . 1.1 ttt-85 -64.53 -53.36 49.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.855 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.694 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 6.9 tp10 -59.14 -12.61 5.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.8 mp -90.92 -9.83 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.826 -1.171 . . . . 0.0 111.244 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.05 -79.3 1.35 Allowed Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.224 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.073 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.09 -37.31 14.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.761 -1.435 . . . . 0.0 109.107 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.688 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -67.82 -23.54 65.19 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.09 -39.49 12.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.811 178.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.78 -43.53 38.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.024 . . . . 0.0 108.344 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 46' ' ' ALA . 1.7 m -90.42 72.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' THR . 10.5 t -48.18 104.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.763 0.792 . . . . 0.0 111.27 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.604 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -126.16 60.8 1.29 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.545 -0.722 . . . . 0.0 109.335 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.542 ' O ' ' CE ' ' A' ' 79' ' ' LYS . 11.3 pt-20 39.28 56.22 2.16 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.995 0.902 . . . . 0.0 109.784 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -33.99 143.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.661 0.743 . . . . 0.0 112.052 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.672 ' H ' ' HG ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -134.44 -176.44 0.58 Allowed Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.2 -25.56 43.03 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.146 1.077 . . . . 0.0 111.765 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 24.6 p-10 -111.85 6.5 19.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.831 -1.168 . . . . 0.0 113.308 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -57.26 149.29 20.38 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.204 -1.56 . . . . 0.0 109.143 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HG3' HD11 ' A' ' 88' ' ' ILE . 11.3 mmt-85 -154.15 179.7 8.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.737 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.073 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -114.94 134.93 54.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.657 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 9.1 m -40.31 -27.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.882 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.226 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.2 m -106.93 45.66 0.97 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.994 -1.067 . . . . 0.0 112.053 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.608 ' NE2' ' CE ' ' A' ' 70' ' ' MET . 90.3 mm-40 -125.34 -47.83 1.72 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.043 0.925 . . . . 0.0 111.394 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.775 HG21 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -84.35 149.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.932 0.872 . . . . 0.0 111.538 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.4 mm -110.9 160.96 9.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.699 ' SD ' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -110.1 104.21 13.05 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 110.224 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.8 OUTLIER -91.1 164.24 26.03 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.86 . . . . 0.0 109.442 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 39.7 Cg_endo -71.88 -0.69 8.81 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.648 1.341 . . . . 0.0 110.503 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.1 pt-20 -110.06 -27.61 9.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.522 HD13 ' CB ' ' A' ' 59' ' ' LYS . 9.5 mt -100.25 54.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.363 -0.835 . . . . 0.0 109.824 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.62 143.96 30.16 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.623 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.23 23.33 8.56 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.696 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.79 118.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.339 1.066 . . . . 0.0 113.166 -176.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 21.1 t -82.03 127.08 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.011 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.7 t -104.21 -175.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.782 -1.199 . . . . 0.0 109.345 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.1 m-20 -161.34 136.66 7.64 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.527 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -90.84 137.95 26.56 Favored Pre-proline 0 C--N 1.289 -2.049 0 C-N-CA 118.896 -1.121 . . . . 0.0 108.987 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 56.3 Cg_endo . . . . . 0 C--N 1.301 -1.954 0 O-C-N 124.172 1.617 . . . . 0.0 111.892 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.643 0.735 . . . . 0.0 110.482 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -90.29 101.11 13.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.133 HG22 ' CG2' ' A' ' 97' ' ' ILE . 48.6 t -109.64 145.52 16.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.677 -1.264 . . . . 0.0 111.118 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.808 ' O ' HG23 ' A' ' 99' ' ' VAL . 6.0 t -130.95 127.81 61.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.45 0.643 . . . . 0.0 109.356 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.949 ' CD1' HG21 ' A' ' 99' ' ' VAL . 49.8 m-85 -102.51 136.53 42.17 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.778 0.799 . . . . 0.0 112.184 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.0 t -120.55 133.54 66.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.429 -0.909 . . . . 0.0 109.642 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.762 ' CB ' HG22 ' A' ' 11' ' ' THR . 24.0 p -79.73 -159.07 0.19 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.642 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.94 -6.72 21.0 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.894 -1.129 . . . . 0.0 108.916 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -100.44 1.61 41.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.45 -22.95 21.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.762 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.9 137.13 17.18 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.986 -1.302 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.1 149.98 51.57 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.232 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 2.6 tpp180 -140.15 155.93 46.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.796 . . . . 0.0 109.714 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.602 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.9 mt-10 -130.92 128.0 39.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.922 -1.112 . . . . 0.0 110.328 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.001 HD11 HD12 ' A' ' 32' ' ' ILE . 14.1 mt -120.43 -170.53 2.0 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.899 -1.126 . . . . 0.0 110.778 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -133.45 81.71 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.899 HG22 ' CB ' ' A' ' 26' ' ' ALA . 39.9 t -98.4 130.62 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.384 -0.823 . . . . 0.0 110.487 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 90' ' ' MET . . . -110.53 -160.29 0.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.799 0.809 . . . . 0.0 111.523 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.6 OUTLIER -70.53 124.13 23.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.642 0.734 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.71 -14.41 29.57 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 17' ' ' VAL . 21.9 t -108.11 166.57 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.832 -1.393 . . . . 0.0 110.373 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.531 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.21 153.77 37.15 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.459 HD22 HG11 ' A' ' 3' ' ' VAL . 16.8 mt -47.09 -27.37 1.35 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.686 -1.258 . . . . 0.0 107.919 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.726 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -72.42 -67.28 0.56 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.096 0.951 . . . . 0.0 110.609 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 21' ' ' VAL 0.255 5.9 tt0 -37.75 -73.41 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.33 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.899 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -43.08 -56.21 3.48 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.558 -1.338 . . . . 0.0 109.264 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.942 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -56.88 -60.42 3.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.644 0.735 . . . . 0.0 109.08 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.744 HG12 ' N ' ' A' ' 29' ' ' SER 0.288 0.9 OUTLIER -33.09 -66.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.658 0.742 . . . . 0.0 109.221 178.041 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.744 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -51.02 -51.87 48.69 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.924 0.869 . . . . 0.0 109.285 178.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.572 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.9 m-80 -60.43 -7.29 1.98 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.33 0.586 . . . . 0.0 109.77 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.93 63.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.001 HD12 HD11 ' A' ' 15' ' ' LEU . 27.5 mt -43.82 -36.45 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.417 -1.049 . . . . 0.0 108.687 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.726 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 44.5 m-85 . . . . . 0 N--CA 1.49 1.573 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.099 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.563 ' SG ' ' CE ' ' A' ' 24' ' ' MET . 1.7 p . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 120.706 0.289 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.28 40.43 10.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.49 40.42 12.98 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.779 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 39.3 t -131.22 -34.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 0.0 111.261 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 75.81 61.42 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.321 -0.862 . . . . 0.0 111.354 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.34 8.52 4.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.373 -0.829 . . . . 0.0 110.124 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.876 ' O ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.88 117.77 33.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.242 -0.911 . . . . 0.0 112.423 -178.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 1.098 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -75.41 0.26 17.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 45' ' ' CYS . 8.4 t -83.73 -32.41 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.575 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.835 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.3 11.68 16.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 179.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.735 ' NE2' HD21 ' A' ' 71' ' ' LEU . 18.0 t-160 -49.16 152.39 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.709 -1.244 . . . . 0.0 109.791 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 83' ' ' ARG . 13.9 m -156.02 160.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.221 -0.924 . . . . 0.0 109.622 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.9 m-30 -119.97 118.06 29.71 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.863 HG21 ' CD1' ' A' ' 88' ' ' ILE . 29.1 t -98.53 155.02 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.365 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.755 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -75.22 131.69 40.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.325 -1.485 . . . . 0.0 109.364 178.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pt-20 -37.49 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.435 -0.791 . . . . 0.0 111.476 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.77 -24.9 67.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.018 . . . . 0.0 111.356 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.979 ' HB3' HD12 ' A' ' 97' ' ' ILE . 33.2 m-85 -123.02 -11.0 8.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.871 -1.143 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.84 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -80.57 -29.42 37.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 108.888 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.8 p-10 -76.41 -26.87 55.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 109.666 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.692 ' CB ' HD13 ' A' ' 94' ' ' LEU . 23.1 mmtm -80.85 -52.44 7.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.554 -0.716 . . . . 0.0 110.192 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.722 HG11 ' CG2' ' A' ' 88' ' ' ILE . 6.0 m -40.91 153.75 0.22 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.535 -0.728 . . . . 0.0 110.48 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.3 Cg_endo -65.79 168.22 15.7 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.061 1.559 . . . . 0.0 111.352 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.66 125.88 30.58 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.392 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.548 ' HB1' ' OE1' ' A' ' 87' ' ' GLN . . . -69.35 170.93 9.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 68' ' ' ILE . 31.3 p30 -96.83 -161.72 0.9 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 111.131 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -73.37 -24.76 60.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.512 -0.742 . . . . 0.0 110.543 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.514 ' NE ' ' O ' ' A' ' 42' ' ' SER . 1.7 mtm-85 -64.71 -43.07 94.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.405 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 4.2 tp10 -66.64 -7.03 17.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.532 -0.73 . . . . 0.0 109.517 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.94 -30.16 4.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.579 -1.326 . . . . 0.0 111.006 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.03 -64.89 1.57 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.854 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.233 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.77 -46.89 42.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.828 -1.395 . . . . 0.0 108.43 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.735 HD21 ' NE2' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -57.13 -25.2 58.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.483 -175.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -36.39 17.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.5 -0.75 . . . . 0.0 108.981 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.35 -32.01 10.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 108.809 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.098 ' CG1' ' HB1' ' A' ' 46' ' ' ALA . 14.7 m -90.12 65.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 75' ' ' THR . 4.8 t -48.87 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.445 0.64 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 77' ' ' GLU . . . -130.27 69.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -0.808 . . . . 0.0 109.109 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.62 46.27 1.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.695 0.76 . . . . 0.0 109.905 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.572 HD13 HD22 ' A' ' 71' ' ' LEU . 9.8 tp -23.93 134.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.601 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.627 ' HD2' ' CD2' ' A' ' 51' ' ' TYR . 5.5 mtpt -110.0 167.92 8.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.751 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.6 Cg_endo -68.19 -28.88 33.6 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.854 1.45 . . . . 0.0 109.379 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.588 ' HB2' HG21 ' A' ' 57' ' ' THR . 11.8 p-10 -97.54 -11.93 23.14 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.643 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 50.4 m -48.99 153.74 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.831 -1.168 . . . . 0.0 110.665 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.8 ttp180 -175.5 158.48 2.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.416 -0.802 . . . . 0.0 110.086 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.233 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -76.38 142.38 41.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.933 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 48' ' ' CYS . 17.3 p -44.88 -26.24 0.39 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.028 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -93.0 29.87 1.74 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.899 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 6.6 tp-100 -126.59 -38.32 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.394 -1.441 . . . . 0.0 112.687 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.863 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -92.6 142.79 12.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.001 -1.079 . . . . 0.0 110.85 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 90' ' ' MET . 7.2 mm -110.52 168.19 4.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.643 ' CB ' HG12 ' A' ' 17' ' ' VAL . 3.5 tpt -109.93 110.65 21.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.866 -1.147 . . . . 0.0 111.137 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.476 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -89.93 165.64 23.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.86 -6.36 18.87 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.864 1.455 . . . . 0.0 110.901 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.7 pt-20 -110.26 -28.48 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.007 . . . . 0.0 110.429 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.692 HD13 ' CB ' ' A' ' 59' ' ' LYS . 8.1 mt -93.78 55.92 2.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 2.8 p30 -100.53 148.98 24.18 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.327 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.677 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.72 34.02 6.46 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.133 ' CG2' HG22 ' A' ' 3' ' ' VAL . 5.0 tt -83.96 157.41 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.214 1.007 . . . . 0.0 113.127 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.534 ' CG2' ' OD1' ' A' ' 53' ' ' ASN . 18.1 t -117.84 124.76 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.214 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.949 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -104.4 -177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.858 -1.151 . . . . 0.0 109.996 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.647 ' H ' HG12 ' A' ' 99' ' ' VAL . 16.5 m-20 -162.26 145.84 11.83 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.29 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.642 HG12 ' ND1' ' A' ' 8' ' ' HIS . 71.7 t -98.27 111.89 60.79 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 120.678 -1.264 . . . . 0.0 108.716 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.649 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.2 Cg_endo . . . . . 0 C--N 1.306 -1.707 0 O-C-N 124.057 1.556 . . . . 0.0 110.941 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.544 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.445 0.641 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.09 109.69 20.73 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.424 -0.797 . . . . 0.0 109.546 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.982 HG22 ' CG2' ' A' ' 97' ' ' ILE . 30.3 t -109.73 144.81 17.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.914 -1.116 . . . . 0.0 110.706 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.891 ' O ' HG23 ' A' ' 99' ' ' VAL . 15.8 t -130.93 124.78 56.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.554 0.692 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.976 ' CD1' HG21 ' A' ' 99' ' ' VAL . 54.1 m-85 -100.38 138.6 37.22 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.702 0.763 . . . . 0.0 112.552 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.6 t -120.88 127.51 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.904 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 11' ' ' THR . 10.2 p -79.78 -159.25 0.2 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.979 -1.076 . . . . 0.0 108.315 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.408 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -102.44 -1.07 31.41 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.98 -1.075 . . . . 0.0 109.177 178.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.44 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -100.4 -4.63 28.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.483 -0.761 . . . . 0.0 109.389 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.27 -31.8 7.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.628 HG22 ' OG ' ' A' ' 7' ' ' SER . 1.1 t -49.94 130.58 22.01 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.899 -1.353 . . . . 0.0 109.802 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.826 ' HG2' HG13 ' A' ' 6' ' ' VAL . 16.2 mtm180 -120.04 134.29 55.29 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.484 0.659 . . . . 0.0 110.864 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.571 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -111.62 156.77 21.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 0.0 109.682 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.725 ' HG2' HG22 ' A' ' 4' ' ' VAL . 32.2 mt-10 -130.89 125.34 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.382 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.831 HD11 ' CA ' ' A' ' 27' ' ' ALA . 11.1 mt -118.72 149.36 41.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.056 . . . . 0.0 111.434 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.72 87.77 3.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 26' ' ' ALA . 41.7 t -98.7 171.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.692 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -121.44 -139.52 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.925 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.7 OUTLIER -104.73 125.74 51.11 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.41 -0.806 . . . . 0.0 110.224 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -8.74 30.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 22' ' ' SER . 69.7 t -98.86 169.49 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.07 -1.253 . . . . 0.0 110.322 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 -175.1 2.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.515 HD22 HG11 ' A' ' 3' ' ' VAL . 19.9 mt -79.9 -36.87 35.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.763 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.7 ttp -79.64 9.02 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.581 ' CG ' HG13 ' A' ' 21' ' ' VAL . 4.7 tt0 -102.03 -70.94 0.73 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.348 -0.845 . . . . 0.0 109.362 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -49.39 -53.65 21.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.723 -1.236 . . . . 0.0 108.516 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.831 ' CA ' HD11 ' A' ' 15' ' ' LEU . . . -53.81 -51.77 62.42 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.714 HG12 ' N ' ' A' ' 29' ' ' SER 0.272 0.7 OUTLIER -38.91 -57.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 177.8 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.714 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.84 -50.34 74.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.056 0.931 . . . . 0.0 109.101 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.581 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.8 m-80 -60.04 -7.88 2.05 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.418 0.628 . . . . 0.0 109.642 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.47 -13.04 59.29 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.793 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 12.7 mt -41.76 -39.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.534 -0.98 . . . . 0.0 109.58 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.763 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 45.8 m-85 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.108 -0.995 . . . . 0.0 111.012 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.582 ' HB2' ' CB ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.023 0.439 . . . . 0.0 110.481 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.29 52.63 8.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.33 34.8 28.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.736 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.7 t -125.73 -42.84 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -1.113 . . . . 0.0 110.281 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.15 57.22 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.369 -0.832 . . . . 0.0 111.342 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 p -132.65 8.24 4.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.884 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.173 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.29 151.55 29.54 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.74 -1.225 . . . . 0.0 113.647 -177.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.578 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -106.61 8.84 31.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.627 -1.296 . . . . 0.0 111.372 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.4 p -103.25 9.79 37.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.794 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.43 14.51 16.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.382 -0.824 . . . . 0.0 109.309 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.786 ' HE2' ' HE1' ' A' ' 51' ' ' TYR . 3.5 t-160 -41.83 141.17 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 48' ' ' CYS . 16.1 m -147.04 155.81 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.9 -1.125 . . . . 0.0 109.326 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.786 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 7.9 m-30 -120.9 121.39 37.96 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.638 0.732 . . . . 0.0 110.67 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.779 ' HB ' HG22 ' A' ' 57' ' ' THR . 16.5 t -91.88 170.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 57' ' ' THR . 6.7 p30 -72.76 -148.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.526 -1.359 . . . . 0.0 109.222 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -102.85 -14.84 16.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.913 -1.117 . . . . 0.0 111.507 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.403 ' N ' ' OD1' ' A' ' 53' ' ' ASN . . . -100.56 -38.24 8.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.802 -1.186 . . . . 0.0 114.072 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.846 ' HB3' HD12 ' A' ' 97' ' ' ILE . 78.6 m-85 -84.24 -11.24 56.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.332 -1.48 . . . . 0.0 111.464 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.779 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.44 -49.16 10.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.934 -1.104 . . . . 0.0 109.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 3.7 p-10 -61.33 -13.53 20.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HB2' HD13 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -93.46 -52.7 4.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.532 -0.73 . . . . 0.0 110.163 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 57' ' ' THR . 6.2 m -46.25 165.81 0.18 Allowed Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.7 Cg_endo -67.36 161.08 44.77 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.102 1.58 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.18 126.29 31.32 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.529 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -69.53 157.9 36.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 31.1 p-10 -100.24 -168.17 1.55 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.897 -1.127 . . . . 0.0 112.067 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -65.05 -19.68 66.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.818 -0.551 . . . . 0.0 110.493 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.14 -53.12 54.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.955 . . . . 0.0 108.809 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 2.1 tt0 -58.95 -47.37 85.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.4 mp -47.97 -26.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.016 -1.052 . . . . 0.0 111.281 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.67 -67.91 1.19 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.059 ' HE2' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.12 -44.05 31.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.35 -1.088 . . . . 0.0 109.279 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.855 HD22 HD11 ' A' ' 78' ' ' LEU 0.255 0.0 OUTLIER -68.63 -25.14 64.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.644 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -91.01 -25.89 19.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.499 -0.751 . . . . 0.0 110.769 178.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.578 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.09 -41.41 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.777 -1.202 . . . . 0.0 109.052 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 49' ' ' HIS . 3.6 m -90.51 87.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.802 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.81 ' O ' HG23 ' A' ' 75' ' ' THR . 9.6 t -47.84 96.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.817 0.818 . . . . 0.0 111.475 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -125.17 47.38 2.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.222 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.563 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.3 pt-20 39.75 60.16 1.71 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.732 0.777 . . . . 0.0 109.384 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.855 HD11 HD22 ' A' ' 71' ' ' LEU . 1.8 tp -27.24 134.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.578 0.704 . . . . 0.0 112.089 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.636 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 5.1 mtpt -104.85 173.71 3.14 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.7 Cg_endo -69.32 -29.26 26.24 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.393 1.207 . . . . 0.0 110.054 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.8 p-10 -106.97 -2.32 21.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 111.061 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.57 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 69.6 m -49.21 161.83 0.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.813 -1.18 . . . . 0.0 111.069 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.721 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.32 166.39 3.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.173 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -83.16 148.56 27.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.58 ' C ' ' HB2' ' A' ' 24' ' ' MET . 66.1 m -49.07 -27.36 3.28 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.1 ' SG ' HD13 ' A' ' 84' ' ' LEU . 4.7 p -106.95 43.65 1.14 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.878 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.4 tp-100 -125.57 -38.06 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.919 -1.113 . . . . 0.0 111.212 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -96.15 147.99 5.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.605 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.5 mm -110.61 161.67 8.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.924 ' HE1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.29 124.31 51.41 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.789 -1.194 . . . . 0.0 110.792 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 3.9 p -110.02 168.07 8.18 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.63 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 43.9 Cg_endo -73.27 -1.75 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.823 1.433 . . . . 0.0 111.59 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -110.08 -24.13 10.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.812 -1.18 . . . . 0.0 110.233 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.924 ' O ' ' HE1' ' A' ' 90' ' ' MET . 4.8 mt -93.73 33.57 1.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.536 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 6.0 p-10 -80.65 144.39 32.34 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.822 0.82 . . . . 0.0 112.501 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.657 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.25 21.59 11.52 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.982 ' CG2' HG22 ' A' ' 3' ' ' VAL . 13.2 tt -74.17 157.49 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 123.131 1.443 . . . . 0.0 113.8 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.569 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 23.2 t -122.92 121.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.261 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.976 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -103.76 -176.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.0 109.531 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.643 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.8 m-20 -160.95 138.86 9.51 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.028 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 6' ' ' VAL . 12.7 t -102.05 116.68 62.84 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.984 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo . . . . . 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 109.953 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.341 0.591 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -80.73 137.56 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.812 . . . . 0.0 109.422 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.544 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 2.5 t -125.74 135.94 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.823 -1.173 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.033 HG13 ' HG3' ' A' ' 14' ' ' GLU . 44.3 t -129.19 124.89 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.496 1.141 . . . . 0.0 110.324 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.894 ' CE2' HD13 ' A' ' 15' ' ' LEU 0.29 30.1 m-85 -98.46 139.96 33.43 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.976 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.021 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.5 t -121.05 155.86 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.032 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.593 ' HB3' HG22 ' A' ' 11' ' ' THR . 97.4 p -119.38 142.05 48.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.437 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -44.65 -23.72 0.15 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.421 -0.799 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.458 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.3 p30 -89.64 -4.07 57.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.067 -1.021 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.13 -32.22 7.23 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.53 131.49 21.02 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.082 -1.246 . . . . 0.0 109.061 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.729 ' HG3' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.67 151.31 46.73 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.439 0.638 . . . . 0.0 111.122 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.722 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.41 118.41 17.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 1.033 ' HG3' HG13 ' A' ' 4' ' ' VAL . 6.9 mp0 -116.29 125.37 52.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 0.0 111.845 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.894 HD13 ' CE2' ' A' ' 5' ' ' TYR 0.25 6.7 mp -110.42 -175.23 2.67 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.225 1.012 . . . . 0.0 111.198 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -119.23 92.35 3.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 5.9 t -98.63 170.07 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.496 -0.752 . . . . 0.0 110.948 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.549 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -134.03 -143.64 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 90' ' ' MET . 1.3 p-10 -95.02 123.57 38.57 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.591 -0.693 . . . . 0.0 110.546 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.52 -7.67 30.21 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.579 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 22' ' ' SER . 46.0 t -98.4 167.91 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.776 -1.426 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.595 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.66 165.14 16.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.511 ' N ' HD23 ' A' ' 23' ' ' LEU . 2.9 mt -59.69 -17.19 32.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.481 -1.387 . . . . 0.0 108.474 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.67 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -82.53 -66.5 0.88 Allowed 'General case' 0 C--O 1.204 -1.34 0 O-C-N 121.479 -0.763 . . . . 0.0 109.03 178.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.546 ' NE2' ' HA ' ' A' ' 21' ' ' VAL 0.27 6.4 tt0 -37.03 -71.15 0.08 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.366 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.57 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -43.21 -66.3 0.39 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.683 -1.261 . . . . 0.0 108.518 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . . . -46.84 -49.9 19.34 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.065 0.936 . . . . 0.0 109.152 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 29' ' ' SER 0.257 0.8 OUTLIER -43.68 -56.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.63 0.729 . . . . 0.0 109.137 179.033 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.696 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.28 -49.42 72.16 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.885 0.85 . . . . 0.0 108.879 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.724 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 1.5 m-80 -59.75 -10.65 3.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.62 -10.56 73.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.712 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 4.1 mt -39.92 -41.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.694 -0.886 . . . . 0.0 110.038 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.67 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 25.6 m-85 . . . . . 0 C--N 1.3 -1.585 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.045 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 7.3 p . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.902 0.382 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.83 29.44 6.17 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.56 34.76 27.56 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.741 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 4.6 p -140.15 7.31 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -1.211 . . . . 0.0 111.752 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.21 58.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.12 -0.987 . . . . 0.0 112.514 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 39' ' ' CYS . 0.9 OUTLIER -133.61 30.78 3.76 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.038 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.5 p -111.25 150.41 29.63 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.11 16.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.086 -1.009 . . . . 0.0 108.672 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.1 t -110.35 -32.36 6.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 111.908 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.722 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.9 m -74.73 8.32 2.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.398 -1.439 . . . . 0.0 110.41 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.074 ' ND1' HG21 ' A' ' 74' ' ' VAL . 23.6 t-160 -46.03 140.53 3.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.65 -1.281 . . . . 0.0 109.292 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 48' ' ' CYS . 13.5 m -144.89 159.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.563 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.6 m-30 -118.4 120.76 38.54 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.767 HG13 HD11 ' A' ' 97' ' ' ILE . 24.2 t -84.45 167.84 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.595 ' ND2' HG23 ' A' ' 98' ' ' VAL . 8.1 p-10 -80.27 -142.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.232 -1.543 . . . . 0.0 110.229 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -101.92 -28.02 12.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.253 -1.53 . . . . 0.0 113.384 -177.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -100.2 23.83 9.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.349 -1.469 . . . . 0.0 113.313 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.945 ' HB3' HD12 ' A' ' 97' ' ' ILE . 73.5 m-85 -140.58 -19.48 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.627 -1.296 . . . . 0.0 110.939 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.703 HG22 ' CG1' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.18 -50.67 9.3 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -64.92 -15.47 62.12 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.969 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.296 0.8 OUTLIER -79.28 -53.9 6.48 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.797 1.76 . . . . 0.0 108.942 179.154 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.812 HG21 HG22 ' A' ' 88' ' ' ILE 0.319 0.3 OUTLIER -77.42 139.44 63.84 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 112.519 -2.128 . . . . 0.0 110.22 -177.817 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -66.67 162.25 38.03 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.092 1.575 . . . . 0.0 112.011 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 -173.42 4.14 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.564 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.589 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -170.41 1.63 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.415 0.626 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.64 -164.4 1.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.0 110.671 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 1.1 pt-20 -61.37 -22.0 64.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.532 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 6.2 ttm180 -64.24 -57.93 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 0.0 109.164 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 15.6 tp10 -59.97 1.15 0.12 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.749 -0.594 . . . . 0.0 111.956 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 6.7 mm -90.9 -39.55 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 110.225 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -83.2 -60.5 2.02 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.104 ' HE2' HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -47.65 -43.7 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.195 -1.179 . . . . 0.0 108.738 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.007 ' O ' HG22 ' A' ' 74' ' ' VAL 0.257 0.0 OUTLIER -73.11 -34.31 66.09 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.819 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -70.29 -21.1 62.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.67 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 74.4 m -48.99 -24.24 1.44 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.088 -1.008 . . . . 0.0 108.696 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.074 HG21 ' ND1' ' A' ' 49' ' ' HIS . 17.4 m -90.12 76.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.662 -0.649 . . . . 0.0 109.786 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 75' ' ' THR . 12.9 t -50.99 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.008 -0.432 . . . . 0.0 111.829 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -131.09 52.35 2.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.867 -1.146 . . . . 0.0 110.443 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 38.93 60.17 1.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.631 -0.668 . . . . 0.0 110.151 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.995 HD21 HD13 ' A' ' 71' ' ' LEU . 2.3 tp -22.91 141.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.44 0.638 . . . . 0.0 112.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -90.7 168.87 13.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.004 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.32 -26.37 41.58 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.653 1.344 . . . . 0.0 109.346 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 14.2 p30 -105.38 -6.74 19.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.752 -0.593 . . . . 0.0 110.958 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.622 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.3 m -48.95 156.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 0.0 111.085 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.59 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.2 ttt180 -175.18 158.79 2.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.73 0.776 . . . . 0.0 110.8 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.104 HD12 ' HE2' ' A' ' 70' ' ' MET . 1.0 OUTLIER -78.85 138.94 38.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.689 -0.632 . . . . 0.0 109.809 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.6 p -44.84 -31.85 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.886 -1.134 . . . . 0.0 110.005 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 3.7 m -101.08 39.58 1.38 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.433 -0.792 . . . . 0.0 111.17 -177.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.717 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 1.8 mm-40 -126.48 -43.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 112.608 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.812 HG22 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -83.75 149.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 118.634 -1.227 . . . . 0.0 110.656 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.9 mm -110.87 160.15 10.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.318 0.58 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 1.9 tpt -110.3 113.91 26.95 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.079 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -91.37 169.15 11.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 109.508 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.508 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 41.8 Cg_endo -72.73 -8.83 23.07 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.782 1.412 . . . . 0.0 111.291 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 1.9 pp20? -110.04 -41.58 4.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.863 -1.148 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.969 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.2 mt -72.56 54.28 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.541 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 50.0 p-10 -101.53 156.18 17.63 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.106 -0.997 . . . . 0.0 112.646 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.658 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.6 27.07 12.03 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.945 HD12 ' HB3' ' A' ' 56' ' ' PHE . 4.9 tt -79.99 157.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 122.219 1.009 . . . . 0.0 112.21 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG23 ' ND2' ' A' ' 53' ' ' ASN . 19.0 t -124.13 125.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.1 t -103.73 -176.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.0 m-20 -162.18 139.24 8.21 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.885 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 6' ' ' VAL . 16.4 t -90.67 117.18 67.77 Favored Pre-proline 0 C--N 1.285 -2.223 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.245 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.2 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 123.855 1.45 . . . . 0.0 110.312 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.56 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.343 0.592 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -80.02 138.6 37.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -0.793 . . . . 0.0 109.873 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.013 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.0 t -127.95 146.73 33.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.012 -1.055 . . . . 0.0 110.141 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.874 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.4 t -130.5 130.06 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.592 0.71 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.98 ' CE1' HG21 ' A' ' 99' ' ' VAL 0.266 46.3 m-85 -106.09 138.83 41.6 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.024 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.3 t -121.71 152.17 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.738 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.57 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 80.5 p -114.97 138.0 51.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.478 ' ND1' ' HA ' ' A' ' 102' ' ' PRO . 1.3 t60 -46.59 -22.38 0.28 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.943 -1.098 . . . . 0.0 110.016 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.1 p30 -85.03 -6.22 59.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.049 . . . . 0.0 110.156 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.25 -36.1 4.46 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.73 133.28 21.66 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.817 -1.402 . . . . 0.0 109.226 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.847 ' HG2' HG22 ' A' ' 6' ' ' VAL . 16.9 mtm105 -129.04 154.9 46.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.283 0.563 . . . . 0.0 111.247 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.743 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -135.58 121.3 19.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 36.4 mt-10 -94.64 123.35 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.875 HD11 ' HA ' ' A' ' 27' ' ' ALA . 8.2 mt -109.79 147.23 33.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.979 . . . . 0.0 110.57 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -99.55 88.07 3.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.954 HG22 ' HB2' ' A' ' 26' ' ' ALA . 56.6 t -98.97 168.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.56 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -125.28 -133.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -108.1 123.98 49.53 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.248 -0.907 . . . . 0.0 110.382 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.32 -8.47 30.78 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 22' ' ' SER . 60.8 t -97.81 170.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.917 -1.343 . . . . 0.0 110.465 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.48 154.4 35.31 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.622 HD21 ' SD ' ' A' ' 90' ' ' MET . 10.0 mt -48.78 -23.35 1.04 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.505 -1.372 . . . . 0.0 109.329 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.776 ' HE2' HG21 ' A' ' 28' ' ' VAL . 1.6 ttt -83.51 -62.73 1.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.621 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.6 tt0 -36.57 -54.22 0.87 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.257 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.954 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -61.39 -49.91 74.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.035 -1.665 . . . . 0.0 107.664 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.875 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -58.16 -61.2 2.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.308 1.051 . . . . 0.0 108.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.776 HG21 ' HE2' ' A' ' 24' ' ' MET 0.293 0.8 OUTLIER -29.63 -59.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.744 178.22 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.73 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -48.18 78.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.108 0.956 . . . . 0.0 108.871 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.589 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.3 m-80 -59.64 -11.42 4.89 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.07 -10.32 73.4 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.867 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 4.8 mt -42.83 -30.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.395 -1.062 . . . . 0.0 108.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.681 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 26.4 m-85 . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 119.457 -0.897 . . . . 0.0 113.09 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.7 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.68 31.39 2.57 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.35 35.61 25.97 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.699 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.17 8.95 2.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -1.179 . . . . 0.0 111.024 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 68.49 54.28 0.53 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.283 1.039 . . . . 0.0 111.285 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.601 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -131.77 30.8 4.31 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.812 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -111.39 149.9 30.55 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.644 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.88 16.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.951 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 t -110.22 -25.13 10.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 112.152 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.635 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 19.0 m -76.71 15.16 0.68 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.509 -1.369 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.72 ' CD2' ' CD2' ' A' ' 71' ' ' LEU . 6.5 t-80 -49.97 136.32 18.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.833 -1.167 . . . . 0.0 108.036 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 49' ' ' HIS . 9.9 m -160.27 170.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.668 -1.27 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 11.4 m-30 -120.4 123.09 42.19 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.563 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.856 HG21 ' CD1' ' A' ' 88' ' ' ILE . 46.6 t -90.48 151.15 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.768 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -73.25 133.77 44.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 119.835 -1.791 . . . . 0.0 109.863 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -40.95 -26.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.724 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.528 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -61.34 -17.23 52.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.875 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.91 ' HB3' HD12 ' A' ' 97' ' ' ILE . 50.1 m-85 -131.02 -9.19 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.011 -1.056 . . . . 0.0 110.835 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 53' ' ' ASN . 1.3 p -80.52 -39.44 27.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -12.11 60.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 109.57 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.615 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.281 22.0 mmmt -79.43 -54.64 5.73 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.669 1.7 . . . . 0.0 108.678 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.964 HG11 HG21 ' A' ' 88' ' ' ILE 0.326 0.3 OUTLIER -81.09 134.23 52.92 Favored Pre-proline 0 C--N 1.279 -2.47 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.943 -178.005 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.67 159.9 50.58 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.079 1.568 . . . . 0.0 112.212 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -81.07 177.44 9.04 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.936 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -152.41 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.403 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.778 ' O ' HD13 ' A' ' 68' ' ' ILE . 47.8 p-10 -100.04 -139.85 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.11 -18.05 50.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 110.109 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.7 OUTLIER -70.05 -52.55 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.936 ' CB ' ' HB3' ' A' ' 63' ' ' ALA . 1.7 tm-20 -58.35 -15.54 10.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.838 -1.164 . . . . 0.0 110.16 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.778 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.5 mp -91.31 -65.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.39 -48.01 26.14 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.271 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.728 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.296 12.3 ttp -48.61 -52.34 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 123.207 1.479 . . . . 0.0 107.744 178.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.941 HD13 HD11 ' A' ' 78' ' ' LEU 0.284 0.0 OUTLIER -62.26 -52.56 63.24 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.379 179.609 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.954 ' HB2' HD13 ' A' ' 78' ' ' LEU . 7.4 tt0 -82.17 20.53 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.519 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.644 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 1.3 m -49.18 -25.42 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.149 -1.594 . . . . 0.0 108.069 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.793 HG23 ' N ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -89.93 -148.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.793 ' N ' HG23 ' A' ' 74' ' ' VAL . 9.6 t -130.78 55.52 1.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.174 -1.579 . . . . 0.0 110.076 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -98.6 32.27 2.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 110.745 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.553 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.1 pt-20 39.19 60.48 1.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.954 HD13 ' HB2' ' A' ' 72' ' ' GLU . 12.4 tp -19.77 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.579 0.704 . . . . 0.0 112.544 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.642 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 3.6 mtpt -97.53 -167.55 0.13 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 43.9 Cg_endo -82.58 -28.23 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.491 1.258 . . . . 0.0 109.777 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 9.8 p-10 -105.89 -7.21 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.52 -0.737 . . . . 0.0 111.508 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.755 ' C ' HD11 ' A' ' 71' ' ' LEU . 1.5 m -49.56 143.68 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.59 -1.319 . . . . 0.0 110.326 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.614 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmt-85 -158.85 151.76 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 110.158 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.812 HD22 ' SG ' ' A' ' 45' ' ' CYS . 12.2 mt -74.34 148.51 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.635 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 18.1 m -47.1 -25.38 0.85 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -110.08 48.18 0.91 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.837 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.542 ' HG2' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -125.24 -38.95 2.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 110.863 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.964 HG21 HG11 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -101.7 155.93 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -110.3 163.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.513 -0.742 . . . . 0.0 109.369 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.622 ' SD ' HD21 ' A' ' 23' ' ' LEU . 2.7 tpt -110.07 106.73 16.32 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 110.438 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.1 p -89.4 163.79 32.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.7 Cg_endo -74.34 -6.88 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.956 1.503 . . . . 0.0 110.54 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.498 ' HG2' ' HG ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -103.47 -27.76 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.597 HD13 ' CB ' ' A' ' 59' ' ' LYS . 9.9 mt -99.97 57.29 0.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 4.8 p-10 -100.43 149.89 23.19 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.662 0.744 . . . . 0.0 112.242 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.646 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.61 22.36 11.36 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.013 ' CG2' HG22 ' A' ' 3' ' ' VAL . 8.3 tt -72.84 154.49 7.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.747 1.261 . . . . 0.0 113.325 -177.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.535 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 5.8 t -122.57 127.76 75.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.334 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.98 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.8 t -103.81 -179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.015 -1.053 . . . . 0.0 108.578 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.578 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.6 m-20 -161.17 138.53 9.02 Favored 'General case' 0 C--N 1.274 -2.711 0 C-N-CA 118.408 -1.317 . . . . 0.0 110.726 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 6' ' ' VAL . 15.2 t -97.38 117.75 65.18 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.676 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 37.2 Cg_endo . . . . . 0 C--N 1.302 -1.873 0 O-C-N 123.95 1.5 . . . . 0.0 110.613 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.611 ' H1 ' ' C ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.563 0.697 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.524 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.4 OUTLIER -80.13 119.66 23.22 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.79 HG22 ' CG2' ' A' ' 97' ' ' ILE . 20.3 t -124.46 148.6 28.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.871 -1.143 . . . . 0.0 111.53 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 ' OE1' ' A' ' 14' ' ' GLU . 4.7 t -131.14 128.8 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.972 ' CE1' HG21 ' A' ' 99' ' ' VAL 0.273 42.2 m-85 -107.68 140.99 39.89 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.2 t -122.16 129.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.05 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.637 ' HB3' HG22 ' A' ' 11' ' ' THR . 77.6 p -79.36 -151.44 0.06 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.553 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.33 -10.51 14.6 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 120.874 -1.141 . . . . 0.0 108.915 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.445 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.7 p30 -100.41 1.99 41.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.34 -31.05 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.637 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.7 135.99 18.14 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.935 -1.332 . . . . 0.0 109.092 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.7 mtm180 -130.16 152.74 49.27 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.411 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.756 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -132.78 121.24 22.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.857 ' OE1' HG22 ' A' ' 4' ' ' VAL . 2.5 mm-40 -94.64 124.14 38.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.146 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.878 HD11 ' CA ' ' A' ' 27' ' ' ALA . 7.2 mt -109.67 147.98 32.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.009 -1.057 . . . . 0.0 111.851 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.02 84.89 2.31 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.698 HG13 HG11 ' A' ' 21' ' ' VAL . 16.6 t -98.89 172.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -177.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -120.3 -144.2 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.418 -0.801 . . . . 0.0 111.252 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.504 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -102.06 133.73 46.41 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.62 -0.675 . . . . 0.0 110.307 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.47 -3.09 57.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.917 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.6 t -100.43 172.48 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -1.105 . . . . 0.0 110.406 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.609 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.97 179.26 4.32 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.791 178.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.518 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 16.1 mt -76.63 -14.82 59.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.782 -1.199 . . . . 0.0 109.534 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.733 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.1 tmt? -90.6 -71.45 0.62 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.679 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.917 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -37.9 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.707 -0.621 . . . . 0.0 112.132 -176.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.645 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -88.37 -52.5 5.16 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.992 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -59.86 -45.43 92.47 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.732 HG21 ' SD ' ' A' ' 24' ' ' MET 0.262 0.8 OUTLIER -42.9 -61.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.72 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.726 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.55 -32.73 70.6 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.45 1.119 . . . . 0.0 108.163 178.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.691 ' CG ' HD21 ' A' ' 15' ' ' LEU . 3.7 m-80 -77.36 10.41 2.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.046 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.06 13.91 36.62 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.992 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 5.1 mt -72.1 -33.93 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.343 -1.092 . . . . 0.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.3 m-85 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.0 111.888 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.639 ' CB ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.032 0.444 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 40.94 28.06 0.22 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . 80.09 30.54 41.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.75 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.8 t -117.58 -36.13 3.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -1.14 . . . . 0.0 109.881 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.33 60.36 0.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.632 0.729 . . . . 0.0 111.762 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -131.95 22.02 4.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -112.56 161.15 17.11 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.495 0.664 . . . . 0.0 111.761 -177.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -110.95 -2.99 15.78 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.576 -1.328 . . . . 0.0 112.623 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -110.32 28.36 8.71 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.284 -1.51 . . . . 0.0 112.656 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 1.016 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.96 -3.4 12.14 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.965 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -43.46 127.6 4.74 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.016 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.4 m -139.17 161.26 28.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.566 -1.334 . . . . 0.0 110.211 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.842 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 5.8 m-30 -116.9 121.8 42.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.69 0.757 . . . . 0.0 110.381 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.743 ' HB ' HG22 ' A' ' 57' ' ' THR . 14.6 t -91.41 172.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.603 ' O ' HG21 ' A' ' 57' ' ' THR . 6.6 p30 -75.84 -148.39 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.445 -1.41 . . . . 0.0 109.21 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 -16.02 16.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.878 -1.139 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.65 -36.12 9.25 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.853 -1.154 . . . . 0.0 113.832 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.745 ' O ' HG13 ' A' ' 60' ' ' VAL . 70.0 m-85 -84.37 -13.21 52.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.338 -1.477 . . . . 0.0 111.608 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.743 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -80.79 -27.67 36.56 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.717 -1.239 . . . . 0.0 109.818 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -24.43 21.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.898 ' CB ' HD21 ' A' ' 94' ' ' LEU . 15.3 mmtm -79.57 -52.12 8.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 56' ' ' PHE . 9.1 m -42.19 166.31 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.616 -0.678 . . . . 0.0 110.044 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 38.1 Cg_endo -66.34 165.29 25.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.027 1.541 . . . . 0.0 111.448 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 114.17 19.35 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.261 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.935 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.1 163.81 23.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.879 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.45 ' O ' HD13 ' A' ' 68' ' ' ILE . 44.3 p-10 -100.3 -146.45 0.34 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 0.0 111.335 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 66' ' ' ARG . 3.6 pt-20 -72.72 -27.76 62.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.55 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.684 ' HG3' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -64.37 -46.83 81.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 108.509 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.935 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 3.0 tm-20 -58.08 -16.05 11.64 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.43 -1.419 . . . . 0.0 109.298 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -92.14 -68.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 110.436 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 68' ' ' ILE . . . -77.38 -49.23 7.51 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.942 ' CE ' HD11 ' A' ' 84' ' ' LEU 0.253 0.0 OUTLIER -48.91 -41.4 33.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.029 1.395 . . . . 0.0 108.268 179.187 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 67' ' ' GLU 0.323 0.0 OUTLIER -77.29 -30.34 54.17 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.737 -179.217 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.841 ' HB2' HD13 ' A' ' 78' ' ' LEU . 6.1 tt0 -86.33 10.24 15.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.868 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 46' ' ' ALA . 33.9 m -48.92 -52.88 22.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.648 -1.283 . . . . 0.0 108.039 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 74' ' ' VAL . 18.3 m -90.48 116.45 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -48.49 98.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.965 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -128.27 38.77 3.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.865 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.24 60.45 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.633 0.73 . . . . 0.0 110.038 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 72' ' ' GLU . 0.4 OUTLIER -27.98 119.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.494 0.664 . . . . 0.0 111.927 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.714 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 1.1 mttp -85.35 -167.68 0.15 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.1 Cg_endo -82.81 -29.02 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.305 1.161 . . . . 0.0 109.135 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.52 ' HB2' HG21 ' A' ' 57' ' ' THR . 42.0 p-10 -106.15 -7.3 18.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.61 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 13.9 m -48.08 128.7 14.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.555 -1.34 . . . . 0.0 110.072 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.649 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -142.29 164.17 30.86 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.82 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.942 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -74.94 136.83 41.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.824 -0.548 . . . . 0.0 111.943 -178.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.605 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 1.9 p -55.99 -22.7 28.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.882 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.1 p -107.13 28.95 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.309 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.558 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 2.7 mm-40 -126.08 -41.28 1.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.175 . . . . 0.0 112.103 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -79.85 146.21 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.689 -178.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.9 mm -111.1 158.86 11.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 4.0 tpt -110.14 114.47 28.0 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.072 -1.017 . . . . 0.0 110.488 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -95.7 165.83 15.8 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.326 -0.858 . . . . 0.0 109.669 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.3 Cg_endo -70.51 -30.01 19.46 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.837 1.441 . . . . 0.0 110.965 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.5 pp20? -83.46 -41.39 18.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.982 -1.074 . . . . 0.0 109.911 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.898 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.6 mt -79.42 60.82 3.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB2' ' CB ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.16 153.61 19.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.862 -1.149 . . . . 0.0 111.652 -178.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.48 19.52 12.2 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.79 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -59.32 126.72 17.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.453 1.12 . . . . 0.0 112.537 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.517 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 2.8 t -105.73 116.63 49.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.972 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.5 t -104.11 -178.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 122.354 1.074 . . . . 0.0 110.542 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.618 ' H ' HG12 ' A' ' 99' ' ' VAL . 5.1 m-20 -162.05 140.24 8.98 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.035 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 52.5 t -96.59 112.08 59.07 Favored Pre-proline 0 N--CA 1.499 1.999 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.017 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.709 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 44.7 Cg_endo . . . . . 0 N--CA 1.496 1.636 0 C-N-CA 122.105 1.87 . . . . 0.0 113.928 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.41 0.624 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 6.2 tmtm? -79.98 109.32 14.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.012 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.9 t -111.37 143.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.997 -1.064 . . . . 0.0 110.75 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.863 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.1 t -130.89 125.09 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.232 1.015 . . . . 0.0 109.519 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.96 ' CD1' HG21 ' A' ' 99' ' ' VAL 0.284 36.6 m-85 -101.02 138.32 38.22 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.585 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG13 ' HG2' ' A' ' 12' ' ' ARG . 3.5 t -121.79 158.02 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.454 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.534 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 60.7 p -120.03 137.86 53.85 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.573 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -43.84 -23.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.018 -1.051 . . . . 0.0 110.409 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' OD2' ' HB ' ' A' ' 11' ' ' THR . 6.6 p-10 -85.94 -3.5 58.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.086 -1.009 . . . . 0.0 110.577 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.22 -42.01 2.08 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.832 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.53 ' CG2' ' CZ ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -49.56 134.48 19.58 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 120.968 -1.313 . . . . 0.0 109.869 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.765 ' HG2' HG13 ' A' ' 6' ' ' VAL . 4.8 mtm180 -130.08 160.68 32.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.036 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.73 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -138.4 123.06 18.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 178.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.57 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.2 mp0 -95.36 128.27 42.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.85 HD11 ' CA ' ' A' ' 27' ' ' ALA . 9.0 mt -121.13 146.2 47.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.048 -1.032 . . . . 0.0 111.718 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 16.2 p30 -100.86 90.05 4.07 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.971 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.5 t -98.85 171.49 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 111.064 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.557 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -118.82 -134.16 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 0.0 110.546 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -110.13 124.36 51.39 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.276 -0.89 . . . . 0.0 110.527 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.39 -8.28 30.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.383 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 22' ' ' SER . 95.9 t -96.07 170.13 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.288 . . . . 0.0 110.651 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.599 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.98 171.72 8.44 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.88 -28.19 67.31 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.21 179.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.781 ' SD ' HG23 ' A' ' 28' ' ' VAL . 0.7 OUTLIER -86.86 4.7 40.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.583 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.569 ' CG ' HG13 ' A' ' 21' ' ' VAL . 5.9 tt0 -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.15 -0.969 . . . . 0.0 109.372 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.971 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -51.24 -47.79 62.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 108.212 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.934 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -60.36 -53.28 59.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.781 HG23 ' SD ' ' A' ' 24' ' ' MET 0.279 0.8 OUTLIER -36.84 -58.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.65 0.738 . . . . 0.0 109.011 178.006 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.704 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.137 0.97 . . . . 0.0 108.459 178.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.587 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.1 m-80 -64.55 -5.0 4.62 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.506 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 74.29 2.06 61.98 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.934 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 3.0 mt -50.22 -30.1 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.329 -1.1 . . . . 0.0 109.393 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.66 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 54.0 m-85 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 112.064 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.2 p . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.852 0.358 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.13 41.96 11.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.32 37.03 22.32 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 10.2 t -126.96 -22.24 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 111.152 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB1' ' NE2' ' A' ' 87' ' ' GLN . . . 58.22 60.72 2.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.381 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.61 7.18 4.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.349 -0.845 . . . . 0.0 110.455 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.871 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.68 116.36 30.64 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.254 -0.904 . . . . 0.0 112.069 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.826 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . -74.98 0.31 16.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.4 t -85.42 -29.55 24.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.903 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.833 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -89.38 11.79 18.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.017 -1.052 . . . . 0.0 109.384 179.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.67 ' NE2' HD21 ' A' ' 71' ' ' LEU . 11.1 t-160 -42.5 139.83 1.41 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 48' ' ' CYS . 34.9 m -146.51 154.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 122.09 0.948 . . . . 0.0 109.929 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.703 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 11.9 m-85 -121.67 129.34 52.7 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.264 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.872 ' HB ' HG22 ' A' ' 57' ' ' THR . 19.1 t -96.12 167.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.772 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.783 ' O ' HG23 ' A' ' 57' ' ' THR . 25.3 p-10 -91.97 136.1 33.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.722 -1.237 . . . . 0.0 109.337 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.8 pt-20 -37.1 -26.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.81 . . . . 0.0 111.989 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -69.81 -16.52 63.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.871 -1.143 . . . . 0.0 111.681 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 68.1 m-85 -131.11 -10.81 3.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.729 -1.232 . . . . 0.0 110.945 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.872 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -80.57 -26.82 37.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 109.018 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 5.7 p-10 -73.4 -31.59 63.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.983 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.829 ' HB2' HD11 ' A' ' 94' ' ' LEU . 1.5 mmtt -79.92 -53.0 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.804 HG11 HG21 ' A' ' 88' ' ' ILE . 5.4 m -40.43 147.04 0.4 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.514 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 41.3 Cg_endo -68.52 170.7 14.43 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.397 1.735 . . . . 0.0 111.146 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 135.4 36.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.33 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -69.2 177.09 2.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 110.884 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -100.22 -156.13 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.338 -0.851 . . . . 0.0 111.015 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.7 pp20? -80.34 -30.79 38.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' O ' ' HE3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -65.0 -37.8 88.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.126 -0.984 . . . . 0.0 109.449 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.705 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 2.3 tm-20 -67.73 -6.89 23.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.684 -0.635 . . . . 0.0 109.478 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -91.47 -35.57 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 110.909 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -77.36 -65.31 1.95 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.174 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.192 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.71 -48.55 40.27 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.017 1.389 . . . . 0.0 108.333 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.113 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -58.91 -30.47 67.84 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.184 -176.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -81.26 -39.58 25.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.6 -0.688 . . . . 0.0 109.476 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.32 -41.53 38.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.816 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.826 HG13 ' HB1' ' A' ' 46' ' ' ALA . 2.8 m -90.42 67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.734 ' O ' HG23 ' A' ' 75' ' ' THR . 8.0 t -48.79 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.685 -0.635 . . . . 0.0 111.349 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.16 64.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.49 60.16 1.64 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.241 1.02 . . . . 0.0 109.813 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.113 HD11 HD22 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -46.87 134.65 9.91 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.991 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -125.36 -176.86 0.5 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.0 Cg_endo -67.04 -25.53 44.04 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.173 1.091 . . . . 0.0 111.297 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 26.0 p-10 -97.91 -13.13 21.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.813 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.703 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 1.4 m -54.44 151.34 7.83 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.596 -1.315 . . . . 0.0 109.761 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.733 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -175.63 163.76 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.188 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.192 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -83.16 145.09 29.39 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.489 -0.757 . . . . 0.0 109.986 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 60.3 p -40.83 -32.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 123.116 1.436 . . . . 0.0 107.973 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.062 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -94.35 46.39 1.15 Allowed 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.655 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -127.43 -43.29 1.61 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.493 -1.379 . . . . 0.0 113.374 -178.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.804 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -103.28 152.88 5.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 122.044 0.926 . . . . 0.0 112.341 -176.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 6.9 mm -106.35 165.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.541 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tpt -110.17 117.7 34.39 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.385 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 10.4 p -95.41 165.67 16.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.648 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.9 Cg_endo -73.25 -1.38 10.52 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.929 1.489 . . . . 0.0 110.345 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -110.08 -51.79 2.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 109.097 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 59' ' ' LYS . 1.3 mt -65.85 57.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.501 -0.749 . . . . 0.0 110.474 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.528 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 1.8 p30 -101.74 142.9 32.37 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.967 -1.083 . . . . 0.0 112.721 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.654 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.68 23.82 8.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.012 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.78 149.99 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.344 1.068 . . . . 0.0 112.904 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.62 HG23 ' ND2' ' A' ' 53' ' ' ASN . 22.1 t -115.09 123.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.788 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.96 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.1 t -103.94 176.7 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.828 -1.17 . . . . 0.0 109.423 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 51' ' ' TYR . 3.0 m-20 -162.53 143.85 10.31 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.349 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG12 ' ND1' ' A' ' 8' ' ' HIS . 53.2 t -94.26 132.98 28.0 Favored Pre-proline 0 C--N 1.287 -2.128 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.608 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.679 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 37.8 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 O-C-N 123.548 1.289 . . . . 0.0 112.852 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.513 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.313 0.578 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -71.34 123.07 21.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.827 HG22 ' CG2' ' A' ' 97' ' ' ILE . 35.1 t -124.3 144.15 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.515 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.788 ' O ' HG23 ' A' ' 99' ' ' VAL . 14.8 t -131.9 124.54 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.486 0.66 . . . . 0.0 109.317 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.03 ' CD1' HG21 ' A' ' 99' ' ' VAL . 69.6 m-85 -102.73 141.6 35.28 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.652 -0.655 . . . . 0.0 111.434 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.074 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.7 t -120.84 148.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.901 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 2.2 p -110.15 139.33 45.41 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -45.36 -22.11 0.12 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.085 -1.009 . . . . 0.0 110.023 -179.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 7' ' ' SER . 9.9 p-10 -82.46 -7.66 59.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.987 -1.071 . . . . 0.0 110.374 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.54 -36.87 4.02 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.173 -0.954 . . . . 0.0 111.673 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.525 HG22 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.64 145.33 5.16 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.586 -1.538 . . . . 0.0 109.499 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.717 ' HG2' HG13 ' A' ' 6' ' ' VAL . 9.8 mtt180 -130.05 158.03 40.75 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.573 -0.704 . . . . 0.0 111.187 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.683 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.6 ttp180 -140.19 122.07 15.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.573 ' CG ' HG22 ' A' ' 4' ' ' VAL . 1.1 mp0 -98.86 123.19 42.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.725 -1.234 . . . . 0.0 110.79 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.793 HD12 ' CE2' ' A' ' 5' ' ' TYR . 9.4 mt -110.4 147.92 33.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -99.96 90.16 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.861 HG22 ' HB2' ' A' ' 26' ' ' ALA . 55.9 t -98.83 172.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 111.045 -177.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.582 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -124.64 -140.77 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.682 . . . . 0.0 110.324 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.91 123.42 47.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.63 -3.07 29.15 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.59 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 22' ' ' SER . 58.1 t -102.52 169.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.732 -1.451 . . . . 0.0 110.519 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.594 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.53 165.29 15.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.808 -0.557 . . . . 0.0 109.553 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -55.57 -33.94 64.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.637 -1.289 . . . . 0.0 107.602 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.773 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.5 ttt -68.43 -65.83 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.553 ' CG ' HG13 ' A' ' 21' ' ' VAL . 6.4 tt0 -38.05 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.861 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -43.8 -56.7 3.67 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.418 -1.426 . . . . 0.0 109.187 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -54.3 -58.71 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.929 0.871 . . . . 0.0 109.535 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.774 HG12 ' N ' ' A' ' 29' ' ' SER 0.277 1.2 t -31.37 -63.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.563 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.774 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.64 -47.04 87.15 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.119 0.961 . . . . 0.0 109.042 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.584 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 4.9 m-80 -59.67 -9.69 2.93 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.89 63.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.799 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 7.8 mt -41.99 -34.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.591 -0.947 . . . . 0.0 109.058 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.773 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.2 m-85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.858 . . . . 0.0 111.9 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 8.5 p . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.671 0.272 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.33 29.94 5.52 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.08 23.32 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.751 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.33 7.24 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.165 -1.197 . . . . 0.0 111.915 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.44 53.28 0.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 0.0 112.329 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.569 ' CA ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -132.57 34.35 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.933 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.2 p -111.39 122.26 47.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -85.82 7.85 22.29 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.127 -1.608 . . . . 0.0 107.887 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.2 p -110.84 -42.47 4.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.757 . . . . 0.0 112.121 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.856 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.6 m -75.34 19.16 0.18 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.54 -1.35 . . . . 0.0 111.791 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.638 ' HD1' HG23 ' A' ' 74' ' ' VAL . 5.0 t-160 -45.58 137.25 5.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.576 -1.327 . . . . 0.0 108.225 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.3 m -139.63 155.2 25.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.775 -1.203 . . . . 0.0 109.952 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.1 m-30 -119.02 122.18 41.57 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.153 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.2 t -100.55 174.66 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.325 -0.859 . . . . 0.0 109.859 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.95 ' O ' HG23 ' A' ' 57' ' ' THR . 10.2 p30 -94.68 137.36 33.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.768 -1.208 . . . . 0.0 109.075 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 53' ' ' ASN . 8.9 pm0 -37.98 -25.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.342 -0.849 . . . . 0.0 111.625 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.923 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -71.49 -44.74 64.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 111.875 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.648 ' O ' HG13 ' A' ' 60' ' ' VAL . 53.4 m-85 -99.12 -9.45 23.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.658 -1.277 . . . . 0.0 111.831 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.95 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -80.29 -33.11 37.95 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.521 -1.362 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.91 -27.02 57.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.67 ' CB ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -79.93 -53.72 6.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 56' ' ' PHE . 11.9 m -41.17 163.49 0.1 Allowed Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 121.472 -0.767 . . . . 0.0 110.337 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -64.89 161.86 34.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.032 1.543 . . . . 0.0 111.915 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.63 26.27 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.815 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.59 152.72 44.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.59 ' O ' HD13 ' A' ' 68' ' ' ILE . 27.6 p-10 -100.18 -173.04 2.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.102 -0.999 . . . . 0.0 111.187 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -54.43 -18.63 4.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.529 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.51 -55.77 18.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.1 tm-20 -59.55 -5.1 0.75 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.837 -0.539 . . . . 0.0 111.4 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.3 mp -91.25 -16.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.344 -1.472 . . . . 0.0 111.488 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.29 -82.45 1.37 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.666 -1.271 . . . . 0.0 110.388 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.095 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -47.84 -33.74 7.81 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.005 -1.291 . . . . 0.0 109.755 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.019 HD22 HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.09 -29.32 70.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -90.32 -23.8 21.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.541 -0.724 . . . . 0.0 109.575 178.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.576 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 16.2 m -48.94 -44.72 40.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 108.779 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.638 HG23 ' HD1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -90.53 80.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.042 178.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.777 ' O ' HG23 ' A' ' 75' ' ' THR . 8.8 t -47.9 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.423 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -118.83 55.41 0.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.777 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 78' ' ' LEU . 1.6 pm0 39.54 48.64 1.84 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 109.457 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.019 HD11 HD22 ' A' ' 71' ' ' LEU . 1.7 tp -19.81 133.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.524 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.633 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -100.81 170.66 6.31 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -68.16 -27.77 34.98 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.559 1.294 . . . . 0.0 109.46 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 57' ' ' THR . 24.4 p-10 -105.77 -4.65 20.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.579 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.9 m -48.83 158.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 0.0 111.036 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.605 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -175.11 167.57 3.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.634 -0.666 . . . . 0.0 109.627 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.095 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -88.68 143.82 26.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.982 . . . . 0.0 110.368 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.654 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 6.4 p -46.57 -36.39 6.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 110.576 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.469 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 12.1 m -94.04 37.43 1.09 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 111.386 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.736 HE21 ' HB2' ' A' ' 43' ' ' ALA . 2.9 mm-40 -126.65 -43.27 1.74 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 112.259 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.795 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -84.18 148.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.549 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.8 mm -111.07 164.17 7.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.762 -0.586 . . . . 0.0 109.788 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.608 ' HE2' ' HB ' ' A' ' 97' ' ' ILE . 2.0 tpt -110.28 86.96 2.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.303 -0.873 . . . . 0.0 110.028 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.469 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 1.3 p -70.54 163.41 63.6 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.46 -0.775 . . . . 0.0 109.858 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -76.93 0.84 9.26 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.9 1.474 . . . . 0.0 110.144 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.541 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 22.8 pt-20 -110.03 -21.28 12.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 109.47 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.67 HD13 ' CB ' ' A' ' 59' ' ' LYS . 10.5 mt -103.98 63.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 109.826 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.55 147.45 25.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.476 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.12 24.36 9.05 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.827 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -65.05 122.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 122.748 1.261 . . . . 0.0 113.045 -176.33 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.469 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 3.8 t -98.75 116.03 40.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.486 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.03 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -104.34 -175.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.38 1.086 . . . . 0.0 110.381 -179.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.659 ' H ' HG12 ' A' ' 99' ' ' VAL . 11.5 m-20 -161.99 139.81 8.81 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.128 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 1.074 HG23 ' O ' ' A' ' 6' ' ' VAL . 5.3 t -96.06 108.04 38.57 Favored Pre-proline 0 C--N 1.289 -2.048 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.1 Cg_endo . . . . . 0 C--N 1.304 -1.768 0 O-C-N 124.175 1.619 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' CA ' ' O ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.513 0.673 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 105.91 4.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.007 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.8 t -109.94 145.92 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.051 -1.031 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 6.7 t -131.19 132.55 63.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.438 -0.789 . . . . 0.0 109.538 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.732 ' HE1' ' HB3' ' A' ' 23' ' ' LEU . 70.9 m-85 -110.21 129.04 55.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.011 0.91 . . . . 0.0 112.02 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.2 t -102.08 119.46 50.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.762 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.663 ' CB ' HG22 ' A' ' 11' ' ' THR . 91.5 p -79.62 130.29 35.23 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -38.18 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.749 -0.594 . . . . 0.0 111.049 -179.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.8 p30 -79.36 -3.07 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.989 -1.069 . . . . 0.0 110.672 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' SER . . . 109.99 -33.48 5.99 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.663 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.71 142.06 9.06 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.946 -1.326 . . . . 0.0 109.29 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HG2' HG13 ' A' ' 6' ' ' VAL . 27.8 mtt180 -126.98 120.84 30.04 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.345 0.593 . . . . 0.0 111.074 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 3.0 ttp180 -99.94 153.04 19.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 5.3 mt-10 -130.51 134.09 46.77 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.852 -1.155 . . . . 0.0 110.238 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.835 HD13 ' CB ' ' A' ' 26' ' ' ALA . 7.4 mt -122.13 144.32 49.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -99.91 86.28 3.24 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.996 HG22 ' HB2' ' A' ' 26' ' ' ALA . 43.8 t -98.43 172.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.59 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.575 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -125.78 -146.52 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 111.282 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -96.71 122.07 39.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.594 0.712 . . . . 0.0 110.354 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.23 -13.14 31.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 22' ' ' SER . 32.7 t -88.26 169.74 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.018 -1.284 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.581 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.49 152.24 39.37 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.813 HD13 HG11 ' A' ' 99' ' ' VAL . 5.4 mt -52.17 -23.29 5.28 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.336 -1.746 . . . . 0.0 107.788 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.755 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -73.17 -66.05 0.73 Allowed 'General case' 0 C--O 1.202 -1.421 0 CA-C-O 121.595 0.712 . . . . 0.0 109.887 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.558 ' NE2' ' HA ' ' A' ' 21' ' ' VAL 0.256 6.7 tt0 -37.13 -70.29 0.1 Allowed 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.735 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.996 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -49.66 -58.93 4.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.94 -1.725 . . . . 0.0 108.666 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.917 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -47.91 -58.74 4.0 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 108.888 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.801 HG12 ' N ' ' A' ' 29' ' ' SER 0.284 1.0 OUTLIER -34.29 -64.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.715 178.176 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.801 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.03 -46.96 86.9 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.872 0.844 . . . . 0.0 109.6 179.097 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.558 ' ND2' HD22 ' A' ' 15' ' ' LEU . 2.8 m-80 -59.87 -7.01 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.419 0.628 . . . . 0.0 109.735 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.59 -18.82 44.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 27' ' ' ALA . 59.5 mt -40.79 -38.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -1.028 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.755 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 23.4 m-85 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.96 . . . . 0.0 113.224 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 121.258 0.552 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.26 31.2 4.52 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.0 32.03 37.33 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.738 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.6 m -131.45 5.32 4.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 0.0 111.172 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.763 ' O ' ' HE1' ' A' ' 70' ' ' MET . . . 71.09 47.93 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.242 -0.911 . . . . 0.0 112.312 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.43 ' HB2' ' HA ' ' A' ' 39' ' ' CYS . 3.2 m -133.16 44.53 2.82 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.053 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.96 153.5 25.43 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -111.55 -3.45 15.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.229 -0.92 . . . . 0.0 108.826 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 p -110.18 -30.49 7.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.272 -0.892 . . . . 0.0 112.039 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.623 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.1 m -80.32 34.0 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.545 -1.347 . . . . 0.0 110.964 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HD1' HG23 ' A' ' 74' ' ' VAL . 8.0 t-160 -60.7 132.8 55.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.923 -1.111 . . . . 0.0 108.091 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 83' ' ' ARG . 19.0 m -139.44 155.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.783 -1.198 . . . . 0.0 109.939 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.3 m-30 -116.21 106.34 13.58 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.928 0.871 . . . . 0.0 109.587 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.064 HG13 HD11 ' A' ' 97' ' ' ILE . 15.8 t -88.09 148.47 4.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.613 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -73.08 127.4 32.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 119.516 -1.99 . . . . 0.0 109.661 178.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 16.8 pt-20 -34.38 -35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.698 -0.626 . . . . 0.0 111.621 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -55.26 -16.61 3.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 60.4 m-85 -128.66 -16.17 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.683 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.845 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -80.29 -32.01 38.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 108.984 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.1 p-10 -74.52 -27.28 60.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.763 ' CB ' HD13 ' A' ' 94' ' ' LEU . 2.2 mmtt -79.88 -53.7 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.498 -0.752 . . . . 0.0 109.763 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 57' ' ' THR . 12.3 m -42.98 166.83 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 110.029 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.7 Cg_endo -62.26 162.16 24.4 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.966 1.508 . . . . 0.0 111.96 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.91 125.32 29.97 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.044 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . . . -69.78 146.28 51.56 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 109.768 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.65 -172.37 2.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.108 -0.995 . . . . 0.0 111.972 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -53.97 -20.81 6.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.59 . . . . 0.0 110.869 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 4.3 ttm180 -64.09 -55.59 20.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.47 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 3.3 tt0 -58.64 -49.97 75.55 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.716 -0.615 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.3 mp -48.01 -26.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 111.457 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.75 -68.7 1.19 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.028 ' CE ' HD12 ' A' ' 84' ' ' LEU . 2.2 ptm -48.51 -41.47 30.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.83 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 71' ' ' LEU 0.25 0.0 OUTLIER -71.1 -24.19 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.925 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 2.5 tt0 -90.78 -13.41 33.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.731 -0.605 . . . . 0.0 109.87 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.748 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 9.7 m -48.52 -49.68 35.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 108.861 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.616 HG23 ' HD1' ' A' ' 49' ' ' HIS . 4.3 m -90.32 92.9 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.791 ' O ' HG23 ' A' ' 75' ' ' THR . 9.1 t -48.29 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.369 -0.832 . . . . 0.0 110.757 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -124.49 50.59 1.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.1 pt-20 39.39 60.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.634 0.73 . . . . 0.0 109.609 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.571 HD11 HD13 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -30.54 122.06 0.2 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.573 0.702 . . . . 0.0 111.806 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -86.05 171.21 10.87 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.8 Cg_endo -66.72 -25.91 46.05 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.46 1.242 . . . . 0.0 109.485 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' A' ' 57' ' ' THR . 6.7 p-10 -109.87 -4.13 16.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.619 -0.676 . . . . 0.0 111.394 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CG ' ' A' ' 79' ' ' LYS . 69.2 m -48.71 143.9 4.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.674 -1.266 . . . . 0.0 110.588 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.831 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.86 165.53 36.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.0 110.046 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.053 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -88.4 143.08 27.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.362 -0.836 . . . . 0.0 109.369 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.623 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 5.7 p -46.64 -46.37 19.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.74 -1.225 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -91.91 38.82 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.598 -0.689 . . . . 0.0 109.893 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.736 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 4.5 tp-100 -123.28 -40.99 2.33 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.41 -0.806 . . . . 0.0 111.318 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.902 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -92.73 149.73 4.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.31 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -110.7 164.28 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.603 ' HE3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.4 126.37 54.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.96 -1.088 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.482 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.55 159.86 28.06 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.722 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -72.71 -1.61 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.915 1.481 . . . . 0.0 110.514 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -110.06 -28.59 8.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.588 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.763 HD13 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -93.48 37.77 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.073 0.94 . . . . 0.0 109.286 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' CB ' ' OG ' ' A' ' 1' ' ' SER . 1.6 p-10 -82.06 142.83 31.98 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.707 0.765 . . . . 0.0 112.196 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.36 28.33 7.23 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.064 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -77.99 133.7 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 122.173 0.987 . . . . 0.0 112.483 -177.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.552 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 16.5 t -102.44 101.63 12.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.373 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.95 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.59 170.15 2.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.063 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -144.32 172.19 13.27 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.197 0.999 . . . . 0.0 111.57 -176.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 102' ' ' PRO . 98.9 t -107.08 109.4 62.99 Favored Pre-proline 0 C--N 1.297 -1.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.264 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.646 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 47.0 Cg_endo . . . . . 0 C--N 1.305 -1.728 0 O-C-N 123.981 1.516 . . . . 0.0 111.585 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.543 ' HB3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -70.18 125.28 26.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.698 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.663 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 3.2 t -121.76 136.88 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.975 -1.078 . . . . 0.0 110.231 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.911 HG13 ' CG ' ' A' ' 14' ' ' GLU . 95.1 t -121.14 110.75 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 112.197 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.108 ' OH ' HD12 ' A' ' 15' ' ' LEU . 19.6 m-30 -82.27 131.4 35.23 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.423 0.63 . . . . 0.0 111.708 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 99' ' ' VAL . 4.4 t -120.49 128.78 76.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.064 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.666 ' HB3' HG22 ' A' ' 11' ' ' THR . 26.8 p -79.33 -159.78 0.21 Allowed 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.95 -1.1 . . . . 0.0 108.5 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -11.33 19.39 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.895 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.55 -0.75 37.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 0.0 109.565 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 -19.9 26.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.82 143.04 7.99 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.958 -1.319 . . . . 0.0 109.223 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 17.2 mtt180 -124.1 139.21 54.16 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.428 0.633 . . . . 0.0 111.329 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.655 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.25 67.82 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.911 ' CG ' HG13 ' A' ' 4' ' ' VAL . 4.0 mp0 -67.51 140.97 57.05 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.919 -1.113 . . . . 0.0 110.849 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.108 HD12 ' OH ' ' A' ' 5' ' ' TYR . 8.8 mt -109.72 150.76 27.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.691 -0.631 . . . . 0.0 110.043 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.35 85.78 3.26 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 26' ' ' ALA . 40.7 t -98.76 171.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.666 0.746 . . . . 0.0 111.337 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.578 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -118.57 -139.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.454 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -105.58 125.73 51.33 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.452 -0.78 . . . . 0.0 110.198 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.67 29.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 22' ' ' SER . 61.1 t -102.18 170.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.933 -1.333 . . . . 0.0 110.199 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.616 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.73 160.33 23.56 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.762 HD21 ' SD ' ' A' ' 90' ' ' MET . 16.8 mt -54.97 -18.4 4.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.694 -1.254 . . . . 0.0 109.448 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 1.225 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -90.23 -58.18 2.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.257 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.7 tt0 -38.63 -64.77 0.41 Allowed 'General case' 0 C--N 1.289 -2.062 0 O-C-N 122.127 -0.358 . . . . 0.0 110.762 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.953 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -48.38 -55.97 9.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.437 -1.415 . . . . 0.0 108.283 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.777 ' HB1' ' CD1' ' A' ' 33' ' ' TYR . . . -52.72 -55.92 19.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.89 ' CG2' ' HE2' ' A' ' 24' ' ' MET 0.264 0.7 OUTLIER -37.32 -47.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.472 177.592 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.8 -43.81 21.76 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.582 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.7 m-80 -59.86 -8.08 2.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 109.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.34 -18.4 18.53 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.592 HD13 ' HD2' ' A' ' 5' ' ' TYR . 58.2 mt -48.92 -29.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.851 -1.382 . . . . 0.0 107.643 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 3.1 m-85 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.675 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.1 p . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.106 0.479 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 48.26 25.48 4.22 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.03 28.81 61.71 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.3 p -140.23 28.09 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.3 . . . . 0.0 111.998 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 66.56 45.29 2.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.577 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -130.6 46.79 2.61 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.054 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -111.72 157.06 20.95 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -177.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.692 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -112.0 -9.76 13.98 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.677 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.2 p -110.48 -30.11 7.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -0.78 . . . . 0.0 112.618 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.863 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.4 m -73.99 66.88 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.31 -1.494 . . . . 0.0 110.197 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.619 ' HE2' ' HE1' ' A' ' 51' ' ' TYR . 4.0 t-160 -87.85 132.74 34.08 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 83' ' ' ARG . 17.1 m -142.29 155.24 18.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 109.277 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.694 ' CD1' ' HE2' ' A' ' 79' ' ' LYS . 5.1 m-30 -120.2 118.11 29.65 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 121.675 0.75 . . . . 0.0 111.015 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.791 ' HB ' HG22 ' A' ' 57' ' ' THR . 42.2 t -97.96 165.71 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.346 -0.846 . . . . 0.0 109.643 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.763 ' O ' HG23 ' A' ' 57' ' ' THR . 21.1 p-10 -89.41 138.31 31.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.38 -1.45 . . . . 0.0 109.388 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -38.38 -26.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.382 -0.824 . . . . 0.0 111.441 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . . . -68.31 -18.0 64.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.965 -1.084 . . . . 0.0 111.551 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 38.5 m-85 -129.62 -14.44 4.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.776 -1.203 . . . . 0.0 110.796 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.791 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -80.88 -22.69 39.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.906 -1.121 . . . . 0.0 108.746 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -85.96 -23.97 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.825 . . . . 0.0 110.028 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HB3' HD22 ' A' ' 94' ' ' LEU . 9.2 mmtt -79.5 -47.66 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.452 -0.78 . . . . 0.0 109.111 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.897 HG11 ' CG2' ' A' ' 88' ' ' ILE . 6.3 m -45.3 161.39 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.786 -0.571 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.512 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -65.19 163.34 29.43 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 112.325 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.21 124.14 29.04 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.76 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.631 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -88.66 160.26 17.45 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.621 ' O ' HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -100.55 -166.86 1.36 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 110.266 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.0 -24.27 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.838 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 4.1 ttm180 -64.79 -15.34 61.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.741 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.0 tp10 -100.28 -3.61 31.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.91 -59.3 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 111.445 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.88 -47.54 24.89 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.988 ' CE ' HD12 ' A' ' 84' ' ' LEU 0.33 1.3 ttp -48.79 -52.3 24.66 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 123.497 1.618 . . . . 0.0 108.666 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD12 ' OE2' ' A' ' 67' ' ' GLU 0.293 0.0 OUTLIER -68.39 -33.85 74.98 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.043 -179.21 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.684 ' HB2' HD22 ' A' ' 78' ' ' LEU . 6.7 tt0 -90.56 7.64 38.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.573 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 5.5 m -48.83 -49.47 39.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.85 -1.156 . . . . 0.0 108.342 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.694 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.3 m -90.48 113.35 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.02 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.791 ' O ' HG23 ' A' ' 75' ' ' THR . 8.9 t -48.57 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.823 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -125.2 44.82 2.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.558 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.7 pt-20 39.56 60.53 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.43 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 72' ' ' GLU . 2.5 tp -32.17 133.59 0.1 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 21.3 mtmt -110.44 172.01 3.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.708 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -66.26 -32.06 42.79 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.507 1.267 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.732 ' HB2' HG21 ' A' ' 57' ' ' THR . 14.5 p-10 -98.79 -10.84 22.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.501 ' OG ' ' HB2' ' A' ' 79' ' ' LYS . 50.2 m -48.92 150.51 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 0.0 109.724 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.666 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -157.59 151.43 24.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.054 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -73.17 130.45 40.29 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -44.81 -20.98 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.991 -1.068 . . . . 0.0 112.149 -176.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.225 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 26.1 m -107.02 39.29 1.9 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.578 -1.326 . . . . 0.0 111.168 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.678 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 34.6 mm-40 -125.06 -45.26 1.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 110.634 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.897 ' CG2' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.88 143.25 12.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.9 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.0 mm -110.68 158.71 10.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.416 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.762 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.9 tpt -110.21 103.89 12.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -98.58 167.61 11.17 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.754 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -72.6 -0.36 8.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.584 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 3.7 pt-20 -110.04 -32.08 7.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 109.55 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' CE ' ' A' ' 90' ' ' MET . 6.8 mt -94.66 35.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.16 0.981 . . . . 0.0 109.187 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -87.94 154.58 20.39 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.667 0.746 . . . . 0.0 112.101 -177.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.642 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.37 24.14 19.75 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.765 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -80.5 152.24 4.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.274 1.035 . . . . 0.0 112.577 -177.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG23 ' ND2' ' A' ' 53' ' ' ASN . 17.6 t -112.68 123.56 68.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -103.91 -175.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.86 -1.15 . . . . 0.0 109.933 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.675 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.9 m-20 -162.11 130.14 4.06 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.989 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 6' ' ' VAL . 54.0 t -89.19 110.36 37.86 Favored Pre-proline 0 C--N 1.277 -2.549 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.642 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.4 Cg_endo . . . . . 0 C--N 1.305 -1.737 0 O-C-N 124.029 1.542 . . . . 0.0 112.139 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.522 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.543 0.687 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -90.25 121.44 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.817 HG22 ' CG2' ' A' ' 97' ' ' ILE . 3.4 t -122.55 143.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.719 -1.238 . . . . 0.0 110.098 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.85 HG22 ' CG ' ' A' ' 14' ' ' GLU . 24.4 t -130.18 122.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.998 0.904 . . . . 0.0 109.147 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.913 ' HE2' HD13 ' A' ' 15' ' ' LEU . 42.1 m-85 -96.95 142.07 29.36 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.802 0.81 . . . . 0.0 111.035 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.002 HG13 ' HG3' ' A' ' 12' ' ' ARG . 2.9 t -113.48 114.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.39 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -79.6 124.56 28.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.504 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -32.4 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.005 -0.434 . . . . 0.0 112.144 -178.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.589 ' OD1' HG22 ' A' ' 11' ' ' THR . 2.6 p-10 -66.99 -9.51 39.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.682 -1.261 . . . . 0.0 110.141 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . 110.0 -31.73 7.25 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.589 HG22 ' OD1' ' A' ' 9' ' ' ASP . 2.7 t -61.58 133.61 55.86 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.965 -1.315 . . . . 0.0 109.272 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 1.002 ' HG3' HG13 ' A' ' 6' ' ' VAL . 13.4 mtm180 -118.53 132.3 56.21 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.169 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.687 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.03 149.15 24.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 179.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.85 ' CG ' HG22 ' A' ' 4' ' ' VAL . 22.9 mt-10 -130.41 120.1 23.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.771 -1.206 . . . . 0.0 110.949 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.913 HD13 ' HE2' ' A' ' 5' ' ' TYR . 1.4 mp -116.87 177.62 4.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.257 1.027 . . . . 0.0 111.914 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -106.75 83.14 1.8 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.986 HG22 ' CB ' ' A' ' 26' ' ' ALA . 58.6 t -98.54 129.22 49.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.538 -0.726 . . . . 0.0 110.305 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.477 ' HA ' ' OG ' ' A' ' 1' ' ' SER . . . -140.0 -171.47 3.18 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.523 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 90' ' ' MET . 1.9 p30 -41.23 115.4 0.6 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.856 0.836 . . . . 0.0 110.324 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.34 -22.23 22.89 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.661 ' HB ' HG13 ' A' ' 17' ' ' VAL . 2.4 t -107.88 157.49 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.849 -1.383 . . . . 0.0 110.86 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -120.96 166.69 13.47 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.671 HD22 HD12 ' A' ' 88' ' ' ILE . 5.1 mp -58.42 -22.09 53.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.368 -1.457 . . . . 0.0 107.897 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.87 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.93 -72.12 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.643 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.608 ' HG2' HG13 ' A' ' 21' ' ' VAL . 4.8 tt0 -37.67 -67.6 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.877 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.986 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -42.37 -73.95 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.499 -1.376 . . . . 0.0 108.613 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.826 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . . . -44.85 -44.74 9.76 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -47.09 -60.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.714 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -50.27 -45.87 54.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.993 0.901 . . . . 0.0 108.748 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.804 ' ND2' HD21 ' A' ' 15' ' ' LEU . 1.5 m-80 -64.93 -2.34 2.58 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.789 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 11.68 84.54 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 15' ' ' LEU 0.268 3.8 mt -70.67 -31.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.568 -0.96 . . . . 0.0 109.134 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.751 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.4 m-85 . . . . . 0 N--CA 1.498 1.937 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.3 p . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.035 0.445 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.44 28.07 3.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.28 35.47 26.6 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.729 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.0 p -140.11 8.38 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -1.204 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 70.3 53.41 0.33 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.149 -0.969 . . . . 0.0 111.935 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.461 ' H ' ' HA ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -133.19 38.44 3.33 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.108 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.62 153.9 24.55 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.95 -2.22 16.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.658 -1.276 . . . . 0.0 108.789 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 p -110.02 -34.49 6.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 111.363 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.84 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.2 m -74.53 63.7 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.561 -1.337 . . . . 0.0 109.794 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.957 ' ND1' HG21 ' A' ' 74' ' ' VAL . 17.1 t-160 -91.78 133.13 35.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.601 HG11 ' OH ' ' A' ' 33' ' ' TYR . 16.9 m -144.58 154.82 14.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.808 -1.182 . . . . 0.0 109.943 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.727 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 7.7 m-30 -116.84 109.57 17.26 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.891 HG21 ' CD1' ' A' ' 88' ' ' ILE . 16.4 t -86.28 158.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.372 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 57' ' ' THR . 11.5 p-10 -78.81 132.43 36.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 119.997 -1.689 . . . . 0.0 109.918 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 53' ' ' ASN . 12.1 pt-20 -38.65 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.98 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -63.87 -23.13 67.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.643 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 24.9 m-85 -122.71 -15.27 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.926 -1.109 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.874 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -78.65 -26.44 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.937 -1.105 . . . . 0.0 108.796 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.0 p-10 -81.83 -26.2 34.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.533 -0.729 . . . . 0.0 109.692 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . 12.5 mmtt -79.79 -52.04 8.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.498 -0.751 . . . . 0.0 109.492 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 56' ' ' PHE . 10.3 m -40.76 162.55 0.1 Allowed Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.602 -0.686 . . . . 0.0 110.515 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.524 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.6 Cg_endo -66.74 165.57 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.068 1.562 . . . . 0.0 111.454 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.62 27.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.622 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.519 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -69.21 166.3 18.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.439 -0.788 . . . . 0.0 109.71 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.71 ' O ' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -100.45 -158.2 0.66 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.977 -1.077 . . . . 0.0 110.929 -179.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 pp20? -78.38 -23.16 46.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.694 -0.628 . . . . 0.0 111.069 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.565 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.84 -48.46 74.28 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.801 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.591 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.11 -6.27 0.84 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.262 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.39 -30.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.617 -1.302 . . . . 0.0 110.668 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.28 -63.22 1.25 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.106 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -48.08 -42.64 29.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 109.222 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.911 HD13 HD11 ' A' ' 78' ' ' LEU 0.26 0.0 OUTLIER -69.45 -23.84 63.72 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.934 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -89.95 -18.68 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.511 -0.743 . . . . 0.0 110.029 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' GLU . 2.1 m -48.51 -31.43 6.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.957 HG21 ' ND1' ' A' ' 49' ' ' HIS . 20.4 m -90.32 87.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 75' ' ' THR . 9.3 t -48.41 82.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.269 -0.894 . . . . 0.0 111.506 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -130.39 40.85 3.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 10.0 pt-20 39.2 60.14 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.764 -0.585 . . . . 0.0 109.754 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.911 HD11 HD13 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -19.93 125.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.264 0.554 . . . . 0.0 112.104 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.626 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -80.05 170.69 14.78 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.4 Cg_endo -65.85 -25.71 52.7 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.477 1.251 . . . . 0.0 109.564 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.675 ' HB2' HG21 ' A' ' 57' ' ' THR . 20.6 p-10 -107.79 -8.25 16.09 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 111.33 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 45.7 m -49.44 158.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.614 -1.304 . . . . 0.0 111.205 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' NH2' HG23 ' A' ' 88' ' ' ILE . 2.3 ttp180 -175.51 156.48 1.96 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.108 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -73.29 135.47 44.42 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.624 ' HG ' ' HE1' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -45.46 -24.3 0.3 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.585 -177.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.3 m -104.79 42.64 1.18 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.894 -1.128 . . . . 0.0 111.401 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.823 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -125.07 -42.53 2.01 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.717 0.77 . . . . 0.0 110.501 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.891 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -89.0 140.04 16.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.354 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 90' ' ' MET . 5.3 mm -110.68 172.56 2.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.933 ' CB ' HG12 ' A' ' 17' ' ' VAL . 1.2 tpt -110.15 115.85 30.48 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.13 -0.982 . . . . 0.0 111.029 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.471 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -96.8 169.56 8.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.664 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.9 -5.65 17.58 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.885 1.466 . . . . 0.0 110.556 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 10.8 pt-20 -110.29 -23.94 10.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.701 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 7.2 mt -96.39 55.9 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -0.995 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -100.84 146.51 27.21 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.066 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.643 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.59 21.73 10.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.817 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -62.48 150.47 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.183 0.992 . . . . 0.0 113.243 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.668 HG23 ' ND2' ' A' ' 53' ' ' ASN . 10.9 t -127.61 89.82 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.977 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.72 162.49 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.441 1.115 . . . . 0.0 110.51 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.571 ' OD2' HG21 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -145.51 170.13 17.01 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.913 -178.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.504 HG12 ' ND1' ' A' ' 8' ' ' HIS . 42.3 t -110.17 128.84 24.69 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.727 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 37.5 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 O-C-N 123.771 1.406 . . . . 0.0 112.942 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.559 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.366 0.603 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.6 ttmm -76.63 135.12 39.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.903 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.77 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 14.8 t -123.43 140.39 47.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.614 -1.304 . . . . 0.0 110.865 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.866 HG13 ' HG2' ' A' ' 14' ' ' GLU . 41.4 t -121.5 117.91 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 122.052 0.93 . . . . 0.0 111.504 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.097 ' CE2' HD13 ' A' ' 15' ' ' LEU . 22.5 m-30 -97.55 135.26 39.64 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.837 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 99' ' ' VAL . 14.4 t -120.05 154.09 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.48 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 11' ' ' THR . 10.7 p -117.06 138.64 51.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.452 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -44.39 -24.28 0.17 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.151 -0.968 . . . . 0.0 110.338 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.5 p30 -85.03 -5.82 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.007 . . . . 0.0 110.401 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.19 -45.61 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.529 HG22 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.73 124.52 9.84 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.877 -1.366 . . . . 0.0 110.011 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.708 ' HD2' HG22 ' A' ' 6' ' ' VAL . 30.7 mtm180 -110.34 156.91 20.1 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.479 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.763 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -134.75 67.78 1.49 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 0.0 109.438 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.866 ' HG2' HG13 ' A' ' 4' ' ' VAL . 1.4 mp0 -69.48 131.49 44.82 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.563 0.697 . . . . 0.0 110.335 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.097 HD13 ' CE2' ' A' ' 5' ' ' TYR . 2.3 mp -114.77 173.5 6.45 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.236 1.017 . . . . 0.0 112.012 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.78 90.76 4.56 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.9 HG13 HG11 ' A' ' 21' ' ' VAL . 95.7 t -98.58 166.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.469 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.559 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -133.01 -160.74 1.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.757 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -82.41 123.75 29.41 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.564 0.697 . . . . 0.0 110.696 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.37 37.08 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.923 HG13 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -106.29 170.2 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 110.65 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.604 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -120.51 175.94 5.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -76.16 -3.67 37.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.216 -1.553 . . . . 0.0 108.218 178.049 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.612 ' HE3' ' H ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -91.18 -77.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 112.022 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.923 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -38.03 -23.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.905 -0.497 . . . . 0.0 111.176 -177.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.635 ' C ' HD22 ' A' ' 15' ' ' LEU . . . -87.7 -45.06 10.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.791 ' HA ' HD12 ' A' ' 32' ' ' ILE 0.265 . . -66.33 -46.13 77.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.887 1.327 . . . . 0.0 107.492 176.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 29' ' ' SER 0.263 0.8 OUTLIER -45.92 -58.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.197 178.64 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.7 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.72 -35.79 75.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.031 178.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.861 ' ND2' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -72.87 12.15 0.56 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.444 0.64 . . . . 0.0 109.831 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 70.08 4.96 51.51 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 27' ' ' ALA . 4.2 mt -66.43 -42.43 90.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -1.109 . . . . 0.0 109.459 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.63 ' HB2' HG23 ' A' ' 28' ' ' VAL . 23.5 m-85 . . . . . 0 C--N 1.301 -1.536 0 C-N-CA 119.183 -1.007 . . . . 0.0 113.448 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.638 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 21.7 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.066 0.46 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 42.59 35.28 1.98 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' H ' ' HE3' ' A' ' 24' ' ' MET . . . 80.27 28.25 49.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 6.2 m -128.58 -3.65 5.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -1.092 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.81 51.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.765 0.793 . . . . 0.0 112.321 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.567 ' OG ' ' HA ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -131.55 38.91 3.55 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.733 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -110.88 150.41 29.22 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.87 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -111.01 -4.4 15.14 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.554 -0.717 . . . . 0.0 109.667 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.2 t -110.56 -21.49 12.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.947 . . . . 0.0 112.754 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.819 ' O ' HG13 ' A' ' 50' ' ' VAL . 34.9 m -75.02 11.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.367 -1.458 . . . . 0.0 111.243 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.103 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 3.3 t-160 -43.69 124.45 3.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.6 m -143.35 163.12 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 120.928 -1.107 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.774 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -118.47 124.63 48.07 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.704 0.764 . . . . 0.0 111.147 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.932 HG21 ' CD1' ' A' ' 88' ' ' ILE . 2.7 t -99.58 165.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.943 ' OD1' ' HB3' ' A' ' 55' ' ' ALA . 9.7 p30 -82.85 134.58 35.09 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 119.892 -1.755 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.1 pt-20 -37.58 -25.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.455 -0.778 . . . . 0.0 111.765 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.943 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -70.68 -40.33 73.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.838 -1.163 . . . . 0.0 111.587 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.845 ' HB3' HD12 ' A' ' 97' ' ' ILE . 61.1 m-85 -102.71 -17.95 15.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.733 -1.229 . . . . 0.0 111.258 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -80.63 -23.43 39.75 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.927 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 55' ' ' ALA . 23.4 p-10 -82.95 -24.11 33.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.566 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.897 ' CB ' HD21 ' A' ' 94' ' ' LEU . 3.4 mmtp -79.85 -49.05 12.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.675 ' N ' HD11 ' A' ' 94' ' ' LEU . 3.0 m -43.54 168.25 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 110.05 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.6 Cg_endo -62.17 164.71 16.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.029 1.541 . . . . 0.0 111.589 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.67 112.79 18.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.898 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.587 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.58 147.24 50.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.763 . . . . 0.0 110.366 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' O ' HD13 ' A' ' 68' ' ' ILE . 23.6 p30 -100.07 -173.38 2.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 110.555 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.63 -26.92 24.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 70' ' ' MET . 5.4 ttm180 -64.83 -18.11 64.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.587 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 3.3 tm-20 -99.96 1.51 42.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.1 mp -91.89 -59.05 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 111.194 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -77.01 -47.77 9.01 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.695 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.323 2.8 ttp -48.58 -50.72 31.26 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 123.547 1.641 . . . . 0.0 108.022 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.626 HD11 ' C ' ' A' ' 82' ' ' SER 0.296 0.0 OUTLIER -70.87 -32.44 69.43 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.709 -179.408 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.649 ' HB2' HD22 ' A' ' 78' ' ' LEU . 4.3 tt0 -89.16 -0.15 57.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.893 -1.129 . . . . 0.0 110.453 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.692 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -49.08 -52.34 26.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.631 -1.293 . . . . 0.0 108.438 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 46' ' ' ALA . 31.1 m -90.48 107.95 19.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.481 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -48.15 103.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.838 -1.164 . . . . 0.0 109.254 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.103 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -120.07 22.51 11.41 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.608 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 71.7 38.27 0.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.672 1.225 . . . . 0.0 108.338 -178.408 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 72' ' ' GLU . 11.3 tp -19.26 134.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.979 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' N ' HD12 ' A' ' 78' ' ' LEU . 2.4 mtpt -128.09 -169.24 0.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 46.2 Cg_endo -81.92 -30.64 1.26 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.697 1.367 . . . . 0.0 109.743 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.7 p-10 -93.7 -12.17 29.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.731 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.626 ' C ' HD11 ' A' ' 71' ' ' LEU . 18.6 m -49.23 155.52 0.68 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.042 . . . . 0.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.85 ' NE ' HG23 ' A' ' 88' ' ' ILE . 2.4 mtp180 -175.29 153.92 1.63 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.733 HD22 ' SG ' ' A' ' 45' ' ' CYS . 11.1 mt -74.61 150.84 39.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.672 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 46.6 p -46.71 -25.94 0.83 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.725 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -110.13 44.95 1.15 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.732 0.777 . . . . 0.0 109.556 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.564 ' HG2' ' CG ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -125.44 -32.77 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.932 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.35 147.18 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.628 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.0 mm -110.3 160.62 9.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 21' ' ' VAL . 2.9 tpt -110.25 112.86 25.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.539 -0.726 . . . . 0.0 110.425 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -97.48 172.66 4.7 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.2 Cg_endo -72.67 -31.87 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.92 1.484 . . . . 0.0 110.558 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 2.4 pp20? -81.04 -44.96 17.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.883 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.897 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.1 mt -75.81 52.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.115 -0.991 . . . . 0.0 111.018 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 4.3 p-10 -101.33 152.86 20.2 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.032 -1.042 . . . . 0.0 111.764 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.626 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.32 22.42 10.56 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.845 HD12 ' HB3' ' A' ' 56' ' ' PHE . 3.6 tt -72.55 154.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 123.175 1.464 . . . . 0.0 113.555 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.636 ' H ' ' ND2' ' A' ' 53' ' ' ASN 0.252 8.1 t -125.37 98.27 4.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.566 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.891 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.74 174.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.134 -1.427 . . . . 0.0 109.726 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.586 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.87 174.03 16.12 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.914 0.864 . . . . 0.0 111.024 -178.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 18.0 t -111.09 130.96 22.43 Favored Pre-proline 0 N--CA 1.498 1.956 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.429 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.937 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 49.7 Cg_endo . . . . . 0 N--CA 1.495 1.615 0 C-N-CA 121.695 1.597 . . . . 0.0 112.683 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.546 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.38 0.609 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -74.8 120.11 19.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.743 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.769 HG22 ' CG2' ' A' ' 97' ' ' ILE . 25.1 t -119.67 146.5 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.769 -1.207 . . . . 0.0 110.983 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 99' ' ' VAL . 16.9 t -131.06 125.83 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.695 0.76 . . . . 0.0 109.856 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.902 ' CD1' HG21 ' A' ' 99' ' ' VAL . 49.2 m-85 -101.52 137.91 39.22 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.486 0.66 . . . . 0.0 111.922 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.5 t -120.77 132.73 69.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.023 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.693 ' HB3' HG22 ' A' ' 11' ' ' THR . 67.6 p -79.39 -153.01 0.07 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.523 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -110.2 -8.13 14.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 120.97 -1.081 . . . . 0.0 108.98 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -100.37 1.65 41.64 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.41 -21.75 23.54 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.87 138.89 14.32 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.024 -1.28 . . . . 0.0 109.449 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 24.6 mtt180 -130.06 148.66 51.93 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.401 0.62 . . . . 0.0 111.215 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.696 ' HG2' HD11 ' A' ' 32' ' ' ILE . 1.4 ttm-85 -140.11 118.9 12.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.43 -0.794 . . . . 0.0 109.888 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.0 mp0 -100.42 124.43 45.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.797 -1.189 . . . . 0.0 110.835 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 27' ' ' ALA . 10.8 mt -110.57 151.83 27.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 110.507 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.11 90.37 3.92 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.911 HG22 ' HB2' ' A' ' 26' ' ' ALA . 50.6 t -98.61 174.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 110.298 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -125.32 -133.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.518 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -110.03 124.04 50.75 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.51 -10.78 30.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 22' ' ' SER . 70.0 t -93.87 169.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.33 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.618 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.36 169.26 10.78 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 3' ' ' VAL . 10.7 mt -60.91 -35.15 75.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.721 -1.237 . . . . 0.0 108.934 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.754 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.9 ttp -66.65 -62.47 1.44 Allowed 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.927 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.614 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.4 tt0 -38.14 -76.72 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.911 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -43.15 -56.39 3.44 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.331 -1.481 . . . . 0.0 109.754 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.879 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -56.74 -53.62 55.69 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.012 0.91 . . . . 0.0 109.412 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.756 HG12 ' N ' ' A' ' 29' ' ' SER 0.284 1.2 t -35.47 -63.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.152 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.756 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.37 -46.67 85.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.112 0.958 . . . . 0.0 108.884 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.578 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.8 m-80 -59.93 -8.6 2.35 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 88.02 -14.64 58.37 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.866 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 7.6 mt -42.75 -38.41 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.692 -0.887 . . . . 0.0 108.643 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.754 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 72.3 m-85 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.511 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 1.3 p . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.026 0.441 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.4 42.92 7.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.8 39.59 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.735 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.8 p -120.9 -32.35 3.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.155 -1.203 . . . . 0.0 110.386 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.53 60.97 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.222 -0.924 . . . . 0.0 111.596 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -132.38 9.27 4.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.203 -0.936 . . . . 0.0 110.998 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.182 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.31 162.03 15.97 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.715 -1.241 . . . . 0.0 114.195 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 73' ' ' CYS . . . -110.14 -22.27 11.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.813 -1.179 . . . . 0.0 110.463 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 47' ' ' THR . 1.6 t -69.83 -14.96 63.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.64 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.833 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -94.72 14.05 22.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 0.0 108.581 178.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.619 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.9 t-160 -46.98 138.52 6.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -144.78 157.09 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.817 -1.177 . . . . 0.0 109.923 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.8 m-30 -119.87 122.06 40.45 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.582 0.706 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.849 HG21 ' CD1' ' A' ' 88' ' ' ILE . 38.7 t -99.44 151.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.12 -0.988 . . . . 0.0 110.354 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.607 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -74.57 125.32 28.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.133 -1.605 . . . . 0.0 109.414 178.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' A' ' 55' ' ' ALA . 2.7 pm0 -34.07 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.702 -0.624 . . . . 0.0 112.19 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.7 -17.25 60.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.881 -1.137 . . . . 0.0 111.301 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.67 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 65.7 m-85 -125.35 -8.98 6.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.869 -1.145 . . . . 0.0 110.193 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.699 HG22 ' HB ' ' A' ' 52' ' ' VAL . 1.3 p -80.35 -34.76 36.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 108.914 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 -17.68 60.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.546 -0.721 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.766 ' CB ' HD13 ' A' ' 94' ' ' LEU 0.278 0.5 OUTLIER -79.34 -55.97 4.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 123.643 1.687 . . . . 0.0 109.423 179.584 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 88' ' ' ILE 0.323 0.3 OUTLIER -77.62 145.4 71.2 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.068 -177.707 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 60' ' ' VAL . 35.8 Cg_endo -61.75 160.0 30.62 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.847 1.446 . . . . 0.0 111.704 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -171.42 3.12 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.151 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.0 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -100.2 158.92 15.52 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.186 0.517 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 68' ' ' ILE . 24.8 p30 -100.45 -173.64 2.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 111.117 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.436 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 21.5 pt-20 -47.8 -24.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.0 ttm180 -64.5 -59.45 4.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.382 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 1.0 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 2.4 tt0 -66.96 14.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.558 -0.714 . . . . 0.0 111.975 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.83 -37.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 119.282 -2.136 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.35 -57.28 1.68 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 1.142 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -48.0 -44.96 31.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.161 -1.199 . . . . 0.0 109.087 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HB2' ' HG3' ' A' ' 67' ' ' GLU 0.3 0.0 OUTLIER -70.95 -30.96 67.4 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.531 -179.27 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 1.2 tt0 -90.9 -11.36 39.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.374 -0.829 . . . . 0.0 110.479 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.6 -50.98 30.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.706 -1.246 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.779 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.3 m -90.21 96.28 6.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 108.878 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.788 ' O ' HG23 ' A' ' 75' ' ' THR . 8.8 t -48.05 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -126.87 45.96 2.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.799 . . . . 0.0 109.91 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.6 pt-20 39.34 58.31 1.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.764 0.792 . . . . 0.0 109.467 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.546 ' CD1' ' HB2' ' A' ' 82' ' ' SER . 12.7 tp -29.72 131.72 0.07 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.56 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 6.8 mtpt -98.96 170.85 6.36 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.084 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.7 Cg_endo -67.4 -28.68 38.89 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.553 1.291 . . . . 0.0 109.768 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 21.7 p-10 -105.01 -5.05 21.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 111.025 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.577 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 72.7 m -48.54 164.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.795 -1.191 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.594 ' CG ' ' OE2' ' A' ' 67' ' ' GLU . 3.1 mtt180 -175.33 174.81 2.29 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.608 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.182 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -96.69 142.25 28.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.44 -0.788 . . . . 0.0 109.341 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 24' ' ' MET . 15.2 m -45.54 -29.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.037 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.1 p -98.68 38.83 1.31 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.619 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -126.79 -44.72 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.189 -1.57 . . . . 0.0 113.289 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.54 150.99 3.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.715 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.4 mm -111.02 161.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.546 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 2.6 tpt -110.25 111.46 22.79 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.812 -1.18 . . . . 0.0 111.043 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.472 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -91.32 156.6 43.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.6 Cg_endo -68.95 -1.42 7.76 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.805 1.423 . . . . 0.0 111.264 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.509 ' C ' HD23 ' A' ' 94' ' ' LEU . 6.3 pm0 -110.09 -27.72 9.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.981 -1.075 . . . . 0.0 110.072 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.766 HD13 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -97.24 58.48 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.267 -0.896 . . . . 0.0 109.78 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.543 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.75 151.1 22.07 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.859 0.838 . . . . 0.0 112.612 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.0 21.08 12.32 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.769 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.26 142.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.079 . . . . 0.0 113.42 -176.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.531 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 21.2 t -107.97 128.82 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.902 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.8 t -104.07 -176.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.789 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 99' ' ' VAL . 9.5 m-20 -161.42 138.11 8.45 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.703 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 40.0 t -96.72 109.29 47.75 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.803 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.72 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 46.5 Cg_endo . . . . . 0 C--N 1.308 -1.583 0 C-N-CA 121.962 1.775 . . . . 0.0 112.309 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 95' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.332 0.587 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.06 117.21 28.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.915 HG22 HG23 ' A' ' 97' ' ' ILE . 3.5 t -120.69 144.14 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.903 HG22 ' CG ' ' A' ' 14' ' ' GLU . 7.9 t -128.53 130.22 68.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 121.803 0.811 . . . . 0.0 109.386 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.856 ' CE2' HD13 ' A' ' 15' ' ' LEU . 44.9 m-85 -106.48 137.61 44.16 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.479 0.657 . . . . 0.0 112.263 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.5 t -120.17 127.97 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.797 -1.161 . . . . 0.0 108.713 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.923 ' CB ' HG22 ' A' ' 11' ' ' THR . 87.4 p -79.47 154.29 29.0 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.707 -1.197 . . . . 0.0 108.213 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.609 ' CE1' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -67.6 -5.28 14.8 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.262 0.553 . . . . 0.0 109.827 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -93.33 -13.2 28.43 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.146 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 28.19 4.19 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.167 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.923 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.6 OUTLIER -109.83 144.42 38.3 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.835 -1.391 . . . . 0.0 108.064 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.759 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -123.71 147.65 47.27 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.856 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.594 ' CD ' ' CD1' ' A' ' 32' ' ' ILE . 2.6 ttm-85 -140.04 146.96 39.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.601 -0.687 . . . . 0.0 109.205 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.903 ' CG ' HG22 ' A' ' 4' ' ' VAL . 12.1 mp0 -130.51 117.26 19.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.633 -1.292 . . . . 0.0 110.965 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.954 HD21 ' ND2' ' A' ' 30' ' ' ASN . 1.3 mp -115.15 -172.64 2.17 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.215 1.007 . . . . 0.0 111.974 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -115.74 98.53 6.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.885 HG12 ' HB3' ' A' ' 90' ' ' MET . 41.4 t -98.48 99.89 9.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.397 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.61 -165.75 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.734 0.778 . . . . 0.0 111.281 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -72.02 121.9 19.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.684 0.754 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.73 -8.17 29.87 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.399 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 22' ' ' SER . 58.2 t -103.77 166.78 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.716 -1.461 . . . . 0.0 110.637 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.598 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.92 153.3 37.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 99' ' ' VAL . 6.5 mt -46.37 -31.39 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.303 . . . . 0.0 109.949 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 1.465 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 11.5 ttt -77.69 -57.89 3.57 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.861 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 21' ' ' VAL . 6.3 tt0 -37.23 -68.8 0.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.99 -0.444 . . . . 0.0 111.203 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.59 ' C ' HD22 ' A' ' 15' ' ' LEU . . . -44.37 -68.69 0.18 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.65 -1.281 . . . . 0.0 108.429 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -47.33 -46.71 25.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.907 0.861 . . . . 0.0 109.638 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.767 HG12 ' N ' ' A' ' 29' ' ' SER . 1.2 t -46.56 -62.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.767 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -48.24 -46.86 35.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.206 1.003 . . . . 0.0 108.674 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.954 ' ND2' HD21 ' A' ' 15' ' ' LEU . 1.3 m-80 -66.02 -2.38 3.99 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.11 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.34 -8.82 60.14 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 15' ' ' LEU . 1.4 mt -42.51 -33.94 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.464 -1.021 . . . . 0.0 109.422 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.731 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 61.2 m-85 -111.21 61.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.374 -0.93 . . . . 0.0 112.849 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.53 48.85 0.82 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.931 -1.106 . . . . 0.0 108.023 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.827 HD12 HG22 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -83.43 -141.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.745 . . . . 0.0 110.698 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.827 HG22 HD12 ' A' ' 35' ' ' ILE . 13.3 m -93.18 -158.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' C ' ' OD1' ' A' ' 38' ' ' ASP . . . -120.05 79.82 0.32 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.9 m-20 -120.16 -69.18 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 109.651 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.676 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 23.7 p -69.84 -33.49 72.36 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.14 33.45 2.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.91 31.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.644 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 43.7 t -140.09 7.98 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.375 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.886 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 65.67 56.75 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.316 1.055 . . . . 0.0 110.997 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.581 ' H ' ' CB ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -132.28 31.6 4.07 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.796 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -110.77 153.13 25.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.39 -4.44 14.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.543 -0.723 . . . . 0.0 109.101 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -110.34 -22.77 11.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.325 -0.859 . . . . 0.0 112.551 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.888 ' O ' HG13 ' A' ' 50' ' ' VAL . 61.6 m -74.72 7.64 2.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.271 -1.518 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.896 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.2 t-160 -43.13 120.2 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.077 -1.014 . . . . 0.0 108.339 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.888 HG13 ' O ' ' A' ' 48' ' ' CYS . 14.9 m -142.96 164.71 16.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.955 -1.091 . . . . 0.0 110.011 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.758 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 12.5 m-30 -115.05 119.23 35.74 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.588 0.708 . . . . 0.0 110.293 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.918 ' HB ' HG22 ' A' ' 57' ' ' THR . 29.3 t -85.53 141.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.919 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -59.13 131.59 51.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 119.548 -1.97 . . . . 0.0 109.711 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 11.3 pt-20 -36.69 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.55 -42.39 67.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.454 -1.404 . . . . 0.0 112.172 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.753 ' O ' HG13 ' A' ' 60' ' ' VAL . 49.6 m-85 -93.85 -4.56 49.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.748 -1.22 . . . . 0.0 109.956 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.919 HG23 ' O ' ' A' ' 53' ' ' ASN . 4.5 p -81.06 -24.78 37.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.878 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -86.04 -30.24 22.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -0.803 . . . . 0.0 109.966 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.84 ' CB ' HD11 ' A' ' 94' ' ' LEU . 7.6 mmtt -79.74 -50.04 11.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 56' ' ' PHE . 4.5 m -39.73 162.92 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 110.975 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 88' ' ' ILE . 38.8 Cg_endo -67.49 166.51 23.57 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.352 1.712 . . . . 0.0 110.957 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 115.18 20.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.822 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.534 ' HB1' ' CG ' ' A' ' 67' ' ' GLU . . . -69.44 146.63 51.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.484 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.494 ' O ' HD13 ' A' ' 68' ' ' ILE . 22.7 p30 -99.9 174.0 6.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.95 -1.094 . . . . 0.0 111.458 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 1.7 pp20? -43.31 -29.18 0.39 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.884 -0.51 . . . . 0.0 110.913 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.1 OUTLIER -64.69 -21.46 66.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.013 -1.054 . . . . 0.0 109.774 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.4 tm-20 -95.88 1.96 53.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.513 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -91.78 -61.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 111.297 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -73.24 -48.52 19.04 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.735 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.308 3.3 ttp -48.63 -49.26 38.0 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 123.312 1.53 . . . . 0.0 108.496 178.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.649 HD12 ' OE2' ' A' ' 67' ' ' GLU 0.298 0.0 OUTLIER -72.35 -33.02 66.97 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 113.478 -1.692 . . . . 0.0 109.269 -179.547 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.931 ' HB2' HD13 ' A' ' 78' ' ' LEU . 3.2 tt0 -86.15 8.59 20.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.091 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.571 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 34.4 m -49.03 -49.44 41.13 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.66 -1.275 . . . . 0.0 108.216 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.2 m -90.52 115.88 30.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.837 ' O ' HG23 ' A' ' 75' ' ' THR . 13.1 t -48.76 85.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.838 . . . . 0.0 111.203 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -117.17 36.38 4.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.931 -1.106 . . . . 0.0 109.977 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.23 52.55 2.15 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.526 0.679 . . . . 0.0 110.192 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.931 HD13 ' HB2' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -19.79 119.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.553 0.692 . . . . 0.0 112.13 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -83.46 -168.01 0.17 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.371 -0.831 . . . . 0.0 108.762 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 42.8 Cg_endo -81.07 -27.17 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.584 1.307 . . . . 0.0 109.395 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.51 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 16.4 p30 -107.73 -5.55 17.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 111.319 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 21.5 m -48.97 153.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.617 -1.302 . . . . 0.0 110.409 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.67 ' HG2' ' OE1' ' A' ' 87' ' ' GLN . 4.9 mtp180 -175.03 153.28 1.61 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.484 -0.76 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.902 ' O ' ' NE2' ' A' ' 87' ' ' GLN . 11.0 mt -74.6 137.62 42.43 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.99 -1.069 . . . . 0.0 109.326 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.679 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 24.3 p -39.58 -22.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.137 -1.602 . . . . 0.0 113.257 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.465 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 11.5 m -110.82 43.43 1.43 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.6 -33.26 2.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.217 -1.552 . . . . 0.0 111.731 178.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.716 HG21 ' CG1' ' A' ' 60' ' ' VAL . 2.3 mt -85.73 148.37 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.007 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -111.43 156.04 12.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.885 ' HB3' HG12 ' A' ' 17' ' ' VAL . 20.6 tpp -108.37 128.59 54.9 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 120.668 -1.27 . . . . 0.0 111.525 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.466 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.7 OUTLIER -97.13 167.78 11.38 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.56 -0.71 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.743 1.391 . . . . 0.0 111.261 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.6 pp20? -110.32 -40.75 4.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.636 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.84 HD11 ' CB ' ' A' ' 59' ' ' LYS . 1.5 mt -73.65 58.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.28 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.71 146.52 27.12 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.442 -1.411 . . . . 0.0 112.087 -178.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 105.46 20.14 9.86 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.915 HG23 HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -73.04 136.56 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 122.365 1.079 . . . . 0.0 111.833 -177.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.802 ' N ' HD12 ' A' ' 97' ' ' ILE . 60.8 t -110.94 122.8 66.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.209 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.5 t -104.27 169.1 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.709 -1.244 . . . . 0.0 109.881 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.3 m-20 -162.06 138.84 8.13 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.73 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 6' ' ' VAL . 4.1 t -90.69 135.34 29.22 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.75 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 33.6 Cg_endo -66.92 126.53 15.4 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.757 1.398 . . . . 0.0 114.767 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.609 ' HA ' ' CE1' ' A' ' 8' ' ' HIS . 7.6 p-10 -103.5 27.34 7.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.653 HH21 ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -49.47 -18.64 0.43 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.193 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' N ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 pt20 -75.91 1.54 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.286 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.556 ' CG ' ' OXT' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.06 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.656 ' H2 ' ' C ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 110.27 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -52.88 122.99 10.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 108.667 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.129 HG22 ' CG2' ' A' ' 97' ' ' ILE . 42.1 t -138.36 144.98 29.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 117.889 -1.524 . . . . 0.0 112.24 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.692 HG13 ' HG3' ' A' ' 14' ' ' GLU . 2.9 t -130.7 130.4 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.799 ' CD1' HG21 ' A' ' 99' ' ' VAL . 42.6 m-85 -103.33 141.46 35.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.82 0.819 . . . . 0.0 112.436 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.852 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.4 t -120.34 157.75 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.194 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.617 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.9 152.19 31.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.732 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.38 -13.41 5.29 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.945 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.2 p30 -96.84 -2.8 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 110.323 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.34 -36.45 4.26 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.154 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.603 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.5 133.18 20.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.768 -1.431 . . . . 0.0 109.229 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.852 ' HG2' HG13 ' A' ' 6' ' ' VAL . 37.4 mtm105 -124.38 162.24 24.26 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.669 0.747 . . . . 0.0 111.288 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' CD ' HG12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -140.17 156.7 46.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.649 -0.657 . . . . 0.0 109.266 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.692 ' HG3' HG13 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -130.69 127.19 38.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.787 -1.195 . . . . 0.0 110.471 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.025 HD11 HD12 ' A' ' 32' ' ' ILE . 12.6 mt -120.45 150.77 40.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 110.744 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -104.0 92.32 4.34 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.874 HG22 ' HB2' ' A' ' 26' ' ' ALA . 46.6 t -98.54 167.23 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 111.002 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -116.01 -133.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.449 -0.782 . . . . 0.0 110.738 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.528 ' CB ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -110.24 123.01 49.0 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.279 -0.888 . . . . 0.0 110.671 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.29 -6.27 30.31 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.481 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 22' ' ' SER . 63.2 t -98.18 169.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.868 -1.372 . . . . 0.0 110.742 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.605 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.68 159.42 25.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.701 HD21 ' SD ' ' A' ' 90' ' ' MET . 10.9 mt -50.48 -35.8 30.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 109.616 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 1.187 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -73.33 -59.72 2.58 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.63 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.594 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.5 tt0 -37.85 -69.66 0.11 Allowed 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.763 -0.586 . . . . 0.0 111.691 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.874 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -47.27 -52.03 17.27 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.303 -1.498 . . . . 0.0 108.863 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -59.05 -59.51 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.766 0.793 . . . . 0.0 109.527 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG23 ' HG3' ' A' ' 24' ' ' MET 0.287 1.1 t -29.97 -60.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.353 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.723 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.53 -47.51 81.31 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.038 0.923 . . . . 0.0 108.872 179.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.578 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.4 m-80 -59.61 -10.67 3.76 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 81.71 -5.54 69.24 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.025 HD12 HD11 ' A' ' 15' ' ' LEU . 38.0 mt -42.92 -30.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.537 -0.978 . . . . 0.0 108.905 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.732 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 57.3 m-85 -109.14 60.58 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.364 -0.835 . . . . 0.0 111.576 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' TYR . 9.4 p-10 -49.34 -22.99 1.24 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.017 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 35' ' ' ILE . 18.1 tt -79.86 105.62 9.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.18 0.514 . . . . 0.0 109.745 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.02 142.77 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.866 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.17 -137.62 5.46 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 2.8 m-20 -106.67 5.13 28.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.274 . . . . 0.0 110.315 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.641 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 25.1 p -69.96 -40.02 75.67 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.732 -0.605 . . . . 0.0 111.423 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.5 31.3 1.59 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.73 35.34 25.48 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.793 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 8.3 t -140.12 -0.8 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -1.128 . . . . 0.0 111.711 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.801 ' HB1' ' HE1' ' A' ' 70' ' ' MET . . . 77.57 57.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.922 0.868 . . . . 0.0 113.336 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -133.55 27.39 4.04 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.025 ' SG ' HD22 ' A' ' 84' ' ' LEU . 5.9 p -111.04 142.28 43.4 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -110.61 8.97 22.99 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.562 ' HB ' HD11 ' A' ' 35' ' ' ILE . 7.4 p -111.01 -30.09 7.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.01 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.654 ' C ' HD23 ' A' ' 84' ' ' LEU . 1.3 m -84.24 32.42 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.966 -1.084 . . . . 0.0 110.631 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.664 ' CE1' ' O ' ' A' ' 71' ' ' LEU . 6.0 t-160 -57.94 134.2 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.602 -1.311 . . . . 0.0 109.673 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 83' ' ' ARG . 34.6 m -150.12 159.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.775 -1.203 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 30.2 m-85 -122.75 134.66 54.43 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.3 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.632 ' HB ' HG22 ' A' ' 57' ' ' THR . 15.1 t -91.57 156.73 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.824 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.586 ' O ' ' CG2' ' A' ' 57' ' ' THR . 4.4 p30 -59.23 -157.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.058 -1.651 . . . . 0.0 108.941 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.27 -7.25 23.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 110.309 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.72 -39.68 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.129 -0.982 . . . . 0.0 113.05 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.649 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 67.4 m-85 -84.7 1.94 44.15 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.739 -1.225 . . . . 0.0 111.772 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.632 HG22 ' HB ' ' A' ' 52' ' ' VAL . 8.3 p -80.56 -54.37 5.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.886 -1.134 . . . . 0.0 109.526 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' N ' ' OG1' ' A' ' 57' ' ' THR . 4.9 p-10 -62.29 -12.01 18.34 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.762 0.791 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.285 0.1 OUTLIER -79.67 -55.1 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 123.458 1.599 . . . . 0.0 109.553 180.0 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 HG23 ' A' ' 88' ' ' ILE 0.321 0.4 OUTLIER -84.6 155.61 62.19 Favored Pre-proline 0 C--N 1.28 -2.43 0 CA-C-N 112.975 -1.92 . . . . 0.0 110.101 -177.552 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 60' ' ' VAL . 36.5 Cg_endo -62.65 159.13 38.3 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.919 1.484 . . . . 0.0 111.858 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.73 -169.99 2.43 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.547 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 83' ' ' ARG . . . -110.11 162.73 14.28 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.763 -0.586 . . . . 0.0 110.918 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 1.024 ' O ' HD13 ' A' ' 68' ' ' ILE . 54.8 p30 -100.33 -156.41 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 111.343 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 6.4 pt-20 -73.73 -28.71 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 110.286 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.6 ttm180 -64.57 -50.76 66.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.293 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 32.9 tt0 -72.53 14.55 0.24 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.856 -0.528 . . . . 0.0 111.903 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.024 HD13 ' O ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -91.65 -46.17 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.385 -1.447 . . . . 0.0 110.2 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -85.32 -60.27 1.84 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.801 ' HE1' ' HB1' ' A' ' 43' ' ' ALA . 2.8 ptm -48.13 -43.93 31.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.904 -1.351 . . . . 0.0 108.295 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.67 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -62.62 -38.56 90.7 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.597 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 2.8 tt0 -83.75 29.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.903 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.911 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -48.79 -81.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.418 -1.426 . . . . 0.0 107.931 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.611 HG21 ' HD3' ' A' ' 104' ' ' ARG . 2.3 m -81.35 129.13 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.25 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.784 ' O ' HG23 ' A' ' 75' ' ' THR . 8.9 t -49.11 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.903 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -104.54 48.41 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 110.202 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.552 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 18.1 pt-20 39.3 60.73 1.47 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.507 -0.746 . . . . 0.0 110.786 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.511 HD22 ' CD ' ' A' ' 72' ' ' GLU . 1.1 tp -30.28 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.541 . . . . 0.0 111.466 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -145.35 -166.56 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.314 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 46.1 Cg_endo -80.76 -32.59 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.334 1.176 . . . . 0.0 110.942 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.519 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 39.7 p-10 -102.52 4.38 38.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 111.429 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -62.96 135.61 57.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.93 -1.106 . . . . 0.0 109.827 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 1.018 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.07 169.28 23.9 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 118.455 -1.298 . . . . 0.0 110.759 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.025 HD22 ' SG ' ' A' ' 45' ' ' CYS . 1.4 mt -90.81 148.35 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.611 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 4.9 m -46.8 -27.53 1.25 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.677 -1.265 . . . . 0.0 110.526 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.187 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 3.9 m -102.38 40.31 1.37 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.287 -0.883 . . . . 0.0 111.511 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.665 HE22 ' HB2' ' A' ' 43' ' ' ALA . 6.9 mm100 -126.25 -41.54 1.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 112.187 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.018 HD11 ' HG3' ' A' ' 83' ' ' ARG . 3.3 mm -79.39 147.71 6.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.2 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.4 mm -112.31 151.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.804 ' HG2' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -110.46 111.72 23.16 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.21 -0.931 . . . . 0.0 110.08 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -100.65 170.86 6.08 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 19' ' ' ASP . 42.3 Cg_endo -73.37 -5.21 16.75 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.824 1.434 . . . . 0.0 110.634 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.506 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.31 -29.54 8.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.117 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 59' ' ' LYS . 7.3 mt -97.0 54.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 109.872 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' HB3' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.39 148.41 25.19 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.278 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.649 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.25 23.32 9.12 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.129 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -78.03 117.94 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.405 1.098 . . . . 0.0 113.324 -176.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 9.5 t -82.55 124.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.826 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.799 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.9 t -104.31 -179.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.673 -1.267 . . . . 0.0 109.547 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 99' ' ' VAL . 9.5 m-20 -161.82 142.47 10.64 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.521 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.765 HG13 ' HD2' ' A' ' 102' ' ' PRO . 50.6 t -92.06 148.01 35.94 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.765 ' HD2' HG13 ' A' ' 101' ' ' VAL . 39.6 Cg_endo -65.71 125.33 14.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.521 1.274 . . . . 0.0 112.611 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.562 ' HB3' ' CB ' ' A' ' 8' ' ' HIS . 6.9 p-10 -110.58 77.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.519 -0.738 . . . . 0.0 109.884 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.611 ' HD3' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -70.38 -77.41 0.09 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -99.7 107.45 19.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.278 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.241 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.553 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.287 0.565 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -81.08 115.69 20.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.855 . . . . 0.0 109.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.708 ' HA ' HG23 ' A' ' 97' ' ' ILE . 3.8 t -109.85 137.37 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.913 -1.117 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.5 t -131.98 128.63 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.2 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.984 ' CE1' HG21 ' A' ' 99' ' ' VAL . 71.1 m-85 -104.75 146.98 28.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.571 0.7 . . . . 0.0 112.385 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.724 HG13 ' HG2' ' A' ' 12' ' ' ARG . 5.2 t -121.24 133.55 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.185 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.632 ' CB ' HG22 ' A' ' 11' ' ' THR . 62.8 p -79.56 -152.56 0.07 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.612 ' ND1' ' CB ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -110.06 -10.6 14.68 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.059 -1.025 . . . . 0.0 108.677 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 9' ' ' ASP . 17.6 p-10 -100.55 3.66 42.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.357 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.57 -39.24 2.97 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.632 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.8 138.13 15.24 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.866 -1.373 . . . . 0.0 109.974 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.724 ' HG2' HG13 ' A' ' 6' ' ' VAL . 54.4 mtt180 -130.25 164.24 24.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.387 0.613 . . . . 0.0 111.215 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -128.2 161.04 30.24 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.316 -0.865 . . . . 0.0 109.09 179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' CG ' HG22 ' A' ' 4' ' ' VAL . 1.1 mp0 -131.11 139.64 49.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.7 -1.25 . . . . 0.0 110.856 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.727 HD11 ' CA ' ' A' ' 27' ' ' ALA . 10.8 mt -128.08 144.89 51.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.902 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.87 84.08 2.09 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.679 HG13 HG11 ' A' ' 21' ' ' VAL . 18.0 t -98.63 172.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.661 0.743 . . . . 0.0 111.526 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.541 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -123.43 -159.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.809 0.814 . . . . 0.0 111.537 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.511 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -87.26 125.56 34.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.312 -179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.01 -5.13 30.45 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.912 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.6 t -102.3 172.1 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 122.442 1.115 . . . . 0.0 110.338 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.619 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -118.47 -169.72 1.76 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.829 HD21 ' SD ' ' A' ' 90' ' ' MET . 18.0 mt -87.99 -14.07 40.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.832 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.828 ' HE3' HG23 ' A' ' 35' ' ' ILE . 2.3 ttp -90.9 -65.86 0.98 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.802 -1.186 . . . . 0.0 112.327 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.912 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.32 -26.42 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 111.44 -178.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -92.35 -34.83 14.03 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.859 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . . . -77.28 -41.84 39.29 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.017 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 33' ' ' TYR . 62.8 t -55.17 -60.42 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.861 -1.15 . . . . 0.0 108.413 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -51.39 -38.31 52.76 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.588 ' CG ' HD21 ' A' ' 15' ' ' LEU . 2.8 m-80 -70.48 1.64 4.86 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.556 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 28' ' ' VAL . . . 84.34 -15.63 38.93 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 mt -41.55 -42.5 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.323 -1.104 . . . . 0.0 108.122 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -161.72 101.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.549 -0.719 . . . . 0.0 109.778 175.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 2.2 p30 -70.66 53.85 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.828 HG23 ' HE3' ' A' ' 24' ' ' MET . 2.3 tt -107.7 87.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.243 0.544 . . . . 0.0 110.871 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.646 HG13 HG11 ' A' ' 28' ' ' VAL . 3.2 m -120.37 32.47 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -0.86 . . . . 0.0 110.567 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.46 -48.6 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -79.81 -41.62 26.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.22 -1.165 . . . . 0.0 110.339 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.9 p -110.84 -48.09 3.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.81 -0.556 . . . . 0.0 110.906 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . 44.53 36.64 4.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.16 28.44 49.29 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.9 m -124.71 -13.67 6.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -1.105 . . . . 0.0 110.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.834 ' HB1' ' HE1' ' A' ' 70' ' ' MET . . . 75.51 55.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.797 0.808 . . . . 0.0 112.689 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -132.14 37.12 3.59 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.966 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.3 p -111.23 157.12 20.47 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' SG ' ' A' ' 73' ' ' CYS . . . -111.89 -10.24 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.016 . . . . 0.0 110.925 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.58 ' CG2' HD13 ' A' ' 35' ' ' ILE . 6.3 t -110.56 -19.01 13.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.857 -1.152 . . . . 0.0 113.257 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.812 ' HB2' HD22 ' A' ' 84' ' ' LEU . 1.8 m -80.36 20.31 0.7 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.316 -1.49 . . . . 0.0 110.994 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.651 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.7 t-160 -48.23 139.86 8.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 48' ' ' CYS . 14.2 m -143.97 156.17 15.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.627 -1.296 . . . . 0.0 109.81 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 2.9 m-30 -119.8 119.02 32.36 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.998 0.904 . . . . 0.0 109.367 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.011 HG13 HD11 ' A' ' 97' ' ' ILE . 21.4 t -100.8 152.0 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 111.009 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -74.29 130.92 40.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.398 -1.439 . . . . 0.0 109.324 178.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -36.79 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.505 -0.747 . . . . 0.0 111.519 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.09 -19.82 63.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.03 -1.043 . . . . 0.0 111.273 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.97 ' CB ' HD13 ' A' ' 97' ' ' ILE . 43.7 m-85 -127.66 -11.36 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.881 -1.137 . . . . 0.0 110.572 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.14 -17.86 48.4 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.191 -0.943 . . . . 0.0 108.975 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.2 p-10 -89.68 -30.83 17.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.589 ' O ' HD11 ' A' ' 94' ' ' LEU . 3.5 mmmm -82.81 12.01 5.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.833 . . . . 0.0 110.259 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.881 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -116.78 155.45 49.03 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.4 Cg_endo -62.94 156.76 52.36 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 124.084 1.57 . . . . 0.0 111.859 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.14 128.09 33.37 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.754 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -69.38 156.24 39.13 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.551 -0.718 . . . . 0.0 110.064 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.685 ' O ' HD13 ' A' ' 68' ' ' ILE . 27.5 p30 -100.57 -172.34 2.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 111.648 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.56 -21.49 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 110.711 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 70' ' ' MET . 2.3 ttm180 -64.12 -59.07 4.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.003 -1.061 . . . . 0.0 109.253 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.79 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 20.1 tt0 -65.55 10.71 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.656 . . . . 0.0 112.436 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.18 -40.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 119.453 -2.029 . . . . 0.0 110.952 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.18 -57.95 1.62 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.024 ' HE2' HD12 ' A' ' 84' ' ' LEU . 6.1 ptm -48.14 -43.05 30.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.222 -1.164 . . . . 0.0 109.173 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.749 HD22 HD11 ' A' ' 78' ' ' LEU 0.281 0.0 OUTLIER -70.29 -33.2 71.27 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.935 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 4.4 tt0 -90.78 3.53 54.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.23 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 46' ' ' ALA . 1.6 m -49.11 -54.73 14.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.665 -1.272 . . . . 0.0 109.457 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 74' ' ' VAL . 34.8 m -90.04 105.72 16.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.786 ' O ' HG23 ' A' ' 75' ' ' THR . 8.9 t -48.53 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.384 -0.823 . . . . 0.0 110.888 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -130.2 50.9 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.92 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.67 60.45 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 110.309 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.749 HD11 HD22 ' A' ' 71' ' ' LEU . 2.3 tp -29.87 144.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.453 0.644 . . . . 0.0 111.787 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 14.5 mtmt -120.6 170.76 6.65 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.747 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.6 Cg_endo -69.48 -30.7 23.16 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.649 1.341 . . . . 0.0 109.926 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 57' ' ' THR . 8.3 p-10 -97.35 -6.39 34.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.742 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 13.1 m -49.12 165.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.767 -1.208 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.695 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.27 167.45 3.39 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.638 -0.664 . . . . 0.0 109.48 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.024 HD12 ' HE2' ' A' ' 70' ' ' MET . 0.8 OUTLIER -95.7 141.4 29.23 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . 4.7 m -41.67 -27.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.024 -1.047 . . . . 0.0 110.462 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 84' ' ' LEU . 2.0 m -108.32 43.78 1.19 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.589 -0.694 . . . . 0.0 111.034 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.714 HE21 ' HB2' ' A' ' 43' ' ' ALA . 3.2 mm-40 -126.08 -33.83 2.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 111.845 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.941 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -92.03 149.97 3.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.003 -1.061 . . . . 0.0 110.267 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 5.2 mm -110.34 156.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.829 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.1 tpt -110.02 113.54 26.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 0.0 110.792 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.455 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -106.51 171.44 4.75 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.357 -0.839 . . . . 0.0 109.661 179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.2 Cg_endo -72.85 -1.62 10.71 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.908 1.478 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 4.7 pt-20 -110.19 -30.66 7.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 59' ' ' LYS . 7.3 mt -94.14 52.94 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.949 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 4.5 p-10 -100.48 145.66 28.0 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.017 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.32 22.0 10.22 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.011 HD11 HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -70.9 130.05 34.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.994 0.902 . . . . 0.0 113.162 -176.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.739 ' N ' HD12 ' A' ' 97' ' ' ILE . 11.0 t -103.75 122.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.984 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.4 t -103.98 -174.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.66 ' H ' HG12 ' A' ' 99' ' ' VAL . 7.2 m-20 -161.7 139.79 9.17 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.065 176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' VAL . 9.6 t -98.13 103.02 15.6 Favored Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.0 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.68 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 41.8 Cg_endo -69.62 80.99 0.81 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.155 1.904 . . . . 0.0 112.772 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.612 ' CB ' ' ND1' ' A' ' 8' ' ' HIS . 12.8 t70 -111.05 39.89 2.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.593 -1.317 . . . . 0.0 110.438 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.536 ' O ' ' NE ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -56.41 -172.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.082 -1.011 . . . . 0.0 111.326 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.44 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 2.1 mt-30 -120.22 -9.13 9.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.412 ' OXT' HG23 ' A' ' 75' ' ' THR . 60.0 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.259 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.55 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.317 0.58 . . . . 0.0 110.475 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -88.86 134.46 33.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.852 . . . . 0.0 109.928 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.98 HG22 ' CG2' ' A' ' 97' ' ' ILE . 14.0 t -122.61 147.43 26.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.883 -1.136 . . . . 0.0 111.155 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.996 HG23 ' HG2' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -131.18 130.86 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 23' ' ' LEU . 83.4 m-85 -111.46 123.73 50.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.462 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.3 t -92.27 151.86 3.51 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.84 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.571 ' CB ' HG22 ' A' ' 11' ' ' THR . 17.1 p -113.53 141.36 47.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.981 -1.074 . . . . 0.0 109.403 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.636 ' CE1' ' CB ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -41.81 -23.88 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.607 -0.683 . . . . 0.0 110.723 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 7' ' ' SER . 6.2 p-10 -93.44 -1.22 55.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.878 -1.139 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.36 -32.05 6.93 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.949 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.571 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.62 141.35 9.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.874 -1.368 . . . . 0.0 109.476 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.7 mtm180 -127.45 124.93 39.6 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.791 -0.568 . . . . 0.0 111.042 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -102.34 157.6 16.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -0.991 . . . . 0.0 109.508 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.996 ' HG2' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -130.58 135.31 47.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.989 -1.069 . . . . 0.0 110.804 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.858 HD11 ' CA ' ' A' ' 27' ' ' ALA . 7.3 mt -124.55 142.0 51.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 111.035 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -99.92 82.38 2.57 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 26' ' ' ALA . 40.5 t -98.17 169.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.575 -0.703 . . . . 0.0 110.413 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.542 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -126.09 -149.95 0.43 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.521 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -90.85 122.65 33.74 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.617 0.722 . . . . 0.0 110.498 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -8.57 30.89 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HA ' ' NE2' ' A' ' 25' ' ' GLN . 18.5 t -96.57 170.01 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.0 -1.294 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.572 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 166.51 13.91 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.7 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 4.8 mt -69.98 -5.34 25.69 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.083 -1.847 . . . . 0.0 108.332 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.826 ' HE1' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -84.22 -72.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.617 ' N ' ' HG3' ' A' ' 24' ' ' MET . 0.0 OUTLIER -42.87 -57.7 2.7 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 121.783 -0.573 . . . . 0.0 112.242 -176.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.813 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -57.95 -57.78 11.29 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 119.57 -1.956 . . . . 0.0 108.386 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.858 ' CA ' HD11 ' A' ' 15' ' ' LEU . . . -51.48 -57.96 7.6 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.516 0.674 . . . . 0.0 109.97 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.068 HG22 ' CG2' ' A' ' 35' ' ' ILE . 13.4 t -39.79 -71.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.302 0.572 . . . . 0.0 109.627 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -48.71 -46.41 40.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -0.835 . . . . 0.0 109.387 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.523 ' ND2' HD22 ' A' ' 15' ' ' LEU . 4.2 m-80 -59.67 -8.57 2.09 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.92 -5.96 76.86 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.8 HG22 ' CE1' ' A' ' 33' ' ' TYR . 2.9 mt -44.68 -35.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.8 ' CE1' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.79 111.01 6.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.025 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -66.47 54.18 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.276 -0.89 . . . . 0.0 109.011 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.068 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.2 tp -103.75 115.51 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.867 -0.52 . . . . 0.0 109.882 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 37' ' ' GLY . 41.1 t -111.73 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 111.083 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -79.88 53.21 4.32 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' CB ' HD11 ' A' ' 35' ' ' ILE . 1.8 m-20 -120.27 -63.95 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -1.193 . . . . 0.0 110.055 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.6 p -110.32 -54.3 2.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.045 -1.034 . . . . 0.0 110.15 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.54 47.54 7.19 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.36 59.38 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 8.0 t -116.93 -36.74 3.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -1.078 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.04 60.68 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 111.331 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.574 ' C ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -131.3 14.01 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.237 -0.914 . . . . 0.0 110.438 178.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.975 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.94 124.28 52.26 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.625 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -79.14 4.55 14.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.689 -1.257 . . . . 0.0 109.885 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.6 p -91.38 -22.83 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.702 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.81 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -95.53 13.63 25.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.049 -1.032 . . . . 0.0 110.029 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.755 ' NE2' HD21 ' A' ' 71' ' ' LEU . 22.3 t-160 -50.51 137.33 19.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.505 -1.372 . . . . 0.0 108.733 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -142.67 158.93 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 102' ' ' PRO . 3.5 m-30 -117.71 109.98 17.29 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.624 0.726 . . . . 0.0 109.694 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.913 ' CG1' HD11 ' A' ' 97' ' ' ILE . 10.7 t -85.61 162.27 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 1.047 ' O ' HG23 ' A' ' 57' ' ' THR . 10.1 p30 -82.92 139.0 33.64 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 119.947 -1.72 . . . . 0.0 109.273 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 53' ' ' ASN . 5.1 pt-20 -41.68 -21.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.995 -1.065 . . . . 0.0 111.503 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.921 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -72.93 -53.02 12.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.756 -1.215 . . . . 0.0 111.637 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.853 ' HB3' HD12 ' A' ' 97' ' ' ILE . 48.3 m-85 -85.03 -4.75 59.27 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.841 -1.162 . . . . 0.0 111.072 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.047 HG23 ' O ' ' A' ' 53' ' ' ASN . 10.2 p -80.28 -51.24 9.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.873 -1.142 . . . . 0.0 109.501 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD2' ' CE ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.05 -12.03 16.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.735 ' HB3' HD13 ' A' ' 94' ' ' LEU 0.284 8.8 mmpt? -79.29 -52.42 8.14 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.876 1.798 . . . . 0.0 108.208 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -84.75 144.59 42.54 Favored Pre-proline 0 C--N 1.279 -2.458 0 CA-C-N 112.201 -2.272 . . . . 0.0 110.435 -177.494 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 36.7 Cg_endo -62.53 162.97 22.45 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.934 1.492 . . . . 0.0 112.145 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -168.64 1.84 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.352 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 87' ' ' GLN . . . -110.9 171.52 7.42 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.379 0.609 . . . . 0.0 111.056 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.693 ' O ' HD13 ' A' ' 68' ' ' ILE . 48.1 p-10 -100.81 -153.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.605 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -71.67 -18.52 62.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.434 -0.791 . . . . 0.0 110.217 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -64.51 -52.16 59.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 109.241 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -63.55 0.09 0.82 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.865 -0.522 . . . . 0.0 111.33 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.1 mp -91.16 -18.78 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 119.79 -1.819 . . . . 0.0 111.359 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.52 -79.58 1.37 Allowed Glycine 0 N--CA 1.495 2.567 0 O-C-N 120.753 -1.217 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.215 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.58 -32.16 7.68 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.169 -1.195 . . . . 0.0 110.134 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.934 HD22 HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -68.64 -30.63 69.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.251 -0.905 . . . . 0.0 108.783 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -85.07 -29.51 24.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.571 -0.705 . . . . 0.0 109.691 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -49.29 -44.26 43.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 109.491 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.625 HG11 ' O ' ' A' ' 46' ' ' ALA . 13.4 m -90.17 70.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.531 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 75' ' ' THR . 9.2 t -48.92 86.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 0.0 111.11 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.588 ' HB1' ' HG3' ' A' ' 104' ' ' ARG . . . -118.12 66.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.02 -1.05 . . . . 0.0 109.529 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 1.7 pm0 39.88 49.08 2.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.814 0.816 . . . . 0.0 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.934 HD11 HD22 ' A' ' 71' ' ' LEU . 2.4 tp -23.46 142.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.363 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.03 170.48 5.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.755 . . . . 0.0 108.978 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 40.3 Cg_endo -69.2 -29.39 26.59 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.649 1.341 . . . . 0.0 109.481 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' A' ' 57' ' ' THR . 23.0 p-10 -99.58 -7.98 25.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.657 -0.652 . . . . 0.0 110.522 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.62 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 67.0 m -48.98 153.58 0.86 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.089 -1.007 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -175.45 161.67 2.74 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.898 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.215 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -78.38 140.22 38.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 179.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.747 ' HB2' ' HE3' ' A' ' 24' ' ' MET . 47.4 m -42.27 -28.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.023 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -92.53 35.6 1.02 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.636 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.681 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 6.9 tp-100 -126.49 -41.93 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.465 -1.397 . . . . 0.0 112.374 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.908 ' CD1' HG21 ' A' ' 52' ' ' VAL . 1.3 mt -94.65 154.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-O 122.099 0.952 . . . . 0.0 111.583 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.2 mm -110.88 160.85 9.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.55 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 3.4 tpt -110.17 113.62 26.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 110.083 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.5 OUTLIER -92.92 166.12 17.19 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.5 Cg_endo -73.02 -25.46 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.955 1.502 . . . . 0.0 110.538 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.4 pm0 -91.32 -26.76 18.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.813 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 59' ' ' LYS . 7.3 mt -94.9 51.0 1.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.058 0.932 . . . . 0.0 109.417 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 4.6 p-10 -100.49 152.53 20.28 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.677 0.751 . . . . 0.0 112.203 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.64 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 97.06 28.1 8.93 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.98 ' CG2' HG22 ' A' ' 3' ' ' VAL . 9.8 tt -74.2 155.02 6.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 123.259 1.504 . . . . 0.0 113.533 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.653 ' HA ' HG12 ' A' ' 4' ' ' VAL . 6.4 t -120.79 91.55 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.362 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -104.66 171.35 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.644 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -145.69 172.79 12.76 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.32 1.057 . . . . 0.0 112.083 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 6' ' ' VAL . 13.1 t -105.69 111.94 64.62 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 42.8 Cg_endo -70.39 -0.3 7.23 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.906 1.477 . . . . 0.0 111.754 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.636 ' CB ' ' CE1' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -53.28 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.962 . . . . 0.0 110.281 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.588 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.31 -172.33 2.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.414 -0.804 . . . . 0.0 111.504 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 30.4 tp60 -120.2 103.03 8.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.243 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.575 ' HA ' ' CE3' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.562 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.502 0.667 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.8 OUTLIER -82.96 109.64 17.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.728 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 2.5 t -109.5 134.54 51.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.921 -1.112 . . . . 0.0 110.634 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.965 HG22 ' OE1' ' A' ' 14' ' ' GLU . 93.4 t -124.11 107.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.259 1.028 . . . . 0.0 111.807 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.774 ' OH ' HD12 ' A' ' 15' ' ' LEU . 22.6 m-30 -83.46 130.26 35.02 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.424 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.4 t -120.18 134.07 64.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.393 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.667 ' HB3' HG22 ' A' ' 11' ' ' THR . 0.0 OUTLIER -79.58 -167.28 1.17 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 108.51 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.508 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.9 OUTLIER -97.94 -9.95 25.35 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.952 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.43 -6.68 25.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 19.48 8.07 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.541 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.667 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -87.88 153.72 21.1 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.844 -1.386 . . . . 0.0 107.754 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 mtm180 -130.13 139.32 50.92 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.229 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.701 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.36 67.87 1.36 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.7 0.762 . . . . 0.0 108.991 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.965 ' OE1' HG22 ' A' ' 4' ' ' VAL . 18.6 mt-10 -67.96 140.21 56.41 Favored 'General case' 0 C--N 1.288 -2.065 0 O-C-N 120.767 -1.208 . . . . 0.0 110.896 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.774 HD12 ' OH ' ' A' ' 5' ' ' TYR . 8.0 mt -110.99 147.1 35.45 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.646 -0.659 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.59 86.43 3.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG13 HG11 ' A' ' 21' ' ' VAL . 25.3 t -98.88 172.32 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.697 0.761 . . . . 0.0 111.833 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.545 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -112.57 -144.78 0.39 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.603 0.716 . . . . 0.0 111.525 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -104.07 124.69 49.5 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.46 0.648 . . . . 0.0 110.346 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.3 3.19 38.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.912 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.5 t -107.65 172.36 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.613 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.65 179.85 4.21 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.876 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.919 HD21 ' SD ' ' A' ' 90' ' ' MET . 14.5 mt -79.06 -6.84 57.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.637 -1.289 . . . . 0.0 109.085 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.628 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.73 -76.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.904 0.859 . . . . 0.0 111.597 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.912 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -39.78 -24.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.075 -177.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.772 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -91.75 -33.18 15.12 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . . . -77.48 -51.35 10.9 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.065 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG13 ' HA ' ' A' ' 34' ' ' ASP . 96.5 t -45.04 -57.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -58.24 -37.72 75.47 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.026 0.917 . . . . 0.0 108.688 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.655 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.1 m-80 -68.92 1.81 3.12 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.279 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 85.78 -14.42 52.27 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 27' ' ' ALA . 1.3 mt -44.76 -54.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -1.196 . . . . 0.0 107.826 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.891 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.84 94.6 2.1 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.257 176.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.641 ' HA ' HG13 ' A' ' 28' ' ' VAL . 1.6 p30 -70.4 53.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.782 -1.199 . . . . 0.0 108.48 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.071 HD13 ' SG ' ' A' ' 48' ' ' CYS . 5.2 tt -89.57 104.1 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.583 . . . . 0.0 111.852 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 36' ' ' VAL . 61.5 t -120.87 37.41 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.138 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.23 -53.62 0.25 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.735 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 44' ' ' SER . 5.1 m-20 -79.41 -78.16 0.16 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.066 -1.255 . . . . 0.0 110.363 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.8 p -68.96 -39.25 79.58 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.771 -0.581 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.21 32.61 3.64 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.769 -2.133 . . . . 0.0 107.769 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.53 35.15 26.64 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 48.2 m -137.98 0.63 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -1.153 . . . . 0.0 111.473 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.875 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 71.82 57.4 0.17 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 112.416 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.464 ' C ' ' HG2' ' A' ' 70' ' ' MET . 3.8 t -133.01 32.11 3.8 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.006 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.6 p -111.87 131.59 55.26 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -91.77 5.4 49.99 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.063 -1.648 . . . . 0.0 109.109 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.791 HG21 HD12 ' A' ' 35' ' ' ILE . 5.9 t -110.55 -40.47 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.221 -0.924 . . . . 0.0 111.897 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 1.071 ' SG ' HD13 ' A' ' 35' ' ' ILE . 2.0 m -74.87 10.61 1.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.495 -1.378 . . . . 0.0 110.976 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.786 ' ND1' HG21 ' A' ' 74' ' ' VAL . 18.1 t-160 -45.88 138.83 4.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.355 -1.466 . . . . 0.0 109.593 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.7 m -140.94 160.38 23.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.037 -1.039 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.675 ' CZ ' ' HG2' ' A' ' 79' ' ' LYS . 10.1 m-30 -119.28 122.19 41.34 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.545 0.688 . . . . 0.0 109.398 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.898 HG21 ' CD1' ' A' ' 88' ' ' ILE . 41.2 t -96.31 169.66 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.339 -0.85 . . . . 0.0 110.079 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 1.041 ' O ' HG23 ' A' ' 57' ' ' THR . 11.9 p30 -86.45 137.41 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.648 -1.283 . . . . 0.0 108.854 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.0 pt-20 -40.3 -22.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.996 -1.065 . . . . 0.0 111.748 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.811 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -72.09 -53.87 11.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.81 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.679 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 55.5 m-85 -84.89 -4.78 59.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 0.0 111.286 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.041 HG23 ' O ' ' A' ' 53' ' ' ASN . 6.5 p -80.35 -52.32 7.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.852 -1.155 . . . . 0.0 109.99 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -63.79 -9.32 13.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.412 -0.805 . . . . 0.0 110.178 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.631 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.299 1.9 mmtp -79.29 -53.23 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.796 1.76 . . . . 0.0 109.086 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.019 HG21 HG22 ' A' ' 88' ' ' ILE 0.336 0.3 OUTLIER -79.28 161.13 68.9 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 112.372 -2.195 . . . . 0.0 110.146 -177.56 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.95 ' HD2' HG22 ' A' ' 60' ' ' VAL . 36.1 Cg_endo -60.63 163.64 15.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.774 1.407 . . . . 0.0 112.638 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.51 -148.23 0.06 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.831 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.796 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . . . -110.09 144.37 38.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.897 ' O ' HD13 ' A' ' 68' ' ' ILE . 49.8 p30 -100.43 -153.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.412 -0.805 . . . . 0.0 109.535 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 66' ' ' ARG . 1.2 pm0 -80.39 -27.37 38.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 110.065 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -75.21 -50.0 17.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.796 ' OE2' ' HB2' ' A' ' 63' ' ' ALA . 30.9 tt0 -63.84 -5.31 4.14 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.49 -0.756 . . . . 0.0 110.996 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.63 -13.47 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 120.28 -1.512 . . . . 0.0 110.524 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -88.84 -80.32 1.3 Allowed Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.256 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.137 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.23 -34.77 10.74 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.977 -1.308 . . . . 0.0 109.528 -179.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.682 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.29 -18.02 63.11 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.791 0.805 . . . . 0.0 109.269 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -90.95 -53.09 4.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.105 -0.997 . . . . 0.0 109.654 178.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.41 -24.08 1.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.807 . . . . 0.0 109.248 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.786 HG21 ' ND1' ' A' ' 49' ' ' HIS . 34.5 m -79.74 57.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.299 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.777 ' O ' HG23 ' A' ' 75' ' ' THR . 9.0 t -48.97 77.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.0 112.534 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.888 ' HB3' ' NH2' ' A' ' 104' ' ' ARG . . . -130.52 63.37 1.57 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.798 -1.189 . . . . 0.0 108.938 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.55 58.17 2.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.732 0.777 . . . . 0.0 109.413 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.682 HD11 HD22 ' A' ' 71' ' ' LEU . 2.5 tp -30.64 138.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.523 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.675 ' HG2' ' CZ ' ' A' ' 51' ' ' TYR . 5.4 mmmt -93.03 168.69 11.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 109.067 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.57 -25.44 40.89 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.71 1.374 . . . . 0.0 109.155 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.549 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 3.3 p30 -113.06 5.46 17.16 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.67 -0.644 . . . . 0.0 111.652 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.595 ' HG ' ' HG2' ' A' ' 79' ' ' LYS . 72.7 m -48.52 144.32 4.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.546 -1.346 . . . . 0.0 111.292 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.651 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -154.93 160.0 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.137 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -85.02 142.61 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.024 . . . . 0.0 110.132 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.663 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 2.4 p -44.66 -25.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.875 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 5.3 m -108.65 40.71 1.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.444 0.64 . . . . 0.0 110.012 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.538 ' CG ' ' OE1' ' A' ' 67' ' ' GLU . 7.3 tp-100 -122.22 -48.47 2.09 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.491 -0.756 . . . . 0.0 111.965 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.019 HG22 HG21 ' A' ' 60' ' ' VAL . 1.2 mt -87.46 153.79 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 121.944 0.878 . . . . 0.0 111.104 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.7 mm -111.26 156.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.919 ' SD ' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -110.5 92.49 4.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.099 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.72 171.73 11.69 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -78.86 -0.77 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.863 1.454 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 2.6 pt-20 -110.08 -31.22 7.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 109.403 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.554 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.3 mt -98.16 51.72 1.03 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.975 0.893 . . . . 0.0 108.791 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 8.0 p-10 -100.48 147.05 26.32 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 121.976 0.893 . . . . 0.0 113.189 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.647 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.57 28.1 7.69 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.679 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.9 125.52 38.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 8.6 t -82.49 120.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.754 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -104.55 -175.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.639 -1.288 . . . . 0.0 110.039 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.665 ' H ' HG12 ' A' ' 99' ' ' VAL . 13.9 m-20 -161.4 136.19 7.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.253 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 6' ' ' VAL . 2.6 t -95.71 115.7 65.7 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.655 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo -61.86 177.33 1.03 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.894 1.729 . . . . 0.0 112.486 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 2.6 p-10 -110.5 100.13 9.01 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.017 0.913 . . . . 0.0 111.503 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.888 ' NH2' ' HB3' ' A' ' 76' ' ' ALA . 8.5 mmp_? -87.76 -51.74 5.7 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' A' ' 105' ' ' GLN . 5.8 pt20 -69.2 96.73 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.561 0.696 . . . . 0.0 110.494 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 5.9 ttmt -85.25 113.34 21.52 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 5.0 t -109.16 137.05 43.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.909 -1.119 . . . . 0.0 110.583 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.914 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 t -131.21 125.38 57.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.992 0.901 . . . . 0.0 108.667 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.006 ' CD1' HG21 ' A' ' 99' ' ' VAL 0.273 52.1 m-85 -105.08 140.21 38.6 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 -177.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.929 HG13 ' HG3' ' A' ' 12' ' ' ARG . 3.4 t -121.49 157.06 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.455 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.641 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 78.3 p -116.41 140.56 49.22 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.548 ' CB ' ' HB2' ' A' ' 103' ' ' ASP . 1.6 p-80 -48.0 -20.75 0.36 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.067 -1.02 . . . . 0.0 109.687 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.461 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 1.8 p30 -89.9 -3.89 57.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 -35.98 4.52 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.896 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.28 132.58 19.97 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.788 -1.419 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.929 ' HG3' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -130.32 153.05 49.06 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.238 0.542 . . . . 0.0 111.668 -178.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.767 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.83 163.45 27.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.916 . . . . 0.0 109.006 177.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.731 ' HG2' HG22 ' A' ' 4' ' ' VAL . 32.8 mt-10 -130.64 120.87 24.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.863 HD21 ' CG ' ' A' ' 30' ' ' ASN . 7.4 mt -109.72 145.45 36.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.872 -1.142 . . . . 0.0 112.123 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -99.7 92.09 5.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.83 HG13 HG11 ' A' ' 21' ' ' VAL . 96.2 t -98.77 170.75 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 112.029 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.597 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -119.67 -151.65 0.49 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.424 0.63 . . . . 0.0 110.623 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' HB2' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.19 121.2 42.18 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.381 -0.824 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 5.95 28.14 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.886 HG13 ' NE2' ' A' ' 25' ' ' GLN . 1.4 t -110.04 174.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -1.106 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.585 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.07 -177.25 3.37 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.19 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HA ' ' OH ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -77.84 -13.31 59.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 109.269 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.678 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -90.13 -73.58 0.52 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.886 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -36.75 -24.8 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 122.048 -0.408 . . . . 0.0 111.64 -177.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.66 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -91.11 -46.37 8.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.827 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -61.81 -54.27 44.48 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.734 HG12 ' N ' ' A' ' 29' ' ' SER 0.283 0.8 OUTLIER -36.38 -60.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.66 177.607 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.734 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -65.14 -42.48 93.79 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.134 0.968 . . . . 0.0 109.148 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.863 ' CG ' HD21 ' A' ' 15' ' ' LEU . 4.8 m-80 -63.85 -3.27 2.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.97 -20.58 24.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.827 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 10.3 mt -42.06 -39.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.445 -1.033 . . . . 0.0 109.281 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.716 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 25.5 m-85 -111.78 67.54 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.149 -0.969 . . . . 0.0 113.036 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -87.81 38.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.848 HD13 ' OG1' ' A' ' 47' ' ' THR . 1.5 pp -79.67 -158.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.346 0.593 . . . . 0.0 110.443 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG12 ' H ' ' A' ' 37' ' ' GLY . 2.9 t -79.89 -174.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 110.011 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -109.8 83.9 0.34 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 44' ' ' SER . 4.3 t0 -119.91 -17.05 8.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -1.141 . . . . 0.0 110.348 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.631 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.6 p -110.31 -42.5 4.12 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.768 -0.583 . . . . 0.0 110.452 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.75 34.62 5.46 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.18 30.05 43.36 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 1.1 t -128.56 -6.79 5.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.137 . . . . 0.0 111.057 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.25 57.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.433 -0.792 . . . . 0.0 112.913 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -133.58 36.98 3.33 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.581 -1.636 . . . . 0.0 106.581 176.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.076 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -111.6 150.06 30.6 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -175.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.37 2.07 18.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.518 -1.364 . . . . 0.0 109.076 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.848 ' OG1' HD13 ' A' ' 35' ' ' ILE . 16.7 p -110.07 -34.52 6.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 111.3 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.634 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 1.8 m -77.92 8.06 5.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.544 -1.347 . . . . 0.0 110.203 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.771 ' NE2' HD21 ' A' ' 71' ' ' LEU . 21.5 t-160 -53.13 150.42 5.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.596 -1.315 . . . . 0.0 108.929 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 49' ' ' HIS . 12.5 m -160.39 164.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.852 0.834 . . . . 0.0 110.919 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.689 ' CE1' ' HB3' ' A' ' 82' ' ' SER . 4.1 m-85 -118.68 122.87 43.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.816 HG21 ' CD1' ' A' ' 88' ' ' ILE . 15.8 t -92.75 151.61 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.241 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -75.18 130.62 39.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.137 -1.602 . . . . 0.0 109.664 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 4.9 pt-20 -35.28 -28.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.792 -0.568 . . . . 0.0 111.984 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -65.92 -18.1 65.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.891 -1.131 . . . . 0.0 111.558 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.669 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 46.9 m-85 -127.89 -11.62 5.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.845 -1.159 . . . . 0.0 110.444 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -80.96 -50.91 9.13 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' OD1' ' HD2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -62.31 -20.98 64.88 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 0.0 109.224 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.879 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.279 20.5 mmmt -79.4 -56.22 4.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.602 1.668 . . . . 0.0 108.923 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 88' ' ' ILE 0.314 0.3 OUTLIER -75.64 138.12 70.44 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 112.856 -1.974 . . . . 0.0 109.854 -178.263 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.22 159.75 41.84 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 124.116 1.587 . . . . 0.0 111.982 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 -167.59 1.44 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.733 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.634 ' HB1' ' OE1' ' A' ' 87' ' ' GLN . . . -110.73 -169.13 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.377 0.608 . . . . 0.0 110.625 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.722 ' O ' HD13 ' A' ' 68' ' ' ILE . 53.4 p30 -100.27 -144.64 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -80.01 -23.81 41.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.768 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.9 ttm-85 -64.74 -50.98 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.627 ' OE2' HD12 ' A' ' 71' ' ' LEU . 11.4 tp10 -59.55 -11.48 4.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.227 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.3 mp -89.97 -16.59 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.658 -1.276 . . . . 0.0 109.813 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -90.6 -63.32 1.23 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.001 ' CE ' HD12 ' A' ' 84' ' ' LEU 0.289 2.9 mpp? -48.6 -48.52 39.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.335 1.541 . . . . 0.0 108.149 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.096 HD13 HD21 ' A' ' 78' ' ' LEU 0.269 0.0 OUTLIER -66.01 -32.04 73.29 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.961 -178.323 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -70.0 -41.98 73.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 109.997 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -41.88 41.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 109.797 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 9.9 m -90.22 63.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 110.181 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.782 ' O ' HG23 ' A' ' 75' ' ' THR . 10.2 t -49.66 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.726 . . . . 0.0 111.113 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.007 ' HB2' ' CG ' ' A' ' 104' ' ' ARG . . . -130.27 74.93 1.62 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -0.999 . . . . 0.0 110.126 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.2 pt-20 39.17 60.46 1.49 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.495 1.141 . . . . 0.0 109.525 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.096 HD21 HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -59.02 120.02 8.35 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.531 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.652 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -104.92 -167.01 0.11 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 41.7 Cg_endo -74.95 -28.27 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.041 1.021 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.575 ' HB3' ' CB ' ' A' ' 57' ' ' THR . 44.6 p-10 -87.16 -28.24 22.57 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.513 -0.742 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.689 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.9 m -49.9 106.37 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.834 -1.166 . . . . 0.0 108.796 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.53 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -145.68 171.91 14.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.796 -1.19 . . . . 0.0 111.48 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.076 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -84.32 136.52 33.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.467 0.651 . . . . 0.0 111.332 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.634 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 3.0 p -42.38 -29.93 0.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 110.832 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.678 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.9 m -98.78 35.24 1.89 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 111.304 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.711 HE21 ' HB2' ' A' ' 43' ' ' ALA . 5.0 mm-40 -126.75 -48.02 1.52 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 113.066 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.816 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -79.86 151.36 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.643 -1.286 . . . . 0.0 110.534 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 89' ' ' ILE . 3.9 mm -111.85 160.05 11.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.662 -0.649 . . . . 0.0 110.159 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.823 ' HE1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.63 118.21 35.59 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.49 -0.756 . . . . 0.0 110.454 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -94.89 167.22 13.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.848 . . . . 0.0 109.713 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' CD ' ' HB2' ' A' ' 19' ' ' ASP . 43.8 Cg_endo -78.65 -2.07 12.15 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.868 1.457 . . . . 0.0 110.714 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' OE2' ' HG ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -110.09 -29.94 7.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.1 -1.0 . . . . 0.0 109.765 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.879 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.6 mt -88.28 66.03 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.457 -0.777 . . . . 0.0 110.351 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' HA ' ' OG ' ' A' ' 1' ' ' SER . 10.3 p30 -101.72 148.38 25.34 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.735 -1.228 . . . . 0.0 113.174 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.669 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 99.03 30.49 6.68 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.664 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -80.2 135.28 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.177 0.989 . . . . 0.0 112.779 -177.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.535 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 12.7 t -102.78 125.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.006 HG21 ' CD1' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -104.25 -179.69 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.996 -1.065 . . . . 0.0 108.971 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-20 -162.07 145.56 12.0 Favored 'General case' 0 C--N 1.276 -2.616 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.547 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 55.0 t -83.86 149.79 57.41 Favored Pre-proline 0 C--N 1.289 -2.033 0 C-N-CA 117.449 -1.7 . . . . 0.0 107.514 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.67 ' HG3' ' CG ' ' A' ' 49' ' ' HIS . 42.1 Cg_endo -92.95 124.4 0.58 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.464 1.443 . . . . 0.0 111.956 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 3.3 t70 -110.4 115.2 29.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 1.007 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.27 0.11 17.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.921 . . . . 0.0 110.284 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -119.97 60.81 0.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.21 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 95' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.518 0.675 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -77.32 127.86 33.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.72 . . . . 0.0 109.605 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.137 HG22 ' CG2' ' A' ' 97' ' ' ILE . 23.0 t -139.5 148.07 23.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.856 -1.152 . . . . 0.0 112.033 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 99' ' ' VAL . 13.8 t -131.41 126.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.835 ' CD1' HG21 ' A' ' 99' ' ' VAL . 54.5 m-85 -100.16 140.36 34.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.636 0.731 . . . . 0.0 112.509 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.939 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.6 t -120.52 134.98 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.21 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.638 ' HB3' HG22 ' A' ' 11' ' ' THR . 36.0 p -79.51 -152.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.619 ' ND1' ' CB ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 -10.43 14.59 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.913 -1.117 . . . . 0.0 108.965 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 58.2 p30 -100.45 3.34 42.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.52 -0.737 . . . . 0.0 109.602 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.47 -29.6 8.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.81 134.88 20.27 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.953 -1.322 . . . . 0.0 109.224 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.939 ' HG2' HG13 ' A' ' 6' ' ' VAL . 12.8 mtm180 -130.11 161.72 30.42 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.612 0.72 . . . . 0.0 111.504 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.849 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.8 ttp180 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.744 ' HG2' HG22 ' A' ' 4' ' ' VAL . 20.0 mt-10 -130.62 124.23 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.833 -1.167 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.941 HD11 ' HA ' ' A' ' 27' ' ' ALA . 12.3 mt -117.95 151.54 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.77 90.55 3.67 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.9 t -98.7 163.63 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.854 . . . . 0.0 110.557 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -112.97 -136.78 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.356 -0.84 . . . . 0.0 110.916 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -108.32 124.43 50.32 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.309 -0.869 . . . . 0.0 110.494 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.28 -7.11 30.52 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 22' ' ' SER . 83.0 t -95.69 168.0 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.027 -1.278 . . . . 0.0 110.543 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.596 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.62 160.14 25.0 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 3' ' ' VAL . 18.4 mt -57.77 -36.04 71.59 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.673 -1.267 . . . . 0.0 109.254 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 1.298 ' SD ' ' SG ' ' A' ' 39' ' ' CYS . 4.7 ttp -79.33 7.24 8.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.062 -1.024 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.566 ' CG ' HG13 ' A' ' 21' ' ' VAL . 4.9 tt0 -102.29 -71.13 0.73 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.54 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.993 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -46.48 -55.43 7.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.758 -1.214 . . . . 0.0 108.614 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -53.55 -53.05 57.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 36' ' ' VAL 0.277 0.7 OUTLIER -37.8 -57.3 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.422 177.769 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.692 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.76 -47.14 85.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.075 0.941 . . . . 0.0 108.821 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.588 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 6.1 m-80 -64.42 -4.03 3.54 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.499 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.03 -14.94 51.37 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.908 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 mt -44.04 -37.9 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.505 -0.997 . . . . 0.0 108.542 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.74 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 72.0 m-85 -114.42 76.93 1.02 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.162 -0.961 . . . . 0.0 111.201 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 33' ' ' TYR . 3.0 p30 -49.13 -22.21 0.91 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.638 -1.289 . . . . 0.0 107.852 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.52 90.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 28' ' ' VAL . 4.1 t -118.55 -25.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 111.104 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.73 30.95 4.77 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.468 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.2 t0 -120.3 -45.9 2.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -1.234 . . . . 0.0 110.638 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.298 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -110.46 -58.04 2.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.072 -1.018 . . . . 0.0 110.165 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.1 46.24 10.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.22 29.72 44.44 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 66.9 m -116.4 -39.42 3.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -1.129 . . . . 0.0 110.583 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.8 ' HB2' ' NE2' ' A' ' 87' ' ' GLN . . . 72.79 59.19 0.12 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 111.66 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.534 ' C ' ' HG2' ' A' ' 70' ' ' MET . 58.3 m -131.91 11.29 4.7 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.205 -0.934 . . . . 0.0 110.196 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.969 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -113.01 120.61 41.97 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -177.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -77.16 -0.87 26.61 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.434 -1.416 . . . . 0.0 109.564 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.452 ' OG1' ' CD1' ' A' ' 35' ' ' ILE . 1.3 p -83.65 -21.18 32.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 111.188 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.833 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -98.44 16.69 20.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.824 -1.172 . . . . 0.0 110.095 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.856 ' HD1' HG23 ' A' ' 74' ' ' VAL . 5.9 t-160 -46.16 134.32 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.604 -1.31 . . . . 0.0 108.054 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 48' ' ' CYS . 18.1 m -138.27 156.24 30.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.766 -1.209 . . . . 0.0 110.037 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.681 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.1 m-30 -118.29 116.67 27.23 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.597 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.849 HG21 ' CD1' ' A' ' 88' ' ' ILE . 22.2 t -94.33 166.09 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 108.909 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 1.009 ' O ' HG23 ' A' ' 57' ' ' THR . 12.5 p30 -84.97 137.2 33.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.278 -1.514 . . . . 0.0 109.023 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 53' ' ' ASN . 6.7 pt-20 -41.05 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.169 -0.957 . . . . 0.0 112.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.654 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -75.61 -51.03 13.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.639 -1.288 . . . . 0.0 111.762 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.726 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 64.4 m-85 -84.96 -5.06 59.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.079 -1.013 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.009 HG23 ' O ' ' A' ' 53' ' ' ASN . 9.7 p -80.3 -55.04 5.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.884 -1.135 . . . . 0.0 109.815 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.452 ' N ' ' OG1' ' A' ' 57' ' ' THR . 1.6 p30 -60.89 -12.42 11.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.429 -0.794 . . . . 0.0 110.769 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.734 ' CB ' HD13 ' A' ' 94' ' ' LEU 0.295 13.5 mtpt -79.4 -54.49 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 123.724 1.726 . . . . 0.0 109.336 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.815 HG22 ' HD2' ' A' ' 61' ' ' PRO 0.324 0.3 OUTLIER -76.51 155.06 83.8 Favored Pre-proline 0 C--N 1.278 -2.506 0 CA-C-N 112.546 -2.115 . . . . 0.0 110.593 -177.441 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.815 ' HD2' HG22 ' A' ' 60' ' ' VAL . 37.5 Cg_endo -63.58 168.09 12.16 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.024 1.539 . . . . 0.0 111.758 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.564 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . . . -80.34 -170.22 2.44 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.543 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.684 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -110.74 157.85 19.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.555 -0.715 . . . . 0.0 111.218 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -79.47 -161.84 0.36 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.496 -0.752 . . . . 0.0 110.884 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.11 -22.59 41.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 111.343 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.554 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -69.73 -42.44 73.95 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 118.029 -1.468 . . . . 0.0 108.612 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.7 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.31 -7.54 1.33 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.819 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.64 HD13 ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -90.41 -15.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.608 -1.307 . . . . 0.0 109.642 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.84 -79.75 1.38 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.524 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.237 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.9 -35.17 14.22 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.881 -1.364 . . . . 0.0 109.778 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -65.35 -30.18 70.99 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 108.575 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.15 -29.08 18.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.474 -0.766 . . . . 0.0 109.561 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -49.02 -48.87 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.046 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.856 HG23 ' HD1' ' A' ' 49' ' ' HIS . 16.5 m -90.07 76.53 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.425 -0.797 . . . . 0.0 109.098 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.828 ' O ' HG23 ' A' ' 75' ' ' THR . 13.1 t -48.25 87.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.782 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.606 ' HA ' ' CD ' ' A' ' 104' ' ' ARG . . . -105.5 41.04 1.43 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.745 -1.222 . . . . 0.0 109.748 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.596 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER 66.78 44.47 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.219 1.009 . . . . 0.0 109.207 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.835 HD11 HD22 ' A' ' 71' ' ' LEU . 1.5 tp -19.42 134.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.53 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.669 ' CG ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.42 172.48 3.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.1 Cg_endo -69.83 -26.69 26.97 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.585 1.308 . . . . 0.0 108.828 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.6 p-10 -104.67 -9.16 18.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.704 -0.622 . . . . 0.0 111.399 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.583 ' OG ' ' CG ' ' A' ' 79' ' ' LYS . 42.7 m -47.86 158.62 0.21 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.524 -1.36 . . . . 0.0 111.406 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.773 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -175.6 161.87 2.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.683 -0.636 . . . . 0.0 109.822 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.237 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -80.33 139.53 36.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.93 . . . . 0.0 109.625 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.627 ' C ' ' HB2' ' A' ' 24' ' ' MET . 20.0 m -38.54 -31.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.515 1.15 . . . . 0.0 108.496 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.032 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -91.44 37.11 0.94 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.184 -178.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.8 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 6.1 mm-40 -127.43 -40.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.409 -1.432 . . . . 0.0 113.444 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -92.61 150.9 3.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.551 -178.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.5 mm -111.35 163.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.603 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.5 tpt -110.28 108.74 18.94 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.905 -1.122 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -88.14 159.64 47.62 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.0 Cg_endo -72.16 -1.08 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.977 1.514 . . . . 0.0 110.82 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' C ' HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -110.1 -27.27 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.022 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 59' ' ' LYS . 8.8 mt -98.38 60.5 1.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 109.931 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 1' ' ' SER . 3.8 p-10 -100.54 145.02 28.83 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.443 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.609 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.81 23.68 8.57 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.137 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.19 115.07 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.357 1.075 . . . . 0.0 113.486 -176.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.488 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 10.5 t -77.25 123.32 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.273 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.835 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.7 t -104.29 -176.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.863 -1.148 . . . . 0.0 109.275 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.653 ' H ' HG12 ' A' ' 99' ' ' VAL . 6.4 m-20 -162.1 141.58 9.7 Favored 'General case' 0 C--N 1.282 -2.332 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.907 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 49.4 t -97.48 102.86 13.94 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.5 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.681 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 41.0 Cg_endo -68.71 79.26 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.306 2.004 . . . . 0.0 113.342 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.619 ' CB ' ' ND1' ' A' ' 8' ' ' HIS . 27.0 t70 -111.49 38.97 2.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.582 -1.324 . . . . 0.0 110.095 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.606 ' CD ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -48.85 -179.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.121 -0.987 . . . . 0.0 111.724 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.26 63.15 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.336 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.42 ' H ' ' NH1' ' A' ' 104' ' ' ARG . 3.6 t-105 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.224 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.586 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.249 0.547 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.498 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.91 124.14 19.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 11.8 t -121.44 145.81 27.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.011 ' O ' HG23 ' A' ' 99' ' ' VAL . 4.3 t -130.98 125.65 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.913 0.863 . . . . 0.0 109.158 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HB2' ' CG ' ' A' ' 13' ' ' ARG 0.265 43.3 m-85 -101.07 135.9 41.79 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.2 t -121.97 119.9 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.27 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.649 ' CB ' HG22 ' A' ' 11' ' ' THR . 77.7 p -79.78 128.58 33.6 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 1.5 t60 -41.74 -24.31 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.174 -0.954 . . . . 0.0 110.574 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -79.45 -3.52 46.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.06 -1.025 . . . . 0.0 110.073 179.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.22 -36.48 4.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.649 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.54 137.06 15.8 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.838 -1.39 . . . . 0.0 108.776 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 12.1 mtm180 -130.15 147.35 51.87 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.712 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.75 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -131.58 119.32 21.31 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 177.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.7 mt-10 -94.92 123.98 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.141 -0.974 . . . . 0.0 110.261 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 27' ' ' ALA . 8.1 mt -109.78 146.81 34.34 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.071 -1.018 . . . . 0.0 110.741 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.63 88.17 3.76 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.89 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.8 t -98.96 165.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.469 -0.769 . . . . 0.0 110.974 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' MET . . . -118.94 -141.44 0.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.583 -0.698 . . . . 0.0 110.547 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -101.14 126.46 47.85 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.508 -0.745 . . . . 0.0 110.49 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -9.74 30.49 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 22' ' ' SER . 55.4 t -99.67 170.73 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.843 -1.387 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.618 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.58 167.68 12.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD21 ' SD ' ' A' ' 90' ' ' MET . 9.2 mt -59.29 -27.96 66.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.699 -1.25 . . . . 0.0 109.447 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 1.226 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -80.26 -58.22 3.24 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.32 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.556 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.2 tt0 -37.98 -68.97 0.13 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.402 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.89 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -47.8 -57.27 5.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.349 -1.469 . . . . 0.0 108.813 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.829 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -52.78 -56.92 12.16 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.936 0.874 . . . . 0.0 108.911 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.768 HG12 ' N ' ' A' ' 29' ' ' SER 0.281 1.2 t -35.34 -63.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.219 178.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.768 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.34 -49.64 71.71 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.074 0.94 . . . . 0.0 109.034 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.587 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 4.3 m-80 -61.36 -6.94 2.52 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.379 0.609 . . . . 0.0 109.445 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 82.28 -7.3 64.57 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.829 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 3.9 mt -44.66 -31.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.305 -1.115 . . . . 0.0 109.323 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 47.4 m-85 -108.71 58.39 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 113.204 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -74.14 51.39 0.41 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.609 -1.307 . . . . 0.0 107.503 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 36' ' ' VAL . 1.7 pp -112.73 178.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.55 -0.719 . . . . 0.0 109.959 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.781 ' O ' HG21 ' A' ' 47' ' ' THR . 1.3 p -120.72 101.35 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.542 -0.724 . . . . 0.0 109.741 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.48 179.01 16.48 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -100.23 0.92 41.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -1.023 . . . . 0.0 110.325 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.594 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 19.5 p -69.57 -36.03 75.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.355 -0.841 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.87 31.82 4.26 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.36 37.27 21.47 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.779 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 20.2 t -138.84 5.67 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -1.122 . . . . 0.0 111.822 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.14 42.58 0.44 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.309 -0.87 . . . . 0.0 113.298 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.2 t -132.35 44.7 2.85 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.981 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.1 p -111.76 130.09 55.91 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.714 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -92.13 6.47 46.44 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.258 -1.526 . . . . 0.0 108.178 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.781 HG21 ' O ' ' A' ' 36' ' ' VAL . 19.0 p -110.65 -40.06 4.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.374 -0.828 . . . . 0.0 111.714 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.861 ' O ' HG13 ' A' ' 50' ' ' VAL . 1.9 m -79.26 24.04 0.36 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.662 -1.274 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.688 ' NE2' ' CD2' ' A' ' 71' ' ' LEU . 6.9 t-160 -46.32 137.01 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.737 -1.227 . . . . 0.0 108.214 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 48' ' ' CYS . 19.3 m -145.86 152.82 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.027 -1.046 . . . . 0.0 110.873 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE1' ' HB3' ' A' ' 102' ' ' PRO . 31.1 m-85 -122.87 128.66 50.64 Favored 'General case' 0 C--N 1.281 -2.413 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.895 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.781 ' HB ' HG22 ' A' ' 57' ' ' THR . 13.6 t -93.88 168.43 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.279 -0.888 . . . . 0.0 109.873 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.763 ' O ' HG21 ' A' ' 57' ' ' THR . 6.8 p30 -67.94 -147.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.609 -1.307 . . . . 0.0 109.518 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -103.34 -16.52 15.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.856 -1.152 . . . . 0.0 111.836 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . . . -100.52 -36.82 9.06 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.703 -1.248 . . . . 0.0 114.146 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.4 m-85 -84.11 -11.0 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.308 -1.495 . . . . 0.0 110.839 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.781 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -81.73 -29.25 33.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD2' ' HA ' ' A' ' 55' ' ' ALA . 2.1 p30 -79.84 -26.89 40.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.522 ' CB ' HD13 ' A' ' 94' ' ' LEU . 21.1 mmtm -79.65 -51.43 9.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.775 HG11 HG21 ' A' ' 88' ' ' ILE . 11.5 m -41.78 153.51 0.27 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.411 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -65.18 160.92 39.67 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.114 1.586 . . . . 0.0 112.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.15 118.01 22.19 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.885 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.694 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.82 163.89 24.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 109.821 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 24.5 p-10 -100.1 -167.61 1.48 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.19 -20.93 29.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.474 -0.766 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' SD ' ' A' ' 70' ' ' MET . 1.1 ttt-85 -64.53 -53.36 49.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.855 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.694 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 6.9 tp10 -59.14 -12.61 5.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.8 mp -90.92 -9.83 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.826 -1.171 . . . . 0.0 111.244 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.05 -79.3 1.35 Allowed Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.224 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.073 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.09 -37.31 14.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.761 -1.435 . . . . 0.0 109.107 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.688 ' CD2' ' NE2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -67.82 -23.54 65.19 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.09 -39.49 12.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.811 178.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.78 -43.53 38.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.061 -1.024 . . . . 0.0 108.344 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 46' ' ' ALA . 1.7 m -90.42 72.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' THR . 10.5 t -48.18 104.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.763 0.792 . . . . 0.0 111.27 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.835 ' HB2' ' CD ' ' A' ' 104' ' ' ARG . . . -126.16 60.8 1.29 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.545 -0.722 . . . . 0.0 109.335 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.542 ' O ' ' CE ' ' A' ' 79' ' ' LYS . 11.3 pt-20 39.28 56.22 2.16 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.995 0.902 . . . . 0.0 109.784 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -33.99 143.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.661 0.743 . . . . 0.0 112.052 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.672 ' H ' ' HG ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -134.44 -176.44 0.58 Allowed Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.2 -25.56 43.03 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.146 1.077 . . . . 0.0 111.765 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 24.6 p-10 -111.85 6.5 19.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.831 -1.168 . . . . 0.0 113.308 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -57.26 149.29 20.38 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.204 -1.56 . . . . 0.0 109.143 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HG3' HD11 ' A' ' 88' ' ' ILE . 11.3 mmt-85 -154.15 179.7 8.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.737 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.073 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -114.94 134.93 54.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 177.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.657 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 9.1 m -40.31 -27.79 0.05 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.882 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.226 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 7.2 m -106.93 45.66 0.97 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.994 -1.067 . . . . 0.0 112.053 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.608 ' NE2' ' CE ' ' A' ' 70' ' ' MET . 90.3 mm-40 -125.34 -47.83 1.72 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.043 0.925 . . . . 0.0 111.394 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.775 HG21 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -84.35 149.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.932 0.872 . . . . 0.0 111.538 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.4 mm -110.9 160.96 9.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.699 ' SD ' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -110.1 104.21 13.05 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 110.224 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.8 OUTLIER -91.1 164.24 26.03 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.86 . . . . 0.0 109.442 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 39.7 Cg_endo -71.88 -0.69 8.81 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.648 1.341 . . . . 0.0 110.503 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.1 pt-20 -110.06 -27.61 9.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.522 HD13 ' CB ' ' A' ' 59' ' ' LYS . 9.5 mt -100.25 54.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.363 -0.835 . . . . 0.0 109.824 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.62 143.96 30.16 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -178.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.623 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.23 23.33 8.56 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.696 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.79 118.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.339 1.066 . . . . 0.0 113.166 -176.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 53' ' ' ASN . 21.1 t -82.03 127.08 39.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.011 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.7 t -104.21 -175.65 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.782 -1.199 . . . . 0.0 109.345 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.1 m-20 -161.34 136.66 7.64 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.527 176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 76.5 t -90.84 137.95 26.56 Favored Pre-proline 0 C--N 1.289 -2.049 0 C-N-CA 118.896 -1.121 . . . . 0.0 108.987 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 56.3 Cg_endo -82.0 110.09 2.02 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.172 1.617 . . . . 0.0 111.892 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.577 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 2.4 m-20 -110.8 79.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.695 -1.253 . . . . 0.0 110.413 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.835 ' CD ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.27 99.94 8.9 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.228 -0.92 . . . . 0.0 109.95 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -119.98 24.05 10.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.166 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.182 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.643 0.735 . . . . 0.0 110.482 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -90.29 101.11 13.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.133 HG22 ' CG2' ' A' ' 97' ' ' ILE . 48.6 t -109.64 145.52 16.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.677 -1.264 . . . . 0.0 111.118 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.808 ' O ' HG23 ' A' ' 99' ' ' VAL . 6.0 t -130.95 127.81 61.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.45 0.643 . . . . 0.0 109.356 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.949 ' CD1' HG21 ' A' ' 99' ' ' VAL . 49.8 m-85 -102.51 136.53 42.17 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.778 0.799 . . . . 0.0 112.184 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.0 t -120.55 133.54 66.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.429 -0.909 . . . . 0.0 109.642 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.762 ' CB ' HG22 ' A' ' 11' ' ' THR . 24.0 p -79.73 -159.07 0.19 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.642 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.94 -6.72 21.0 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.894 -1.129 . . . . 0.0 108.916 178.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -100.44 1.61 41.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.612 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.45 -22.95 21.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.762 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.9 137.13 17.18 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.986 -1.302 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -130.1 149.98 51.57 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.232 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 2.6 tpp180 -140.15 155.93 46.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.426 -0.796 . . . . 0.0 109.714 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.602 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.9 mt-10 -130.92 128.0 39.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.922 -1.112 . . . . 0.0 110.328 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.001 HD11 HD12 ' A' ' 32' ' ' ILE . 14.1 mt -120.43 -170.53 2.0 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.899 -1.126 . . . . 0.0 110.778 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -133.45 81.71 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.899 HG22 ' CB ' ' A' ' 26' ' ' ALA . 39.9 t -98.4 130.62 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.384 -0.823 . . . . 0.0 110.487 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 90' ' ' MET . . . -110.53 -160.29 0.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.799 0.809 . . . . 0.0 111.523 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.6 OUTLIER -70.53 124.13 23.49 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.642 0.734 . . . . 0.0 110.117 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.71 -14.41 29.57 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' HG13 ' A' ' 17' ' ' VAL . 21.9 t -108.11 166.57 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.832 -1.393 . . . . 0.0 110.373 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.531 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.21 153.77 37.15 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.459 HD22 HG11 ' A' ' 3' ' ' VAL . 16.8 mt -47.09 -27.37 1.35 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.686 -1.258 . . . . 0.0 107.919 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.726 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -72.42 -67.28 0.56 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.096 0.951 . . . . 0.0 110.609 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 21' ' ' VAL 0.255 5.9 tt0 -37.75 -73.41 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.33 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.899 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -43.08 -56.21 3.48 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.558 -1.338 . . . . 0.0 109.264 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.942 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -56.88 -60.42 3.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.644 0.735 . . . . 0.0 109.08 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.744 HG12 ' N ' ' A' ' 29' ' ' SER 0.288 0.9 OUTLIER -33.09 -66.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.658 0.742 . . . . 0.0 109.221 178.041 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.744 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -51.02 -51.87 48.69 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.924 0.869 . . . . 0.0 109.285 178.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.572 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.9 m-80 -60.43 -7.29 1.98 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.33 0.586 . . . . 0.0 109.77 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.93 63.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.001 HD12 HD11 ' A' ' 15' ' ' LEU . 27.5 mt -43.82 -36.45 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.417 -1.049 . . . . 0.0 108.687 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.726 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 44.5 m-85 -104.5 64.26 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.099 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.94 50.97 0.11 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.704 -1.248 . . . . 0.0 108.382 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 36' ' ' VAL . 3.4 pt -104.55 -147.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.596 -0.69 . . . . 0.0 109.899 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' N ' HG13 ' A' ' 35' ' ' ILE . 6.6 t -96.88 174.77 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.91 . . . . 0.0 109.704 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -120.06 85.98 0.39 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' C ' ' SG ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -120.33 6.45 10.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -1.184 . . . . 0.0 110.661 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.563 ' SG ' ' CE ' ' A' ' 24' ' ' MET . 1.7 p -110.52 -54.09 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.056 -1.028 . . . . 0.0 111.09 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.28 40.43 10.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.49 40.42 12.98 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.779 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 39.3 t -131.22 -34.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 0.0 111.261 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 75.81 61.42 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.321 -0.862 . . . . 0.0 111.354 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.34 8.52 4.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.373 -0.829 . . . . 0.0 110.124 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.876 ' O ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.88 117.77 33.7 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.242 -0.911 . . . . 0.0 112.423 -178.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.098 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -75.41 0.26 17.58 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 45' ' ' CYS . 8.4 t -83.73 -32.41 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.575 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.835 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.3 11.68 16.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 179.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.735 ' NE2' HD21 ' A' ' 71' ' ' LEU . 18.0 t-160 -49.16 152.39 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.709 -1.244 . . . . 0.0 109.791 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 83' ' ' ARG . 13.9 m -156.02 160.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.221 -0.924 . . . . 0.0 109.622 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 3.9 m-30 -119.97 118.06 29.71 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.863 HG21 ' CD1' ' A' ' 88' ' ' ILE . 29.1 t -98.53 155.02 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.365 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.755 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -75.22 131.69 40.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.325 -1.485 . . . . 0.0 109.364 178.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pt-20 -37.49 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.435 -0.791 . . . . 0.0 111.476 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.77 -24.9 67.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.018 . . . . 0.0 111.356 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.979 ' HB3' HD12 ' A' ' 97' ' ' ILE . 33.2 m-85 -123.02 -11.0 8.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.871 -1.143 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.84 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -80.57 -29.42 37.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 108.888 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 4.8 p-10 -76.41 -26.87 55.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 109.666 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.692 ' CB ' HD13 ' A' ' 94' ' ' LEU . 23.1 mmtm -80.85 -52.44 7.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.554 -0.716 . . . . 0.0 110.192 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.722 HG11 ' CG2' ' A' ' 88' ' ' ILE . 6.0 m -40.91 153.75 0.22 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.535 -0.728 . . . . 0.0 110.48 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.3 Cg_endo -65.79 168.22 15.7 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.061 1.559 . . . . 0.0 111.352 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.66 125.88 30.58 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.392 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.548 ' HB1' ' OE1' ' A' ' 87' ' ' GLN . . . -69.35 170.93 9.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 68' ' ' ILE . 31.3 p30 -96.83 -161.72 0.9 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 111.131 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -73.37 -24.76 60.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.512 -0.742 . . . . 0.0 110.543 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.514 ' NE ' ' O ' ' A' ' 42' ' ' SER . 1.7 mtm-85 -64.71 -43.07 94.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.405 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 4.2 tp10 -66.64 -7.03 17.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.532 -0.73 . . . . 0.0 109.517 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.94 -30.16 4.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.579 -1.326 . . . . 0.0 111.006 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -84.03 -64.89 1.57 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.854 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.233 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.77 -46.89 42.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.828 -1.395 . . . . 0.0 108.43 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.735 HD21 ' NE2' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -57.13 -25.2 58.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.483 -175.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -36.39 17.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.5 -0.75 . . . . 0.0 108.981 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.35 -32.01 10.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.921 . . . . 0.0 108.809 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.098 ' CG1' ' HB1' ' A' ' 46' ' ' ALA . 14.7 m -90.12 65.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.613 ' O ' HG23 ' A' ' 75' ' ' THR . 4.8 t -48.87 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.445 0.64 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.005 ' HB2' ' CG ' ' A' ' 104' ' ' ARG . . . -130.27 69.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.407 -0.808 . . . . 0.0 109.109 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 39.62 46.27 1.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.695 0.76 . . . . 0.0 109.905 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD13 HD22 ' A' ' 71' ' ' LEU . 9.8 tp -23.93 134.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.601 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.627 ' HD2' ' CD2' ' A' ' 51' ' ' TYR . 5.5 mtpt -110.0 167.92 8.39 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.751 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.6 Cg_endo -68.19 -28.88 33.6 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.854 1.45 . . . . 0.0 109.379 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.588 ' HB2' HG21 ' A' ' 57' ' ' THR . 11.8 p-10 -97.54 -11.93 23.14 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.643 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 50.4 m -48.99 153.74 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.831 -1.168 . . . . 0.0 110.665 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.8 ttp180 -175.5 158.48 2.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.416 -0.802 . . . . 0.0 110.086 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.233 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -76.38 142.38 41.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.933 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 48' ' ' CYS . 17.3 p -44.88 -26.24 0.39 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.028 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -93.0 29.87 1.74 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.899 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 6.6 tp-100 -126.59 -38.32 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.394 -1.441 . . . . 0.0 112.687 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.863 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -92.6 142.79 12.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.001 -1.079 . . . . 0.0 110.85 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 90' ' ' MET . 7.2 mm -110.52 168.19 4.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.643 ' CB ' HG12 ' A' ' 17' ' ' VAL . 3.5 tpt -109.93 110.65 21.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.866 -1.147 . . . . 0.0 111.137 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.476 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -89.93 165.64 23.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.86 -6.36 18.87 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.864 1.455 . . . . 0.0 110.901 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 1.7 pt-20 -110.26 -28.48 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.007 . . . . 0.0 110.429 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.692 HD13 ' CB ' ' A' ' 59' ' ' LYS . 8.1 mt -93.78 55.92 2.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 2.8 p30 -100.53 148.98 24.18 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.327 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.677 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.72 34.02 6.46 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.133 ' CG2' HG22 ' A' ' 3' ' ' VAL . 5.0 tt -83.96 157.41 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.214 1.007 . . . . 0.0 113.127 -177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.534 ' CG2' ' OD1' ' A' ' 53' ' ' ASN . 18.1 t -117.84 124.76 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.214 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.949 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -104.4 -177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.858 -1.151 . . . . 0.0 109.996 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.647 ' H ' HG12 ' A' ' 99' ' ' VAL . 16.5 m-20 -162.26 145.84 11.83 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.29 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.642 HG12 ' ND1' ' A' ' 8' ' ' HIS . 71.7 t -98.27 111.89 60.79 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 120.678 -1.264 . . . . 0.0 108.716 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.649 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.2 Cg_endo -67.77 133.82 30.65 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.057 1.556 . . . . 0.0 110.941 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 36.3 p-10 -110.19 106.99 16.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 109.938 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 1.005 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -99.14 110.47 23.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.116 -0.99 . . . . 0.0 109.929 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -149.27 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.626 ' N ' ' CE3' ' A' ' 106' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.106 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.544 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.445 0.641 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.09 109.69 20.73 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.424 -0.797 . . . . 0.0 109.546 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.982 HG22 ' CG2' ' A' ' 97' ' ' ILE . 30.3 t -109.73 144.81 17.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.914 -1.116 . . . . 0.0 110.706 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.891 ' O ' HG23 ' A' ' 99' ' ' VAL . 15.8 t -130.93 124.78 56.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.554 0.692 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.976 ' CD1' HG21 ' A' ' 99' ' ' VAL . 54.1 m-85 -100.38 138.6 37.22 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.702 0.763 . . . . 0.0 112.552 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG13 ' HG2' ' A' ' 12' ' ' ARG . 2.6 t -120.88 127.51 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.904 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.628 ' OG ' HG22 ' A' ' 11' ' ' THR . 10.2 p -79.78 -159.25 0.2 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.979 -1.076 . . . . 0.0 108.315 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.408 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -102.44 -1.07 31.41 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.98 -1.075 . . . . 0.0 109.177 178.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.44 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -100.4 -4.63 28.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.483 -0.761 . . . . 0.0 109.389 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.27 -31.8 7.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.628 HG22 ' OG ' ' A' ' 7' ' ' SER . 1.1 t -49.94 130.58 22.01 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.899 -1.353 . . . . 0.0 109.802 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.826 ' HG2' HG13 ' A' ' 6' ' ' VAL . 16.2 mtm180 -120.04 134.29 55.29 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.484 0.659 . . . . 0.0 110.864 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.571 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -111.62 156.77 21.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 0.0 109.682 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.725 ' HG2' HG22 ' A' ' 4' ' ' VAL . 32.2 mt-10 -130.89 125.34 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.382 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.831 HD11 ' CA ' ' A' ' 27' ' ' ALA . 11.1 mt -118.72 149.36 41.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.056 . . . . 0.0 111.434 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.72 87.77 3.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 26' ' ' ALA . 41.7 t -98.7 171.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.451 -0.781 . . . . 0.0 110.692 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.584 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -121.44 -139.52 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.925 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.7 OUTLIER -104.73 125.74 51.11 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.41 -0.806 . . . . 0.0 110.224 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.54 -8.74 30.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 22' ' ' SER . 69.7 t -98.86 169.49 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.07 -1.253 . . . . 0.0 110.322 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.25 -175.1 2.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.515 HD22 HG11 ' A' ' 3' ' ' VAL . 19.9 mt -79.9 -36.87 35.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.763 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.7 ttp -79.64 9.02 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.581 ' CG ' HG13 ' A' ' 21' ' ' VAL . 4.7 tt0 -102.03 -70.94 0.73 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.348 -0.845 . . . . 0.0 109.362 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -49.39 -53.65 21.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.723 -1.236 . . . . 0.0 108.516 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.831 ' CA ' HD11 ' A' ' 15' ' ' LEU . . . -53.81 -51.77 62.42 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.714 HG12 ' N ' ' A' ' 29' ' ' SER 0.272 0.7 OUTLIER -38.91 -57.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 177.8 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.714 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.84 -50.34 74.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.056 0.931 . . . . 0.0 109.101 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.581 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.8 m-80 -60.04 -7.88 2.05 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.418 0.628 . . . . 0.0 109.642 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.47 -13.04 59.29 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.793 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 12.7 mt -41.76 -39.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.534 -0.98 . . . . 0.0 109.58 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.763 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 45.8 m-85 -99.04 56.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.108 -0.995 . . . . 0.0 111.012 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.45 -2.7 4.89 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.466 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.808 HG23 ' N ' ' A' ' 36' ' ' VAL . 1.1 tt -79.07 -141.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.374 -0.829 . . . . 0.0 109.56 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.909 HG21 ' OG1' ' A' ' 47' ' ' THR . 32.7 m -80.37 134.71 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.778 -1.201 . . . . 0.0 110.527 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.07 57.55 0.57 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -80.59 7.4 10.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -1.146 . . . . 0.0 110.313 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.582 ' HB2' ' CB ' ' A' ' 86' ' ' CYS . 0.8 OUTLIER -110.75 -64.4 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.176 -0.953 . . . . 0.0 110.481 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 45.29 52.63 8.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.33 34.8 28.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.736 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.7 t -125.73 -42.84 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -1.113 . . . . 0.0 110.281 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.15 57.22 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.369 -0.832 . . . . 0.0 111.342 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 p -132.65 8.24 4.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.884 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.173 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.29 151.55 29.54 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.74 -1.225 . . . . 0.0 113.647 -177.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' CB ' ' CB ' ' A' ' 73' ' ' CYS . . . -106.61 8.84 31.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.627 -1.296 . . . . 0.0 111.372 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.909 ' OG1' HG21 ' A' ' 36' ' ' VAL . 7.4 p -103.25 9.79 37.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.794 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.43 14.51 16.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.382 -0.824 . . . . 0.0 109.309 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.786 ' HE2' ' HE1' ' A' ' 51' ' ' TYR . 3.5 t-160 -41.83 141.17 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 48' ' ' CYS . 16.1 m -147.04 155.81 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.9 -1.125 . . . . 0.0 109.326 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.786 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 7.9 m-30 -120.9 121.39 37.96 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.638 0.732 . . . . 0.0 110.67 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.779 ' HB ' HG22 ' A' ' 57' ' ' THR . 16.5 t -91.88 170.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 57' ' ' THR . 6.7 p30 -72.76 -148.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.526 -1.359 . . . . 0.0 109.222 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -102.85 -14.84 16.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.913 -1.117 . . . . 0.0 111.507 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.403 ' N ' ' OD1' ' A' ' 53' ' ' ASN . . . -100.56 -38.24 8.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.802 -1.186 . . . . 0.0 114.072 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.846 ' HB3' HD12 ' A' ' 97' ' ' ILE . 78.6 m-85 -84.24 -11.24 56.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.332 -1.48 . . . . 0.0 111.464 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.779 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.44 -49.16 10.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.934 -1.104 . . . . 0.0 109.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 3.7 p-10 -61.33 -13.53 20.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.628 ' HB2' HD13 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -93.46 -52.7 4.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.532 -0.73 . . . . 0.0 110.163 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 57' ' ' THR . 6.2 m -46.25 165.81 0.18 Allowed Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.7 Cg_endo -67.36 161.08 44.77 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.102 1.58 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.18 126.29 31.32 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.762 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.529 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -69.53 157.9 36.27 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.533 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 31.1 p-10 -100.24 -168.17 1.55 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.897 -1.127 . . . . 0.0 112.067 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -65.05 -19.68 66.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.818 -0.551 . . . . 0.0 110.493 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.14 -53.12 54.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.955 . . . . 0.0 108.809 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 2.1 tt0 -58.95 -47.37 85.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.4 mp -47.97 -26.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.016 -1.052 . . . . 0.0 111.281 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.67 -67.91 1.19 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.059 ' HE2' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.12 -44.05 31.59 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.35 -1.088 . . . . 0.0 109.279 179.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.855 HD22 HD11 ' A' ' 78' ' ' LEU 0.255 0.0 OUTLIER -68.63 -25.14 64.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.644 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -91.01 -25.89 19.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.499 -0.751 . . . . 0.0 110.769 178.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.578 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.09 -41.41 26.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.777 -1.202 . . . . 0.0 109.052 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 49' ' ' HIS . 3.6 m -90.51 87.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.802 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.81 ' O ' HG23 ' A' ' 75' ' ' THR . 9.6 t -47.84 96.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.817 0.818 . . . . 0.0 111.475 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.752 ' HB2' ' CG ' ' A' ' 104' ' ' ARG . . . -125.17 47.38 2.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.222 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.563 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.3 pt-20 39.75 60.16 1.71 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.732 0.777 . . . . 0.0 109.384 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.855 HD11 HD22 ' A' ' 71' ' ' LEU . 1.8 tp -27.24 134.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.578 0.704 . . . . 0.0 112.089 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.636 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 5.1 mtpt -104.85 173.71 3.14 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 39.7 Cg_endo -69.32 -29.26 26.24 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.393 1.207 . . . . 0.0 110.054 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 22.8 p-10 -106.97 -2.32 21.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 111.061 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.57 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 69.6 m -49.21 161.83 0.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.813 -1.18 . . . . 0.0 111.069 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.721 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.32 166.39 3.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.173 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -83.16 148.56 27.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.58 ' C ' ' HB2' ' A' ' 24' ' ' MET . 66.1 m -49.07 -27.36 3.28 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.1 ' SG ' HD13 ' A' ' 84' ' ' LEU . 4.7 p -106.95 43.65 1.14 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.878 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 6.4 tp-100 -125.57 -38.06 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.919 -1.113 . . . . 0.0 111.212 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -96.15 147.99 5.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.605 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.5 mm -110.61 161.67 8.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.924 ' HE1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.29 124.31 51.41 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.789 -1.194 . . . . 0.0 110.792 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 3.9 p -110.02 168.07 8.18 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.435 -0.79 . . . . 0.0 109.63 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 43.9 Cg_endo -73.27 -1.75 11.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.823 1.433 . . . . 0.0 111.59 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -110.08 -24.13 10.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.812 -1.18 . . . . 0.0 110.233 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.924 ' O ' ' HE1' ' A' ' 90' ' ' MET . 4.8 mt -93.73 33.57 1.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.536 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 6.0 p-10 -80.65 144.39 32.34 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.822 0.82 . . . . 0.0 112.501 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.657 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.25 21.59 11.52 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.982 ' CG2' HG22 ' A' ' 3' ' ' VAL . 13.2 tt -74.17 157.49 6.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 123.131 1.443 . . . . 0.0 113.8 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.569 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 23.2 t -122.92 121.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.261 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.976 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.4 t -103.76 -176.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.0 109.531 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.643 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.8 m-20 -160.95 138.86 9.51 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.028 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 6' ' ' VAL . 12.7 t -102.05 116.68 62.84 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.984 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.8 Cg_endo -64.55 169.34 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 109.953 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.519 ' O ' ' NE ' ' A' ' 104' ' ' ARG . 3.0 p-10 -110.33 78.56 1.13 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.777 -1.202 . . . . 0.0 112.009 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.752 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 11.9 mmp_? -110.46 87.89 2.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -119.87 8.47 11.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 110.22 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.274 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.341 0.591 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -80.73 137.56 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.812 . . . . 0.0 109.422 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.544 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 2.5 t -125.74 135.94 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.823 -1.173 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.033 HG13 ' HG3' ' A' ' 14' ' ' GLU . 44.3 t -129.19 124.89 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.496 1.141 . . . . 0.0 110.324 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.894 ' CE2' HD13 ' A' ' 15' ' ' LEU 0.29 30.1 m-85 -98.46 139.96 33.43 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.976 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.021 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.5 t -121.05 155.86 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.032 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.593 ' HB3' HG22 ' A' ' 11' ' ' THR . 97.4 p -119.38 142.05 48.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.437 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -44.65 -23.72 0.15 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.421 -0.799 . . . . 0.0 110.613 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.458 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.3 p30 -89.64 -4.07 57.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.067 -1.021 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.13 -32.22 7.23 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.53 131.49 21.02 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.082 -1.246 . . . . 0.0 109.061 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.729 ' HG3' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -125.67 151.31 46.73 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.439 0.638 . . . . 0.0 111.122 -179.032 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.722 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -134.41 118.41 17.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 1.033 ' HG3' HG13 ' A' ' 4' ' ' VAL . 6.9 mp0 -116.29 125.37 52.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 0.0 111.845 -178.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.894 HD13 ' CE2' ' A' ' 5' ' ' TYR 0.25 6.7 mp -110.42 -175.23 2.67 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.225 1.012 . . . . 0.0 111.198 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -119.23 92.35 3.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 5.9 t -98.63 170.07 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.496 -0.752 . . . . 0.0 110.948 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.549 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -134.03 -143.64 0.21 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 90' ' ' MET . 1.3 p-10 -95.02 123.57 38.57 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.591 -0.693 . . . . 0.0 110.546 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.52 -7.67 30.21 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.579 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 22' ' ' SER . 46.0 t -98.4 167.91 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.776 -1.426 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.595 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.66 165.14 16.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.511 ' N ' HD23 ' A' ' 23' ' ' LEU . 2.9 mt -59.69 -17.19 32.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.481 -1.387 . . . . 0.0 108.474 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.67 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -82.53 -66.5 0.88 Allowed 'General case' 0 C--O 1.204 -1.34 0 O-C-N 121.479 -0.763 . . . . 0.0 109.03 178.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' NE2' ' HA ' ' A' ' 21' ' ' VAL 0.27 6.4 tt0 -37.03 -71.15 0.08 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.366 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.57 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -43.21 -66.3 0.39 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.683 -1.261 . . . . 0.0 108.518 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . . . -46.84 -49.9 19.34 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.065 0.936 . . . . 0.0 109.152 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 29' ' ' SER 0.257 0.8 OUTLIER -43.68 -56.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.63 0.729 . . . . 0.0 109.137 179.033 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.696 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.28 -49.42 72.16 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.885 0.85 . . . . 0.0 108.879 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.724 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 1.5 m-80 -59.75 -10.65 3.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.62 -10.56 73.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.712 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 4.1 mt -39.92 -41.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.694 -0.886 . . . . 0.0 110.038 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.67 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 25.6 m-85 -108.68 59.41 0.6 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.045 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -60.46 -15.98 32.03 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.794 ' CD1' HG21 ' A' ' 47' ' ' THR . 10.1 tt -79.71 77.34 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.304 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.639 HG12 ' HA2' ' A' ' 40' ' ' GLY . 3.9 t -120.15 73.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.055 -1.028 . . . . 0.0 110.493 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.28 -2.47 12.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -120.1 -64.28 1.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.157 -1.202 . . . . 0.0 110.039 -179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 7.3 p -69.11 -37.47 78.38 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.707 -0.621 . . . . 0.0 111.105 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.639 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . 47.83 29.44 6.17 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.56 34.76 27.56 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.741 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 4.6 p -140.15 7.31 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -1.211 . . . . 0.0 111.752 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.21 58.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.12 -0.987 . . . . 0.0 112.514 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -133.61 30.78 3.76 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.038 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.5 p -111.25 150.41 29.63 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.11 16.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.086 -1.009 . . . . 0.0 108.672 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.794 HG21 ' CD1' ' A' ' 35' ' ' ILE . 14.1 t -110.35 -32.36 6.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 111.908 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.722 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.9 m -74.73 8.32 2.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.398 -1.439 . . . . 0.0 110.41 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.074 ' ND1' HG21 ' A' ' 74' ' ' VAL . 23.6 t-160 -46.03 140.53 3.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.65 -1.281 . . . . 0.0 109.292 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 48' ' ' CYS . 13.5 m -144.89 159.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.563 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.6 m-30 -118.4 120.76 38.54 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.767 HG13 HD11 ' A' ' 97' ' ' ILE . 24.2 t -84.45 167.84 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.595 ' ND2' HG23 ' A' ' 98' ' ' VAL . 8.1 p-10 -80.27 -142.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.232 -1.543 . . . . 0.0 110.229 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -101.92 -28.02 12.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.253 -1.53 . . . . 0.0 113.384 -177.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . . . -100.2 23.83 9.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.349 -1.469 . . . . 0.0 113.313 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.945 ' HB3' HD12 ' A' ' 97' ' ' ILE . 73.5 m-85 -140.58 -19.48 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.627 -1.296 . . . . 0.0 110.939 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.703 HG22 ' CG1' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -81.18 -50.67 9.3 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -64.92 -15.47 62.12 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.969 ' CB ' HD21 ' A' ' 94' ' ' LEU 0.296 0.8 OUTLIER -79.28 -53.9 6.48 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.797 1.76 . . . . 0.0 108.942 179.154 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.812 HG21 HG22 ' A' ' 88' ' ' ILE 0.319 0.3 OUTLIER -77.42 139.44 63.84 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 112.519 -2.128 . . . . 0.0 110.22 -177.817 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -66.67 162.25 38.03 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.092 1.575 . . . . 0.0 112.011 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 -173.42 4.14 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.564 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.589 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -170.41 1.63 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.415 0.626 . . . . 0.0 110.898 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.64 -164.4 1.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.0 110.671 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 1.1 pt-20 -61.37 -22.0 64.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.483 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.532 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 6.2 ttm180 -64.24 -57.93 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 0.0 109.164 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 15.6 tp10 -59.97 1.15 0.12 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.749 -0.594 . . . . 0.0 111.956 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 6.7 mm -90.9 -39.55 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 110.225 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 72' ' ' GLU . . . -83.2 -60.5 2.02 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.104 ' HE2' HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -47.65 -43.7 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.195 -1.179 . . . . 0.0 108.738 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.007 ' O ' HG22 ' A' ' 74' ' ' VAL 0.257 0.0 OUTLIER -73.11 -34.31 66.09 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.819 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -70.29 -21.1 62.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.67 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 74.4 m -48.99 -24.24 1.44 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.088 -1.008 . . . . 0.0 108.696 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.074 HG21 ' ND1' ' A' ' 49' ' ' HIS . 17.4 m -90.12 76.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.662 -0.649 . . . . 0.0 109.786 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 75' ' ' THR . 12.9 t -50.99 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 122.008 -0.432 . . . . 0.0 111.829 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -131.09 52.35 2.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.867 -1.146 . . . . 0.0 110.443 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.8 OUTLIER 38.93 60.17 1.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.631 -0.668 . . . . 0.0 110.151 -179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.995 HD21 HD13 ' A' ' 71' ' ' LEU . 2.3 tp -22.91 141.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.44 0.638 . . . . 0.0 112.037 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -90.7 168.87 13.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.004 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.1 Cg_endo -67.32 -26.37 41.58 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.653 1.344 . . . . 0.0 109.346 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 14.2 p30 -105.38 -6.74 19.3 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.752 -0.593 . . . . 0.0 110.958 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.622 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.3 m -48.95 156.05 0.55 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 0.0 111.085 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.59 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.2 ttt180 -175.18 158.79 2.46 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.73 0.776 . . . . 0.0 110.8 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.104 HD12 ' HE2' ' A' ' 70' ' ' MET . 1.0 OUTLIER -78.85 138.94 38.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.689 -0.632 . . . . 0.0 109.809 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.6 p -44.84 -31.85 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.886 -1.134 . . . . 0.0 110.005 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 3.7 m -101.08 39.58 1.38 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.433 -0.792 . . . . 0.0 111.17 -177.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.717 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 1.8 mm-40 -126.48 -43.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 112.608 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.812 HG22 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -83.75 149.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 118.634 -1.227 . . . . 0.0 110.656 -179.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.9 mm -110.87 160.15 10.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.318 0.58 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 1.9 tpt -110.3 113.91 26.95 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.079 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -91.37 169.15 11.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 109.508 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.508 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 41.8 Cg_endo -72.73 -8.83 23.07 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.782 1.412 . . . . 0.0 111.291 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' HG3' ' OG1' ' A' ' 91' ' ' THR . 1.9 pp20? -110.04 -41.58 4.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.863 -1.148 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.969 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.2 mt -72.56 54.28 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.541 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 50.0 p-10 -101.53 156.18 17.63 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.106 -0.997 . . . . 0.0 112.646 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.658 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.6 27.07 12.03 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.945 HD12 ' HB3' ' A' ' 56' ' ' PHE . 4.9 tt -79.99 157.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 122.219 1.009 . . . . 0.0 112.21 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG23 ' ND2' ' A' ' 53' ' ' ASN . 19.0 t -124.13 125.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.1 t -103.73 -176.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 109.409 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.0 m-20 -162.18 139.24 8.21 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.885 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 6' ' ' VAL . 16.4 t -90.67 117.18 67.77 Favored Pre-proline 0 C--N 1.285 -2.223 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.245 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.654 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.2 Cg_endo -64.59 154.69 70.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.855 1.45 . . . . 0.0 110.312 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.501 ' OD1' ' NH2' ' A' ' 104' ' ' ARG . 6.1 p-10 -105.59 91.06 3.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 0.0 111.302 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.629 ' NE ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.1 44.57 1.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.379 -0.826 . . . . 0.0 109.723 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.07 2.82 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.188 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.56 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.343 0.592 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -80.02 138.6 37.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -0.793 . . . . 0.0 109.873 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.013 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.0 t -127.95 146.73 33.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.012 -1.055 . . . . 0.0 110.141 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.874 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.4 t -130.5 130.06 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.592 0.71 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.98 ' CE1' HG21 ' A' ' 99' ' ' VAL 0.266 46.3 m-85 -106.09 138.83 41.6 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.024 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.3 t -121.71 152.17 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.738 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.57 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 80.5 p -114.97 138.0 51.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' CD2' ' HB3' ' A' ' 103' ' ' ASP . 1.3 t60 -46.59 -22.38 0.28 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.943 -1.098 . . . . 0.0 110.016 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 2.1 p30 -85.03 -6.22 59.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.049 . . . . 0.0 110.156 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.25 -36.1 4.46 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.73 133.28 21.66 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.817 -1.402 . . . . 0.0 109.226 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.847 ' HG2' HG22 ' A' ' 6' ' ' VAL . 16.9 mtm105 -129.04 154.9 46.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.283 0.563 . . . . 0.0 111.247 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.743 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -135.58 121.3 19.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 36.4 mt-10 -94.64 123.35 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.875 HD11 ' HA ' ' A' ' 27' ' ' ALA . 8.2 mt -109.79 147.23 33.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.979 . . . . 0.0 110.57 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -99.55 88.07 3.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.954 HG22 ' HB2' ' A' ' 26' ' ' ALA . 56.6 t -98.97 168.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.56 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -125.28 -133.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p-10 -108.1 123.98 49.53 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.248 -0.907 . . . . 0.0 110.382 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.32 -8.47 30.78 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 22' ' ' SER . 60.8 t -97.81 170.46 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.917 -1.343 . . . . 0.0 110.465 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.62 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.48 154.4 35.31 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.622 HD21 ' SD ' ' A' ' 90' ' ' MET . 10.0 mt -48.78 -23.35 1.04 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.505 -1.372 . . . . 0.0 109.329 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.681 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.6 ttt -83.51 -62.73 1.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.621 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.6 tt0 -36.57 -54.22 0.87 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.257 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.954 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -61.39 -49.91 74.98 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.035 -1.665 . . . . 0.0 107.664 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.875 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -58.16 -61.2 2.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.308 1.051 . . . . 0.0 108.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.73 HG12 ' N ' ' A' ' 29' ' ' SER 0.293 0.8 OUTLIER -29.63 -59.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.744 178.22 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.73 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -63.56 -48.18 78.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.108 0.956 . . . . 0.0 108.871 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.589 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.3 m-80 -59.64 -11.42 4.89 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.07 -10.32 73.4 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.867 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 4.8 mt -42.83 -30.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.395 -1.062 . . . . 0.0 108.742 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.681 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 26.4 m-85 -118.08 67.4 0.76 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.457 -0.897 . . . . 0.0 113.09 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -89.93 26.53 1.8 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.045 HD11 ' SG ' ' A' ' 48' ' ' CYS . 5.2 pt -79.67 -162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.427 0.632 . . . . 0.0 110.191 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.629 ' C ' HG21 ' A' ' 47' ' ' THR . 9.1 m -120.64 87.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.462 -0.774 . . . . 0.0 110.611 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.25 150.69 17.44 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER -86.76 6.1 33.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.078 -1.248 . . . . 0.0 110.245 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.7 p -69.36 -35.35 75.78 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.768 -0.583 . . . . 0.0 111.291 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.68 31.39 2.57 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.35 35.61 25.97 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.699 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.17 8.95 2.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -1.179 . . . . 0.0 111.024 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 68.49 54.28 0.53 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.283 1.039 . . . . 0.0 111.285 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.601 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -131.77 30.8 4.31 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.812 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -111.39 149.9 30.55 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.644 ' HB1' ' CB ' ' A' ' 73' ' ' CYS . . . -111.17 -1.88 16.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.951 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.629 HG21 ' C ' ' A' ' 36' ' ' VAL . 1.7 t -110.22 -25.13 10.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.358 -0.839 . . . . 0.0 112.152 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 1.045 ' SG ' HD11 ' A' ' 35' ' ' ILE . 19.0 m -76.71 15.16 0.68 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.509 -1.369 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.72 ' CD2' ' CD2' ' A' ' 71' ' ' LEU . 6.5 t-80 -49.97 136.32 18.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.833 -1.167 . . . . 0.0 108.036 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 49' ' ' HIS . 9.9 m -160.27 170.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.668 -1.27 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 11.4 m-30 -120.4 123.09 42.19 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.563 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.856 HG21 ' CD1' ' A' ' 88' ' ' ILE . 46.6 t -90.48 151.15 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.768 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -73.25 133.77 44.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 119.835 -1.791 . . . . 0.0 109.863 178.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -40.95 -26.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.724 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.528 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -61.34 -17.23 52.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.875 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.91 ' HB3' HD12 ' A' ' 97' ' ' ILE . 50.1 m-85 -131.02 -9.19 3.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.011 -1.056 . . . . 0.0 110.835 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 53' ' ' ASN . 1.3 p -80.52 -39.44 27.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -12.11 60.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 109.57 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.615 ' CG ' ' HA ' ' A' ' 56' ' ' PHE 0.281 22.0 mmmt -79.43 -54.64 5.73 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 123.669 1.7 . . . . 0.0 108.678 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.964 HG11 HG21 ' A' ' 88' ' ' ILE 0.326 0.3 OUTLIER -81.09 134.23 52.92 Favored Pre-proline 0 C--N 1.279 -2.47 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.943 -178.005 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.67 159.9 50.58 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.079 1.568 . . . . 0.0 112.212 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -81.07 177.44 9.04 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.936 ' HB3' ' CB ' ' A' ' 67' ' ' GLU . . . -110.79 -152.41 0.5 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.725 -0.609 . . . . 0.0 110.403 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.778 ' O ' HD13 ' A' ' 68' ' ' ILE . 47.8 p-10 -100.04 -139.85 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.11 -18.05 50.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 110.109 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 70' ' ' MET . 0.7 OUTLIER -70.05 -52.55 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.936 ' CB ' ' HB3' ' A' ' 63' ' ' ALA . 1.7 tm-20 -58.35 -15.54 10.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.838 -1.164 . . . . 0.0 110.16 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.778 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.5 mp -91.31 -65.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.39 -48.01 26.14 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 119.834 -1.174 . . . . 0.0 110.271 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.728 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.296 12.3 ttp -48.61 -52.34 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 123.207 1.479 . . . . 0.0 107.744 178.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.941 HD13 HD11 ' A' ' 78' ' ' LEU 0.284 0.0 OUTLIER -62.26 -52.56 63.24 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.379 179.609 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.954 ' HB2' HD13 ' A' ' 78' ' ' LEU . 7.4 tt0 -82.17 20.53 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.519 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.644 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 1.3 m -49.18 -25.42 2.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.149 -1.594 . . . . 0.0 108.069 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.823 HG21 ' O ' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -89.93 -148.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.793 ' N ' HG23 ' A' ' 74' ' ' VAL . 9.6 t -130.78 55.52 1.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.174 -1.579 . . . . 0.0 110.076 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.924 ' HB2' ' HB2' ' A' ' 104' ' ' ARG . . . -98.6 32.27 2.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 110.745 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.553 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.1 pt-20 39.19 60.48 1.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.676 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.954 HD13 ' HB2' ' A' ' 72' ' ' GLU . 12.4 tp -19.77 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.579 0.704 . . . . 0.0 112.544 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.642 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 3.6 mtpt -97.53 -167.55 0.13 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 43.9 Cg_endo -82.58 -28.23 1.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.491 1.258 . . . . 0.0 109.777 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 9.8 p-10 -105.89 -7.21 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.52 -0.737 . . . . 0.0 111.508 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.755 ' C ' HD11 ' A' ' 71' ' ' LEU . 1.5 m -49.56 143.68 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.59 -1.319 . . . . 0.0 110.326 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.614 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 mmt-85 -158.85 151.76 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 110.158 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.812 HD22 ' SG ' ' A' ' 45' ' ' CYS . 12.2 mt -74.34 148.51 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.635 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 18.1 m -47.1 -25.38 0.85 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -110.08 48.18 0.91 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.331 0.586 . . . . 0.0 109.837 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.542 ' HG2' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -125.24 -38.95 2.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 110.863 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.964 HG21 HG11 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -101.7 155.93 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -110.3 163.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.513 -0.742 . . . . 0.0 109.369 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.622 ' SD ' HD21 ' A' ' 23' ' ' LEU . 2.7 tpt -110.07 106.73 16.32 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 110.438 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 1.1 p -89.4 163.79 32.29 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 43.7 Cg_endo -74.34 -6.88 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.956 1.503 . . . . 0.0 110.54 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.498 ' HG2' ' HG ' ' A' ' 94' ' ' LEU . 2.7 pt-20 -103.47 -27.76 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.597 HD13 ' CB ' ' A' ' 59' ' ' LYS . 9.9 mt -99.97 57.29 0.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 4.8 p-10 -100.43 149.89 23.19 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.662 0.744 . . . . 0.0 112.242 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.646 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.61 22.36 11.36 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.013 ' CG2' HG22 ' A' ' 3' ' ' VAL . 8.3 tt -72.84 154.49 7.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.747 1.261 . . . . 0.0 113.325 -177.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.535 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 5.8 t -122.57 127.76 75.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.334 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.98 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.8 t -103.81 -179.55 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.015 -1.053 . . . . 0.0 108.578 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.578 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.6 m-20 -161.17 138.53 9.02 Favored 'General case' 0 C--N 1.274 -2.711 0 C-N-CA 118.408 -1.317 . . . . 0.0 110.726 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 6' ' ' VAL . 15.2 t -97.38 117.75 65.18 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.676 ' HG3' ' CE1' ' A' ' 49' ' ' HIS . 37.2 Cg_endo -65.23 -166.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.95 1.5 . . . . 0.0 110.613 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.589 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 4.5 p-10 -110.03 -0.14 18.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.992 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.924 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -110.29 78.51 1.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.191 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.7 2.34 15.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.546 ' C ' ' CE3' ' A' ' 106' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.611 ' H1 ' ' C ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.563 0.697 . . . . 0.0 110.242 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' CB ' ' OD1' ' A' ' 95' ' ' ASP . 0.4 OUTLIER -80.13 119.66 23.22 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.79 HG22 ' CG2' ' A' ' 97' ' ' ILE . 20.3 t -124.46 148.6 28.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.871 -1.143 . . . . 0.0 111.53 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 ' OE1' ' A' ' 14' ' ' GLU . 4.7 t -131.14 128.8 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.972 ' CE1' HG21 ' A' ' 99' ' ' VAL 0.273 42.2 m-85 -107.68 140.99 39.89 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 99' ' ' VAL . 3.2 t -122.16 129.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.05 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.637 ' HB3' HG22 ' A' ' 11' ' ' THR . 77.6 p -79.36 -151.44 0.06 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.629 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.33 -10.51 14.6 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 120.874 -1.141 . . . . 0.0 108.915 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.445 ' OD1' ' HB ' ' A' ' 11' ' ' THR . 3.7 p30 -100.41 1.99 41.86 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.34 -31.05 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.637 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -49.7 135.99 18.14 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.935 -1.332 . . . . 0.0 109.092 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.7 mtm180 -130.16 152.74 49.27 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.144 -0.623 . . . . 0.0 111.411 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.756 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -132.78 121.24 22.71 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.857 ' OE1' HG22 ' A' ' 4' ' ' VAL . 2.5 mm-40 -94.64 124.14 38.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.146 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.878 HD11 ' CA ' ' A' ' 27' ' ' ALA . 7.2 mt -109.67 147.98 32.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.009 -1.057 . . . . 0.0 111.851 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.02 84.89 2.31 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.698 HG13 HG11 ' A' ' 21' ' ' VAL . 16.6 t -98.89 172.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.443 -0.786 . . . . 0.0 110.952 -177.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -120.3 -144.2 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.418 -0.801 . . . . 0.0 111.252 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.504 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -102.06 133.73 46.41 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.62 -0.675 . . . . 0.0 110.307 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.47 -3.09 57.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.917 HG13 ' CD ' ' A' ' 25' ' ' GLN . 2.6 t -100.43 172.48 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -1.105 . . . . 0.0 110.406 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.609 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -119.97 179.26 4.32 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.791 178.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.518 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 16.1 mt -76.63 -14.82 59.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.782 -1.199 . . . . 0.0 109.534 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.733 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.1 tmt? -90.6 -71.45 0.62 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.679 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.917 ' CD ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -37.9 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.707 -0.621 . . . . 0.0 112.132 -176.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.645 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -88.37 -52.5 5.16 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.992 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -59.86 -45.43 92.47 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.732 HG21 ' SD ' ' A' ' 24' ' ' MET 0.262 0.8 OUTLIER -42.9 -61.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.72 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.726 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.55 -32.73 70.6 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.45 1.119 . . . . 0.0 108.163 178.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.691 ' CG ' HD21 ' A' ' 15' ' ' LEU . 3.7 m-80 -77.36 10.41 2.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.046 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.06 13.91 36.62 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.992 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 5.1 mt -72.1 -33.93 48.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.343 -1.092 . . . . 0.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.3 m-85 -103.8 52.26 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.0 111.888 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -79.1 48.72 0.88 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 36' ' ' VAL . 6.3 pt -79.98 -144.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.334 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.724 HG12 ' N ' ' A' ' 37' ' ' GLY . 30.4 t -85.26 -89.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 110.343 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.724 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -79.97 178.19 53.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -119.55 162.19 19.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -1.1 . . . . 0.0 110.206 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.639 ' CB ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -110.46 -26.38 9.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 0.0 109.938 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 40.94 28.06 0.22 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . 80.09 30.54 41.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.75 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.8 t -117.58 -36.13 3.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -1.14 . . . . 0.0 109.881 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 73.33 60.36 0.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.632 0.729 . . . . 0.0 111.762 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -131.95 22.02 4.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.529 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -112.56 161.15 17.11 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.495 0.664 . . . . 0.0 111.761 -177.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.658 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -110.95 -2.99 15.78 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.576 -1.328 . . . . 0.0 112.623 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 18.0 p -110.32 28.36 8.71 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.284 -1.51 . . . . 0.0 112.656 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 1.016 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.96 -3.4 12.14 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 109.257 179.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.965 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -43.46 127.6 4.74 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.016 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.4 m -139.17 161.26 28.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.566 -1.334 . . . . 0.0 110.211 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.842 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 5.8 m-30 -116.9 121.8 42.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.69 0.757 . . . . 0.0 110.381 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.743 ' HB ' HG22 ' A' ' 57' ' ' THR . 14.6 t -91.41 172.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.603 ' O ' HG21 ' A' ' 57' ' ' THR . 6.6 p30 -75.84 -148.39 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.445 -1.41 . . . . 0.0 109.21 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 -16.02 16.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.878 -1.139 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 59' ' ' LYS . . . -100.65 -36.12 9.25 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.853 -1.154 . . . . 0.0 113.832 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.745 ' O ' HG13 ' A' ' 60' ' ' VAL . 70.0 m-85 -84.37 -13.21 52.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.338 -1.477 . . . . 0.0 111.608 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.743 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -80.79 -27.67 36.56 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.717 -1.239 . . . . 0.0 109.818 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -24.43 21.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.898 ' CB ' HD21 ' A' ' 94' ' ' LEU . 15.3 mmtm -79.57 -52.12 8.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 56' ' ' PHE . 9.1 m -42.19 166.31 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.616 -0.678 . . . . 0.0 110.044 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 38.1 Cg_endo -66.34 165.29 25.2 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.027 1.541 . . . . 0.0 111.448 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.65 114.17 19.35 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.261 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.935 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.1 163.81 23.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.879 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.45 ' O ' HD13 ' A' ' 68' ' ' ILE . 44.3 p-10 -100.3 -146.45 0.34 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.893 . . . . 0.0 111.335 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 66' ' ' ARG . 3.6 pt-20 -72.72 -27.76 62.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 110.55 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.684 ' HG3' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -64.37 -46.83 81.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 108.509 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.935 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 3.0 tm-20 -58.08 -16.05 11.64 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.43 -1.419 . . . . 0.0 109.298 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -92.14 -68.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.176 -0.952 . . . . 0.0 110.436 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 68' ' ' ILE . . . -77.38 -49.23 7.51 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.942 ' CE ' HD11 ' A' ' 84' ' ' LEU 0.253 0.0 OUTLIER -48.91 -41.4 33.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.029 1.395 . . . . 0.0 108.268 179.187 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 67' ' ' GLU 0.323 0.0 OUTLIER -77.29 -30.34 54.17 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.737 -179.217 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.841 ' HB2' HD13 ' A' ' 78' ' ' LEU . 6.1 tt0 -86.33 10.24 15.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.868 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 46' ' ' ALA . 33.9 m -48.92 -52.88 22.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.648 -1.283 . . . . 0.0 108.039 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 74' ' ' VAL . 18.3 m -90.48 116.45 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.59 -0.694 . . . . 0.0 109.456 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -48.49 98.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.174 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.965 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -128.27 38.77 3.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.865 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.4 pt-20 39.24 60.45 1.51 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.633 0.73 . . . . 0.0 110.038 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 72' ' ' GLU . 0.4 OUTLIER -27.98 119.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.494 0.664 . . . . 0.0 111.927 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.714 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 1.1 mttp -85.35 -167.68 0.15 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 43.1 Cg_endo -82.81 -29.02 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.305 1.161 . . . . 0.0 109.135 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.52 ' HB2' HG21 ' A' ' 57' ' ' THR . 42.0 p-10 -106.15 -7.3 18.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.61 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 13.9 m -48.08 128.7 14.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.555 -1.34 . . . . 0.0 110.072 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.649 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -142.29 164.17 30.86 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.82 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.942 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -74.94 136.83 41.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.824 -0.548 . . . . 0.0 111.943 -178.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.605 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 1.9 p -55.99 -22.7 28.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.882 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.1 p -107.13 28.95 7.54 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.309 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.558 ' NE2' ' HA ' ' A' ' 87' ' ' GLN . 2.7 mm-40 -126.08 -41.28 1.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.175 . . . . 0.0 112.103 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -79.85 146.21 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.689 -178.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.9 mm -111.1 158.86 11.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 4.0 tpt -110.14 114.47 28.0 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.072 -1.017 . . . . 0.0 110.488 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -95.7 165.83 15.8 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.326 -0.858 . . . . 0.0 109.669 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.3 Cg_endo -70.51 -30.01 19.46 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.837 1.441 . . . . 0.0 110.965 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 1.5 pp20? -83.46 -41.39 18.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.982 -1.074 . . . . 0.0 109.911 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.898 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.6 mt -79.42 60.82 3.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB2' ' CB ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -101.16 153.61 19.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.862 -1.149 . . . . 0.0 111.652 -178.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 103.48 19.52 12.2 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.79 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -59.32 126.72 17.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.453 1.12 . . . . 0.0 112.537 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.517 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 2.8 t -105.73 116.63 49.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.972 HG21 ' CE1' ' A' ' 5' ' ' TYR . 1.5 t -104.11 -178.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 122.354 1.074 . . . . 0.0 110.542 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.618 ' H ' HG12 ' A' ' 99' ' ' VAL . 5.1 m-20 -162.05 140.24 8.98 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.035 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 52.5 t -96.59 112.08 59.07 Favored Pre-proline 0 N--CA 1.499 1.999 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.017 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.709 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 44.7 Cg_endo -73.57 98.32 1.03 Allowed 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.105 1.87 . . . . 0.0 113.928 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.629 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -111.6 87.39 2.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.713 -1.242 . . . . 0.0 109.522 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.552 ' NE ' ' C ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -110.19 22.6 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.866 -1.146 . . . . 0.0 111.683 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.457 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 5.5 tp60 -64.02 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.226 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.512 ' N ' ' O ' ' A' ' 104' ' ' ARG . 98.6 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.231 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.41 0.624 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 6.2 tmtm? -79.98 109.32 14.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.012 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.9 t -111.37 143.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.997 -1.064 . . . . 0.0 110.75 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.863 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.1 t -130.89 125.09 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.232 1.015 . . . . 0.0 109.519 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.96 ' CD1' HG21 ' A' ' 99' ' ' VAL 0.284 36.6 m-85 -101.02 138.32 38.22 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.585 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG13 ' HG2' ' A' ' 12' ' ' ARG . 3.5 t -121.79 158.02 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.454 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.534 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 60.7 p -120.03 137.86 53.85 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.573 ' ND1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -43.84 -23.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.018 -1.051 . . . . 0.0 110.409 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' OD2' ' HB ' ' A' ' 11' ' ' THR . 6.6 p-10 -85.94 -3.5 58.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.086 -1.009 . . . . 0.0 110.577 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.22 -42.01 2.08 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.832 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.53 ' CG2' ' CZ ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -49.56 134.48 19.58 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 120.968 -1.313 . . . . 0.0 109.869 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.765 ' HG2' HG13 ' A' ' 6' ' ' VAL . 4.8 mtm180 -130.08 160.68 32.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.036 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.73 ' CG ' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -138.4 123.06 18.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.085 -1.009 . . . . 0.0 110.062 178.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.57 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.2 mp0 -95.36 128.27 42.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.85 HD11 ' CA ' ' A' ' 27' ' ' ALA . 9.0 mt -121.13 146.2 47.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.048 -1.032 . . . . 0.0 111.718 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 16.2 p30 -100.86 90.05 4.07 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.971 HG22 ' HB2' ' A' ' 26' ' ' ALA . 42.5 t -98.85 171.49 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 111.064 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -118.82 -134.16 0.33 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 0.0 110.546 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -110.13 124.36 51.39 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.276 -0.89 . . . . 0.0 110.527 -179.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.39 -8.28 30.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.383 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 22' ' ' SER . 95.9 t -96.07 170.13 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.288 . . . . 0.0 110.651 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.599 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.98 171.72 8.44 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.88 -28.19 67.31 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.21 179.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.781 ' SD ' HG23 ' A' ' 28' ' ' VAL . 0.7 OUTLIER -86.86 4.7 40.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.583 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.569 ' CG ' HG13 ' A' ' 21' ' ' VAL . 5.9 tt0 -101.22 -64.72 1.02 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.15 -0.969 . . . . 0.0 109.372 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.971 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -51.24 -47.79 62.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.043 -1.036 . . . . 0.0 108.212 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.934 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -60.36 -53.28 59.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.781 HG23 ' SD ' ' A' ' 24' ' ' MET 0.279 0.8 OUTLIER -36.84 -58.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.65 0.738 . . . . 0.0 109.011 178.006 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.704 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.137 0.97 . . . . 0.0 108.459 178.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.587 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.1 m-80 -64.55 -5.0 4.62 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.506 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 74.29 2.06 61.98 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.934 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 3.0 mt -50.22 -30.1 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.329 -1.1 . . . . 0.0 109.393 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.66 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 54.0 m-85 -105.98 53.39 0.71 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 112.064 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.24 45.85 0.39 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 108.599 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.935 HD11 ' OG1' ' A' ' 47' ' ' THR . 1.3 tt -120.26 173.24 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 121.459 -0.776 . . . . 0.0 109.072 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.923 ' O ' HG21 ' A' ' 47' ' ' THR . 2.5 p -79.8 87.58 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 110.159 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 126.98 6.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 12.1 p30 -107.57 59.97 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 42' ' ' SER . 1.2 p -110.65 -57.35 2.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.307 -0.871 . . . . 0.0 110.797 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.13 41.96 11.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.32 37.03 22.32 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 10.2 t -126.96 -22.24 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 111.152 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB1' ' NE2' ' A' ' 87' ' ' GLN . . . 58.22 60.72 2.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 111.381 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.61 7.18 4.45 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.349 -0.845 . . . . 0.0 110.455 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.871 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.68 116.36 30.64 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.254 -0.904 . . . . 0.0 112.069 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.826 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . -74.98 0.31 16.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.935 ' OG1' HD11 ' A' ' 35' ' ' ILE . 9.4 t -85.42 -29.55 24.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.903 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.833 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -89.38 11.79 18.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.017 -1.052 . . . . 0.0 109.384 179.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.67 ' NE2' HD21 ' A' ' 71' ' ' LEU . 11.1 t-160 -42.5 139.83 1.41 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.556 -0.715 . . . . 0.0 109.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 48' ' ' CYS . 34.9 m -146.51 154.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 122.09 0.948 . . . . 0.0 109.929 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.703 ' CZ ' ' HB3' ' A' ' 82' ' ' SER . 11.9 m-85 -121.67 129.34 52.7 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.264 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.872 ' HB ' HG22 ' A' ' 57' ' ' THR . 19.1 t -96.12 167.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.772 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.783 ' O ' HG23 ' A' ' 57' ' ' THR . 25.3 p-10 -91.97 136.1 33.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.722 -1.237 . . . . 0.0 109.337 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 53' ' ' ASN . 10.8 pt-20 -37.1 -26.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.81 . . . . 0.0 111.989 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -69.81 -16.52 63.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.871 -1.143 . . . . 0.0 111.681 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 68.1 m-85 -131.11 -10.81 3.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.729 -1.232 . . . . 0.0 110.945 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.872 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -80.57 -26.82 37.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 109.018 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 5.7 p-10 -73.4 -31.59 63.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.983 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.829 ' HB2' HD11 ' A' ' 94' ' ' LEU . 1.5 mmtt -79.92 -53.0 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.804 HG11 HG21 ' A' ' 88' ' ' ILE . 5.4 m -40.43 147.04 0.4 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.514 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 41.3 Cg_endo -68.52 170.7 14.43 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.397 1.735 . . . . 0.0 111.146 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 135.4 36.0 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.33 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -69.2 177.09 2.9 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.631 -0.668 . . . . 0.0 110.884 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -100.22 -156.13 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.338 -0.851 . . . . 0.0 111.015 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.7 pp20? -80.34 -30.79 38.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.585 -0.697 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' O ' ' HE3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -65.0 -37.8 88.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.126 -0.984 . . . . 0.0 109.449 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.705 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 2.3 tm-20 -67.73 -6.89 23.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.684 -0.635 . . . . 0.0 109.478 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 ' CD1' ' OE1' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -91.47 -35.57 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 110.909 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' MET . . . -77.36 -65.31 1.95 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.174 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.192 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -48.71 -48.55 40.27 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.017 1.389 . . . . 0.0 108.333 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.113 HD22 HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -58.91 -30.47 67.84 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.184 -176.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -81.26 -39.58 25.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.6 -0.688 . . . . 0.0 109.476 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.32 -41.53 38.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.079 -1.013 . . . . 0.0 108.816 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.826 HG13 ' HB1' ' A' ' 46' ' ' ALA . 2.8 m -90.42 67.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.734 ' O ' HG23 ' A' ' 75' ' ' THR . 8.0 t -48.79 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.685 -0.635 . . . . 0.0 111.349 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.02 ' HB2' ' HG2' ' A' ' 104' ' ' ARG . . . -130.16 64.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.4 pt-20 39.49 60.16 1.64 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.241 1.02 . . . . 0.0 109.813 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.113 HD11 HD22 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -46.87 134.65 9.91 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.991 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -125.36 -176.86 0.5 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 38.0 Cg_endo -67.04 -25.53 44.04 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.173 1.091 . . . . 0.0 111.297 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 26.0 p-10 -97.91 -13.13 21.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.813 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.703 ' HB3' ' CZ ' ' A' ' 51' ' ' TYR . 1.4 m -54.44 151.34 7.83 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.596 -1.315 . . . . 0.0 109.761 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.733 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -175.63 163.76 2.94 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.188 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.192 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -83.16 145.09 29.39 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.489 -0.757 . . . . 0.0 109.986 179.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 33' ' ' TYR . 60.3 p -40.83 -32.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 123.116 1.436 . . . . 0.0 107.973 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.062 ' SG ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -94.35 46.39 1.15 Allowed 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.78 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.655 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -127.43 -43.29 1.61 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.493 -1.379 . . . . 0.0 113.374 -178.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.804 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -103.28 152.88 5.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 122.044 0.926 . . . . 0.0 112.341 -176.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 6.9 mm -106.35 165.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.541 ' CE ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tpt -110.17 117.7 34.39 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.385 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 10.4 p -95.41 165.67 16.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.648 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.9 Cg_endo -73.25 -1.38 10.52 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.929 1.489 . . . . 0.0 110.345 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -110.08 -51.79 2.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 109.097 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 59' ' ' LYS . 1.3 mt -65.85 57.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.501 -0.749 . . . . 0.0 110.474 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.528 ' CB ' ' HA ' ' A' ' 1' ' ' SER . 1.8 p30 -101.74 142.9 32.37 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.967 -1.083 . . . . 0.0 112.721 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.654 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.68 23.82 8.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.012 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.78 149.99 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.344 1.068 . . . . 0.0 112.904 -177.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.62 HG23 ' ND2' ' A' ' 53' ' ' ASN . 22.1 t -115.09 123.99 71.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.788 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.96 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.1 t -103.94 176.7 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.828 -1.17 . . . . 0.0 109.423 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 51' ' ' TYR . 3.0 m-20 -162.53 143.85 10.31 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.349 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG12 ' ND1' ' A' ' 8' ' ' HIS . 53.2 t -94.26 132.98 28.0 Favored Pre-proline 0 C--N 1.287 -2.128 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.608 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.679 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 37.8 Cg_endo -79.42 135.21 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.548 1.289 . . . . 0.0 112.852 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.564 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 3.9 t70 -110.79 103.81 12.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 109.638 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 1.02 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.33 25.21 12.04 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.345 -0.847 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -120.0 -159.17 0.77 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 110.165 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.57 ' HA ' ' CE3' ' A' ' 106' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.259 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.513 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.313 0.578 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -71.34 123.07 21.46 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.827 HG22 ' CG2' ' A' ' 97' ' ' ILE . 35.1 t -124.3 144.15 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.515 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.788 ' O ' HG23 ' A' ' 99' ' ' VAL . 14.8 t -131.9 124.54 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.486 0.66 . . . . 0.0 109.317 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.03 ' CD1' HG21 ' A' ' 99' ' ' VAL . 69.6 m-85 -102.73 141.6 35.28 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.652 -0.655 . . . . 0.0 111.434 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.074 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.7 t -120.84 148.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.901 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 2.2 p -110.15 139.33 45.41 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 103' ' ' ASP . 0.3 OUTLIER -45.36 -22.11 0.12 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.085 -1.009 . . . . 0.0 110.023 -179.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 7' ' ' SER . 9.9 p-10 -82.46 -7.66 59.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.987 -1.071 . . . . 0.0 110.374 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.54 -36.87 4.02 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.173 -0.954 . . . . 0.0 111.673 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.525 HG22 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.64 145.33 5.16 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.586 -1.538 . . . . 0.0 109.499 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.717 ' HG2' HG13 ' A' ' 6' ' ' VAL . 9.8 mtt180 -130.05 158.03 40.75 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.573 -0.704 . . . . 0.0 111.187 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.683 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.6 ttp180 -140.19 122.07 15.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.573 ' CG ' HG22 ' A' ' 4' ' ' VAL . 1.1 mp0 -98.86 123.19 42.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.725 -1.234 . . . . 0.0 110.79 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.793 HD12 ' CE2' ' A' ' 5' ' ' TYR . 9.4 mt -110.4 147.92 33.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -99.96 90.16 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.861 HG22 ' HB2' ' A' ' 26' ' ' ALA . 55.9 t -98.83 172.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 111.045 -177.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.582 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -124.64 -140.77 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.682 . . . . 0.0 110.324 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -103.91 123.42 47.11 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.63 -3.07 29.15 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.59 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 22' ' ' SER . 58.1 t -102.52 169.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.732 -1.451 . . . . 0.0 110.519 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.594 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.53 165.29 15.88 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.808 -0.557 . . . . 0.0 109.553 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -55.57 -33.94 64.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.637 -1.289 . . . . 0.0 107.602 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.773 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 1.5 ttt -68.43 -65.83 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.553 ' CG ' HG13 ' A' ' 21' ' ' VAL . 6.4 tt0 -38.05 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.861 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -43.8 -56.7 3.67 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.418 -1.426 . . . . 0.0 109.187 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.799 ' HB1' ' CG2' ' A' ' 32' ' ' ILE . . . -54.3 -58.71 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.929 0.871 . . . . 0.0 109.535 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.774 HG12 ' N ' ' A' ' 29' ' ' SER 0.277 1.2 t -31.37 -63.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.563 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.774 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.64 -47.04 87.15 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.119 0.961 . . . . 0.0 109.042 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.584 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 4.9 m-80 -59.67 -9.69 2.93 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 84.67 -9.89 63.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.799 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 7.8 mt -41.99 -34.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.591 -0.947 . . . . 0.0 109.058 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.773 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.2 m-85 -106.81 61.04 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.858 . . . . 0.0 111.9 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.43 43.45 0.18 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.672 -1.267 . . . . 0.0 109.147 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.614 HD11 ' HB ' ' A' ' 47' ' ' THR . 0.2 OUTLIER -120.76 126.64 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.311 -0.868 . . . . 0.0 109.48 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' H ' HG12 ' A' ' 36' ' ' VAL . 3.0 p -80.0 117.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.44 -156.96 10.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -115.25 3.37 14.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.231 -1.158 . . . . 0.0 110.116 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 8.5 p -69.53 -39.91 77.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.534 -0.729 . . . . 0.0 111.683 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 47.33 29.94 5.52 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.8 36.08 23.32 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.751 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -140.33 7.24 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.165 -1.197 . . . . 0.0 111.915 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 71.44 53.28 0.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 0.0 112.329 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.569 ' CA ' ' HG2' ' A' ' 70' ' ' MET . 0.3 OUTLIER -132.57 34.35 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.933 ' O ' HD11 ' A' ' 84' ' ' LEU . 1.2 p -111.39 122.26 47.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 -175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -85.82 7.85 22.29 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.127 -1.608 . . . . 0.0 107.887 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.614 ' HB ' HD11 ' A' ' 35' ' ' ILE . 10.2 p -110.84 -42.47 4.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.757 . . . . 0.0 112.121 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.856 ' O ' HG13 ' A' ' 50' ' ' VAL . 2.6 m -75.34 19.16 0.18 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.54 -1.35 . . . . 0.0 111.791 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.638 ' HD1' HG23 ' A' ' 74' ' ' VAL . 5.0 t-160 -45.58 137.25 5.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.576 -1.327 . . . . 0.0 108.225 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 48' ' ' CYS . 17.3 m -139.63 155.2 25.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.775 -1.203 . . . . 0.0 109.952 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.1 m-30 -119.02 122.18 41.57 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.153 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 57' ' ' THR . 5.2 t -100.55 174.66 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.325 -0.859 . . . . 0.0 109.859 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.95 ' O ' HG23 ' A' ' 57' ' ' THR . 10.2 p30 -94.68 137.36 33.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.768 -1.208 . . . . 0.0 109.075 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 53' ' ' ASN . 8.9 pm0 -37.98 -25.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.342 -0.849 . . . . 0.0 111.625 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.923 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -71.49 -44.74 64.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 111.875 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.648 ' O ' HG13 ' A' ' 60' ' ' VAL . 53.4 m-85 -99.12 -9.45 23.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.658 -1.277 . . . . 0.0 111.831 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.95 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -80.29 -33.11 37.95 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.521 -1.362 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.91 -27.02 57.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.67 ' CB ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -79.93 -53.72 6.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.809 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 56' ' ' PHE . 11.9 m -41.17 163.49 0.1 Allowed Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 121.472 -0.767 . . . . 0.0 110.337 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 37.5 Cg_endo -64.89 161.86 34.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.032 1.543 . . . . 0.0 111.915 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.63 26.27 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.815 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.59 152.72 44.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.494 -0.754 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.59 ' O ' HD13 ' A' ' 68' ' ' ILE . 27.6 p-10 -100.18 -173.04 2.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.102 -0.999 . . . . 0.0 111.187 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -54.43 -18.63 4.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.792 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.529 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -64.51 -55.77 18.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.1 tm-20 -59.55 -5.1 0.75 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.837 -0.539 . . . . 0.0 111.4 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.3 mp -91.25 -16.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.344 -1.472 . . . . 0.0 111.488 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.29 -82.45 1.37 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.666 -1.271 . . . . 0.0 110.388 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.095 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -47.84 -33.74 7.81 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.005 -1.291 . . . . 0.0 109.755 -178.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.019 HD22 HD11 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -65.09 -29.32 70.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -90.32 -23.8 21.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.541 -0.724 . . . . 0.0 109.575 178.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.576 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 16.2 m -48.94 -44.72 40.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 108.779 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.638 HG23 ' HD1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -90.53 80.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.042 178.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.777 ' O ' HG23 ' A' ' 75' ' ' THR . 8.8 t -47.9 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.423 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.914 ' HB2' ' HD3' ' A' ' 104' ' ' ARG . . . -118.83 55.41 0.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -0.753 . . . . 0.0 109.777 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' C ' ' A' ' 78' ' ' LEU . 1.6 pm0 39.54 48.64 1.84 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 109.457 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.019 HD11 HD22 ' A' ' 71' ' ' LEU . 1.7 tp -19.81 133.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.524 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.633 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -100.81 170.66 6.31 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -68.16 -27.77 34.98 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.559 1.294 . . . . 0.0 109.46 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 57' ' ' THR . 24.4 p-10 -105.77 -4.65 20.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.579 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 69.9 m -48.83 158.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.791 -1.193 . . . . 0.0 111.036 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.605 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -175.11 167.57 3.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.634 -0.666 . . . . 0.0 109.627 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.095 HD12 ' CE ' ' A' ' 70' ' ' MET . 0.7 OUTLIER -88.68 143.82 26.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.982 . . . . 0.0 110.368 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.654 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 6.4 p -46.57 -36.39 6.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 110.576 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.469 ' SG ' ' OG ' ' A' ' 85' ' ' SER . 12.1 m -94.04 37.43 1.09 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 111.386 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.736 HE21 ' HB2' ' A' ' 43' ' ' ALA . 2.9 mm-40 -126.65 -43.27 1.74 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 112.259 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.795 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -84.18 148.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.549 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.8 mm -111.07 164.17 7.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.762 -0.586 . . . . 0.0 109.788 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.608 ' HE2' ' HB ' ' A' ' 97' ' ' ILE . 2.0 tpt -110.28 86.96 2.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.303 -0.873 . . . . 0.0 110.028 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.469 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 1.3 p -70.54 163.41 63.6 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.46 -0.775 . . . . 0.0 109.858 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -76.93 0.84 9.26 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.9 1.474 . . . . 0.0 110.144 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.541 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 22.8 pt-20 -110.03 -21.28 12.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 109.47 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.67 HD13 ' CB ' ' A' ' 59' ' ' LYS . 10.5 mt -103.98 63.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 109.826 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.55 147.45 25.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.476 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.12 24.36 9.05 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.827 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -65.05 122.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 122.748 1.261 . . . . 0.0 113.045 -176.33 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.469 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 3.8 t -98.75 116.03 40.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.486 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.03 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -104.34 -175.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.38 1.086 . . . . 0.0 110.381 -179.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.659 ' H ' HG12 ' A' ' 99' ' ' VAL . 11.5 m-20 -161.99 139.81 8.81 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.128 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.074 HG23 ' O ' ' A' ' 6' ' ' VAL . 5.3 t -96.06 108.04 38.57 Favored Pre-proline 0 C--N 1.289 -2.048 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 42.1 Cg_endo -68.02 91.96 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.175 1.619 . . . . 0.0 110.904 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . 0.5 OUTLIER -110.16 108.11 18.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.969 -1.082 . . . . 0.0 110.401 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.914 ' HD3' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.31 140.17 44.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.238 -0.914 . . . . 0.0 110.066 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -120.12 2.85 10.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 11.4 m95 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.202 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' CA ' ' O ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.513 0.673 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.26 105.91 4.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.007 HG22 ' CG2' ' A' ' 97' ' ' ILE . 4.8 t -109.94 145.92 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.051 -1.031 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 6.7 t -131.19 132.55 63.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.438 -0.789 . . . . 0.0 109.538 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.732 ' HE1' ' HB3' ' A' ' 23' ' ' LEU . 70.9 m-85 -110.21 129.04 55.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.011 0.91 . . . . 0.0 112.02 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.2 t -102.08 119.46 50.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.762 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.663 ' CB ' HG22 ' A' ' 11' ' ' THR . 91.5 p -79.62 130.29 35.23 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.607 ' CG ' ' HB3' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -38.18 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.749 -0.594 . . . . 0.0 111.049 -179.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' SER . 1.8 p30 -79.36 -3.07 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.989 -1.069 . . . . 0.0 110.672 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' SER . . . 109.99 -33.48 5.99 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.663 HG22 ' CB ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.71 142.06 9.06 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.946 -1.326 . . . . 0.0 109.29 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HG2' HG13 ' A' ' 6' ' ' VAL . 27.8 mtt180 -126.98 120.84 30.04 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.345 0.593 . . . . 0.0 111.074 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 3.0 ttp180 -99.94 153.04 19.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 5.3 mt-10 -130.51 134.09 46.77 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.852 -1.155 . . . . 0.0 110.238 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.835 HD13 ' CB ' ' A' ' 26' ' ' ALA . 7.4 mt -122.13 144.32 49.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 111.145 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -99.91 86.28 3.24 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.996 HG22 ' HB2' ' A' ' 26' ' ' ALA . 43.8 t -98.43 172.84 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.59 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.575 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -125.78 -146.52 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 111.282 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -96.71 122.07 39.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.594 0.712 . . . . 0.0 110.354 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.23 -13.14 31.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 22' ' ' SER . 32.7 t -88.26 169.74 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.018 -1.284 . . . . 0.0 110.258 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.581 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.49 152.24 39.37 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.813 HD13 HG11 ' A' ' 99' ' ' VAL . 5.4 mt -52.17 -23.29 5.28 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.336 -1.746 . . . . 0.0 107.788 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.755 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -73.17 -66.05 0.73 Allowed 'General case' 0 C--O 1.202 -1.421 0 CA-C-O 121.595 0.712 . . . . 0.0 109.887 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.558 ' NE2' ' HA ' ' A' ' 21' ' ' VAL 0.256 6.7 tt0 -37.13 -70.29 0.1 Allowed 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.735 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.996 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -49.66 -58.93 4.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.94 -1.725 . . . . 0.0 108.666 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.917 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -47.91 -58.74 4.0 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 108.888 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.801 HG12 ' N ' ' A' ' 29' ' ' SER 0.284 1.0 OUTLIER -34.29 -64.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.715 178.176 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.801 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.03 -46.96 86.9 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.872 0.844 . . . . 0.0 109.6 179.097 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.558 ' ND2' HD22 ' A' ' 15' ' ' LEU . 2.8 m-80 -59.87 -7.01 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.419 0.628 . . . . 0.0 109.735 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 89.59 -18.82 44.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 27' ' ' ALA . 59.5 mt -40.79 -38.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -1.028 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.755 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 23.4 m-85 -109.55 59.79 0.6 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.96 . . . . 0.0 113.224 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -66.76 -10.9 52.15 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 35' ' ' ILE . 2.4 tt -80.02 106.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.322 0.582 . . . . 0.0 110.294 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.9 t -85.85 131.55 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.05 -135.05 4.89 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -114.47 37.98 3.22 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.185 -1.186 . . . . 0.0 109.99 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p -110.04 -36.0 5.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.781 -0.575 . . . . 0.0 109.792 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.26 31.2 4.52 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.0 32.03 37.33 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.738 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.6 m -131.45 5.32 4.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 0.0 111.172 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.763 ' O ' ' HE1' ' A' ' 70' ' ' MET . . . 71.09 47.93 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.242 -0.911 . . . . 0.0 112.312 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 3.2 m -133.16 44.53 2.82 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.053 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.96 153.5 25.43 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 73' ' ' CYS . . . -111.55 -3.45 15.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.229 -0.92 . . . . 0.0 108.826 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.59 ' HB ' HD11 ' A' ' 35' ' ' ILE . 21.6 p -110.18 -30.49 7.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.272 -0.892 . . . . 0.0 112.039 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.623 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 2.1 m -80.32 34.0 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.545 -1.347 . . . . 0.0 110.964 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HD1' HG23 ' A' ' 74' ' ' VAL . 8.0 t-160 -60.7 132.8 55.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.923 -1.111 . . . . 0.0 108.091 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 83' ' ' ARG . 19.0 m -139.44 155.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.783 -1.198 . . . . 0.0 109.939 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 4.3 m-30 -116.21 106.34 13.58 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.928 0.871 . . . . 0.0 109.587 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.064 HG13 HD11 ' A' ' 97' ' ' ILE . 15.8 t -88.09 148.47 4.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.613 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -73.08 127.4 32.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 119.516 -1.99 . . . . 0.0 109.661 178.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 16.8 pt-20 -34.38 -35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.698 -0.626 . . . . 0.0 111.621 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -55.26 -16.61 3.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.666 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 60.4 m-85 -128.66 -16.17 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 0.0 110.683 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.845 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -80.29 -32.01 38.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 108.984 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.1 p-10 -74.52 -27.28 60.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.425 -0.797 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.763 ' CB ' HD13 ' A' ' 94' ' ' LEU . 2.2 mmtt -79.88 -53.7 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.498 -0.752 . . . . 0.0 109.763 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 57' ' ' THR . 12.3 m -42.98 166.83 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 110.029 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.7 Cg_endo -62.26 162.16 24.4 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.966 1.508 . . . . 0.0 111.96 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.91 125.32 29.97 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.044 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . . . -69.78 146.28 51.56 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 109.768 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' ND2' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -100.65 -172.37 2.18 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.108 -0.995 . . . . 0.0 111.972 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -53.97 -20.81 6.78 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.59 . . . . 0.0 110.869 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 4.3 ttm180 -64.09 -55.59 20.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 109.47 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 3.3 tt0 -58.64 -49.97 75.55 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.716 -0.615 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.533 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 1.3 mp -48.01 -26.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 111.457 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.75 -68.7 1.19 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.028 ' CE ' HD12 ' A' ' 84' ' ' LEU . 2.2 ptm -48.51 -41.47 30.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.83 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 71' ' ' LEU 0.25 0.0 OUTLIER -71.1 -24.19 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.925 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 2.5 tt0 -90.78 -13.41 33.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.731 -0.605 . . . . 0.0 109.87 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.748 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 9.7 m -48.52 -49.68 35.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.878 -1.139 . . . . 0.0 108.861 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.616 HG23 ' HD1' ' A' ' 49' ' ' HIS . 4.3 m -90.32 92.9 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.791 ' O ' HG23 ' A' ' 75' ' ' THR . 9.1 t -48.29 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.369 -0.832 . . . . 0.0 110.757 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.869 ' HB2' ' HD3' ' A' ' 104' ' ' ARG . . . -124.49 50.59 1.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 20.1 pt-20 39.39 60.1 1.62 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.634 0.73 . . . . 0.0 109.609 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.571 HD11 HD13 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -30.54 122.06 0.2 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.573 0.702 . . . . 0.0 111.806 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -86.05 171.21 10.87 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.8 Cg_endo -66.72 -25.91 46.05 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.46 1.242 . . . . 0.0 109.485 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' A' ' 57' ' ' THR . 6.7 p-10 -109.87 -4.13 16.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.619 -0.676 . . . . 0.0 111.394 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CG ' ' A' ' 79' ' ' LYS . 69.2 m -48.71 143.9 4.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.674 -1.266 . . . . 0.0 110.588 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.831 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.86 165.53 36.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.0 110.046 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.053 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -88.4 143.08 27.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.362 -0.836 . . . . 0.0 109.369 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.623 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 5.7 p -46.64 -46.37 19.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.74 -1.225 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -91.91 38.82 1.0 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.598 -0.689 . . . . 0.0 109.893 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.736 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 4.5 tp-100 -123.28 -40.99 2.33 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.41 -0.806 . . . . 0.0 111.318 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.902 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -92.73 149.73 4.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.31 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 89' ' ' ILE . 4.6 mm -110.7 164.28 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.603 ' HE3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.4 126.37 54.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.96 -1.088 . . . . 0.0 110.544 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.482 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.55 159.86 28.06 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.536 -0.728 . . . . 0.0 109.722 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 42.5 Cg_endo -72.71 -1.61 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.915 1.481 . . . . 0.0 110.514 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 2.4 pt-20 -110.06 -28.59 8.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.588 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.763 HD13 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -93.48 37.77 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.073 0.94 . . . . 0.0 109.286 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' CB ' ' OG ' ' A' ' 1' ' ' SER . 1.6 p-10 -82.06 142.83 31.98 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.707 0.765 . . . . 0.0 112.196 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 100.36 28.33 7.23 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.064 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -77.99 133.7 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 122.173 0.987 . . . . 0.0 112.483 -177.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.552 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 16.5 t -102.44 101.63 12.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.373 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.95 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.59 170.15 2.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.176 -1.41 . . . . 0.0 110.063 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -144.32 172.19 13.27 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 122.197 0.999 . . . . 0.0 111.57 -176.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 102' ' ' PRO . 98.9 t -107.08 109.4 62.99 Favored Pre-proline 0 C--N 1.297 -1.715 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.264 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.646 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 47.0 Cg_endo -71.09 94.99 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.981 1.516 . . . . 0.0 111.585 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.607 ' HB3' ' CG ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -110.33 112.9 25.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.851 -1.156 . . . . 0.0 109.876 178.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.869 ' HD3' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.66 113.62 26.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.61 5.32 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 110.251 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.21 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.543 ' HB3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -70.18 125.28 26.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.698 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.663 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 3.2 t -121.76 136.88 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.975 -1.078 . . . . 0.0 110.231 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.911 HG13 ' CG ' ' A' ' 14' ' ' GLU . 95.1 t -121.14 110.75 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.247 -0.908 . . . . 0.0 112.197 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.108 ' OH ' HD12 ' A' ' 15' ' ' LEU . 19.6 m-30 -82.27 131.4 35.23 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.423 0.63 . . . . 0.0 111.708 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 99' ' ' VAL . 4.4 t -120.49 128.78 76.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.064 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.666 ' HB3' HG22 ' A' ' 11' ' ' THR . 26.8 p -79.33 -159.78 0.21 Allowed 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.95 -1.1 . . . . 0.0 108.5 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.551 ' CB ' ' HB2' ' A' ' 103' ' ' ASP . 0.3 OUTLIER -101.5 -11.33 19.39 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.895 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.55 -0.75 37.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 0.0 109.565 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 -19.9 26.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.82 143.04 7.99 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.958 -1.319 . . . . 0.0 109.223 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 17.2 mtt180 -124.1 139.21 54.16 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.428 0.633 . . . . 0.0 111.329 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.655 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -140.25 67.82 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.911 ' CG ' HG13 ' A' ' 4' ' ' VAL . 4.0 mp0 -67.51 140.97 57.05 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.919 -1.113 . . . . 0.0 110.849 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.108 HD12 ' OH ' ' A' ' 5' ' ' TYR . 8.8 mt -109.72 150.76 27.84 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.691 -0.631 . . . . 0.0 110.043 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.35 85.78 3.26 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 26' ' ' ALA . 40.7 t -98.76 171.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.666 0.746 . . . . 0.0 111.337 -176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.578 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -118.57 -139.22 0.35 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.454 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -105.58 125.73 51.33 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.452 -0.78 . . . . 0.0 110.198 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.67 29.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 22' ' ' SER . 61.1 t -102.18 170.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.933 -1.333 . . . . 0.0 110.199 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.616 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -120.73 160.33 23.56 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.762 HD21 ' SD ' ' A' ' 90' ' ' MET . 16.8 mt -54.97 -18.4 4.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.694 -1.254 . . . . 0.0 109.448 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 1.225 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -90.23 -58.18 2.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.257 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.543 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.7 tt0 -38.63 -64.77 0.41 Allowed 'General case' 0 C--N 1.289 -2.062 0 O-C-N 122.127 -0.358 . . . . 0.0 110.762 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.953 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -48.38 -55.97 9.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.437 -1.415 . . . . 0.0 108.283 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.777 ' HB1' ' CD1' ' A' ' 33' ' ' TYR . . . -52.72 -55.92 19.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 33' ' ' TYR 0.264 0.7 OUTLIER -37.32 -47.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.472 177.592 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.8 -43.81 21.76 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.017 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.582 ' CG ' HD21 ' A' ' 15' ' ' LEU . 1.7 m-80 -59.86 -8.08 2.01 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.439 0.638 . . . . 0.0 109.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.34 -18.4 18.53 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.592 HD13 ' HD2' ' A' ' 5' ' ' TYR . 58.2 mt -48.92 -29.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.851 -1.382 . . . . 0.0 107.643 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 3.1 m-85 -100.54 56.42 0.9 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 21.4 p-10 -70.81 56.17 0.18 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.512 -1.367 . . . . 0.0 107.397 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 33' ' ' TYR . 6.0 pt -79.65 -151.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 37' ' ' GLY . 2.0 t -118.09 -142.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.417 -0.802 . . . . 0.0 110.143 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -120.48 83.9 0.36 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.743 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.463 ' CB ' ' HA ' ' A' ' 45' ' ' CYS . 6.5 m-20 -120.23 -66.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.126 -1.22 . . . . 0.0 109.159 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.662 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 2.1 p -69.07 -14.13 62.84 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.741 -0.599 . . . . 0.0 110.23 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 48.26 25.48 4.22 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.03 28.81 61.71 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.3 p -140.23 28.09 2.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.3 . . . . 0.0 111.998 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 66.56 45.29 2.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 112.297 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.577 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -130.6 46.79 2.61 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.054 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -111.72 157.06 20.95 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -177.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.692 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -112.0 -9.76 13.98 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.677 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.2 p -110.48 -30.11 7.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -0.78 . . . . 0.0 112.618 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.863 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.4 m -73.99 66.88 1.23 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.31 -1.494 . . . . 0.0 110.197 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.619 ' HE2' ' HE1' ' A' ' 51' ' ' TYR . 4.0 t-160 -87.85 132.74 34.08 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 83' ' ' ARG . 17.1 m -142.29 155.24 18.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.693 -1.254 . . . . 0.0 109.277 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.694 ' CD1' ' HE2' ' A' ' 79' ' ' LYS . 5.1 m-30 -120.2 118.11 29.65 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 121.675 0.75 . . . . 0.0 111.015 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.791 ' HB ' HG22 ' A' ' 57' ' ' THR . 42.2 t -97.96 165.71 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.346 -0.846 . . . . 0.0 109.643 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.763 ' O ' HG23 ' A' ' 57' ' ' THR . 21.1 p-10 -89.41 138.31 31.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.38 -1.45 . . . . 0.0 109.388 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' O ' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -38.38 -26.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.382 -0.824 . . . . 0.0 111.441 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . . . -68.31 -18.0 64.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.965 -1.084 . . . . 0.0 111.551 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 38.5 m-85 -129.62 -14.44 4.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.776 -1.203 . . . . 0.0 110.796 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.791 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -80.88 -22.69 39.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.906 -1.121 . . . . 0.0 108.746 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -85.96 -23.97 26.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.825 . . . . 0.0 110.028 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HB3' HD22 ' A' ' 94' ' ' LEU . 9.2 mmtt -79.5 -47.66 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.452 -0.78 . . . . 0.0 109.111 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.897 HG11 ' CG2' ' A' ' 88' ' ' ILE . 6.3 m -45.3 161.39 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.786 -0.571 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.512 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.0 Cg_endo -65.19 163.34 29.43 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 112.325 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.21 124.14 29.04 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.76 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.631 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -88.66 160.26 17.45 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.621 ' O ' HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -100.55 -166.86 1.36 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 110.266 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.0 -24.27 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.838 . . . . 0.0 110.377 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HB2' ' ND2' ' A' ' 64' ' ' ASN . 4.1 ttm180 -64.79 -15.34 61.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.741 ' OE2' HD12 ' A' ' 71' ' ' LEU . 3.0 tp10 -100.28 -3.61 31.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.91 -59.3 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 111.445 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -72.88 -47.54 24.89 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.988 ' CE ' HD12 ' A' ' 84' ' ' LEU 0.33 1.3 ttp -48.79 -52.3 24.66 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 123.497 1.618 . . . . 0.0 108.666 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD12 ' OE2' ' A' ' 67' ' ' GLU 0.293 0.0 OUTLIER -68.39 -33.85 74.98 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.052 -1.885 . . . . 0.0 109.043 -179.21 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.684 ' HB2' HD22 ' A' ' 78' ' ' LEU . 6.7 tt0 -90.56 7.64 38.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.433 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.573 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . 5.5 m -48.83 -49.47 39.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.85 -1.156 . . . . 0.0 108.342 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.694 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.3 m -90.48 113.35 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.02 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.791 ' O ' HG23 ' A' ' 75' ' ' THR . 8.9 t -48.57 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.823 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.006 ' HB2' ' HG2' ' A' ' 104' ' ' ARG . . . -125.2 44.82 2.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.558 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 9.7 pt-20 39.56 60.53 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.43 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 72' ' ' GLU . 2.5 tp -32.17 133.59 0.1 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 21.3 mtmt -110.44 172.01 3.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.708 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.3 Cg_endo -66.26 -32.06 42.79 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.507 1.267 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.732 ' HB2' HG21 ' A' ' 57' ' ' THR . 14.5 p-10 -98.79 -10.84 22.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 110.466 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.501 ' OG ' ' HB2' ' A' ' 79' ' ' LYS . 50.2 m -48.92 150.51 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.883 -1.136 . . . . 0.0 109.724 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.666 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -157.59 151.43 24.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 110.186 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.054 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -73.17 130.45 40.29 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.63 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -44.81 -20.98 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.991 -1.068 . . . . 0.0 112.149 -176.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.225 ' SG ' ' SD ' ' A' ' 24' ' ' MET . 26.1 m -107.02 39.29 1.9 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.578 -1.326 . . . . 0.0 111.168 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.678 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 34.6 mm-40 -125.06 -45.26 1.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.661 0.743 . . . . 0.0 110.634 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.897 ' CG2' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.88 143.25 12.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.9 -179.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.0 mm -110.68 158.71 10.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 109.416 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.762 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.9 tpt -110.21 103.89 12.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -98.58 167.61 11.17 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.754 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.8 Cg_endo -72.6 -0.36 8.72 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.584 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 3.7 pt-20 -110.04 -32.08 7.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 109.55 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' CE ' ' A' ' 90' ' ' MET . 6.8 mt -94.66 35.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.16 0.981 . . . . 0.0 109.187 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 1' ' ' SER . 0.7 OUTLIER -87.94 154.58 20.39 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.667 0.746 . . . . 0.0 112.101 -177.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.642 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 94.37 24.14 19.75 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.765 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -80.5 152.24 4.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 122.274 1.035 . . . . 0.0 112.577 -177.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG23 ' ND2' ' A' ' 53' ' ' ASN . 17.6 t -112.68 123.56 68.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 4' ' ' VAL . 1.4 t -103.91 -175.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.86 -1.15 . . . . 0.0 109.933 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.675 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.9 m-20 -162.11 130.14 4.06 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.989 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 6' ' ' VAL . 54.0 t -89.19 110.36 37.86 Favored Pre-proline 0 C--N 1.277 -2.549 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.642 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 39.4 Cg_endo -65.03 134.7 40.78 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.029 1.542 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 8' ' ' HIS . 6.2 t0 -110.41 115.59 29.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.664 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 1.006 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.09 70.74 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.082 -1.011 . . . . 0.0 110.136 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.13 41.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.219 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.522 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.543 0.687 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -90.25 121.44 32.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.817 HG22 ' CG2' ' A' ' 97' ' ' ILE . 3.4 t -122.55 143.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.719 -1.238 . . . . 0.0 110.098 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.85 HG22 ' CG ' ' A' ' 14' ' ' GLU . 24.4 t -130.18 122.68 54.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.998 0.904 . . . . 0.0 109.147 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.913 ' HE2' HD13 ' A' ' 15' ' ' LEU . 42.1 m-85 -96.95 142.07 29.36 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.802 0.81 . . . . 0.0 111.035 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.002 HG13 ' HG3' ' A' ' 12' ' ' ARG . 2.9 t -113.48 114.66 47.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.39 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -79.6 124.56 28.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.611 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -32.4 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.005 -0.434 . . . . 0.0 112.144 -178.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.589 ' OD1' HG22 ' A' ' 11' ' ' THR . 2.6 p-10 -66.99 -9.51 39.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.682 -1.261 . . . . 0.0 110.141 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . 110.0 -31.73 7.25 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.589 HG22 ' OD1' ' A' ' 9' ' ' ASP . 2.7 t -61.58 133.61 55.86 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.965 -1.315 . . . . 0.0 109.272 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 1.002 ' HG3' HG13 ' A' ' 6' ' ' VAL . 13.4 mtm180 -118.53 132.3 56.21 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.169 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.687 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -103.03 149.15 24.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 179.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.85 ' CG ' HG22 ' A' ' 4' ' ' VAL . 22.9 mt-10 -130.41 120.1 23.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.771 -1.206 . . . . 0.0 110.949 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.913 HD13 ' HE2' ' A' ' 5' ' ' TYR . 1.4 mp -116.87 177.62 4.64 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.257 1.027 . . . . 0.0 111.914 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -106.75 83.14 1.8 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.986 HG22 ' CB ' ' A' ' 26' ' ' ALA . 58.6 t -98.54 129.22 49.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.538 -0.726 . . . . 0.0 110.305 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.477 ' HA ' ' OG ' ' A' ' 1' ' ' SER . . . -140.0 -171.47 3.18 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.523 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 90' ' ' MET . 1.9 p30 -41.23 115.4 0.6 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.856 0.836 . . . . 0.0 110.324 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.34 -22.23 22.89 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.661 ' HB ' HG13 ' A' ' 17' ' ' VAL . 2.4 t -107.88 157.49 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.849 -1.383 . . . . 0.0 110.86 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -120.96 166.69 13.47 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.671 HD22 HD12 ' A' ' 88' ' ' ILE . 5.1 mp -58.42 -22.09 53.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.368 -1.457 . . . . 0.0 107.897 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.87 ' SD ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -81.93 -72.12 0.45 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.643 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.608 ' HG2' HG13 ' A' ' 21' ' ' VAL . 4.8 tt0 -37.67 -67.6 0.19 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.877 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.986 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -42.37 -73.95 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.499 -1.376 . . . . 0.0 108.613 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.826 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . . . -44.85 -44.74 9.76 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -47.09 -60.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.714 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -50.27 -45.87 54.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.993 0.901 . . . . 0.0 108.748 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.804 ' ND2' HD21 ' A' ' 15' ' ' LEU . 1.5 m-80 -64.93 -2.34 2.58 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.789 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 11.68 84.54 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 15' ' ' LEU 0.268 3.8 mt -70.67 -31.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.568 -0.96 . . . . 0.0 109.134 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.751 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 49.4 m-85 -108.7 56.47 0.62 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.369 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -73.88 50.7 0.36 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.932 -1.105 . . . . 0.0 108.522 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.76 HD13 ' SG ' ' A' ' 48' ' ' CYS . 1.1 pp -81.74 -146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.565 -0.709 . . . . 0.0 110.862 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 37' ' ' GLY . 1.4 p -99.15 -156.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 0.0 110.46 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.67 ' N ' HG13 ' A' ' 36' ' ' VAL . . . -120.19 83.91 0.36 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 44' ' ' SER . 61.4 m-20 -120.15 -58.24 1.88 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 6.3 p -69.31 -28.0 65.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.798 -0.564 . . . . 0.0 110.709 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 46.44 28.07 3.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 80.28 35.47 26.6 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.729 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 5.0 p -140.11 8.38 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -1.204 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 86' ' ' CYS . . . 70.3 53.41 0.33 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.149 -0.969 . . . . 0.0 111.935 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -133.19 38.44 3.33 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.108 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -110.62 153.9 24.55 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.95 -2.22 16.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.658 -1.276 . . . . 0.0 108.789 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 p -110.02 -34.49 6.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 111.363 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.84 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.2 m -74.53 63.7 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.561 -1.337 . . . . 0.0 109.794 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.957 ' ND1' HG21 ' A' ' 74' ' ' VAL . 17.1 t-160 -91.78 133.13 35.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.601 HG11 ' OH ' ' A' ' 33' ' ' TYR . 16.9 m -144.58 154.82 14.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.808 -1.182 . . . . 0.0 109.943 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.727 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 7.7 m-30 -116.84 109.57 17.26 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.891 HG21 ' CD1' ' A' ' 88' ' ' ILE . 16.4 t -86.28 158.81 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.372 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 57' ' ' THR . 11.5 p-10 -78.81 132.43 36.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 119.997 -1.689 . . . . 0.0 109.918 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 53' ' ' ASN . 12.1 pt-20 -38.65 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.98 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -63.87 -23.13 67.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.033 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.643 ' CZ ' ' O ' ' A' ' 96' ' ' GLY . 24.9 m-85 -122.71 -15.27 7.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.926 -1.109 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.874 HG22 ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -78.65 -26.44 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.937 -1.105 . . . . 0.0 108.796 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 59' ' ' LYS . 6.0 p-10 -81.83 -26.2 34.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.533 -0.729 . . . . 0.0 109.692 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . 12.5 mmtt -79.79 -52.04 8.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.498 -0.751 . . . . 0.0 109.492 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 56' ' ' PHE . 10.3 m -40.76 162.55 0.1 Allowed Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.602 -0.686 . . . . 0.0 110.515 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.524 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 38.6 Cg_endo -66.74 165.57 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.068 1.562 . . . . 0.0 111.454 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.62 27.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.622 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -69.21 166.3 18.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.439 -0.788 . . . . 0.0 109.71 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.71 ' O ' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -100.45 -158.2 0.66 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.977 -1.077 . . . . 0.0 110.929 -179.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.2 pp20? -78.38 -23.16 46.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.694 -0.628 . . . . 0.0 111.069 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.565 ' O ' ' HG2' ' A' ' 70' ' ' MET . 0.0 OUTLIER -64.84 -48.46 74.28 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.801 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.591 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.2 tm-20 -59.11 -6.27 0.84 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.262 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -91.39 -30.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.617 -1.302 . . . . 0.0 110.668 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -90.28 -63.22 1.25 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.106 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -48.08 -42.64 29.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 109.222 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.911 HD13 HD11 ' A' ' 78' ' ' LEU 0.26 0.0 OUTLIER -69.45 -23.84 63.72 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.934 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -89.95 -18.68 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.511 -0.743 . . . . 0.0 110.029 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' GLU . 2.1 m -48.51 -31.43 6.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.957 HG21 ' ND1' ' A' ' 49' ' ' HIS . 20.4 m -90.32 87.17 2.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 75' ' ' THR . 9.3 t -48.41 82.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.269 -0.894 . . . . 0.0 111.506 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.901 ' HB2' ' NH2' ' A' ' 104' ' ' ARG . . . -130.39 40.85 3.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.987 -1.071 . . . . 0.0 110.426 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 10.0 pt-20 39.2 60.14 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.764 -0.585 . . . . 0.0 109.754 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.911 HD11 HD13 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -19.93 125.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.264 0.554 . . . . 0.0 112.104 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.626 ' HG3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -80.05 170.69 14.78 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 37.4 Cg_endo -65.85 -25.71 52.7 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.477 1.251 . . . . 0.0 109.564 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.675 ' HB2' HG21 ' A' ' 57' ' ' THR . 20.6 p-10 -107.79 -8.25 16.09 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 111.33 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 45.7 m -49.44 158.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.614 -1.304 . . . . 0.0 111.205 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' NH2' HG23 ' A' ' 88' ' ' ILE . 2.3 ttp180 -175.51 156.48 1.96 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.108 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -73.29 135.47 44.42 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.624 ' HG ' ' HE1' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -45.46 -24.3 0.3 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.585 -177.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.3 m -104.79 42.64 1.18 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.894 -1.128 . . . . 0.0 111.401 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.823 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -125.07 -42.53 2.01 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.717 0.77 . . . . 0.0 110.501 179.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.891 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -89.0 140.04 16.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.354 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 90' ' ' MET . 5.3 mm -110.68 172.56 2.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.933 ' CB ' HG12 ' A' ' 17' ' ' VAL . 1.2 tpt -110.15 115.85 30.48 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.13 -0.982 . . . . 0.0 111.029 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.471 ' OG1' ' HG ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -96.8 169.56 8.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.664 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.9 -5.65 17.58 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.885 1.466 . . . . 0.0 110.556 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' CD2' ' A' ' 94' ' ' LEU . 10.8 pt-20 -110.29 -23.94 10.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.701 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 7.2 mt -96.39 55.9 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -0.995 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -100.84 146.51 27.21 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.066 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.643 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 102.59 21.73 10.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.817 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -62.48 150.47 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.183 0.992 . . . . 0.0 113.243 -177.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.668 HG23 ' ND2' ' A' ' 53' ' ' ASN . 10.9 t -127.61 89.82 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.977 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.72 162.49 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 122.441 1.115 . . . . 0.0 110.51 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.571 ' OD2' HG21 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -145.51 170.13 17.01 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.913 -178.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.504 HG12 ' ND1' ' A' ' 8' ' ' HIS . 42.3 t -110.17 128.84 24.69 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.727 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 37.5 Cg_endo -71.73 106.38 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.771 1.406 . . . . 0.0 112.942 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.611 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.81 10.01 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.901 ' NH2' ' HB2' ' A' ' 76' ' ' ALA 0.265 0.0 OUTLIER -29.59 143.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.087 178.883 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.471 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.7 mm100 -120.17 94.62 4.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 75' ' ' THR . 6.7 m95 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.559 ' N ' ' HA ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.366 0.603 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.6 ttmm -76.63 135.12 39.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.903 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.77 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 14.8 t -123.43 140.39 47.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.614 -1.304 . . . . 0.0 110.865 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.866 HG13 ' HG2' ' A' ' 14' ' ' GLU . 41.4 t -121.5 117.91 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 122.052 0.93 . . . . 0.0 111.504 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.097 ' CE2' HD13 ' A' ' 15' ' ' LEU . 22.5 m-30 -97.55 135.26 39.64 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.837 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 99' ' ' VAL . 14.4 t -120.05 154.09 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.48 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 11' ' ' THR . 10.7 p -117.06 138.64 51.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 0.5 OUTLIER -44.39 -24.28 0.17 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.151 -0.968 . . . . 0.0 110.338 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' OD2' ' OG ' ' A' ' 7' ' ' SER . 1.5 p30 -85.03 -5.82 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.007 . . . . 0.0 110.401 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.19 -45.61 1.29 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.529 HG22 ' OG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -49.73 124.52 9.84 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.877 -1.366 . . . . 0.0 110.011 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.708 ' HD2' HG22 ' A' ' 6' ' ' VAL . 30.7 mtm180 -110.34 156.91 20.1 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.479 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.763 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -134.75 67.78 1.49 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 0.0 109.438 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.866 ' HG2' HG13 ' A' ' 4' ' ' VAL . 1.4 mp0 -69.48 131.49 44.82 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.563 0.697 . . . . 0.0 110.335 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.097 HD13 ' CE2' ' A' ' 5' ' ' TYR . 2.3 mp -114.77 173.5 6.45 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.236 1.017 . . . . 0.0 112.012 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.78 90.76 4.56 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.9 HG13 HG11 ' A' ' 21' ' ' VAL . 95.7 t -98.58 166.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.469 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.559 ' HA ' ' N ' ' A' ' 1' ' ' SER . . . -133.01 -160.74 1.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.757 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -82.41 123.75 29.41 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.564 0.697 . . . . 0.0 110.696 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.37 37.08 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.923 HG13 ' NE2' ' A' ' 25' ' ' GLN . 2.6 t -106.29 170.2 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -1.168 . . . . 0.0 110.65 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.604 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -120.51 175.94 5.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -76.16 -3.67 37.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.216 -1.553 . . . . 0.0 108.218 178.049 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.59 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.18 -77.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 112.022 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.923 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -38.03 -23.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.905 -0.497 . . . . 0.0 111.176 -177.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.635 ' C ' HD22 ' A' ' 15' ' ' LEU . . . -87.7 -45.06 10.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.791 ' HA ' HD12 ' A' ' 32' ' ' ILE 0.265 . . -66.33 -46.13 77.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.887 1.327 . . . . 0.0 107.492 176.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 29' ' ' SER 0.263 0.8 OUTLIER -45.92 -58.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.197 178.64 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.7 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.72 -35.79 75.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.031 178.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.861 ' ND2' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -72.87 12.15 0.56 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.444 0.64 . . . . 0.0 109.831 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 70.08 4.96 51.51 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 27' ' ' ALA . 4.2 mt -66.43 -42.43 90.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -1.109 . . . . 0.0 109.459 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.63 ' HB2' HG23 ' A' ' 28' ' ' VAL . 23.5 m-85 -108.82 61.19 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.183 -1.007 . . . . 0.0 113.448 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 11.0 p-10 -84.62 43.33 0.97 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.813 HD12 ' CG2' ' A' ' 47' ' ' THR . 30.4 pt -79.86 -146.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.321 0.582 . . . . 0.0 110.784 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.503 ' N ' HG13 ' A' ' 35' ' ' ILE . 6.6 m -92.19 -155.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 0.0 110.52 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.1 84.42 0.37 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 44' ' ' SER . 13.9 m-20 -120.12 -35.3 3.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -1.179 . . . . 0.0 109.797 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 21.7 p -110.29 -36.25 5.86 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.852 -0.53 . . . . 0.0 110.116 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 42.59 35.28 1.98 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.55 ' H ' ' HE3' ' A' ' 24' ' ' MET . . . 80.27 28.25 49.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 6.2 m -128.58 -3.65 5.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -1.092 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.81 51.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.765 0.793 . . . . 0.0 112.321 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.567 ' OG ' ' HA ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -131.55 38.91 3.55 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.733 ' SG ' HD22 ' A' ' 84' ' ' LEU . 1.8 p -110.88 150.41 29.22 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.87 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -111.01 -4.4 15.14 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.554 -0.717 . . . . 0.0 109.667 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.813 ' CG2' HD12 ' A' ' 35' ' ' ILE . 6.2 t -110.56 -21.49 12.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.947 . . . . 0.0 112.754 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.819 ' O ' HG13 ' A' ' 50' ' ' VAL . 34.9 m -75.02 11.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.367 -1.458 . . . . 0.0 111.243 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.103 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 3.3 t-160 -43.69 124.45 3.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.6 m -143.35 163.12 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 120.928 -1.107 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.774 ' HE1' ' HE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -118.47 124.63 48.07 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.704 0.764 . . . . 0.0 111.147 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.932 HG21 ' CD1' ' A' ' 88' ' ' ILE . 2.7 t -99.58 165.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.943 ' OD1' ' HB3' ' A' ' 55' ' ' ALA . 9.7 p30 -82.85 134.58 35.09 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 119.892 -1.755 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.1 pt-20 -37.58 -25.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.455 -0.778 . . . . 0.0 111.765 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.943 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -70.68 -40.33 73.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.838 -1.163 . . . . 0.0 111.587 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.845 ' HB3' HD12 ' A' ' 97' ' ' ILE . 61.1 m-85 -102.71 -17.95 15.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.733 -1.229 . . . . 0.0 111.258 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -80.63 -23.43 39.75 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.927 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 55' ' ' ALA . 23.4 p-10 -82.95 -24.11 33.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.566 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.897 ' CB ' HD21 ' A' ' 94' ' ' LEU . 3.4 mmtp -79.85 -49.05 12.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.675 ' N ' HD11 ' A' ' 94' ' ' LEU . 3.0 m -43.54 168.25 0.07 OUTLIER Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 110.05 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 36.6 Cg_endo -62.17 164.71 16.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.029 1.541 . . . . 0.0 111.589 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.67 112.79 18.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.898 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.587 ' HB1' ' CB ' ' A' ' 67' ' ' GLU . . . -69.58 147.24 50.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.763 . . . . 0.0 110.366 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' O ' HD13 ' A' ' 68' ' ' ILE . 23.6 p30 -100.07 -173.38 2.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 110.555 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.63 -26.92 24.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.547 -0.721 . . . . 0.0 110.672 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 70' ' ' MET . 5.4 ttm180 -64.83 -18.11 64.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.587 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 3.3 tm-20 -99.96 1.51 42.71 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.585 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.1 mp -91.89 -59.05 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 111.194 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -77.01 -47.77 9.01 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.695 ' HE2' HD12 ' A' ' 84' ' ' LEU 0.323 2.8 ttp -48.58 -50.72 31.26 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 123.547 1.641 . . . . 0.0 108.022 178.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.626 HD11 ' C ' ' A' ' 82' ' ' SER 0.296 0.0 OUTLIER -70.87 -32.44 69.43 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.709 -179.408 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.649 ' HB2' HD22 ' A' ' 78' ' ' LEU . 4.3 tt0 -89.16 -0.15 57.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.893 -1.129 . . . . 0.0 110.453 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.692 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -49.08 -52.34 26.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.631 -1.293 . . . . 0.0 108.438 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 46' ' ' ALA . 31.1 m -90.48 107.95 19.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.565 -0.709 . . . . 0.0 109.481 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 75' ' ' THR . 1.0 OUTLIER -48.15 103.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.838 -1.164 . . . . 0.0 109.254 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.103 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . . . -120.07 22.51 11.41 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.608 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 71.7 38.27 0.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.672 1.225 . . . . 0.0 108.338 -178.408 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 72' ' ' GLU . 11.3 tp -19.26 134.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.979 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' N ' HD12 ' A' ' 78' ' ' LEU . 2.4 mtpt -128.09 -169.24 0.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 79' ' ' LYS . 46.2 Cg_endo -81.92 -30.64 1.26 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.697 1.367 . . . . 0.0 109.743 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.605 ' HB2' HG21 ' A' ' 57' ' ' THR . 13.7 p-10 -93.7 -12.17 29.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.731 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.626 ' C ' HD11 ' A' ' 71' ' ' LEU . 18.6 m -49.23 155.52 0.68 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.042 . . . . 0.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.85 ' NE ' HG23 ' A' ' 88' ' ' ILE . 2.4 mtp180 -175.29 153.92 1.63 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.733 HD22 ' SG ' ' A' ' 45' ' ' CYS . 11.1 mt -74.61 150.84 39.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.672 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 46.6 p -46.71 -25.94 0.83 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.725 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m -110.13 44.95 1.15 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.732 0.777 . . . . 0.0 109.556 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.564 ' HG2' ' CG ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -125.44 -32.77 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.932 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.35 147.18 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.711 -0.618 . . . . 0.0 109.628 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.0 mm -110.3 160.62 9.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 21' ' ' VAL . 2.9 tpt -110.25 112.86 25.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.539 -0.726 . . . . 0.0 110.425 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -97.48 172.66 4.7 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.2 Cg_endo -72.67 -31.87 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.92 1.484 . . . . 0.0 110.558 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 94' ' ' LEU . 2.4 pp20? -81.04 -44.96 17.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.883 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.897 HD21 ' CB ' ' A' ' 59' ' ' LYS . 1.1 mt -75.81 52.07 0.66 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.115 -0.991 . . . . 0.0 111.018 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 1' ' ' SER . 4.3 p-10 -101.33 152.86 20.2 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.032 -1.042 . . . . 0.0 111.764 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.626 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.32 22.42 10.56 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.845 HD12 ' HB3' ' A' ' 56' ' ' PHE . 3.6 tt -72.55 154.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 123.175 1.464 . . . . 0.0 113.555 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.636 ' H ' ' ND2' ' A' ' 53' ' ' ASN 0.252 8.1 t -125.37 98.27 4.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.566 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.891 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.74 174.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.134 -1.427 . . . . 0.0 109.726 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.586 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -156.87 174.03 16.12 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.914 0.864 . . . . 0.0 111.024 -178.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 18.0 t -111.09 130.96 22.43 Favored Pre-proline 0 N--CA 1.498 1.956 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.429 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.937 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 49.7 Cg_endo -73.36 134.67 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.695 1.597 . . . . 0.0 112.683 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.598 ' HB3' ' CB ' ' A' ' 8' ' ' HIS . 0.6 OUTLIER -111.83 107.44 16.49 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.272 -0.892 . . . . 0.0 111.624 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.642 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -110.75 53.87 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.007 -1.058 . . . . 0.0 110.039 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -104.99 73.72 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.161 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 97.8 m95 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.234 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.546 ' CB ' ' HG3' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.38 0.609 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.0 OUTLIER -74.8 120.11 19.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.743 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.769 HG22 ' CG2' ' A' ' 97' ' ' ILE . 25.1 t -119.67 146.5 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.769 -1.207 . . . . 0.0 110.983 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 99' ' ' VAL . 16.9 t -131.06 125.83 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.695 0.76 . . . . 0.0 109.856 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.902 ' CD1' HG21 ' A' ' 99' ' ' VAL . 49.2 m-85 -101.52 137.91 39.22 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.486 0.66 . . . . 0.0 111.922 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.5 t -120.77 132.73 69.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.023 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.693 ' HB3' HG22 ' A' ' 11' ' ' THR . 67.6 p -79.39 -153.01 0.07 Allowed 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.617 ' CG ' ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.2 -8.13 14.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 120.97 -1.081 . . . . 0.0 108.98 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -100.37 1.65 41.64 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.41 -21.75 23.54 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 7' ' ' SER . 0.3 OUTLIER -49.87 138.89 14.32 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.024 -1.28 . . . . 0.0 109.449 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 24.6 mtt180 -130.06 148.66 51.93 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.401 0.62 . . . . 0.0 111.215 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.696 ' HG2' HD11 ' A' ' 32' ' ' ILE . 1.4 ttm-85 -140.11 118.9 12.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.43 -0.794 . . . . 0.0 109.888 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 4' ' ' VAL . 3.0 mp0 -100.42 124.43 45.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.797 -1.189 . . . . 0.0 110.835 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 27' ' ' ALA . 10.8 mt -110.57 151.83 27.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 110.507 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.11 90.37 3.92 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.911 HG22 ' HB2' ' A' ' 26' ' ' ALA . 50.6 t -98.61 174.58 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 110.298 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 17' ' ' VAL . . . -125.32 -133.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.518 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.498 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 1.1 p-10 -110.03 124.04 50.75 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.51 -10.78 30.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 22' ' ' SER . 70.0 t -93.87 169.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.33 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.618 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -121.36 169.26 10.78 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 3' ' ' VAL . 10.7 mt -60.91 -35.15 75.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.721 -1.237 . . . . 0.0 108.934 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.754 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . 2.9 ttp -66.65 -62.47 1.44 Allowed 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.927 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.614 ' CG ' HG13 ' A' ' 21' ' ' VAL . 7.4 tt0 -38.14 -76.72 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.911 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -43.15 -56.39 3.44 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.331 -1.481 . . . . 0.0 109.754 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.879 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -56.74 -53.62 55.69 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.012 0.91 . . . . 0.0 109.412 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.756 HG12 ' N ' ' A' ' 29' ' ' SER 0.284 1.2 t -35.47 -63.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.152 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.756 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.37 -46.67 85.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.112 0.958 . . . . 0.0 108.884 179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.578 ' ND2' ' CD2' ' A' ' 15' ' ' LEU . 5.8 m-80 -59.93 -8.6 2.35 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 88.02 -14.64 58.37 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.866 ' CG2' ' HB1' ' A' ' 27' ' ' ALA . 7.6 mt -42.75 -38.41 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.692 -0.887 . . . . 0.0 108.643 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.754 ' CE2' ' HA ' ' A' ' 24' ' ' MET . 72.3 m-85 -112.79 76.81 1.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 19.4 p30 -49.01 -20.4 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.604 -1.238 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.822 ' CD1' HG23 ' A' ' 47' ' ' THR . 1.7 tt -78.95 90.28 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.0 9.63 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.042 -1.036 . . . . 0.0 110.692 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.75 21.77 27.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.53 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 1.4 m-20 -120.07 -50.06 2.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 0.0 110.615 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.511 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 1.3 p -110.39 -50.99 2.91 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 44.4 42.92 7.37 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.8 39.59 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.735 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 9.8 p -120.9 -32.35 3.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.155 -1.203 . . . . 0.0 110.386 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 42' ' ' SER . . . 72.53 60.97 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.222 -0.924 . . . . 0.0 111.596 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -132.38 9.27 4.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.203 -0.936 . . . . 0.0 110.998 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.182 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.31 162.03 15.97 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.715 -1.241 . . . . 0.0 114.195 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 73' ' ' CYS . . . -110.14 -22.27 11.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.813 -1.179 . . . . 0.0 110.463 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.822 HG23 ' CD1' ' A' ' 35' ' ' ILE . 1.6 t -69.83 -14.96 63.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.64 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.833 ' HB2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -94.72 14.05 22.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 0.0 108.581 178.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.619 ' CD2' ' HG3' ' A' ' 102' ' ' PRO . 3.9 t-160 -46.98 138.52 6.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 48' ' ' CYS . 15.7 m -144.78 157.09 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.817 -1.177 . . . . 0.0 109.923 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 6.8 m-30 -119.87 122.06 40.45 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.582 0.706 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.849 HG21 ' CD1' ' A' ' 88' ' ' ILE . 38.7 t -99.44 151.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.12 -0.988 . . . . 0.0 110.354 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.607 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -74.57 125.32 28.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.133 -1.605 . . . . 0.0 109.414 178.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' A' ' 55' ' ' ALA . 2.7 pm0 -34.07 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.702 -0.624 . . . . 0.0 112.19 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -62.7 -17.25 60.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.881 -1.137 . . . . 0.0 111.301 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.67 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 65.7 m-85 -125.35 -8.98 6.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.869 -1.145 . . . . 0.0 110.193 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.699 HG22 ' HB ' ' A' ' 52' ' ' VAL . 1.3 p -80.35 -34.76 36.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 108.914 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 -17.68 60.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.546 -0.721 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.766 ' CB ' HD13 ' A' ' 94' ' ' LEU 0.278 0.5 OUTLIER -79.34 -55.97 4.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 123.643 1.687 . . . . 0.0 109.423 179.584 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 88' ' ' ILE 0.323 0.3 OUTLIER -77.62 145.4 71.2 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.068 -177.707 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 60' ' ' VAL . 35.8 Cg_endo -61.75 160.0 30.62 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.847 1.446 . . . . 0.0 111.704 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -80.74 -171.42 3.12 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.151 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.0 ' HB1' ' HB3' ' A' ' 67' ' ' GLU . . . -100.2 158.92 15.52 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.186 0.517 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 68' ' ' ILE . 24.8 p30 -100.45 -173.64 2.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 111.117 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.436 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 21.5 pt-20 -47.8 -24.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.0 ttm180 -64.5 -59.45 4.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.124 -0.985 . . . . 0.0 109.382 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 1.0 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 2.4 tt0 -66.96 14.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.558 -0.714 . . . . 0.0 111.975 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.2 mp -90.83 -37.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 119.282 -2.136 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 73' ' ' CYS . . . -90.35 -57.28 1.68 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 1.142 ' CE ' HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -48.0 -44.96 31.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.161 -1.199 . . . . 0.0 109.087 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HB2' ' HG3' ' A' ' 67' ' ' GLU 0.3 0.0 OUTLIER -70.95 -30.96 67.4 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.531 -179.27 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 68' ' ' ILE . 1.2 tt0 -90.9 -11.36 39.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.374 -0.829 . . . . 0.0 110.479 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -48.6 -50.98 30.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.706 -1.246 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.779 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.3 m -90.21 96.28 6.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 108.878 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.788 ' O ' HG23 ' A' ' 75' ' ' THR . 8.8 t -48.05 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.888 ' HB2' ' CD ' ' A' ' 104' ' ' ARG . . . -126.87 45.96 2.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.799 . . . . 0.0 109.91 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 76' ' ' ALA . 11.6 pt-20 39.34 58.31 1.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.764 0.792 . . . . 0.0 109.467 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.546 ' CD1' ' HB2' ' A' ' 82' ' ' SER . 12.7 tp -29.72 131.72 0.07 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.56 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HD2' ' CE2' ' A' ' 51' ' ' TYR . 6.8 mtpt -98.96 170.85 6.36 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.084 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 38.7 Cg_endo -67.4 -28.68 38.89 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.553 1.291 . . . . 0.0 109.768 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 81' ' ' ASN . 21.7 p-10 -105.01 -5.05 21.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 111.025 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.577 ' OG ' ' HG3' ' A' ' 79' ' ' LYS . 72.7 m -48.54 164.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.795 -1.191 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.594 ' CG ' ' OE2' ' A' ' 67' ' ' GLU . 3.1 mtt180 -175.33 174.81 2.29 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.608 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.182 HD11 ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -96.69 142.25 28.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.44 -0.788 . . . . 0.0 109.341 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 24' ' ' MET . 15.2 m -45.54 -29.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.037 ' SG ' HD13 ' A' ' 84' ' ' LEU . 1.1 p -98.68 38.83 1.31 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.619 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -126.79 -44.72 1.64 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.189 -1.57 . . . . 0.0 113.289 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.849 ' CD1' HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.54 150.99 3.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.715 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 89' ' ' ILE . 5.4 mm -111.02 161.56 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.546 ' HG3' ' CB ' ' A' ' 1' ' ' SER . 2.6 tpt -110.25 111.46 22.79 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.812 -1.18 . . . . 0.0 111.043 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.472 ' O ' ' OG ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -91.32 156.6 43.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 19' ' ' ASP . 41.6 Cg_endo -68.95 -1.42 7.76 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.805 1.423 . . . . 0.0 111.264 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.509 ' C ' HD23 ' A' ' 94' ' ' LEU . 6.3 pm0 -110.09 -27.72 9.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.981 -1.075 . . . . 0.0 110.072 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.766 HD13 ' CB ' ' A' ' 59' ' ' LYS . 7.5 mt -97.24 58.48 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.267 -0.896 . . . . 0.0 109.78 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.543 ' HB2' ' CA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -100.75 151.1 22.07 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.859 0.838 . . . . 0.0 112.612 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.641 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 101.0 21.08 12.32 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.769 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.26 142.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.079 . . . . 0.0 113.42 -176.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.531 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 21.2 t -107.97 128.82 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.902 HG21 ' CD1' ' A' ' 5' ' ' TYR . 1.8 t -104.07 -176.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.881 -1.137 . . . . 0.0 108.789 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 99' ' ' VAL . 9.5 m-20 -161.42 138.11 8.45 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.703 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 40.0 t -96.72 109.29 47.75 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.803 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.72 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 46.5 Cg_endo -69.65 107.8 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.962 1.775 . . . . 0.0 112.309 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.617 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -111.32 109.98 20.24 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.802 -1.186 . . . . 0.0 110.729 178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.888 ' CD ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.6 86.62 2.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.934 -1.103 . . . . 0.0 109.887 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -108.44 16.82 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.258 179.926 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ' GA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_